Citrus Sinensis ID: 013519
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 441 | 2.2.26 [Sep-21-2011] | |||||||
| P27450 | 419 | Probable serine/threonine | no | no | 0.873 | 0.918 | 0.512 | 1e-116 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.757 | 0.858 | 0.568 | 1e-112 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.716 | 0.766 | 0.611 | 1e-111 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.782 | 0.699 | 0.566 | 1e-110 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.741 | 0.667 | 0.583 | 1e-109 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.789 | 0.848 | 0.555 | 1e-108 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.702 | 0.784 | 0.594 | 1e-107 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.718 | 0.814 | 0.570 | 1e-106 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.770 | 0.798 | 0.556 | 1e-103 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.775 | 0.802 | 0.528 | 1e-103 |
| >sp|P27450|CX32_ARATH Probable serine/threonine-protein kinase Cx32, chloroplastic OS=Arabidopsis thaliana GN=At4g35600 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 419 bits (1077), Expect = e-116, Method: Compositional matrix adjust.
Identities = 205/400 (51%), Positives = 279/400 (69%), Gaps = 15/400 (3%)
Query: 22 RTGANSLTGKENKADGLEMAGEINDVKDEHERKADDADEGRQLGDGDGGDKNMPSSGEIV 81
+TG +S N ++G E + ++ G+Q D + SG+++
Sbjct: 15 KTGLHSHATTNNHSNGTEFSSTTG--------ATTNSSVGQQSQFSDISTGIISDSGKLL 66
Query: 82 TPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKS 141
LK++ DL+ ATKNF+PD+MLG+GGFG+V++GWVD TLAP++VG G VA+K+
Sbjct: 67 ESPNLKVYNFLDLKTATKNFKPDSMLGQGGFGKVYRGWVDATTLAPSRVGSGMIVAIKRL 126
Query: 142 NPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS 201
N +S+QG EW++EV FLG SH NLVKL+GYC ED++ LLVYE+M KGSLE+HLFR+
Sbjct: 127 NSESVQGFAEWRSEVNFLGMLSHRNLVKLLGYCREDKELLLVYEFMPKGSLESHLFRRN- 185
Query: 202 AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP 261
+P PW+ R+KI I AA+ L FLHS ++ VIYRDFKASNILLD +Y+AKLSDFGLAKLGP
Sbjct: 186 -DPFPWDLRIKIVIGAARGLAFLHSLQREVIYRDFKASNILLDSNYDAKLSDFGLAKLGP 244
Query: 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321
D SHVTTRIMGTYGYAAPEY+ATGHLYVKSDV+ FGVVLLE++TGL A +T RP G+
Sbjct: 245 ADEKSHVTTRIMGTYGYAAPEYMATGHLYVKSDVFAFGVVLLEIMTGLTAHNTKRPRGQE 304
Query: 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381
LVD+ RP L++K R+K+IMD ++ QY K A +I + C+E +PKNRP M+EV+E
Sbjct: 305 SLVDWLRPELSNKHRVKQIMDKGIKGQYTTKVATEMARITLSCIEPDPKNRPHMKEVVEV 364
Query: 382 LQNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRSQS 421
L++I + + P + + + N++ R PH+ R ++
Sbjct: 365 LEHIQGLNVVPNRSSTKQAVANSS-----RSSPHHYRYKA 399
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 406 bits (1044), Expect = e-112, Method: Compositional matrix adjust.
Identities = 191/336 (56%), Positives = 259/336 (77%), Gaps = 2/336 (0%)
Query: 74 MP-SSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGV 132
MP + GEI+ LK F+L +L++AT+NFRPD+++GEGGFG VFKGW+D +LAP+K G
Sbjct: 40 MPRTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGT 99
Query: 133 GKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSL 192
G +AVK+ N + QG REW AE+ +LG+ HPNLVKLIGYC E+ LLVYE+M +GSL
Sbjct: 100 GIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSL 159
Query: 193 ENHLFRKGSA-EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251
ENHLFR+G+ +PL WNTR+++A+ AA+ L FLH+++ VIYRDFKASNILLD +YNAKL
Sbjct: 160 ENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKL 219
Query: 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRA 311
SDFGLA+ GP+ NSHV+TR+MGT GYAAPEY+ATGHL VKSDVY FGVVLLE+L+G RA
Sbjct: 220 SDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRA 279
Query: 312 LDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKN 371
+D N+P GEH LVD+ARP LT+KRRL ++MDPRL+ QY + AL + + C+ + K+
Sbjct: 280 IDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKS 339
Query: 372 RPSMEEVLETLQNISVIEIEPKKKAKARGNYNNNSN 407
RP+M E+++T++ + + + K++ + + +N N
Sbjct: 340 RPTMNEIVKTMEELHIQKEASKEQQNPQISIDNIIN 375
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 400 bits (1029), Expect = e-111, Method: Compositional matrix adjust.
Identities = 194/317 (61%), Positives = 241/317 (76%), Gaps = 1/317 (0%)
Query: 73 NMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGV 132
N + GEI+ LK FT +L+AAT+NFRPD++LGEGGFG VFKGW+D +TL +K G
Sbjct: 41 NPRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGT 100
Query: 133 GKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSL 192
G +AVKK N D QG +EW AEV +LG+FSHPNLVKLIGYC ED LLVYE+M +GSL
Sbjct: 101 GVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSL 160
Query: 193 ENHLFRKGSA-EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251
ENHLFR+GS +PL W RLK+A+ AAK L FLH++E SVIYRDFK SNILLD YNAKL
Sbjct: 161 ENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKL 220
Query: 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRA 311
SDFGLAK GP SHV+TRIMGTYGYAAPEY+ATGHL KSDVY +GVVLLE+L+G RA
Sbjct: 221 SDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRA 280
Query: 312 LDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKN 371
+D NRP GE LV++ARP L +KR+L +++D RL++QY ++ A + ++CL E K
Sbjct: 281 VDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKL 340
Query: 372 RPSMEEVLETLQNISVI 388
RP+M EV+ L++I +
Sbjct: 341 RPNMNEVVSHLEHIQTL 357
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 399 bits (1025), Expect = e-110, Method: Compositional matrix adjust.
Identities = 201/355 (56%), Positives = 251/355 (70%), Gaps = 10/355 (2%)
Query: 77 SGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAV 136
S E+ ++L+ FT DL+ +T+NFRP+++LGEGGFG VFKGW++ AP K G G V
Sbjct: 118 SEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 177
Query: 137 AVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL 196
AVK NPD +QG +EW AE+ FLG HPNLVKL+GYC ED Q LLVYE+M +GSLENHL
Sbjct: 178 AVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 237
Query: 197 FRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSE-KSVIYRDFKASNILLDGSYNAKLSDFG 255
FR+ + PLPW+ R+KIA+ AAK L+FLH K VIYRDFK SNILLD YNAKLSDFG
Sbjct: 238 FRR--SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFG 295
Query: 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315
LAK P +G +HV+TR+MGTYGYAAPEYV TGHL KSDVY FGVVLLEMLTG R++D N
Sbjct: 296 LAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 355
Query: 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM 375
RP+GEH LV++ARP L DKRR +++DPRLE + IKGA Q+ +CL +PK RP M
Sbjct: 356 RPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKM 415
Query: 376 EEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRSQSPLHSKHGDH 430
+V+E L+ + P K A +Y + +R + RSQ S++G H
Sbjct: 416 SDVVEALKPL------PHLKDMASSSYYFQTMQAERLKNGSGRSQG-FGSRNGQH 463
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 394 bits (1012), Expect = e-109, Method: Compositional matrix adjust.
Identities = 196/336 (58%), Positives = 242/336 (72%), Gaps = 9/336 (2%)
Query: 77 SGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAV 136
S E+ ++LK F+ DL+ AT+NFRP+++LGEGGFG VFKGWV+ AP K G G V
Sbjct: 112 SEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTV 171
Query: 137 AVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL 196
AVK NPD +QG +EW AE+ +LG HPNLVKL+GYC ED Q LLVYE+M +GSLENHL
Sbjct: 172 AVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 231
Query: 197 FRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSE-KSVIYRDFKASNILLDGSYNAKLSDFG 255
FR+ + PLPW+ R+KIA+ AAK L+FLH K VIYRDFK SNILLDG YNAKLSDFG
Sbjct: 232 FRR--SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFG 289
Query: 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315
LAK P +G +HV+TR+MGTYGYAAPEYV TGHL KSDVY FGVVLLEMLTG R++D N
Sbjct: 290 LAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 349
Query: 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM 375
RP+GEH LV++ARP L DKRR +++DPRLE + +KGA Q+ +CL + K RP M
Sbjct: 350 RPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKM 409
Query: 376 EEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQR 411
EV+E L+ + P K A +Y + +R
Sbjct: 410 SEVVEVLKPL------PHLKDMASASYYFQTMQAER 439
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 391 bits (1004), Expect = e-108, Method: Compositional matrix adjust.
Identities = 196/353 (55%), Positives = 251/353 (71%), Gaps = 5/353 (1%)
Query: 37 GLEMAGEINDVKDEHERKADDADEGRQLGDGDGGDKNMPS---SGEIVTPNYLKMFTLQD 93
G+ ++ ++ K D D G LG PS GEI+ LK F+ +
Sbjct: 2 GICLSAQVKAESSGASTKYDAKDIG-SLGSKASSVSVRPSPRTEGEILQSPNLKSFSFAE 60
Query: 94 LRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ 153
L++AT+NFRPD++LGEGGFG VFKGW+D K+L ++ G G +AVKK N D QG +EW
Sbjct: 61 LKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQGHQEWL 120
Query: 154 AEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLK 212
AEV +LG+FSH +LVKLIGYC ED LLVYE+M +GSLENHLFR+G +PL W RLK
Sbjct: 121 AEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLRLK 180
Query: 213 IAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRI 272
+A+ AAK L FLHSSE VIYRDFK SNILLD YNAKLSDFGLAK GPI SHV+TR+
Sbjct: 181 VALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRV 240
Query: 273 MGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332
MGT+GYAAPEY+ATGHL KSDVY FGVVLLE+L+G RA+D NRPSGE LV++A+P L
Sbjct: 241 MGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEWAKPYLV 300
Query: 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+KR++ +++D RL++QY ++ A + ++CL E K RP+M EV+ L++I
Sbjct: 301 NKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHI 353
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 390 bits (1002), Expect = e-107, Method: Compositional matrix adjust.
Identities = 185/311 (59%), Positives = 237/311 (76%), Gaps = 1/311 (0%)
Query: 76 SSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKA 135
+ GEI++ +K FT +L+ AT+NFRPD+++GEGGFG VFKGW+D TL PTK G G
Sbjct: 42 TEGEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLV 101
Query: 136 VAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENH 195
+AVKK N + QG REW E+ +LG+ SHPNLVKLIGYC ED LLVYE+MQKGSLENH
Sbjct: 102 IAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENH 161
Query: 196 LFRKGS-AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254
LFR+G+ +PLPW R+ +A+DAAK L FLHS VIYRD KASNILLD YNAKLSDF
Sbjct: 162 LFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDF 221
Query: 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDT 314
GLA+ GP+ S+V+TR+MGTYGYAAPEY+++GHL +SDVY FGV+LLE+L+G RALD
Sbjct: 222 GLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDH 281
Query: 315 NRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS 374
NRP+ E LVD+ARP LT KR++ I+D RL+ QY + A+ + ++CL EPK+RP+
Sbjct: 282 NRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPT 341
Query: 375 MEEVLETLQNI 385
M++V+ LQ +
Sbjct: 342 MDQVVRALQQL 352
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 385 bits (989), Expect = e-106, Method: Compositional matrix adjust.
Identities = 182/319 (57%), Positives = 235/319 (73%), Gaps = 2/319 (0%)
Query: 76 SSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKA 135
+ GEI++ +K F+ +L+ AT+NFR D+++GEGGFG VF+GW+D TL PTK G
Sbjct: 36 TEGEILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLV 95
Query: 136 VAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENH 195
+AVK+ NPD QG REW E+ +LG+ SHPNLVKLIGYC ED Q LLVYE+M KGSLENH
Sbjct: 96 IAVKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENH 155
Query: 196 LFRKGSAE--PLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253
LF G+ + PL W R+K+A+DAAK L FLHS VIYRD KASNILLD +NAKLSD
Sbjct: 156 LFANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSD 215
Query: 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALD 313
FGLA+ GP+ S+V+TR+MGT+GYAAPEYV+TGHL +SDVY FGVVLLE+L G +ALD
Sbjct: 216 FGLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALD 275
Query: 314 TNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP 373
NRP+ E LVD+ARP LT +R++ I+D RL QY +GA+ I ++CL EPK+RP
Sbjct: 276 HNRPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRP 335
Query: 374 SMEEVLETLQNISVIEIEP 392
+M++V+ L + ++P
Sbjct: 336 TMDQVVRALVQLQDSVVKP 354
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 377 bits (968), Expect = e-103, Method: Compositional matrix adjust.
Identities = 193/347 (55%), Positives = 240/347 (69%), Gaps = 7/347 (2%)
Query: 76 SSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKA 135
+ GEI++ LK FT +L+ AT+NFRPD++LGEGGFG VFKGW+D TL +K G G
Sbjct: 58 TEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIV 117
Query: 136 VAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENH 195
VAVKK + QG +EW EV +LG+ SHPNLVKL+GYC E LLVYE+M KGSLENH
Sbjct: 118 VAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENH 177
Query: 196 LFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255
LFR+G A+PL W R+K+AI AAK LTFLH ++ VIYRDFKA+NILLD +N+KLSDFG
Sbjct: 178 LFRRG-AQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFG 236
Query: 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315
LAK GP +HV+T++MGT+GYAAPEYVATG L KSDVY FGVVLLE+L+G RA+D +
Sbjct: 237 LAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKS 296
Query: 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM 375
+ E LVD+A P L DKR+L +IMD RL QYP KGA A + ++CL + K RP M
Sbjct: 297 KVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKM 356
Query: 376 EEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRSQSP 422
EVL L ++E K GN D+ RG + +SP
Sbjct: 357 SEVLAKLD-----QLESTKPGTGVGN-RQAQIDSPRGSNGSIVQKSP 397
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 376 bits (966), Expect = e-103, Method: Compositional matrix adjust.
Identities = 186/352 (52%), Positives = 242/352 (68%), Gaps = 10/352 (2%)
Query: 76 SSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKA 135
+ GEI++ LK FT +L+ ATKNFR D +LGEGGFG VFKGW+D +L ++ G G
Sbjct: 61 TEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIV 120
Query: 136 VAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENH 195
VAVK+ P+ QG +EW EV +LG+ SHPNLV L+GYC E LLVYE+M KGSLENH
Sbjct: 121 VAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENH 180
Query: 196 LFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255
LFR+G A+PL W R+K+A+ AAK LTFLH ++ VIYRDFKA+NILLD +NAKLSDFG
Sbjct: 181 LFRRG-AQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFG 239
Query: 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315
LAK GP N+HV+T+++GT+GYAAPEYVATG L KSDVY FGVVLLE+++G RA+D +
Sbjct: 240 LAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNS 299
Query: 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM 375
E+ LVD+A P L DKR+L +IMD +L QYP KGA A + ++CL + K RP M
Sbjct: 300 NGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKM 359
Query: 376 EEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRSQSPLHSKH 427
EVL TL+ + + A+ + ++ R H + +SP+ H
Sbjct: 360 SEVLVTLEQLESV---------AKPGTKHTQMESPRFHHSSVMQKSPVRYSH 402
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 441 | ||||||
| 255539232 | 435 | serine/threonine-protein kinase cx32, pu | 0.859 | 0.871 | 0.693 | 1e-153 | |
| 225457554 | 482 | PREDICTED: probable serine/threonine-pro | 0.893 | 0.817 | 0.625 | 1e-145 | |
| 297745555 | 487 | unnamed protein product [Vitis vinifera] | 0.843 | 0.763 | 0.657 | 1e-144 | |
| 224086048 | 326 | predicted protein [Populus trichocarpa] | 0.675 | 0.914 | 0.799 | 1e-143 | |
| 359491910 | 418 | PREDICTED: probable serine/threonine-pro | 0.916 | 0.966 | 0.602 | 1e-139 | |
| 224061873 | 362 | predicted protein [Populus trichocarpa] | 0.800 | 0.975 | 0.667 | 1e-136 | |
| 42563260 | 484 | putative protein kinase [Arabidopsis tha | 0.789 | 0.719 | 0.662 | 1e-136 | |
| 6554483 | 442 | putative protein kinase; 59396-62219 [Ar | 0.789 | 0.787 | 0.662 | 1e-136 | |
| 297842391 | 506 | hypothetical protein ARALYDRAFT_476789 [ | 0.789 | 0.687 | 0.645 | 1e-135 | |
| 388511677 | 394 | unknown [Lotus japonicus] | 0.725 | 0.812 | 0.719 | 1e-134 |
| >gi|255539232|ref|XP_002510681.1| serine/threonine-protein kinase cx32, putative [Ricinus communis] gi|223551382|gb|EEF52868.1| serine/threonine-protein kinase cx32, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1412), Expect = e-153, Method: Compositional matrix adjust.
Identities = 267/385 (69%), Positives = 319/385 (82%), Gaps = 6/385 (1%)
Query: 55 ADDADEGRQLGDGDGGDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGR 114
A++ + + G + + P +G+IVTPN LKMFTL +L++AT+NFRPDT+LGEGGFGR
Sbjct: 45 AENINVAAEYGSNNSSRETTPPTGKIVTPN-LKMFTLAELKSATRNFRPDTVLGEGGFGR 103
Query: 115 VFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174
VFKG++D KT AP++VGVG AVAVKKS+PDS QGL EWQ+EVKFLGKFSHPNLVKL+GYC
Sbjct: 104 VFKGYIDEKTYAPSRVGVGMAVAVKKSSPDSPQGLEEWQSEVKFLGKFSHPNLVKLLGYC 163
Query: 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYR 234
WEDRQFLLVYEYMQKGSLENHLFRKG AEPLPW+ RLK+AI AA+ L FLH+SEKSVIYR
Sbjct: 164 WEDRQFLLVYEYMQKGSLENHLFRKG-AEPLPWHVRLKVAIGAAQGLAFLHTSEKSVIYR 222
Query: 235 DFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSD 294
DFK SNILLDG YNAKLSDFGLAKLGPI+GNSHVTTR+MGTYGYAAPEYVATGHLYV+SD
Sbjct: 223 DFKTSNILLDGDYNAKLSDFGLAKLGPINGNSHVTTRVMGTYGYAAPEYVATGHLYVRSD 282
Query: 295 VYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGA 354
VYGFGVVLLEMLTG RALD NRP+ E L+++A PSL++KR+L KIMDPRLE QYPIKGA
Sbjct: 283 VYGFGVVLLEMLTGRRALDNNRPNSEQNLIEWATPSLSEKRKLTKIMDPRLEGQYPIKGA 342
Query: 355 LLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGHP 414
+ A ++I++CLE++PK+RPSMEE+L+TL+ I+ ++ +PK+ + Q H
Sbjct: 343 MQAAELILQCLESDPKSRPSMEEILDTLEKINCMKEKPKESKSKAQKQADKRQQRQSAH- 401
Query: 415 HNRRSQ---SPLHSKHGDHNNGTRA 436
NR S SPLH K+GDH NG RA
Sbjct: 402 QNRNSHRPISPLHYKYGDHGNGARA 426
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225457554|ref|XP_002272490.1| PREDICTED: probable serine/threonine-protein kinase Cx32, chloroplastic-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 521 bits (1343), Expect = e-145, Method: Compositional matrix adjust.
Identities = 269/430 (62%), Positives = 319/430 (74%), Gaps = 36/430 (8%)
Query: 1 MGLCYGTPVDDGP--SKPPSPGSRTGANSLTGKENKADGLEMAGEINDVKDEHERKADDA 58
MG C G + P SKPPSP + N K++K+ + K + A
Sbjct: 1 MGNCCGAQANVNPASSKPPSPAELSNNNI---KQDKSIKERSGSGSGNGSSNGGEKTETA 57
Query: 59 DEGRQLGDGDGGDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKG 118
+ +G+I+TPN LKMFT +L++AT+NFRPDTMLGEGGFGRVFKG
Sbjct: 58 E-----------------TGKIITPN-LKMFTFAELKSATRNFRPDTMLGEGGFGRVFKG 99
Query: 119 WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178
WVD KT APTKV VG VAVKKSNP+S QGL+EWQ+EVKFLGKF+HPNLVKL+GYCWED+
Sbjct: 100 WVDEKTYAPTKVSVGIPVAVKKSNPESEQGLKEWQSEVKFLGKFTHPNLVKLLGYCWEDK 159
Query: 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKA 238
QFLLVYEYMQKGSLENHLFR G AEPL W RLKIAI AA+ L FLH+SEK+VIYRDFK+
Sbjct: 160 QFLLVYEYMQKGSLENHLFRVG-AEPLTWEIRLKIAIGAARGLAFLHTSEKTVIYRDFKS 218
Query: 239 SNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGF 298
SN+LLDG YNAKLSDFGLAKLGP +G+SHVTTRI+GTYGYAAPEY+ATGHLYVKSDVYGF
Sbjct: 219 SNVLLDGDYNAKLSDFGLAKLGPSNGDSHVTTRIVGTYGYAAPEYIATGHLYVKSDVYGF 278
Query: 299 GVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAG 358
GVVLLEMLTG +ALD NRP G+ LV++A+PSLT+KR+LKKIMDPRL +QYP+K A A
Sbjct: 279 GVVLLEMLTGNQALDLNRPPGQQNLVEWAKPSLTNKRKLKKIMDPRLRDQYPLKAAAQAA 338
Query: 359 QIIIKCLEAEPKNRPSMEEVLETLQNISVIEIEP-KKKAKARGNYNNNSNDNQRGHPHNR 417
++I+KCLE++PKNRPSMEEVLETL+ I+ I+ +P K+ K N P
Sbjct: 339 ELILKCLESDPKNRPSMEEVLETLKRINEIKEKPNSKEVKVATN-----------QPQLH 387
Query: 418 RSQSPLHSKH 427
+SP H KH
Sbjct: 388 HHRSPYHPKH 397
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745555|emb|CBI40720.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1337), Expect = e-144, Method: Compositional matrix adjust.
Identities = 261/397 (65%), Positives = 307/397 (77%), Gaps = 25/397 (6%)
Query: 1 MGLCYGTPVDDGP--SKPPSPGSRTGANSLTGKENKADGLEMAGEINDVKDEHERKADDA 58
MG C G + P SKPPSP E++ N++K + K
Sbjct: 1 MGNCCGAQANVNPASSKPPSP-------------------ELSN--NNIKQDKSIKERSG 39
Query: 59 DEGRQLGDGDGGDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKG 118
G +G+I+TPN LKMFT +L++AT+NFRPDTMLGEGGFGRVFKG
Sbjct: 40 SGSGNGSSNGGEKTETAETGKIITPN-LKMFTFAELKSATRNFRPDTMLGEGGFGRVFKG 98
Query: 119 WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178
WVD KT APTKV VG VAVKKSNP+S QGL+EWQ+EVKFLGKF+HPNLVKL+GYCWED+
Sbjct: 99 WVDEKTYAPTKVSVGIPVAVKKSNPESEQGLKEWQSEVKFLGKFTHPNLVKLLGYCWEDK 158
Query: 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKA 238
QFLLVYEYMQKGSLENHLFR G AEPL W RLKIAI AA+ L FLH+SEK+VIYRDFK+
Sbjct: 159 QFLLVYEYMQKGSLENHLFRVG-AEPLTWEIRLKIAIGAARGLAFLHTSEKTVIYRDFKS 217
Query: 239 SNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGF 298
SN+LLDG YNAKLSDFGLAKLGP +G+SHVTTRI+GTYGYAAPEY+ATGHLYVKSDVYGF
Sbjct: 218 SNVLLDGDYNAKLSDFGLAKLGPSNGDSHVTTRIVGTYGYAAPEYIATGHLYVKSDVYGF 277
Query: 299 GVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAG 358
GVVLLEMLTG +ALD NRP G+ LV++A+PSLT+KR+LKKIMDPRL +QYP+K A A
Sbjct: 278 GVVLLEMLTGNQALDLNRPPGQQNLVEWAKPSLTNKRKLKKIMDPRLRDQYPLKAAAQAA 337
Query: 359 QIIIKCLEAEPKNRPSMEEVLETLQNISVIEIEPKKK 395
++I+KCLE++PKNRPSMEEVLETL+ I+ I+ +P K
Sbjct: 338 ELILKCLESDPKNRPSMEEVLETLKRINEIKEKPNSK 374
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224086048|ref|XP_002307794.1| predicted protein [Populus trichocarpa] gi|222857243|gb|EEE94790.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 513 bits (1321), Expect = e-143, Method: Compositional matrix adjust.
Identities = 239/299 (79%), Positives = 274/299 (91%), Gaps = 1/299 (0%)
Query: 87 KMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI 146
K+FTL +L++AT+NFRPDT+LGEGGFGRVFKGWVD KT AP KVG G AVAVKKSNPDS
Sbjct: 12 KLFTLAELKSATRNFRPDTVLGEGGFGRVFKGWVDEKTYAPAKVGCGMAVAVKKSNPDSS 71
Query: 147 QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLP 206
QGL+EWQ+EVK LGKFSHPNLV+L+GYCWE+ QFLLVYEYMQKGSLE HLFRKG AEPLP
Sbjct: 72 QGLQEWQSEVKLLGKFSHPNLVRLLGYCWEENQFLLVYEYMQKGSLEKHLFRKG-AEPLP 130
Query: 207 WNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNS 266
WN R+KIAI AA+ L FLH+SEKSVIYRDFK SNILLDG++NAKLSDFGLAK GP++GNS
Sbjct: 131 WNVRIKIAIGAAEGLAFLHTSEKSVIYRDFKTSNILLDGAFNAKLSDFGLAKFGPLNGNS 190
Query: 267 HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF 326
HVTTR+MGTYGYAAPEYVATGHLYVKSDVYGFGVVLLE+LTGL+ALDTNRP + LV+F
Sbjct: 191 HVTTRVMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLELLTGLKALDTNRPIWQQNLVEF 250
Query: 327 ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
ARPSL+DKR+LKKIMDPRLEEQYPIK A+ A ++I++CLE++PK+RPSME+VLETL+ I
Sbjct: 251 ARPSLSDKRKLKKIMDPRLEEQYPIKAAVQAAELILQCLESDPKSRPSMEKVLETLKKI 309
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491910|ref|XP_002272452.2| PREDICTED: probable serine/threonine-protein kinase Cx32, chloroplastic-like [Vitis vinifera] gi|297745554|emb|CBI40719.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 503 bits (1294), Expect = e-139, Method: Compositional matrix adjust.
Identities = 265/440 (60%), Positives = 315/440 (71%), Gaps = 36/440 (8%)
Query: 1 MGLCYGTPVDDGPS--KPPSPGSRTGANSLTGKENKADGLEMAGEINDVKDEHERKADDA 58
MG C G + P+ KPPSP E++ N++K + K
Sbjct: 1 MGNCCGAQANVNPASRKPPSP-------------------ELSK--NNIKQDKSIKERSG 39
Query: 59 DEGRQLGDGDGGDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKG 118
G + +G I+TPN LKMFT +L++AT+NFRP TMLGEGGFGRVFKG
Sbjct: 40 SGSGNGSSNGGEKTEIAETGTIITPN-LKMFTFAELKSATRNFRPHTMLGEGGFGRVFKG 98
Query: 119 WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178
WVD KT APTKV VG VAVKKSNP+S QGL+EWQ+EVKFLGKF+HPNLVKL+GYC ED+
Sbjct: 99 WVDEKTYAPTKVSVGIPVAVKKSNPESEQGLKEWQSEVKFLGKFTHPNLVKLLGYCCEDQ 158
Query: 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKA 238
QFLLVYEYM KGSLENHLF+ G AE L W RLKIAI AA+ L FLH+SEK+VIYRDFK+
Sbjct: 159 QFLLVYEYMHKGSLENHLFKLGGAESLTWEIRLKIAIGAARGLAFLHTSEKTVIYRDFKS 218
Query: 239 SNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGF 298
SNILLDG YNAKLSDFGLAKLGP DG+SHVTT+I+GTYGYAAPEY+ATGHLYVKSDVYGF
Sbjct: 219 SNILLDGDYNAKLSDFGLAKLGPSDGDSHVTTQIVGTYGYAAPEYIATGHLYVKSDVYGF 278
Query: 299 GVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAG 358
GVVLLEMLTG + LD NRP G+ LV++ +P L +KR+LKKIMDPRL +QYP+K A
Sbjct: 279 GVVLLEMLTGKQTLDINRPPGQLNLVEWTKPLLPNKRKLKKIMDPRLRDQYPLKAATQVA 338
Query: 359 QIIIKCLEAEPKNRPSMEEVLETLQNISVIEIEP-KKKAKARGNYNNNSNDNQRGHPHNR 417
++I+KCLE++PKNRPSMEEVLETL+ I+ I+ +P K+AKA + PH+
Sbjct: 339 ELILKCLESDPKNRPSMEEVLETLKRINEIKEKPNSKEAKA---------ATTQPQPHHH 389
Query: 418 RSQSPLHSKHGDHNNGTRAR 437
R SP KHG G AR
Sbjct: 390 R--SPHRPKHGGTGAGIGAR 407
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224061873|ref|XP_002300641.1| predicted protein [Populus trichocarpa] gi|222842367|gb|EEE79914.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 491 bits (1264), Expect = e-136, Method: Compositional matrix adjust.
Identities = 241/361 (66%), Positives = 291/361 (80%), Gaps = 8/361 (2%)
Query: 76 SSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKA 135
+SG+I+ K+FTL +L++AT+NF+P+T+LGEGGFGRVFKGWVD KT AP KVG G A
Sbjct: 6 ASGQIILAP--KLFTLAELKSATRNFKPNTVLGEGGFGRVFKGWVDEKTYAPAKVGTGMA 63
Query: 136 VAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENH 195
VAVKKS+P+S QGL EWQ+EV+FLGK SHPNLVKL+GYCWED FLLVYEYMQKGSLE H
Sbjct: 64 VAVKKSSPESSQGLEEWQSEVEFLGKLSHPNLVKLLGYCWEDEHFLLVYEYMQKGSLEKH 123
Query: 196 LFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255
LFRKG AEPL W+ RLKIAI AA+ L FLH+S+KSVIYRDFK SNILLDG+YNAKLSDFG
Sbjct: 124 LFRKG-AEPLAWDIRLKIAIGAAQGLAFLHTSDKSVIYRDFKTSNILLDGAYNAKLSDFG 182
Query: 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315
LAKLGP++G+SHVTTRIMGTYGYAAPEY+ATGHLYVKSDVYGFGVVLLE+LTGL+ALDTN
Sbjct: 183 LAKLGPLNGDSHVTTRIMGTYGYAAPEYLATGHLYVKSDVYGFGVVLLELLTGLKALDTN 242
Query: 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM 375
RPSG+H LV++ARP L ++R+LKKIMDP LEE+YP+K A+ A ++I++CLE++ + RPSM
Sbjct: 243 RPSGQHNLVEYARPFLLERRKLKKIMDPGLEERYPLKAAMQAAELILRCLESDLRIRPSM 302
Query: 376 EEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRSQSPLHSKHGDHNNGTR 435
EEV L I+I+ K+ + + + R R QSPL +HG R
Sbjct: 303 EEVSGIL-----IKIKDVKEKPKKSKSSCSDGSYARRQEERSRHQSPLQPRHGGTGYKVR 357
Query: 436 A 436
A
Sbjct: 358 A 358
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42563260|ref|NP_177762.3| putative protein kinase [Arabidopsis thaliana] gi|133778900|gb|ABO38790.1| At1g76360 [Arabidopsis thaliana] gi|332197707|gb|AEE35828.1| putative protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 490 bits (1262), Expect = e-136, Method: Compositional matrix adjust.
Identities = 232/350 (66%), Positives = 290/350 (82%), Gaps = 2/350 (0%)
Query: 70 GDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTK 129
G K +P SG+IVTPN LKMFTL +L+ ATKNFRP++++GEGGFG+VFKGWVD KTLAP++
Sbjct: 133 GRKAVPPSGKIVTPN-LKMFTLVELKTATKNFRPESVIGEGGFGQVFKGWVDEKTLAPSR 191
Query: 130 VGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQK 189
GVG VAVKKSNPDS QGL EWQ EV+FLGKF HPNLVKL+GYCWE+ QFLLVYEY+ K
Sbjct: 192 AGVGIPVAVKKSNPDSEQGLHEWQCEVRFLGKFHHPNLVKLLGYCWEENQFLLVYEYLPK 251
Query: 190 GSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249
GSLENHLF KG AE LPW+TRLKIAI+AA+ LTFLH+SEKSVIYRDFKASNILLD +++A
Sbjct: 252 GSLENHLFSKG-AEALPWDTRLKIAIEAAQGLTFLHNSEKSVIYRDFKASNILLDSNFHA 310
Query: 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGL 309
KLSDFGLAK GPI+G SHVTTR+MGT GYAAPEY+ATGHLYV+SDVYGFGVVLLE+LTGL
Sbjct: 311 KLSDFGLAKNGPINGFSHVTTRVMGTQGYAAPEYMATGHLYVRSDVYGFGVVLLELLTGL 370
Query: 310 RALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEP 369
RALD NRPS + LV++A+P L K++++K+MDPRLE++YP+ ++I++CLEA+P
Sbjct: 371 RALDPNRPSAQQNLVEWAKPGLNQKKKVQKMMDPRLEQKYPLLAVTKTAELILRCLEADP 430
Query: 370 KNRPSMEEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRS 419
KNRP M++VL L+ + I +P+++ + R + + + P+ RR+
Sbjct: 431 KNRPPMDDVLRELEVVRTIRDQPQEERRKRSSGPDTNRVRGNDSPYGRRT 480
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|6554483|gb|AAF16665.1|AC012394_14 putative protein kinase; 59396-62219 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 490 bits (1261), Expect = e-136, Method: Compositional matrix adjust.
Identities = 232/350 (66%), Positives = 290/350 (82%), Gaps = 2/350 (0%)
Query: 70 GDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTK 129
G K +P SG+IVTPN LKMFTL +L+ ATKNFRP++++GEGGFG+VFKGWVD KTLAP++
Sbjct: 91 GRKAVPPSGKIVTPN-LKMFTLVELKTATKNFRPESVIGEGGFGQVFKGWVDEKTLAPSR 149
Query: 130 VGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQK 189
GVG VAVKKSNPDS QGL EWQ EV+FLGKF HPNLVKL+GYCWE+ QFLLVYEY+ K
Sbjct: 150 AGVGIPVAVKKSNPDSEQGLHEWQCEVRFLGKFHHPNLVKLLGYCWEENQFLLVYEYLPK 209
Query: 190 GSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249
GSLENHLF KG AE LPW+TRLKIAI+AA+ LTFLH+SEKSVIYRDFKASNILLD +++A
Sbjct: 210 GSLENHLFSKG-AEALPWDTRLKIAIEAAQGLTFLHNSEKSVIYRDFKASNILLDSNFHA 268
Query: 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGL 309
KLSDFGLAK GPI+G SHVTTR+MGT GYAAPEY+ATGHLYV+SDVYGFGVVLLE+LTGL
Sbjct: 269 KLSDFGLAKNGPINGFSHVTTRVMGTQGYAAPEYMATGHLYVRSDVYGFGVVLLELLTGL 328
Query: 310 RALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEP 369
RALD NRPS + LV++A+P L K++++K+MDPRLE++YP+ ++I++CLEA+P
Sbjct: 329 RALDPNRPSAQQNLVEWAKPGLNQKKKVQKMMDPRLEQKYPLLAVTKTAELILRCLEADP 388
Query: 370 KNRPSMEEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRS 419
KNRP M++VL L+ + I +P+++ + R + + + P+ RR+
Sbjct: 389 KNRPPMDDVLRELEVVRTIRDQPQEERRKRSSGPDTNRVRGNDSPYGRRT 438
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297842391|ref|XP_002889077.1| hypothetical protein ARALYDRAFT_476789 [Arabidopsis lyrata subsp. lyrata] gi|297334918|gb|EFH65336.1| hypothetical protein ARALYDRAFT_476789 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1257), Expect = e-135, Method: Compositional matrix adjust.
Identities = 237/367 (64%), Positives = 297/367 (80%), Gaps = 19/367 (5%)
Query: 70 GDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTK 129
G K +P SG+IVTPN LKMFTL +L+ ATKNFRP++++GEGGFG+VFKGWVD KTLAP++
Sbjct: 138 GRKAVPPSGKIVTPN-LKMFTLVELKTATKNFRPESVIGEGGFGQVFKGWVDEKTLAPSR 196
Query: 130 VGVGKAVAVKKSNPDSIQGLREWQA---------------EVKFLGKFSHPNLVKLIGYC 174
GVG VAVKKSNPDS QGL EWQA EV+FLGKF HPNLVKL+GYC
Sbjct: 197 AGVGIPVAVKKSNPDSEQGLHEWQAIGNYTCSYLIKEEECEVRFLGKFHHPNLVKLLGYC 256
Query: 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYR 234
WE+ QFLLVYEY+ KGSLENHLF KG AE LPW+TRLKIAI+AA+ LTFLH+SEKSVIYR
Sbjct: 257 WEENQFLLVYEYLPKGSLENHLFSKG-AEALPWDTRLKIAIEAAQGLTFLHNSEKSVIYR 315
Query: 235 DFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSD 294
DFKASNILLD +++AKLSDFGLAK GPI+G SHVTTR+MGT GYAAPEY+ATGHLYV+SD
Sbjct: 316 DFKASNILLDSTFHAKLSDFGLAKNGPINGFSHVTTRVMGTQGYAAPEYMATGHLYVRSD 375
Query: 295 VYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGA 354
VYGFGVVLLE+LTGLRALD NRPS + LV++A+P L K++++K+MDPRLE +YP+
Sbjct: 376 VYGFGVVLLELLTGLRALDPNRPSAQQNLVEWAKPVLNQKKKVQKMMDPRLEHKYPLLAV 435
Query: 355 LLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGH- 413
+ ++I++CLEA+PKNRP M++VL L+ + I +PK++ + R + +++ N+ RG+
Sbjct: 436 VKTAELILRCLEADPKNRPPMDDVLRELEVVRTIRDQPKEERRKRSSGSDHDNNRVRGND 495
Query: 414 -PHNRRS 419
P+ RR+
Sbjct: 496 SPYGRRT 502
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388511677|gb|AFK43900.1| unknown [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1250), Expect = e-134, Method: Compositional matrix adjust.
Identities = 231/321 (71%), Positives = 272/321 (84%), Gaps = 1/321 (0%)
Query: 75 PSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGK 134
P +G+IV PN LKMF L DL+ AT+NF+PDT+LGEGGFGRVFKGW+D KT P++VGVG
Sbjct: 49 PCTGKIVKPN-LKMFPLDDLKTATRNFKPDTILGEGGFGRVFKGWIDPKTFKPSRVGVGI 107
Query: 135 AVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLEN 194
VAVKKS+ DS+QGL EWQ+EVKFLGKFSHPNLVKL+GYCWE+ FLLVYEYMQKGSLE+
Sbjct: 108 PVAVKKSSSDSLQGLEEWQSEVKFLGKFSHPNLVKLLGYCWEESCFLLVYEYMQKGSLES 167
Query: 195 HLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254
HLFRK EPL W+ RLKIAI AA+ L FLH+ EKSVIYRDFK+SNIL D +NAKLSDF
Sbjct: 168 HLFRKEGPEPLSWDIRLKIAIGAARGLAFLHNLEKSVIYRDFKSSNILPDRDFNAKLSDF 227
Query: 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDT 314
GLAKLGPI+G SH+TTR+MGTYGYAAPEY+ATGHLYVKSDVYGFGVVLLE+LTGL ALD
Sbjct: 228 GLAKLGPINGRSHITTRVMGTYGYAAPEYMATGHLYVKSDVYGFGVVLLEILTGLIALDK 287
Query: 315 NRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS 374
NRP+ LV +A PSL+DK+ LKKIMDP++++QY IK ALL Q+I+ CLE++PKNRPS
Sbjct: 288 NRPTYGQNLVGYAMPSLSDKKSLKKIMDPKMDQQYSIKAALLIAQLILTCLESDPKNRPS 347
Query: 375 MEEVLETLQNISVIEIEPKKK 395
ME+VL TL+ I+ +PK K
Sbjct: 348 MEDVLSTLEKAQSIKHKPKVK 368
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 441 | ||||||
| TAIR|locus:2014614 | 484 | AT1G76360 [Arabidopsis thalian | 0.789 | 0.719 | 0.64 | 1.1e-121 | |
| TAIR|locus:2059642 | 414 | Kin3 "kinase 3" [Arabidopsis t | 0.766 | 0.816 | 0.605 | 1.1e-108 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.784 | 0.889 | 0.537 | 3.1e-99 | |
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.782 | 0.699 | 0.546 | 9.4e-98 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.714 | 0.744 | 0.594 | 3.2e-97 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.691 | 0.622 | 0.597 | 4.7e-96 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.804 | 0.783 | 0.526 | 9.7e-96 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.702 | 0.784 | 0.572 | 3e-94 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.798 | 0.826 | 0.509 | 1.7e-91 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.770 | 0.798 | 0.533 | 4.5e-91 |
| TAIR|locus:2014614 AT1G76360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1197 (426.4 bits), Expect = 1.1e-121, P = 1.1e-121
Identities = 224/350 (64%), Positives = 281/350 (80%)
Query: 70 GDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTX 129
G K +P SG+IVTPN LKMFTL +L+ ATKNFRP++++GEGGFG+VFKGWVD KTLAP+
Sbjct: 133 GRKAVPPSGKIVTPN-LKMFTLVELKTATKNFRPESVIGEGGFGQVFKGWVDEKTLAPSR 191
Query: 130 XXXXXXXXXXXSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQK 189
SNPDS QGL EWQ EV+FLGKF HPNLVKL+GYCWE+ QFLLVYEY+ K
Sbjct: 192 AGVGIPVAVKKSNPDSEQGLHEWQCEVRFLGKFHHPNLVKLLGYCWEENQFLLVYEYLPK 251
Query: 190 GSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249
GSLENHLF KG AE LPW+TRLKIAI+AA+ LTFLH+SEKSVIYRDFKASNILLD +++A
Sbjct: 252 GSLENHLFSKG-AEALPWDTRLKIAIEAAQGLTFLHNSEKSVIYRDFKASNILLDSNFHA 310
Query: 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGL 309
KLSDFGLAK GPI+G SHVTTR+MGT GYAAPEY+ATGHLYV+SDVYGFGVVLLE+LTGL
Sbjct: 311 KLSDFGLAKNGPINGFSHVTTRVMGTQGYAAPEYMATGHLYVRSDVYGFGVVLLELLTGL 370
Query: 310 RALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEP 369
RALD NRPS + LV++A+P L K++++K+MDPRLE++YP+ ++I++CLEA+P
Sbjct: 371 RALDPNRPSAQQNLVEWAKPGLNQKKKVQKMMDPRLEQKYPLLAVTKTAELILRCLEADP 430
Query: 370 KNRPSMEEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRS 419
KNRP M++VL L+ + I +P+++ + R + + + P+ RR+
Sbjct: 431 KNRPPMDDVLRELEVVRTIRDQPQEERRKRSSGPDTNRVRGNDSPYGRRT 480
|
|
| TAIR|locus:2059642 Kin3 "kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1074 (383.1 bits), Expect = 1.1e-108, P = 1.1e-108
Identities = 209/345 (60%), Positives = 255/345 (73%)
Query: 70 GDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTX 129
G+ P + PN L++F+L +LRA+T+NFR + +LGEGGFG+VFKGW++ KT P
Sbjct: 57 GEDAYPDGQILPIPN-LRIFSLAELRASTRNFRSENVLGEGGFGKVFKGWLEDKT--PGK 113
Query: 130 XXXXXXXXXXXSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQK 189
N +S QG EWQ EV FLG+ SHPNLVKL+GYC E + LLVYEYMQK
Sbjct: 114 QSNGTVIAVKKLNAESFQGFEEWQCEVNFLGRVSHPNLVKLLGYCLEGEELLLVYEYMQK 173
Query: 190 GSLENHLFRKGSA-EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248
GSLENHLFRKGSA +PL W RLKIAI AAK L FLH+SEK VIYRDFKASNILLDGSYN
Sbjct: 174 GSLENHLFRKGSAVQPLSWEIRLKIAIGAAKGLAFLHASEKQVIYRDFKASNILLDGSYN 233
Query: 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG 308
AK+SDFGLAKLGP SH+TTR+MGT+GYAAPEYVATGHLYVKSDVYGFGVVL E+LTG
Sbjct: 234 AKISDFGLAKLGPSASQSHITTRVMGTHGYAAPEYVATGHLYVKSDVYGFGVVLAEILTG 293
Query: 309 LRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAE 368
L ALD RP+G+H L ++ +P L+++R+L+ IMDPRLE +YP K A Q+ +KCL E
Sbjct: 294 LHALDPTRPTGQHNLTEWIKPHLSERRKLRSIMDPRLEGKYPFKSAFRVAQLALKCLGPE 353
Query: 369 PKNRPSMEEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGH 413
PKNRPSM+EV+E+L+ I +P ++ R + S Q+GH
Sbjct: 354 PKNRPSMKEVVESLELIEAANEKPLERRTTRAS---PSIRQQQGH 395
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 985 (351.8 bits), Expect = 3.1e-99, P = 3.1e-99
Identities = 187/348 (53%), Positives = 256/348 (73%)
Query: 74 MP-SSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTXXXX 132
MP + GEI+ LK F+L +L++AT+NFRPD+++GEGGFG VFKGW+D +LAP+
Sbjct: 40 MPRTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGT 99
Query: 133 XXXXXXXXSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSL 192
N + QG REW AE+ +LG+ HPNLVKLIGYC E+ LLVYE+M +GSL
Sbjct: 100 GIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSL 159
Query: 193 ENHLFRKGSA-EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251
ENHLFR+G+ +PL WNTR+++A+ AA+ L FLH+++ VIYRDFKASNILLD +YNAKL
Sbjct: 160 ENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKL 219
Query: 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRA 311
SDFGLA+ GP+ NSHV+TR+MGT GYAAPEY+ATGHL VKSDVY FGVVLLE+L+G RA
Sbjct: 220 SDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRA 279
Query: 312 LDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKN 371
+D N+P GEH LVD+ARP LT+KRRL ++MDPRL+ QY + AL + + C+ + K+
Sbjct: 280 IDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKS 339
Query: 372 RPSMEEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRS 419
RP+M E+++T++ + + + K++ + + +N N + + + R S
Sbjct: 340 RPTMNEIVKTMEELHIQKEASKEQQNPQISIDNIINKSPQAVNYPRPS 387
|
|
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 971 (346.9 bits), Expect = 9.4e-98, P = 9.4e-98
Identities = 194/355 (54%), Positives = 243/355 (68%)
Query: 77 SGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTXXXXXXXX 136
S E+ ++L+ FT DL+ +T+NFRP+++LGEGGFG VFKGW++ AP
Sbjct: 118 SEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 177
Query: 137 XXXXSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL 196
NPD +QG +EW AE+ FLG HPNLVKL+GYC ED Q LLVYE+M +GSLENHL
Sbjct: 178 AVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 237
Query: 197 FRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSE-KSVIYRDFKASNILLDGSYNAKLSDFG 255
FR+ PLPW+ R+KIA+ AAK L+FLH K VIYRDFK SNILLD YNAKLSDFG
Sbjct: 238 FRRSL--PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFG 295
Query: 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315
LAK P +G +HV+TR+MGTYGYAAPEYV TGHL KSDVY FGVVLLEMLTG R++D N
Sbjct: 296 LAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 355
Query: 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM 375
RP+GEH LV++ARP L DKRR +++DPRLE + IKGA Q+ +CL +PK RP M
Sbjct: 356 RPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKM 415
Query: 376 EEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRSQSPLHSKHGDH 430
+V+E L+ + P K A +Y + +R + RSQ S++G H
Sbjct: 416 SDVVEALKPL------PHLKDMASSSYYFQTMQAERLKNGSGRSQG-FGSRNGQH 463
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 966 (345.1 bits), Expect = 3.2e-97, P = 3.2e-97
Identities = 189/318 (59%), Positives = 236/318 (74%)
Query: 73 NMPSSGEIV-TPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTXXX 131
N + GEI+ +PN LK FT +L+AAT+NFRPD++LGEGGFG VFKGW+D +TL +
Sbjct: 52 NPRTEGEILQSPN-LKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPG 110
Query: 132 XXXXXXXXXSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGS 191
N D QG +EW AEV +LG+FSHPNLVKLIGYC ED LLVYE+M +GS
Sbjct: 111 TGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGS 170
Query: 192 LENHLFRKGSA-EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250
LENHLFR+GS +PL W RLK+A+ AAK L FLH++E SVIYRDFK SNILLD YNAK
Sbjct: 171 LENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAK 230
Query: 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLR 310
LSDFGLAK GP SHV+TRIMGTYGYAAPEY+ATGHL KSDVY +GVVLLE+L+G R
Sbjct: 231 LSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRR 290
Query: 311 ALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPK 370
A+D NRP GE LV++ARP L +KR+L +++D RL++QY ++ A + ++CL E K
Sbjct: 291 AVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIK 350
Query: 371 NRPSMEEVLETLQNISVI 388
RP+M EV+ L++I +
Sbjct: 351 LRPNMNEVVSHLEHIQTL 368
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 955 (341.2 bits), Expect = 4.7e-96, P = 4.7e-96
Identities = 184/308 (59%), Positives = 225/308 (73%)
Query: 77 SGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTXXXXXXXX 136
S E+ ++LK F+ DL+ AT+NFRP+++LGEGGFG VFKGWV+ AP
Sbjct: 112 SEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTV 171
Query: 137 XXXXSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL 196
NPD +QG +EW AE+ +LG HPNLVKL+GYC ED Q LLVYE+M +GSLENHL
Sbjct: 172 AVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 231
Query: 197 FRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSE-KSVIYRDFKASNILLDGSYNAKLSDFG 255
FR+ PLPW+ R+KIA+ AAK L+FLH K VIYRDFK SNILLDG YNAKLSDFG
Sbjct: 232 FRRSL--PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFG 289
Query: 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315
LAK P +G +HV+TR+MGTYGYAAPEYV TGHL KSDVY FGVVLLEMLTG R++D N
Sbjct: 290 LAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 349
Query: 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM 375
RP+GEH LV++ARP L DKRR +++DPRLE + +KGA Q+ +CL + K RP M
Sbjct: 350 RPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKM 409
Query: 376 EEVLETLQ 383
EV+E L+
Sbjct: 410 SEVVEVLK 417
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 952 (340.2 bits), Expect = 9.7e-96, P = 9.7e-96
Identities = 189/359 (52%), Positives = 238/359 (66%)
Query: 27 SLTGKENKADG-LEMAGEINDVKDEHERKADDADEGRQLGDGDGGDKNMPSSGEIVTPNY 85
S +K D + I + K E+ + G + G SGE+ +
Sbjct: 28 SCISSRSKVDSSMNATAVIAEPKKVIEKLEGHPAPTKDTGCAESGSSTPLMSGELKYSSK 87
Query: 86 LKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTXXXXXXXXXXXXSNPDS 145
L++F DL+ AT+NFRP+++LGEGGFG VFKGW++ AP NPD
Sbjct: 88 LRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDG 147
Query: 146 IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPL 205
+QG +EW AE+ FLG HP+LVKL+GYC E+ Q LLVYE+M +GSLENHLFR+ PL
Sbjct: 148 LQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFRR--TLPL 205
Query: 206 PWNTRLKIAIDAAKDLTFLHS-SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG 264
PW+ R+KIA+ AAK L FLH +EK VIYRDFK SNILLDG YNAKLSDFGLAK P +
Sbjct: 206 PWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEK 265
Query: 265 NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV 324
SHV+TR+MGTYGYAAPEYV TGHL KSDVY FGVVLLE+LTG R++D +RP+GE LV
Sbjct: 266 KSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQNLV 325
Query: 325 DFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
++ RP L DK+R +++DPRLE Y IKGA A Q+ +CL + K RP M EV+E L+
Sbjct: 326 EWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEALK 384
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 938 (335.3 bits), Expect = 3.0e-94, P = 3.0e-94
Identities = 178/311 (57%), Positives = 229/311 (73%)
Query: 76 SSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTXXXXXXX 135
+ GEI++ +K FT +L+ AT+NFRPD+++GEGGFG VFKGW+D TL PT
Sbjct: 42 TEGEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLV 101
Query: 136 XXXXXSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENH 195
N + QG REW E+ +LG+ SHPNLVKLIGYC ED LLVYE+MQKGSLENH
Sbjct: 102 IAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENH 161
Query: 196 LFRKGSA-EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254
LFR+G+ +PLPW R+ +A+DAAK L FLHS VIYRD KASNILLD YNAKLSDF
Sbjct: 162 LFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDF 221
Query: 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDT 314
GLA+ GP+ S+V+TR+MGTYGYAAPEY+++GHL +SDVY FGV+LLE+L+G RALD
Sbjct: 222 GLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDH 281
Query: 315 NRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS 374
NRP+ E LVD+ARP LT KR++ I+D RL+ QY + A+ + ++CL EPK+RP+
Sbjct: 282 NRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPT 341
Query: 375 MEEVLETLQNI 385
M++V+ LQ +
Sbjct: 342 MDQVVRALQQL 352
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 912 (326.1 bits), Expect = 1.7e-91, P = 1.7e-91
Identities = 180/353 (50%), Positives = 233/353 (66%)
Query: 76 SSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTXXXXXXX 135
+ GEI++ LK FT +L+ ATKNFR D +LGEGGFG VFKGW+D +L +
Sbjct: 61 TEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIV 120
Query: 136 XXXXXSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENH 195
P+ QG +EW EV +LG+ SHPNLV L+GYC E LLVYE+M KGSLENH
Sbjct: 121 VAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENH 180
Query: 196 LFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255
LFR+G A+PL W R+K+A+ AAK LTFLH ++ VIYRDFKA+NILLD +NAKLSDFG
Sbjct: 181 LFRRG-AQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFG 239
Query: 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315
LAK GP N+HV+T+++GT+GYAAPEYVATG L KSDVY FGVVLLE+++G RA+D +
Sbjct: 240 LAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNS 299
Query: 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM 375
E+ LVD+A P L DKR+L +IMD +L QYP KGA A + ++CL + K RP M
Sbjct: 300 NGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKM 359
Query: 376 EEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRSQSPLHSKHG 428
EVL TL+ + + K + ++S+ Q+ + LH G
Sbjct: 360 SEVLVTLEQLESVAKPGTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTPG 412
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 908 (324.7 bits), Expect = 4.5e-91, P = 4.5e-91
Identities = 185/347 (53%), Positives = 232/347 (66%)
Query: 76 SSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTXXXXXXX 135
+ GEI++ LK FT +L+ AT+NFRPD++LGEGGFG VFKGW+D TL +
Sbjct: 58 TEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIV 117
Query: 136 XXXXXSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENH 195
+ QG +EW EV +LG+ SHPNLVKL+GYC E LLVYE+M KGSLENH
Sbjct: 118 VAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENH 177
Query: 196 LFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255
LFR+G A+PL W R+K+AI AAK LTFLH ++ VIYRDFKA+NILLD +N+KLSDFG
Sbjct: 178 LFRRG-AQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFG 236
Query: 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315
LAK GP +HV+T++MGT+GYAAPEYVATG L KSDVY FGVVLLE+L+G RA+D +
Sbjct: 237 LAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKS 296
Query: 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM 375
+ E LVD+A P L DKR+L +IMD RL QYP KGA A + ++CL + K RP M
Sbjct: 297 KVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKM 356
Query: 376 EEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRSQSP 422
EVL L ++E K GN D+ RG + +SP
Sbjct: 357 SEVLAKLD-----QLESTKPGTGVGN-RQAQIDSPRGSNGSIVQKSP 397
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.V.2121.1 | hypothetical protein (326 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 441 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-55 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-33 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-29 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-27 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 1e-55
Identities = 89/279 (31%), Positives = 126/279 (45%), Gaps = 67/279 (24%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVKFLGKFSHP 165
LGEGGFG V+ D KT GK VA+K + L E E++ L K +HP
Sbjct: 1 LGEGGFGTVYLAR-DKKT--------GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
N+VKL G ++ LV EY + GSL++ L L + L+I + + L +LH
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG--KLSEDEILRILLQILEGLEYLH 109
Query: 226 SSEKSVIYRDFKASNILLD-GSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
S +I+RD K NILLD + KL+DFGL+KL + + + I+GT Y APE +
Sbjct: 110 S--NGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVL 165
Query: 285 ATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDP 343
Y KSD++ GV+L E+ P L D
Sbjct: 166 LGKGYYSEKSDIWSLGVILYEL-----------------------PELKD---------- 192
Query: 344 RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
+I K L+ +P+ RPS +E+LE L
Sbjct: 193 ----------------LIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 2e-52
Identities = 99/279 (35%), Positives = 141/279 (50%), Gaps = 34/279 (12%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSH 164
LG G FG V+K G GK VAVK S + + + E++ L + SH
Sbjct: 7 LGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSH 57
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
PN+V+LI + LV EY + G L ++L R G PL + KIA+ + L +L
Sbjct: 58 PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYL 114
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
HS +I+RD K NILLD + K++DFGLAK + +S T +GT Y APE +
Sbjct: 115 HS--NGIIHRDLKPENILLDENGVVKIADFGLAKK--LLKSSSSLTTFVGTPWYMAPEVL 170
Query: 285 ATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDP 343
G+ Y K DV+ GV+L E+LTG SGE+ L + +++I+ P
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTG-----KPPFSGEN--------ILDQLQLIRRILGP 217
Query: 344 RLEEQYP--IKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
LE P G+ A +I KCL +P RP+ EE+L+
Sbjct: 218 PLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 8e-51
Identities = 91/289 (31%), Positives = 134/289 (46%), Gaps = 50/289 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHP 165
LGEG FG V+KG TL G VAVK S + E+ E + K SHP
Sbjct: 7 LGEGAFGEVYKG-----TLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
N+V+L+G C + +V EYM G L + L + G E L L++A+ AK + +L
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG--EKLTLKDLLQMALQIAKGMEYLE 119
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT------RIMGTYGYA 279
S K+ ++RD A N L+ + K+SDFGL++ D + M
Sbjct: 120 S--KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------ 171
Query: 280 APEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP----SGEHVLVDFARPSLTDKR 335
APE + G KSDV+ FGV+L E+ T +P S E VL L D
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGE-----QPYPGMSNEEVL-----ELLEDGY 221
Query: 336 RLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
RL + P +E Y +++++C +P++RP+ E++E L
Sbjct: 222 RLPR---PENCPDELY---------ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 9e-51
Identities = 86/281 (30%), Positives = 134/281 (47%), Gaps = 33/281 (11%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSH 164
LGEG FG V+KG L VAVK D S Q + E+ E + + K H
Sbjct: 6 KLGEGAFGEVYKG-----KLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
PN+VKL+G C E+ +V EYM+ G L ++L + + L + L A+ A+ + +L
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT---YGYAAP 281
S K+ I+RD A N L+ + K+SDFGL++ D R G + AP
Sbjct: 119 ES--KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAP 172
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341
E + G KSDV+ FGV+L E+ T GE P ++++ L+ +
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTL----------GEQ-----PYPGMSNEEVLEYLK 217
Query: 342 DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
+ Q P L ++++C +P++RP+ E++E L
Sbjct: 218 NGYRLPQPPNCPPELY-DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-50
Identities = 88/281 (31%), Positives = 137/281 (48%), Gaps = 32/281 (11%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSH 164
LGEG FG V+KG TL G VAVK D S Q + E+ E + + K H
Sbjct: 6 KLGEGAFGEVYKG-----TLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
PN+VKL+G C E+ ++V EYM G L ++L RK + L + L A+ A+ + +L
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT---YGYAAP 281
S K+ I+RD A N L+ + K+SDFGL++ D ++ G + AP
Sbjct: 120 ES--KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAP 173
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341
E + G KSDV+ FGV+L E+ T GE P +++ L+ +
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTL----------GEE-----PYPGMSNAEVLEYLK 218
Query: 342 DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
+ P L +++++C +P++RP+ E++E L
Sbjct: 219 KGYRLPKPPNCPPELY-KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-48
Identities = 92/279 (32%), Positives = 132/279 (47%), Gaps = 40/279 (14%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVKFLGKFSHP 165
LGEG FG+V+ D KT GK VA+K I+ RE E+K L K HP
Sbjct: 7 LGEGSFGKVYLA-RDKKT--------GKLVAIKVIKKKKIKKDRERILREIKILKKLKHP 57
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
N+V+L ++ + LV EY + G L + L ++G L + L +LH
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG---RLSEDEARFYLRQILSALEYLH 114
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA 285
S K +++RD K NILLD + KL+DFGLA+ +D +TT + GT Y APE V
Sbjct: 115 S--KGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPE-VL 168
Query: 286 TGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRP--SGEHVLVDFARPSLTDKRRLKKIMD 342
G Y D++ GV+L E+LTG +P G+ L++ KKI
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTG-------KPPFPGDDQLLEL----------FKKIGK 211
Query: 343 PRLEEQYPIKGALLAGQIII-KCLEAEPKNRPSMEEVLE 380
P+ P + +I K L +P+ R + EE L+
Sbjct: 212 PKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 6e-46
Identities = 89/299 (29%), Positives = 129/299 (43%), Gaps = 61/299 (20%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNPDSIQGLREWQAEVKFLGKFSHP 165
LGEG FG V+KG K G VAVK S + +++ E + + K HP
Sbjct: 3 LGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHL------FRKGSAEPLPWNTRLKIAIDAAK 219
N+V+L+G C E+ LV EYM+ G L ++L F L L AI AK
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT------RIM 273
+ +L S K ++RD A N L+ K+SDFGL++ D T R M
Sbjct: 117 GMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 274 GTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-------GLRALDTNRPSGEHVLVDF 326
APE + G KSDV+ FGV+L E+ T GL +
Sbjct: 175 ------APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV------------ 216
Query: 327 ARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
L RL K P +E Y ++++ C + +P++RP+ E++E L+
Sbjct: 217 -LEYLRKGYRLPK---PEYCPDELY---------ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 81/281 (28%), Positives = 122/281 (43%), Gaps = 37/281 (13%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSN--PDSIQGLREWQAEVKFLGKFS 163
+LG G FG V+ +D T G+ +AVK DS + L + E++ L
Sbjct: 7 LLGRGSFGSVYLA-LDKDT--------GELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 164 HPNLVKLIGYCW--EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDL 221
HPN+V+ G E + EY+ GSL + L + G LP K + L
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGL 114
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAP 281
+LHS +++RD K +NIL+D KL+DFG AK T + GT + AP
Sbjct: 115 AYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 282 EYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP-SLTDKRRLKK 339
E V G Y +D++ G ++EM TG + + P + L K
Sbjct: 173 E-VIRGEEYGRAADIWSLGCTVIEMATG-----------KPPWSELGNPMAA-----LYK 215
Query: 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
I + P + A + KCL +PK RP+ +E+L+
Sbjct: 216 IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-35
Identities = 80/291 (27%), Positives = 125/291 (42%), Gaps = 35/291 (12%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSH 164
LGEG FG+V P G+ VAVK N Q +++ E++ L H
Sbjct: 11 QLGEGHFGKVELC-----RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH 65
Query: 165 PNLVKLIGYCWED--RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
N+VK G C + R L+ EY+ GSL ++L + + + L + K +
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMD 123
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT--RIMGTYGYAA 280
+L S + I+RD A NIL++ K+SDFGLAK+ P D + + + Y A
Sbjct: 124 YLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-A 180
Query: 281 PEYVATGHLYVKSDVYGFGVVLLEMLT---------GLRALDTNRPSGEHVLVDFARPSL 331
PE + T SDV+ FGV L E+ T G+ ++ L
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE-LL 239
Query: 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
+ RL + +E Y ++ C EAEP++RPS +++ +
Sbjct: 240 KEGERLPR-PPSCPDEVY---------DLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 82/284 (28%), Positives = 129/284 (45%), Gaps = 39/284 (13%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLG 160
F +G+GGFG V+K HK GK VA+K +S + + E++ L
Sbjct: 2 FEILEKIGKGGFGEVYKAR--HKRT-------GKEVAIKVIKLESKEKKEKIINEIQILK 52
Query: 161 KFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
K HPN+VK G + + L +V E+ GSL++ L K + + L + + + K
Sbjct: 53 KCKHPNIVKYYG-SYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLK 109
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA 279
L +LHS +I+RD KA+NILL KL DFGL+ ++ ++GT +
Sbjct: 110 GLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWM 164
Query: 280 APEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339
APE + K+D++ G+ +E+ G P E L + L K
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEG------KPPYSE----------LPPMKALFK 208
Query: 340 IMD---PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
I P L P K + + KCL+ P+ RP+ E++L+
Sbjct: 209 IATNGPPGLRN--PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 7e-33
Identities = 93/342 (27%), Positives = 144/342 (42%), Gaps = 27/342 (7%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFL 159
++R LGEG FG V+ D K +A K +A K + + + E++ L
Sbjct: 1 SYRILRKLGEGSFGEVYLA-RDRKLVA------LKVLAKKLESKSKE--VERFLREIQIL 51
Query: 160 GKFSHP-NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
+HP N+VKL + ++ LV EY+ GSLE+ L + G PL + L I
Sbjct: 52 ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQIL 111
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYN-AKLSDFGLAKLGPIDGNS----HVTTRIM 273
L +LH K +I+RD K NILLD KL DFGLAKL P G++ + + +
Sbjct: 112 SALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169
Query: 274 GTYGYAAPEYVA---TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330
GT GY APE + + SD++ G+ L E+LTGL + GE ++
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE-----GEKNSSATSQTL 224
Query: 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVIEI 390
+ L P + A ++ K L +PKNR S L ++
Sbjct: 225 KIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL--SHDLLAHLK 282
Query: 391 EPKKKAKARGNYNNNSNDNQRGHPHNRRSQSPLHSKHGDHNN 432
+ ++++ P S L+S ++
Sbjct: 283 LKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSD 324
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 81/286 (28%), Positives = 136/286 (47%), Gaps = 47/286 (16%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVKFLGKFSHP 165
+G+G FG V+KG + T VAVK L+ + E + L ++ HP
Sbjct: 3 IGKGNFGDVYKGVLKGNTE----------VAVKTCRSTLPPDLKRKFLQEAEILKQYDHP 52
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
N+VKLIG C + + +V E + GSL L +K + L L++++DAA + +L
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLE 110
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL--GPIDGNSHVTTRIMGTYGYAAPEY 283
S K+ I+RD A N L+ + K+SDFG+++ G I S +I + APE
Sbjct: 111 S--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEA 166
Query: 284 VATGHLYVKSDVYGFGVVLLEMLTG----LRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339
+ G +SDV+ +G++L E + + +N+ + E + + P+
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGYRMPA--------- 216
Query: 340 IMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
P+L EE Y +++++C +P+NRPS E+ LQ
Sbjct: 217 ---PQLCPEEIY---------RLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 82/285 (28%), Positives = 129/285 (45%), Gaps = 48/285 (16%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+G+G FG V G G+ VAVK DS + + AE + HPN
Sbjct: 14 IGKGEFGDVMLG-----------DYRGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPN 61
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
LV+L+G + +V EYM KGSL ++L +G A + +L A+D + + +L
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE- 119
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY--GYAAPEYV 284
EK+ ++RD A N+L+ AK+SDFGLAK + + + G + APE +
Sbjct: 120 -EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDS---GKLPVKWTAPEAL 171
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344
KSDV+ FG++L E+ + R V + R L D + P
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPLKD-------VVPH 211
Query: 345 LEEQY----PIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+E+ Y P +++ C E +P RP+ +++ E L I
Sbjct: 212 VEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-31
Identities = 83/292 (28%), Positives = 133/292 (45%), Gaps = 41/292 (14%)
Query: 99 KNFRPDTMLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVK 157
+ F + LG G FG V++G W + VA+K D + +++Q EV+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVR-----------VAIKILKSDDLLKQQDFQKEVQ 54
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
L + H +L+ L C ++ E M+KGSL R + LP + + +A
Sbjct: 55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL-AFLRSPEGQVLPVASLIDMACQV 113
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
A+ + +L E++ I+RD A NIL+ K++DFGLA+L D +I Y
Sbjct: 114 AEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYK 169
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337
+ APE + G KSDV+ FG++L EM T + V + P + +
Sbjct: 170 WTAPEAASHGTFSTKSDVWSFGILLYEMFT-------------YGQVPY--PGMNNHEVY 214
Query: 338 KKIMD----PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+I P P K +I+++C AEP++RPS + + E L NI
Sbjct: 215 DQITAGYRMPC-----PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK--SNPDSIQGLREWQAEVKFLGKFSH 164
+G G FG V+KG ++ +T G VA+K+ + L+ E+ L H
Sbjct: 8 IGRGAFGVVYKG-LNLET--------GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH 58
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
PN+VK IG ++ EY + GSL + + G P P + + L +L
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYL 115
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
H E+ VI+RD KA+NIL KL+DFG+A ++ S ++GT + APE +
Sbjct: 116 H--EQGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTG 308
SD++ G ++E+LTG
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 5e-29
Identities = 75/287 (26%), Positives = 129/287 (44%), Gaps = 39/287 (13%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFL 159
+ +G+G FG+V+ V K + K+ V K + + + + EVK L
Sbjct: 1 KYEIIKQIGKGSFGKVYL--VRRK--SDGKLYVLKEIDLSNMSEKER---EDALNEVKIL 53
Query: 160 GKFSHPNLVKLIGYCWEDRQFLL-VYEYMQKGSLENHL-FRKGSAEPLPWNTRLKIAIDA 217
K +HPN++K +E++ L V EY G L + +K +P P L +
Sbjct: 54 KKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
L +LHS + +++RD K NI L + KL DFG++K+ + + ++GT
Sbjct: 113 CLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPY 168
Query: 278 YAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336
Y +PE + Y KSD++ G VL E+ T + GE++ L
Sbjct: 169 YLSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKHPFE-----GENL------LEL----- 211
Query: 337 LKKIMD---PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
KI+ P + QY + L ++ L+ +P+ RPS+ ++L+
Sbjct: 212 ALKILKGQYPPIPSQYSSE---LR-NLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 87/290 (30%), Positives = 135/290 (46%), Gaps = 33/290 (11%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
+LGEG FG V +G + + KV AV K + + + E+ +E + F HP
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKV----AVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 166 NLVKLIGYCWEDRQF------LLVYEYMQKGSLENHLFR---KGSAEPLPWNTRLKIAID 216
N++KLIG C+E +++ +M+ G L + L G E LP T LK +D
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT- 275
A + +L S ++ I+RD A N +L ++DFGL+K G+ + RI
Sbjct: 122 IALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSK-KIYSGDYYRQGRIAKMP 178
Query: 276 YGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
+ A E +A KSDV+ FGV + E+ T R H + D+ L
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDY----LRHGN 232
Query: 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
RLK+ D L+E Y ++ C A+PK+RP+ ++ E L+NI
Sbjct: 233 RLKQPEDC-LDELY---------DLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 82/284 (28%), Positives = 126/284 (44%), Gaps = 19/284 (6%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVKFLGKFSHP 165
LGEG FG+V D P G G+ VAVK + Q W+ E+ L H
Sbjct: 12 LGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 166 NLVKLIGYCWE--DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
N+VK G C E + L+ EY+ GSL ++L + L L A + + +
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAY 122
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG--YAAP 281
LHS + I+RD A N+LLD K+ DFGLAK P +G+ + R G + A
Sbjct: 123 LHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDGDSPVFWYAV 179
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341
E + SDV+ FGV L E+LT + + E ++ + +T RL +++
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMT-VVRLIELL 237
Query: 342 DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ + P ++ C E E K RP+ ++ L+ +
Sbjct: 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 9e-26
Identities = 79/283 (27%), Positives = 123/283 (43%), Gaps = 45/283 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSN-PDSIQGLREWQAEVKFLGKFSHP 165
LG+G G V+K V HK PT GK A+KK + + ++ E+K L P
Sbjct: 9 LGQGSSGVVYK--VRHK---PT----GKIYALKKIHVDGDEEFRKQLLRELKTLRSCESP 59
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
+VK G +++ + +V EYM GSL + L +P IA K L +LH
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDG--NSHVTTRIMGTYGYAAPE 282
+ ++ +I+RD K SN+L++ K++DFG++K L N+ V GT Y +PE
Sbjct: 117 T-KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPE 170
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSG-----EHVLVDFARPSLTDKRRL 337
+ +D++ G+ LLE G + + D PSL
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSLPA---- 225
Query: 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ P + I CL+ +PK RPS E+L+
Sbjct: 226 -EEFSPEFRD------------FISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 74/218 (33%), Positives = 100/218 (45%), Gaps = 43/218 (19%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGKFS 163
LG+G FG+V V K GK A+K I +E + E L + +
Sbjct: 1 LGKGSFGKVLL--VRKK-------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51
Query: 164 HPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS----------AEPLPWNTRLK 212
HP +VKL Y ++ + L LV EY G L +HL ++G AE +
Sbjct: 52 HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAE-------IV 103
Query: 213 IAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRI 272
+A++ +LHS +IYRD K NILLD + KL+DFGLAK S T
Sbjct: 104 LALE------YLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFC 154
Query: 273 MGTYGYAAPEYV-ATGHLYVKSDVYGFGVVLLEMLTGL 309
GT Y APE + G+ D + GV+L EMLTG
Sbjct: 155 -GTPEYLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 85/289 (29%), Positives = 133/289 (46%), Gaps = 58/289 (20%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG G FG V+ G W TKV AVK P ++ + E + + K H
Sbjct: 14 LGAGQFGEVWMGTWNGT-----TKV------AVKTLKPGTMS-PEAFLQEAQIMKKLRHD 61
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
LV+L C E+ +V EYM KGSL + L + G + L + +A A+ + +L
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT---YGYAAPE 282
S ++ I+RD A NIL+ + K++DFGLA+L I+ + T R G + APE
Sbjct: 121 S--RNYIHRDLAARNILVGENLVCKIADFGLARL--IEDD-EYTAR-EGAKFPIKWTAPE 174
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD 342
G +KSDV+ FG++L E++T R P +T++ L+++
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRV---------------PYPGMTNREVLEQVER 219
Query: 343 ----PRL----EEQYPIKGALLAGQIIIKCLEAEPKNRPSME---EVLE 380
PR EE Y ++++C + +P+ RP+ E LE
Sbjct: 220 GYRMPRPPNCPEELY---------DLMLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 78/278 (28%), Positives = 129/278 (46%), Gaps = 36/278 (12%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
+G G FG V+ G W L KV + K+ + ++ E + + K SHP
Sbjct: 12 IGSGQFGLVWLGYW-----LEKRKVAI-------KTIREGAMSEEDFIEEAQVMMKLSHP 59
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-FRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
LV+L G C E LV+E+M+ G L ++L ++G T L + +D + + +L
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYL 116
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
SS +VI+RD A N L+ + K+SDFG+ + +D +T +++PE
Sbjct: 117 ESS--NVIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVF 173
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344
+ KSDV+ FGV++ E+ + + NR + E V ++ RL K PR
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV------ETINAGFRLYK---PR 224
Query: 345 LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
L Q +++ C + P++RPS +L L
Sbjct: 225 LASQS-------VYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 76/283 (26%), Positives = 124/283 (43%), Gaps = 43/283 (15%)
Query: 106 MLGEGGFGRVFKGW-VDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSH 164
+LG G FG V++G +D K V++ + +++ + E+ L K H
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKE-----VSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKDLTF 223
PN+V+ +G E+ + E + GSL L + GS EP+ +I L +
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI----LLGLEY 117
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM-----GTYGY 278
LH ++ ++RD K +NIL+D + KL+DFG+AK V G+ +
Sbjct: 118 LHD--RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYW 167
Query: 279 AAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337
APE +A Y + +D++ G +LEM TG P + V +
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATG------KPPWSQLEGVAA----------V 211
Query: 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
KI + P + A I+KCL+ +P RP+ E+LE
Sbjct: 212 FKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 43/290 (14%)
Query: 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-EWQAEVKFLGKF 162
+ ++G G FG V +G L K VA+K S R ++ E +G+F
Sbjct: 9 EKVIGGGEFGEVCRG---RLKLPGKKE---IDVAIKTLKAGSSDKQRLDFLTEASIMGQF 62
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
HPN+++L G + R +++ EYM+ GSL+ L R+ + + + A +
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGK-FTVGQLVGMLRGIASGMK 120
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG----- 277
+L SE + ++RD A NIL++ + K+SDFG L +S T G G
Sbjct: 121 YL--SEMNYVHRDLAARNILVNSNLVCKVSDFG---LSRRLEDSEATYTTKG--GKIPIR 173
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP--SLTDKR 335
+ APE +A SDV+ FG+V+ E+++ GE RP ++++
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS----------YGE-------RPYWDMSNQD 216
Query: 336 RLKKIMDP-RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384
+K + D RL P+ Q+++ C + + RP+ +++ TL
Sbjct: 217 VIKAVEDGYRL--PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD------SIQGLREWQA 154
+ LGEG +G V+K D KT G+ VA+KK D LRE
Sbjct: 1 YEKLEKLGEGTYGVVYKAR-DKKT--------GEIVALKKIRLDNEEEGIPSTALRE--- 48
Query: 155 EVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA 214
+ L + HPN+VKL+ +R+ LV+EY L+ +L ++ PL N I
Sbjct: 49 -ISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG--PLSPNLIKSIM 104
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
+ L + HS +++RD K NIL++ KL+DFGLA+ I ++ T ++
Sbjct: 105 YQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV- 160
Query: 275 TYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
T Y APE + Y + D++ G + EM+TG
Sbjct: 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 73/277 (26%), Positives = 115/277 (41%), Gaps = 37/277 (13%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA--EVKFLGKFSH 164
+G+G FG VFK K + A+K+ + + +A E + L K
Sbjct: 8 IGKGSFGVVFK--------VVRKAD-KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
+++ + + +V EY + G L L + PLP + + I L L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHK-LLKMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
HS K +++RD K+ N+ LD N K+ D G+AKL + N++ I+GT Y +PE
Sbjct: 118 HS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELC 173
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344
KSDV+ GVVL E TG D N + L+ KI+
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALI-------------LKIIRGV 217
Query: 345 LEEQYPIKGALLAG--QIIIKCLEAEPKNRPSMEEVL 379
P+ Q+I +CL + + RP ++L
Sbjct: 218 FP---PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 80/286 (27%), Positives = 126/286 (44%), Gaps = 40/286 (13%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGL-REWQAEVKFLGKFSHP 165
LG G FG V KG K G VAVK + I +E+ E + + HP
Sbjct: 3 LGHGNFGSVVKGVYL------MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
+V+LIG C + +LV E G L +L ++ +P + ++A A + +L
Sbjct: 57 CIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRRE---IPVSDLKELAHQVAMGMAYLE 112
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNSHVTTRIMGTY--GYAAPE 282
K ++RD A N+LL + AK+SDFG+++ LG G+ + G + + APE
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTAGRWPLKWYAPE 168
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341
+ G KSDV+ +GV L E + G +P GE + L RL +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYG------AKPYGEMKGAE-VIAMLESGERLPR-- 219
Query: 342 DPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
P +E Y I++ C + P++RP+ E+ T +
Sbjct: 220 -PEECPQEIYS---------IMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 89/286 (31%), Positives = 125/286 (43%), Gaps = 50/286 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSI---QGLREWQAEVKFLGK 161
LG G G V K V H+ PT GK +AVK + + Q LRE + L K
Sbjct: 9 LGAGNSGVVSK--VLHR---PT----GKIMAVKTIRLEINEAIQKQILRE----LDILHK 55
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDL 221
+ P +V G + + + EYM GSL+ K +P KIA+ K L
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDK--ILKEVQGRIPERILGKIAVAVLKGL 113
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG---NSHVTTRIMGTYGY 278
T+LH K +I+RD K SNIL++ KL DFG + G NS T + GT Y
Sbjct: 114 TYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFG------VSGQLVNSLAKTFV-GTSSY 165
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338
APE + VKSD++ G+ L+E+ TG P P L+
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATG------RFPYPPE-----NDPPDGIFELLQ 214
Query: 339 KIMD---PRL-EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
I++ PRL ++ + CL +P+ RPS +E+LE
Sbjct: 215 YIVNEPPPRLPSGKFSPD----FQDFVNLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 38/305 (12%)
Query: 87 KMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP-DS 145
K T+ D+ ++ K + ++ G G +KG K++ G VK+ N +S
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKG----KSIKN-----GMQFVVKEINDVNS 728
Query: 146 IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPL 205
I +E+ +GK HPN+VKLIG C ++ L++EY++ +L L L
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNL 777
Query: 206 PWNTRLKIAIDAAKDLTFLHSS-EKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG 264
W R KIAI AK L FLH +V+ + I++DG L L L D
Sbjct: 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT 836
Query: 265 NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH-VL 323
+++ Y APE T + KSD+YGFG++L+E+LTG D G H +
Sbjct: 837 KCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE--FGVHGSI 888
Query: 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALL--AGQIIIKCLEAEPKNRPSMEEVLET 381
V++AR +D L +DP + + + + + C +P RP +VL+T
Sbjct: 889 VEWARYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947
Query: 382 LQNIS 386
L++ S
Sbjct: 948 LESAS 952
|
Length = 968 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 106 MLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVK----KSNPDSIQGLREWQAEVKFLG 160
+LG G FG V+KG W+ P V VA+K +++P + + E E +
Sbjct: 14 VLGSGAFGTVYKGVWI------PEGEKVKIPVAIKVLREETSPKANK---EILDEAYVMA 64
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSL----ENHLFRKGSAEPLPWNTRLKIAID 216
HP++V+L+G C Q L+ + M G L NH GS L W ++
Sbjct: 65 SVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI----- 118
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
AK +++L EK +++RD A N+L+ + K++DFGLAKL +D +
Sbjct: 119 -AKGMSYL--EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
+ A E + KSDV+ +GV + E++T
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-23
Identities = 79/283 (27%), Positives = 138/283 (48%), Gaps = 42/283 (14%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-EWQAEVKFLGKFSH 164
+LG+G FG VFKG + KT VAVK D Q L+ ++ +E + L ++ H
Sbjct: 2 LLGKGNFGEVFKGTLKDKT----------PVAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
PN+VKLIG C + + +V E + G + L +K + L +K A+DAA + +L
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK--KDELKTKQLVKFALDAAAGMAYL 109
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT-YGYAAPEY 283
S K+ I+RD A N L+ + K+SDFG+++ D + ++ + + APE
Sbjct: 110 ES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQE--DDGIYSSSGLKQIPIKWTAPEA 165
Query: 284 VATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDP 343
+ G +SDV+ +G++L E + L P +T+++ +++
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFS---------------LGVCPYPGMTNQQAREQV--- 207
Query: 344 RLEEQY----PIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
E+ Y P K +++ +C + +P+NRP E+ + L
Sbjct: 208 --EKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 3e-23
Identities = 85/319 (26%), Positives = 125/319 (39%), Gaps = 81/319 (25%)
Query: 86 LKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK----- 140
LK + + ++ +GEG G V+K T GK VA+KK
Sbjct: 8 LKDIVSEGDP--RELYKNLEKIGEGASGEVYKA---------TDRATGKEVAIKKMRLRK 56
Query: 141 SNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRK 199
N + I E+ + HPN+V + L +V EYM GSL
Sbjct: 57 QNKELIIN------EILIMKDCKHPNIVDYYD-SYLVGDELWVVMEYMDGGSL------- 102
Query: 200 GSAEPLPWN-TRLKIAIDAA------KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252
+ + N R+ A + L +LHS ++VI+RD K+ NILL + KL+
Sbjct: 103 --TDIITQNFVRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLA 158
Query: 253 DFGL-AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTG-- 308
DFG A+L S + ++GT + APE V Y K D++ G++ +EM G
Sbjct: 159 DFGFAAQLTK--EKSKRNS-VVGTPYWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEGEP 214
Query: 309 -------LRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQII 361
LRAL G P L + + L
Sbjct: 215 PYLREPPLRALFLITTKGI--------PPLKNPEKWSPEFKDFLN--------------- 251
Query: 362 IKCLEAEPKNRPSMEEVLE 380
KCL +P+ RPS EE+L+
Sbjct: 252 -KCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 4e-23
Identities = 80/293 (27%), Positives = 135/293 (46%), Gaps = 52/293 (17%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFL 159
++ ++G G +G V++G V G+ VA+K N D+ + + Q EV L
Sbjct: 3 YQRLELIGRGAYGAVYRG---------KHVPTGRVVALKIINLDTPDDDVSDIQREVALL 53
Query: 160 GKFSH---PNLVKLIGYCW-EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
+ PN+ K G + + + ++ EY + GS+ L + G + ++ +
Sbjct: 54 SQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVL 111
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
A L ++H VI+RD KA+NIL+ + N KL DFG+A L ++ NS + +GT
Sbjct: 112 VA---LKYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGT 164
Query: 276 YGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334
+ APE + G Y K+D++ G+ + EM TG P +D
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATG-------------------NPPYSDV 205
Query: 335 RRLKKIM------DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381
+ +M PRLE+ + L + + CL+ EPK R S EE+L++
Sbjct: 206 DAFRAMMLIPKSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 4e-23
Identities = 79/282 (28%), Positives = 129/282 (45%), Gaps = 48/282 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+GEG FG V +G G+ VAVK D + + E + K H N
Sbjct: 14 IGEGEFGAVLQGEY-----------TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKN 60
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
LV+L+G + ++ V E M KG+L N L +G A + L+ ++D A+ + +L S
Sbjct: 61 LVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLES 118
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT 286
K +++RD A NIL+ AK+SDFGLA++G + + +++ + APE +
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKL--PVKWTAPEALKH 171
Query: 287 GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI-----M 341
KSDV+ +GV+L E+ + RA P ++ K + + M
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRA---------------PYPKMSLKEVKECVEKGYRM 216
Query: 342 DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
+P + ++ C E EPK RPS ++ E L+
Sbjct: 217 EPPEGCPADVY------VLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 8e-23
Identities = 83/292 (28%), Positives = 124/292 (42%), Gaps = 44/292 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFL------G 160
LG G FG V++G + ++ VAVK + P+S Q E FL
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVEL----QVAVK-TLPESCSE----QDESDFLMEALIMS 64
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLF----RKGSAEPLPWNTRLKIAID 216
KF+H N+V+LIG +E ++ E M G L++ L R L L A D
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDG---SYNAKLSDFGLAKLGPIDGNSHVTT--R 271
AK +L E I+RD A N LL AK++DFG+A+ I S+ R
Sbjct: 125 VAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYRKGGR 180
Query: 272 IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331
M + PE G K+DV+ FGV+L E+ + R + E + +
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF------V 234
Query: 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
T R +DP P+ +I+ C + P++RP+ +LE +Q
Sbjct: 235 TGGGR----LDPPKGCPGPVY------RIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 9e-23
Identities = 82/286 (28%), Positives = 118/286 (41%), Gaps = 52/286 (18%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG G FG V G W +A + G S D I+ E K + K SHP
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAM-----SEDDFIE-------EAKVMMKLSHP 59
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFR---KGSAEPLPWNTRLKIAIDAAKDLT 222
NLV+L G C + R +V EYM G L N+L K E L L + D + +
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL-----LDMCSDVCEAME 114
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG-NSHVTTRIMGTYGYAAP 281
+L I+RD A N L+ K+SDFGLA+ D S T+ +A P
Sbjct: 115 YLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPP 170
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSG---EHVLVDFARPSLTDKRRLK 338
E KSDV+ FGV++ E+ + + + E V + RL
Sbjct: 171 EVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY---------RLY 221
Query: 339 KIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
+ P+L E Y I+ C +P++RP+ +++L L
Sbjct: 222 R---PKLAPTEVY---------TIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-22
Identities = 79/291 (27%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-----SNPDSIQGLREWQA 154
N+R +LG+G FGRV+ + V G+ +AVK+ +P++ + + +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCY---------DVDTGRELAVKQVPFDPDSPETKKEVNALEC 53
Query: 155 EVKFLGKFSHPNLVKLIGYCWEDRQFLLVY-EYMQKGSLENHLFRKGSAEPLPWNTRLKI 213
E++ L H +V+ G C D + L ++ EYM GS+++ L G L K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKY 109
Query: 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNSHVTTRI 272
+ + +LHS+ +++RD K +NIL D + N KL DFG +K L I + +
Sbjct: 110 TRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167
Query: 273 MGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331
GT + +PE V +G Y K+DV+ G ++EMLT +P
Sbjct: 168 TGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLT-------------------EKPPW 207
Query: 332 TDKRRLK---KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
+ + KI Q P + A + + K RPS EE+L
Sbjct: 208 AEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 68/209 (32%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG+G FG V D P + G+ VAVKK + + LR+++ E++ L H
Sbjct: 11 QLGKGNFGSVELCRYD-----PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHD 65
Query: 166 NLVKLIGYCWE--DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
N+VK G C+ R LV EY+ GSL ++L + E L L A K + +
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEY 123
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR-----IMGTYGY 278
L K ++RD NIL++ K+ DFGL K+ P D + I +
Sbjct: 124 L--GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----W 177
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
APE + V SDV+ FGVVL E+ T
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 72/292 (24%), Positives = 127/292 (43%), Gaps = 42/292 (14%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHP 165
LG+G FG V++G K + VA+K N + S++ E+ E + +F+
Sbjct: 14 LGQGSFGMVYEGLA--KGVVKG--EPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAE-------PLPWNTRLKIAIDAA 218
++V+L+G + L+V E M KG L+++L + P +++A + A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL------GPIDGNSHVTTRI 272
+ +L K ++RD A N ++ K+ DFG+ + G + R
Sbjct: 130 DGMAYLA--AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 273 MGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332
M APE + G KSDV+ FGVVL EM T L + L+
Sbjct: 188 M------APESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAEQPYQGLS 226
Query: 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384
++ LK ++D + P +++ C + PK RP+ E++ +L++
Sbjct: 227 NEEVLKFVIDGGHLDL-PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 81/283 (28%), Positives = 117/283 (41%), Gaps = 43/283 (15%)
Query: 108 GEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA---EVKFLGKFSH 164
G+G FG+V V + TK K A+K N + E + L + +H
Sbjct: 9 GKGAFGKVCI--VQKRD---TK----KMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH 59
Query: 165 PNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKG--SAEPLPWNTRLKIAIDAAKDL 221
P LV L Y ++D + + LV + + G L HL +K S E + I + L
Sbjct: 60 PFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE----QVKFWIC-EIVLAL 113
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAP 281
+LHS K +I+RD K NILLD + ++DF +A D TT GT GY AP
Sbjct: 114 EYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAP 168
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341
E + V D + GV E L G R + R R ++
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS-----------RTIRDQIRAKQETA 217
Query: 342 DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384
D YP + A I K LE +P+ R + + L+ L+N
Sbjct: 218 DV----LYPATWSTEAIDAINKLLERDPQKR--LGDNLKDLKN 254
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 81/312 (25%), Positives = 130/312 (41%), Gaps = 62/312 (19%)
Query: 107 LGEGGFGRV-----------------FKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGL 149
LGEG FG V D L VAVK PD+
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVL----------VAVKVLRPDASDNA 62
Query: 150 R-EWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAE----- 203
R ++ EVK L + S PN+ +L+G C D ++ EYM+ G L N +K AE
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSGLA 121
Query: 204 ----PLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK- 258
L ++T L +A A + +L + ++RD N L+ +Y K++DFG+++
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRN 179
Query: 259 -----LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALD 313
+ G + + R M A E V G KSDV+ FGV L E+LT R
Sbjct: 180 LYSSDYYRVQGRAPLPIRWM------AWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233
Query: 314 TNRPSGEHVLVDFARPSLTDKRRLKKIMDPRL-EEQYPIKGALLAGQIIIKCLEAEPKNR 372
+ + V+ + D R++ P ++ Y +++++C + ++R
Sbjct: 234 YEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIY---------ELMLECWRRDEEDR 284
Query: 373 PSMEEVLETLQN 384
P+ E+ LQ
Sbjct: 285 PTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-22
Identities = 61/203 (30%), Positives = 106/203 (52%), Gaps = 18/203 (8%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG G +G V++G W + VAVK D+++ + E+ E + + HP
Sbjct: 14 LGGGQYGEVYEGVWKKY----------SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 62
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
NLV+L+G C + F ++ E+M G+L ++L R+ + + + L +A + + +L
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG-NSHVTTRIMGTYGYAAPEYV 284
K+ I+RD A N L+ ++ K++DFGL++L D +H + + APE +
Sbjct: 122 K--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESL 177
Query: 285 ATGHLYVKSDVYGFGVVLLEMLT 307
A +KSDV+ FGV+L E+ T
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-22
Identities = 66/226 (29%), Positives = 98/226 (43%), Gaps = 36/226 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+G+G FGRVF+ L P + AV + K S ++Q E + +F HPN
Sbjct: 13 IGQGAFGRVFQARA--PGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPN 69
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHL-----------------FRKGSAEPLPWNT 209
+VKL+G C + L++EYM G L L RK PLP +
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 210 --RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL------AKLGP 261
+L IA A + +L SE+ ++RD N L+ + K++DFGL A
Sbjct: 130 TEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
N + R M PE + +SDV+ +GVVL E+ +
Sbjct: 188 ASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 6e-22
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK----KSNPDSIQGLREWQAEVKFLGKF 162
LGEG FG+V+KG + P + +VA+K + P Q E++ E + +
Sbjct: 13 LGEGAFGKVYKG----ELTGPNERLSATSVAIKTLKENAEPKVQQ---EFRQEAELMSDL 65
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRK-------------GSAEPLPWNT 209
HPN+V L+G C +++ +++EY+ G L L R L +
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269
L IAI A + +L S ++RD A N L+ K+SDFGL++ D S
Sbjct: 126 FLHIAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR----DIYSADY 179
Query: 270 TRIMGT----YGYAAPEYVATGHLYVKSDVYGFGVVLLEM 305
R+ + PE + G +SD++ FGVVL E+
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 8e-22
Identities = 74/284 (26%), Positives = 128/284 (45%), Gaps = 47/284 (16%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LG G FG V++G ++ T VAVK P ++ +++ AE + + K HP
Sbjct: 14 LGAGQFGEVWEGLWNNTT----------PVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPK 62
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHL-FRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
L++L C + +V E M+ GSL +L G A LP + +A A + +L
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLP--QLIDMAAQVASGMAYLE 120
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNSHVTTRIMGTYGYAAPEYV 284
+ ++ I+RD A N+L+ + K++DFGLA+ + + + + APE
Sbjct: 121 A--QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAA 176
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344
+KSDV+ FG++L E++T R P +T+ L++
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGR---------------MPYPGMTNAEVLQQ----- 216
Query: 345 LEEQY----PIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384
+++ Y P I++ C + +P +RP+ ETLQ
Sbjct: 217 VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPT----FETLQW 256
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-21
Identities = 67/260 (25%), Positives = 126/260 (48%), Gaps = 29/260 (11%)
Query: 130 VGVGKAVAVKK------SNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183
V G +AVK+ ++ + + + + E++ + + +HP++++++G ED F L
Sbjct: 22 VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81
Query: 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243
E+M GS+ + L + G + + L++LH E +I+RD K +N+L+
Sbjct: 82 VEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLI 136
Query: 244 DGS-YNAKLSDFGLA-KLGP-IDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFG 299
D + +++DFG A +L G +++GT + APE V G Y +S DV+ G
Sbjct: 137 DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE-VLRGEQYGRSCDVWSVG 195
Query: 300 VVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQ 359
V++EM T + + S L+ F S T + + + P L +
Sbjct: 196 CVIIEMATAKPPWNAEKHSNHLALI-FKIASATTAPSIPEHLSPGLRD------------ 242
Query: 360 IIIKCLEAEPKNRPSMEEVL 379
+ ++CLE +P++RP E+L
Sbjct: 243 VTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 73/257 (28%), Positives = 116/257 (45%), Gaps = 34/257 (13%)
Query: 136 VAVKKSN----PDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGS 191
VA+K+ + S+ LR+ EV+ + + +HPN+VK + LV Y+ GS
Sbjct: 29 VAIKRIDLEKCQTSVDELRK---EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85
Query: 192 LEN---HLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248
L + + +G + T LK + K L +LHS+ + I+RD KA NILL +
Sbjct: 86 LLDIMKSSYPRGGLDEAIIATVLK---EVLKGLEYLHSNGQ--IHRDIKAGNILLGEDGS 140
Query: 249 AKLSDFGLAK--LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEM 305
K++DFG++ D V +GT + APE + H Y K+D++ FG+ +E+
Sbjct: 141 VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIEL 200
Query: 306 LTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIK--GALLAGQIIIK 363
TG P +L P P LE K ++I
Sbjct: 201 ATGAAPYSKYPPMKVLMLTLQNDP-------------PSLETGADYKKYSKSFR-KMISL 246
Query: 364 CLEAEPKNRPSMEEVLE 380
CL+ +P RP+ EE+L+
Sbjct: 247 CLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 80/295 (27%), Positives = 121/295 (41%), Gaps = 40/295 (13%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVKFLGKFS 163
++GEG +G V K +K G+ VA+K K + D + EVK L +
Sbjct: 8 VVGEGAYGVVLK--CRNKA-------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR 58
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLEN-HLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
H N+V L + LV+EY+++ LE G LP + + +
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG----LPPDAVRSYIWQLLQAIA 114
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPE 282
+ HS ++I+RD K NIL+ S KL DFG A+ S +T + T Y APE
Sbjct: 115 YCHS--HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE 171
Query: 283 YVATGHLYVKS-DVYGFGVVLLEMLTG----------------LRALDTNRPSGEHVLVD 325
+ Y K DV+ G ++ E+L G + L PS H
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPS--HQ-EL 228
Query: 326 FARPSLTDKRRLKKIMDPR-LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
F+ + P LE +YP K + A + CL +PK R + +E+L
Sbjct: 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-21
Identities = 79/285 (27%), Positives = 133/285 (46%), Gaps = 48/285 (16%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+G+G FG V G D++ G VAVK D+ + + AE + + H N
Sbjct: 14 IGKGEFGDVMLG--DYR---------GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 60
Query: 167 LVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
LV+L+G E++ L +V EYM KGSL ++L +G + L + LK ++D + + +L
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE 119
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNSHVTTRIMGTYGYAAPEYV 284
++ + ++RD A N+L+ AK+SDFGL K + + + APE +
Sbjct: 120 AN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEAL 171
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344
KSDV+ FG++L E+ + R V + R L D + PR
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPLKD-------VVPR 211
Query: 345 LEEQY----PIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+E+ Y P + ++ +C + RPS ++ E L++I
Sbjct: 212 VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 9e-21
Identities = 76/284 (26%), Positives = 131/284 (46%), Gaps = 44/284 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LG G FG V+ G+ + T VA+K S+ + AE + + HP
Sbjct: 14 LGAGQFGEVWMGYYNGHT----------KVAIKSLKQGSMS-PEAFLAEANLMKQLQHPR 62
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
LV+L ++ ++ EYM+ GSL + L + L N + +A A+ + F+
Sbjct: 63 LVRLYAVVTQE-PIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIE- 119
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY--GYAAPEYV 284
K+ I+RD +A+NIL+ + K++DFGLA+L I+ N + T R + + APE +
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARL--IEDNEY-TAREGAKFPIKWTAPEAI 175
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344
G +KSDV+ FG++L E++T R P +T+ ++
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGR---------------IPYPGMTNPEVIQN----- 215
Query: 345 LEEQY----PIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384
LE Y P +++ C + +P+ RP+ E + L++
Sbjct: 216 LERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 76/211 (36%), Positives = 99/211 (46%), Gaps = 34/211 (16%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGKFS 163
LG G FGRV V HK G GK A+K + I L++ + E + L
Sbjct: 9 LGTGSFGRVML--VRHK-------GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 164 HPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA-IDAAKDL 221
HP LV L G ++D L LV EY+ G L +HL RK P P R A + A L
Sbjct: 60 HPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPV-ARFYAAQVVLA--L 114
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM---GTYGY 278
+LHS ++YRD K N+LLD K++DFG AK V R GT Y
Sbjct: 115 EYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPEY 164
Query: 279 AAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
APE + Y K+ D + G+++ EML G
Sbjct: 165 LAPE-IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 81/312 (25%), Positives = 124/312 (39%), Gaps = 66/312 (21%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVK 157
+F+ ++GEG F V + K A+K D Q ++E VK
Sbjct: 1 DDFKFGKIIGEGSFSTVVLA---------KEKETNKEYAIKIL--DKRQLIKEKKVKYVK 49
Query: 158 F----LGKFS-HPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTR 210
L + + HP ++KL Y ++D + L V EY G L ++ + GS E TR
Sbjct: 50 IEKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK---CTR 105
Query: 211 LKIA--IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNSH 267
A + A L +LHS K +I+RD K NILLD + K++DFG AK L P
Sbjct: 106 FYAAEILLA---LEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160
Query: 268 VTTRIM-----------------GTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLR 310
GT Y +PE + SD++ G ++ +MLTG
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
Query: 311 ALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPK 370
+ + +KI+ LE +P A +I K L +P+
Sbjct: 221 PFRGS----------------NEYLTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQ 262
Query: 371 NRPSMEEVLETL 382
+R + E + L
Sbjct: 263 DRLGVNEGYDEL 274
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 83/297 (27%), Positives = 129/297 (43%), Gaps = 47/297 (15%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKA---VAVKKSNPDSI-QGLREWQAEVKFLGK 161
LG G FG V++G A +G G VAVK + Q +E+ E +
Sbjct: 2 FLGSGAFGEVYEG------TATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSN 55
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLP-----WNTRLKIAID 216
F+HPN+VKL+G C + ++ E M+ G L ++L R E L I +D
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLD 114
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILL-----DGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
AK +L I+RD A N L+ D K+ DFGLA+ I + +
Sbjct: 115 VAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYYRKE 170
Query: 272 IMGTYG--YAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFAR 328
G + APE + G +SDV+ FGV++ E+LT G +P
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLG------QQP----------Y 214
Query: 329 PSLTDKRRLKKIMDP-RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384
P+L ++ L+ + RL++ + Q++ C +P RP+ + + E LQN
Sbjct: 215 PALNNQEVLQHVTAGGRLQKPENCPDKIY--QLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 76/290 (26%), Positives = 118/290 (40%), Gaps = 25/290 (8%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNPDSIQGLREWQAEVKF 158
N + T LG G FG VF K + G V VK E++ E+
Sbjct: 6 NLQEITTLGRGEFGEVFLA----KAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLF----RKGSAEPLPWNTRLKIA 214
K SH N+V+L+G C E ++ EY G L+ L + +P P +T+ K+A
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
+ L H S ++RD A N L+ K+S L+K + + +
Sbjct: 122 LCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALI 180
Query: 275 TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334
+ APE V KSDV+ FGV++ E+ T GE L+D+
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT----------QGE-----LPFYGLSDE 225
Query: 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384
L ++ +LE P +++ +C PK+RPS E++ L
Sbjct: 226 EVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 54/224 (24%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD------SIQGLREWQAEVKFLG 160
+GEG +G+V+K G+ VA+KK + I +RE +K L
Sbjct: 7 IGEGTYGQVYKA---------RNKKTGELVALKKIRMENEKEGFPITAIRE----IKLLQ 53
Query: 161 KFSHPNLVKLIGYCWEDRQ--FLLVYEYMQ---KGSLENHLFRKGSAEPLPWNTRLKIAI 215
K HPN+V+L + +V+EYM G L++ K
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV--------------KFTE 99
Query: 216 DAAK--------DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSH 267
K L +LHS +++RD K SNIL++ KL+DFGLA+ ++
Sbjct: 100 SQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157
Query: 268 VTTRIMGTYGYAAPEYV--ATGHLY-VKSDVYGFGVVLLEMLTG 308
T R++ T Y PE + AT Y + D++ G +L E+ G
Sbjct: 158 YTNRVI-TLWYRPPELLLGAT--RYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 77/310 (24%), Positives = 131/310 (42%), Gaps = 44/310 (14%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFL 159
N LGEG FG+V K V AV + K N S + LR+ +E L
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTV--AVKMLKENASSSE-LRDLLSEFNLL 57
Query: 160 GKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL---------------FRKGSA-- 202
+ +HP+++KL G C +D LL+ EY + GSL + L R S
Sbjct: 58 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 203 ----EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258
L + A ++ + +L +E +++RD A N+L+ K+SDFGL++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYV-KSDVYGFGVVLLEMLTGLRALDTNRP 317
+ + ++ + A E + H+Y +SDV+ FGV+L E++T L N
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVT----LGGNPY 230
Query: 318 SGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEE 377
G RL ++ + P + +++ C + EP RP+ +
Sbjct: 231 PG------------IAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFAD 278
Query: 378 VLETLQNISV 387
+ + L+ + V
Sbjct: 279 ISKELEKMMV 288
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 78/289 (26%), Positives = 122/289 (42%), Gaps = 44/289 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGKFS 163
+G+G FG V K V K+ GK + K+ + ++ +E Q +EV L +
Sbjct: 8 IGKGSFGTVRK--VRRKS-------DGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELK 57
Query: 164 HPNLVKLIGYCWE-DRQFLLVY---EYMQKGSLENHLFRKGSAE--PLPWNTRLKIAIDA 217
HPN+V+ DR +Y EY + G L L +K E + +I
Sbjct: 58 HPNIVRYYD--RIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQL 114
Query: 218 AKDLTFLH---SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
L H +V++RD K +NI LD + N KL DFGLAK+ + +S +G
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVG 172
Query: 275 TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334
T Y +PE + KSD++ G ++ E+ P AR L
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL-------SPPFT------ARNQLQLA 219
Query: 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
++K+ R+ +Y L ++I L +P RPS EE+L+
Sbjct: 220 SKIKEGKFRRIPYRY--SSEL--NEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 82/305 (26%), Positives = 128/305 (41%), Gaps = 64/305 (20%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVKFLGKFSHP 165
LGEG FG+VF G H L P + VAVK + R+ ++ E + L F H
Sbjct: 13 LGEGAFGKVFLGECYH--LEPE--NDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKG-----SAEPLPWNTRL------KIA 214
N+VK G C E ++V+EYM+ G L L G P L +IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK------LGPIDGNSHV 268
+ A + +L S + ++RD N L+ K+ DFG+++ + G++ +
Sbjct: 129 VQIASGMVYLAS--QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 269 TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-------GLRALDTNRPSGEH 321
R M PE + +SDV+ FGVVL E+ T GL +N E
Sbjct: 187 PIRWM------PPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL----SNEEVIEC 236
Query: 322 VLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
+ + RL + PR E Y I++ C + +P+ R +++++
Sbjct: 237 I----------TQGRLLQ--RPRTCPSEVY---------DIMLGCWKRDPQQRINIKDIH 275
Query: 380 ETLQN 384
E LQ
Sbjct: 276 ERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 76/286 (26%), Positives = 123/286 (43%), Gaps = 43/286 (15%)
Query: 107 LGEGGFGRVFKGW-VDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
+G G FG+V+ +D L K + ++ ++P +I+ + + E+K L HP
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKE-----IRIQDNDPKTIKEIAD---EMKVLELLKHP 59
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
NLVK G + + EY G+LE L G + + L +LH
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEG--LAYLH 116
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM----GTYGYAAP 281
S +++RD K +NI LD + KL DFG A + N+ + GT Y AP
Sbjct: 117 S--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVK--LKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 282 EYV--ATGHLYVKS-DVYGFGVVLLEMLTGLR---ALDTNRPSGEHVLVDFARPSLTDKR 335
E + G + ++ D++ G V+LEM TG R LD HV +P + D
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG-HKPPIPD-- 229
Query: 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381
++ + + +CLE++PK RP+ E+L+
Sbjct: 230 --------------SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 9e-20
Identities = 81/284 (28%), Positives = 124/284 (43%), Gaps = 34/284 (11%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKA-----VAVKKSNPDSIQGLRE-WQAEVKFLG 160
LG G FG+V + T G+ K+ VAVK P + RE +E+K +
Sbjct: 43 LGAGAFGKVVEA---------TAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 161 KF-SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
+H N+V L+G C L++ EY G L N L RK + L L + AK
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAK 152
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA 279
+ FL S K+ I+RD A N+LL K+ DFGLA+ D N V +
Sbjct: 153 GMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 280 APEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339
APE + +SDV+ +G++L E+ + L +N G V F + R +
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFS----LGSNPYPGMPVDSKFYKLIKEGYRMAQP 266
Query: 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
P E Y I+ C +A+P RP+ +++++ +
Sbjct: 267 EHAP--AEIY---------DIMKTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 88/296 (29%), Positives = 122/296 (41%), Gaps = 61/296 (20%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHP 165
LGEG G V K K T + NPD Q LRE ++ P
Sbjct: 9 LGEGAGGSVTK--CRLK---NTGMIFALKTITTDPNPDLQKQILRE----LEINKSCKSP 59
Query: 166 NLVKLIGYCWEDRQ--FLLVYEYMQKGSLEN---HLFRKG---SAEPLPWNTRLKIAIDA 217
+VK G ++ + EY + GSL++ + ++G + L KIA
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-----GKIAESV 114
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
K L++LHS + +I+RD K SNILL KL DFG++ G + NS T GT
Sbjct: 115 LKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVS--GEL-VNSLAGT-FTGTSF 168
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNR----PSGEHVL---------V 324
Y APE + + SDV+ G+ LLE + NR P GE L V
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLE-------VAQNRFPFPPEGEPPLGPIELLSYIV 221
Query: 325 DFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ P L D E IK + I +CLE +P RP+ ++LE
Sbjct: 222 NMPNPELKD------------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 79/296 (26%), Positives = 132/296 (44%), Gaps = 42/296 (14%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK--SNPDSIQGLREWQAEVKFLGKFS 163
++GEG +G V K HK G+ VA+KK + D + E++ L +
Sbjct: 8 LVGEGSYGMVMK--CKHKE-------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLEN-HLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
H NLV LI ++ LV+E++ L++ + G L + K + +
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIE 114
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPE 282
F HS ++I+RD K NIL+ S KL DFG A+ + V T + T Y APE
Sbjct: 115 FCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWYRAPE 170
Query: 283 YVATGHLYVKS-DVYGFGVVLLEMLTG----------------LRALDTNRPSGEHVLVD 325
+ Y ++ D++ G ++ EMLTG ++ L P + +
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI--- 227
Query: 326 FARPSLTDKRRLKKIMDPR-LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
F + L RL ++ + LE+++P K + L + +CL +P +RPS ++L
Sbjct: 228 FQKNPLFAGMRLPEVKEIEPLEKRFP-KLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 83/291 (28%), Positives = 131/291 (45%), Gaps = 31/291 (10%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFSHP 165
LGEG FG+V D P G+ VAVK P+S + + + E++ L H
Sbjct: 12 LGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 166 NLVKLIGYCWED--RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
N+VK G C ED L+ E++ GSL+ +L R + L +LK A+ K + +
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDY 124
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID-GNSHVTTRIMGTYGYAAPE 282
L S + ++RD A N+L++ + K+ DFGL K D V + + APE
Sbjct: 125 LGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTGLRA--------LDTNRPSGEHVLVDFARPSLTDK 334
+ Y+ SDV+ FGV L E+LT + L P+ + V L +
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242
Query: 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+RL + P E+ Q++ KC E +P R + + ++E + I
Sbjct: 243 KRLPR--PPNCPEE--------VYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 5e-19
Identities = 96/313 (30%), Positives = 135/313 (43%), Gaps = 72/313 (23%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-----SNPDSIQGLREWQAEVKFLGK 161
LG+G +G V+K +D +T + VA+KK N Q R ++ E+ FL +
Sbjct: 15 LGKGAYGIVWKA-IDRRT--------KEVVALKKIFDAFRNATDAQ--RTFR-EIMFLQE 62
Query: 162 FS-HPNLVKLIGY--CWEDRQFLLVYEYM--------QKGSLEN-HLFRKGSAEPLPWNT 209
HPN+VKL+ D+ LV+EYM + LE+ H
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH-------------- 108
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNSH- 267
+ I K L ++HS VI+RD K SNILL+ KL+DFGLA+ L ++ N
Sbjct: 109 KRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166
Query: 268 -VTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG---------LRALD--- 313
V T + T Y APE + Y K D++ G +L EML G L L+
Sbjct: 167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII 226
Query: 314 --TNRPSGEHVLV---DFARPSLTD-KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEA 367
PS E + FA L R +K L+E P K + A ++ K L
Sbjct: 227 EVIGPPSAEDIESIKSPFAATMLDSLPSRPRK----PLDELLP-KASDDALDLLKKLLVF 281
Query: 368 EPKNRPSMEEVLE 380
P R + EE LE
Sbjct: 282 NPNKRLTAEEALE 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 6e-19
Identities = 81/291 (27%), Positives = 122/291 (41%), Gaps = 53/291 (18%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFSH 164
LG+G FG V +G W T G VAVK D + + ++ E + H
Sbjct: 3 LGDGSFGVVRRGEWS-------TSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH 55
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
NL++L G ++V E GSL + L RK + +T A+ A + +L
Sbjct: 56 ENLIRLYGVVL-THPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT---RIMGTYGYAAP 281
S K I+RD A NILL K+ DFGL + P + + +V ++ + + AP
Sbjct: 114 ES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAP 169
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLT-------GLRALDTNRPSGEHVLVDFARPSLTDK 334
E + T SDV+ FGV L EM T GL SG +L DK
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--------SGSQIL------KKIDK 215
Query: 335 R--RLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
RL++ P ++ Y ++++C P +RP+ + E L
Sbjct: 216 EGERLERPEACP--QDIY---------NVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 8e-19
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 103 PDTMLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLG- 160
+GEG FG V++G ++ + AVAVK + +RE KFL
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPE-------NEKIAVAVKTCKNCTSPSVRE-----KFLQE 57
Query: 161 -----KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
+F HP++VKLIG + +V E G L ++L + + L + + +
Sbjct: 58 AYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSY 114
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT-TRIMG 274
+ L +L S K ++RD A N+L+ KL DFGL++ ++ S+ ++
Sbjct: 115 QLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKL 170
Query: 275 TYGYAAPEYVATGHLYVKSDVYGFGVVLLEML 306
+ APE + SDV+ FGV + E+L
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 8e-19
Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 21/206 (10%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA--EVKFLGKFSH 164
+GEG +G V+K D T G+ VA+KK A E+K L + +H
Sbjct: 7 IGEGTYGVVYKAR-DKLT--------GEIVAIKKIKLRFESEGIPKTALREIKLLKELNH 57
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLK-IAIDAAKDLTF 223
PN++KL+ LV+E+M + K LP + +K + L F
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYK---LIKDRQRGLP-ESLIKSYLYQLLQGLAF 113
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEY 283
HS +++RD K N+L++ KL+DFGLA+ T + T Y APE
Sbjct: 114 CHSH--GILHRDLKPENLLINTEGVLKLADFGLARS--FGSPVRPYTHYVVTRWYRAPEL 169
Query: 284 VATGHLYVKS-DVYGFGVVLLEMLTG 308
+ Y D++ G + E+L+
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 38/292 (13%)
Query: 107 LGEGGFGRVFKGWVDHK-TLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LGEG FG V +G ++ ++ V K +S + ++ +E + +F HP
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE------MEDFLSEAVCMKEFDHP 60
Query: 166 NLVKLIGYCWEDRQF------LLVYEYMQKGSLENHL-FRKGSAEP--LPWNTRLKIAID 216
N+++LIG C + + +++ +M+ G L + L + + P LP +K D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT- 275
A + +L S KS I+RD A N +L+ + N ++DFGL+K +G+ + RI
Sbjct: 121 IASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSK-KIYNGDYYRQGRIAKMP 177
Query: 276 YGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LVDFARPSLTDK 334
+ A E +A KSDV+ FGV + E+ T R T P E+ + D+ R
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIAT--RG-QTPYPGVENSEIYDYLRQG---- 230
Query: 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386
RLK+ D L+ Y ++ C PK+RPS E + L+
Sbjct: 231 NRLKQPPDC-LDGLY---------SLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 75/289 (25%), Positives = 124/289 (42%), Gaps = 48/289 (16%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFSH 164
+LG+G +G V+ G + L K V + SN + + + Q EV L H
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVK-----QVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
N+V+ +G C +D + E++ GS+ + L R G PLP K + +L
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYL 118
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK----LGPIDGNSHVTTRIMGTYGYAA 280
H V++RD K +N++L + KL DFG A+ +G +S++ + GT + A
Sbjct: 119 H--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 281 PEYV-ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339
PE + +G+ KSD++ G + EM TG +P L RL
Sbjct: 177 PEVINESGYGR-KSDIWSIGCTVFEMATG-------------------KPPLASMDRLAA 216
Query: 340 I--------MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ + PRL + + + A + CL + RPS ++L
Sbjct: 217 MFYIGAHRGLMPRLPDSF----SAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 77/284 (27%), Positives = 127/284 (44%), Gaps = 37/284 (13%)
Query: 100 NFRPDTMLGEGGFGRVFKG--WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVK 157
+F+ LG+G +G V+K D++ A +V +G +K D++ E++
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS--QKEREDAVN-------EIR 51
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLF-RKGSAEPLPWNTRLKIAID 216
L +HPN++ + + +V EY G L + RK + +P +I I
Sbjct: 52 ILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
+ L LH E+ +++RD K++NILL + K+ D G++K+ + T+I GT
Sbjct: 112 LLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQI-GTP 165
Query: 277 GYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
Y APE V G Y KSD++ G +L EM T F S+ D R
Sbjct: 166 HYMAPE-VWKGRPYSYKSDIWSLGCLLYEMATF--------------APPFEARSMQDLR 210
Query: 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
K+ + PI L I L+ +PK RP+ +++L
Sbjct: 211 --YKVQRGKYPPIPPIYSQDLQ-NFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 73/296 (24%), Positives = 128/296 (43%), Gaps = 34/296 (11%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPT-------KVGVGKAVAVKKSNPDSIQGLR-EWQAEVKF 158
LGEG FG V V + PT + G VAVK PD+ + R ++ EVK
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRK-------------GSAEPL 205
L + PN+++L+G C ++ ++ EYM+ G L L A L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 206 P---WNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPI 262
P +++ L +A+ A + +L S + ++RD N L+ + K++DFG+++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 263 DGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV 322
+ R + + A E + G SDV+ FGV L E+L + + E V
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQV 250
Query: 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEV 378
++ A D+ R + P Q + +++++C + + RPS ++
Sbjct: 251 -IENAGEFFRDQGRQVYLFRPPPCPQ-GLY------ELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 72/210 (34%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREW-QAEVKFLGKF 162
+LG+G FG+V LA K G + AVK D I E E + L
Sbjct: 2 VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 163 S-HPNLVKLIGYCW--EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
HP L +L C+ +DR F V EY+ G L H+ R G A +
Sbjct: 53 GKHPFLTQLHS-CFQTKDRLFF-VMEYVNGGDLMFHIQRSGR---FDEPRARFYAAEIVL 107
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA 279
L FLH E+ +IYRD K N+LLD + K++DFG+ K G + G + T+ GT Y
Sbjct: 108 GLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYI 163
Query: 280 APEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
APE + + Y + D + GV+L EML G
Sbjct: 164 APE-ILSYQPYGPAVDWWALGVLLYEMLAG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 40/288 (13%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKS--NPDSIQGLREWQ--------AE 155
++G+G +GRV+ V G+ +AVK+ Q +E
Sbjct: 8 LIGKGTYGRVYLA---------LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
++ L H N+V+ +G+ + + EY+ GS+ + L G E
Sbjct: 59 IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE---QLVRFFTE 115
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP-IDGNSHVTTRIMG 274
+ L +LHS K +++RD KA N+L+D K+SDFG++K I N + G
Sbjct: 116 QVLEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ-NMSMQG 172
Query: 275 TYGYAAPEYVATGH--LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332
+ + APE + + K D++ G V+LEM G R E + F L
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE----EAIAAMF---KLG 225
Query: 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+KR P + + + +A + C P NRP+ E+L+
Sbjct: 226 NKRSA-----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 87/304 (28%), Positives = 136/304 (44%), Gaps = 61/304 (20%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVKFLGKFS 163
MLG+G FG V + ++ G + VAVK K++ S + E+ E + +F
Sbjct: 6 MLGKGEFGSV------REAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 164 HPNLVKLIGYCWEDRQF------LLVYEYMQKGSLENHLF--RKGSAEP--LPWNTRLKI 213
HPN++KLIG R +++ +M+ G L L R G EP LP T ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE-EPFTLPLQTLVRF 118
Query: 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM 273
ID A + +L S K+ I+RD A N +L+ + ++DFGL+K +I
Sbjct: 119 MIDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSK------------KIY 164
Query: 274 -GTY-----------GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321
G Y + A E +A SDV+ FGV + E++T R T E+
Sbjct: 165 SGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--RG-QTPYAGVEN 221
Query: 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381
+ L RLK+ D LE+ Y +++ +C EPK RPS + + +
Sbjct: 222 SEI---YNYLIKGNRLKQPPDC-LEDVY---------ELMCQCWSPEPKCRPSFQHLRDQ 268
Query: 382 LQNI 385
L+ I
Sbjct: 269 LELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-18
Identities = 72/278 (25%), Positives = 120/278 (43%), Gaps = 36/278 (12%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG G FG V G W +A + G S D I+ E K + K SHP
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAM-----SEEDFIE-------EAKVMMKLSHP 59
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLF-RKGSAEPLPWNTRLKIAIDAAKDLTFL 224
LV+L G C + + +V E+M+ G L N+L R+G + L + D + + +L
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYL 116
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
+ S I+RD A N L+ + K+SDFG+ + +D ++ ++ PE
Sbjct: 117 ERN--SFIHRDLAARNCLVSSTGVVKVSDFGMTRY-VLDDEYTSSSGAKFPVKWSPPEVF 173
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344
KSDV+ FGV++ E+ T + + + E V ++ RL + P+
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV------EMISRGFRLYR---PK 224
Query: 345 LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
L + ++ C +P+ RP+ E+L +
Sbjct: 225 LASMTVYE-------VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-18
Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 52/287 (18%)
Query: 107 LGEGGFGRV----FKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF 162
LG G FG V ++G D VA+K S+ E+ E K + K
Sbjct: 12 LGTGQFGVVKYGKWRGQYD--------------VAIKMIKEGSMSE-DEFIEEAKVMMKL 56
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
SH LV+L G C + R +V EYM G L N+L R+ P + L++ D + +
Sbjct: 57 SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQP-SQLLEMCKDVCEGMA 114
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG-NSHVTTRIMGTYGYAAP 281
+L S K I+RD A N L+D K+SDFGL++ D S V ++ ++ P
Sbjct: 115 YLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPP 170
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLT-GLRALD--TNRPSGEHVLVDFARPSLTDKRRLK 338
E + KSDV+ FGV++ E+ + G + N + E V + RL
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV---------SQGLRLY 221
Query: 339 KIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
+ P L E+ Y I+ C + + RP+ +++L +++
Sbjct: 222 R---PHLASEKVY---------AIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 4e-18
Identities = 76/298 (25%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFL 159
+ + ++G G FG V G + P K + A+ K+ Q R++ +E +
Sbjct: 5 CIKIEKVIGAGEFGEVCSG----RLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIM 59
Query: 160 GKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
G+F HPN++ L G + + ++V EYM+ GSL+ L RK + + + A
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQ-FTVIQLVGMLRGIAS 117
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG-- 277
+ +L S+ ++RD A NIL++ + K+SDFGL+++ D + TTR G
Sbjct: 118 GMKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGK 170
Query: 278 ----YAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP--SL 331
+ APE +A SDV+ +G+V+ E+++ GE RP +
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS----------YGE-------RPYWEM 213
Query: 332 TDKRRLKKIMDPRLEEQY----PIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+++ +K I EE Y P+ Q+++ C + + RP E+++ L +
Sbjct: 214 SNQDVIKAI-----EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 6e-18
Identities = 78/277 (28%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFSHP 165
+G+G FG VFKG +D++T K VA+K + + + + + Q E+ L + P
Sbjct: 12 IGKGSFGEVFKG-IDNRT--------QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
+ K G +D + ++ EY+ GS + L G PL I + K L +LH
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG---PLDETQIATILREILKGLDYLH 118
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA 285
S +K I+RD KA+N+LL KL+DFG+A G + +GT + APE +
Sbjct: 119 SEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIK 174
Query: 286 TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRL 345
K+D++ G+ +E+ G P L+ P P L
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTL 221
Query: 346 EEQY--PIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
E Y P+K + + CL EP RP+ +E+L+
Sbjct: 222 EGNYSKPLK------EFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 36/240 (15%)
Query: 89 FTLQDLRAATKNFRPDTMLGEGGFGRVF----KGWVDHKTLAPTKV-GVGKAVAVKKSNP 143
F Q LR K LGEG FG V +G + + G VAVK
Sbjct: 2 FPRQQLRLKEK-------LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRA 54
Query: 144 DSIQGLR-EWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRK--- 199
D + R ++ E+K + + +PN+++L+G C D ++ EYM+ G L L ++
Sbjct: 55 DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIE 114
Query: 200 ---GSAEPLPWNTR---LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253
A +P + L +A+ A + +L S + ++RD N L+ Y K++D
Sbjct: 115 STFTHANNIPSVSIANLLYMAVQIASGMKYLASL--NFVHRDLATRNCLVGNHYTIKIAD 172
Query: 254 FGLAK------LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
FG+++ I G + + R M A E + G SDV+ FGV L EM T
Sbjct: 173 FGMSRNLYSGDYYRIQGRAVLPIRWM------AWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 7e-18
Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LG G FG V+ G+ ++ T VAVK P ++ ++ + E + H
Sbjct: 14 LGAGQFGEVWMGYYNNST----------KVAVKTLKPGTMS-VQAFLEEANLMKTLQHDK 62
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHL-FRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
LV+L ++ ++ EYM KGSL + L +G LP + + A+ + ++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE 120
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY--GYAAPEY 283
K+ I+RD +A+N+L+ S K++DFGLA++ I+ N + T R + + APE
Sbjct: 121 --RKNYIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEY-TAREGAKFPIKWTAPEA 175
Query: 284 VATGHLYVKSDVYGFGVVLLEMLT 307
+ G +KSDV+ FG++L E++T
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 9e-18
Identities = 79/284 (27%), Positives = 137/284 (48%), Gaps = 38/284 (13%)
Query: 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS 163
+ LG G FG V+ + T VAVK P S+ + + AE +
Sbjct: 11 EKKLGAGQFGEVWMATYNKHT----------KVAVKTMKPGSMS-VEAFLAEANVMKTLQ 59
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-FRKGSAEPLPWNTRLKIAIDAAKDLT 222
H LVKL ++ +++ E+M KGSL + L +GS +PLP + + A+ +
Sbjct: 60 HDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 116
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY--GYAA 280
F+ +++ I+RD +A+NIL+ S K++DFGLA++ I+ N + T R + + A
Sbjct: 117 FIE--QRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEY-TAREGAKFPIKWTA 171
Query: 281 PEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340
PE + G +KSDV+ FG++L+E++T R + E + +L R+ +
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI------RALERGYRMPR- 224
Query: 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384
+ EE Y I+++C + P+ RP+ E + L +
Sbjct: 225 PENCPEELY---------NIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 9e-18
Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 36/281 (12%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+G G FG VF G + T V V + +++ P ++ ++ E + L ++SHPN
Sbjct: 3 IGRGNFGEVFSGRLRADN---TPVAVK---SCRETLPPDLKA--KFLQEARILKQYSHPN 54
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
+V+LIG C + + +V E +Q G L +G L +++ +AA + +L S
Sbjct: 55 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLES 112
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT-YGYAAPEYVA 285
K I+RD A N L+ K+SDFG+++ DG T + + APE +
Sbjct: 113 --KHCIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 286 TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI-MDPR 344
G +SDV+ FG++L E + L +L++++ + I R
Sbjct: 170 YGRYSSESDVWSFGILLWEAFS---------------LGAVPYANLSNQQTREAIEQGVR 214
Query: 345 LE--EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
L E P +++ +C E +P RPS V + LQ
Sbjct: 215 LPCPELCPDA----VYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 107 LGEGGFGRVFKGWVDHK----TLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF 162
LG G G V K V H +A V +G +V+K Q LRE Q + +
Sbjct: 13 LGAGNGGSVSK--VKHIPTGTVMAKKVVHIGAKSSVRK------QILRELQ----IMHEC 60
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
P +V G + + E+M GSL+ +++KG P+P KIA+ + LT
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGG--PIPVEILGKIAVAVVEGLT 117
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPE 282
+L++ +++RD K SNIL++ KL DFG++ G + NS + +GT Y +PE
Sbjct: 118 YLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGVS--GELI-NS-IADTFVGTSTYMSPE 172
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTG 308
+ G VKSDV+ G+ ++E+ G
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 35/284 (12%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFL 159
++ P +LG+G FG ++ + V K V + + + + R+ E+ L
Sbjct: 1 HYIPIRVLGKGAFGEA----TLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVIL 53
Query: 160 GKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
HPN++ + +D L+ EY G+L + + R+ + L
Sbjct: 54 SLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVS 112
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNSHVTTRIMGTYGY 278
++++H + +++RD K NI L + KL DFG++K LG S T ++GT Y
Sbjct: 113 AVSYIHKA--GILHRDIKTLNIFLTKAGLIKLGDFGISKILG--SEYSMAET-VVGTPYY 167
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338
+PE KSD++ G VL E+LT R D P LV
Sbjct: 168 MSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---LVV------------- 211
Query: 339 KIMDPRLEEQYPIKGALLAG--QIIIKCLEAEPKNRPSMEEVLE 380
KI+ P+ + ++ L+ +P+ RP+ +EVL+
Sbjct: 212 KIVQ---GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 85/296 (28%), Positives = 136/296 (45%), Gaps = 64/296 (21%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLG 160
F LGEG +G V+K HK G+ VA+K + L+E E+ L
Sbjct: 5 FDILEKLGEGSYGSVYKAI--HKET-------GQVVAIKVVPVEE--DLQEIIKEISILK 53
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI---DA 217
+ P +VK G +++ +V EY GS+ + + K + + L T +IA
Sbjct: 54 QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTL---TEEEIAAILYQT 108
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA-KLGPIDGNSHVTTRIMGTY 276
K L +LHS++K I+RD KA NILL+ AKL+DFG++ +L D + T ++GT
Sbjct: 109 LKGLEYLHSNKK--IHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNT-VIGTP 163
Query: 277 GYAAPEYVA-TGHLYVKSDVYGFGVVLLEMLTG---------LRALDT--NRPSGEHVLV 324
+ APE + G+ K+D++ G+ +EM G +RA+ N+P
Sbjct: 164 FWMAPEVIQEIGYNN-KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP------ 216
Query: 325 DFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
P+L+D P K + + KCL +P+ RPS ++L+
Sbjct: 217 ----PTLSD----------------PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 106 MLGEGGFGRVF--KGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS 163
++G G FG V + D K + + K + V++ D Q E + L S
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLV------IIKQIPVEQMTKDERLAA---QNECQVLKLLS 57
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
HPN+++ ED+ ++V EY G+L ++ ++ + L +T L + L
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHH 116
Query: 224 LHSSEKSVIYRDFKASNILLDGSYN-AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPE 282
+H+ K +++RD K NILLD K+ DFG++K I + ++GT Y +PE
Sbjct: 117 VHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISK---ILSSKSKAYTVVGTPCYISPE 171
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTGLRALD-TNRPS 318
KSD++ G VL E+ + RA + N P+
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 73/280 (26%), Positives = 128/280 (45%), Gaps = 36/280 (12%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LG G FG V+ G + T VAVK P ++ + E + + K H
Sbjct: 14 LGNGQFGEVWMGTWNGNT----------KVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDK 62
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
LV+L E +V EYM KGSL + L + G L + +A A + ++
Sbjct: 63 LVQLYAVVSE-EPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY--GYAAPEYV 284
+ I+RD +++NIL+ K++DFGLA+L I+ N + T R + + APE
Sbjct: 120 -RMNYIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEY-TARQGAKFPIKWTAPEAA 175
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344
G +KSDV+ FG++L E++T R P + ++ L+++ +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRV---------------PYPGMNNREVLEQV-ERG 219
Query: 345 LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384
P + +++++C + +P+ RP+ E + L++
Sbjct: 220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-17
Identities = 75/291 (25%), Positives = 132/291 (45%), Gaps = 45/291 (15%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKS--NPDSIQGLREWQA--- 154
N+R +LG+G FGRV+ + V G+ +A K+ +P+S + +E A
Sbjct: 3 NWRRGKLLGQGAFGRVYLCY---------DVDTGRELAAKQVQFDPESPETSKEVSALEC 53
Query: 155 EVKFLGKFSHPNLVKLIGYCWED---RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRL 211
E++ L H +V+ G C D + + EYM GS+++ L G+ L +
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA---LTESVTR 109
Query: 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNSHVTT 270
K + +++LHS+ +++RD K +NIL D + N KL DFG +K L I +
Sbjct: 110 KYTRQILEGMSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR 167
Query: 271 RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330
+ GT + +PE ++ K+DV+ G ++EMLT +P
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-------------------EKPP 208
Query: 331 LTDKRRLKKIMDPRLEEQYPIKGALLA--GQIIIKCLEAEPKNRPSMEEVL 379
+ + I + P + ++ + + C+ E ++RPS EE+L
Sbjct: 209 WAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-17
Identities = 76/288 (26%), Positives = 134/288 (46%), Gaps = 36/288 (12%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF 158
++ R D LG+G FG V+ G T G K VA+K P ++ + E +
Sbjct: 6 ESLRLDVKLGQGCFGEVWMG---------TWNGTTK-VAIKTLKPGTMMP-EAFLQEAQI 54
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
+ K H LV L E+ ++ V E+M KGSL + L ++G + L + +A A
Sbjct: 55 MKKLRHDKLVPLYAVVSEEPIYI-VTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIA 112
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY-- 276
+ ++ + I+RD +A+NIL+ + K++DFGLA+L I+ N + T R +
Sbjct: 113 DGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEY-TARQGAKFPI 167
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336
+ APE G +KSDV+ FG++L E++T R P + ++
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV---------------PYPGMVNREV 212
Query: 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384
L+++ + P +++ C + +P RP+ E + L++
Sbjct: 213 LEQV-ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 76/290 (26%), Positives = 138/290 (47%), Gaps = 44/290 (15%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-EWQAEVKFLGKFSH 164
++G G FG VF+G + K +V AVA+K P + R ++ +E +G+FSH
Sbjct: 12 VIGAGEFGEVFRGIL--KMPGRKEV----AVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRK-GSAEPLPWNTRLKIAIDAAKDLTF 223
N+++L G + + +++ EYM+ G+L+ +L G L+ A + +
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKY 122
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG-----Y 278
L S+ + ++RD A NIL++ + K+SDFGL+++ D TT + G +
Sbjct: 123 L--SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGGKIPIRW 176
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP--SLTDKRR 336
APE +A SDV+ FG+V+ E+++ GE RP +++
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMS----------FGE-------RPYWDMSNHEV 219
Query: 337 LKKIMDP-RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+K I D RL P+ Q++++C + + RP +++ L +
Sbjct: 220 MKAINDGFRLPA--PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 52/289 (17%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFL 159
F +G+G FG V+K +D +T + VA+K + + + + + Q E++FL
Sbjct: 3 FTLLECIGKGSFGEVYKA-IDKRT--------NQVVAIKVIDLEEAEDEIEDIQQEIQFL 53
Query: 160 GKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
+ P + K G + + ++ EY GS L + G L I +
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPG---KLDETYIAFILREVLL 109
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA 279
L +LH K I+RD KA+NILL + KL+DFG++ G + +GT +
Sbjct: 110 GLEYLHEEGK--IHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFVGTPFWM 165
Query: 280 APEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK---RR 336
APE + K+D++ G+ +E+ G P L+D R
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGE-------------------PPLSDLHPMRV 206
Query: 337 LKKIMD---PRLEEQY---PIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
L I P LE P K + CL +PK RPS +E+L
Sbjct: 207 LFLIPKNNPPSLEGNKFSKPFKD------FVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 75/292 (25%), Positives = 126/292 (43%), Gaps = 41/292 (14%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LGEG FG+VF + L+PTK + VAVK ++ +++Q E + L H +
Sbjct: 13 LGEGAFGKVF--LAECYNLSPTKDKM--LVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKG-------SAEPLPWNTR------LKI 213
+VK G C + ++V+EYM+ G L L G +P L I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM 273
A A + +L S + ++RD N L+ + K+ DFG+++ V M
Sbjct: 129 ASQIASGMVYLAS--QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 274 GTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLT 332
+ PE + +SDV+ FGV+L E+ T G + + +T
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------EVIECIT 239
Query: 333 DKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
R L++ PR+ +E Y I++ C + EP+ R +++E+ + L
Sbjct: 240 QGRVLER---PRVCPKEVY---------DIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 98 TKNFRPDTMLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKK-SNPDSIQGLREWQAE 155
R +LG G FG V KG W+ P + VA+K + Q +E
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWI------PEGDSIKIPVAIKTIQDRSGRQTFQEITDH 59
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLF-RKGSAEP---LPWNTRL 211
+ +G H +V+L+G C LV + GSL +H+ + S +P L W
Sbjct: 60 MLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW---- 114
Query: 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
+ AK + +L E +++R+ A NILL +++DFG+A L D + +
Sbjct: 115 --CVQIAKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170
Query: 272 IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
+ A E + G +SDV+ +GV + EM++
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-17
Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 48/286 (16%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF 158
++ R + LG+G FG V+ G + T VA+K P ++ + E +
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTT----------RVAIKTLKPGTMSP-EAFLQEAQV 54
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
+ K H LV+L E+ ++ V EYM KGSL + F KG RL +D A
Sbjct: 55 MKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLD--FLKGEMGKY---LRLPQLVDMA 108
Query: 219 KDLT--FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
+ + + ++RD +A+NIL+ + K++DFGLA+L I+ N + T R +
Sbjct: 109 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEY-TARQGAKF 165
Query: 277 --GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334
+ APE G +KSDV+ FG++L E+ T R P + ++
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNR 210
Query: 335 RRLKKIMDPRLEEQY----PIKGALLAGQIIIKCLEAEPKNRPSME 376
L ++ E Y P + ++ +C EP+ RP+ E
Sbjct: 211 EVLDQV-----ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 6e-17
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 35/220 (15%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG---------LREWQAEV 156
++G G FG V+ G G+ +AVK+ S+ L E+
Sbjct: 7 LIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREI 57
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQFLLVY-EYMQKGSLENHLFRKGS-AEPLPWNTRLKIA 214
L + H N+V+ +G D L ++ EY+ GS+ L G+ E L N +I
Sbjct: 58 ALLKELQHENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL 116
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR--- 271
K L +LH+ + +I+RD K +NIL+D K+SDFG++K ++ NS T
Sbjct: 117 ----KGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGA 168
Query: 272 ---IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG 308
+ G+ + APE V K+D++ G +++EMLTG
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 7e-17
Identities = 78/310 (25%), Positives = 137/310 (44%), Gaps = 60/310 (19%)
Query: 84 NYLKMFTLQ-DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSN 142
L++ D R+ NF +GEG G V +A T G+ VAVKK +
Sbjct: 6 AALQLVVDPGDPRSYLDNF---VKIGEGSTGIV--------CIA-TDKSTGRQVAVKKMD 53
Query: 143 PDSIQGLREWQA------EVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL 196
LR+ Q EV + + HPN+V++ + +V E+++ G+L + +
Sbjct: 54 ------LRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV 107
Query: 197 FRKGSAEPLPWNTRLKIA---IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253
E +IA + K L+FLH+ + VI+RD K+ +ILL KLSD
Sbjct: 108 THTRMNEE-------QIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSD 158
Query: 254 FGL-AKLGPIDGNSHVTTR--IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLR 310
FG A++ + V R ++GT + APE ++ + D++ G++++EM+ G
Sbjct: 159 FGFCAQV-----SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213
Query: 311 ALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPK 370
F P L +R++ + P+L+ + + L + + + L +P
Sbjct: 214 PY-------------FNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRS--FLDRMLVRDPA 258
Query: 371 NRPSMEEVLE 380
R + E+L
Sbjct: 259 QRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 54/157 (34%), Positives = 84/157 (53%), Gaps = 14/157 (8%)
Query: 155 EVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA 214
E+K L + + P +V G + D + + E+M GSL+ L + G +P N KI+
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPENILGKIS 105
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA-KLGPID--GNSHVTTR 271
I + LT+L + +++RD K SNIL++ KL DFG++ +L ID NS V TR
Sbjct: 106 IAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTR 162
Query: 272 IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG 308
Y +PE + H V+SD++ G+ L+EM G
Sbjct: 163 -----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 8e-17
Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 14/206 (6%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
++G G FG V +G + P K + A+ KS Q R++ +E +G+F HP
Sbjct: 11 VIGAGEFGEVCRGRLKL----PGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHP 65
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-FRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
N++ L G + R +++ E+M+ G+L++ L G + L+ A + +L
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL 122
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG---TYGYAAP 281
SE + ++RD A NIL++ + K+SDFGL++ D + T +G + AP
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLT 307
E +A SDV+ +G+V+ E+++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 79/289 (27%), Positives = 120/289 (41%), Gaps = 57/289 (19%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+G G +G V+K D T G+ VA+K + Q E+ L + HPN
Sbjct: 11 IGSGTYGDVYKA-RDIAT--------GELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 167 LVKLIG-YCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI---DAAKDLT 222
+V G Y D+ ++ V EY GSL++ + + PL L+IA + K L
Sbjct: 62 IVAYFGSYLRRDKLWI-VMEYCGGGSLQDIY--QVTRGPLS---ELQIAYVCRETLKGLA 115
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPE 282
+LH + K I+RD K +NILL + KL+DFG++ + +GT + APE
Sbjct: 116 YLHETGK--IHRDIKGANILLTEDGDVKLADFGVS--AQLTATIAKRKSFIGTPYWMAPE 171
Query: 283 YVA---TGHLYVKSDVYGFGVVLLEMLTG---------LRALDTNRPSGEHVLVDFARPS 330
A G K D++ G+ +E+ +RAL S F P
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN------FPPPK 225
Query: 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
L DK + + I KCL +PK RP+ ++L
Sbjct: 226 LKDKEKWSPVFH----------------DFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 76/288 (26%), Positives = 130/288 (45%), Gaps = 36/288 (12%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP-DSIQGLREWQAEVKFLGKFSH 164
++G+G FG V+ H TL + G AVK N ++ + ++ E + FSH
Sbjct: 2 VIGKGHFGCVY-----HGTLIDSD-GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSH 55
Query: 165 PNLVKLIGYCWEDRQF-LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
PN++ L+G C L+V YM+ G L + R + P + + + AK + +
Sbjct: 56 PNVLSLLGICLPSEGSPLVVLPYMKHGDLR-NFIRSETHNPTVKDL-IGFGLQVAKGMEY 113
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK--LGPIDGNSHVTTRIMGTYGYAAP 281
L + K ++RD A N +LD S+ K++DFGLA+ + H T + A
Sbjct: 114 L--ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341
E + T KSDV+ FGV+L E++T R + + L RRL
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITVY----LLQGRRL---- 221
Query: 342 DPRLEEQY---PIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386
L+ +Y P+ ++++ C +P+ RP+ E++ ++ I
Sbjct: 222 ---LQPEYCPDPLY------EVMLSCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKS--NPDSIQGLREWQA--- 154
N+R +LG+G FGRV+ + G+ +AVK+ +P+S + +E A
Sbjct: 3 NWRLGKLLGQGAFGRVYLCY---------DADTGRELAVKQVQFDPESPETSKEVNALEC 53
Query: 155 EVKFLGKFSHPNLVKLIGYCWED---RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRL 211
E++ L H +V+ G C D R + E+M GS+++ L G+ L N
Sbjct: 54 EIQLLKNLLHERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGA---LTENVTR 109
Query: 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNSHVTT 270
K + +++LHS+ +++RD K +NIL D N KL DFG +K L I +
Sbjct: 110 KYTRQILEGVSYLHSN--MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK 167
Query: 271 RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
+ GT + +PE ++ K+D++ G ++EMLT
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 79/288 (27%), Positives = 127/288 (44%), Gaps = 53/288 (18%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LG+G FG+V+K HK K + ++ L ++ E+ L + HPN
Sbjct: 13 LGDGAFGKVYK--AQHKE--TGLFAAAKIIQIESEEE-----LEDFMVEIDILSECKHPN 63
Query: 167 LVKLI-GYCWEDRQFLLVYEYMQKGSLENHLFR--KGSAEPLPWNTRLKIAI---DAAKD 220
+V L Y +E++ ++L+ E+ G+L++ + +G EP +I +
Sbjct: 64 IVGLYEAYFYENKLWILI-EFCDGGALDSIMLELERGLTEP-------QIRYVCRQMLEA 115
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAA 280
L FLHS VI+RD KA NILL + KL+DFG++ T +GT + A
Sbjct: 116 LNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMA 171
Query: 281 PEYVATGHL----Y-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
PE VA Y K+D++ G+ L+E+ P L R
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQM-------EP---------PHHELNPMR 215
Query: 336 RLKKIMD---PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
L KI+ P L++ P K + + CL +P +RP+ E+L+
Sbjct: 216 VLLKILKSEPPTLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 19/193 (9%)
Query: 133 GKAVAVKKSNPDSIQGLRE---WQAEVKFLGKFSHPNLVKLI--GYCWEDRQFLLVYEYM 187
G VA+K D+ + + ++ E + HPN+V L+ G F V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYV 61
Query: 188 QKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL---D 244
+L L G LP ++ + L H+ + +++RD K NI++
Sbjct: 62 PGRTLREVLAADG---ALPAGETGRLMLQVLDALACAHN--QGIVHRDLKPQNIMVSQTG 116
Query: 245 GSYNAKLSDFGLAKLGPIDGNSHV-----TTRIMGTYGYAAPEYVATGHLYVKSDVYGFG 299
+AK+ DFG+ L P ++ V TT ++GT Y APE + + SD+Y +G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 300 VVLLEMLTGLRAL 312
++ LE LTG R +
Sbjct: 177 LIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 33/222 (14%)
Query: 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNPDSIQGLREWQAEVKFLGKF 162
+ ++GEG FG+V + + K G+ A+K S R++ E++ L K
Sbjct: 7 EDVIGEGNFGQVIRAMI-------KKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 163 S-HPNLVKLIGYCWEDRQFLLV-YEYMQKGSLENHLFRK-------------GSAEPLPW 207
HPN++ L+G C E+R +L + EY G+L + L + G+A L
Sbjct: 60 GHHPNIINLLGAC-ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 208 NTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSH 267
L+ A D A + +L SEK I+RD A N+L+ + +K++DFGL++ G
Sbjct: 119 QQLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEV 171
Query: 268 VTTRIMGTYG--YAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
+ MG + A E + KSDV+ FGV+L E+++
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 86/306 (28%), Positives = 121/306 (39%), Gaps = 80/306 (26%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVKFLGKFS- 163
+GEG +G+V+K KT G+ VA+K D + E + E L K+S
Sbjct: 14 IGEGTYGKVYKA-RHKKT--------GQLVAIKIMDIIEDEEE---EIKEEYNILRKYSN 61
Query: 164 HPNLVKLIG------YCWEDRQFLLVYEYMQKGS---LENHLFRKGSAEPLPWNTRLKIA 214
HPN+ G D Q LV E GS L L +KG W IA
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IA 116
Query: 215 I---DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
+ + L +LH E VI+RD K NILL + KL DFG++ + + +
Sbjct: 117 YILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVS--------AQLDST 166
Query: 272 IM------GTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGE 320
+ GT + APE +A +SDV+ G+ +E+ G
Sbjct: 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG------------ 214
Query: 321 HVLVDFARPSLTDK---RRLKKIM---DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS 374
+P L D R L KI P L+ P + I +CL + RP
Sbjct: 215 -------KPPLCDMHPMRALFKIPRNPPPTLKS--PENWSKKFNDFISECLIKNYEQRPF 265
Query: 375 MEEVLE 380
MEE+LE
Sbjct: 266 MEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 37/225 (16%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEV---KFLGK 161
LGEG FG+V K + L VAVK D+ + L + +E+ K +GK
Sbjct: 19 PLGEGAFGQVVKA--EAVGLDNPNETS--TVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEP-----LPWNTRLKI--- 213
H N++ L+G C ++ +V EY G+L + L + P +
Sbjct: 75 --HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 214 -----AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPID---- 263
A A+ + FL S K I+RD A N+L+ + K++DFGLA+ + ID
Sbjct: 133 DLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 264 -GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
N + + M APE + +SDV+ FGV+L E+ T
Sbjct: 191 TTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 41/278 (14%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFSHP 165
+G+G FG VFKG +D++T + VA+K + + + + + Q E+ L + P
Sbjct: 12 IGKGSFGEVFKG-IDNRT--------QQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
+ K G + + ++ EY+ GS + L R G + T LK + K L +LH
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLK---EILKGLDYLH 118
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA 285
S +K I+RD KA+N+LL + KL+DFG+A G + +GT + APE +
Sbjct: 119 SEKK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQ 174
Query: 286 TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-DFARPSLTDK--RRLKKIMD 342
K+D++ G+ +E+ G P L+ P+LT + + K+ +D
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFID 234
Query: 343 PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
CL +P RP+ +E+L+
Sbjct: 235 --------------------ACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 74/250 (29%), Positives = 102/250 (40%), Gaps = 64/250 (25%)
Query: 99 KNFRPDTMLGEGGFGRVFKGW-VDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVK 157
+F ++G G FG V+ D + KV + K+ +K+ + I +R AE
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKV-LRKSDMIKR---NQIAHVR---AERD 53
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS----------AEPLP 206
L P +VKL Y ++D + L LV EYM G L N L RK AE
Sbjct: 54 ILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAE--- 109
Query: 207 WNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-------- 258
L +A+D+ L F+H RD K NIL+D + KL+DFGL K
Sbjct: 110 ----LVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157
Query: 259 ----------LGPIDGNSHVTTR---------IMGTYGYAAPEYVATGHLY-VKSDVYGF 298
L + +GT Y APE V G Y ++ D +
Sbjct: 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSL 216
Query: 299 GVVLLEMLTG 308
GV+L EML G
Sbjct: 217 GVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAV-AVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LGEG FG+VF + L P + + AV A+K+++ + Q ++Q E + L H
Sbjct: 13 LGEGAFGKVFLAECHN--LLPEQDKMLVAVKALKEASESARQ---DFQREAELLTVLQHQ 67
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSL---------ENHLFRKGSAEP---LPWNTRLKI 213
++V+ G C E R L+V+EYM+ G L + + G L L I
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM 273
A A + +L S ++RD N L+ K+ DFG+++ V R M
Sbjct: 128 ASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 274 GTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
+ PE + +SD++ FGVVL E+ T
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG--LREWQAEVKFLGKFSH 164
+GEG G VFK D +T G+ VA+KK ++G + E+K L H
Sbjct: 8 IGEGAHGIVFKA-KDRET--------GETVALKKVALRRLEGGIPNQALREIKALQACQH 58
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
P +VKL+ F+LV EYM L L + PLP K + ++
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVL--RDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
H++ +++RD K +N+L+ K++DFGLA+L + + ++ T Y APE +
Sbjct: 116 HAN--GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELL 172
Query: 285 ATGHLYVKS-DVYGFGVVLLEMLTG 308
Y D++ G + E+L G
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 74/276 (26%), Positives = 121/276 (43%), Gaps = 37/276 (13%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+G+G FG V+KG + TK V + + D I+ + Q E+ L + P
Sbjct: 12 IGKGSFGEVYKGIDNR-----TKEVVAIKIIDLEEAEDEIEDI---QQEITVLSQCDSPY 63
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
+ + G + + ++ EY+ GS + L + G E T L+ + K L +LHS
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILR---EILKGLDYLHS 119
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT 286
K I+RD KA+N+LL + KL+DFG+A G + +GT + APE +
Sbjct: 120 ERK--IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 287 GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLE 346
K+D++ G+ +E+ G P L+ P P LE
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLE 222
Query: 347 EQY--PIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
QY P K + + CL +P+ RP+ +E+L+
Sbjct: 223 GQYSKPFK------EFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREW---QAEVKFLGKFS 163
LG GGFGRV V K + A+K I + +E + L + +
Sbjct: 1 LGVGGFGRVEL--VKVK-------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN 51
Query: 164 HPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA--IDAAKD 220
HP +VKL ++D++++ ++ EY G L L +G + + R IA + A
Sbjct: 52 HPFIVKLYRT-FKDKKYIYMLMEYCLGGELWTILRDRGLFDE--YTARFYIACVVLA--- 105
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAA 280
+LH+ + +IYRD K N+LLD + KL DFG AK + T GT Y A
Sbjct: 106 FEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAK---KLKSGQKTWTFCGTPEYVA 160
Query: 281 PEYV-ATGHLYVKSDVYGFGVVLLEMLTG 308
PE + G+ + D + G++L E+LTG
Sbjct: 161 PEIILNKGYDFS-VDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 78/213 (36%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGK 161
++G+G FG+V HK GK AVK +I +E + AE L K
Sbjct: 1 KVIGKGSFGKVLL--AKHKA-------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLK 51
Query: 162 -FSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKI-AIDA 217
HP LV L Y ++ L V +Y+ G L HL R+ S EP R + A +
Sbjct: 52 NVKHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAAEI 105
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
A L +LHS ++IYRD K NILLD + L+DFGL K G I+ + T+ GT
Sbjct: 106 ASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG-IEHSK-TTSTFCGTPE 161
Query: 278 YAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGL 309
Y APE V Y ++ D + G VL EML GL
Sbjct: 162 YLAPE-VLRKQPYDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 69/221 (31%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEV 156
+F +LG+G FG+V LA K G + A+K D + + E
Sbjct: 1 DFNFLMVLGKGSFGKVM--------LAERK-GTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 157 KFLGKFSHPNLVKLIGYCWE--DRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKI 213
+ L P + + C++ DR + V EY+ G L H+ + G EP +I
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYF-VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEI 110
Query: 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM 273
++ L FLH + +IYRD K N++LD + K++DFG+ K +DG VTTR
Sbjct: 111 SVG----LFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTF 161
Query: 274 -GTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALD 313
GT Y APE +A D + +GV+L EML G D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-16
Identities = 78/279 (27%), Positives = 125/279 (44%), Gaps = 35/279 (12%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP-DSIQGLREWQAEVKFLGKFSHP 165
LG+G FG V+ D K +A ++ V K + V + NP +++Q +E Q L K HP
Sbjct: 8 LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ----LLSKLDHP 62
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFR-KGSAEPLPWNTRLKIAIDAAKDLTFL 224
+VK E F ++ EY + L+ L K + + L N + I + ++
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
H ++ +++RD KA NI L + K+ DFG+++L + G+ + T GT Y +PE +
Sbjct: 123 H--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEAL 177
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALD-TNRPSGEHVLVDFARPSLTDK--RRLKKIM 341
KSD++ G +L EM A + N S +V+ PSL + R+L IM
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM 237
Query: 342 DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
L +P RPS E+L
Sbjct: 238 Q--------------------SMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-16
Identities = 65/206 (31%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFS 163
LG+GGFG V A GK A KK + + +G + E K L K S
Sbjct: 1 LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51
Query: 164 HPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
+V L Y +E + L LV M G L+ H++ G P + A L
Sbjct: 52 SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLE 109
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPE 282
LH ++ ++YRD K N+LLD N ++SD GLA + G + R GT GY APE
Sbjct: 110 HLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAV--ELKGGKKIKGRA-GTPGYMAPE 164
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTG 308
+ D + G L EM+ G
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 72/213 (33%), Positives = 102/213 (47%), Gaps = 33/213 (15%)
Query: 110 GGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG---LREWQAEVKFLGKFSHPN 166
G +GRVF LA K G A+K + + + E L + P
Sbjct: 4 GAYGRVF--------LAKKKS-TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 167 LVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWN-TRLKIA-IDAAKDLTF 223
+VKL Y ++ ++ L LV EY+ G L + L GS L + R+ IA I A L +
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGS---LDEDVARIYIAEIVLA--LEY 108
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG-------PIDGNSHVTTRIMGTY 276
LHS+ +I+RD K NIL+D + + KL+DFGL+K+G D RI+GT
Sbjct: 109 LHSN--GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE-DKRIVGTP 165
Query: 277 GYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
Y APE V G + K+ D + G +L E L G
Sbjct: 166 DYIAPE-VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 74/212 (34%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGK 161
+LG+G FG+V LA K G + A+K D I + E + L
Sbjct: 6 MVLGKGSFGKVM--------LAERK-GTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL 56
Query: 162 FSHPNLVKLIGYCWE--DRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAA 218
P + + C++ DR + V EY+ G L H+ + G EP +IAI
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYF-VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG-- 113
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM-GTYG 277
L FLHS K +IYRD K N++LD + K++DFG+ K G TTR GT
Sbjct: 114 --LFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG---KTTRTFCGTPD 166
Query: 278 YAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
Y APE +A Y KS D + FGV+L EML G
Sbjct: 167 YIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 90/309 (29%), Positives = 127/309 (41%), Gaps = 57/309 (18%)
Query: 83 PNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSN 142
P ++F+ D K F +G G FG V+ V + VA+KK +
Sbjct: 2 PEIAELFSKDD---PEKLFTDLREIGHGSFGAVYFA---------RDVRTNEVVAIKKMS 49
Query: 143 PDSIQGLREWQ---AEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGS----LENH 195
Q +WQ EV+FL + HPN ++ G + LV EY GS LE H
Sbjct: 50 YSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVH 108
Query: 196 LFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255
+K PL I A + L +LHS E+ I+RD KA NILL KL+DFG
Sbjct: 109 --KK----PLQEVEIAAICHGALQGLAYLHSHER--IHRDIKAGNILLTEPGTVKLADFG 160
Query: 256 LAKL-GPIDGNSHVTTRIMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLLEMLTGLRA 311
A L P NS V GT + APE + G K DV+ G+ +E+
Sbjct: 161 SASLVSP--ANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
Query: 312 L-DTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPK 370
L + N S + + P+L+ + + CL+ P+
Sbjct: 214 LFNMNAMSALYHIAQNDSPTLS-----------------SNDWSDYFRNFVDSCLQKIPQ 256
Query: 371 NRPSMEEVL 379
+RPS EE+L
Sbjct: 257 DRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 70/212 (33%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGK---- 161
+LG+G FG+V LA K G+ AVK D I L++ E K
Sbjct: 2 VLGKGSFGKVM--------LARLK-ESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILS 50
Query: 162 --FSHPNLVKLIGYCWE--DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKI-AID 216
+HP L +L C++ DR F V E++ G L H+ + + R + A +
Sbjct: 51 LARNHPFLTQLY-CCFQTPDRLFF-VMEFVNGGDLMFHIQKSRRFD----EARARFYAAE 104
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
L FLH +K +IYRD K N+LLD + KL+DFG+ K G +G + T+ GT
Sbjct: 105 ITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTP 160
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG 308
Y APE + D + GV+L EML G
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 64/215 (29%), Positives = 93/215 (43%), Gaps = 42/215 (19%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGKFS 163
LG G FGRV HK G G+ A+K I +++ Q E L + S
Sbjct: 26 LGTGSFGRV--RIAKHK-------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK---- 219
HP +V ++ ++ + + E++ G L HL + G + D AK
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG-----------RFPNDVAKFYHA 125
Query: 220 --DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR---IMG 274
L F + K +IYRD K N+LLD + K++DFG AK V R + G
Sbjct: 126 ELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--------KVPDRTFTLCG 177
Query: 275 TYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTG 308
T Y APE + + GH D + GV+L E + G
Sbjct: 178 TPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-----LREWQA 154
NF+ LGEG + V+KG G+ VA+K+ + D+ +G +RE
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIRE--- 48
Query: 155 EVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA 214
+ + + H N+V+L + + +LV+EYM K L+ ++ G L NT
Sbjct: 49 -ISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
K + F H E V++RD K N+L++ KL+DFGLA+ I N+ +
Sbjct: 107 YQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-- 162
Query: 275 TYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGL 309
T Y AP+ + Y S D++ G ++ EM+TG
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 107 LGEGGFGRVFKGWV-----DHKTLAPTKVGVGKAVAVKK-SNPDSIQGLREWQAEVKFLG 160
LGE FG+++KG + DH L VA+K + ++ Q E+Q E +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQL----------VAIKTLKDINNPQQWGEFQQEASLMA 62
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS--------------AEPLP 206
+ HPN+V L+G +++ +++EY+ +G L L + L
Sbjct: 63 ELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122
Query: 207 WNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNS 266
L IAI A + +L S +++D A NIL+ + K+SD GL++
Sbjct: 123 HGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY 180
Query: 267 HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
V + + + PE + G SD++ FGVVL E+ +
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNPDSIQGLREWQAEVKFLGKFSH 164
++GEG FG+V K + K G+ A+K+ S R++ E++ L K H
Sbjct: 2 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 165 -PNLVKLIGYCWEDRQFLLV-YEYMQKGSLENHLFRK-------------GSAEPLPWNT 209
PN++ L+G C E R +L + EY G+L + L + +A L
Sbjct: 55 HPNIINLLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269
L A D A+ + +L S+K I+RD A NIL+ +Y AK++DFGL++ G
Sbjct: 114 LLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 166
Query: 270 TRIMGTYG--YAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
+ MG + A E + SDV+ +GV+L E+++
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 72/280 (25%), Positives = 123/280 (43%), Gaps = 42/280 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSN--PDSIQGLREWQAEVKFLGKFSH 164
+G+G +G V V H+T GK +KK N S + + + E + L + H
Sbjct: 8 VGKGSYGEV--SLVRHRTD-------GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH 58
Query: 165 PNLVKLIGYCWE--DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
PN+V WE D +V + + G L H ++ + LP N ++ + A L
Sbjct: 59 PNIV-AYRESWEGEDGLLYIVMGFCEGGDLY-HKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPE 282
+LH EK +++RD K N+ L + K+ D G+A++ ++ + + ++GT Y +PE
Sbjct: 117 YLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPYYMSPE 172
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLT---GLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339
+ KSDV+ G + EM T A D N S + +++ P +
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--SLVYRIIEGKLPPMPKD----- 225
Query: 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
P L G++I L P+ RPS++ +L
Sbjct: 226 -YSPEL------------GELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 76/304 (25%), Positives = 130/304 (42%), Gaps = 48/304 (15%)
Query: 107 LGEGGFGRV-------FKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-EWQAEVKF 158
LGEG FG V + ++D VAVK D+ + R ++ E+K
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFR--------KGSAEPLPWNTR 210
+ + PN+++L+ C ++ EYM+ G L L R K + ++T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK------LGPIDG 264
+ +A A + +L S + ++RD N L+ +Y K++DFG+++ I G
Sbjct: 133 IFMATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190
Query: 265 NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV 324
+ + R M + E + G SDV+ FGV L E+LT + ++ S E V+
Sbjct: 191 RAVLPIRWM------SWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE 244
Query: 325 ---DFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
+F R D+ R + P L + Y ++++ C K RPS +E+
Sbjct: 245 NTGEFFR----DQGRQVYLPKPALCPDSLY---------KLMLSCWRRNAKERPSFQEIH 291
Query: 380 ETLQ 383
TL
Sbjct: 292 ATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 72/210 (34%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGK---- 161
MLG+G FG+VF LA K G + A+K D + L + E + K
Sbjct: 2 MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLS 50
Query: 162 --FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
+ HP L L V EY+ G L H+ + LP T A +
Sbjct: 51 LAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHI-QSCHKFDLPRATFY--AAEIIC 107
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA 279
L FLHS K ++YRD K NILLD + K++DFG+ K + G++ T GT Y
Sbjct: 108 GLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENML-GDAK-TCTFCGTPDYI 163
Query: 280 APEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
APE + G Y S D + FGV+L EML G
Sbjct: 164 APE-ILLGQKYNTSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 75/290 (25%), Positives = 132/290 (45%), Gaps = 60/290 (20%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSH 164
+LG G G V+K + + + +AVK D +++ ++ +E++ L K
Sbjct: 8 ILGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS 58
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
P ++ G + + + + E+M GSL+ ++RK +P + +IA+ K LT+L
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSLD--VYRK-----IPEHVLGRIAVAVVKGLTYL 111
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
S + +++RD K SN+L++ KL DFG++ NS T + GT Y APE +
Sbjct: 112 WSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYV-GTNAYMAPERI 165
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP-------SLTDKRRL 337
+ + SDV+ G+ +E+ G F P SL + L
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGR----------------FPYPQIQKNQGSLMPLQLL 209
Query: 338 KKIMDPRLEEQYPIKGALLAGQ-------IIIKCLEAEPKNRPSMEEVLE 380
+ I+D E P+ L GQ I +C+ +PK RP+ E +++
Sbjct: 210 QCIVD----EDPPV---LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 36/292 (12%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LGEG FG+VF + L P + + VAVK S +++ E + L H +
Sbjct: 13 LGEGAFGKVF--LAECYNLCPEQDKI--LVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKG-------SAEP---LPWNTRLKIAID 216
+VK G C E ++V+EYM+ G L L G L + L IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
A + +L S + ++RD N L+ + K+ DFG+++ V M
Sbjct: 129 IAAGMVYLAS--QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336
+ PE + +SDV+ GVVL E+ T + + E + +T R
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI------ECITQGRV 240
Query: 337 LKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386
L++ PR +E Y +++ C + EP R +++E+ LQN++
Sbjct: 241 LQR---PRTCPKEVY---------DLMLGCWQREPHMRLNIKEIHSLLQNLA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 67/205 (32%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
+LG+G FG+VF + + G A+ V K ++ + E L + +HP
Sbjct: 3 VLGQGSFGKVFL----VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHP 58
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI-DAAKDLTFL 224
+VKL + + L+ ++++ G L F + S E + +K + + A L L
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHL 114
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
HS +IYRD K NILLD + KL+DFGL+K ID GT Y APE V
Sbjct: 115 HSL--GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKK-AYSFCGTVEYMAPEVV 170
Query: 285 -ATGHLYVKSDVYGFGVVLLEMLTG 308
GH +D + FGV++ EMLTG
Sbjct: 171 NRRGHTQ-SADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 68/214 (31%), Positives = 97/214 (45%), Gaps = 37/214 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK---SNPDSIQ---GLREWQAEVKFLG 160
+GEG +G VFK ++ G+ VA+KK S D + LRE ++ L
Sbjct: 9 IGEGSYGVVFK--CRNRE-------TGQIVAIKKFVESEDDPVIKKIALRE----IRMLK 55
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFR--KGSAEPLPWNTRLKIAIDAA 218
+ HPNLV LI R+ LV+EY ++ N L + +G +P + KI
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRG----VPEHLIKKIIWQTL 110
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL---GPIDGNSHVTTRIMGT 275
+ + F H + I+RD K NIL+ KL DFG A++ D +V TR
Sbjct: 111 QAVNFCHKH--NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR---- 164
Query: 276 YGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
Y APE + Y DV+ G V E+LTG
Sbjct: 165 -WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-15
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKS--NPDSIQGLREWQA--- 154
N+R +LG G FG V+ + G+ +AVK+ +PDS + +E A
Sbjct: 3 NWRLGKLLGRGAFGEVYLCY---------DADTGRELAVKQVPFDPDSQETSKEVNALEC 53
Query: 155 EVKFLGKFSHPNLVKLIGYCWED---RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRL 211
E++ L H +V+ G C D ++ + EYM GS+++ L G+ L N
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA---LTENVTR 109
Query: 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNSHVTT 270
+ + +++LHS+ +++RD K +NIL D + N KL DFG +K + I +
Sbjct: 110 RYTRQILQGVSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK 167
Query: 271 RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
+ GT + +PE ++ K+DV+ ++EMLT
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 72/245 (29%), Positives = 100/245 (40%), Gaps = 60/245 (24%)
Query: 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK----SNPDS--IQGLR 150
+++ LGEG FG V+K KT G+ VA+KK + D I LR
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKA-RQIKT--------GRVVALKKILMHNEKDGFPITALR 56
Query: 151 EWQAEVKFLGKFSHPNLVKLIGYCWE--DRQ------FLLVYEYMQK---GSLENHLFR- 198
E +K L K HPN+V LI E D+ +V YM G LEN +
Sbjct: 57 E----IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKL 112
Query: 199 -----KGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253
K L +LH E +++RD KA+NIL+D K++D
Sbjct: 113 TESQIKCYMLQLLEGIN------------YLH--ENHILHRDIKAANILIDNQGILKIAD 158
Query: 254 FGLAKL---------GPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLL 303
FGLA+ G G + T ++ T Y PE + Y + D++G G V
Sbjct: 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFA 218
Query: 304 EMLTG 308
EM T
Sbjct: 219 EMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 7e-15
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 37/204 (18%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG---------LREWQAEVK 157
LGEG + V+K D +T G+ VA+KK + LRE +K
Sbjct: 8 LGEGTYAVVYKA-RDKET--------GRIVAIKKIKLGERKEAKDGINFTALRE----IK 54
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAID 216
L + HPN++ L+ + + + LV+E+M+ LE + + S P + + +
Sbjct: 55 LLQELKHPNIIGLLD-VFGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPADIK-SYMLM 110
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
+ L +LHS +++RD K +N+L+ KL+DFGLA+ N +T +++ T
Sbjct: 111 TLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV-TR 166
Query: 277 GYAAPEYVATGHLYVKSDVYGFGV 300
Y APE L + YG GV
Sbjct: 167 WYRAPE------LLFGARHYGVGV 184
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEV 156
+ +G G FGRV L ++ A+K + L++ Q E
Sbjct: 2 DLERIKTVGTGTFGRVH--------LVRDRIS-EHYYALKVMAIPEVIRLKQEQHVHNEK 52
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAID 216
+ L + SHP +++L + R ++ EY+ G L ++L G +T L A +
Sbjct: 53 RVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASE 109
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
L +LHS K ++YRD K NILLD + KL+DFG AK T + GT
Sbjct: 110 IVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTP 162
Query: 277 GYAAPEYVA-TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSG 319
Y APE + GH D + G+++ EML G + P G
Sbjct: 163 EYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 7e-15
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 40/219 (18%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-----SNPDSIQGLREWQAEVKFLGK 161
LG+G FG V+ + +T G+ VA+KK + + LRE VK L K
Sbjct: 7 LGDGTFGSVYLA-RNKET--------GELVAIKKMKKKFYSWEECMNLRE----VKSLRK 53
Query: 162 F-SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
HPN+VKL E+ + V+EYM +G+L L + +P + I +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAA 280
L +H +RD K N+L+ G K++DFGLA+ I T + T Y A
Sbjct: 112 LAHIHKH--GFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYV-STRWYRA 166
Query: 281 PEYVATGHLYVKS-------DVYGFGVVLLEMLTGLRAL 312
PE + ++S D++ G ++ E+ T LR L
Sbjct: 167 PE------ILLRSTSYSSPVDIWALGCIMAELYT-LRPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 7e-15
Identities = 63/235 (26%), Positives = 98/235 (41%), Gaps = 72/235 (30%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP---DSIQGLREWQAEVKFLGKFS 163
+G G +G V VD +T G+ VA+KK + D I R + E+K L
Sbjct: 8 IGSGAYGVVCSA-VDKRT--------GRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLR 57
Query: 164 HPNLVKLI-------GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAID 216
H N++ L+ + D +V E M+ T L I
Sbjct: 58 HENIIGLLDILRPPSPEDFND--VYIVTELME--------------------TDLHKVIK 95
Query: 217 AAKDLT----------------FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260
+ + LT +LHS+ +VI+RD K SNIL++ + + K+ DFGLA+
Sbjct: 96 SPQPLTDDHIQYFLYQILRGLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153
Query: 261 PIDGNS------HVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
D + +V TR Y APE + + Y K+ D++ G + E+LT
Sbjct: 154 DPDEDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 71/219 (32%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-------SNPDSIQGLREWQ 153
FR +LG G FG+V LA K G+ A+K + D ++ L +
Sbjct: 1 FRCLAVLGRGHFGKVL--------LAEYK-KTGELYAIKALKKGDIIAR-DEVESLMCEK 50
Query: 154 AEVKFLGKFSHPNLVKLIGYCW--EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRL 211
+ HP LV L C+ ED V EY G L H+ +EP R
Sbjct: 51 RIFETANSERHPFLVNLFA-CFQTEDHVCF-VMEYAAGGDLMMHIHTDVFSEP-----RA 103
Query: 212 KI-AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT 270
A L +LH E ++YRD K N+LLD K++DFGL K G G T+
Sbjct: 104 VFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM--GFGDRTS 159
Query: 271 RIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
GT + APE V T Y ++ D +G GV++ EML G
Sbjct: 160 TFCGTPEFLAPE-VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 8e-15
Identities = 71/287 (24%), Positives = 122/287 (42%), Gaps = 46/287 (16%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAV-----AVKKSNPDSIQGLREWQAEVKFLGK 161
LG G FG V+K K + K + A K + + + + +EV + +
Sbjct: 8 LGSGAFGCVYKV---RKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 162 -FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENH---LFRKGS--AEPLPWNTRLKIAI 215
HPN+V+ E+ + +V + ++ L H L K E WN +++ +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL-GPIDGNSHVTTRIMG 274
L +LH EK +++RD +NI+L ++DFGLAK P S +T+ ++G
Sbjct: 125 A----LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP---ESKLTS-VVG 175
Query: 275 TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334
T Y+ PE V K+DV+ FG +L +M T P ++ A
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLA------- 222
Query: 335 RRLKKIMDPRLEEQYPIKGALLAGQI---IIKCLEAEPKNRPSMEEV 378
KI++ E P+ + + + I CL + + RP + +V
Sbjct: 223 ---TKIVEAVYE---PLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 73/211 (34%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKF 162
+LG+G FG+V LA K G + A+K D + + E + L
Sbjct: 7 VLGKGSFGKV--------MLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 163 SHPNLVKLIGYCWE--DRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAK 219
P + + C++ DR + V EY+ G L + + G EP +IAI
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYF-VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG--- 113
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM-GTYGY 278
L FLHS K +IYRD K N++LD + K++DFG+ K DG VTT+ GT Y
Sbjct: 114 -LFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDY 167
Query: 279 AAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
APE +A Y KS D + FGV+L EML G
Sbjct: 168 IAPEIIAY-QPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 85/323 (26%), Positives = 125/323 (38%), Gaps = 95/323 (29%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSN-PDSIQG-----LREWQAEVKFLG 160
+GEG +G V+K + G+ VA+KK P S +G LRE A +K L
Sbjct: 7 IGEGAYGTVYKA---------RDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLE 56
Query: 161 KFSHPNLVKLIGYC--WE-DRQFL--LVYEYMQK---GSLENHLFRKGSAEPLPWNTRLK 212
F HPN+V+L+ C DR+ LV+E++ + L P P
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC--------PKP-----G 103
Query: 213 IAIDAAKDLT--------FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG 264
+ + KDL FLHS +++RD K NIL+ K++DFGLA+ I
Sbjct: 104 LPPETIKDLMRQLLRGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLAR---IYS 158
Query: 265 NSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323
T ++ T Y APE V Y D++ G + E+ R L
Sbjct: 159 FEMALTSVVVTLWYRAPE-VLLQSSYATPVDMWSVGCIFAELFR-RRPL----------- 205
Query: 324 VDFARPSLTDKRRLKKIMD----PRLEEQYPIKGALL----------------------A 357
F ++ +L KI D P EE++P +L
Sbjct: 206 --F--RGTSEADQLDKIFDVIGLPS-EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEG 260
Query: 358 GQIIIKCLEAEPKNRPSMEEVLE 380
++ K L P R S E L+
Sbjct: 261 LDLLKKMLTFNPHKRISAFEALQ 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 70/209 (33%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGKF 162
+LG+G FG+V L K GK A+K + I E E + L
Sbjct: 2 LLGKGTFGKVI--------LVREKAT-GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 163 SHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKD 220
HP L L Y ++ L V EY G L HL R+ +E R A +
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGA-EIVSA 107
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAA 280
L +LHS V+YRD K N++LD + K++DFGL K G DG + GT Y A
Sbjct: 108 LGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLA 163
Query: 281 PEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
PE V + Y ++ D +G GVV+ EM+ G
Sbjct: 164 PE-VLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-EWQAEVKFLGKFSHP 165
LG G FG V KG + K + A+ V K+ + + +R E E + + + +P
Sbjct: 3 LGSGNFGCVKKGVYKMR-----KKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNP 55
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
+V++IG C E +LV E G L + F G + + + +++ + + +L
Sbjct: 56 YIVRMIGVC-EAEALMLVMEMASGGPL--NKFLSGKKDEITVSNVVELMHQVSMGMKYLE 112
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNSHVTTRIMGTY--GYAAPE 282
K+ ++RD A N+LL + AK+SDFGL+K LG D S+ R G + + APE
Sbjct: 113 --GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD--SYYKARSAGKWPLKWYAPE 168
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLT 307
+ +SDV+ +G+ + E +
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVKFLGKFSHP 165
LGE FG+V+KG + +AVA+K + LRE ++ E + HP
Sbjct: 13 LGEDRFGKVYKGHL----FGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHP 68
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFR----------------KGSAEPLPWNT 209
N+V L+G +++ +++ Y L L K + EP +
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF-- 126
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL------AKLGPID 263
+ I A + FL S V+++D N+L+ N K+SD GL A +
Sbjct: 127 -VHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
GNS + R M +PE + G + SD++ +GVVL E+ +
Sbjct: 184 GNSLLPIRWM------SPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 81/308 (26%), Positives = 133/308 (43%), Gaps = 60/308 (19%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREWQAEVKFLG 160
+GEG +G+V+K D T G+ VA+KK D+ I +RE +K L
Sbjct: 15 IGEGTYGQVYKA-RDKDT--------GELVALKKVRLDNEKEGFPITAIRE----IKILR 61
Query: 161 KFSHPNLVKL----------IGYCWEDRQFLLVYEYMQK---GSLENHL--FRKGSAEPL 205
+ +H N+V L + + + F LV+EYM G LE+ L F + +
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121
Query: 206 PWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGN 265
+K ++ L + H +K+ ++RD K SNILL+ KL+DFGLA+L + +
Sbjct: 122 -----MKQLLEG---LNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 266 SHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRPSGEHVLV 324
T +++ T Y PE + Y + DV+ G +L E+ T N+ + L+
Sbjct: 172 RPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230
Query: 325 -------------DFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKN 371
D + + + KK RL E++ A ++ L +P
Sbjct: 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPT-PALDLLDHMLTLDPSK 289
Query: 372 RPSMEEVL 379
R + EE L
Sbjct: 290 RCTAEEAL 297
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 100 NFRPDTMLGEGGFGRVFKG--WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVK 157
NF+ + +G G F V++ +D K +A KV + + + K + D ++ E+
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK-ARQDCVK-------EID 54
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-FRKGSAEPLPWNTRLKIAID 216
L + +HPN++K + ED + +V E G L + + K +P T K +
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
+ +HS + V++RD K +N+ + + KL D GL + + ++GT
Sbjct: 115 LCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTP 170
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEM 305
Y +PE + KSD++ G +L EM
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 82/284 (28%), Positives = 122/284 (42%), Gaps = 41/284 (14%)
Query: 100 NFRPDTMLGEGGFGRVF----KGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAE 155
NF +LG G +G+VF G D L KV + KA V+K+ + + E
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKV-LKKATIVQKA-----KTAEHTRTE 54
Query: 156 VKFLGKF-SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKG---SAEPLPWNTRL 211
+ L P LV L D + L+ +Y+ G L HL+++ +E + +
Sbjct: 55 RQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEI 114
Query: 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
+A+D LH + +IYRD K NILLD + L+DFGL+K +
Sbjct: 115 VLALDH------LH--QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYS 165
Query: 272 IMGTYGYAAPEYVATGHL-YVKS-DVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329
GT Y APE + G + K+ D + GV+ E+LTG VD +
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT----------VDGEQN 215
Query: 330 SLTD-KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR 372
S ++ RR+ K P +P + A I K LE +PK R
Sbjct: 216 SQSEISRRILKSKPP-----FPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKF 158
+F + LG G G VFK V HK P+ + + + + + P Q +RE Q
Sbjct: 6 DFEKISELGAGNGGVVFK--VSHK---PSGLIMARKLIHLEIKPAIRNQIIRELQV---- 56
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
L + + P +V G + D + + E+M GSL+ L + G +P K++I
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVI 113
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA-KLGPIDGNSHVTTRIMGTYG 277
K LT+L K +++RD K SNIL++ KL DFG++ +L NS V TR
Sbjct: 114 KGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----S 167
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLTG 308
Y +PE + H V+SD++ G+ L+EM G
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 35/221 (15%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFS- 163
++GEG FG+V K + K G+ A+K+ + + R++ E++ L K
Sbjct: 14 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 164 HPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKG--------------SAEPLPWN 208
HPN++ L+G C E R +L L EY G+L + L RK +A L
Sbjct: 67 HPNIINLLGAC-EHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQ 124
Query: 209 TRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHV 268
L A D A+ + +L S+K I+RD A NIL+ +Y AK++DFGL++ G
Sbjct: 125 QLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVY 177
Query: 269 TTRIMGTYG--YAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
+ MG + A E + SDV+ +GV+L E+++
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 72/279 (25%), Positives = 112/279 (40%), Gaps = 40/279 (14%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
++GEG FGR V H + K + + KS+ ++ R+ E L K HP
Sbjct: 7 VVGEGSFGRAL--LVQHVN--SDQKYAMKEIRLPKSSSA-VEDSRK---EAVLLAKMKHP 58
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-FRKGSAEP----LPWNTRLKIAIDAAKD 220
N+V D +V EY G L + ++G P L W ++ + +
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ---- 114
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAA 280
H EK V++RD K+ NI L + KL DFG A+L G T +GT Y
Sbjct: 115 ----HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVP 168
Query: 281 PEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340
PE KSD++ G +L E+ T N S +++++ + S
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN--SWKNLILKVCQGSYKP------- 219
Query: 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
L Y + L Q+ + P++RPS +L
Sbjct: 220 ----LPSHYSYELRSLIKQMFKR----NPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 106 MLGEGGFGRVFK-----GWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLG 160
+LG+GG+G+VF+ G K A + V K + ++ D+ +AE L
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFA---MKVLKKATIVRNQKDTAHT----KAERNILE 55
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
HP +V LI + L+ EY+ G L HL R+G +T + +
Sbjct: 56 AVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI---FMEDTACFYLSEISLA 112
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAA 280
L LH + +IYRD K NILLD + KL+DFGL K +G VT GT Y A
Sbjct: 113 LEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMA 168
Query: 281 PEYVA-TGHLYVKSDVYGFGVVLLEMLTG 308
PE + +GH D + G ++ +MLTG
Sbjct: 169 PEILMRSGH-GKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 69/212 (32%), Positives = 101/212 (47%), Gaps = 30/212 (14%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGK---- 161
+LG+G FG+V LA K G + A+K D + L + E + +
Sbjct: 2 VLGKGSFGKVM--------LAELK-GTNEFFAIKALKKDVV--LEDDDVECTMVERRVLA 50
Query: 162 --FSHPNLVKLIGYC-WEDRQFLL-VYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
+ HP L L +C ++ ++ L V EY+ G L H+ G + R A +
Sbjct: 51 LAWEHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE--ARARF-YAAEI 105
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
L FLH K +IYRD K N+LLD + K++DFG+ K ++G +T GT
Sbjct: 106 ICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN-MNGEGKAST-FCGTPD 161
Query: 278 YAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
Y APE + G Y +S D + FGV+L EML G
Sbjct: 162 YIAPE-ILKGQKYNESVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 30/217 (13%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVKFLGKFS 163
+L EG FGR+F G L K G + V VK K + IQ Q G S
Sbjct: 13 LLQEGTFGRIFYG-----ILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG-LS 66
Query: 164 HPNLVKLIGYCWEDRQFLLV-YEYMQKGSLENHLFRKGSAEPLPWNTRLK------IAID 216
H N++ ++ C ED + V Y YM G+L+ L ++ L +AI
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL-QQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPID-----GNSHVTT 270
A +++LH + VI++D A N ++D K++D L++ L P+D N +
Sbjct: 126 IACGMSYLHK--RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 271 RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
+ M A E + SDV+ FGV+L E++T
Sbjct: 184 KWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREW 152
+ + +GEG +G+VFK K G G+ VA+K+ + + +RE
Sbjct: 1 QQYECVAEIGEGAYGKVFKA-------RDLKNG-GRFVALKRVRVQTGEEGMPLSTIRE- 51
Query: 153 QAEVKFLGKFSHPNLVKLIGYCWEDR-----QFLLVYEYMQKGSLENHLFRKGSAEPLPW 207
A ++ L F HPN+V+L C R + LV+E++ + L +L K +P
Sbjct: 52 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPT 109
Query: 208 NTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSH 267
T + + L FLHS V++RD K NIL+ S KL+DFGLA+ I
Sbjct: 110 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 164
Query: 268 VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEML 306
T ++ T Y APE + D++ G + EM
Sbjct: 165 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 53/157 (33%), Positives = 75/157 (47%), Gaps = 9/157 (5%)
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
S+P LV L + LV EY+ G L H+ R+ LP A + L
Sbjct: 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALN 110
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPE 282
FLH E+ +IYRD K N+LLD + KL+D+G+ K G G++ T+ GT Y APE
Sbjct: 111 FLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPE 166
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTGLRALD--TNRP 317
+ D + GV++ EM+ G D T+ P
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 110 GGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQAEVKFL-GKFSHP 165
G FG V+ LA K G A+K KS+ + + +AE + + P
Sbjct: 7 GAFGSVY--------LA-KKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP 57
Query: 166 NLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
+ KL Y ++ + +L LV EY+ G + + G LP + + + + L
Sbjct: 58 YVAKLY-YSFQSKDYLYLVMEYLNGGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDL 113
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
H ++ +I+RD K N+L+D + + KL+DFGL++ G + +GT Y APE +
Sbjct: 114 H--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETI 165
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP 317
SD + G V+ E L G P
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+G+G FG+V + V + ++ K + +K++ S + AE L + + P
Sbjct: 1 IGKGSFGKVMQ--VRKRD--TQRIYALKTI--RKAHIVSRSEVTHTLAERTVLAQVNCPF 54
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
+V L + LV ++ G L +HL R+G + +R + A +
Sbjct: 55 IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFD----LSRARFYT-AELLCALENL 109
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT 286
+ +VIYRD K NILLD + L DFGL KL + T GT Y APE +
Sbjct: 110 HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNM--KDDDKTNTFCGTPEYLAPELL-L 166
Query: 287 GHLYVKS-DVYGFGVVLLEMLTGL 309
GH Y K+ D + GV+L EMLTGL
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTGL 190
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 68/212 (32%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGK---- 161
+LG+G FG+V LA K G + A+K D I L++ + K
Sbjct: 2 VLGKGSFGKVM--------LAELK-GTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILA 50
Query: 162 --FSHPNLVKLIGYC---WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAID 216
HP L L +C +DR F V EY+ G L +F+ + A +
Sbjct: 51 LAAKHPFLTAL--HCCFQTKDRLFF-VMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAE 104
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
L FLH VIYRD K NILLD + KL+DFG+ K G ++G TT GT
Sbjct: 105 VTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTP 160
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG 308
Y APE + D + GV++ EM+ G
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 6e-14
Identities = 70/296 (23%), Positives = 125/296 (42%), Gaps = 36/296 (12%)
Query: 87 KMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI 146
K+ T+ + K + +G+G G VF V G+ VA+K+ N
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTA---------IDVATGQEVAIKQINLQKQ 57
Query: 147 QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLP 206
E+ + + +PN+V + + +V EY+ GSL + + E
Sbjct: 58 PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEA-- 115
Query: 207 WNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL-AKLGPIDGN 265
+ + + L FLH+++ VI+RD K+ N+LL + KL+DFG A++ P
Sbjct: 116 --QIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP---E 168
Query: 266 SHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRA-LDTNRPSGEHVLV 324
+ ++GT + APE V K D++ G++ +EM+ G L+ N +++
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
Query: 325 DFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
P L + +L I L +CLE + + R S +E+L+
Sbjct: 229 TNGTPELQNPEKLSPIFRDFLN----------------RCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 75/293 (25%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQA--EVKFLGKFS 163
+G G FG+V G H+ ++ +V V + A + PD + L+E Q E+
Sbjct: 3 IGNGWFGKVLLGEA-HRGMSKARVVVKELRA--SATPDEQLLFLQEVQPYRELN------ 53
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRL--KIAIDAAKDL 221
HPN+++ +G C E +LLV E+ G L+N+L + ++A + A L
Sbjct: 54 HPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGL 113
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT-RIMGTYGYAA 280
+LH ++ I+ D N L + K+ D+GLA L + ++T + A
Sbjct: 114 LWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLA 170
Query: 281 PEYVATGHLYV-------KSDVYGFGVVLLEMLTGLRALDTNRP----SGEHVLVDFARP 329
PE V + KS+++ GV + E+ T ++P S E VL R
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLSDEQVLKQVVR- 224
Query: 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
+ K+ P+L+ +Y + +++ C +P+ RP+ EEV E L
Sbjct: 225 -----EQDIKLPKPQLDLKYSDRWY----EVMQFCW-LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 74/286 (25%), Positives = 121/286 (42%), Gaps = 39/286 (13%)
Query: 101 FRPDTMLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKK-SNPDSIQGLREWQAEVKF 158
F+ +LG G FG V+KG W+ P V VA+K+ S + +E E
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSL----ENHLFRKGSAEPLPWNTRLKIA 214
+ +P++ +L+G C L+ + M G L H GS L W
Sbjct: 63 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 115
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
+ AK + +L E+ +++RD A N+L+ + K++DFGLAKL D +
Sbjct: 116 VQIAKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173
Query: 275 TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTD 333
+ A E + +SDV+ +GV + E++T G + D P+ E + L
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI------LEK 226
Query: 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
RL Q PI + I++KC + +RP E++
Sbjct: 227 GERLP---------QPPI-CTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 100 NFRPDTMLGEGGFGRVFKG--WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVK 157
NFR + +G G F V++ +D +A KV + + K + D I+ E+
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK-ARADCIK-------EID 54
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL--FRKGSAEPLPWNTRLKIAI 215
L + +HPN++K ED + +V E G L + F+K +P T K +
Sbjct: 55 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFV 113
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
L +HS + V++RD K +N+ + + KL D GL + + ++GT
Sbjct: 114 QLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGT 169
Query: 276 YGYAAPEYVATGHLYVKSDVYGFGVVLLEM 305
Y +PE + KSD++ G +L EM
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 75/290 (25%), Positives = 126/290 (43%), Gaps = 43/290 (14%)
Query: 106 MLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVKFLGKF 162
+LG G FG V+KG W P V VA+K + N S + +E E +
Sbjct: 14 VLGSGAFGTVYKGIW------IPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGV 66
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLF----RKGSAEPLPWNTRLKIAIDAA 218
P + +L+G C LV + M G L +++ R GS + L W + A
Sbjct: 67 GSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIA 119
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY 278
K +++L E +++RD A N+L+ + K++DFGLA+L ID + +
Sbjct: 120 KGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDK-RR 336
A E + +SDV+ +GV + E++T G + D P+ E P L +K R
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPARE-------IPDLLEKGER 229
Query: 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386
L + P + I++KC + + RP E+++ ++
Sbjct: 230 LPQ----------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+GEG FG+ V K K V K + + K +P + E + EV L HPN
Sbjct: 8 IGEGSFGKAI--LVKSKE--DGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPN 60
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHL-FRKGSAEP----LPWNTRLKIAIDAAKDL 221
+V+ E+ +V +Y + G L + ++G P L W ++ +A+
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK----- 115
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAP 281
H ++ +++RD K+ NI L KL DFG+A++ ++ + +GT Y +P
Sbjct: 116 ---HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSP 170
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLT 307
E KSD++ G VL EM T
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 76/273 (27%), Positives = 109/273 (39%), Gaps = 37/273 (13%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA---EVKFLGKFS 163
LG+GGFG V A GK A KK N ++ + ++ E + L K
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV- 50
Query: 164 HPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEP-LPWNTRLKIAIDAAKDL 221
H + + Y ++ + L LV M G L H++ P P L
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGL 110
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAP 281
LH ++ +IYRD K N+LLD N ++SD GLA + DG S T GT G+ AP
Sbjct: 111 EHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSK-TKGYAGTPGFMAP 166
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK-- 339
E + D + GV L EM+ A R GE V + + LK+
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIA---ARGPFRARGEKV----------ENKELKQRI 213
Query: 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR 372
+ D YP K + + L +P+ R
Sbjct: 214 LNDS---VTYPDKFSPASKSFCEALLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 84/314 (26%), Positives = 127/314 (40%), Gaps = 53/314 (16%)
Query: 77 SGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAV 136
+G + P ++F +D + R +G G FG V+ V + V
Sbjct: 6 AGSLKDPEIAELFFKEDPEKLFTDLRE---IGHGSFGAVYFA---------RDVRTNEVV 53
Query: 137 AVKKSNPDSIQGLREWQ---AEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGS-- 191
A+KK + Q +WQ EVKFL + HPN ++ G + LV EY +
Sbjct: 54 AIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASD 113
Query: 192 -LENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250
LE H +PL I A + L +LHS ++I+RD KA NILL K
Sbjct: 114 LLEVH------KKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVK 165
Query: 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLLEMLT 307
L+DFG A + NS V GT + APE + G K DV+ G+ +E+
Sbjct: 166 LADFGSASIAS-PANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 219
Query: 308 GLRAL-DTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLE 366
L + N S + + P+L + + CL+
Sbjct: 220 RKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN-----------------FVDSCLQ 262
Query: 367 AEPKNRPSMEEVLE 380
P++RP+ EE+L+
Sbjct: 263 KIPQDRPTSEELLK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 62/259 (23%), Positives = 115/259 (44%), Gaps = 35/259 (13%)
Query: 128 TKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYM 187
T+ GK VAVKK + Q EV + + H N+V + + +V E++
Sbjct: 42 TEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101
Query: 188 QKGSLENHLFRKGSAEPLPWNTRLK------IAIDAAKDLTFLHSSEKSVIYRDFKASNI 241
+ G+L + + +TR+ + + + L++LH+ + VI+RD K+ +I
Sbjct: 102 EGGALTD----------IVTHTRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSI 149
Query: 242 LLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVV 301
LL KLSDFG + ++GT + APE ++ + D++ G++
Sbjct: 150 LLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 207
Query: 302 LLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQII 361
++EM+ G P F P L RR++ + PR+++ + + L +
Sbjct: 208 VIEMIDG-------EPPY------FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG--FL 252
Query: 362 IKCLEAEPKNRPSMEEVLE 380
L EP R + +E+L+
Sbjct: 253 DLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 9/152 (5%)
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
+HP LV L + + V E++ G L H+ R+ LP + + + L
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISLALN 110
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPE 282
FLH E+ +IYRD K N+LLD + KL+D+G+ K G G++ T+ GT Y APE
Sbjct: 111 FLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAPE 166
Query: 283 YVATGHLYVKS-DVYGFGVVLLEMLTGLRALD 313
+ G Y S D + GV++ EM+ G D
Sbjct: 167 -ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ---GLREWQAEVKFLGKFS 163
LG+GGFG V V + GK A KK + ++ G + E + L K +
Sbjct: 1 LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51
Query: 164 HPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
P +V L Y +E + L LV M G L+ H++ G ++ I + +T
Sbjct: 52 SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGER-----GLEMERVIHYSAQIT 105
Query: 223 --FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAA 280
LH ++YRD K N+LLD N +LSD GLA DG + T+ GT GY A
Sbjct: 106 CGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKT--ITQRAGTNGYMA 162
Query: 281 PEYVATGHLYVKSDVYGFGVVLLEMLTG 308
PE + D + G + EM+ G
Sbjct: 163 PEILKEEPYSYPVDWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 80/287 (27%), Positives = 128/287 (44%), Gaps = 51/287 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LG+G FG+V+K A K G A K S + L ++ E++ L +HP
Sbjct: 20 LGDGAFGKVYK--------AKNK-ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFR--KGSAEPLPWNTRLKIAIDAAKDLTFL 224
+VKL+G + D + ++ E+ G+++ + +G EP + ++A L +L
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQVICRQMLEA---LQYL 126
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR---IMGTYGYAAP 281
HS +I+RD KA N+LL + KL+DFG++ N R +GT + AP
Sbjct: 127 HS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSA-----KNVKTLQRRDSFIGTPYWMAP 179
Query: 282 EYVA------TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
E V T + Y K+D++ G+ L+EM P E L R
Sbjct: 180 EVVMCETMKDTPYDY-KADIWSLGITLIEM------AQIEPPHHE----------LNPMR 222
Query: 336 RLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
L KI +P Q P K ++ + L+ P+ RPS ++LE
Sbjct: 223 VLLKIAKSEPPTLSQ-PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 68/297 (22%), Positives = 135/297 (45%), Gaps = 52/297 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGK-----AVAVKKSNPD-SIQGLREWQAEVKFLG 160
LG+G FG V++G GV K VA+K N S++ E+ E +
Sbjct: 14 LGQGSFGMVYEG---------IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK 64
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFR-------KGSAEPLPWNTRLKI 213
+F+ ++V+L+G + + L++ E M +G L+++L P +++
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPID-----GNSH 267
A + A + +L++++ ++RD A N ++ + K+ DFG+ + + D G
Sbjct: 125 AGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 268 VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327
+ R M +PE + G SDV+ FGVVL E+ T L +
Sbjct: 183 LPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQP 221
Query: 328 RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384
+++++ L+ +M+ L ++ P + +++ C + PK RPS E++ +++
Sbjct: 222 YQGMSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 66/218 (30%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-----SNPDSIQGLREWQAEVKFLGK 161
+G G FG V K HK G +AVK+ + + L + ++
Sbjct: 12 IGRGAFGTVNKML--HKPS-------GTIMAVKRIRSTVDEKEQKRLLMDLDVVMR---S 59
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLEN-----HLFRKGSAEPLPWNTRLKIAID 216
P +VK G + + + E M SL+ + K +P KIA+
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSV---IPEEILGKIAVA 115
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG---NSHVTTRIM 273
K L +L E +I+RD K SNILLD + N KL DFG I G +S TR
Sbjct: 116 TVKALNYL-KEELKIIHRDVKPSNILLDRNGNIKLCDFG------ISGQLVDSIAKTRDA 168
Query: 274 GTYGYAAPEYVATGHL--Y-VKSDVYGFGVVLLEMLTG 308
G Y APE + Y V+SDV+ G+ L E+ TG
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 71/282 (25%), Positives = 123/282 (43%), Gaps = 36/282 (12%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
+LG G FG + +G + P+K + A+ ++ Q R + AE LG+F H
Sbjct: 12 ILGTGRFGELCRGCLK----LPSKRELPVAIHTLRAGCSDKQR-RGFLAEALTLGQFDHS 66
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
N+V+L G ++V EYM G+L++ L RK + L + + A + +L
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQ-LVAGQLMGMLPGLASGMKYL- 123
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG--YAAPEY 283
SE +++ A +L++ K+S F D + + T + G +AAPE
Sbjct: 124 -SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 284 VATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP--SLTDKRRLKKIM 341
+ H SDV+ FG+V+ E+++ GE RP ++ + +K +
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMS----------YGE-------RPYWDMSGQDVIKAVE 222
Query: 342 DP-RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
D RL P L Q+++ C + E RP ++ L
Sbjct: 223 DGFRLPA--PRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 7/151 (4%)
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
+HP LV L + + V EY+ G L H+ R+ LP + + + L
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALN 110
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPE 282
+LH E+ +IYRD K N+LLD + KL+D+G+ K G G++ T+ GT Y APE
Sbjct: 111 YLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPE 166
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTGLRALD 313
+ D + GV++ EM+ G D
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 42/219 (19%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-----IQGLREWQAEVKFLGK 161
+GEG +G V T G VA+KK +P + LRE +K L +
Sbjct: 13 IGEGAYGMVCSA-THKPT--------GVKVAIKKISPFEHQTFCQRTLRE----IKILRR 59
Query: 162 FSHPNLVKL------IGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
F H N++ + + +V E M E L++ + L N ++ +
Sbjct: 60 FKHENIIGILDIIRPPSFE-SFNDVYIVQELM-----ETDLYKLIKTQHLS-NDHIQYFL 112
Query: 216 -DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
+ L ++HS+ +V++RD K SN+LL+ + + K+ DFGLA+ I H T +
Sbjct: 113 YQILRGLKYIHSA--NVLHRDLKPSNLLLNTNCDLKICDFGLAR---IADPEHDHTGFLT 167
Query: 275 TY----GYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
Y Y APE + Y K+ D++ G +L EML+
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 163 SH--PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
SH P +VK GY D + E M L+ L R P+P + K+ + K
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKA 126
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA-KLGPIDGNSHVTTRIMGTYGYA 279
L +L + VI+RD K SNILLD S N KL DFG++ +L +D + TR G Y
Sbjct: 127 LHYL-KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAK--TRSAGCAAYM 181
Query: 280 APEYV----ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
APE + +++DV+ G+ L+E+ TG + T+
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK---------------TEFE 226
Query: 336 RLKKIMDPRLEEQYPIKG-ALLAGQIIIKCLEAEPKNRPSMEEVLE 380
L KI+ P +G + + CL + + RP E+L+
Sbjct: 227 VLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 98 TKNFRPDTMLGEGGFGRVFKG--WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAE 155
NF+ + +G+G F V+K +D + +A KV + + + K+ D ++ E
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-AKARQDCLK-------E 52
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL--FRKGSAEPLPWNTRLKI 213
+ L + HPN++K + E+ + +V E G L + F+K +P T K
Sbjct: 53 IDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTIWKY 111
Query: 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT--- 270
+ L +HS K +++RD K +N+ + + KL D GL + S TT
Sbjct: 112 FVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRF-----FSSKTTAAH 164
Query: 271 RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEM 305
++GT Y +PE + KSD++ G +L EM
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 79/277 (28%), Positives = 117/277 (42%), Gaps = 36/277 (12%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA----EV 156
FR +LG+GGFG V A GK A KK I+ R+ +A E
Sbjct: 2 FRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEK 51
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
+ L K + +V L Y +E + L LV M G L+ H++ G+ + A
Sbjct: 52 QILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-FDEERAVFYAA 109
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
+ L LH + ++YRD K NILLD + ++SD GLA I + R+ GT
Sbjct: 110 EITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLAV--EIPEGETIRGRV-GT 164
Query: 276 YGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
GY APE V D +G G ++ EM+ G + + V+ R
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---------R 215
Query: 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR 372
R+K+ +E+Y K + A I + L +P R
Sbjct: 216 RVKED-----QEEYSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 68/248 (27%), Positives = 114/248 (45%), Gaps = 22/248 (8%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVK 157
+F + LG G G V K V HK P+ + + + + + P Q +RE Q
Sbjct: 5 DDFERISELGAGNGGVVTK--VQHK---PSGLIMARKLIHLEIKPAIRNQIIRELQV--- 56
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
L + + P +V G + D + + E+M GSL+ L A+ +P K++I
Sbjct: 57 -LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAV 112
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA-KLGPIDGNSHVTTRIMGTY 276
+ L +L + +++RD K SNIL++ KL DFG++ +L NS V TR
Sbjct: 113 LRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR----- 166
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336
Y +PE + H V+SD++ G+ L+E+ G + P + + F RP + +
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIFGRPVVDGEEG 224
Query: 337 LKKIMDPR 344
+ PR
Sbjct: 225 EPHSISPR 232
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 73/209 (34%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGK- 161
++G+G FG+V LA K+ GK AVK + +E + AE L K
Sbjct: 2 VIGKGSFGKVL--------LAKRKLD-GKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKD 220
HP LV L + V +++ G L HL R+ S EP R A + A
Sbjct: 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAA-EIASA 108
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAA 280
L +LHS ++YRD K NILLD + L+DFGL K G S TT GT Y A
Sbjct: 109 LGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGI--AQSDTTTTFCGTPEYLA 164
Query: 281 PEYVATGHLYVKSDVYGFGVVLLEMLTGL 309
PE + D + G VL EML GL
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 29/210 (13%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK----SNPDSI--QGLREWQAEVKFLG 160
+GEG +G V+KG +K G+ VA+KK S + + +RE + L
Sbjct: 8 IGEGTYGVVYKG--RNKK-------TGQIVAMKKIRLESEEEGVPSTAIRE----ISLLK 54
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
+ HPN+V L ++ + L++E++ L+ +L + + +
Sbjct: 55 ELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQG 113
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LG-PIDGNSHVTTRIMGTYGY 278
+ F HS + V++RD K N+L+D KL+DFGLA+ G P+ V T + T Y
Sbjct: 114 ILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV----RVYTHEVVTLWY 167
Query: 279 AAPEYVATGHLY-VKSDVYGFGVVLLEMLT 307
APE + Y D++ G + EM T
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 69/213 (32%), Positives = 98/213 (46%), Gaps = 32/213 (15%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGK---- 161
+LG+G FG+V LA K G G+ AVK D + L + E + K
Sbjct: 2 VLGKGSFGKVL--------LAELK-GKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLA 50
Query: 162 --FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
+ +P L L V E++ G L H+ KG + + AA+
Sbjct: 51 LAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFD------LYRATFYAAE 104
Query: 220 ---DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
L FLHS K +IYRD K N++LD + K++DFG+ K + G++ +T GT
Sbjct: 105 IVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKEN-VFGDNRAST-FCGTP 160
Query: 277 GYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
Y APE + G Y S D + FGV+L EML G
Sbjct: 161 DYIAPE-ILQGLKYTFSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 67/208 (32%), Positives = 89/208 (42%), Gaps = 32/208 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGKFS 163
+G G FG V+ T + VAVKK + Q +WQ EVKFL +
Sbjct: 29 IGHGSFGAVYFA---------TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGS---LENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
HPN ++ G ++ LV EY + LE H +PL I A +
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH------KKPLQEVEIAAITHGALQG 133
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAA 280
L +LHS I+RD KA NILL KL+DFG A NS V GT + A
Sbjct: 134 LAYLHSHNM--IHRDIKAGNILLTEPGQVKLADFGSASKSS-PANSFV-----GTPYWMA 185
Query: 281 PEYVAT---GHLYVKSDVYGFGVVLLEM 305
PE + G K DV+ G+ +E+
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 85/282 (30%), Positives = 122/282 (43%), Gaps = 36/282 (12%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-EWQA--EVK 157
FR +LG+GGFG V V GK A K+ I+ + E A E +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQ 52
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAID 216
L K + +V L Y +E + L LV M G L+ H++ G+ P +
Sbjct: 53 ILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGN----PGFEEERALFY 107
Query: 217 AAKDLTFL-HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
AA+ L L ++ +YRD K NILLD + ++SD GLA P +G S + R+ GT
Sbjct: 108 AAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIP-EGES-IRGRV-GT 164
Query: 276 YGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
GY APE + + D +G G ++ EM+ G R E V + D+R
Sbjct: 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF---RGRKEKV-----KREEVDRR 216
Query: 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEE 377
L+ EE Y K + A I L +PK R +E
Sbjct: 217 VLET------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 106 MLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFS 163
+LG G FG V+KG WV P V VA+K N + + E+ E +
Sbjct: 14 VLGSGAFGTVYKGIWV------PEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSL----ENHLFRKGSAEPLPWNTRLKIAIDAAK 219
HP+LV+L+G C LV + M G L H GS L W + AK
Sbjct: 68 HPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAK 120
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA 279
+ +L E+ +++RD A N+L+ + K++DFGLA+L D + +
Sbjct: 121 GMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 178
Query: 280 APEYVATGHLYVKSDVYGFGVVLLEMLT 307
A E + +SDV+ +GV + E++T
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQA-EVK 157
NF+ +GEG +G V+K A K+ G+ VA+KK D+ +G+ E+
Sbjct: 1 NFQKVEKIGEGTYGVVYK--------ARNKL-TGEVVALKKIRLDTETEGVPSTAIREIS 51
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
L + +HPN+VKL+ + + LV+E++ + L+ + +P
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASPLSGIPLPLIKSYLFQL 109
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LG-PIDGNSHVTTRIMGT 275
+ L F HS V++RD K N+L++ KL+DFGLA+ G P+ +H T
Sbjct: 110 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----T 163
Query: 276 YGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRAL 312
Y APE + Y + D++ G + EM+T RAL
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 33/178 (18%)
Query: 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG---NSHV 268
KIA+ K L +LHS + SVI+RD K SN+L++ + KL DFG I G +S
Sbjct: 107 KIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFG------ISGYLVDSVA 159
Query: 269 TTRIMGTYGYAAPEYV----ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-- 322
T G Y APE + VKSDV+ G+ ++E+ TG D+ + + +
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ 219
Query: 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+V+ P L ++ + D + KCL+ K RP+ E+L+
Sbjct: 220 VVEEPSPQLPAEKFSPEFQD-----------------FVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 107 LGEGGFGRVF--KGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSH 164
+GEG FG+++ K D + ++ + K +K + EV L K H
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS---------KKEVILLAKMKH 58
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSA-----EPLPWNTRLKIAIDAAK 219
PN+V E+ + +V EY G L + R+ + L W ++ + +
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK--- 115
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYN---AKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
H ++ +++RD K+ NI L S N AKL DFG+A+ ++ + + +GT
Sbjct: 116 -----HIHDRKILHRDIKSQNIFL--SKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTP 166
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
Y +PE K+D++ G VL E+ T
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 34/211 (16%)
Query: 107 LGEGGFGRVFKGW-VDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG+G FG+V+K + LA KV + S + L ++ E+ L HP
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKV----------IDTKSEEELEDYMVEIDILASCDHP 62
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFR--KGSAEPLPWNTRLKIAIDAAKD-LT 222
N+VKL+ + + ++ E+ G+++ + + EP ++++ + L
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEP-----QIRVVCKQTLEALN 117
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR---IMGTYGYA 279
+LH E +I+RD KA NIL + KL+DFG++ N+ R +GT +
Sbjct: 118 YLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSA-----KNTRTIQRRDSFIGTPYWM 170
Query: 280 APEYV----ATGHLY-VKSDVYGFGVVLLEM 305
APE V + Y K+DV+ G+ L+EM
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 67/213 (31%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA----EV 156
FR +LG+GGFG V V GK A KK I+ R+ ++ E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKK-RKGESMALNEK 51
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
+ L K + +V L Y +E + L LV M G L+ H++ G A + A
Sbjct: 52 QILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-FEEGRAVFYAA 109
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
+ L LH ++ ++YRD K NILLD + ++SD GLA P + R+ GT
Sbjct: 110 EICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRV-GT 164
Query: 276 YGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG 308
GY APE V D + G +L EM+ G
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 9e-13
Identities = 57/248 (22%), Positives = 102/248 (41%), Gaps = 27/248 (10%)
Query: 139 KKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFL----LVYEYMQKGSLEN 194
KK + + + E+K L + N++K+ G+ + L L+ EY +G L
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 195 HLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254
L ++ L + T+L +AID K L L+ Y++ + + L+ +Y K+
Sbjct: 112 VLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP-YKNLTSVSFLVTENYKLKIICH 167
Query: 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDT 314
GL K+ +V M + Y + + + +K D+Y GVVL E+ TG
Sbjct: 168 GLEKILSSPPFKNVNF--MVYFSYKMLNDIFSEYT-IKDDIYSLGVVLWEIFTG------ 218
Query: 315 NRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS 374
+LT K I++ + P+ L I+ C + RP+
Sbjct: 219 ----------KIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPN 268
Query: 375 MEEVLETL 382
++E+L L
Sbjct: 269 IKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 69/283 (24%), Positives = 119/283 (42%), Gaps = 41/283 (14%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
+LG+G +G V+ D T + K + + S +Q L E E+ H
Sbjct: 15 VLGKGTYGIVYAA-RDLSTQVRIAI---KEIPERDSR--YVQPLHE---EIALHSYLKHR 65
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
N+V+ +G E+ F + E + GSL L K T + + L +LH
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 226 SSEKSVIYRDFKASNILLDGSYNA--KLSDFG----LAKLGPIDGNSHVTTRIMGTYGYA 279
+ +++RD K N+L++ +Y+ K+SDFG LA + P T GT Y
Sbjct: 126 --DNQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINP------CTETFTGTLQYM 176
Query: 280 APEYVATGH--LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337
APE + G +D++ G ++EM TG +P ++ P +
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATG-------KPP----FIELGEPQAA----M 221
Query: 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
K+ ++ + P + A I++C E +P R S ++L+
Sbjct: 222 FKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK----KSNPDS--IQGLREWQA 154
+ P +G G +G V+K H G VA+K ++N D + +RE A
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHS---------GHFVALKSVRVQTNEDGLPLSTVRE-VA 51
Query: 155 EVKFLGKFSHPNLVKLIGYCWEDR-----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNT 209
+K L F HPN+V+L+ C R + LV+E++ + L +L K LP T
Sbjct: 52 LLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYL-DKVPPPGLPAET 109
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269
+ + L FLH++ +++RD K NIL+ KL+DFGLA+ I
Sbjct: 110 IKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMAL 164
Query: 270 TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEML 306
T ++ T Y APE + D++ G + EM
Sbjct: 165 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 68/214 (31%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA----EV 156
FR +LG+GGFG V V GK A KK I+ R+ +A E
Sbjct: 2 FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKK-RKGEAMALNEK 51
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
+ L K + +V L Y +E + L LV M G L+ H++ G+ P +
Sbjct: 52 RILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGN----PGFDEQRAIF 106
Query: 216 DAAKDLTFLHSSEKS-VIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
AA+ L ++ ++YRD K NILLD + ++SD GLA P +G + V R+ G
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIP-EGET-VRGRV-G 163
Query: 275 TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG 308
T GY APE + D +G G ++ EM+ G
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 67/207 (32%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGKF 162
+LG+G FG+V L K G+ A+K + I E E + L
Sbjct: 2 LLGKGTFGKVI--------LVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKI-AIDAAKDL 221
HP L L + V EY G L HL R E + R + + L
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSAL 108
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAP 281
+LHS EK+V+YRD K N++LD + K++DFGL K G DG + T GT Y AP
Sbjct: 109 DYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAP 165
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLTG 308
E + D +G GVV+ EM+ G
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 67/208 (32%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGKF 162
+LG+G FG+V L K G+ A+K + I E E + L
Sbjct: 2 LLGKGTFGKVI--------LVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 163 SHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKI-AIDAAKD 220
HP L L Y ++ L V EY G L HL R E + R + +
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSA 107
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAA 280
L +LHS + V+YRD K N++LD + K++DFGL K G DG + T GT Y A
Sbjct: 108 LEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 163
Query: 281 PEYVATGHLYVKSDVYGFGVVLLEMLTG 308
PE + D +G GVV+ EM+ G
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 75/294 (25%), Positives = 133/294 (45%), Gaps = 46/294 (15%)
Query: 107 LGEGGFGRVFKGWVDH--KTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFS 163
LG+G FG V++G K A T+V AVK N S++ E+ E + F+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRV------AVKTVNESASLRERIEFLNEASVMKGFT 67
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL--FRKGS----AEPLP-WNTRLKIAID 216
++V+L+G + + L+V E M G L+++L R + P P +++A +
Sbjct: 68 CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPID-----GNSHVTT 270
A + +L++ K ++RD A N ++ + K+ DFG+ + + D G +
Sbjct: 128 IADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 271 RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330
R M APE + G SD++ FGVVL E+ + L +
Sbjct: 186 RWM------APESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQG 224
Query: 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384
L++++ LK +MD +Q P ++ C + PK RP+ E++ L++
Sbjct: 225 LSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-12
Identities = 86/288 (29%), Positives = 129/288 (44%), Gaps = 49/288 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFSHP 165
LG+G +G V+K V H+ PT G +A+K+ + + + E+ L K P
Sbjct: 9 LGKGNYGSVYK--VLHR---PT----GVTMAMKEIRLELDESKFNQIIMELDILHKAVSP 59
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSA-EPLPWNTRLKIAIDAAKDLTFL 224
+V G + + + EYM GSL+ L+ G A E +P + +I K L FL
Sbjct: 60 YIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGN---SHVTTRIMGTYGYAAP 281
E ++I+RD K +N+L++G+ KL DFG + GN S T I G Y AP
Sbjct: 119 -KEEHNIIHRDVKPTNVLVNGNGQVKLCDFG------VSGNLVASLAKTNI-GCQSYMAP 170
Query: 282 EYVATGHLY------VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
E + +G V+SDV+ G+ +LEM G P + + FA
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYANI-FA-------- 217
Query: 336 RLKKIMD---PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+L I+D P L Y A + KCL P RP+ ++LE
Sbjct: 218 QLSAIVDGDPPTLPSGYSDD----AQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 54/175 (30%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 134 KAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLI-GYCWEDRQFLLVYEYMQKGSL 192
K V VK ++ G + E+ L SH ++ LI Y W+ +++ +Y K L
Sbjct: 120 KKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KCDL 172
Query: 193 ENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252
++ R G PLP + I + L +LH + +I+RD K NI LD NA L
Sbjct: 173 FTYVDRSG---PLPLEQAITIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVLG 227
Query: 253 DFGLA-KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEML 306
DFG A KL ++ GT +PE +A K+D++ G+VL EM
Sbjct: 228 DFGAACKLDAHP-DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 6e-12
Identities = 79/305 (25%), Positives = 131/305 (42%), Gaps = 54/305 (17%)
Query: 87 KMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI 146
K+ T+ + K + +G+G G V+ V G+ VA+K+ N
Sbjct: 7 KLRTIVSVGDPKKKYTRFEKIGQGASGTVYTA---------IDVATGQEVAIKQMNL-QQ 56
Query: 147 QGLREWQA-EVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPL 205
Q +E E+ + + HPN+V + + +V EY+ GSL + +
Sbjct: 57 QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD----------V 106
Query: 206 PWNTRLKIAIDAA------KDLTFLHSSEKSVIYRDFKASNILL--DGSYNAKLSDFGL- 256
T + AA + L FLHS++ VI+RD K+ NILL DGS KL+DFG
Sbjct: 107 VTETCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGS--VKLTDFGFC 162
Query: 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRA-LDTN 315
A++ P + ++GT + APE V K D++ G++ +EM+ G L+ N
Sbjct: 163 AQITP---EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219
Query: 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM 375
+++ P L + +L I L +CLE + + R S
Sbjct: 220 PLRALYLIATNGTPELQNPEKLSAIFRDFLN----------------RCLEMDVEKRGSA 263
Query: 376 EEVLE 380
+E+L+
Sbjct: 264 KELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 68/211 (32%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 106 MLGEGGFGRVFKGWVDHKT---LAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF 162
++G+G FG+V K+ KV + K +KK + I R L
Sbjct: 2 VIGKGSFGKVL--LAKRKSDGSFYAVKV-LQKKTILKKKEQNHIMAERN-----VLLKNL 53
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKI-AIDAAKD 220
HP LV L + V +Y+ G L HL R+ EP R + A + A
Sbjct: 54 KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASA 108
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG--PIDGNSHVTTRIMGTYGY 278
+ +LHS ++IYRD K NILLD + L+DFGL K G P + T+ GT Y
Sbjct: 109 IGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE----TTSTFCGTPEY 162
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLTGL 309
APE + D + G VL EML GL
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVKFLGKFSH 164
LG G FG V KG K K VAVK K++ + E E + + +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSE-------KTVAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
P +V++IG C E ++LV E + G L L + ++ + + +L
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTE---KNITELVHQVSMGMKYL 111
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY--GYAAPE 282
E + ++RD A N+LL + AK+SDFGL+K D N + + G + + APE
Sbjct: 112 E--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN-YYKAKTHGKWPVKWYAPE 168
Query: 283 YVATGHLYVKSDVYGFGVVLLE 304
+ KSDV+ FGV++ E
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 70/225 (31%), Positives = 101/225 (44%), Gaps = 46/225 (20%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AE 155
K+F+ T +G+GG+G+VF LA K G+ VA+K+ + L E + E
Sbjct: 1 KDFQILTQVGQGGYGQVF--------LA-KKKDTGEIVALKRMKKSLLFKLNEVRHVLTE 51
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYM----------QKGSLENHLFRKGSAEP 204
L LVKL+ Y ++D ++L L EY+ G L R AE
Sbjct: 52 RDILTTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEM 110
Query: 205 LPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG 264
A+DA +L ++H RD K N L+D S + KL+DFGL+K
Sbjct: 111 F-------EAVDALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGIVTYA 155
Query: 265 NSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
NS ++G+ Y APE V G Y + D + G +L E L G
Sbjct: 156 NS-----VVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 7e-12
Identities = 65/209 (31%), Positives = 90/209 (43%), Gaps = 34/209 (16%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGKFS 163
+G G FG V+ V + VA+KK + Q +WQ EV+FL K
Sbjct: 23 IGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGS---LENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
HPN ++ G + LV EY + LE H +PL + A +
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH------KKPLQEVEIAAVTHGALQG 127
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL-GPIDGNSHVTTRIMGTYGYA 279
L +LHS ++I+RD KA NILL KL DFG A + P N V GT +
Sbjct: 128 LAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANXFV-----GTPYWM 178
Query: 280 APEYVAT---GHLYVKSDVYGFGVVLLEM 305
APE + G K DV+ G+ +E+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 8e-12
Identities = 67/276 (24%), Positives = 117/276 (42%), Gaps = 36/276 (13%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+G+G G V+ + G+ VA+K+ N E+ + + +PN
Sbjct: 27 IGQGASGTVYTA---------IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
+V + + +V EY+ GSL + + E + + + L FLHS
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALDFLHS 133
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGL-AKLGPIDGNSHVTTRIMGTYGYAAPEYVA 285
++ VI+RD K+ NILL + KL+DFG A++ P + ++GT + APE V
Sbjct: 134 NQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPEVVT 188
Query: 286 TGHLYVKSDVYGFGVVLLEMLTGLRA-LDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344
K D++ G++ +EM+ G L+ N +++ P L + RL +
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF 248
Query: 345 LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
L +CLE + R S +E+L+
Sbjct: 249 LN----------------RCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 112 FGRVFKGWVDHKTLAPTKVGV------------GKAVAVKK-SNPDSIQGL-REWQAEVK 157
FG VF+ + L P +G G+ VA+KK P S L + E+K
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYE--YMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
L H N++ L F+ E Y L L R ++ PL
Sbjct: 62 LLKHLRHENIISLSDI------FISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLY 115
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
+ L ++HS+ V++RD K SNIL++ + + K+ DFGLA++ +V+TR
Sbjct: 116 QILRGLKYVHSA--GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY--- 170
Query: 276 YGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTG 308
Y APE + T Y V+ D++ G + EML G
Sbjct: 171 --YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 29/221 (13%)
Query: 107 LGEGGFGRVFK----GWVDHKTLAPTKVGVG--KAVAVKKSNPDSIQGLREWQAEVKFLG 160
LGEG FG+V G K TKV V K+ A +K D I + +K +G
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEM----MKMIG 81
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-FRKGSA------------EPLPW 207
K H N++ L+G C +D ++ EY KG+L +L R+ E L +
Sbjct: 82 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 208 NTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNS 266
+ A A+ + +L S K I+RD A N+L+ K++DFGLA+ + ID
Sbjct: 140 KDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 267 HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
T + + APE + +SDV+ FGV+L E+ T
Sbjct: 198 KTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 64/207 (30%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 107 LGEGGFGRVFK-GWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSH- 164
+G+G FG+V++ D + + KV K + KK +I E L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTI-------GERNILVRTLLD 53
Query: 165 --PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
P +V L D LV +YM G L HL ++G R K I A L
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS----EDRAKFYI-AELVLA 108
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPE 282
H + ++YRD K NILLD + + L DFGL+K D + T GT Y APE
Sbjct: 109 LEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPE 166
Query: 283 YVATGHLYVKS-DVYGFGVVLLEMLTG 308
+ Y K D + GV++ EM G
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 2e-11
Identities = 66/276 (23%), Positives = 118/276 (42%), Gaps = 36/276 (13%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+G+G G V+ V G+ VA+++ N E+ + + +PN
Sbjct: 28 IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
+V + + +V EY+ GSL + + E + + + L FLHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHS 134
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGL-AKLGPIDGNSHVTTRIMGTYGYAAPEYVA 285
++ VI+RD K+ NILL + KL+DFG A++ P + ++GT + APE V
Sbjct: 135 NQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPEVVT 189
Query: 286 TGHLYVKSDVYGFGVVLLEMLTGLRA-LDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344
K D++ G++ +EM+ G L+ N +++ P L + +L I
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249
Query: 345 LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
L +CL+ + + R S +E+L+
Sbjct: 250 LN----------------RCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 107 LGEGGFGRVF--------KGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF 158
LGEG FG+V K D V + K A K D I + +K
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQ--TVTVAVKMLKDNATDKDLADLISEMEL----MKL 73
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-------------FRKGSAEPL 205
+GK H N++ L+G C ++ ++ EY KG+L L K E L
Sbjct: 74 IGK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 206 PWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDG 264
+ + A A+ + +L S + I+RD A N+L+ K++DFGLA+ + ID
Sbjct: 132 SFKDLVSCAYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189
Query: 265 NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
+ + + APE + +SDV+ FG+++ E+ T
Sbjct: 190 YKKTSNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 78/286 (27%), Positives = 124/286 (43%), Gaps = 45/286 (15%)
Query: 100 NFRPDTMLGEGGFGRVF--KGWVDHKT--LAPTKVGVGKAVAVKKSNPDSIQGLREWQAE 155
NF +LG G +G+VF + H + L KV + KA V+K+ + + E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKV-LKKATIVQKA-----KTTEHTRTE 54
Query: 156 VKFLGKFSHPNLVKLIGYCWE-DRQFLLVYEYMQKGSLENHLFRK---GSAEPLPWNTRL 211
+ L + + Y ++ D + L+ +Y+ G L HL ++ E ++ +
Sbjct: 55 RQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEI 114
Query: 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
+A++ H + +IYRD K NILLD + + L+DFGL+K D +
Sbjct: 115 VLALE--------HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS- 165
Query: 272 IMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328
GT Y AP+ V GH D + GV++ E+LTG VD +
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTG----------ASPFTVDGEK 214
Query: 329 PSLTD--KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR 372
S + +R LK E YP + + LA II + L +PK R
Sbjct: 215 NSQAEISRRILKS------EPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 39/221 (17%)
Query: 108 GEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-------LREWQAEVKFLG 160
G G +GRV+K GK A+KK D Q RE + L
Sbjct: 9 GRGTYGRVYKAK----RKNGK---DGKEYAIKKFKGDKEQYTGISQSACRE----IALLR 57
Query: 161 KFSHPNLVKLIGYCWE--DRQFLLVYEYMQKGSLE-NHLFRKGSAEPLPWNTRLKIAIDA 217
+ H N+V L+ E D+ L+++Y + + R+ +P + +
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNA----KLSDFGLAKL------GPIDGNSH 267
+ +LHS+ V++RD K +NIL+ G K+ D GLA+L D +
Sbjct: 118 LNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 268 VTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLT 307
V T Y APE + Y K+ D++ G + E+LT
Sbjct: 176 VV-----TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD------SIQGLREW 152
F +GEG +G V++ D + G+ VA+KK D I LRE
Sbjct: 7 TEFEKLNRIGEGTYGIVYRA-RDTTS--------GEIVALKKVRMDNERDGIPISSLRE- 56
Query: 153 QAEVKFLGKFSHPNLVKLIGYCWEDR--QFLLVYEYMQK--GSLENHLFRKGSAEPLPWN 208
+ L HPN+V+L LV EY ++ SL +++ P +
Sbjct: 57 ---ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT-----PFSES 108
Query: 209 TRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL-GPIDGNSH 267
+ + + L +LH E +I+RD K SN+LL K++DFGLA+ G
Sbjct: 109 QVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--P 164
Query: 268 VTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
+T +++ T Y APE + Y + D++ G +L E+L
Sbjct: 165 MTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGKF 162
+LG+G FG+V L K GK A+K + I E E + L
Sbjct: 2 LLGKGTFGKVI--------LVREKAS-GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 163 SHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKI-AIDAAKD 220
HP L L Y ++ + L V EY+ G L HL R E + R + +
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSA 107
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAA 280
L +LHS + ++YRD K N++LD + K++DFGL K G D + T GT Y A
Sbjct: 108 LDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLA 163
Query: 281 PEYVATGHLYVKSDVYGFGVVLLEMLTG 308
PE + D +G GVV+ EM+ G
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 70/208 (33%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 106 MLGEGGFGRVF--KGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS 163
++G+G FG+V + + K A KV KA+ +KK I R L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYA-VKVLQKKAI-LKKKEEKHIMSERN-----VLLKNVK 54
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKI-AIDAAKDL 221
HP LV L + V +Y+ G L HL R+ EP R + A + A L
Sbjct: 55 HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASAL 109
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAP 281
+LHS +++YRD K NILLD + L+DFGL K I+ N T+ GT Y AP
Sbjct: 110 GYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNG-TTSTFCGTPEYLAP 165
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLTGL 309
E + D + G VL EML GL
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP--DSIQGLREWQAEVKFLGKFSH 164
LGEG FG+V K V AV + K + + L +K +GK H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 80
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-------------FRKGSAEPLPWNTRL 211
N++ L+G C +D ++ EY KG+L +L + E + + +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNSHVTT 270
A+ + +L S + I+RD A N+L+ + K++DFGLA+ + ID T
Sbjct: 141 SCTYQVARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 271 RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
+ + APE + +SDV+ FGV++ E+ T
Sbjct: 199 GRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 80/315 (25%), Positives = 131/315 (41%), Gaps = 71/315 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD------SIQGLREWQAEVKFLG 160
+G+G FG VFK HK + VA+KK + I LRE +K L
Sbjct: 20 IGQGTFGEVFK--ARHKK-------TKQIVALKKVLMENEKEGFPITALRE----IKILQ 66
Query: 161 KFSHPNLVKLIGYCW-----EDR---QFLLVYEYMQ---KGSLENHLFRKGSAEPLPWNT 209
H N+V LI C +R F LV+E+ + G L N + +E
Sbjct: 67 LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEI---KK 123
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK---LGPIDGNS 266
+K+ ++ L ++H ++ +++RD KA+NIL+ KL+DFGLA+ L +
Sbjct: 124 VMKMLLNG---LYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178
Query: 267 HVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD 325
T R++ T Y PE + Y D++G G ++ EM T + N + L+
Sbjct: 179 RYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237
Query: 326 FARPSLT---------------------DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKC 364
S+T KR++K+ + P +++ + A +I K
Sbjct: 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPH-------ALDLIDKL 290
Query: 365 LEAEPKNRPSMEEVL 379
L +P R + L
Sbjct: 291 LVLDPAKRIDADTAL 305
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 78/303 (25%), Positives = 121/303 (39%), Gaps = 45/303 (14%)
Query: 91 LQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR 150
L LR F ++G G +G+V+KG V G+ A+K + +
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTEDEE-E 57
Query: 151 EWQAEVKFLGKFSH-PNLVKLIGY------CWEDRQFLLVYEYMQKGSLENHLFRKGSAE 203
E + E+ L K+SH N+ G D Q LV E+ GS+ + L +
Sbjct: 58 EIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGN 116
Query: 204 PLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263
L + I + + L LH+ + VI+RD K N+LL + KL DFG++ +D
Sbjct: 117 ALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLD 172
Query: 264 GNSHVTTRIMGTYGYAAPEYVATGH-----LYVKSDVYGFGVVLLEMLTGLRALDTNRPS 318
+GT + APE +A +SD++ G+ +EM G L P
Sbjct: 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232
Query: 319 GEHVLVDF-ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEE 377
L+ P L K+ KK +D I CL +RPS E+
Sbjct: 233 RALFLIPRNPPPKLKSKKWSKKFID-----------------FIEGCLVKNYLSRPSTEQ 275
Query: 378 VLE 380
+L+
Sbjct: 276 LLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 25/216 (11%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ-----AEVKFLGK 161
LG G FGRV LA K VA+K+ I +++ Q +E K L
Sbjct: 38 LGTGSFGRVI--------LATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKILNY 87
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDL 221
+HP V L G ++ LV E++ G L R + P + A A L
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN---KRFPNDVGCFYA--AQIVL 142
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAP 281
F + +++YRD K N+LLD K++DFG AK+ +D ++ + GT Y AP
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--VDTRTYT---LCGTPEYIAP 197
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP 317
E + +D + G+ + E+L G N P
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 62/256 (24%), Positives = 114/256 (44%), Gaps = 39/256 (15%)
Query: 133 GKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSL 192
GK VAVKK + Q EV + + H N+V++ + +V E+++ G+L
Sbjct: 45 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 193 ENHLFRKGSAEPLPWNTRLK------IAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS 246
+ + +TR+ + + K L+ LH+ + VI+RD K+ +ILL
Sbjct: 105 TD----------IVTHTRMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHD 152
Query: 247 YNAKLSDFGLAKLGPIDGNSHVTTR--IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLE 304
KLSDFG + V R ++GT + APE ++ + D++ G++++E
Sbjct: 153 GRVKLSDFGFCA----QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 208
Query: 305 MLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKC 364
M+ G P F P L + ++ + P+L+ + + L G + +
Sbjct: 209 MVDG-------EPPY------FNEPPLKAMKMIRDNLPPKLKNLHKVS-PSLKG-FLDRL 253
Query: 365 LEAEPKNRPSMEEVLE 380
L +P R + E+L+
Sbjct: 254 LVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 107 LGEGGFGRVFK----GWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF 162
LGEG FG+V G K P V V K + ++ D + E + +K +GK
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAV-KMLKDDATDKDLSDLVSEMEM-MKMIGK- 76
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFR-------------KGSAEPLPWNT 209
H N++ L+G C +D ++ EY KG+L +L K E L +
Sbjct: 77 -HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNSHV 268
+ A A+ + +L S + I+RD A N+L+ K++DFGLA+ + ID
Sbjct: 136 LVSCAYQVARGMEYLAS--QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 269 TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
T + + APE + +SDV+ FGV+L E+ T
Sbjct: 194 TNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 38/297 (12%)
Query: 86 LKMFTLQ-DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD 144
L+M Q D R+ +N+ +GEG G V H G+ VAVK +
Sbjct: 10 LRMVVDQGDPRSLLENY---IKIGEGSTGIVCIAREKHS---------GRQVAVKMMDLR 57
Query: 145 SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEP 204
Q EV + + H N+V++ + ++ E++Q G+L + + S
Sbjct: 58 KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQTR 113
Query: 205 LPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG 264
L + + L +LHS + VI+RD K+ +ILL KLSDFG I
Sbjct: 114 LNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISK 169
Query: 265 NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP-SGEHVL 323
+ ++GT + APE ++ + D++ G++++EM+ G ++ P L
Sbjct: 170 DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229
Query: 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
D P L + ++ ++ LE + L EP+ R + +E+L+
Sbjct: 230 RDSPPPKLKNAHKISPVLRDFLE----------------RMLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 75/281 (26%), Positives = 123/281 (43%), Gaps = 29/281 (10%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+G G FG+V G V+ P +V V K + V S + ++ L E Q H N
Sbjct: 3 IGNGWFGKVILGEVN-SGYTPAQVVV-KELRVSASVQEQMKFLEEAQP----YRSLQHSN 56
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRL--KIAIDAAKDLTFL 224
L++ +G C E +LLV E+ G L+ +L AE + + ++A + A L L
Sbjct: 57 LLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
H + + I+ D N LL K+ D+GL+ + ++ + APE V
Sbjct: 117 H--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 285 --ATGHLYV-----KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337
G+L V +S+V+ GV + E+ L + S E VL + T + +
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFE-LGSQPYRHLSDEQVL------TYTVREQQ 227
Query: 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEV 378
K+ PRL + P+ +++ +P+ RPS EEV
Sbjct: 228 LKLPKPRL--KLPLSDRWYE---VMQFCWLQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 87/343 (25%), Positives = 144/343 (41%), Gaps = 92/343 (26%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSN------PDSIQGLREWQA 154
++ ++G+G +G V +D T G+ VA+KK N D+ + LRE
Sbjct: 2 YKIQEVIGKGSYGVVCSA-IDTHT--------GEKVAIKKINDVFEHVSDATRILRE--- 49
Query: 155 EVKFLGKFSHPNLV--KLIGYCWEDRQF---LLVYEYMQKGSLENHLFRKGSAEPLPWNT 209
+K L HP++V K I R+F +V+E M+ +
Sbjct: 50 -IKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--------------------S 88
Query: 210 RLKIAIDAAKDLT----------------FLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253
L I A DLT ++H++ +V +RD K NIL + K+ D
Sbjct: 89 DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA--NVFHRDLKPKNILANADCKLKICD 146
Query: 254 FGLAKLGPIDGNSHVT-TRIMGTYGYAAPEYVATGHLYVKS----DVYGFGVVLLEMLTG 308
FGLA++ D + + T + T Y APE G + K D++ G + E+LTG
Sbjct: 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTG 204
Query: 309 ---------LRALDT-----NRPSGE---HVLVDFARPSLTDKRRLKKIMDPRLEEQYPI 351
+ LD PS E V + AR L+ R+ + + +++P
Sbjct: 205 KPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPV---PFSQKFP- 260
Query: 352 KGALLAGQIIIKCLEAEPKNRPSMEEVLET--LQNISVIEIEP 392
LA +++ + L +PK+RP+ EE L + ++ +E EP
Sbjct: 261 NADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREP 303
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 29/228 (12%)
Query: 91 LQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVA----VKKSNPDSI 146
++DLR +++ ++G G FG V V HK+ KV K ++ +K+S+
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEV--QLVRHKS--TRKVYAMKLLSKFEMIKRSDSAFF 90
Query: 147 QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLP 206
W+ E + + P +V+L +DR +V EYM G L N + E
Sbjct: 91 -----WE-ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA 144
Query: 207 --WNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG 264
+ + +A+DA + F+H RD K N+LLD S + KL+DFG +G
Sbjct: 145 RFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196
Query: 265 NSHVTTRIMGTYGYAAPEYVAT----GHLYVKSDVYGFGVVLLEMLTG 308
T + GT Y +PE + + G+ + D + GV L EML G
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 72/290 (24%), Positives = 129/290 (44%), Gaps = 49/290 (16%)
Query: 107 LGEGGFGRVFKG----WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF 162
LG+G F ++FKG D+ L T+V + ++ +S + + +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSES------FFEAASMMSQL 56
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
SH +LV G C + ++V EY++ GSL+ +L + + + W +L++A A L
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALH 114
Query: 223 FLHSSEKSVIYRDFKASNILL-----DGSYNA---KLSDFGLA-KLGPIDGNSHVTTRIM 273
FL +K + + + A N+LL + N KLSD G++ + P + + RI
Sbjct: 115 FLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE---ILLERI- 168
Query: 274 GTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332
+ PE + +L + +D + FG L E+ +G G+ L S
Sbjct: 169 ---PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG----------GDKPL------SAL 209
Query: 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
D ++ + + R + P K LA +I +C++ EP RPS ++ L
Sbjct: 210 DSQKKLQFYEDRHQLPAP-KWTELA-NLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 65/209 (31%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQ---GLREWQAEVKFLGK 161
+GEG F V K KT GK A+K K + S++ LRE QA ++ L
Sbjct: 7 IGEGTFSEVLKA-QSRKT--------GKYYAIKCMKKHFKSLEQVNNLREIQA-LRRLS- 55
Query: 162 FSHPNLVKLIGYCWEDR--QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
HPN+++LI ++ + + LV+E M E KG PLP K
Sbjct: 56 -PHPNILRLIEVLFDRKTGRLALVFELMDMNLYE---LIKGRKRPLPEKRVKSYMYQLLK 111
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA 279
L +H + +RD K NIL+ KL+DFG + I T I T Y
Sbjct: 112 SLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGSCR--GIYSKPPYTEYI-STRWYR 165
Query: 280 APEYVATGHLY-VKSDVYGFGVVLLEMLT 307
APE + T Y K D++ G V E+L+
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREWQAEVKFLG 160
+GEG +G VFK + +T + VA+K+ D LRE + L
Sbjct: 8 IGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDDDEGVPSSALRE----ICLLK 54
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
+ H N+V+L D++ LV+EY + L+ + F + + P K
Sbjct: 55 ELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKY-FDSCNGDIDP-EIVKSFMFQLLKG 111
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LG-PIDGNSHVTTRIMGTYGY 278
L F HS +V++RD K N+L++ + KL+DFGLA+ G P+ S T Y
Sbjct: 112 LAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV----TLWY 165
Query: 279 AAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRAL 312
P+ + LY S D++ G + E+ R L
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 65/237 (27%), Positives = 102/237 (43%), Gaps = 44/237 (18%)
Query: 93 DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK---SNPDSI-QG 148
DL + + RP LG G G VF VD K VAVKK ++P S+
Sbjct: 2 DLGSRYMDLRP---LGCGSNGLVFSA-VDSDC--------DKRVAVKKIVLTDPQSVKHA 49
Query: 149 LREWQAEVKFLGKFSHPNLVKL--------------IGYCWEDRQFLLVYEYMQKGSLEN 194
LRE +K + + H N+VK+ +G E +V EYM E
Sbjct: 50 LRE----IKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ET 100
Query: 195 HLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG-SYNAKLSD 253
L PL + L ++HS+ +V++RD K +N+ ++ K+ D
Sbjct: 101 DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANVFINTEDLVLKIGD 158
Query: 254 FGLAK-LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
FGLA+ + P + + + T Y +P + + + Y K+ D++ G + EMLTG
Sbjct: 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 41/216 (18%)
Query: 107 LGEGGFGRVFKGW--VDHKTLAPTKV-------GVGKAVAVKKSNPDSIQGLREWQAEVK 157
+GEG +G V+K V ++T+A K+ GV + A++ E+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGV-PSTAIR---------------EIS 53
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRL--KIAI 215
L + H N+V+L +++ LV+EY+ L+ H+ S+ N RL
Sbjct: 54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHM---DSSPDFAKNPRLIKTYLY 109
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA-KLSDFGLAK-LG-PIDGNSHVTTRI 272
+ + + HS V++RD K N+L+D NA KL+DFGLA+ G P+ +H
Sbjct: 110 QILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-- 165
Query: 273 MGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLT 307
T Y APE + Y D++ G + EM+
Sbjct: 166 --TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 1e-09
Identities = 75/300 (25%), Positives = 117/300 (39%), Gaps = 45/300 (15%)
Query: 94 LRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ 153
LR F ++G G +G+V+KG K G A+ V D + +++
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKG-------RHVKTGQLAAIKVMDVTGDEEEEIKQ-- 51
Query: 154 AEVKFLGKFSH-PNLVKLIGYCWE------DRQFLLVYEYMQKGSLENHLFRKGSAEPLP 206
E+ L K+SH N+ G + D Q LV E+ GS+ + L + L
Sbjct: 52 -EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLK 109
Query: 207 WNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNS 266
I + + L+ LH + VI+RD K N+LL + KL DFG++ +D
Sbjct: 110 EEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTV 165
Query: 267 HVTTRIMGTYGYAAPEYVATGH-----LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321
+GT + APE +A KSD++ G+ +EM G L P
Sbjct: 166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 225
Query: 322 VLVDF-ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
L+ P L K+ KK I CL RP+ E++++
Sbjct: 226 FLIPRNPAPRLKSKKWSKKFQ-----------------SFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 39/214 (18%)
Query: 109 EGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREWQAEVKFLGKF 162
EG +G V++ D KT G+ VA+KK + I LRE + L K
Sbjct: 15 EGTYGVVYRA-RDKKT--------GEIVALKKLKMEKEKEGFPITSLRE----INILLKL 61
Query: 163 SHPNLVKL----IGYCWEDRQFLLVYEYMQ---KGSLENHLFRKGSAEPLPWNTRLKIAI 215
HPN+V + +G + +V EY++ K +E K + +
Sbjct: 62 QHPNIVTVKEVVVGS--NLDKIYMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLL 116
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
LH + +++RD K SN+LL+ K+ DFGLA+ T+++ T
Sbjct: 117 SGVA---HLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVT 169
Query: 276 YGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTG 308
Y APE + Y D++ G + E+LT
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 57/239 (23%), Positives = 96/239 (40%), Gaps = 59/239 (24%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK--SNPDSIQGLREWQAEVK 157
++P +G G +G V +D ++ GK VA+KK D + E+K
Sbjct: 6 RYKPIENIGSGAYGVVCSA-IDTRS--------GKKVAIKKIPHAFDVPTLAKRTLRELK 56
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFL-----------LVYEYMQ---------KGSLENHLF 197
L F H N++ + R L +V + M+ L
Sbjct: 57 ILRHFKHDNIIAI-------RDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHI 109
Query: 198 RKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257
R + L + L ++HS+ +VI+RD K SN+L++ ++ DFG+A
Sbjct: 110 RYFLYQLL-------------RGLKYIHSA--NVIHRDLKPSNLLVNEDCELRIGDFGMA 154
Query: 258 KL---GPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRAL 312
+ P + +T + T Y APE + + Y + D++ G + EML G R L
Sbjct: 155 RGLSSSPTEHKYFMTEYV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LGEG + V+KG K+ K+ K + +++ +RE L H N
Sbjct: 13 LGEGSYATVYKG----KSKVNGKLVALKVIRLQEEEGTPFTAIRE----ASLLKGLKHAN 64
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
+V L LV+EY+ + G P N +L + + L+++H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPE--NVKLFL-FQLLRGLSYIH- 120
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT 286
++ +++RD K N+L+ + KL+DFGLA+ + SH + + T Y P+ +
Sbjct: 121 -QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SHTYSNEVVTLWYRPPDVLLG 177
Query: 287 GHLYVKS-DVYGFGVVLLEMLTGLRAL 312
Y D++G G + +EM+ G+ A
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 40/215 (18%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQAEVKFLGKFS 163
+G G G V+K V H+ PT G+ A+K ++ D+++ R+ E++ L +
Sbjct: 82 IGSGAGGTVYK--VIHR---PT----GRLYALKVIYGNHEDTVR--RQICREIEILRDVN 130
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
HPN+VK + + ++ E+M GSLE + L +A + +
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT--HIADEQFLA-----DVARQILSGIAY 183
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-----LGPIDGNSHVTTRIMGTYGY 278
LH + +++RD K SN+L++ + N K++DFG+++ + P NS V GT Y
Sbjct: 184 LHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC--NSSV-----GTIAY 234
Query: 279 AAPEYVATG---HLY--VKSDVYGFGVVLLEMLTG 308
+PE + T Y D++ GV +LE G
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
|
Length = 353 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 50/220 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ------GLREWQAEVKFLG 160
+GEG +G V+K + G+ VA+KK ++ +RE + L
Sbjct: 7 IGEGTYGVVYKA----RDKLT-----GEIVALKKIRLETEDEGVPSTAIRE----ISLLK 53
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA-- 218
+ +HPN+V+L+ + + LV+E++ L K + P +D
Sbjct: 54 ELNHPNIVRLLDVVHSENKLYLVFEFL-------DLDLKKYMDSSP-----LTGLDPPLI 101
Query: 219 --------KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LG-PIDGNSHV 268
+ + + HS V++RD K N+L+D KL+DFGLA+ G P+ +H
Sbjct: 102 KSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159
Query: 269 TTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLT 307
T Y APE + Y D++ G + EM+
Sbjct: 160 VV----TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 60/223 (26%), Positives = 86/223 (38%), Gaps = 37/223 (16%)
Query: 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGK 161
T++G+ + HK VAVKK N D S + L+ Q E+ +
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKP-------TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQ 55
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQKGS----LENHLFRKGSAEPLPWNTRLKIAI-- 215
HPN++ + D + +V M GS L+ H F +G E L IA
Sbjct: 56 LQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH-FPEGLPE-------LAIAFIL 107
Query: 216 -DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID--GNSHVTTRI 272
D L ++HS K I+R KAS+ILL G LS GL + G
Sbjct: 108 KDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHD 163
Query: 273 MGTYG-----YAAPEYVATG-HLY-VKSDVYGFGVVLLEMLTG 308
+ +PE + Y KSD+Y G+ E+ G
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 29/174 (16%)
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID------GNSHVTTR 271
AK + FL S + I+RD A NILL + K+ DFGLA+ D G++ + +
Sbjct: 189 AKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 272 IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331
M APE + ++SDV+ FGV+L E+ + L + G + +F R L
Sbjct: 247 WM------APETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCR-RL 295
Query: 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ R++ D E Y Q ++ C EP RP+ E++E L N+
Sbjct: 296 KEGTRMRA-PDYTTPEMY---------QTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 73/284 (25%), Positives = 115/284 (40%), Gaps = 42/284 (14%)
Query: 100 NFRPDTMLGEGGFGRVF----KGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAE 155
NF +LG G +G+VF D L KV A+ K + + R
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRK---GSAEPLPWNTRLK 212
V+ P LV L + + L+ +Y+ G + HL+++ E ++ +
Sbjct: 61 VR-----QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEII 115
Query: 213 IAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRI 272
+A++ H + ++YRD K NILLD + L+DFGL+K + T
Sbjct: 116 LALE--------HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK-EFLSEEKERTYSF 166
Query: 273 MGTYGYAAPEYV--ATGHLYVKSDVYGFGVVLLEMLTGLR--ALDTNRPSGEHVLVDFAR 328
GT Y APE + GH D + G+++ E+LTG L+ R + V
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNTQSEV------ 219
Query: 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR 372
+R LK DP +P A ++ K L +PK R
Sbjct: 220 ----SRRILK--CDP----PFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LGEG + VFKG L V + K + ++ +RE V L H N
Sbjct: 13 LGEGTYATVFKG---RSKLTENLVAL-KEIRLEHEEGAPCTAIRE----VSLLKNLKHAN 64
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
+V L +R LV+EY+ L+ +L G+ + N ++ + L++ H
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMH-NVKI-FMFQLLRGLSYCH- 120
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT 286
++ +++RD K N+L++ KL+DFGLA+ + ++ + T Y P+ +
Sbjct: 121 -KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 177
Query: 287 GHLYVKS-DVYGFGVVLLEMLTG 308
Y D++G G +L EM TG
Sbjct: 178 STEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 23/160 (14%)
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
H K +I+RD K++NILL + KL DFG +K+ + V GT Y APE
Sbjct: 158 HVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW 217
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344
K+D++ GV+L E+LT R D GE+ ++++M
Sbjct: 218 RRKPYSKKADMFSLGVLLYELLTLKRPFD-----GEN---------------MEEVMHKT 257
Query: 345 LEEQY---PIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381
L +Y P + +I+ L ++PK RPS ++L
Sbjct: 258 LAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 66/257 (25%), Positives = 101/257 (39%), Gaps = 46/257 (17%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKF 162
++G GGFG V+ K GK A+K + I QG E L
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 163 SH---PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
S P +V + + + + M G L HL + G + + K
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--------------VFSEK 97
Query: 220 DLTFL---------HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT 270
++ F H + V+YRD K +NILLD + ++SD GLA D +
Sbjct: 98 EMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPH 153
Query: 271 RIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329
+GT+GY APE + G Y S D + G +L ++L G ++ +H + R
Sbjct: 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRM 210
Query: 330 SLTDKRRLKKIMDPRLE 346
+LT L P L+
Sbjct: 211 TLTVNVELPDSFSPELK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 59/255 (23%), Positives = 96/255 (37%), Gaps = 42/255 (16%)
Query: 155 EVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA 214
E L +HP+++++ +V + L +L ++ + PLP + L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKR--SRPLPIDQALIIE 163
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
+ L +LH+ + +I+RD K NI ++ + D G A+ + + G
Sbjct: 164 KQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---GLAG 218
Query: 275 TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334
T APE +A K+D++ G+VL EML + + PS V L
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278
Query: 335 RRLKKI------MDP--RLEEQY----------------------PIKGALLAGQIIIKC 364
K+ DP RL + PI G L + K
Sbjct: 279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFL----VHKM 334
Query: 365 LEAEPKNRPSMEEVL 379
L + RPS EE+L
Sbjct: 335 LTFDAAMRPSAEEIL 349
|
Length = 357 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 32/85 (37%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
H + V+YRD K +NILLD + ++SD GLA D + +GT+GY APE +
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVL 167
Query: 285 ATGHLYVKS-DVYGFGVVLLEMLTG 308
G Y S D + G +L ++L G
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ------GLREWQAEVKFLG 160
+GEG +G+V+K D T GK VA+KK+ + + LRE + L
Sbjct: 9 IGEGTYGKVYKA-RDKNT--------GKLVALKKTRLEMDEEGIPPTALRE----ISLLQ 55
Query: 161 KFSH-PNLVKLIGYCWEDR-----QFLLVYEYMQ---KGSLENHLFRKGSAEPLPWNTRL 211
S +V+L+ + LV+EY+ K ++++ +G PLP T
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSN--GRGPGRPLPAKTIK 113
Query: 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA-KLSDFGLAKLGPIDGNSHVTT 270
K + H V++RD K N+L+D K++D GL + I S+ T
Sbjct: 114 SFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--T 169
Query: 271 RIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
+ T Y APE + Y D++ G + EM
Sbjct: 170 HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 70/298 (23%), Positives = 117/298 (39%), Gaps = 50/298 (16%)
Query: 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA 154
R ++F +G G +G V+K V G+ A+K + + Q
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQ 55
Query: 155 EVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA 214
E+ + H N+V G + + E+ GSL++ G PL + ++
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVS 112
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
+ + L +LHS K ++RD K +NILL + + KL+DFG++ I +G
Sbjct: 113 RETLQGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIG 168
Query: 275 TYGYAAPEYVAT---GHLYVKSDVYGFGVVLLEM---------LTGLRALDTNRPSGEHV 322
T + APE A G D++ G+ +E+ L +RAL S
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS---- 224
Query: 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+F P L DK +K + + L PK RP+ E++L+
Sbjct: 225 --NFQPPKLKDK----------------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 68/243 (27%), Positives = 96/243 (39%), Gaps = 48/243 (19%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQAE 155
K+F+ +LG+G GRVF L K G GK A+K K ++ E
Sbjct: 1 KHFKKIKLLGKGDVGRVF--------LVRLK-GTGKLFALKVLDKKEMIKRNKVKRVLTE 51
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNT-RLKIA 214
+ L HP L L + LV +Y G L L ++ + L R A
Sbjct: 52 QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARFYAA 110
Query: 215 -IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL-------------- 259
+ A L +LH ++YRD K NILL S + LSDF L+K
Sbjct: 111 EVLLA--LEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 260 GPIDGNSH----------VTTRIM---GTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEM 305
G + + + R GT Y APE V +G + + D + G++L EM
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEM 225
Query: 306 LTG 308
L G
Sbjct: 226 LYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 68/288 (23%), Positives = 114/288 (39%), Gaps = 44/288 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR---EWQAEVKFLGKFS 163
LG+G F ++KG + VG V R + + + S
Sbjct: 3 LGQGTFTNIYKG--VLRV-QSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLS 59
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
H +LVKL G C D + ++V EY++ G L+ L R+ + L W +L +A A L +
Sbjct: 60 HKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHY 116
Query: 224 LHSSEKSVIYRDFKASNILL-----DGSYN--AKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
L +K +++ + NIL+ + Y KLSD G+ + RI
Sbjct: 117 LE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI---- 168
Query: 277 GYAAPEYVATGH--LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334
+ APE + G L + +D + FG LLE+ + + P L+
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICS-----NGEEP-------------LSTL 210
Query: 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
+K + + + P+ +I +C +P RPS +L L
Sbjct: 211 SSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LGEG + VFKG L V + K + ++ +RE V L H N
Sbjct: 14 LGEGTYATVFKG---RSKLTENLVAL-KEIRLEHEEGAPCTAIRE----VSLLKDLKHAN 65
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
+V L D+ LV+EY+ K L+ ++ G+ + N ++ + + L + H
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH-NVKIFL-YQILRGLAYCH- 121
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT 286
+ V++RD K N+L++ KL+DFGLA+ + ++ + T Y P+ +
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 178
Query: 287 GHLY-VKSDVYGFGVVLLEMLTG 308
Y + D++G G + EM +G
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 81/348 (23%), Positives = 132/348 (37%), Gaps = 95/348 (27%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKF-S 163
+LG G FG+V V+ K VAVK + + +E+K L +
Sbjct: 14 VLGHGAFGKV----VEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN 69
Query: 164 HPNLVKLIGYCWEDRQFLLV-YEYMQKGSLENHLFRK----------------------- 199
H N+V L+G C + L+V E+ + G+L N L K
Sbjct: 70 HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVE 129
Query: 200 -------------------------GSAEPLP-----WNTRLKI------AIDAAKDLTF 223
GS P W + L + + A+ + F
Sbjct: 130 QSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEF 189
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID------GNSHVTTRIMGTYG 277
L S + I+RD A NILL + K+ DFGLA+ D G++ + + M
Sbjct: 190 LAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM---- 243
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337
APE + +SDV+ FGV+L E+ + L + G + +F + L D R+
Sbjct: 244 --APESIFDKVYTTQSDVWSFGVLLWEIFS----LGASPYPGVQINEEFCQ-RLKDGTRM 296
Query: 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ P +I++ C + +PK RP+ ++E L ++
Sbjct: 297 RA----------PENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 37/232 (15%)
Query: 91 LQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVA----VKKSNPDSI 146
+ LR ++F ++G G FG V V HK+ +V K ++ +K+S+
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEV--QLVRHKS--SKQVYAMKLLSKFEMIKRSDSAFF 90
Query: 147 QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAE-P 204
R+ A ++ + + Y ++D ++L +V EYM G L N + + + P
Sbjct: 91 WEERDIMA-------HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIP 140
Query: 205 LPW----NTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260
W + +A+DA + F+H RD K N+LLD S + KL+DFG
Sbjct: 141 EKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKM 192
Query: 261 PIDGNSHVTTRIMGTYGYAAPEYVAT--GHLYV--KSDVYGFGVVLLEMLTG 308
+G T + GT Y +PE + + G Y + D + GV L EML G
Sbjct: 193 DANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 29/189 (15%)
Query: 203 EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPI 262
EPL + + A+ + FL S + I+RD A NILL + K+ DFGLA+
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYK 225
Query: 263 D------GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNR 316
D G++ + + M APE + +SDV+ FGV+L E+ + L +
Sbjct: 226 DPDYVRKGDARLPLKWM------APESIFDKVYTTQSDVWSFGVLLWEIFS----LGASP 275
Query: 317 PSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSME 376
G + +F R L + R++ + E Y I++ C P++RP+
Sbjct: 276 YPGVQIDEEFCR-RLKEGTRMRA-PEYATPEIY---------SIMLDCWHNNPEDRPTFS 324
Query: 377 EVLETLQNI 385
E++E L ++
Sbjct: 325 ELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LGEG + V+KG L V + K + ++ +RE V L H N
Sbjct: 14 LGEGTYATVYKG---RSKLTDNLVAL-KEIRLEHEEGAPCTAIRE----VSLLKDLKHAN 65
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
+V L ++ LV+EY+ K L+ +L G++ + N +L + + L + H
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH-NVKLFL-FQLLRGLNYCH- 121
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT 286
+ V++RD K N+L++ KL+DFGLA+ I ++ + T Y P+ +
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLG 178
Query: 287 GHLY-VKSDVYGFGVVLLEMLTG 308
Y + D++G G + EM TG
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 85/317 (26%), Positives = 124/317 (39%), Gaps = 65/317 (20%)
Query: 88 MFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ 147
M L+ L T + +G+G +G+V+K T G AVK +P S
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYK---------VTNKKDGSLAAVKILDPISDV 61
Query: 148 GLREWQAEVKFLGKFS-HPNLVKLIGYCWEDR-----QFLLVYEYMQKGS---LENHLFR 198
E +AE L HPN+VK G ++ Q LV E GS L L
Sbjct: 62 D-EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 199 KGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL-A 257
G + L I A L LH++ +I+RD K +NILL KL DFG+ A
Sbjct: 121 CG--QRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSA 176
Query: 258 KLGPIDGNSHVTTRI-----MGTYGYAAPEYVATGHLY-----VKSDVYGFGVVLLEMLT 307
+L +TR+ +GT + APE +A Y + DV+ G+ +E+
Sbjct: 177 QL--------TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228
Query: 308 GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM----DPRLEEQYPIKGALLAGQIIIK 363
G P L D +K + +P +P K I +
Sbjct: 229 G-------------------DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQ 269
Query: 364 CLEAEPKNRPSMEEVLE 380
CL + + RPS+ +LE
Sbjct: 270 CLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 73/263 (27%), Positives = 100/263 (38%), Gaps = 81/263 (30%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ----- 153
+F ++G G FG V V K G A+KK + L + Q
Sbjct: 1 DDFESIKVIGRGAFGEV--RLVQKKD-------TGHIYAMKKLRKSEM--LEKEQVAHVR 49
Query: 154 AEVKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKG--SAEPLPWNTR 210
AE L + +P +VKL Y ++D +L L+ EY+ G + L +K + E TR
Sbjct: 50 AERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE----ETR 104
Query: 211 LKI-----AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGN 265
I AID+ L ++H RD K N+LLD + KLSDFGL +
Sbjct: 105 FYIAETILAIDSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCT--GLK-K 153
Query: 266 SHVTT----------------------------------RIM-----GTYGYAAPEYVAT 286
SH T R + GT Y APE V
Sbjct: 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFL 212
Query: 287 GHLYVKS-DVYGFGVVLLEMLTG 308
Y K D + GV++ EML G
Sbjct: 213 QTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 81/322 (25%), Positives = 121/322 (37%), Gaps = 84/322 (26%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR---EWQAEVKFLGKF 162
++G+GG G V+ LA V + VA+KK D + + E K
Sbjct: 9 LIGKGGMGEVY--------LAYDPV-CSRRVALKKIREDLSENPLLKKRFLREAKIAADL 59
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYM----------------QKGSLENHLFRKGSAEPLP 206
HP +V + C + VY M QK SL L K S
Sbjct: 60 IHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF- 115
Query: 207 WNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-------- 258
L I + ++HS K V++RD K NILL + D+G A
Sbjct: 116 ----LSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169
Query: 259 LGPIDGN------SHVTT--RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLR 310
L ID + S +T +I+GT Y APE + +D+Y GV+L +MLT
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT--- 226
Query: 311 ALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRL----EEQYP---IKGALLAGQIIIK 363
+ P +++ +KI + E P I L QI +K
Sbjct: 227 ---------------LSFP--YRRKKGRKISYRDVILSPIEVAPYREIPPFL--SQIAMK 267
Query: 364 CLEAEPKNR-PSMEEVLETLQN 384
L +P R S++E+ + L+
Sbjct: 268 ALAVDPAERYSSVQELKQDLEP 289
|
Length = 932 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNP--DSIQGLREWQAEVKFLGK 161
+G G +G V +D +T G+ VA+KK S P I R ++ E+ L
Sbjct: 21 KQVGSGAYGSVCSA-IDKRT--------GEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKH 70
Query: 162 FSHPNLVKLIGYCWEDRQ-----------FLLVYEYMQKGSLENHLFRKGSAEPLPWNTR 210
H N++ D F LV YMQ L+ + S + + +
Sbjct: 71 MQHENVIG-----LLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQY--- 121
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT 270
+ L ++HS+ +I+RD K N+ ++ K+ DFGLA+ + +V T
Sbjct: 122 --LVYQMLCGLKYIHSA--GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 177
Query: 271 RIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
R Y APE + Y ++ D++ G ++ EMLTG
Sbjct: 178 R-----WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 73/288 (25%), Positives = 112/288 (38%), Gaps = 56/288 (19%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+G G +G V+K + G+ AVK + Q E+ + + H N
Sbjct: 17 VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI---DAAKDLTF 223
+V G + + EY GSL++ G PL + L+IA + + L +
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG---PL---SELQIAYVCRETLQGLAY 121
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEY 283
LHS K ++RD K +NILL + + KL+DFG+A I +GT + APE
Sbjct: 122 LHSKGK--MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEV 177
Query: 284 VA---TGHLYVKSDVYGFGVVLLEM---------LTGLRALDTNRPSGEHVLVDFARPSL 331
A G D++ G+ +E+ L +RAL S +F P L
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS------NFQPPKL 231
Query: 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
DK K + + L PK RP+ E +L
Sbjct: 232 KDK----------------TKWSSTFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 64/242 (26%), Positives = 105/242 (43%), Gaps = 44/242 (18%)
Query: 153 QAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNT--- 209
++E+ L H +VK D + LL+ EY G L N ++ E LP+
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL-NKQIKQRLKEHLPFQEYEV 171
Query: 210 -----RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG 264
++ +A+D +HS + +++RD K++NI L + KL DFG +K
Sbjct: 172 GLLFYQIVLALDE------VHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223
Query: 265 NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV 324
+ V + GT Y APE K+D++ GV+L E+LT +RP
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT------LHRP------- 270
Query: 325 DFARPSLTDKRRLKKIMDPRLEEQY-----PIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
F PS ++IM L +Y P+ + A ++ L P RP+ +++L
Sbjct: 271 -FKGPS------QREIMQQVLYGKYDPFPCPVSSGMKA--LLDPLLSKNPALRPTTQQLL 321
Query: 380 ET 381
T
Sbjct: 322 HT 323
|
Length = 478 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 41/161 (25%), Positives = 65/161 (40%), Gaps = 23/161 (14%)
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLP------WNTRLKIAIDAA 218
PN+V L Y + LV ++ + G L +H+ +P W + +A+DA
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI---SKFLNIPEECVKRWAAEMVVALDA- 100
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY 278
LH + ++ RD +NILLD + +L+ F + + Y
Sbjct: 101 -----LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----Y 148
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSG 319
APE D + G +L E+LTG + L PSG
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-----LREWQAEVKFLGK 161
LGEG + V+KG G+ VA+K+ + +G +RE L
Sbjct: 13 LGEGSYATVYKGRSKL---------TGQLVALKEIRLEHEEGAPFTAIRE----ASLLKD 59
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDL 221
H N+V L + LV+EY+ L+ ++ G N RL + L
Sbjct: 60 LKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLS-MHNVRL-FLFQLLRGL 116
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAP 281
+ H + V++RD K N+L+ KL+DFGLA+ + S + + T Y P
Sbjct: 117 AYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--SKTYSNEVVTLWYRPP 172
Query: 282 EYVATGHLYVKS-DVYGFGVVLLEMLTGL 309
+ + Y S D++G G + EM TG
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 12/199 (6%)
Query: 118 GWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQA-EVKFLGKFSHPNLVKLIG-Y 173
G+ +T P G A K+ + G R A E L +HP++++L G +
Sbjct: 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTF 152
Query: 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIY 233
+ L++ Y K L +L K + L I + + +LH E +I+
Sbjct: 153 TYNKFTCLILPRY--KTDLYCYLAAK---RNIAICDILAIERSVLRAIQYLH--ENRIIH 205
Query: 234 RDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS 293
RD KA NI ++ + L DFG A P+D N++ GT APE +A
Sbjct: 206 RDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAV 264
Query: 294 DVYGFGVVLLEMLTGLRAL 312
D++ G+VL EM T +L
Sbjct: 265 DIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 91 LQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVA----VKKSNPDSI 146
++ L+ +++ ++G G FG V V HK + KV K ++ +K+S+
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEV--QLVRHK--SSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 147 QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLP 206
W+ E + + P +V+L +D+ +V EYM G L N + E
Sbjct: 91 -----WE-ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA 144
Query: 207 --WNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG 264
+ + +A+DA +HS +I+RD K N+LLD + KL+DFG G
Sbjct: 145 KFYTAEVVLALDA------IHS--MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196
Query: 265 NSHVTTRIMGTYGYAAPEYVAT----GHLYVKSDVYGFGVVLLEMLTG 308
T + GT Y +PE + + G+ + D + GV L EML G
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 59/249 (23%), Positives = 100/249 (40%), Gaps = 57/249 (22%)
Query: 95 RAATKNFRP-DTMLGEGGFGRVFKGW--VDHKTLAPTKVGVGKAVAVKKSNPDSIQ---- 147
+ ++ + LGEG +G+V K + + K +A KV K + + Q
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKV---KIIEISNDVTKDRQLVGM 60
Query: 148 ------GLREWQAEVKFLGKFSHPNLVKLIG-YCWEDRQFL-LVYEYMQKGSLENHLFRK 199
LRE +K + + H N++ L+ Y D F+ LV + M L+ + RK
Sbjct: 61 CGIHFTTLRE----LKIMNEIKHENIMGLVDVYVEGD--FINLVMDIMA-SDLKKVVDRK 113
Query: 200 GSAEPLPWNTRLK------IAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253
RL I + L LH ++RD +NI ++ K++D
Sbjct: 114 ---------IRLTESQVKCILLQILNGLNVLHKW--YFMHRDLSPANIFINSKGICKIAD 162
Query: 254 FGLA-------------KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFG 299
FGLA K + +T++++ T Y APE + Y + D++ G
Sbjct: 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVG 221
Query: 300 VVLLEMLTG 308
+ E+LTG
Sbjct: 222 CIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 32/212 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNP--DSIQGLREWQAEVKFLGKFS 163
+G G +G+V D KT G+ VA+KK S P +I R ++ E++ L
Sbjct: 23 VGSGAYGQVCSA-FDTKT--------GRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMD 72
Query: 164 HPNLVKLI-----GYCWED-RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
H N++ L+ ED + LV M G+ N++ + + L + +
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVK---CQKLSDDHIQFLVYQI 127
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
+ L ++HS+ +I+RD K SNI ++ K+ DFGLA+ + +V TR
Sbjct: 128 LRGLKYIHSA--GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 278 YAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
Y APE + Y ++ D++ G ++ E+LTG
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 23/151 (15%)
Query: 174 CWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNT-RLKIAIDAAKDLTFLHSSEKSV 231
+E ++ L +V EY++ G L G LP + R+ A + L +LH+ +
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLKNIG---ALPVDMARMYFA-ETVLALEYLHNY--GI 122
Query: 232 IYRDFKASNILLDGSYNAKLSDFGLAKLGPI-------DGNSHVTTR------IMGTYGY 278
++RD K N+L+ + KL+DFGL+K+G + +G+ TR + GT Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 279 AAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
APE V Y K D + G++L E L G
Sbjct: 183 IAPE-VILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA--EVKFLGKFSH 164
LGEG + V+KG +++ G+ VA+K + + +G+ + A E L H
Sbjct: 13 LGEGSYATVYKGI--------SRIN-GQLVALKVISMKTEEGV-PFTAIREASLLKGLKH 62
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
N+V L V+EYM + + G P +N RL + L ++
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHP--YNVRL-FMFQLLRGLAYI 119
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
H + +++RD K N+L+ KL+DFGLA+ I ++ + + T Y P+ +
Sbjct: 120 HG--QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVL 175
Query: 285 ATGHLYVKS-DVYGFGVVLLEMLTG 308
Y + D++G G + +EML G
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 17/173 (9%)
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT 270
L + AK ++FL S K+ I+RD A NILL K+ DFGLA+ D N V
Sbjct: 217 LSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274
Query: 271 RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330
+ APE + +SDV+ +G++L E+ + L ++ G V F +
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS----LGSSPYPGMPVDSKFYKMI 330
Query: 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
R L P E Y I+ C +A+P RP+ +++++ ++
Sbjct: 331 KEGYRMLSPECAP--SEMY---------DIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 32/220 (14%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGL---REWQAEVK 157
PD +G G FG V W + T GK VA+KK P+ Q L + E+K
Sbjct: 2 VEPDRPIGYGAFGVV---W------SVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELK 51
Query: 158 FLGKFSHPNLVKLIGY-------CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTR 210
L F H N++ + +E + +V E MQ L + S +PL +
Sbjct: 52 MLCFFKHDNVLSALDILQPPHIDPFE--EIYVVTELMQS-DLHKIIV---SPQPLSSDHV 105
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT 270
+ L +LHS+ +++RD K N+L++ + K+ DFGLA++ D + H+T
Sbjct: 106 KVFLYQILRGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQ 163
Query: 271 RIMGTYGYAAPEYVATG--HLYVKSDVYGFGVVLLEMLTG 308
++ Y Y APE + G H D++ G + E+L
Sbjct: 164 EVVTQY-YRAPE-ILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 2/104 (1%)
Query: 204 PLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263
PL + L+ + A+ + FL S K+ I+RD A N+LL AK+ DFGLA+ D
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
N V + APE + V+SDV+ +G++L E+ +
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 53/181 (29%), Positives = 80/181 (44%), Gaps = 28/181 (15%)
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK---LGPIDGNSHVTTRIMGTYG 277
L ++HS+ +V++RD K N+L++ K+ DFGLA+ P + +T + T
Sbjct: 118 LKYIHSA--NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRW 174
Query: 278 YAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG----------------LRALDTNRPSGE 320
Y APE + + Y K+ DV+ G +L E+L L+ L T P E
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT--PD-E 231
Query: 321 HVLVDFARPSLTDK-RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
L P + R L I E +P LA ++ K L +P R S+EE L
Sbjct: 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFP-NANPLALDLLEKLLAFDPTKRISVEEAL 290
Query: 380 E 380
E
Sbjct: 291 E 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 67/288 (23%), Positives = 117/288 (40%), Gaps = 44/288 (15%)
Query: 107 LGEGGFGRVFKG--WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSH 164
+G G FG+V + D +A V KA A K + +Q Q + + H
Sbjct: 3 IGNGWFGKVLLSEIYTD-TGVARVVVKELKANASSKEQNEFLQ-----QGDPYRI--LQH 54
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLE----NHLFRKGSAEPLPWNTRLKIAIDAAKD 220
PN+++ +G C E +LLV+EY + G L+ + + +++ L ++A + A
Sbjct: 55 PNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAG 111
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID-GNSHVTT--RIMGTYG 277
+T +H + + ++ D N L K+ D+G +GP ++ T
Sbjct: 112 VTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYG---IGPSRYKEDYIETEDDKCVPLR 166
Query: 278 YAAPEYVATGHLYV-------KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330
+ APE V H + S+V+ GV L E+ N L D +
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF-------ENAAQPYSHLSDREVLN 219
Query: 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEV 378
K + K+ P+LE Y + +++ C P+ R + EEV
Sbjct: 220 HVIKDQQVKLFKPQLELPYSERWY----EVLQFCW-LSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 53/202 (26%), Positives = 84/202 (41%), Gaps = 18/202 (8%)
Query: 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243
Y+ ++N L GS E L L A+ + FL S K+ ++RD A N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGS-EGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNVLL 270
Query: 244 DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLL 303
K+ DFGLA+ D N + APE + SDV+ +G++L
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330
Query: 304 EMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIK 363
E+ + L G V F + R K D +E Y I++K
Sbjct: 331 EIFS----LGGTPYPGMIVDSTFYNKIKSGYRMAKP--DHATQEVY---------DIMVK 375
Query: 364 CLEAEPKNRPSMEEVLETLQNI 385
C +EP+ RPS + + ++++
Sbjct: 376 CWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 81/292 (27%), Positives = 117/292 (40%), Gaps = 53/292 (18%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGL-REWQAEVKFLGKFS-H 164
+G+G +G+VFK V +K G AVK +P I + E +AE L S H
Sbjct: 26 IGKGTYGKVFK--VLNKK-------NGSKAAVKILDP--IHDIDEEIEAEYNILKALSDH 74
Query: 165 PNLVKLIG-YCWEDR----QFLLVYEYMQKGS---LENHLFRKGS--AEPLPWNTRLKIA 214
PN+VK G Y +D Q LV E GS L ++G EP+ I
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII----AYIL 130
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
+A L LH I+RD K +NILL KL DFG++ + +G
Sbjct: 131 HEALMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVG 186
Query: 275 TYGYAAPEYVATGHLY-----VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329
T + APE +A + DV+ G+ +E+ G D
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG----------------DPPLA 230
Query: 330 SLTDKRRLKKI-MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
L R L KI +P P + I KCL + + RP++ ++L+
Sbjct: 231 DLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNPDSIQGLREWQ-AEVKFLGKFS 163
++GEG +G V K HK + VA+KK + + + ++E E+K L
Sbjct: 8 VVGEGAYGVVLK--CRHKE-------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
N+V+L + LV+EY++K LE L + P R I K + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYI-YQLIKAIHW 115
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEY 283
H ++ +++RD K N+L+ + KL DFG A+ +G++ T + T Y +PE
Sbjct: 116 CHKND--IVHRDIKPENLLISHNDVLKLCDFGFAR-NLSEGSNANYTEYVATRWYRSPEL 172
Query: 284 VATGHLYVKS-DVYGFGVVLLEMLTG 308
+ G Y K+ D++ G +L E+ G
Sbjct: 173 L-LGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 67/267 (25%), Positives = 114/267 (42%), Gaps = 43/267 (16%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKT--LAPTKVGVGKAVAVKKSNPDSIQGLREWQAEV 156
K+F +++G G FG V + + T + KV +KKS + + + ++ E
Sbjct: 1 KDFDVKSLVGRGHFGEV-QVVREKATGDIYAMKV-------MKKSVLLAQETVSFFEEER 52
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWN------T 209
L + P + +L Y ++D+ L LV EY G L + L R + +
Sbjct: 53 DILSISNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNR--YEDQFDEDMAQFYLA 109
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269
L +AI + + ++H RD K N+L+D + + KL+DFG A + N V
Sbjct: 110 ELVLAIHSVHQMGYVH--------RDIKPENVLIDRTGHIKLADFGSA--ARLTANKMVN 159
Query: 270 TRI-MGTYGYAAPEYVATGHLYVKS------DVYGFGVVLLEMLTGLRALDTNRPSGEHV 322
+++ +GT Y APE + T + K D + GV+ EM+ G P E
Sbjct: 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG------RSPFHEGT 213
Query: 323 LVDFARPSLTDKRRLKKIMDPRLEEQY 349
+ +R LK DP++ +
Sbjct: 214 SAKTYNNIMNFQRFLKFPEDPKVSSDF 240
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 8e-07
Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 36/233 (15%)
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
+ + SH +L + G C + ++V E+++ G L+ L ++ P+ W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILL------DGSYN-AKLSDFGLAKLGPIDGNSHVTT 270
A L++L +K++++ + A NILL +G+ KLSD G++ + V
Sbjct: 127 ASALSYLE--DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERV-E 182
Query: 271 RIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329
RI + APE V G L +D + FG LLE+ D P E P
Sbjct: 183 RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI-----CFDGEVPLKERT------P 227
Query: 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
S ++ KK RL E + A L Q CL EP RPS +L L
Sbjct: 228 SEKERFYEKKH---RLPEPSCKELATLISQ----CLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 52/168 (30%), Positives = 76/168 (45%), Gaps = 31/168 (18%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQAEV 156
+F ++G+G FG V K GK A+K KS L +AE
Sbjct: 2 DFHTVKVIGKGAFGEV---------RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAER 52
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIA 214
L + P +V L Y ++D Q+L L+ E++ G L L + + +E + TR +A
Sbjct: 53 DVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMA 108
Query: 215 -----IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257
I+A L F+H RD K NIL+D + KLSDFGL+
Sbjct: 109 ECVLAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 155 EVKFLGKFSHPNLVKL--IGYCWEDRQFLLVYEYMQKG---SLENHLFRKGSAEP--LPW 207
E+ L + HPN++ L + DR+ L+++Y + ++ H K + +P LP
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 208 NTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS----YNAKLSDFGLAKL--GP 261
+ + + +LH++ V++RD K +NIL+ G K++D G A+L P
Sbjct: 108 SMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLT 307
+ + + ++ T+ Y APE + Y K+ D++ G + E+LT
Sbjct: 166 LKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 37/230 (16%)
Query: 90 TLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGL 149
T+ ++ ++ + +G G +G V +D +T G VA+KK L
Sbjct: 9 TIWEVPDRYRDLKQ---VGSGAYGTVCSA-LDRRT--------GAKVAIKKLYRPFQSEL 56
Query: 150 REWQA--EVKFLGKFSHPNLVKLIGYCWED------RQFLLVYEYMQK--GSLENHLFRK 199
+A E++ L H N++ L+ D F LV +M G L H
Sbjct: 57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---- 112
Query: 200 GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259
E L + + K L ++H++ +I+RD K N+ ++ K+ DFGLA+
Sbjct: 113 ---EKLSEDRIQFLVYQMLKGLKYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167
Query: 260 GPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
+ +V TR Y APE + Y ++ D++ G ++ EMLTG
Sbjct: 168 TDSEMTGYVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 43/167 (25%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 155 EVKFLGKFSHPNLVKL--IGYCWEDRQFLLVYEYMQKG---SLENHLFRKGSAEP--LPW 207
E+ L + HPN++ L + DR+ L+++Y + ++ H K + +P LP
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 208 NTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS----YNAKLSDFGLAKL--GP 261
+ + +LH++ V++RD K +NIL+ G K++D G A+L P
Sbjct: 108 GMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLT 307
+ + + ++ T+ Y APE + Y K+ D++ G + E+LT
Sbjct: 166 LKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 33/228 (14%)
Query: 90 TLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNP-DSIQ 147
T+ ++ +N P +G G +G V + D KT G VAVKK S P SI
Sbjct: 11 TIWEVPERYQNLSP---VGSGAYGSVCAAF-DTKT--------GLRVAVKKLSRPFQSII 58
Query: 148 GLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQF------LLVYEYMQKGSLENHLFRKGS 201
+ E++ L H N++ L+ R LV M G+ N++ +
Sbjct: 59 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--- 113
Query: 202 AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP 261
+ L + + + L ++HS++ +I+RD K SN+ ++ K+ DFGLA+
Sbjct: 114 CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD 171
Query: 262 IDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTG 308
+ +V TR Y APE + H D++ G ++ E+LTG
Sbjct: 172 DEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 22/155 (14%)
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
+ SH ++V L G C D + ++V E+++ G L+ + RK PW + K+A A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASA 117
Query: 221 LTFLHSSEKSVIYRDFKASNILL-----DGSYNA--KLSDFGLAKLGPID--GNSHVTTR 271
L++L +K +++ + NILL DG KLSD G+ PI R
Sbjct: 118 LSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PITVLSRQECVER 171
Query: 272 IMGTYGYAAPEYVA-TGHLYVKSDVYGFGVVLLEM 305
I + APE V + +L + +D + FG L E+
Sbjct: 172 I----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 24/187 (12%)
Query: 133 GKAVAVKKSNP------DSIQGLREWQAEVKFLGKFSHPNLVKL--IGYCWEDRQF---L 181
+ VA+KK D+ + LRE +K L H N++ + I F
Sbjct: 30 NEKVAIKKIANAFDNRIDAKRTLRE----IKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85
Query: 182 LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNI 241
+VYE M + H + S++ L + + L ++HS+ +V++RD K SN+
Sbjct: 86 IVYELMDT---DLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSA--NVLHRDLKPSNL 139
Query: 242 LLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGV 300
LL+ + + K+ DFGLA+ T + T Y APE + Y + DV+ G
Sbjct: 140 LLNANCDLKICDFGLARTT--SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGC 197
Query: 301 VLLEMLT 307
+ E+L
Sbjct: 198 IFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 48/234 (20%)
Query: 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA 154
R+ K+++ ++G G FG V++ + + VA+KK +Q +
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAIC---------IDTSEKVAIKK----VLQDPQYKNR 108
Query: 155 EVKFLGKFSHPNLVKLIGYCW-------EDRQFL---------LVYEYMQKGSLENHLFR 198
E+ + +H N++ L Y + E FL V++YM+ + NH
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNH--- 165
Query: 199 KGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD-GSYNAKLSDFGLA 257
LP + + L ++HS K + +RD K N+L+D ++ KL DFG A
Sbjct: 166 -----ALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218
Query: 258 K--LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
K L S++ +R Y APE + Y D++ G ++ EM+ G
Sbjct: 219 KNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 40/163 (24%), Positives = 70/163 (42%), Gaps = 22/163 (13%)
Query: 155 EVKFLGKFSHPNLVKLIGYC-WEDRQFLL-------VYEYMQKGSLENHLFRKGSAEPLP 206
E+ LG+ +H N++K+ E +++ +Y +M + + PL
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD------WKDRPLL 266
Query: 207 WNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNS 266
TR I + ++H K +I+RD K NI L+ L DFG A P +
Sbjct: 267 KQTR-AIMKQLLCAVEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAM--PFE-KE 320
Query: 267 HVTTRI--MGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
+GT +PE +A +D++ G++LL+ML+
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 74/326 (22%), Positives = 126/326 (38%), Gaps = 47/326 (14%)
Query: 6 GTPVDDGPSKPPSPGSRTG--------ANSLTGKENKADGLEMAGEINDVKDEHERKADD 57
P D PS + A + +E G E + +D + D+
Sbjct: 49 PPPEHDPPSPHGARDEAARLCQIQELLAEMRSSEEYPDSGAEAEDDDDDDAPDDVAYPDE 108
Query: 58 ADEGRQLGDGDGGDKNMPSSGEI----VTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFG 113
E L D + G +TP L+ + RA ++ +P + + + G
Sbjct: 109 YAEDDFLPGDGAPDHDPAPCGPAPPGGLTPEELERLDREAARAISRGCKPPSEVAKVVAG 168
Query: 114 RVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGL---REWQA----EVKFLGKFSHPN 166
G+ H+ L P G + S+PD Q + W A E + L + SHP
Sbjct: 169 L---GFAIHRALTPGSEGC----VFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPA 221
Query: 167 LVKLIGY-------CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
++ L+ C L++ +Y + L +L + L T + + +A
Sbjct: 222 VLALLDVRVVGGLTC------LVLPKY--RSDLYTYLGARLRPLGLAQVTAVARQLLSAI 273
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA 279
D ++H + +I+RD K N+L++G + L DFG A ++ I GT
Sbjct: 274 D--YIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329
Query: 280 APEYVATGHLYVKS-DVYGFGVVLLE 304
APE +A G Y S D++ G+V+ E
Sbjct: 330 APEVLA-GDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 67/253 (26%), Positives = 97/253 (38%), Gaps = 72/253 (28%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNPDSIQGLREWQAEVK----FLGK 161
+G G FG V L KV A+K D + R A VK L +
Sbjct: 9 IGIGAFGEV--------CLV-RKVDTNALYAMKTLRKADVLM--RNQAAHVKAERDILAE 57
Query: 162 FSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLP--WNTRLKIAIDA 217
+ +VKL Y ++D+ L V +Y+ G + + L R G E L + L AI++
Sbjct: 58 ADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIES 116
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL--------------------- 256
+ F+H RD K NIL+D + KL+DFGL
Sbjct: 117 VHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQ 168
Query: 257 --------------AKLGPIDG-NSHVTTRIM-----GTYGYAAPEYVA-TGHLYVKSDV 295
+L P++ R + GT Y APE + TG+ + D
Sbjct: 169 DSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDW 227
Query: 296 YGFGVVLLEMLTG 308
+ GV+L EML G
Sbjct: 228 WSVGVILYEMLVG 240
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 31/152 (20%)
Query: 173 YCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLP------WNTRLKIAIDAAKDLTFLH 225
Y ++D L LV +Y G L L + + LP + + +AID+ L ++H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLGYVH 125
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFG----LAKLGPIDGNSHVTTRIMGTYGYAAP 281
RD K N+LLD + + +L+DFG L G + N V GT Y +P
Sbjct: 126 --------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-----GTPDYISP 172
Query: 282 EYV-----ATGHLYVKSDVYGFGVVLLEMLTG 308
E + G + D + GV + EML G
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 29/133 (21%), Positives = 45/133 (33%), Gaps = 17/133 (12%)
Query: 133 GKAVAVKKSNPDSIQGLREWQAEVKFLGKF--SHPNLV-KLIGYCWEDRQFLLVYEYMQK 189
+ +K + RE EV L + V K++ D L+ E+
Sbjct: 21 DEDYVLKINPSREKGADRE--REVAIL-QLLARKGLPVPKVLASGESDGWSYLLMEW--- 74
Query: 190 GSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS-SEKSVIYRDFKASNILLDGSYN 248
+E + S E IA A+ L LH + + D NIL+D
Sbjct: 75 --IEGETLDEVSEEEKE-----DIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI 127
Query: 249 AKLSDFGLAKLGP 261
+ D+ A GP
Sbjct: 128 LGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 32/86 (37%), Positives = 48/86 (55%), Gaps = 7/86 (8%)
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEY 283
LHS+ +I+RD K SNI++ K+ DFGLA+ G S + T + T Y APE
Sbjct: 134 LHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE- 187
Query: 284 VATGHLYVKS-DVYGFGVVLLEMLTG 308
V G Y ++ D++ G ++ EM+ G
Sbjct: 188 VILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 29/85 (34%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEY 283
LHS+ +I+RD K SNI++ K+ DFGLA+ G S + T + T Y APE
Sbjct: 142 LHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 196
Query: 284 VATGHLYVKSDVYGFGVVLLEMLTG 308
+ D++ G ++ EM+ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEY 283
LHS+ +I+RD K SNI++ K+ DFGLA+ G S + T + T Y APE
Sbjct: 135 LHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 189
Query: 284 VATGHLYVKSDVYGFGVVLLEML 306
+ D++ G ++ EM+
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 46/174 (26%), Positives = 68/174 (39%), Gaps = 47/174 (27%)
Query: 173 YCWED-RQFLLVYEYMQKGSLENHLFRKGS---AEPLPWNTRLKIAIDAAKDLTFLHSSE 228
Y ++D R L+ E++ G + L +K + + +AIDA L F+H
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH--- 124
Query: 229 KSVIYRDFKASNILLDGSYNAKLSDFG----------------LAKLGPID--------- 263
RD K N+LLD + KLSDFG L P D
Sbjct: 125 -----RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179
Query: 264 --------GNSHVTTRIMGTYGYAAPE-YVATGHLYVKSDVYGFGVVLLEMLTG 308
+ +GT Y APE ++ TG+ + D + GV++ EML G
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 33/219 (15%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNP-DSIQGLREWQAEV 156
+N P +G G +G V + D + + VAVKK S P S+ R E+
Sbjct: 18 QNLTP---VGSGAYGSVCSAY-DTRLR--------QKVAVKKLSRPFQSLIHARRTYREL 65
Query: 157 KFLGKFSHPNLVKLI-----GYCWEDRQFLLVYEYMQKGSLENHL-FRKGSAEPLPWNTR 210
+ L H N++ L+ E+ + + + L N + +K S E + +
Sbjct: 66 RLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF--- 122
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT 270
+ + L ++HS+ +I+RD K SN+ ++ ++ DFGLA+ + +V T
Sbjct: 123 --LIYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVAT 178
Query: 271 RIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
R Y APE + Y ++ D++ G ++ E+L G
Sbjct: 179 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 27/85 (31%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEY 283
LHS+ +I+RD K SNI++ K+ DFGLA+ N +T ++ Y Y APE
Sbjct: 139 LHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NFMMTPYVVTRY-YRAPEV 193
Query: 284 VATGHLYVKSDVYGFGVVLLEMLTG 308
+ D++ G ++ E++ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 110 GGFGRVFKGW-VDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLV 168
G FG+V+ G ++ L KV VKK++ + + + QAE L P +V
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKV-------VKKADMINKNMVHQVQAERDALALSKSPFIV 67
Query: 169 KLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKDLTFLHSS 227
L LV EY+ G +++ L G E +K + A L +LH
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE----MAVKYISEVALALDYLH-- 121
Query: 228 EKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259
+I+RD K N+L+ + KL+DFGL+K+
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 57/249 (22%), Positives = 105/249 (42%), Gaps = 47/249 (18%)
Query: 92 QDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE 151
+D+ +T+ F+ ++LGEG FG+V + W D K V + + V + R+
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAW-DRKRKEYCAVKIVRNVP---------KYTRD 171
Query: 152 WQAEVKFLGKFSHPN------LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPL 205
+ E++F+ K + L+K+ Y + + + L + + + G
Sbjct: 172 AKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHG----- 226
Query: 206 PWNTR--LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA-------------- 249
P++ R +I L + H +E +++ D K NIL++ S
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFH-TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285
Query: 250 --KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV-ATGHLYVKSDVYGFGVVLLEML 306
++ D G G D H T I+ T Y +PE V G +Y +D++ G ++ E+
Sbjct: 286 RVRICDLG----GCCD-ERHSRTAIVSTRHYRSPEVVLGLGWMY-STDMWSMGCIIYELY 339
Query: 307 TGLRALDTN 315
TG DT+
Sbjct: 340 TGKLLYDTH 348
|
Length = 467 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 39/142 (27%), Positives = 65/142 (45%), Gaps = 18/142 (12%)
Query: 176 EDRQFLLVYEYMQKGSLENHL--FRKGSAEPLP--WNTRLKIAIDAAKDLTFLHSSEKSV 231
++ LV +Y G L L F E + + + IAID+ L ++H
Sbjct: 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH------ 125
Query: 232 IYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV-----AT 286
RD K NIL+D + + +L+DFG + L ++ + ++ +GT Y +PE +
Sbjct: 126 --RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 287 GHLYVKSDVYGFGVVLLEMLTG 308
G + D + GV + EML G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 51/191 (26%), Positives = 84/191 (43%), Gaps = 24/191 (12%)
Query: 133 GKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKG 190
G V V+ ++ ++ + L+ Q EV F HPN++ ++ +M G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 191 SLENHLFR----KGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS 246
S N L + +G +E L N I A + L +LH + I+R+ KAS+IL+ G
Sbjct: 85 S-ANSLLKTYFPEGMSEALIGN----ILFGALRGLNYLH--QNGYIHRNIKASHILISGD 137
Query: 247 YNAKLSDFGLAKLGPI--DGNSHVTTRIMGTYGYA-----APEYVATG-HLY-VKSDVYG 297
LS GL+ L + +G + + +PE + + Y VKSD+Y
Sbjct: 138 GLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYS 195
Query: 298 FGVVLLEMLTG 308
G+ E+ TG
Sbjct: 196 VGITACELATG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 29/90 (32%), Positives = 43/90 (47%), Gaps = 2/90 (2%)
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
A + FL S K+ ++RD A N+L+ K+ DFGLA+ D N
Sbjct: 249 ANGMEFLAS--KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307
+ APE + SDV+ FG++L E+ T
Sbjct: 307 WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 52/212 (24%), Positives = 79/212 (37%), Gaps = 51/212 (24%)
Query: 81 VTPNYLKMFTLQDL-RAATKNFRPDTM-----LGEGGFGRVFKGWVDHKTLAPTKVGVGK 134
V P ++ MF L L +F+ D LGEG FG V+K +L +
Sbjct: 108 VAPGFVDMFVLAPLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKA-----SLVNKQSKKEG 162
Query: 135 AVAVKKSNPDSIQGLRE-WQAE----------VKFLGKFSHPNLVKLIGYCWEDRQFLLV 183
+KK+ G E W E F+ F P K ++ ++ LV
Sbjct: 163 KYVLKKATE---YGAVEIWMNERVRRACPNSCADFVYGFLEPVSSK------KEDEYWLV 213
Query: 184 YEYMQKGSL-------------ENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF----LHS 226
+ Y + +L E +L K P KI + + F LHS
Sbjct: 214 WRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS 273
Query: 227 SEKSVIYRDFKASNILLD-GSYNAKLSDFGLA 257
+ +++RD K NI+ GS + K+ D G A
Sbjct: 274 T--GIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 41/146 (28%), Positives = 64/146 (43%), Gaps = 19/146 (13%)
Query: 173 YCWEDRQFL-LVYEYMQKGSLENHL--FRKGSAEPLP--WNTRLKIAIDAAKDLTFLHSS 227
Y ++D +L LV +Y G L L F E + + + +AI + L ++H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125
Query: 228 EKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV--- 284
RD K N+LLD + + +L+DFG DG + + GT Y +PE +
Sbjct: 126 ------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEILQAM 178
Query: 285 --ATGHLYVKSDVYGFGVVLLEMLTG 308
G + D + GV + EML G
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 34/103 (33%), Positives = 47/103 (45%), Gaps = 22/103 (21%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGK-----AVAVK--KSN--PDSIQGLREWQAEVK 157
LG G FG+V + T G+GK VAVK K++ D + L +E+K
Sbjct: 46 LGAGAFGKVVEA---------TAFGLGKEDNVLRVAVKMLKASAHTDEREAL---MSELK 93
Query: 158 FLGKF-SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRK 199
L H N+V L+G C L++ EY G L N L +K
Sbjct: 94 ILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 65/253 (25%), Positives = 100/253 (39%), Gaps = 68/253 (26%)
Query: 107 LGEGGFGRV-FKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG G FG V VD K L K K V ++ + +AE L + +
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQ-------VAHVKAERDILAEADNE 61
Query: 166 NLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLP--WNTRLKIAIDAAKDL 221
+V+L Y ++D+ L V +Y+ G + + L R G E L + L A+++ +
Sbjct: 62 WVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA------------------------ 257
F+H RD K NIL+D + KL+DFGL
Sbjct: 121 GFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172
Query: 258 ---------------KLGPID---GNSH---VTTRIMGTYGYAAPE-YVATGHLYVKSDV 295
+L P++ H + ++GT Y APE + TG+ + D
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDW 231
Query: 296 YGFGVVLLEMLTG 308
+ GV+L EML G
Sbjct: 232 WSVGVILYEMLVG 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 52/205 (25%), Positives = 77/205 (37%), Gaps = 58/205 (28%)
Query: 153 QAEVKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLP--WN 208
+AE L + + +VKL Y ++D+ L V +Y+ G + + L R E L +
Sbjct: 49 KAERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYI 107
Query: 209 TRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA----------- 257
L +AI++ + F+H RD K NIL+D + KL+DFGL
Sbjct: 108 AELTLAIESVHKMGFIH--------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159
Query: 258 ----------KLGPID-----GNSHVTTRIM-------------------GTYGYAAPEY 283
+ P D N R+ GT Y APE
Sbjct: 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219
Query: 284 VATGHLYVKSDVYGFGVVLLEMLTG 308
+ D + GV+L EML G
Sbjct: 220 LLRKGYTQLCDWWSVGVILFEMLVG 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 21/163 (12%)
Query: 99 KNFRPDTMLGEGGFGRV-FKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVK 157
++F ++G G FG V D + K+ + KA ++K I+ R+ E
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKI-LRKADMLEKEQVGHIRAERDILVEAD 59
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS---AEPLPWNTRLKI 213
L +VK+ Y ++D+ L L+ E++ G + L +K + E + +
Sbjct: 60 SLW------VVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL 112
Query: 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256
AID+ L F+H RD K N+LLD + KLSDFGL
Sbjct: 113 AIDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 441 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.28 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.28 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.13 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.05 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.91 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.9 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.71 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.67 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.58 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.5 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.47 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.38 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.34 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.29 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.17 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.14 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.13 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.11 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.05 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.0 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.97 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.89 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.83 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.8 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.61 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.6 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.54 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.45 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.43 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.38 | |
| PLN02236 | 344 | choline kinase | 97.09 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.07 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.94 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.92 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.88 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.81 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.72 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.57 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.31 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.24 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.12 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.06 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.04 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.04 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.67 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.65 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.2 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.06 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.03 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 94.56 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.08 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.03 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-53 Score=388.99 Aligned_cols=253 Identities=28% Similarity=0.428 Sum_probs=213.9
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
+.+.++.||+|..|+||++ .++.+++.+|+|++... .....+++.+|+++++..+||+||.+|+.|+.+.
T Consensus 80 dle~~~~lG~G~gG~V~kv---------~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKV---------RHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred HhhhhhhcccCCCcEEEEE---------EEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 3445678999999999999 45556899999999555 3345678999999999999999999999999999
Q ss_pred -eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 179 -QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 179 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
.+.|+||||++|+|++++...+ .+++...-.|+.++++||.|||. ..+||||||||+|||++..|+|||||||.+
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~-~~~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHE-ERKIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhh-ccCeeeccCCHHHeeeccCCCEEecccccc
Confidence 5999999999999999997654 48899999999999999999995 489999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
+.... ....+++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+ ........+
T Consensus 227 ~~lvn----S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-----------~~~~~~~Ll 291 (364)
T KOG0581|consen 227 GILVN----SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-----------PYLDIFELL 291 (364)
T ss_pred HHhhh----hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-----------CCCCHHHHH
Confidence 86432 256778999999999999999999999999999999999999999975411 112223334
Q ss_pred hhhcCccccccCCh-hhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIMDPRLEEQYPI-KGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+.+... ...|. .+++++++|+..||+.||.+||++.++++|
T Consensus 292 ~~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 292 CAIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 44444222 23455 488899999999999999999999999987
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-54 Score=396.89 Aligned_cols=253 Identities=30% Similarity=0.415 Sum_probs=210.1
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-------HHHHHHHHHHHHhcCCCCCccc
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-------GLREWQAEVKFLGKFSHPNLVK 169 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~ 169 (441)
..+.|.+.+.||.|+||.|-+| .++.+++.||||+++..... ....+.+|++||++|+|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla---------~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~ 240 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLA---------YEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR 240 (475)
T ss_pred hcceeEeeeeecCCceeEEEEE---------EEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence 4567889999999999999999 55667999999998764221 2334679999999999999999
Q ss_pred eEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC---
Q 013519 170 LIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS--- 246 (441)
Q Consensus 170 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~--- 246 (441)
++++|......||||||++||+|.+.+..++. +.+.....+++|++.|+.|||+ +||+||||||+|||+..+
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDAED 315 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHH--cCcccccCCcceEEeccCCcc
Confidence 99999999999999999999999999987764 6677888999999999999997 999999999999999766
Q ss_pred CceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCC---ccccchhHHHHHHHHHhCCCCCCCCCCCCCcee
Q 013519 247 YNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY---VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323 (441)
Q Consensus 247 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~ 323 (441)
..+||+|||+|+.. +....+.++||||.|.|||++.+..+. .++||||||||||.+|+|.+||.......
T Consensus 316 ~llKItDFGlAK~~---g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---- 388 (475)
T KOG0615|consen 316 CLLKITDFGLAKVS---GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---- 388 (475)
T ss_pred eEEEecccchhhcc---ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc----
Confidence 77999999999964 355677889999999999999877544 47899999999999999999997543211
Q ss_pred ecccccccchhhhhhhhcCcccc--ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 324 VDFARPSLTDKRRLKKIMDPRLE--EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+ ..++....+. .......++++++||.+||..||++|||+.|+|+|
T Consensus 389 ------sl-----~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 389 ------SL-----KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ------cH-----HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11 1122222221 12345677889999999999999999999999986
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-52 Score=400.22 Aligned_cols=288 Identities=52% Similarity=0.907 Sum_probs=244.4
Q ss_pred cccccCHHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCC
Q 013519 85 YLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSH 164 (441)
Q Consensus 85 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h 164 (441)
....|++.++..++++|....+||+|+||.||+|.... +..||||++........++|.+|+.+|.+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH 130 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence 56779999999999999999999999999999997764 47899998877654314569999999999999
Q ss_pred CCccceEEEEEeCC-eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccC-CCCeeecCCCCCcEE
Q 013519 165 PNLVKLIGYCWEDR-QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSS-EKSVIYRDFKASNIL 242 (441)
Q Consensus 165 pniv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivHrDlkp~Nil 242 (441)
||+|+++|||.+.+ ..+||+||+++|+|.++|...... +++|..+++|+.++|+||+|||.. ...||||||||+|||
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNIL 209 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNIL 209 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHee
Confidence 99999999999998 599999999999999999875543 899999999999999999999973 236999999999999
Q ss_pred EcCCCceEEecccCCCCCCCCCCcceEeee-ccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCc
Q 013519 243 LDGSYNAKLSDFGLAKLGPIDGNSHVTTRI-MGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321 (441)
Q Consensus 243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~ 321 (441)
||+++++||+|||+|+..+.. ... .... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...+....
T Consensus 210 LD~~~~aKlsDFGLa~~~~~~-~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~ 287 (361)
T KOG1187|consen 210 LDEDFNAKLSDFGLAKLGPEG-DTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGEL 287 (361)
T ss_pred ECCCCCEEccCccCcccCCcc-ccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccc
Confidence 999999999999999865431 111 1222 8999999999999999999999999999999999999998876655555
Q ss_pred eeecccccccchhhhhhhhcCcccc-ccCCh-hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLE-EQYPI-KGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
.+.+|..+.+... .+..++|+.+. ..++. .....+..+..+|++.+|.+||+|.+|++.|+.+.
T Consensus 288 ~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 288 SLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 5667765544443 78889999987 55554 56667889999999999999999999999986544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=406.80 Aligned_cols=249 Identities=28% Similarity=0.459 Sum_probs=215.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
..|...+.||+|||+.||.+ ++..+|..||+|++.... ....+.+.+||+|.+.|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~---------~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEA---------RDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEE---------EEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 46999999999999999999 455569999999987642 234667889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+.+++|||+|+|..++|..++.++ +++++.+++.++.||+.||.|||+ .+|+|||||..|+||+++.+|||+|||
T Consensus 89 Ds~nVYivLELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred cCCceEEEEEecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheeecCcCcEEecccc
Confidence 999999999999999999999754 579999999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
||..... ......+.||||.|+|||++....++..+||||+|||||.||+|++||+... -.+
T Consensus 164 LAt~le~--~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~----------------vke 225 (592)
T KOG0575|consen 164 LATQLEY--DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT----------------VKE 225 (592)
T ss_pred eeeeecC--cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch----------------HHH
Confidence 9987543 3345677899999999999999999999999999999999999999997542 112
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+..+.... -.+|...+.++++||.+||+.||.+|||+++||.+
T Consensus 226 ty~~Ik~~~--Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 226 TYNKIKLNE--YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHHHhcC--cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222222111 13466778889999999999999999999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-53 Score=386.16 Aligned_cols=251 Identities=32% Similarity=0.458 Sum_probs=212.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|+++++||+|+||+||.+ +++.+++.||+|++++... ...+...+|..||.+++||+||.++..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~V---------rk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQV---------RKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEEE---------EEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 467999999999999999999 4446799999999887633 3467788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
++...+|||+||+.||.|+..|.+.+. +++..++.++.+|+.||.|||+ +|||||||||+|||||.+|+++|+||
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDF 169 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDF 169 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEecc
Confidence 999999999999999999999987764 8899999999999999999997 99999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
||++.... ....+.++|||+.|||||++.+.+|+..+|+|||||++|||++|..||...+. .
T Consensus 170 gL~k~~~~--~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~----------------~ 231 (357)
T KOG0598|consen 170 GLCKEDLK--DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV----------------K 231 (357)
T ss_pred ccchhccc--CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH----------------H
Confidence 99986432 23445668999999999999999999999999999999999999999976431 1
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP----SMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~eil~~ 381 (441)
....++.... ....|.-.+.++++++.++|..||++|. ++.+|-+|
T Consensus 232 ~~~~~I~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 232 KMYDKILKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHHHHHhcCc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 2222333222 1233444677899999999999999996 56665543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=376.01 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=211.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEE-EEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIG-YCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~-~~~ 175 (441)
.+|.++++||+|+||.||++ .+..+|+.+|.|.++.. +....+.+..|+.+|++|+|||||++++ .|.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv---------~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKV---------QCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred HHHHHHHHHcCCcchheEEe---------eeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 46888999999999999999 66677999999998865 3455677889999999999999999998 455
Q ss_pred eCCe-EEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhcc--CCCCeeecCCCCCcEEEcCCCceEE
Q 013519 176 EDRQ-FLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHS--SEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 176 ~~~~-~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
+++. ++||||||.+|+|..++.... ..+.+++.++|+++.|++.||..+|+ ...-|+||||||.||+|+.+|.|||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 5555 899999999999999987633 24678999999999999999999997 3345999999999999999999999
Q ss_pred ecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccccc
Q 013519 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
+||||++.+. .......+++|||.||+||.+.+.+|+.++|||||||++|||+.-..||.+..-
T Consensus 170 GDfGL~r~l~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-------------- 233 (375)
T KOG0591|consen 170 GDFGLGRFLS--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL-------------- 233 (375)
T ss_pred ccchhHhHhc--chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--------------
Confidence 9999999754 333445678999999999999999999999999999999999999999976421
Q ss_pred chhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
-..-.++-...+.......++..+..||..|+..||+.||+.-.++..+
T Consensus 234 --~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 234 --LSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred --HHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 0111223222222222266788899999999999999999865555443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=382.32 Aligned_cols=203 Identities=31% Similarity=0.508 Sum_probs=182.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
..+|.+.+.||.|+||+||+|+.. .++..||||.+... +.+..+.+..|+.+|+.++|||||+++++++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~---------~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHK---------KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccceehhhccCcceEEEEEeEec---------cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 357899999999999999999544 45789999998877 5566777889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC------Cce
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS------YNA 249 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~------~~~ 249 (441)
.++.+|||||||+||+|.++|.+++ .+++.+++.++.|++.||++||. ++||||||||+||||+.. -.+
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~L 154 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPVL 154 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCceE
Confidence 9999999999999999999998876 48999999999999999999996 999999999999999765 458
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP 317 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~ 317 (441)
||+|||+|+... ......+.||+|.|||||++..+.|+.|+|+||+|+|||++++|+.||+...+
T Consensus 155 KIADFGfAR~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 155 KIADFGFARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred EecccchhhhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 999999999754 34456678999999999999999999999999999999999999999986543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=389.30 Aligned_cols=256 Identities=33% Similarity=0.554 Sum_probs=214.1
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcE-EEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKA-VAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~-vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
..+.+.||.|+||+||+|.|.. .. ||||++..... ...+.|.+|+.+|.+++|||||+++|++.+.
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g-----------~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRG-----------TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCC-----------ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3445569999999999998884 45 99999876532 2256899999999999999999999999988
Q ss_pred C-eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCC-eeecCCCCCcEEEcCCC-ceEEecc
Q 013519 178 R-QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKS-VIYRDFKASNILLDGSY-NAKLSDF 254 (441)
Q Consensus 178 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-ivHrDlkp~Nill~~~~-~~kl~DF 254 (441)
. .++|||||+++|+|.+++.+. ....+++..++.++.||++||.|||+ .+ ||||||||+|||++.++ ++||+||
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~--~~~iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS--EGPIIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc--CCCeeecccChhhEEEcCCCCEEEECCC
Confidence 7 799999999999999999875 34679999999999999999999997 77 99999999999999997 9999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhh--cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA--TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|+++...... ...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....+
T Consensus 189 Glsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------------- 251 (362)
T KOG0192|consen 189 GLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------------- 251 (362)
T ss_pred ccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---------------
Confidence 9998643211 2334478999999999999 56999999999999999999999999976533
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
......+.....+..+|..++..+..|+.+||..||+.||++.+++..|+.+...
T Consensus 252 -~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 252 -VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred -HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 1112222333444455666888899999999999999999999999999877653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=364.72 Aligned_cols=264 Identities=28% Similarity=0.398 Sum_probs=210.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-H-HHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-Q-GLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
+.|+.+.++|+|+||+||+| +.+.+|+.||||++..... . ..+-..+|+++|++|+|||+|.++++|..
T Consensus 2 ekYE~LgkvGEGSYGvV~KC---------rnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKC---------RNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred cHHhhhhccccCcceEEEEe---------ccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 46888889999999999999 5556799999999866533 2 23446789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...+++|+|||+. ++.+.|.+.. ..++...+..+++|++.|+.|+|+ ++||||||||+||||+.+|.+||||||+
T Consensus 73 krklhLVFE~~dh-TvL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELERYP--NGVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred cceeEEEeeecch-HHHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchh
Confidence 9999999999987 4445565544 458899999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
|+.... .....+.++.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+.|.+.+..+....+...-..+....
T Consensus 148 AR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh 225 (396)
T KOG0593|consen 148 ARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH 225 (396)
T ss_pred hHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH
Confidence 997543 3445677889999999999988 6899999999999999999999999988776655443332222222211
Q ss_pred hhhhhcC--c--------------cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMD--P--------------RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~--~--------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+ +++. + .+...+| ..+..+.+|+++||..||++|++.+++|.|
T Consensus 226 q--~iF~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 226 Q--SIFSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred H--HHhccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1 1111 1 1111222 233467799999999999999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=383.87 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=217.7
Q ss_pred HHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcC-CCCCccce
Q 013519 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKF-SHPNLVKL 170 (441)
Q Consensus 95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~~ 170 (441)
....++|.+++.||+|+|++||+| +++.+++.||||++.+... ..+..+.+|-.+|.+| .||.|++|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A---------~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLA---------REKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred cCChhhcchhheeccccceeEEEe---------eecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 445678999999999999999999 5566799999999877643 2344577899999999 69999999
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 171 IGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 171 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
+..|+++..+|+|+||+++|+|.++|.+.++ |++...+.++.+|+.||.|||+ .|||||||||+|||||+++++|
T Consensus 140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 140 YFTFQDEESLYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred EEEeecccceEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEE
Confidence 9999999999999999999999999998875 8889999999999999999997 9999999999999999999999
Q ss_pred EecccCCCCCCCCCCc-----------ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 013519 251 LSDFGLAKLGPIDGNS-----------HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSG 319 (441)
Q Consensus 251 l~DFGla~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~ 319 (441)
|+|||.|+.+...... ....+++||..|.+||++.....++.+|||+||||||.|+.|.+||.....
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-- 292 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-- 292 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--
Confidence 9999999976432211 112569999999999999999999999999999999999999999975432
Q ss_pred CceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 320 EHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+.+++. +.-.+|...++.+.+||.++|..||.+|+++.+|.+|
T Consensus 293 --------------yliFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 293 --------------YLIFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --------------HHHHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 122233332 2224677777889999999999999999999999886
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=352.93 Aligned_cols=237 Identities=30% Similarity=0.440 Sum_probs=208.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|+.++.||.|+||+|.+++.+ .++..+|+|++..... .+++...+|..+|+.+.||+++++++.|.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k---------~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREK---------HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred hhhhheeeeccCccceEEEEEEc---------cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 57888999999999999999544 4589999999987644 44566778999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+.+.+||||||++||.|+.++++.+ .+++..++.++.||+.||.|||+ .+|++|||||+|||||.+|.+||+|||
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEecc
Confidence 9999999999999999999998765 48899999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+|+.. ...+.+.||||.|+|||+++..+|+.++|+|||||++|||+.|..||....+ ..
T Consensus 190 FAK~v-----~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----------------~~ 248 (355)
T KOG0616|consen 190 FAKRV-----SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----------------IQ 248 (355)
T ss_pred ceEEe-----cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----------------HH
Confidence 99863 2337789999999999999999999999999999999999999999976533 22
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCC
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR 372 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 372 (441)
...+|+...+ .+|.-.+..+++|+.++|+.|-.+|
T Consensus 249 iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 249 IYEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 3444544443 4677778889999999999999999
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=375.35 Aligned_cols=250 Identities=29% Similarity=0.435 Sum_probs=210.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC----ch-HHHHHHHHHHHHHhcCC-CCCccceE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD----SI-QGLREWQAEVKFLGKFS-HPNLVKLI 171 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpniv~~~ 171 (441)
...|.+.+.||+|+||+|+.|+. ..++..||+|++... .. ...+.+.+|+.+++.++ ||||++++
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~---------~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ 86 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKH---------RLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLL 86 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeee---------ccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEE
Confidence 46899999999999999999944 345789999977664 11 23456778999999999 99999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC-CceE
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS-YNAK 250 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~k 250 (441)
+++.....+|+|||||.||+|++++...+ .+.+.++..++.|++.|+.|||+ +||+||||||+|||++.+ +++|
T Consensus 87 ev~~t~~~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 87 EVFATPTKIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred EEEecCCeEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCCEE
Confidence 99999999999999999999999998754 47789999999999999999997 999999999999999999 9999
Q ss_pred EecccCCCCCCCCCCcceEeeeccccccCcchhhhcCC-CC-ccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccc
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH-LY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 328 (441)
|+|||++.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+....
T Consensus 162 l~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~----------- 228 (370)
T KOG0583|consen 162 LSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV----------- 228 (370)
T ss_pred EeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----------
Confidence 99999998653 2334567789999999999999987 87 889999999999999999999976321
Q ss_pred cccchhhhhhhhcCccccccCChhh-HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYPIKG-ALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....++....+ .+|... +.++..|+.+||..||.+|+++.+|+++
T Consensus 229 -----~~l~~ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 229 -----PNLYRKIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred -----HHHHHHHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 111222222222 344445 7889999999999999999999999954
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=365.23 Aligned_cols=257 Identities=30% Similarity=0.446 Sum_probs=209.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|...+.||+|+||.||++... .+|...|||.+...+....+.+.+|+.+|.+++|||||++++......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~---------~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNK---------KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred chhhhhccccCccceEEEEEEec---------CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 45777889999999999999543 348899999987765444677899999999999999999999754444
Q ss_pred --eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC-CCceEEeccc
Q 013519 179 --QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG-SYNAKLSDFG 255 (441)
Q Consensus 179 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DFG 255 (441)
.++++|||+++|+|.+++.+.+. .+++..+..+..|++.||.|||+ +|||||||||+|||++. ++.+||+|||
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaDFG 163 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLADFG 163 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEeccCc
Confidence 69999999999999999988763 69999999999999999999997 99999999999999999 7999999999
Q ss_pred CCCCCCC-CCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 256 LAKLGPI-DGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 256 la~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
+++.... .........+.||+.|||||++..+ ....++|||||||++.||+||+.||.... ..
T Consensus 164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~---------------~~ 228 (313)
T KOG0198|consen 164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF---------------EE 228 (313)
T ss_pred cccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc---------------ch
Confidence 9986432 1112223457899999999999863 23359999999999999999999996520 11
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
...+..+........+|...+.++++|+.+|+..||++|||+.++|++.-
T Consensus 229 ~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 229 AEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred HHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 11122222222233667778889999999999999999999999999854
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=371.85 Aligned_cols=254 Identities=26% Similarity=0.350 Sum_probs=210.6
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
..++|+++++||+|+||.||+| .++.+|..+|+|++++... ..+..++.|-.+|....+|+||+++..
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLa---------rKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs 209 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLA---------RKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS 209 (550)
T ss_pred CcccchhheeeccccceeEEEE---------EEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence 4578999999999999999999 6667799999999988643 456778899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
|++..++||||||++||++..+|.+.+ .|++..++.++.+++.|+..||. .|+|||||||+|+|||..|++||+|
T Consensus 210 FQD~~~LYLiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~--~gyIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 210 FQDKEYLYLIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQ--LGYIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred ecCCCeeEEEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHH--cCcccccCChhheeecCCCCEeecc
Confidence 999999999999999999999998776 59999999999999999999996 9999999999999999999999999
Q ss_pred ccCCCCCCCC-----------------------CCc----------------------ceEeeeccccccCcchhhhcCC
Q 013519 254 FGLAKLGPID-----------------------GNS----------------------HVTTRIMGTYGYAAPEYVATGH 288 (441)
Q Consensus 254 FGla~~~~~~-----------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~ 288 (441)
|||+.-.... ... ....+.+|||.|+|||++.+.+
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 9999532110 000 0012358999999999999999
Q ss_pred CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCcc--ccccCChhhHHHHHHHHHHhcc
Q 013519 289 LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR--LEEQYPIKGALLAGQIIIKCLE 366 (441)
Q Consensus 289 ~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~ 366 (441)
|+..+|+||||||+||||.|.+||....+.. ...+++.-. +.......++.++++||.+||.
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~----------------T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~ 428 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQE----------------TYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC 428 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc
Confidence 9999999999999999999999998765432 222222222 1111223445789999999999
Q ss_pred cCCCCCC---CHHHHHHH
Q 013519 367 AEPKNRP---SMEEVLET 381 (441)
Q Consensus 367 ~dp~~Rp---s~~eil~~ 381 (441)
||++|. .+.||-+|
T Consensus 429 -d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 429 -DPENRLGSKGAEEIKKH 445 (550)
T ss_pred -CHHHhcCcccHHHHhcC
Confidence 999997 47777664
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=372.00 Aligned_cols=256 Identities=30% Similarity=0.449 Sum_probs=214.6
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 179 (441)
.+.+++.||+|.||.||.|+|+.. ..||+|.++.... ..+.|.+|+++|++|+|+|||++++++..+..
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~----------~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGS----------TKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCC----------CcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 445678899999999999999864 3688887766432 23577899999999999999999999999889
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
+||||||++.|+|.++|... ....+.....+.++.|||.|++||++ +++|||||.+.||||+++..+||+|||||+.
T Consensus 276 iyIVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred eEEEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheeeccCceEEEcccccccc
Confidence 99999999999999999872 33568889999999999999999997 9999999999999999999999999999994
Q ss_pred CCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 260 GPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
.. +..........-...|.|||.+..+.++.|||||||||+||||+| |+.||... + ...+.
T Consensus 353 ~~-d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m----------------s-n~ev~ 414 (468)
T KOG0197|consen 353 IG-DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM----------------S-NEEVL 414 (468)
T ss_pred cC-CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC----------------C-HHHHH
Confidence 32 222222222233467999999999999999999999999999999 66776543 1 23344
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
+.++...+-..|..|+..+.+|+..||..+|++|||++.+...|+.+..
T Consensus 415 ~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 415 ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 5566667777899999999999999999999999999999998887654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=376.12 Aligned_cols=249 Identities=28% Similarity=0.408 Sum_probs=215.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.-|++++.||.|+-|.|.+| ++..+|+..|||++.... ......+.+|+-||+.+.||||+++|++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrla---------kh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLA---------KHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehhh---------hcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 45889999999999999999 667789999999987652 122456789999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
++.++|+|+||++||.|+++|.++| ++++.++.+++.||+.|+.|||. .+|+||||||+|+|||..+++||+|||
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~--~~icHRDLKpENlLLd~~~nIKIADFG 157 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHA--FNICHRDLKPENLLLDVKNNIKIADFG 157 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhh--hcceeccCCchhhhhhcccCEeeeccc
Confidence 9999999999999999999999887 48899999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+|.+. .......+.||+|.|.|||++.+.+|+ .++||||.|||||.||||+.||++.+ -+
T Consensus 158 MAsLe---~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN----------------ir 218 (786)
T KOG0588|consen 158 MASLE---VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN----------------IR 218 (786)
T ss_pred eeecc---cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc----------------HH
Confidence 99853 344556778999999999999999997 89999999999999999999997532 11
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
..+.++-...+ +.|...+.++++||.+||..||++|.|++||++|-
T Consensus 219 ~LLlKV~~G~f--~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 219 VLLLKVQRGVF--EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HHHHHHHcCcc--cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 22223322222 34677888899999999999999999999999974
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=368.24 Aligned_cols=268 Identities=26% Similarity=0.353 Sum_probs=208.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.+.|+.+++||+|+||.||+| ++..+|+.||+|++..++ ........+||.||++|.||||++|.+...
T Consensus 116 ~~~feki~kIGeGTyg~VYkA---------r~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt 186 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKA---------RDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVT 186 (560)
T ss_pred hHHHHHHHHhcCcchhheeEe---------eecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence 456888899999999999999 556679999999988765 344566778999999999999999999988
Q ss_pred eC--CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 176 ED--RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 176 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+. ..+|||+|||+. +|.-++...+ -.|+..++..++.|++.||.|||+ +||+|||||.+|||||.+|.+||+|
T Consensus 187 ~~~~~siYlVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKiaD 261 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIAD 261 (560)
T ss_pred ecCCceEEEEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEecc
Confidence 76 689999999987 7777775433 468999999999999999999997 9999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee--------
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-------- 324 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-------- 324 (441)
||||+++....... .+..+-|.+|+|||++++. .|+.++|+||.||||.||++|++.|.+.....+...+
T Consensus 262 FGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 262 FGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT 340 (560)
T ss_pred ccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence 99999765544333 4556779999999999986 6889999999999999999999999876543221111
Q ss_pred --cccccccchhhhhhh--hcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 325 --DFARPSLTDKRRLKK--IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 325 --~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.|....+.....+.. -....+.+. -...+..+.+|+..||..||.+|.|+.++|+.
T Consensus 341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 341 EDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred hhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111111110000000 000011111 12344567799999999999999999999974
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=368.05 Aligned_cols=248 Identities=30% Similarity=0.432 Sum_probs=215.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|.+.+.||+|+||+|||| +.+.+.+.||+|.+.+. ..+.++.+.+|++|++.|+|||||.++++|+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKg---------rrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKG---------RRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeec---------ccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 47888899999999999999 55566899999988665 34567889999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...+++|.|||.| +|+.+|...+ .++++.+..++.+++.||.|||+ .+|+|||+||.|||++.+|.+|+||||+
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhh
Confidence 9999999999987 9999997665 59999999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
|+... .+..+.+++.|||.|||||++.+++|+..+|+||||||+||+++|++||....- -..
T Consensus 147 Ar~m~--~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si----------------~~L 208 (808)
T KOG0597|consen 147 ARAMS--TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI----------------TQL 208 (808)
T ss_pred hhhcc--cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH----------------HHH
Confidence 99754 355677889999999999999999999999999999999999999999964311 111
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+..|.... -.+|...+..+..|+..+|..||..|.++.+++.|
T Consensus 209 v~~I~~d~--v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 209 VKSILKDP--VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHhcCC--CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 22222221 13456777789999999999999999999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=368.01 Aligned_cols=266 Identities=24% Similarity=0.350 Sum_probs=212.7
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCC-CCCccceEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFS-HPNLVKLIGY 173 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~~~~~ 173 (441)
.-++|.+++.||.|+||.||+| +.+.++..||||+++.... +..- -.||+..|++|+ |||||++.++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la---------~~~~~~~~VAIK~MK~Kf~s~ee~~-nLREvksL~kln~hpniikL~Ev 77 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLA---------KSKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNPHPNIIKLKEV 77 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEe---------eecCCCceeeHHHHHhhhccHHHHH-HHHHHHHHHhcCCCCcchhhHHH
Confidence 3468999999999999999999 5555688999998876532 2222 247999999999 9999999999
Q ss_pred EEeCC-eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEe
Q 013519 174 CWEDR-QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252 (441)
Q Consensus 174 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 252 (441)
+.+++ .+|+|||||+. +|++++..+ .+.|++..++.|+.||++||+|+|. +|+.||||||+|||+.....+||+
T Consensus 78 i~d~~~~L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKia 152 (538)
T KOG0661|consen 78 IRDNDRILYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIA 152 (538)
T ss_pred hhccCceEeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEec
Confidence 99987 99999999965 999999776 4789999999999999999999996 999999999999999999999999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-c-c---
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-D-F--- 326 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-~-~--- 326 (441)
|||+||... .....+.++.|.+|+|||+++. +-|+.++|||++|||++||.+-++.|.+....++..-+ + .
T Consensus 153 DFGLARev~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP 229 (538)
T KOG0661|consen 153 DFGLAREVR---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTP 229 (538)
T ss_pred ccccccccc---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCC
Confidence 999999643 3344567889999999999866 45778999999999999999999999887654433211 0 0
Q ss_pred cccccchhhhhhhhcCccccc--------cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 327 ARPSLTDKRRLKKIMDPRLEE--------QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+.....+...++-.+.. ..+. .+.++.+||.+||.+||++|||+.++|++
T Consensus 230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccccchhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111222223333333333222 2233 67788899999999999999999999986
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-48 Score=370.05 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=216.6
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
....|..-..||+|+.|.||.| .+..+++.||||++........+.+.+|+.+|+..+|+|||.+++.|..
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A---------~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv 341 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVA---------RKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV 341 (550)
T ss_pred hhhhhcchhhhccccccceeee---------eeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc
Confidence 3457888889999999999999 5556688999999988777667778899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
.+.+++||||++||+|.+.+... .+++.++..|+++++.||.|||. +||+|||||.+|||++.+|.+||+|||+
T Consensus 342 ~deLWVVMEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~--~gIiHrDIKSDnILL~~~g~vKltDFGF 415 (550)
T KOG0578|consen 342 GDELWVVMEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHA--RGIIHRDIKSDNILLTMDGSVKLTDFGF 415 (550)
T ss_pred cceeEEEEeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHh--cceeeeccccceeEeccCCcEEEeeeee
Confidence 99999999999999999988543 38899999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+..+.... ....+.+|||+|||||++....|++++||||||++++||+-|.+||-...+-... ..
T Consensus 416 caqi~~~~--~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl-------------yL 480 (550)
T KOG0578|consen 416 CAQISEEQ--SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------------YL 480 (550)
T ss_pred eecccccc--CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH-------------HH
Confidence 97654332 3456689999999999999999999999999999999999999999654332111 11
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+. .+....-..+...+..+++|+.+||+.|+++|+++.|+|+|
T Consensus 481 Ia--~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 481 IA--TNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred Hh--hcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11 11222334567788889999999999999999999999986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=333.25 Aligned_cols=266 Identities=26% Similarity=0.371 Sum_probs=208.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHH--HHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG--LREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.+|...+.||+|.||+||+| .+..+|+.||||+++..+... -....+|+..|+.++|+||+.++++|..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka---------~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKA---------RDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEE---------EecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 46888899999999999999 455579999999987764331 2345689999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...+.||+||++. +|+..+.... ..+....+..++.++++||+|||. +.|+||||||.|+|++.+|.+||+|||+
T Consensus 73 ~~~l~lVfEfm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 73 KSNLSLVFEFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred CCceEEEEEeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEEcCCCcEEeecccc
Confidence 9999999999975 8988886544 578899999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee----------ec
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL----------VD 325 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~----------~~ 325 (441)
|+.+..... .....+-|.+|+|||.+.+. .|+..+||||.|||+.||+-|.+.|.+.++.++... .+
T Consensus 148 Ar~f~~p~~--~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~ 225 (318)
T KOG0659|consen 148 ARFFGSPNR--IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQ 225 (318)
T ss_pred hhccCCCCc--ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCccc
Confidence 998654332 22333779999999999886 688999999999999999999888877654332221 11
Q ss_pred ccc-cccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 326 FAR-PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 326 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
|+. ..+.+-..+..+-.+.....+ ...+..+.+|+.+||..||.+|+++.|+|++
T Consensus 226 WP~~~~lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 226 WPEMTSLPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CccccccccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111 111111112211222222223 3345556899999999999999999999987
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=352.03 Aligned_cols=264 Identities=25% Similarity=0.349 Sum_probs=210.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.+.|++.++||.|..++||+|+ ....+..||||+++.+.. ..+..+++|+..|+.++||||++++..|..
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~---------c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLAR---------CIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred ccceeEEEEEeccceeEeeeee---------ecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 3679999999999999999994 445579999999987743 346889999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
+..+|+||.||.+|++.+++...-. ..+++..+..|++++++||.|||. +|.||||||+.||||+.+|.|||+|||.
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCcee
Confidence 9999999999999999999976433 458999999999999999999997 9999999999999999999999999998
Q ss_pred CCCCCCCCCcce--EeeeccccccCcchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 257 AKLGPIDGNSHV--TTRIMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 257 a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
+-.....+.... ...++||++|||||++.. .+|+.|+||||||++..||.+|..||....+.....+.-...+...
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTL 252 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCc
Confidence 754433222111 156799999999999754 4799999999999999999999999987655432221111111100
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. .. .+........+..++.++..||+.||.+|||+.++|++
T Consensus 253 ~----t~----~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 L----TS----GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred c----cc----cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0 00 00111112233467899999999999999999999974
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=364.40 Aligned_cols=267 Identities=26% Similarity=0.393 Sum_probs=208.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||.||+|.+... .....+..||+|++.... ......+.+|+.+|..+ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGI----DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEecc----CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 46899999999999999999975321 122346789999987543 23456788999999999 8999999999887
Q ss_pred eC-CeEEEEEeecCCCCHHHHHHhcCC-----------------------------------------------------
Q 013519 176 ED-RQFLLVYEYMQKGSLENHLFRKGS----------------------------------------------------- 201 (441)
Q Consensus 176 ~~-~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 201 (441)
.. ..+++||||+++|+|.+++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 468999999999999999875321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccc
Q 013519 202 ------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275 (441)
Q Consensus 202 ------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 275 (441)
..++++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...............++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 1347888999999999999999997 99999999999999999999999999999754322211122234567
Q ss_pred cccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhH
Q 013519 276 YGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGA 354 (441)
Q Consensus 276 ~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (441)
+.|+|||++.+..++.++|||||||+||||++ |..||....... .+...+........+..++
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~ 303 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----------------EFCQRLKDGTRMRAPENAT 303 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----------------HHHHHHhcCCCCCCCCCCC
Confidence 88999999999999999999999999999997 999996532110 0111111111112344556
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 355 LLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 355 ~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 67889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=371.21 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=211.2
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCC-CCCccceEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFS-HPNLVKLIG 172 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~~~~ 172 (441)
..++|+++++||+|.||+|+++... .+++.+|||.+++... +.++..+.|.+|+.... ||++++++.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k---------~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~ 436 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELK---------GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFS 436 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEc---------CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccc
Confidence 3478999999999999999999554 4578999999988743 45677888999998886 999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEe
Q 013519 173 YCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252 (441)
Q Consensus 173 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 252 (441)
.|+.+.++|+||||+.||++..+.. ...+++..+..++..++.||.|||. +||||||||.+|||||.+|++||+
T Consensus 437 ~fQT~~~l~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 437 CFQTKEHLFFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred ccccCCeEEEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEec
Confidence 9999999999999999999543332 2458999999999999999999996 999999999999999999999999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|||+++.... ....+.++||||.|||||++.+..|+.++|+|||||+|||||.|..||.+++.
T Consensus 511 DFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE--------------- 573 (694)
T KOG0694|consen 511 DFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE--------------- 573 (694)
T ss_pred ccccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---------------
Confidence 9999996443 33467889999999999999999999999999999999999999999986532
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM-----EEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~eil~~ 381 (441)
.+....|+.. ...||..++.++..++.++|..+|++|.-+ .+|.++
T Consensus 574 -ee~FdsI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 574 -EEVFDSIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred -HHHHHHHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 2222233322 225788888999999999999999999854 555543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=350.02 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=214.9
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
...+|++.+.||+|.||+|-+| .....|+.||||.++.+.. +.+-.+++||+||..|+||||+++|.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A---------~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV 121 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLA---------YEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV 121 (668)
T ss_pred hhhHHHHHHHhcCCcccceeeh---------hhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh
Confidence 3568999999999999999998 4445699999999887644 456678899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
|+..+...|||||..+|.|++|+.+++. |++.+++.+++||+.|+.|||. ++++|||||.+|||||.++++||+|
T Consensus 122 FENkdKIvivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHk--nrVvHRDLKLENILLD~N~NiKIAD 196 (668)
T KOG0611|consen 122 FENKDKIVIVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHK--NRVVHRDLKLENILLDQNNNIKIAD 196 (668)
T ss_pred hcCCceEEEEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhh--ccceecccchhheeecCCCCeeeec
Confidence 9999999999999999999999988764 8999999999999999999996 9999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|||+-++. ......++||+|-|.+||++.+.+|. +.+|-|||||+||.|+.|..||++.+
T Consensus 197 FGLSNly~---~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---------------- 257 (668)
T KOG0611|consen 197 FGLSNLYA---DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---------------- 257 (668)
T ss_pred cchhhhhc---cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch----------------
Confidence 99997653 33456789999999999999999987 89999999999999999999998742
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
.+..+.++-.....+ ...+..+.-||.+||..||++|.|+.+|..|..
T Consensus 258 hk~lvrQIs~GaYrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 258 HKRLVRQISRGAYRE---PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred HHHHHHHhhcccccC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 233344444333322 222334668999999999999999999998753
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=359.25 Aligned_cols=268 Identities=26% Similarity=0.440 Sum_probs=220.1
Q ss_pred cCHHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCC
Q 013519 89 FTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPN 166 (441)
Q Consensus 89 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpn 166 (441)
....++....+++.+...||+|.||+||+|+|+. .||||+++.+. .+.++.|+.|+.+|++-+|-|
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~N 449 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHEN 449 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhh
Confidence 3446677777888899999999999999999985 59999987763 457889999999999999999
Q ss_pred ccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC
Q 013519 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS 246 (441)
Q Consensus 167 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 246 (441)
|+-+.|++..... .||+.+|+|-+|+.+|+-.. ..|.....+.|+.||++|+.|||. ++|||||||..||||.++
T Consensus 450 IlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~ 524 (678)
T KOG0193|consen 450 ILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHED 524 (678)
T ss_pred heeeehhhcCCce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccC
Confidence 9999999988877 99999999999999997544 568899999999999999999997 999999999999999999
Q ss_pred CceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee
Q 013519 247 YNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG---HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323 (441)
Q Consensus 247 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~ 323 (441)
++|||+||||+..-.............|...|||||+++.+ +|++.+||||||||+|||+||..||.... .++.+
T Consensus 525 ~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~--~dqIi 602 (678)
T KOG0193|consen 525 LKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN--RDQII 602 (678)
T ss_pred CcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC--hhheE
Confidence 99999999999764444333444456788999999999754 78899999999999999999999998332 22333
Q ss_pred ecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
....+..+.. .. ......++.++++|+..||..++++||.+.+||..|+.+.
T Consensus 603 fmVGrG~l~p----------d~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 603 FMVGRGYLMP----------DL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred EEecccccCc----------cc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 2222221111 00 1223467778999999999999999999999999887655
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=357.02 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=209.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
..|...+.||+|.||.||+| .+..+++.||||++..+.. ..+..+++|+.+|..++++||.++|+.|..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~---------~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKA---------IDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccchhccccccceeeee---------eeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 45677789999999999999 4455689999999988744 4577899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..++++||||.||++.+.|.... .+.+..+..++++++.||.|||. .+.+|||||+.|||+..+|.|||+|||.+
T Consensus 84 ~~LwiiMey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILLSESGDVKLADFGVA 158 (467)
T ss_pred ccHHHHHHHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhh--cceecccccccceeEeccCcEEEEeccee
Confidence 99999999999999999985433 35778888899999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
...... .....+++|||.|||||++....|+.|+||||||++.+||.+|.+|+....+.....++ +.
T Consensus 159 ~ql~~~--~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI--pk--------- 225 (467)
T KOG0201|consen 159 GQLTNT--VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI--PK--------- 225 (467)
T ss_pred eeeech--hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec--cC---------
Confidence 754332 23346789999999999999989999999999999999999999999876663222111 11
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+...++..+++|+..||+.||+.||++.++|++
T Consensus 226 ------~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 226 ------SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ------CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 11112223455668899999999999999999999985
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=342.63 Aligned_cols=280 Identities=26% Similarity=0.332 Sum_probs=217.1
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcC--CCchHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSN--PDSIQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
.....|...+.||.|+||.|+.| .+..+++.||||++. ..+....+...+|+.+|+.++|+||+.++++
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA---------~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di 89 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSA---------KDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDI 89 (359)
T ss_pred eccceecccccccCcceeeEEEE---------EEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEee
Confidence 34567777899999999999999 455568999999987 4455566778899999999999999999999
Q ss_pred EEe-----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 174 CWE-----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 174 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
+.. -+.+|+|+|+| +-+|...+... ..++...+..+++|+++||.|+|+ .+|+||||||.|+|++.+..
T Consensus 90 ~~p~~~~~f~DvYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHS--AnViHRDLKPsNll~n~~c~ 163 (359)
T KOG0660|consen 90 FRPPSRDKFNDVYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHS--ANVIHRDLKPSNLLLNADCD 163 (359)
T ss_pred cccccccccceeEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhc--ccccccccchhheeeccCCC
Confidence 865 35799999999 55888888544 348899999999999999999998 99999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
+||+|||+|+...........+..+-|.+|.|||++.. ..|+.+.||||+|||+.||++|+..|.+........++...
T Consensus 164 lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~ 243 (359)
T KOG0660|consen 164 LKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL 243 (359)
T ss_pred EEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence 99999999997644333444567888999999999865 57899999999999999999999999887654433222111
Q ss_pred ccccchhhhhhhhc---------------CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhccccccc
Q 013519 328 RPSLTDKRRLKKIM---------------DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET--LQNISVIEI 390 (441)
Q Consensus 328 ~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~--L~~i~~~~~ 390 (441)
.+.. ....+..+- ...+...+| ..++.+.+|+.+||..||.+|+|++|+|+| |......+.
T Consensus 244 lGtP-~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 244 LGTP-SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred cCCC-CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 1111 111111111 011122233 455678899999999999999999999987 555554444
Q ss_pred Cc
Q 013519 391 EP 392 (441)
Q Consensus 391 ~~ 392 (441)
+|
T Consensus 322 EP 323 (359)
T KOG0660|consen 322 EP 323 (359)
T ss_pred CC
Confidence 44
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=347.09 Aligned_cols=260 Identities=27% Similarity=0.361 Sum_probs=208.2
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--------------HHHHHHHHHHHH
Q 013519 93 DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--------------QGLREWQAEVKF 158 (441)
Q Consensus 93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~E~~~ 158 (441)
+-....++|++.+.||+|.||+|-+|+ ...+++.||||++..... ..++.+++||.|
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar---------~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIai 161 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLAR---------DEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAI 161 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEe---------ecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHH
Confidence 334567899999999999999999994 444589999998765321 124578899999
Q ss_pred HhcCCCCCccceEEEEEeC--CeEEEEEeecCCCCHHHHHHhcCCCCC-CCHHHHHHHHHHHHHHHhhhccCCCCeeecC
Q 013519 159 LGKFSHPNLVKLIGYCWED--RQFLLVYEYMQKGSLENHLFRKGSAEP-LPWNTRLKIAIDAAKDLTFLHSSEKSVIYRD 235 (441)
Q Consensus 159 l~~l~hpniv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrD 235 (441)
|++|.|||||+|+++.-+. +.+|||+|||..|.+... ....+ +.+.++++++++++.||.|||. +||||||
T Consensus 162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRD 235 (576)
T KOG0585|consen 162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHY--QGIIHRD 235 (576)
T ss_pred HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHh--cCeeccc
Confidence 9999999999999998764 679999999999887432 23344 8999999999999999999997 9999999
Q ss_pred CCCCcEEEcCCCceEEecccCCCCCCCC---CCcceEeeeccccccCcchhhhcCC---C-CccccchhHHHHHHHHHhC
Q 013519 236 FKASNILLDGSYNAKLSDFGLAKLGPID---GNSHVTTRIMGTYGYAAPEYVATGH---L-YVKSDVYGFGVVLLEMLTG 308 (441)
Q Consensus 236 lkp~Nill~~~~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~~DvwSlG~il~elltg 308 (441)
|||+|+||+++|+|||+|||.+..+... ..........|||.|+|||.+.++. + +.+.||||+||+||.|+.|
T Consensus 236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 9999999999999999999999764322 1222334478999999999998732 3 3788999999999999999
Q ss_pred CCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 309 LRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 309 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
+.||.... ......+|.+..+.-.......+.+++||.+||+.||+.|.++.+|..|..
T Consensus 316 ~~PF~~~~----------------~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 316 QLPFFDDF----------------ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred cCCcccch----------------HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 99996542 123344555544433333345678999999999999999999999998764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=336.07 Aligned_cols=268 Identities=21% Similarity=0.276 Sum_probs=208.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHH--HHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG--LREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|+.++.|++|+||.||+| +++.++..||+|+++.+.... --.-.+||.+|.+++|||||.+..+..
T Consensus 75 v~efe~lnrI~EGtyGiVYRa---------kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRA---------KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred HHHHHHHhhcccCcceeEEEe---------ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 356888899999999999999 556678999999988764221 123457999999999999999999887
Q ss_pred eC--CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 176 ED--RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 176 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
.. +.+|||||||+. +|..++...+ +++...++..++.|++.|+.|||. +.|+||||||+|+|++..|.+||+|
T Consensus 146 G~~~d~iy~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~--~wilHRDLK~SNLLm~~~G~lKiaD 220 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHD--NWILHRDLKTSNLLLSHKGILKIAD 220 (419)
T ss_pred ccccceeeeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhh--ceeEecccchhheeeccCCcEEecc
Confidence 54 579999999987 8988887655 679999999999999999999996 9999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee--------
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-------- 324 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-------- 324 (441)
||+||.+... ....+..+-|.+|+|||++.+. .|+.++|+||+|||+.||+++++.|.+....++...+
T Consensus 221 FGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt 298 (419)
T KOG0663|consen 221 FGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS 298 (419)
T ss_pred cchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc
Confidence 9999975432 2335667889999999999886 5889999999999999999999999876543322110
Q ss_pred cccccccchhh-----hhhhhcCccccccCChh-hHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 325 DFARPSLTDKR-----RLKKIMDPRLEEQYPIK-GALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 325 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...++.+..-. ...+..-..++..++.. .++...+|+..+|..||.+|.|+.+.|++
T Consensus 299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00001111100 01111111223333333 55778899999999999999999999987
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=321.76 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=213.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++++.||+|-||.||+|+.+ .++-.||+|++.+... ....++.+|++|-..|+||||+++|++|.
T Consensus 22 ~dfeigr~LgkgkFG~vYlarek---------ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREK---------KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred hhccccccccCCccccEeEeeec---------cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 57999999999999999999554 4478999999876543 23457889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+....|+++||...|+|+..|.... ...+++.....++.|++.||.|+|. ++||||||||+|+|++..+.+||+|||
T Consensus 93 d~~riyLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCC
Confidence 9999999999999999999997543 2568888999999999999999996 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
.+...+ .....+.|||..|.+||.+.+..++..+|+|++|++.||++.|..||.... ..+
T Consensus 170 wsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~----------------~~e 229 (281)
T KOG0580|consen 170 WSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS----------------HSE 229 (281)
T ss_pred ceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh----------------hHH
Confidence 997532 334567899999999999999999999999999999999999999997543 122
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.+..+... .-.+|...+..+.++|.+||..+|.+|.+..|++++-
T Consensus 230 tYkrI~k~--~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 230 TYKRIRKV--DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred HHHHHHHc--cccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 22233221 2245677778899999999999999999999999874
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=356.83 Aligned_cols=266 Identities=28% Similarity=0.380 Sum_probs=209.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|++... ....++..||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGL----GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecC----CcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 45799999999999999999976432 122345689999987643 33456688999999999 7999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC------------------------------------------------------
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS------------------------------------------------------ 201 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 201 (441)
....+++|||||++|+|.+++.....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999999864321
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcce
Q 013519 202 -------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHV 268 (441)
Q Consensus 202 -------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 268 (441)
..++++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++..........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 1347888999999999999999997 9999999999999999999999999999975432222111
Q ss_pred EeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccc
Q 013519 269 TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEE 347 (441)
Q Consensus 269 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (441)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..+..........
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~----------------~~~~~~~~~~~~~ 334 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN----------------SKFYKMVKRGYQM 334 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----------------HHHHHHHHcccCc
Confidence 222345678999999999999999999999999999997 99999653211 1111111111222
Q ss_pred cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 348 QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 348 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
..+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 23334456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=355.98 Aligned_cols=265 Identities=28% Similarity=0.389 Sum_probs=207.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||+||+|.+... ....++..||||+++... ....+.+.+|+.+|..+ +||||+++++++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 45799999999999999999975321 123346789999987543 33456788999999999 7999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC------------------------------------------------------
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS------------------------------------------------------ 201 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 201 (441)
+....++|||||++|+|.+++.....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 99999999999999999999865321
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 202 ------------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 202 ------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 1247888999999999999999997 89999999999999999999999999999754332
Q ss_pred CCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhhcC
Q 013519 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD 342 (441)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (441)
..........++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+.+.+.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----------------~~~~~~~~ 331 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----------------SKFYKMIK 331 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----------------HHHHHHHH
Confidence 22111222345667999999999999999999999999999998 88888543211 01111111
Q ss_pred ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 343 PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 343 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
.......+...+.++.+|+.+||+.||++||++.+|++.|+.
T Consensus 332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 111222233445678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=349.35 Aligned_cols=243 Identities=28% Similarity=0.389 Sum_probs=199.8
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFL 181 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 181 (441)
++||+|+||.||+|.. ..+++.||||++.... ......+.+|+.+|++++||||+++++++...+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVRE---------KATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEE---------CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 4799999999999954 3458899999887542 233456778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCC
Q 013519 182 LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP 261 (441)
Q Consensus 182 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~ 261 (441)
+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus 72 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 72 FVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 9999999999999987643 58899999999999999999997 899999999999999999999999999997532
Q ss_pred CCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhc
Q 013519 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341 (441)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (441)
. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.
T Consensus 147 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----------------~~~~~~~~ 208 (323)
T cd05571 147 S--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------------EKLFELIL 208 (323)
T ss_pred c--CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH----------------HHHHHHHH
Confidence 2 12223456799999999999999999999999999999999999999964321 01111111
Q ss_pred CccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 342 DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
.. ...++...+..+.+||.+||+.||++|| ++.+++++
T Consensus 209 ~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 209 ME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred cC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 11 1133455667789999999999999999 89999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=351.64 Aligned_cols=246 Identities=28% Similarity=0.419 Sum_probs=204.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||.||+|... .+++.||+|.+.... ....+.+.+|+.+|++++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHK---------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 57899999999999999999554 347899999886542 233566889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+++.+++||||+.+|+|.+++.+.+ .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg 163 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFG 163 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999997653 47889999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....+ ..
T Consensus 164 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----------------~~ 222 (329)
T PTZ00263 164 FAKKVPD-----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----------------FR 222 (329)
T ss_pred CceEcCC-----CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----------------HH
Confidence 9975322 12346799999999999999999999999999999999999999964321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-----MEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~eil~~ 381 (441)
....+.... ..+|...+..+.+||.+||+.||.+||+ +++++.|
T Consensus 223 ~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 223 IYEKILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHHhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111222211 1234445667889999999999999996 7888876
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=336.59 Aligned_cols=255 Identities=26% Similarity=0.341 Sum_probs=209.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH---HHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ---GLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
..|++++.||.|.-|+||++.... ++..+|+|++.+.... .+.+.+.|-+||..++||.+..||+.|+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~---------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe 147 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRG---------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE 147 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecC---------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence 457778899999999999996554 4689999999876543 3456677999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
.+...|+|||||+||+|..+++++. .+.+++..++.++.+++.||.|||. .|||+|||||+||||-++|+|.|+||.
T Consensus 148 t~~~~cl~meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHm--lGivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 148 TDKYSCLVMEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHM--LGIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred ccceeEEEEecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHh--hceeeccCCcceeEEecCCcEEeeecc
Confidence 9999999999999999998887654 4779999999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCC--------------------------------CCc----------------------ceEeeeccccccCcc
Q 013519 256 LAKLGPID--------------------------------GNS----------------------HVTTRIMGTYGYAAP 281 (441)
Q Consensus 256 la~~~~~~--------------------------------~~~----------------------~~~~~~~gt~~y~aP 281 (441)
|+...... ... ....+++||-.|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 98532100 000 112347899999999
Q ss_pred hhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHH
Q 013519 282 EYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQII 361 (441)
Q Consensus 282 E~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 361 (441)
|++.+...+.++|+|+|||+||||+.|..||.+... +..+..++...+.-.-....+..+++||
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLI 368 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEPEVSSAAKDLI 368 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCCcchhHHHHHH
Confidence 999999999999999999999999999999976532 2333344433332222225567799999
Q ss_pred HHhcccCCCCCCC----HHHHHHH
Q 013519 362 IKCLEAEPKNRPS----MEEVLET 381 (441)
Q Consensus 362 ~~~l~~dp~~Rps----~~eil~~ 381 (441)
+++|..||.+|.. +.||-+|
T Consensus 369 r~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 369 RKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHhccChhhhhccccchHHhhcC
Confidence 9999999999998 8888765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=346.38 Aligned_cols=246 Identities=28% Similarity=0.377 Sum_probs=203.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDR---------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEc---------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 36889999999999999999543 347899999986532 233556888999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+...+++||||+++|+|.+++...+ .+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEEecC
Confidence 9999999999999999999997653 58889999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .
T Consensus 147 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~----------------~ 205 (291)
T cd05612 147 FAKKLRD-----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF----------------G 205 (291)
T ss_pred cchhccC-----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------H
Confidence 9975422 123457999999999999999999999999999999999999999653211 1
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-----MEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~eil~~ 381 (441)
....+.... ..++...+..+.+||.+||+.||.+||+ +.+++++
T Consensus 206 ~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 206 IYEKILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111111111 1234445667889999999999999995 9999877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=350.94 Aligned_cols=252 Identities=27% Similarity=0.371 Sum_probs=215.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|..++++|+|+||.++++ .++..++.+++|++..... ...+....|+.+++++.|||||.+++.|+.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lv---------rhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLV---------RHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhhh---------hhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 57899999999999999998 4445577999999876543 334467789999999999999999999999
Q ss_pred CCe-EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 177 DRQ-FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 177 ~~~-~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
++. ++|||+||+||+|.+.|.+.. ...++++.++.|+.|++.|+.|||. +.|+|||||+.|||++.++.|||+|||
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecchh
Confidence 888 999999999999999998755 4679999999999999999999996 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+|+...... ....+..||+.||.||++.+.+|+.|+|||||||++|||++-+.+|...+- ..
T Consensus 152 laK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m----------------~~ 213 (426)
T KOG0589|consen 152 LAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM----------------SE 213 (426)
T ss_pred hhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch----------------HH
Confidence 999754322 356678999999999999999999999999999999999999999975421 12
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+.+++... ....|..++.++..||..||..+|+.||++.++|.+
T Consensus 214 Li~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 214 LILKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 233333322 345677788889999999999999999999999975
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=342.89 Aligned_cols=270 Identities=23% Similarity=0.386 Sum_probs=206.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccc-------cccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccce
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLA-------PTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKL 170 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~ 170 (441)
++|++.+.||+|+||.||+|.+...... ......+..||+|.+.... ......+.+|+.+|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 5789999999999999999976543210 0122345689999987653 3345678899999999999999999
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHhcC----------------CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeec
Q 013519 171 IGYCWEDRQFLLVYEYMQKGSLENHLFRKG----------------SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYR 234 (441)
Q Consensus 171 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHr 234 (441)
++++.+.+..++||||+.+|+|.+++.... ....+++..++.++.|++.||.|||+ .+|+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~ivH~ 162 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS--LNFVHR 162 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH--CCcccc
Confidence 999999999999999999999999986532 11346788999999999999999997 899999
Q ss_pred CCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh--CCCCC
Q 013519 235 DFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT--GLRAL 312 (441)
Q Consensus 235 Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--g~~p~ 312 (441)
||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999999999975432222222233456788999999999999999999999999999997 45566
Q ss_pred CCCCCCCCceeecccccccchhhhhhhhcC---ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 313 DTNRPSGEHVLVDFARPSLTDKRRLKKIMD---PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
...... ..+ ......+. .......+..++..+.+|+.+||+.||++|||+.+|.+.|+
T Consensus 243 ~~~~~~--~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 243 GELTDE--QVI-----------ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CcCCHH--HHH-----------HHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 542211 000 00101110 01111223455677899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=365.32 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=213.3
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEE-E
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGY-C 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~-~ 174 (441)
...++++.+.|.+|||+.||+|.... .+..||+|++-..+...++.+++||.+|+.|+ |+|||.+++. .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~ 105 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSA 105 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence 34578888999999999999995543 35899999988888888999999999999998 9999999993 2
Q ss_pred Ee------CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 175 WE------DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 175 ~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
.. .-+++|+||||.||.|.+++..+.... |++.++++|+.|+++|+++||.....|||||||-+||||+.+|+
T Consensus 106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred ccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence 21 136899999999999999998765543 99999999999999999999987778999999999999999999
Q ss_pred eEEecccCCCCCCCCCCc-ceE------eeeccccccCcchhh---hcCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 013519 249 AKLSDFGLAKLGPIDGNS-HVT------TRIMGTYGYAAPEYV---ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPS 318 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~-~~~------~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~ 318 (441)
+||||||.|+-....... ... -...-|+.|+|||++ .+.+++.|+|||+|||+||-|+....||+.....
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 999999999742221111 000 012458999999987 5678999999999999999999999999764221
Q ss_pred CCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 013519 319 GEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVIE 389 (441)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~~ 389 (441)
.|++..+.-.....++..+.+||..||+.||++||++.++++.+..+....
T Consensus 265 --------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 --------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred --------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 123333322223467788999999999999999999999999887765544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=368.12 Aligned_cols=267 Identities=27% Similarity=0.438 Sum_probs=221.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-HHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-GLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
..+.+..+.||+|+||+||+|....-. .......||||.++..... ..++|++|+++|..|+|||||+++|+|.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~----p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLL----PGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCC----CCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 345667789999999999999765431 1234678999999887655 77899999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCC-----------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGS-----------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG 245 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 245 (441)
++.++||+|||..|+|.++|..+.. ..+|+..+.+.|+.|||.|+.||-+ +.+|||||...|+||.+
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~--~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS--HHFVHRDLATRNCLVGE 638 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--Ccccccchhhhhceecc
Confidence 9999999999999999999975431 2348889999999999999999997 88999999999999999
Q ss_pred CCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceee
Q 013519 246 SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLV 324 (441)
Q Consensus 246 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~ 324 (441)
+..|||+||||+|..-............-..+|||||.++.++|+.+||||||||+|||+++ |+.||.+..
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-------- 710 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-------- 710 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc--------
Confidence 99999999999986433222222222334578999999999999999999999999999999 788886542
Q ss_pred cccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 325 DFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
..+.+.-+-...+ -..|..|+.++..|+..||+.+|.+||+++||-..|+.+..
T Consensus 711 --------n~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 711 --------NQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred --------hHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 2333333334444 56789999999999999999999999999999999987653
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=339.45 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=200.8
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH---HHHHHHHHHHHHhcCCCCCccceEEEEEe----C
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ---GLREWQAEVKFLGKFSHPNLVKLIGYCWE----D 177 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~ 177 (441)
..||+|++|.||+|.+. ++.||||.+...... ..+.+.+|+.+|++++||||+++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-----------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEEC-----------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 57999999999999663 678999998765332 25678899999999999999999999877 3
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..+++||||+++|+|.+++... ..+++...+.++.+++.||.|||. ..+++||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~Hrdlkp~nill~~~~~~kl~dfg~~ 170 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYK-YTNKPYKNLTSVSFLVTENYKLKIICHGLE 170 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHh-cCCCCCCcCChhhEEECCCCcEEEcccchH
Confidence 5789999999999999999754 358899999999999999999996 348899999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 171 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----------------~~ 229 (283)
T PHA02988 171 KILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----------------KE 229 (283)
T ss_pred hhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----------------HH
Confidence 753221 123468899999999976 6899999999999999999999999965321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
....+.........+..++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 230 ~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 230 IYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 111121112222344456778999999999999999999999999998654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=347.17 Aligned_cols=268 Identities=23% Similarity=0.309 Sum_probs=206.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||.||++... .++..+|+|.+.... ......+.+|+++|++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHK---------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEEC---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 368999999999999999999543 457899999887653 3345678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++.+++||||+++++|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhh-cCCEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 999999999999999999986643 48899999999999999999996 34699999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeec-----------
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD----------- 325 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~----------- 325 (441)
++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 151 ~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (331)
T cd06649 151 SGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEP 226 (331)
T ss_pred cccccc----cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCc
Confidence 875422 12234579999999999999999999999999999999999999996432110000000
Q ss_pred --cc-----------------ccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 326 --FA-----------------RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 326 --~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.. .+..........+.............+.++.+||.+||+.||++|||+.+++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00 0000000000001111111111123566789999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=340.91 Aligned_cols=252 Identities=28% Similarity=0.381 Sum_probs=203.0
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
|++.+.||+|+||+||+|... .+++.||+|.+..... .....+.+|+.++..++|+||+++++++.++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~ 72 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEe---------cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC
Confidence 677889999999999999543 3588999998865432 2234577899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 73 DALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred CeEEEEEEecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999999998886543 2458899999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
+..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ...+
T Consensus 150 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-------------~~~~ 213 (285)
T cd05631 150 VQIPEG---ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-------------REEV 213 (285)
T ss_pred EEcCCC---CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-------------HHHH
Confidence 753221 122345799999999999999999999999999999999999999975432110 0111
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-----MEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~eil~~ 381 (441)
.... ......++...+..+.+|+.+||+.||++||+ +++++++
T Consensus 214 ~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 214 DRRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHh-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1111 11112344456677889999999999999997 8899875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=347.33 Aligned_cols=251 Identities=27% Similarity=0.349 Sum_probs=214.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH---HHHHHHHHHHHHhcCC-CCCccceEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ---GLREWQAEVKFLGKFS-HPNLVKLIGY 173 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~-hpniv~~~~~ 173 (441)
...|.+.+.||.|.||.||++ ..+.+|+.+|+|.+...... ....+.+|+.+|+++. |||||.++++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~---------~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~ 104 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLC---------REKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA 104 (382)
T ss_pred cccEEehhhhCCCCceEEEEE---------EecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 467899999999999999999 55556999999998776442 3467899999999999 9999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC----Cce
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS----YNA 249 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~----~~~ 249 (441)
|++...+++|||+|.||.|++.+... .+++..+..++.|++.++.|||+ .||+||||||+|+|+... +.+
T Consensus 105 ~e~~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 105 FEDPDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred EEcCCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCcE
Confidence 99999999999999999999999876 28899999999999999999997 999999999999999533 579
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
|++|||++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.........
T Consensus 179 k~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------- 247 (382)
T KOG0032|consen 179 KLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------- 247 (382)
T ss_pred EEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH--------
Confidence 9999999987533 45677899999999999999999999999999999999999999999775432211
Q ss_pred ccchhhhhhhhcCc--cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 330 SLTDKRRLKKIMDP--RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 330 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
..+... .+........+..+.+++.+||..||.+|+++.++|+|-
T Consensus 248 --------~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 248 --------LAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred --------HHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 122211 233344455677899999999999999999999999973
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=324.50 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=207.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|.+.++||+|.|+.||++ .+..+|+.+|+|+++... ....+.+.+|++|-+.|+|||||++.+.+.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc---------~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~ 80 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 80 (355)
T ss_pred chhhhHHHHHccCchHHHHHH---------HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence 467888899999999999998 556678999998776542 235678899999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC---CCceEEe
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG---SYNAKLS 252 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~kl~ 252 (441)
.....|||+|++.|++|..-|..+ ..+++..+-..+.||+.+|.|+|. ++|||||+||+|+|+-+ .--+||+
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeec
Confidence 999999999999999998877654 235677888899999999999997 99999999999999943 3459999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|||+|.... .......+.|||.|||||++...+|+..+|||+-|||||-|+.|..||.+...
T Consensus 156 ~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--------------- 217 (355)
T KOG0033|consen 156 DFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------------- 217 (355)
T ss_pred ccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---------------
Confidence 999998643 34445668899999999999999999999999999999999999999976421
Q ss_pred hhhhhhhhcCcc--ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPR--LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+.+..++... +........++++++|+.+||..||.+|.|+.|+|+|
T Consensus 218 -~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 218 -HRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred -HHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 12222222221 2222344567789999999999999999999999975
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=335.67 Aligned_cols=264 Identities=26% Similarity=0.456 Sum_probs=212.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++.+.||+|+||.||+|...... .......|++|.+.... ......+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPN----ERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCC----CCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 46888999999999999999765431 12345789999887553 33456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD 244 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 244 (441)
...+++|||+++++|.+++.+... ...+++..++.++.|++.||.|||. .+++|+||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccceEEEc
Confidence 999999999999999999976422 1457889999999999999999997 8999999999999999
Q ss_pred CCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCcee
Q 013519 245 GSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVL 323 (441)
Q Consensus 245 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~ 323 (441)
.++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----- 233 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----- 233 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence 999999999999975432222222334466889999999998999999999999999999998 99998653211
Q ss_pred ecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
. +...+........+..++..+.+|+.+||+.||.+||++.+|+++|+.+
T Consensus 234 -----------~-~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 234 -----------E-VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -----------H-HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1 1111111122234556778899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=347.70 Aligned_cols=254 Identities=25% Similarity=0.344 Sum_probs=203.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||.||+|... .+++.||||++.... ......+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK---------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 36889999999999999999544 347899999987542 233556788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+.+.+|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEEEeCc
Confidence 9999999999999999999996543 58889999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||.......... ...
T Consensus 147 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~----------~i~ 211 (333)
T cd05600 147 LSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE----------NLK 211 (333)
T ss_pred CCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH----------HHH
Confidence 9975322 2344679999999999999999999999999999999999999996543211000 000
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+............+..+.+||.+||..+|++||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 212 YWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred hccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000000000000012346678899999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=349.52 Aligned_cols=243 Identities=28% Similarity=0.435 Sum_probs=203.1
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 179 (441)
....++-||.|+.|-||+|+++ +..||||+++.-. ..+|+-|++|+||||+.+.++|.....
T Consensus 125 ~IsELeWlGSGaQGAVF~Grl~-----------netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 125 EISELEWLGSGAQGAVFLGRLH-----------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred HhhhhhhhccCcccceeeeecc-----------CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCce
Confidence 3344678999999999999877 5689999875322 347889999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
++||||||..|.|...|... +.+.......|..+||.|+.|||. +.|||||||.-||||..+..|||+|||-++.
T Consensus 187 yCIiMEfCa~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~--hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHL--HKIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred eEEeeeccccccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHH--hhHhhhccCCCceEeeccceEEeccccchHh
Confidence 99999999999999999654 468888999999999999999997 8899999999999999999999999999985
Q ss_pred CCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhh
Q 013519 260 GPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339 (441)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (441)
... ....-.++||..|||||++...+.+.|+|||||||||||||||..||..-.... +-| .
T Consensus 262 ~~~---~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw------------G 322 (904)
T KOG4721|consen 262 LSD---KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW------------G 322 (904)
T ss_pred hhh---hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE------------e
Confidence 322 233445899999999999999999999999999999999999999996532211 001 1
Q ss_pred hcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
+-...+.-..|..|+.-++-|++.||+..|..||++.+||.||+-
T Consensus 323 VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 323 VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 112223334577888889999999999999999999999998853
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=347.17 Aligned_cols=247 Identities=26% Similarity=0.343 Sum_probs=203.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||.||+|..... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 5799999999999999999965432 14689999875432 233456788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+.+.+++||||+.+|+|.+++.+.. .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCC
Confidence 9999999999999999999997654 48899999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||....+. .
T Consensus 177 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----------------~ 235 (340)
T PTZ00426 177 FAKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL----------------L 235 (340)
T ss_pred CCeecCC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH----------------H
Confidence 9975321 123467999999999999999999999999999999999999999653211 1
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
....+.... ..+|...+..+.++|.+||+.||++|+ ++++++++
T Consensus 236 ~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 236 IYQKILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111122111 123445566788999999999999995 89999887
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=339.98 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=216.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHH--HHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG--LREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
..-|.+.+.||+|.|++|-+| +++.+|..||||++.+...+. ...+.+|++.|+.++|||||++|++..
T Consensus 17 AGLYDLekTlG~GHFAVVKLA---------rHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD 87 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLA---------RHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID 87 (864)
T ss_pred eeeehhhhhhcCCceehhhhh---------hhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc
Confidence 455888889999999999998 788899999999998765433 345778999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE-cCCCceEEecc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL-DGSYNAKLSDF 254 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill-~~~~~~kl~DF 254 (441)
....+|||+|+-++|+|++||.++. ..+.+..+.+++.||+.|+.|+|+ ..+|||||||+||.+ ..-|-|||+||
T Consensus 88 TQTKlyLiLELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHq--LHVVHRDLKPENVVFFEKlGlVKLTDF 163 (864)
T KOG4717|consen 88 TQTKLYLILELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQ--LHVVHRDLKPENVVFFEKLGLVKLTDF 163 (864)
T ss_pred ccceEEEEEEecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhh--hhhhcccCCcceeEEeeecCceEeeec
Confidence 9999999999999999999998875 468899999999999999999997 889999999999877 56688999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
|++-.+. ......+.||+..|.|||++++..|+ +++||||||||||-|++|+.||+....
T Consensus 164 GFSNkf~---PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---------------- 224 (864)
T KOG4717|consen 164 GFSNKFQ---PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---------------- 224 (864)
T ss_pred cccccCC---CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----------------
Confidence 9997543 33456778999999999999999999 789999999999999999999976433
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~ 380 (441)
.+.+..+++-.. ..|...+.+|++||..||..||.+|.+.+||..
T Consensus 225 SETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 225 SETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 233444555433 457888999999999999999999999999985
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=360.94 Aligned_cols=255 Identities=22% Similarity=0.279 Sum_probs=207.2
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 179 (441)
.|.+.+.||+|+||.||+|..... .+..||+|.+..........+.+|+.+|+.++|||||++++++...+.
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~--------~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSD--------PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCC--------CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 488899999999999999954322 156788898766665556678889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 180 FLLVYEYMQKGSLENHLFRK-GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
+||||||+++|+|.+++... ....++++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 99999999999999988643 223468899999999999999999997 899999999999999999999999999998
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
..............+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+.
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----------------~~~~~ 281 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----------------REIMQ 281 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHH
Confidence 64332222234456799999999999999999999999999999999999999964321 11111
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+..... ...+..++..+.+||.+||..||++||++.+++.+
T Consensus 282 ~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 282 QVLYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1111111 12344556678999999999999999999999864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=343.49 Aligned_cols=243 Identities=26% Similarity=0.384 Sum_probs=199.3
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFL 181 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 181 (441)
+.||+|+||.||++.. ..+++.||+|++.... ......+.+|+.+|+.++||||+++++++...+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVRE---------KASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 3699999999999954 3458899999986542 234556788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCC
Q 013519 182 LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP 261 (441)
Q Consensus 182 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~ 261 (441)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 72 lv~Ey~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 72 FVMEYVNGGELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred EEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 9999999999998886543 58899999999999999999997 899999999999999999999999999987532
Q ss_pred CCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhc
Q 013519 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341 (441)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (441)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.
T Consensus 147 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----------------~~~~~~~ 208 (328)
T cd05593 147 TD--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------KLFELIL 208 (328)
T ss_pred Cc--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH----------------HHHHHhc
Confidence 21 12234467999999999999999999999999999999999999999643211 1111111
Q ss_pred CccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 342 DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
.. ...+|...+..+.+||.+||+.||++|+ ++.+++++
T Consensus 209 ~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 209 ME--DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred cC--CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11 1123455667788999999999999997 89999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=342.00 Aligned_cols=241 Identities=29% Similarity=0.379 Sum_probs=197.3
Q ss_pred ecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 107 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
||+|+||+||+|+.. .+++.||+|.+... .......+.+|+.+|.+++||||+++++++...+..++|
T Consensus 1 lg~G~~g~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKR---------DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 799999999999543 34789999988643 223455678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
|||+++|+|.+++.+.+ .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 72 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 72 LAFINGGELFHHLQREG---RFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred EcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 99999999999997643 48899999999999999999997 99999999999999999999999999999753221
Q ss_pred CCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCc
Q 013519 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDP 343 (441)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (441)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+...
T Consensus 147 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~----------------~~~~~~~~~~ 208 (312)
T cd05585 147 --DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV----------------NEMYRKILQE 208 (312)
T ss_pred --CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH----------------HHHHHHHHcC
Confidence 2223456799999999999999999999999999999999999999964321 1111122211
Q ss_pred cccccCChhhHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 013519 344 RLEEQYPIKGALLAGQIIIKCLEAEPKNRPS---MEEVLET 381 (441)
Q Consensus 344 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~eil~~ 381 (441)
. ..++...+..+.+|+.+||+.||++||+ +.+++.+
T Consensus 209 ~--~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 209 P--LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred C--CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 1 1344556677899999999999999974 6777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=339.52 Aligned_cols=268 Identities=22% Similarity=0.263 Sum_probs=201.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++.+.||+|+||+||+|+.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK---------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC---------CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 36899999999999999999554 347899999876542 2234567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++.+++||||++++.+..+.. .. ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~-~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLEE-MP--NGVPPEKVRSYIYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred CCEEEEEEecCCCCHHHHHHh-cC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccC
Confidence 999999999999877665442 22 358899999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..................+.....
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 147 ARNLSEGS-NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred cccccccc-cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 98643221 11223457899999999999999999999999999999999999999754321110000000000000000
Q ss_pred --------hhhhcCc------cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 337 --------LKKIMDP------RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 337 --------~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+ .....+....+..+.+|+.+||+.||++|||++++|+|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 00011122345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=344.06 Aligned_cols=243 Identities=28% Similarity=0.393 Sum_probs=198.9
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFL 181 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 181 (441)
+.||+|+||.||++.. ..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVRE---------KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 4799999999999954 3458899999986542 233456778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCC
Q 013519 182 LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP 261 (441)
Q Consensus 182 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~ 261 (441)
+||||+++|+|..++.+.. .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus 72 lv~E~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 72 FVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 9999999999998886543 58899999999999999999997 899999999999999999999999999987532
Q ss_pred CCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhc
Q 013519 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341 (441)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (441)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.
T Consensus 147 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----------------~~~~~~~ 208 (323)
T cd05595 147 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------RLFELIL 208 (323)
T ss_pred CC--CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHh
Confidence 11 12233467999999999999999999999999999999999999999643211 1111111
Q ss_pred CccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 342 DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
... ..+|...+..+.+||.+||+.||++|+ ++.+++++
T Consensus 209 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 209 MEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 111 123455667788999999999999998 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=329.63 Aligned_cols=269 Identities=25% Similarity=0.327 Sum_probs=202.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH--HHHHHHHHHHHHhcCCCCC-ccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--GLREWQAEVKFLGKFSHPN-LVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-iv~~~~~~~ 175 (441)
..|..++.||+|+||+||+|+. +.+|+.||+|++.....+ ......+|+.+|+.|+|+| ||.+++++.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~---------~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARS---------KRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEE---------ecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence 3456667899999999999944 445899999998776432 2234568999999999999 999999999
Q ss_pred eCC------eEEEEEeecCCCCHHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 176 EDR------QFLLVYEYMQKGSLENHLFRKGSA-EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 176 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
..+ .+++|+||++. +|..++...... ..++...+..++.|++.||+|||+ ++|+||||||+||||+++|.
T Consensus 82 ~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi~~~G~ 158 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLISSSGV 158 (323)
T ss_pred ecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEECCCCc
Confidence 877 89999999965 999999775532 457778999999999999999997 99999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee--c
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV--D 325 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~--~ 325 (441)
+||+|||+|+..... ....+..++|.+|+|||++.+. .|+..+||||+|||++||++++..|.+....+....+ .
T Consensus 159 lKlaDFGlAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~ 236 (323)
T KOG0594|consen 159 LKLADFGLARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL 236 (323)
T ss_pred EeeeccchHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 999999999864322 2234566889999999999988 7889999999999999999999999876542211100 0
Q ss_pred ccccccchhhhhhhh--cCccccccC-C-------hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 326 FARPSLTDKRRLKKI--MDPRLEEQY-P-------IKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 326 ~~~~~~~~~~~~~~~--~~~~~~~~~-~-------~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...|....+..+... .+..+.... + ........+++.+||+.+|.+|.|++.+|.|
T Consensus 237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000000000000000 000000000 0 1112467799999999999999999999997
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=342.39 Aligned_cols=267 Identities=25% Similarity=0.348 Sum_probs=204.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||.||+|... .++..+|+|.+.... ......+.+|+++++.++||||++++++|.+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHK---------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEEC---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 368999999999999999999543 347889999877642 2344668899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++.+++||||+.+++|.+++.+.+ .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~-~~~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 999999999999999999997643 47889999999999999999996 35799999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee------ccc---
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV------DFA--- 327 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~------~~~--- 327 (441)
+..... .......||..|+|||++.+..++.++|||||||++|+|++|+.||............ ...
T Consensus 151 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (333)
T cd06650 151 SGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE 226 (333)
T ss_pred chhhhh----hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccc
Confidence 875321 1123457899999999999989999999999999999999999999643321100000 000
Q ss_pred -------------------ccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 -------------------RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+..........+.............+.++.+|+.+||+.||++|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000000000000000000000111245678899999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=350.11 Aligned_cols=252 Identities=25% Similarity=0.280 Sum_probs=199.3
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.|++++.||+|+||+||+|.. ..+++.||||++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~---------~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACK---------VDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 588899999999999999954 3458899999986542 2345678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
.+.+++|||||++|+|.+++.+.. .+++..+..++.|++.||.|||. .||+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 999999999999999999987643 48889999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCc---------------------------------------------ceEeeeccccccCcchhhhcCCCCc
Q 013519 257 AKLGPIDGNS---------------------------------------------HVTTRIMGTYGYAAPEYVATGHLYV 291 (441)
Q Consensus 257 a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 291 (441)
++........ ......+||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 8642110000 0112357999999999999999999
Q ss_pred cccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCc--cccccCChhhHHHHHHHHHHhc--cc
Q 013519 292 KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDP--RLEEQYPIKGALLAGQIIIKCL--EA 367 (441)
Q Consensus 292 ~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l--~~ 367 (441)
++|||||||++|||++|..||....+.. ....+... ..........+.++.+||.+|+ ..
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~ 291 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTE----------------TQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAE 291 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHH----------------HHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcc
Confidence 9999999999999999999996543211 11111111 1111112235667889999855 45
Q ss_pred CCCCCCCHHHHHHH
Q 013519 368 EPKNRPSMEEVLET 381 (441)
Q Consensus 368 dp~~Rps~~eil~~ 381 (441)
+|..|+++.+++.|
T Consensus 292 ~~~~R~~~~~~l~h 305 (381)
T cd05626 292 ERLGRNGADDIKAH 305 (381)
T ss_pred cccCCCCHHHHhcC
Confidence 55569999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=347.66 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=198.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||+||+|.. ..+++.||+|++.... ......+.+|+.++..++||||+++++.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQK---------KDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 4688999999999999999944 3458899999986542 233456788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+...+|+|||||++|+|.+++.+.+ .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFG 146 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFG 146 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeecc
Confidence 9999999999999999999997653 58899999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCC---------------------------------cceEeeeccccccCcchhhhcCCCCccccchhHHHHH
Q 013519 256 LAKLGPIDGN---------------------------------SHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVL 302 (441)
Q Consensus 256 la~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il 302 (441)
+++....... .......+||+.|+|||++.+..++.++|||||||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 9875321100 0011245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCC--hhhHHHHHHHHHHhcccCCC---CCCCHHH
Q 013519 303 LEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYP--IKGALLAGQIIIKCLEAEPK---NRPSMEE 377 (441)
Q Consensus 303 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~---~Rps~~e 377 (441)
|||++|+.||...... .....+........+| ...+..+.++|.+|+. +|. .||+++|
T Consensus 227 ~ell~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~e 289 (363)
T cd05628 227 YEMLIGYPPFCSETPQ----------------ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEE 289 (363)
T ss_pred HHHHhCCCCCCCCCHH----------------HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHH
Confidence 9999999999654221 1111111110001111 1245668889988765 444 4689999
Q ss_pred HHHH
Q 013519 378 VLET 381 (441)
Q Consensus 378 il~~ 381 (441)
|+++
T Consensus 290 i~~h 293 (363)
T cd05628 290 IKTN 293 (363)
T ss_pred HhCC
Confidence 9987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=330.00 Aligned_cols=259 Identities=23% Similarity=0.372 Sum_probs=206.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|.+.+.||+|+||.||+|++... ...+..||+|.++... ......+.+|+.++++++||||+++++++..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLP------SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG 78 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecC------CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence 5688999999999999999976532 1236789999987653 23446788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++|+|.+++.+.. ..+++..++.++.|++.||+|||. .+++||||||+|||++.++.++++|||.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECCCccc
Confidence 99999999999999999987643 358899999999999999999996 99999999999999999999999999987
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
....... ........++..|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----------------~~ 217 (266)
T cd05064 155 QEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----------------DV 217 (266)
T ss_pred ccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----------------HH
Confidence 6432111 111112345678999999999999999999999999999875 99999653211 11
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
+..+ ........+..++..+.+++.+||+.+|++||++.+|++.|..+
T Consensus 218 ~~~~-~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 218 IKAV-EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHH-HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111 11111223455667788999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=339.67 Aligned_cols=267 Identities=24% Similarity=0.347 Sum_probs=200.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|.+.+.||.|+||+||+|+.. .++..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSK---------LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEEC---------CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 57999999999999999999543 3478999998865432 2234567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++ +|.+++...+ ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~DfG~~ 150 (288)
T cd07871 76 RCLTLVFEYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLA 150 (288)
T ss_pred CeEEEEEeCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEECcCcce
Confidence 999999999975 8998886543 357889999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-c-cc------c
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-D-FA------R 328 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-~-~~------~ 328 (441)
+..... ........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||............ . .. .
T Consensus 151 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07871 151 RAKSVP--TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228 (288)
T ss_pred eeccCC--CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 753221 112233568999999999876 56889999999999999999999999654321110000 0 00 0
Q ss_pred cccchhhhhhhhcCccccc----cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 PSLTDKRRLKKIMDPRLEE----QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+.+...........+.... ......+.++.+||.+||+.||.+|||++|+++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000111111111111100 0112345678899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=349.35 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=201.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||+||+|... .+++.||||++.... ......+.+|+.+|..++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKK---------DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 36899999999999999999543 457899999986532 234456788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
++..+++|||||.+|+|.+++...+ .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeecc
Confidence 9999999999999999999997643 58899999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcc------------------------------------eEeeeccccccCcchhhhcCCCCccccchhHH
Q 013519 256 LAKLGPIDGNSH------------------------------------VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFG 299 (441)
Q Consensus 256 la~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 299 (441)
+++......... .....+||+.|+|||++.+..++.++||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 986532111000 01124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccC--ChhhHHHHHHHHHHhcccCCCCCCC---
Q 013519 300 VVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQY--PIKGALLAGQIIIKCLEAEPKNRPS--- 374 (441)
Q Consensus 300 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps--- 374 (441)
|++|||++|..||...... .....+........+ ....+..+.+||.+||. +|.+|++
T Consensus 227 ~il~el~~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~ 289 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQ----------------ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNG 289 (364)
T ss_pred hHHHHhhcCCCCCCCCCHH----------------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCC
Confidence 9999999999999654321 111111111100011 12345678899999996 9999997
Q ss_pred HHHHHHH
Q 013519 375 MEEVLET 381 (441)
Q Consensus 375 ~~eil~~ 381 (441)
+.+++++
T Consensus 290 ~~~ll~h 296 (364)
T cd05599 290 VNEIKSH 296 (364)
T ss_pred HHHHhcC
Confidence 9999886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=348.26 Aligned_cols=267 Identities=25% Similarity=0.375 Sum_probs=209.3
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCC-CCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFS-HPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 174 (441)
..++|++.++||+|+||.||+|..... .....+..||||++..... ...+.+.+|+.+|.++. ||||+++++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGL----SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEccc----CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 356899999999999999999976432 1223356799999876433 33567889999999996 99999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCC-----------------------------------------------------
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGS----------------------------------------------------- 201 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 201 (441)
.+...+|||||||++|+|.++|.....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999998865321
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcE
Q 013519 202 ----------------------------------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNI 241 (441)
Q Consensus 202 ----------------------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 241 (441)
...+++..++.++.|++.||.|||. .+|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp~Ni 268 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHhE
Confidence 1247888899999999999999997 8999999999999
Q ss_pred EEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCC
Q 013519 242 LLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGE 320 (441)
Q Consensus 242 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~ 320 (441)
|++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~- 347 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS- 347 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence 999999999999999975432222222223456788999999999999999999999999999997 888886432110
Q ss_pred ceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 321 HVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
.+............+..++..+.+++.+||+.||++||++.++.+.|+.+
T Consensus 348 ---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 348 ---------------TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ---------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 00011111111223445567788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=342.12 Aligned_cols=266 Identities=26% Similarity=0.399 Sum_probs=207.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|++.++||+|+||.||+|..... ....+++.||+|++.... ......+..|+.++.++ +||||+++++++.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~----~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGI----EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred HHHhhhhcccccCcCceEEecccccc----ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 35799999999999999999965432 233456899999987543 33445677899999999 7999999999886
Q ss_pred e-CCeEEEEEeecCCCCHHHHHHhcCC-----------------------------------------------------
Q 013519 176 E-DRQFLLVYEYMQKGSLENHLFRKGS----------------------------------------------------- 201 (441)
Q Consensus 176 ~-~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 201 (441)
. ...++++|||+++++|.+++.....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 5 4578899999999999999864321
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeecccc
Q 013519 202 -----AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276 (441)
Q Consensus 202 -----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 276 (441)
..++++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||+++...............++.
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 1368899999999999999999996 999999999999999999999999999998643222222222345677
Q ss_pred ccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHH
Q 013519 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGAL 355 (441)
Q Consensus 277 ~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (441)
.|+|||++.+..++.++|||||||++|||++ |..||....... .+...+........+...+.
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~ 303 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----------------EFCRRLKEGTRMRAPEYATP 303 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----------------HHHHHHhccCCCCCCccCCH
Confidence 8999999999999999999999999999998 999986532110 01111111111122344556
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 356 LAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 356 ~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
.+.+++.+||+.+|++||++.+++++|+.+
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=349.96 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=198.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||+||+|.. ..+++.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQK---------KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEE---------CCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 3688999999999999999944 3458899999876532 234567888999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+...+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfG 146 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFG 146 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999998654 358889999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCc---------------------------------------------ceEeeeccccccCcchhhhcCCCC
Q 013519 256 LAKLGPIDGNS---------------------------------------------HVTTRIMGTYGYAAPEYVATGHLY 290 (441)
Q Consensus 256 la~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~ 290 (441)
+++........ ......+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 99632110000 000124699999999999999999
Q ss_pred ccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCCh--hhHHHHHHHHHHhcccC
Q 013519 291 VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPI--KGALLAGQIIIKCLEAE 368 (441)
Q Consensus 291 ~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~d 368 (441)
.++|||||||++|||++|..||...... ..+..+........+|. ..+..+.+||.+||. +
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~ 289 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSH----------------ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-N 289 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHH----------------HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-C
Confidence 9999999999999999999999653221 01111111000011121 345678899999997 6
Q ss_pred CCCC---CCHHHHHHH
Q 013519 369 PKNR---PSMEEVLET 381 (441)
Q Consensus 369 p~~R---ps~~eil~~ 381 (441)
|.+| +++.+++.+
T Consensus 290 ~~~r~~r~~~~~~l~h 305 (377)
T cd05629 290 AENRLGRGGAHEIKSH 305 (377)
T ss_pred HhhcCCCCCHHHHhcC
Confidence 6665 599999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=342.29 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=194.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+|+..+.||+|+||.||+|... .+++.||||++..... .....+.+|+.+|+.++|+||+++++++...
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHR---------PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEEC---------CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 45677889999999999999543 3478999999865433 3356788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+++|+|.... ...+..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 145 ~~~~lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DfG~~ 215 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVS 215 (353)
T ss_pred CeEEEEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEcccccc
Confidence 9999999999999986432 24567888999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
+..... ........||..|+|||++.. ...+.++|||||||++|||++|+.||....... +
T Consensus 216 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----------~- 281 (353)
T PLN00034 216 RILAQT--MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----------W- 281 (353)
T ss_pred eecccc--cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----------H-
Confidence 764321 112234579999999998743 234468999999999999999999996322110 0
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+. .......+..++..+.+||.+||..||++||++.|++++
T Consensus 282 -~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 282 -ASLMCAIC-MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -HHHHHHHh-ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000010 011112344556678999999999999999999999987
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.99 Aligned_cols=266 Identities=29% Similarity=0.462 Sum_probs=218.5
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
..++..+.++||+|+||.||+|.+...... ....||||..... ....+.++.+|+++|+.++|||||++||+
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-----~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGF-----KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCc-----eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 345666778999999999999988653210 1122899988853 35678899999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
...+..++||||+|.||+|.++|.+.+. .++..+.+.++.+++.||.|||+ +++|||||..+|+|++.++.+||+|
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~--k~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHS--KNCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHH--CCCcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999999987653 68999999999999999999997 9999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEe-eeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeeccccccc
Q 013519 254 FGLAKLGPIDGNSHVTT-RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
||+++.... ..... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+...
T Consensus 306 FGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-------------- 368 (474)
T KOG0194|consen 306 FGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-------------- 368 (474)
T ss_pred cccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--------------
Confidence 999986321 11111 1124578999999999999999999999999999999 7788865422
Q ss_pred chhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccccc
Q 013519 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVIEI 390 (441)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~~~ 390 (441)
.....++.....+...|...+.++..++.+||..+|++||+|.++.+.|+.+.....
T Consensus 369 --~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 369 --YEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --HHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 122233434455556677888889999999999999999999999999987765433
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=331.55 Aligned_cols=262 Identities=27% Similarity=0.424 Sum_probs=208.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-HHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-GLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|.+.+.||+|+||.||+|..... .....+..||+|.+...... ....+.+|+++|+.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHL----EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccc----cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 4688889999999999999976432 11234678999998765443 457889999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCC-----------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGS-----------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS 246 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 246 (441)
...++||||+++++|.+++...+. ...+++..+..++.|++.||.|||+ .+++||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNCLVGYD 158 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceEEEcCC
Confidence 999999999999999999976432 2457888999999999999999997 899999999999999999
Q ss_pred CceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeec
Q 013519 247 YNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVD 325 (441)
Q Consensus 247 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~ 325 (441)
+.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~------- 231 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE------- 231 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------
Confidence 9999999999975322211111223345788999999999999999999999999999998 99998643211
Q ss_pred ccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 326 FARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
.....+.. ......+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 232 ---------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 ---------EVIECITQ-GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---------HHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111111 1111223455677889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=340.06 Aligned_cols=246 Identities=30% Similarity=0.425 Sum_probs=199.8
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc----hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS----IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 180 (441)
+.||+|+||.||+++... ....++.||+|.+.... ......+.+|+.+|+.++||||+++++++..++.+
T Consensus 2 ~~lg~G~~g~V~~~~~~~------~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVT------GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcc------cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence 589999999999996542 12357899999886532 22345577899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
|+||||+++++|.+++.+.+ .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 99999999999999987654 47788899999999999999997 99999999999999999999999999998743
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+
T Consensus 151 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~----------------~~~~~~~ 212 (323)
T cd05584 151 IHE--GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR----------------KKTIDKI 212 (323)
T ss_pred ccC--CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH----------------HHHHHHH
Confidence 221 1223346799999999999998999999999999999999999999965321 1112222
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
.... ...+...+..+.+||.+||+.+|++|| ++.+++++
T Consensus 213 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 213 LKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 2211 123445567788999999999999999 89998875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=311.23 Aligned_cols=265 Identities=25% Similarity=0.355 Sum_probs=211.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|||+-||++ ....++..||+|++...+.+..+...+|++..++++||||++++++...+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV---------~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLV---------KGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred CceEEEeeeecCCCceeeeee---------cccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 468999999999999999998 56667999999999988888889999999999999999999999886543
Q ss_pred -----CeEEEEEeecCCCCHHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 178 -----RQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 178 -----~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
...||+++|...|+|.+.+.+... ...+++.+++.|+.++++||.+||.....++||||||.|||+.+.+.++|
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 359999999999999999876443 34789999999999999999999974445999999999999999999999
Q ss_pred ecccCCCCCCCCCCcce-------EeeeccccccCcchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCc
Q 013519 252 SDFGLAKLGPIDGNSHV-------TTRIMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~ 321 (441)
.|||.++.......... ...-.-|..|+|||.+. +...+.++|||||||+||.|+.|..||+..-..+..
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 99999986432211110 01124578999999884 446779999999999999999999999754333322
Q ss_pred eeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
+.... .++.+........++.+.+||++||+.||.+||++.+++.+++.+
T Consensus 251 laLAv--------------~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 251 LALAV--------------QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred EEEee--------------eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 21111 111111111223566788999999999999999999999998764
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=330.93 Aligned_cols=262 Identities=24% Similarity=0.418 Sum_probs=207.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+|++.+.||+|+||+||+|.+... ....+..+++|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~-----~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLP-----GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecC-----CCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 4678889999999999999975321 2234678999998754 334456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGS--------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
...++||||+++++|.+++..... ...+++..++.++.|++.||.|||+ ++|+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~nili 157 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILI 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccceEEE
Confidence 999999999999999999864321 2347888999999999999999997 899999999999999
Q ss_pred cCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCce
Q 013519 244 DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHV 322 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~ 322 (441)
+.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----- 232 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----- 232 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence 9999999999999976433222222233456778999999998899999999999999999998 8888854321
Q ss_pred eecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
..+.+..........+..++..+.+++.+||+.||++||++.+|+++|..
T Consensus 233 ------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 ------------QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 01111111111112344556778899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=338.01 Aligned_cols=268 Identities=23% Similarity=0.340 Sum_probs=197.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|.+.+.||+|+||+||+|... .+++.||||++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSK---------VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEEC---------CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 368999999999999999999543 3578999999865432 223456789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
....++||||+. ++|.+++.... ..++...+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 75 KETLTLVFEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred CCeEEEEEECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECCCCc
Confidence 999999999995 58888776543 357889999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee---ecccccc--
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL---VDFARPS-- 330 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~---~~~~~~~-- 330 (441)
++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........... .....+.
T Consensus 150 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
T cd07869 150 ARAKSVP--SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED 227 (303)
T ss_pred ceeccCC--CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChh
Confidence 8743211 112234568999999999875 4578899999999999999999999975422110000 0000000
Q ss_pred -cchhhhhhhh--------cCccccccC-ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 331 -LTDKRRLKKI--------MDPRLEEQY-PIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 331 -~~~~~~~~~~--------~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+......... ....+...+ ....+..+.+|+.+||+.||++|||+.++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000000000 000000000 01123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=331.53 Aligned_cols=265 Identities=23% Similarity=0.376 Sum_probs=206.3
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
..++|++.+.||+|+||.||+|.+... .....+..||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 456899999999999999999976532 122346789999886542 334556889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC-------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS-------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
+....++||||+++++|.+++.+... ...+++..++.++.|++.||.|||+ .+++|+||||+|||+++++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEEcCCCC
Confidence 99999999999999999999865322 1345778899999999999999997 89999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeeccc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 327 (441)
++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------- 228 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------- 228 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---------
Confidence 99999999875322211111112345778999999999999999999999999999999 67888543210
Q ss_pred ccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 328 RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
.....+..... ...+..++..+.+++.+||+.+|++||++.|+++.|++
T Consensus 229 -------~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 229 -------QVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -------HHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111111 12234455678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=340.38 Aligned_cols=246 Identities=27% Similarity=0.392 Sum_probs=197.5
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHH---hcCCCCCccceEEEE
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFL---GKFSHPNLVKLIGYC 174 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l---~~l~hpniv~~~~~~ 174 (441)
|++.+.||+|+||.||+|... .+++.||||.+.... ....+.+.+|++++ +.++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK---------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 677889999999999999554 347899999986542 22344566666554 567899999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
...+.+|+||||+++++|..++.. ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCcc
Confidence 999999999999999999888743 358999999999999999999997 99999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+++.... ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .
T Consensus 146 g~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~----------------~ 207 (324)
T cd05589 146 GLCKEGMG--FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE----------------E 207 (324)
T ss_pred cCCccCCC--CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH----------------H
Confidence 99874322 12223456799999999999999999999999999999999999999965321 1
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
.....+.... ..++...+..+.++|.+||+.||.+|| ++.+++++
T Consensus 208 ~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 208 EVFDSIVNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1111121111 123445667788999999999999999 67888775
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=346.94 Aligned_cols=252 Identities=28% Similarity=0.373 Sum_probs=204.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||+||+|... .+++.||||++..... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK---------DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC---------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 36899999999999999999543 3588999999865421 33566888999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+++.+++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg 146 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFG 146 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCC
Confidence 999999999999999999999765 358899999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCC---------------------------CcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhC
Q 013519 256 LAKLGPIDG---------------------------NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG 308 (441)
Q Consensus 256 la~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg 308 (441)
+++...... .........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 997643222 00122345799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCceeecccccccchhhhhhhhcC--ccccccCChhhHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 013519 309 LRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD--PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-MEEVLET 381 (441)
Q Consensus 309 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~eil~~ 381 (441)
+.||...... .....+.. ..+........+..+.+||.+||. ||.+||+ +.+++++
T Consensus 227 ~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 227 FPPFYSDTLQ----------------ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCCHH----------------HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 9999654311 11111211 111111111246778899999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=331.11 Aligned_cols=266 Identities=27% Similarity=0.400 Sum_probs=211.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|.+.+.||+|+||+||++..... .....+..+|+|.+..........+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccC----CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 5788999999999999999965331 122345679999988766666678899999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcC----------CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 179 QFLLVYEYMQKGSLENHLFRKG----------SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
.+++||||+++++|.+++...+ ....+++..++.++.|++.||.|||+ .|++||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCc
Confidence 9999999999999999987543 12348999999999999999999997 99999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeeccc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 327 (441)
++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------- 229 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------- 229 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---------
Confidence 99999999975432221111222345778999999999999999999999999999998 88888543211
Q ss_pred ccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 328 RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
.....+..... ...+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 230 -------~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 230 -------EVIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -------HHHHHHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11111111111 11233445678899999999999999999999999987763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=341.88 Aligned_cols=252 Identities=23% Similarity=0.281 Sum_probs=202.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||+||+|.. ..+++.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVRE---------KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 3688999999999999999944 34588999999875422 34556888999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+.+.+++||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEECCCCCEEeccCC
Confidence 9999999999999999999997652 358899999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhh------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVA------TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
++........ .......||+.|+|||++. ...++.++|||||||++|+|++|..||......
T Consensus 148 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----------- 215 (330)
T cd05601 148 SAARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----------- 215 (330)
T ss_pred CCeECCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----------
Confidence 9976432221 1233457999999999987 456789999999999999999999999653211
Q ss_pred ccchhhhhhhhcCccccccCC--hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKRRLKKIMDPRLEEQYP--IKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+..++.......++ ...+..+.+|+.+||. +|.+||++.+++++
T Consensus 216 -----~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 216 -----KTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1111221111111111 2345678899999998 99999999999976
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=341.63 Aligned_cols=244 Identities=28% Similarity=0.396 Sum_probs=198.4
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFL 181 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 181 (441)
+.||+|+||+||++.. ..+++.||+|.+.... ......+..|++++..++||||+++++++..+..++
T Consensus 1 ~~lG~G~~g~V~~~~~---------~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKE---------KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 4699999999999944 3458899999886542 233456778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCC
Q 013519 182 LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP 261 (441)
Q Consensus 182 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~ 261 (441)
+||||+++|+|..++.+.. .+++..+..++.|++.||.|||+ ..||+||||||+|||++.++.+||+|||+++...
T Consensus 72 lv~E~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~-~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 72 FVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 9999999999999886543 58899999999999999999995 3799999999999999999999999999987432
Q ss_pred CCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhc
Q 013519 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341 (441)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (441)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+.
T Consensus 148 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~----------------~~~~~~i~ 209 (325)
T cd05594 148 KD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------------EKLFELIL 209 (325)
T ss_pred CC--CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH----------------HHHHHHHh
Confidence 21 1223346799999999999999999999999999999999999999964321 01111111
Q ss_pred CccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 342 DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
.. ...++...+..+.+|+.+||+.||++|+ ++.+++++
T Consensus 210 ~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 210 ME--EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred cC--CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11 1123445667788999999999999997 89999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=347.84 Aligned_cols=251 Identities=25% Similarity=0.312 Sum_probs=199.1
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.|+++++||+|+||+||+|+. ..+++.||+|++.... ......+.+|+.+++.++||||+++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~---------~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARK---------VDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEE---------CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 588899999999999999944 3458899999987542 2345678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++.+|+|||||++|+|.+++.+.+ .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCC
Confidence 999999999999999999987653 47889999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCC---------------------------------------------cceEeeeccccccCcchhhhcCCCCc
Q 013519 257 AKLGPIDGN---------------------------------------------SHVTTRIMGTYGYAAPEYVATGHLYV 291 (441)
Q Consensus 257 a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 291 (441)
++....... .......+||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 753211000 00112357999999999999999999
Q ss_pred cccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcC--ccccccCChhhHHHHHHHHHHhcccCC
Q 013519 292 KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD--PRLEEQYPIKGALLAGQIIIKCLEAEP 369 (441)
Q Consensus 292 ~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp 369 (441)
++|||||||++|||++|+.||....+. .....+.. ...........+..+.++|.+|+ .+|
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p 290 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPL----------------ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGP 290 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHH----------------HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCH
Confidence 999999999999999999999654321 11111111 11111112234567889998876 599
Q ss_pred CCCCC---HHHHHHH
Q 013519 370 KNRPS---MEEVLET 381 (441)
Q Consensus 370 ~~Rps---~~eil~~ 381 (441)
++|++ +.++++|
T Consensus 291 ~~R~~~~~~~ei~~h 305 (382)
T cd05625 291 EDRLGKNGADEIKAH 305 (382)
T ss_pred hHcCCCCCHHHHhcC
Confidence 99997 8888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=331.64 Aligned_cols=266 Identities=25% Similarity=0.404 Sum_probs=212.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|.+.+.||+|+||.||+|.+... ........+++|.+........+.+.+|+.++++++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNL----SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeecc----CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4578889999999999999965432 122345679999988777666678899999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG 245 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 245 (441)
..++||||+++++|.+++...+. ...+++..++.++.|++.||.|||. ++|+||||||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATRNCLVGA 158 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEcc
Confidence 99999999999999999976431 2347899999999999999999996 99999999999999999
Q ss_pred CCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceee
Q 013519 246 SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLV 324 (441)
Q Consensus 246 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~ 324 (441)
++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||+| |..||......
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------ 232 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------ 232 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence 99999999999975432221112233456788999999999999999999999999999999 99998543211
Q ss_pred cccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 325 DFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
..+..+.. ......+..++..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 233 ----------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 233 ----------EVIECITQ-GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ----------HHHHHHhC-CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 01111111 11112233455678899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=336.03 Aligned_cols=261 Identities=23% Similarity=0.374 Sum_probs=206.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+|++.+.||+|+||.||+|.+... .......||+|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecC-----CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 5699999999999999999976532 11224469999987543 34556788999999999999999999998764
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEcccccc
Confidence 5789999999999999997643 357889999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...............++..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-----------------~~ 219 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------------SE 219 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----------------HH
Confidence 86543222211222334678999999999999999999999999999998 9999864321 01
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
+..++........+..++..+.+++.+||..+|++||++.+++..|..+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 220 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111111122223445567889999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=348.89 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=199.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.+|++++.||+|+||.||+|... .+++.||||.+..... .....+.+|+.+|+.++||||+++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKV---------DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC---------CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 36899999999999999999543 4588999999865322 23456788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+++.+++|||||++|+|.+++.+.+ .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999999997643 47888999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCC-----------------------------------------cceEeeeccccccCcchhhhcCCCCcccc
Q 013519 256 LAKLGPIDGN-----------------------------------------SHVTTRIMGTYGYAAPEYVATGHLYVKSD 294 (441)
Q Consensus 256 la~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 294 (441)
+|..+..... .......+||+.|+|||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 9853210000 00012357999999999999999999999
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcC--ccccccCChhhHHHHHHHHHHhcccCCCCC
Q 013519 295 VYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD--PRLEEQYPIKGALLAGQIIIKCLEAEPKNR 372 (441)
Q Consensus 295 vwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 372 (441)
||||||++|||++|+.||....+... ...+.. ...........+..+.++|.+|+ .+|.+|
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R 289 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAET----------------QLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDR 289 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHH----------------HHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhc
Confidence 99999999999999999975432110 001110 01111112234566788999976 599999
Q ss_pred C---CHHHHHHH
Q 013519 373 P---SMEEVLET 381 (441)
Q Consensus 373 p---s~~eil~~ 381 (441)
+ ++.+++++
T Consensus 290 ~~~~t~~ell~h 301 (376)
T cd05598 290 LGKNGADEIKAH 301 (376)
T ss_pred CCCCCHHHHhCC
Confidence 9 99999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=330.92 Aligned_cols=263 Identities=24% Similarity=0.342 Sum_probs=199.5
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC-
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR- 178 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 178 (441)
.|.-.+++|.|+||.||+|.... +++.||||++-.+.. .-.+|+.+|+.+.|||||+++.+|....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 46667899999999999996554 378999999876643 2246999999999999999999887532
Q ss_pred ----eEEEEEeecCCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC-CceEEe
Q 013519 179 ----QFLLVYEYMQKGSLENHLFRK-GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS-YNAKLS 252 (441)
Q Consensus 179 ----~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~ 252 (441)
.+.+||||++. +|...+... .....++...+.-+..|+++||+|||+ .||+||||||.|+|+|.+ |.+|||
T Consensus 92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKic 168 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKIC 168 (364)
T ss_pred CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEec
Confidence 34699999976 888888642 123567888899999999999999997 999999999999999876 899999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeec--cccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD--FARP 329 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~--~~~~ 329 (441)
|||.|+....... ..++.-|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.+.+..+....+- +..|
T Consensus 169 DFGSAK~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 169 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP 245 (364)
T ss_pred cCCcceeeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence 9999997543322 2445668999999999886 68899999999999999999999998866443332211 0111
Q ss_pred ccchhh---------hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKR---------RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.-.+.. ...++....+...+....++++.+|+.++|..+|.+|.++.|++.+
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111100 0011111111122445567788999999999999999999999986
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=339.89 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=202.6
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc----hHHHHHHHHHHHHHhcCC-CCCccceEEEE
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS----IQGLREWQAEVKFLGKFS-HPNLVKLIGYC 174 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 174 (441)
+|++.+.||+|+||+||+++... ...+++.||+|++.... ....+.+..|+.++..++ ||||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVT------GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcc------cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 48889999999999999986532 23358899999886432 223456778999999995 99999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
..++.+++||||+.+|+|.+++.+.. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Df 149 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLTDF 149 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEeeC
Confidence 99999999999999999999987643 48899999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
|+++...... ........||+.|+|||++.+. .++.++|||||||++|||++|..||........ .
T Consensus 150 G~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------------~ 216 (332)
T cd05614 150 GLSKEFLSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT------------Q 216 (332)
T ss_pred cCCccccccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC------------H
Confidence 9997543221 1223346799999999999865 478899999999999999999999964322110 0
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
......+.. ....++...+..+.+++.+||+.||++|| ++.+++++
T Consensus 217 ~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 217 SEVSRRILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 000111111 11223445566788999999999999999 78899876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=344.93 Aligned_cols=252 Identities=24% Similarity=0.279 Sum_probs=202.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|++.+.||+|+||.||+|... .+++.||+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~ 112 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHK---------SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF 112 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 467999999999999999999543 458899999886432 22334577899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+++.+++||||+++|+|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~Df 186 (370)
T cd05596 113 QDDKYLYMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADF 186 (370)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEec
Confidence 9999999999999999999988543 37788899999999999999997 99999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccc
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG----HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 330 (441)
|+++...... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 187 G~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------------- 252 (370)
T cd05596 187 GTCMKMDANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------------- 252 (370)
T ss_pred cceeeccCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-------------
Confidence 9997542211 1112345799999999998754 378999999999999999999999965421
Q ss_pred cchhhhhhhhcCccccccCCh--hhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 013519 331 LTDKRRLKKIMDPRLEEQYPI--KGALLAGQIIIKCLEAEPKN--RPSMEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~--Rps~~eil~~ 381 (441)
......+........++. ..+..+.+||.+||+.+|++ |+++.+++++
T Consensus 253 ---~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 253 ---VGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---HHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111222222111111222 35677899999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=356.11 Aligned_cols=257 Identities=27% Similarity=0.334 Sum_probs=207.0
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
..++|.+.+.||+|+||+||+|+. ..+++.||||.+... .......+.+|+.++..++|+||++++..+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~---------~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~ 100 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKR---------VSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF 100 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEE---------cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence 346899999999999999999944 345889999988654 334456788899999999999999998877
Q ss_pred EeCC--------eEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC
Q 013519 175 WEDR--------QFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG 245 (441)
Q Consensus 175 ~~~~--------~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 245 (441)
.... .+++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCS 178 (496)
T ss_pred ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEeC
Confidence 5432 3689999999999999986532 23568899999999999999999997 89999999999999999
Q ss_pred CCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeec
Q 013519 246 SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD 325 (441)
Q Consensus 246 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~ 325 (441)
++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------- 250 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------- 250 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------
Confidence 999999999999864332222333456899999999999999999999999999999999999999964321
Q ss_pred ccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 326 FARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+..+.... ....+...+..+.+|+.+||+.||.+||++.+++++
T Consensus 251 --------~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 --------EEVMHKTLAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --------HHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 01111111111 112345566778999999999999999999999875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=344.61 Aligned_cols=253 Identities=25% Similarity=0.290 Sum_probs=200.9
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
..++|++.+.||+|+||.||+|... .+++.+|+|.+... .......+.+|+.+++.++||||++++++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHK---------SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 111 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3468999999999999999999543 45789999987542 12234557789999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+.++..+|+|||||++|+|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~D 185 (370)
T cd05621 112 FQDDKYLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLAD 185 (370)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999998543 37888999999999999999997 9999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH----LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
||+++...... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.....
T Consensus 186 FG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------------ 252 (370)
T cd05621 186 FGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------------ 252 (370)
T ss_pred cccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------------
Confidence 99997542211 11223567999999999997643 77899999999999999999999965321
Q ss_pred ccchhhhhhhhcCccccccCCh--hhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 013519 330 SLTDKRRLKKIMDPRLEEQYPI--KGALLAGQIIIKCLEAEPKN--RPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~--Rps~~eil~~ 381 (441)
......+........+|. ..+..+.+++.+||..++.+ |+++.++++|
T Consensus 253 ----~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 253 ----VGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----HHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111222222211112222 34667889999999865544 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=323.89 Aligned_cols=260 Identities=24% Similarity=0.405 Sum_probs=207.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|.+.+.||+|+||+||+|.+... ......|++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLP------GKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccC------CCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 5788999999999999999977532 1125689999887653 33456788899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECccchh
Confidence 99999999999999999997643 368899999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----------------~~~ 217 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----------------QDV 217 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----------------HHH
Confidence 86532222111222345678999999998999999999999999999998 9888854211 011
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
...+. .......+..++..+.+|+.+||+.+|++||++.+++++|+.+
T Consensus 218 ~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 218 IKAVE-DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111 1111122344567788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=337.20 Aligned_cols=248 Identities=29% Similarity=0.400 Sum_probs=200.3
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCC-CccceEEEEE
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHP-NLVKLIGYCW 175 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~ 175 (441)
+|++.+.||+|+||.||+|... .+++.||+|++.... ....+.+..|+.++..+.|+ +|+.+++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 4888999999999999999544 347899999886542 23455677899999999764 6888999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
..+.+|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecC
Confidence 9999999999999999999986543 47889999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+++..... .......+||+.|+|||++.+..++.++|||||||++|+|+||+.||..... ..
T Consensus 147 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----------------~~ 208 (324)
T cd05587 147 MCKENIFG--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----------------DE 208 (324)
T ss_pred cceecCCC--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----------------HH
Confidence 98743211 2223456899999999999999999999999999999999999999964321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM-----EEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~eil~~ 381 (441)
....+... ...++...+..+.+++.+||..||.+|++. .+++++
T Consensus 209 ~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 209 LFQSIMEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11122211 123345566778899999999999999976 677654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=340.62 Aligned_cols=266 Identities=25% Similarity=0.402 Sum_probs=196.4
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|++.+.||+|+||.||+|+. ..++..||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAID---------THTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEE---------CCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 588899999999999999954 345889999988643 223345678899999999999999999988643
Q ss_pred -----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEe
Q 013519 178 -----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252 (441)
Q Consensus 178 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 252 (441)
..+|+|||||. ++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 72 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL~ 145 (338)
T cd07859 72 SRREFKDIYVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKIC 145 (338)
T ss_pred CCCCCceEEEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEc
Confidence 35899999995 68988886543 58899999999999999999997 899999999999999999999999
Q ss_pred cccCCCCCCCCCCc-ceEeeeccccccCcchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ecc-c
Q 013519 253 DFGLAKLGPIDGNS-HVTTRIMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VDF-A 327 (441)
Q Consensus 253 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~~-~ 327 (441)
|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... ... .
T Consensus 146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~ 225 (338)
T cd07859 146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG 225 (338)
T ss_pred cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence 99999753222111 11234579999999999876 6788999999999999999999999965432110000 000 0
Q ss_pred ccccchh--------hhhhhhcCcc----ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTDK--------RRLKKIMDPR----LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~~--------~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+..... ......+... +...+ ...+..+.+++.+||+.||++||++.+++++
T Consensus 226 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 0000000000 00011 1234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=328.49 Aligned_cols=264 Identities=26% Similarity=0.399 Sum_probs=208.6
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
+|++.+.||+|+||.||+|..... ........+++|.+.... ......+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRL----KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecC----CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 477889999999999999976432 122234678999876553 334567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcC---------------------CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKG---------------------SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFK 237 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlk 237 (441)
..++||||+.+++|.+++.... ....+++..++.++.|++.||.|||. .+|+|||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKLVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CCeehhhhh
Confidence 9999999999999999986421 12357889999999999999999996 999999999
Q ss_pred CCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 013519 238 ASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNR 316 (441)
Q Consensus 238 p~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~ 316 (441)
|+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999975432222111223345678999999998899999999999999999998 999986432
Q ss_pred CCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 317 PSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
+. .+............+..++..+.+++.+||+.+|++||++.++++.|+++-
T Consensus 235 ~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 235 PE-----------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HH-----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11 111122222222334455677889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.91 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=199.1
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKF-SHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 180 (441)
++||+|+||.||+|... .+++.||+|++.... ......+..|..++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELK---------KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 47999999999999544 347899999987542 23455678899999998 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
|+|||||++|+|.+++.+.+ .+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~~g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred EEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 99999999999998886543 58999999999999999999997 99999999999999999999999999998742
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
.. ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ..........+
T Consensus 147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~-------~~~~~~~~~~~ 217 (329)
T cd05588 147 IR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD-------QNTEDYLFQVI 217 (329)
T ss_pred cc--CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc-------ccchHHHHHHH
Confidence 21 1122345689999999999999999999999999999999999999996432211000 00000011111
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS------MEEVLET 381 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~eil~~ 381 (441)
.... ...|...+..+.++|.+||+.||.+|++ +.+++++
T Consensus 218 ~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 218 LEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1111 1234556677889999999999999997 6788875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=336.67 Aligned_cols=243 Identities=28% Similarity=0.414 Sum_probs=196.5
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKF-SHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 180 (441)
++||+|+||+||+|+.. .+++.||||++.... ......+..|..++..+ +||||+++++++...+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLK---------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEc---------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 37999999999999543 347899999886532 22345667788888876 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
|+||||+++|+|.+++.+.. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred EEEEcCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 99999999999999886543 58899999999999999999997 99999999999999999999999999998753
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+
T Consensus 147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----------------~~~~~~i 208 (320)
T cd05590 147 IF--NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----------------DDLFEAI 208 (320)
T ss_pred Cc--CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----------------HHHHHHH
Confidence 22 12223456799999999999999999999999999999999999999965321 1111122
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM------EEVLET 381 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~eil~~ 381 (441)
.... ..++...+..+.+|+.+||+.||++||++ ++++++
T Consensus 209 ~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 209 LNDE--VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred hcCC--CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 2111 12344456678899999999999999998 777765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=336.42 Aligned_cols=243 Identities=27% Similarity=0.405 Sum_probs=197.2
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKF-SHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 180 (441)
++||+|+||.||+|... .+++.||+|++.... ......+..|..++..+ +||||+++++++..++.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELK---------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 36999999999999543 347899999987542 23345567788888866 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
|+||||+++|+|..++.... .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~E~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 99999999999999886543 58889999999999999999997 89999999999999999999999999998753
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+..+
T Consensus 147 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~----------------~~~~~~i 208 (321)
T cd05591 147 ILN--GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE----------------DDLFESI 208 (321)
T ss_pred ccC--CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH----------------HHHHHHH
Confidence 221 1223446799999999999999999999999999999999999999965421 1111122
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-------SMEEVLET 381 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-------s~~eil~~ 381 (441)
.... ..+|...+..+.+|+.+||+.||++|| ++.+++++
T Consensus 209 ~~~~--~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 209 LHDD--VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 2111 123444566788999999999999999 88899876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=335.53 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=198.2
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKF-SHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 180 (441)
++||+|+||+||+|... .+++.||+|.+... .......+..|+.++.++ +||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK---------KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 47999999999999544 34789999988754 223455677899988877 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
++||||+++|+|..++.+.. .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~E~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred EEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 99999999999998886543 58899999999999999999997 89999999999999999999999999999753
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ..........+
T Consensus 147 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-------~~~~~~~~~~i 217 (329)
T cd05618 147 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QNTEDYLFQVI 217 (329)
T ss_pred cCC--CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc-------cccHHHHHHHH
Confidence 211 122344679999999999999999999999999999999999999996422111000 00000111111
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS------MEEVLET 381 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~eil~~ 381 (441)
.... ..+|...+..+.+||.+||+.||++||+ +.++++|
T Consensus 218 ~~~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 218 LEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred hcCC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1111 1345566777889999999999999998 5788775
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=342.07 Aligned_cols=267 Identities=24% Similarity=0.357 Sum_probs=210.3
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCC-CCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFS-HPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 174 (441)
..++|.+.+.||+|+||.||+|++... .....++.||+|++.... ....+.+.+|+.+|.++. ||||+++++++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGL----SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCC----CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 345788899999999999999987642 122346789999997653 233456889999999997 99999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCC-----------------------------------------------------
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGS----------------------------------------------------- 201 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 201 (441)
......++|||||.+|+|.+++.+...
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999975421
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCC
Q 013519 202 ------------------------------------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKAS 239 (441)
Q Consensus 202 ------------------------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~ 239 (441)
...+++..++.++.|++.||.|||+ .+|+||||||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlkp~ 268 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLAAR 268 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCCcc
Confidence 1246777889999999999999996 89999999999
Q ss_pred cEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 013519 240 NILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPS 318 (441)
Q Consensus 240 Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~ 318 (441)
|||++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 99999999999999999975422211111223456788999999998899999999999999999998 8888854321
Q ss_pred CCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 319 GEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
.......+........+..++..+.+|+.+||..+|++||++.+|++.|+.+
T Consensus 348 ---------------~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 348 ---------------NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ---------------hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111112222233445667789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=328.09 Aligned_cols=262 Identities=23% Similarity=0.377 Sum_probs=207.5
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
+|++.+.||+|+||+||+|.+.... ....++.||+|.+..... .....+.+|+.++..++||||+++++++....
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTA----PGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCC----CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 4777889999999999999765421 122467899999876543 33466889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcC-------------CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKG-------------SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG 245 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 245 (441)
..++++||+.+++|.+++.... ....+++..++.++.|++.||.|||+ .||+||||||+|||++.
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNVLVFD 159 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchhheEecC
Confidence 9999999999999999985321 12357888999999999999999997 89999999999999999
Q ss_pred CCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceee
Q 013519 246 SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLV 324 (441)
Q Consensus 246 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~ 324 (441)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------- 232 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------- 232 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence 99999999999875433222222233456789999999998899999999999999999998 7778754321
Q ss_pred cccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 325 DFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
......+.... ....+..++..+.+|+.+||+.+|++||++.+|+..|+.
T Consensus 233 ---------~~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 ---------QDVIEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---------HHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111122211 123355677778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=341.94 Aligned_cols=261 Identities=22% Similarity=0.252 Sum_probs=197.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|.+.+.||+|+||.||+|+. ..+++.||+|.... ..+.+|+.+|++++||||++++++|..+.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d---------~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 156 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACID---------NKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNK 156 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEE---------CCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECC
Confidence 5799999999999999999944 34588999997542 34578999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++|||++. ++|..++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 157 ~~~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 157 FTCLILPRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred eeEEEEecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 9999999995 6888888654 358899999999999999999997 899999999999999999999999999997
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCc-----eeecc----c--
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH-----VLVDF----A-- 327 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~-----~~~~~----~-- 327 (441)
..... .........||+.|+|||++.+..++.++|||||||++|||++|..||......... .+... .
T Consensus 231 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~ 309 (391)
T PHA03212 231 FPVDI-NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH 309 (391)
T ss_pred ccccc-cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCC
Confidence 53211 112233467999999999999999999999999999999999999887543211100 00000 0
Q ss_pred ccc--cchhhhhhhhc----C-----ccccccC--ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPS--LTDKRRLKKIM----D-----PRLEEQY--PIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~--~~~~~~~~~~~----~-----~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
... ......+...+ . +.....+ ....+..+.+||.+||+.||++|||+.|+|++
T Consensus 310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 00000000000 0 0000000 01235578899999999999999999999975
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=329.58 Aligned_cols=266 Identities=26% Similarity=0.379 Sum_probs=209.5
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcC-CCCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKF-SHPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 174 (441)
..++|.+.+.||+|+||.||++.+.... .......+|+|.+... .......+.+|+.++.++ +||||+++++++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~----~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLD----NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCC----CCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3467889999999999999999765321 1233578999988764 334456688999999999 799999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhc-------------CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcE
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRK-------------GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNI 241 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 241 (441)
..+..+++||||+++|+|..++... .....+++..++.++.|++.||.|||+ .+|+||||||+||
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~Ni 163 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNV 163 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccceeeE
Confidence 9999999999999999999998653 123568899999999999999999996 9999999999999
Q ss_pred EEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCC
Q 013519 242 LLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGE 320 (441)
Q Consensus 242 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~ 320 (441)
|++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 241 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 241 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence 999999999999999986432221111222335678999999999999999999999999999998 88888543210
Q ss_pred ceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 321 HVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
.+.+.+........+..++..+.+|+.+||..+|++|||+.++++.|+.+
T Consensus 242 ---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 242 ---------------ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 01111111112223445566788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=329.28 Aligned_cols=268 Identities=26% Similarity=0.389 Sum_probs=194.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcC---CCCCccceEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKF---SHPNLVKLIGY 173 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~~~~~ 173 (441)
++|++.+.||+|+||+||+|..... .+..||+|.+..... .....+.+|+.+++.+ .||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC--------CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 3689999999999999999965321 267899998764321 1223455677776665 69999999998
Q ss_pred EEe-----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 174 CWE-----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 174 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
+.. ...+++||||+. ++|.+++..... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCCC
Confidence 852 456899999996 589998865432 458899999999999999999997 99999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-eeccc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LVDFA 327 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~ 327 (441)
+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... +....
T Consensus 149 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~ 225 (290)
T cd07862 149 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225 (290)
T ss_pred EEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 999999999754321 22344678999999999999999999999999999999999999997643211000 00000
Q ss_pred c-c---ccchhhhh-hhhcCccc---cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 R-P---SLTDKRRL-KKIMDPRL---EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~-~---~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. + .+.....+ ...+.... ........+..+.+|+.+||+.||++|||+.++|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 0 00000000 00000000 001112345667899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=341.99 Aligned_cols=263 Identities=23% Similarity=0.289 Sum_probs=196.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
..|.+.+.||+|+||.||+|... ..++.||||.... ..+.+|+++|++++|||||++++++...+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~---------~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHP---------DYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEEC---------CCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 46999999999999999999544 3478999996432 23467999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++|||++. ++|..++.... ..+++..++.|+.|++.||.|||+ .||+||||||+||||+.++.+||+|||+++
T Consensus 234 ~~~lv~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 234 LTCLVLPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred EEEEEEEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCCce
Confidence 9999999995 68888886543 368999999999999999999997 899999999999999999999999999997
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCC-c-----ee--eccc---
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGE-H-----VL--VDFA--- 327 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~-~-----~~--~~~~--- 327 (441)
...............||+.|+|||++.+..++.++|||||||+||||++|..++........ . .. +...
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 64332222223346799999999999999999999999999999999998766533221100 0 00 0000
Q ss_pred c---cccchhhhhhhhc-------Cccccc-cCC--hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 R---PSLTDKRRLKKIM-------DPRLEE-QYP--IKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~---~~~~~~~~~~~~~-------~~~~~~-~~~--~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. +.....+...... .+.... .+. ...+..+.+||.+||+.||.+|||+.|+|++
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0000000000000 000000 000 1234468899999999999999999999987
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=325.24 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=208.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|.+.++||+|+||.||++..... .....+..+++|.+..........+.+|+++++.++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 4678889999999999999965432 123346789999988776666778999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCC------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGS------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS 246 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 246 (441)
..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+ .+++||||||+|||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRNCLVGQG 158 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhhEEEcCC
Confidence 99999999999999999976432 1347889999999999999999996 999999999999999999
Q ss_pred CceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeec
Q 013519 247 YNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVD 325 (441)
Q Consensus 247 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~ 325 (441)
+.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------- 231 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------- 231 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------
Confidence 9999999999875432211111222345678999999999999999999999999999998 88888543211
Q ss_pred ccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 326 FARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
.....+... .....+..++..+.+|+.+||+.||++||++.+|++.|+
T Consensus 232 ---------~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 ---------EAIECITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---------HHHHHHHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111111 111223445667889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.83 Aligned_cols=248 Identities=28% Similarity=0.386 Sum_probs=199.6
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
+|.+.+.||+|+||.||+|... .+++.||+|.+.... ......+..|..++..+ .||+|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 4788899999999999999544 347899999886542 22334566788888877 4899999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
..+.+++||||+++|+|.+++...+ .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCC
Confidence 9999999999999999999886653 48899999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 147 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----------------~~ 208 (323)
T cd05616 147 MCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----------------DE 208 (323)
T ss_pred CceecCCC--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----------------HH
Confidence 99743211 1223456799999999999999999999999999999999999999965321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM-----EEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~eil~~ 381 (441)
....+.... ..+|...+..+.+|+.+||+.||++|++. .+++++
T Consensus 209 ~~~~i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 209 LFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHHHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 111222111 12345566778999999999999999974 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=322.65 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=206.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|.+.+.||+|+||.||+|.+.. .++.|++|.+.... .....+.+|+.+++.++||||+++++++..+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence 457788899999999999996543 47889999987553 33567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.+++||||+++++|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 9999999999999999986543 2458899999999999999999997 899999999999999999999999999997
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
...... ........++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..
T Consensus 153 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----------------~~ 214 (263)
T cd05052 153 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QV 214 (263)
T ss_pred ccccce-eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HH
Confidence 543211 111111234567999999999999999999999999999998 88888643211 01
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
...+........+..++..+.+++.+||..+|++||++.++++.|+.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 215 YELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111111222234555667899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=330.73 Aligned_cols=243 Identities=27% Similarity=0.407 Sum_probs=193.2
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKF-SHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 180 (441)
++||+|+||+||+|... .+++.||+|.+.... ....+.+..|..++..+ +||||+++++++.....+
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELK---------GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 37999999999999554 347899999886532 12334455677777654 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
++||||+++|+|.+++...+ .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred EEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 99999999999999886543 58899999999999999999997 99999999999999999999999999999753
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
... .......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+
T Consensus 147 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----------------~~~~~~i 208 (316)
T cd05592 147 MNG--EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----------------DELFDSI 208 (316)
T ss_pred CCC--CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----------------HHHHHHH
Confidence 221 1233456799999999999999999999999999999999999999965321 1111111
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSME-EVLET 381 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-eil~~ 381 (441)
.. ....++...+..+.+|+.+||+.||++||++. +++++
T Consensus 209 ~~--~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 209 LN--DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred Hc--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11 11223455666788999999999999999875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=322.05 Aligned_cols=261 Identities=22% Similarity=0.330 Sum_probs=207.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||.||+|+.. .+++.||||.+... .......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL---------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe---------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 47899999999999999999554 34789999976542 2344556888999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
+.+..++||||+++++|.+++.... ....++...++.++.|++.||.|||+ .+++|+||||+|||++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECcc
Confidence 9999999999999999999886422 22457889999999999999999996 99999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|++...... ........|++.|+|||.+.+..++.++||||||+++|+|++|..||....... .
T Consensus 151 g~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--------------~ 214 (267)
T cd08228 151 GLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--------------F 214 (267)
T ss_pred ccceeccch--hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH--------------H
Confidence 998754321 111223568899999999998889999999999999999999999985432110 0
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
.....+.........+...+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 215 SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0011111111111222345567889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=333.29 Aligned_cols=243 Identities=30% Similarity=0.408 Sum_probs=192.2
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHH-HHhcCCCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVK-FLGKFSHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~ 180 (441)
++||+|+||+||+|... .+++.||+|++..... .....+..|.. +++.++||||+++++++.+.+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK---------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 47999999999999543 4588999999865422 12234444544 56789999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
++||||+.+|+|..++.+.. .+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred EEEEcCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 99999999999999886543 58899999999999999999997 89999999999999999999999999998753
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
.. ........+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+
T Consensus 147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----------------~~~~~~i 208 (323)
T cd05575 147 IE--HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT----------------AEMYDNI 208 (323)
T ss_pred cc--CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH----------------HHHHHHH
Confidence 21 12223456799999999999999999999999999999999999999964321 1111122
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCCHH----HHHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSME----EVLET 381 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~----eil~~ 381 (441)
..... ..+...+..+.++|.+||+.||.+||++. +++++
T Consensus 209 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 209 LNKPL--RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HcCCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 22111 12334466788999999999999999874 66553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=331.06 Aligned_cols=243 Identities=28% Similarity=0.408 Sum_probs=194.0
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKF-SHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 180 (441)
++||+|+||.||+|... .+++.||+|.+.... ......+..|..++..+ +||||+++++++.+++.+
T Consensus 1 ~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 47999999999999544 358899999886542 12344566788888754 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
|+||||+.+|+|..++...+ .+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred EEEECCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 99999999999999886643 47889999999999999999997 99999999999999999999999999998742
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+
T Consensus 147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----------------~~~~~~ 208 (316)
T cd05620 147 VF--GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----------------ELFESI 208 (316)
T ss_pred cc--CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHH
Confidence 21 122234568999999999999999999999999999999999999999643210 011111
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSME-EVLET 381 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-eil~~ 381 (441)
... ...++...+..+.+|+.+||+.||++||++. ++++|
T Consensus 209 ~~~--~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 209 RVD--TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred HhC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 110 1123444566788999999999999999985 66544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=319.49 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=197.0
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
+.||+|+||.||+|... .+++.+|+|...... ......+.+|+++++.++||||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR---------ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEe---------cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 36999999999999553 347899999876543 34456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
|||+++++|.+++...+ ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 72 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 72 MELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred EeeccCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCcccccc
Confidence 99999999999986543 357899999999999999999997 89999999999999999999999999998753211
Q ss_pred CCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhhcC
Q 013519 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD 342 (441)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (441)
..........++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ........
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----------------~~~~~~~~ 210 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----------------QQTREAIE 210 (252)
T ss_pred cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----------------HHHHHHHH
Confidence 10000011123456999999999899999999999999999998 8888854211 00111111
Q ss_pred ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 343 PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 343 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
.......+..++..+.+|+.+||+.+|++||++.++++.|+
T Consensus 211 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 211 QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11122334455677889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=323.97 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=203.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++.+.||+|+||+||+|.+.... ......+++|.+.... ......+..|+.+++++.||||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEG-----DSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCC-----CceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 46888999999999999999764321 1112358888876543 234467788999999999999999999875 4
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++|+||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCCccc
Confidence 56789999999999999997643 358899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...............++..|+|||++.+..++.++|||||||++|||++ |..||....+. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----------------~ 219 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-----------------E 219 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----------------H
Confidence 86433222222233457788999999998899999999999999999998 99998653211 0
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
+.+++........+..++..+.+++.+||..+|++|||+.|+++.|..+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 220 VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred HHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11111111111223334556789999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=327.62 Aligned_cols=264 Identities=27% Similarity=0.398 Sum_probs=208.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|..... .....+..+|+|.+.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGL----SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecC----CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 35789999999999999999975322 123346789999887553 33456788999999999 7999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
..+..++||||+.+|+|.+++.+... ..+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999999865432 348899999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~---------------- 250 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD---------------- 250 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch----------------
Confidence 9975433222112223346788999999999999999999999999999998 99998643211
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
...............+...+..+.+++.+||..+|++||++.++++.|++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 251 SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 11111111111112233445678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=335.92 Aligned_cols=246 Identities=28% Similarity=0.379 Sum_probs=197.8
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLL 182 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 182 (441)
+.||+|+||.||+++.. ....+++.||+|++..... .....+..|+.+|++++||||+++++++.+++.+|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKI------TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEe------ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 57999999999998543 1223588999999875432 223456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCC
Q 013519 183 VYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPI 262 (441)
Q Consensus 183 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~ 262 (441)
||||+.+|+|.+++.+.. .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 76 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred EEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 999999999999986543 58899999999999999999997 8999999999999999999999999999975322
Q ss_pred CCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcC
Q 013519 263 DGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD 342 (441)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (441)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..
T Consensus 151 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----------------~~~~~~i~~ 212 (318)
T cd05582 151 H--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR----------------KETMTMILK 212 (318)
T ss_pred C--CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH----------------HHHHHHHHc
Confidence 1 1223456899999999999998999999999999999999999999965321 111111211
Q ss_pred ccccccCChhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 013519 343 PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-----MEEVLET 381 (441)
Q Consensus 343 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~eil~~ 381 (441)
.. ...+...+..+.+||.+||+.||++||+ +.+++.+
T Consensus 213 ~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 213 AK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred CC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 11 1234455677889999999999999999 5556543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=333.20 Aligned_cols=243 Identities=28% Similarity=0.430 Sum_probs=197.5
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKF-SHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 180 (441)
++||+|+||+||+|... .+++.||||.+.... ......+..|..++..+ +||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELK---------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 47999999999999554 347899999887542 23345667888999888 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
++||||+++|+|..++.+.+ .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred EEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 99999999999999886653 58899999999999999999997 99999999999999999999999999998742
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+
T Consensus 147 ~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~----------------~~~~~~i 208 (318)
T cd05570 147 ILG--GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE----------------DELFQSI 208 (318)
T ss_pred CcC--CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH----------------HHHHHHH
Confidence 221 1223446799999999999999999999999999999999999999964321 1111111
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM-----EEVLET 381 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~eil~~ 381 (441)
.... ..++...+..+.+||.+||..||++||++ .+++++
T Consensus 209 ~~~~--~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 209 LEDE--VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HcCC--CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1111 12344556778899999999999999999 888875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=324.03 Aligned_cols=273 Identities=29% Similarity=0.411 Sum_probs=207.0
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeC--
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWED-- 177 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 177 (441)
|.+.+.||+|+||+||++.... .....+..||+|.+..... .....+.+|+++|+.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDP-----ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEcc-----ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 3888999999999999876532 2234578899999876532 3456788899999999999999999987653
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..+++||||+++++|.+++... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcEEEeecccc
Confidence 4689999999999999998653 48999999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcce-EeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHV-TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+.......... .....++..|+|||++.+..++.++||||||+++|+|+||..||........... ........ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~-~~~ 232 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQGQMT-VVR 232 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh-cccccccc-hhh
Confidence 86432221111 1123456679999999888999999999999999999999999865332111111 00000000 111
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
+............+..++..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11222222222334556678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=323.52 Aligned_cols=256 Identities=30% Similarity=0.488 Sum_probs=210.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
..+|.+.+.||.|+||.||+|.... +..+++|.+..........+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 4578899999999999999996543 578999998877665567788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+++++|.+++.... ...+++..++.++.|++.||.|||+ .||+|+||||+|||++.++.+||+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccch
Confidence 99999999999999999997643 3468899999999999999999996 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
....... .......++..|+|||++....++.++||||||+++|+|++ |+.||..... ...
T Consensus 152 ~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----------------~~~ 213 (261)
T cd05148 152 RLIKEDV--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----------------HEV 213 (261)
T ss_pred hhcCCcc--ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----------------HHH
Confidence 7543211 11223345678999999998899999999999999999998 8899864321 111
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
+..+. .......+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 214 YDQIT-AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHH-hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11111 1222233456667788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=341.84 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=199.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||+||+|... .+++.||+|++.... ......+.+|+.++..++||||+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKK---------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 36888999999999999999543 458899999886432 233566788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+.+.+|+|||||++|+|.+++.+.+ .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999987643 58899999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCc---------------------------------ceEeeeccccccCcchhhhcCCCCccccchhHHHHH
Q 013519 256 LAKLGPIDGNS---------------------------------HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVL 302 (441)
Q Consensus 256 la~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il 302 (441)
+++........ ......+||+.|+|||++.+..++.++|||||||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 98743211000 001235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCC--hhhHHHHHHHHHHhcccCCCCCCC---HHH
Q 013519 303 LEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYP--IKGALLAGQIIIKCLEAEPKNRPS---MEE 377 (441)
Q Consensus 303 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps---~~e 377 (441)
|||++|+.||....+. .....+........+| ...+..+.+||.+|+ .||.+|++ +.+
T Consensus 227 yel~tG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 289 (360)
T cd05627 227 YEMLIGYPPFCSETPQ----------------ETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEE 289 (360)
T ss_pred eecccCCCCCCCCCHH----------------HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHH
Confidence 9999999999654321 1111111111111111 124567889999987 49999984 788
Q ss_pred HHHH
Q 013519 378 VLET 381 (441)
Q Consensus 378 il~~ 381 (441)
+++|
T Consensus 290 i~~h 293 (360)
T cd05627 290 IKSH 293 (360)
T ss_pred HhcC
Confidence 8876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=324.11 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=208.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|.+.+.||+|+||.||+|...... ....+..|++|.+.... ......+.+|+.+|..++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVV----KGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccC----CCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 357889999999999999999765421 12345789999987553 3445678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCC-------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGS-------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
....++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccChheEEEcCCCCE
Confidence 9999999999999999999975332 2246788999999999999999996 999999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 328 (441)
||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---------- 228 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---------- 228 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH----------
Confidence 9999999875432222122233456788999999998899999999999999999998 88888543211
Q ss_pred cccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
. ..+..........+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 229 ------~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 229 ------E-VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ------H-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1 11111111112234455777899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=349.24 Aligned_cols=265 Identities=22% Similarity=0.343 Sum_probs=195.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
..+|.+.+.||+|+||+||+|... .+++.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~---------~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICI---------DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEEC---------CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 457999999999999999999543 347899999886543 2335799999999999999999887532
Q ss_pred --------CeEEEEEeecCCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC-
Q 013519 178 --------RQFLLVYEYMQKGSLENHLFRK-GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY- 247 (441)
Q Consensus 178 --------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~- 247 (441)
..+++||||+++ +|.+++... .....+++..++.++.|++.||.|||+ .+|+||||||+|||++.++
T Consensus 132 ~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~~~~~ 208 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTH 208 (440)
T ss_pred ccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEcCCCC
Confidence 246799999975 677766532 223568899999999999999999997 9999999999999998664
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-e-
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-V- 324 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~- 324 (441)
.+||+|||+|+..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||........... .
T Consensus 209 ~vkL~DFGla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 209 TLKLCDFGSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred ceeeeccccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 6999999999854321 122345789999999998764 689999999999999999999999975432111000 0
Q ss_pred cccccccchhhh----hh-----hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 325 DFARPSLTDKRR----LK-----KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 325 ~~~~~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+....... .. .+....+...+|...+.++.+||.+||..||.+|||+.|+|++
T Consensus 286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000000000 00 0000111222344556789999999999999999999999976
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=321.18 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=203.6
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
|.+.+.||+|+||.||+|..... ...+..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQD------DGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecC------CCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 56788999999999999976432 1235789999887542 344567889999999999999999999886654
Q ss_pred e------EEEEEeecCCCCHHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 179 Q------FLLVYEYMQKGSLENHLFRKG---SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 179 ~------~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
. .++||||+++|+|..++.... ....+++..++.++.|++.||.|||. .+|+||||||+||++++++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECCCCeE
Confidence 3 799999999999999886532 22468899999999999999999996 899999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 328 (441)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---------- 222 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---------- 222 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----------
Confidence 9999999976432221111222345678999999988899999999999999999999 88888543210
Q ss_pred cccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
.....+... .....+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus 223 ------~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 223 ------EIYDYLRHG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ------HHHHHHHcC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111111 11223445667789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=312.34 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=206.5
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--------hHHHHHHHHHHHHHhcCC-CCCc
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--------IQGLREWQAEVKFLGKFS-HPNL 167 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~-hpni 167 (441)
.-+.|...+.||.|..++|.++ ..+.+++.+|+|++.... ....+.-.+|+.||+++. ||+|
T Consensus 15 fy~~y~pkeilgrgvss~vrRc---------i~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~I 85 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRC---------IHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYI 85 (411)
T ss_pred HHhhcChHHHhcccchhhhhhh---------hhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcE
Confidence 3467888899999999999988 455568889999864421 123445667999999996 9999
Q ss_pred cceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 168 VKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 168 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
+++.++|+.+..+|+|+|.|+.|.|+++|...- .+++++.++|+.|+..|+.|||. ++||||||||+|||++++.
T Consensus 86 I~l~D~yes~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILlddn~ 160 (411)
T KOG0599|consen 86 IDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILLDDNM 160 (411)
T ss_pred EEeeeeccCcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheeecccc
Confidence 999999999999999999999999999996553 58899999999999999999997 9999999999999999999
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCc
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT------GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~ 321 (441)
++||+|||+|+.... .......||||+|+|||.+.. .+|+..+|+|++|||+|.|+.|..||....
T Consensus 161 ~i~isDFGFa~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk----- 232 (411)
T KOG0599|consen 161 NIKISDFGFACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK----- 232 (411)
T ss_pred ceEEeccceeeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----
Confidence 999999999986543 344567899999999999854 468889999999999999999999995321
Q ss_pred eeecccccccchhhhhhhhcCccc--cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.+ -.+.-++...+ ......+.+...++||.+||+.||.+|.|++|+|.|-
T Consensus 233 --------Qm---lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 233 --------QM---LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred --------HH---HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 11 11222332222 2223345667789999999999999999999999863
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=341.55 Aligned_cols=264 Identities=25% Similarity=0.377 Sum_probs=203.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-C-----CCccceEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-H-----PNLVKLIG 172 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~~~~ 172 (441)
-+|.++++||+|+||.|.+|+.. .+++.||||+++.... ..++-..|+.||..|+ | -|+|++++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~---------~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDH---------KTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred EEEEEEEEecccccceeEEEEec---------CCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 38899999999999999999554 4589999999987643 3455667999999997 4 48999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC--CceE
Q 013519 173 YCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS--YNAK 250 (441)
Q Consensus 173 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~--~~~k 250 (441)
+|...+++|||+|++. -+|.++|..+. ...++...++.++.||+.||.+||. .+|||+||||+||||..- ..||
T Consensus 256 ~F~fr~HlciVfELL~-~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 256 YFYFRNHLCIVFELLS-TNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred ccccccceeeeehhhh-hhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcCcee
Confidence 9999999999999995 59999997654 4679999999999999999999996 999999999999999544 3699
Q ss_pred EecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee----cc
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV----DF 326 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~----~~ 326 (441)
|+|||.|+... ... .+.+.+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+....+..-.+ ..
T Consensus 332 VIDFGSSc~~~----q~v-ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~ 406 (586)
T KOG0667|consen 332 VIDFGSSCFES----QRV-YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL 406 (586)
T ss_pred EEecccccccC----Ccc-eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence 99999998632 222 2677889999999999999999999999999999999998888776533221100 00
Q ss_pred c----------------c----cccchhhh---------hhh--------hcCc----cccccCChhhHHHHHHHHHHhc
Q 013519 327 A----------------R----PSLTDKRR---------LKK--------IMDP----RLEEQYPIKGALLAGQIIIKCL 365 (441)
Q Consensus 327 ~----------------~----~~~~~~~~---------~~~--------~~~~----~~~~~~~~~~~~~~~~li~~~l 365 (441)
+ . +....... ..+ ...| .+....+......+.+++++||
T Consensus 407 Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L 486 (586)
T KOG0667|consen 407 PPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL 486 (586)
T ss_pred CCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence 0 0 00000000 000 0001 0111122234566789999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 013519 366 EAEPKNRPSMEEVLET 381 (441)
Q Consensus 366 ~~dp~~Rps~~eil~~ 381 (441)
+.||.+|+|..++|+|
T Consensus 487 ~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 487 EWDPAERITPAQALNH 502 (586)
T ss_pred ccCchhcCCHHHHhcC
Confidence 9999999999999997
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=325.86 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=197.8
Q ss_pred ecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 107 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
||+|+||+||++.. ..+++.||+|.+..... ...+.+..|+.+++.++||||+++++++..+..+++|
T Consensus 1 lg~G~~g~Vy~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQM---------RATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEE---------ccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 79999999999944 34588999999865432 2345667899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPI 262 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~ 262 (441)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++.....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 99999999998875432 23568999999999999999999997 8999999999999999999999999999975432
Q ss_pred CCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcC
Q 013519 263 DGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD 342 (441)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (441)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ........+..
T Consensus 150 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~------------~~~~~~~~~~~ 215 (280)
T cd05608 150 G--QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV------------ENKELKQRILN 215 (280)
T ss_pred C--CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch------------hHHHHHHhhcc
Confidence 1 122334579999999999999999999999999999999999999996532210 00011111111
Q ss_pred ccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 343 PRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 343 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
.. ..++...+..+.+++.+||+.||++|| ++++++++
T Consensus 216 ~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 216 DS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 11 123445667788999999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=339.70 Aligned_cols=258 Identities=26% Similarity=0.292 Sum_probs=202.3
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccc
Q 013519 93 DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVK 169 (441)
Q Consensus 93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~ 169 (441)
++....++|++.+.||+|+||.||+|... .+++.+|+|.+.... ......+.+|+.+++.++||||++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~ 107 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHK---------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEEC---------CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence 33445679999999999999999999544 457899999875422 223455778999999999999999
Q ss_pred eEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 170 LIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 170 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
+++++.+...+++|||||++|+|.+++... .++...+..++.|++.||.|||+ .+|+||||||+|||++.++.+
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~i 181 (371)
T cd05622 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHL 181 (371)
T ss_pred EEEEEEcCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCE
Confidence 999999999999999999999999988543 37888899999999999999997 999999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeec
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH----LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD 325 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~ 325 (441)
||+|||+++...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.....
T Consensus 182 kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------- 252 (371)
T cd05622 182 KLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------- 252 (371)
T ss_pred EEEeCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------
Confidence 999999997543211 11223567999999999997643 78899999999999999999999965321
Q ss_pred ccccccchhhhhhhhcCccccccC--ChhhHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 013519 326 FARPSLTDKRRLKKIMDPRLEEQY--PIKGALLAGQIIIKCLEAEPKN--RPSMEEVLETL 382 (441)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~--Rps~~eil~~L 382 (441)
......+........+ ....+..+.++|.+||..++.+ |+++.+++++.
T Consensus 253 --------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 253 --------VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred --------HHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111222221111111 2245677889999999844443 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=327.30 Aligned_cols=253 Identities=29% Similarity=0.390 Sum_probs=203.2
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.|++.++||+|+||+||++... .+++.||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc---------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 4788899999999999999543 3478999998865432 223456789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++.+++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999999998886543 2468999999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
++..... .......|++.|+|||++.+..++.++|||||||++|||++|..||....... ....
T Consensus 149 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-------------~~~~ 212 (285)
T cd05605 149 AVEIPEG---ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-------------KREE 212 (285)
T ss_pred ceecCCC---CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-------------HHHH
Confidence 9754221 12234578999999999999999999999999999999999999996532110 0011
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
+...+. .....++...+..+.+|+.+||..||++|| ++++++++
T Consensus 213 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 213 VERRVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111111 111223445667788999999999999999 88899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=331.24 Aligned_cols=243 Identities=29% Similarity=0.428 Sum_probs=193.3
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhc-CCCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGK-FSHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~ 180 (441)
+.||+|+||+||+|... .+++.||+|.+.... ......+..|..++.. ++||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELK---------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 37999999999999544 347899999886542 1223455667788876 4899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999999999999998654 357889999999999999999997 99999999999999999999999999998743
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
.. .........||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+
T Consensus 147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----------------~~~~~i 208 (316)
T cd05619 147 ML--GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE----------------ELFQSI 208 (316)
T ss_pred CC--CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----------------HHHHHH
Confidence 21 112234567999999999999999999999999999999999999999643210 001111
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSME-EVLET 381 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-eil~~ 381 (441)
... ...++...+..+.+|+.+||+.||++||++. +++++
T Consensus 209 ~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 209 RMD--NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred HhC--CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 100 1123344566788999999999999999997 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=320.64 Aligned_cols=256 Identities=23% Similarity=0.404 Sum_probs=204.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||.||+|.... +..|++|.+..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3578999999999999999996542 45799998776443 356788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++++|.+++.+.. ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccc
Confidence 99999999999999999987643 2457889999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+....... .......++..|+|||++....++.++|||||||++|+|++ |..||...... ..
T Consensus 151 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----------------~~ 213 (261)
T cd05072 151 RVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----------------DV 213 (261)
T ss_pred eecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----------------HH
Confidence 76432111 11122345678999999998899999999999999999998 99998643211 00
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
...+. .......+..++..+.+++.+||..+|++||+++++++.|+.+
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 214 MSALQ-RGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHH-cCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11111 0111112234556788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=324.29 Aligned_cols=255 Identities=35% Similarity=0.548 Sum_probs=198.2
Q ss_pred CCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 013519 103 PDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFL 181 (441)
Q Consensus 103 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 181 (441)
+.+.||.|.||.||+|.+.. .....+..|+||.++.. .....+.+.+|++++++++||||+++++++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~-----~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ-----KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES-----TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEc-----ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence 35689999999999998873 12334688999999664 3345788999999999999999999999999888899
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCC
Q 013519 182 LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP 261 (441)
Q Consensus 182 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~ 261 (441)
+|||||++|+|.++|... ....+++..++.|+.|++.||.|||+ .+++|+||+++|||++.++.+||+|||+++...
T Consensus 78 lv~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccccc-cccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc
Confidence 999999999999999876 22568999999999999999999997 899999999999999999999999999997642
Q ss_pred CCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
............+...|+|||.+....++.++||||||+++|||++ |+.||.... .......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~----------------~~~~~~~~ 218 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD----------------NEEIIEKL 218 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC----------------HHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------cccccccc
Confidence 2212222223456788999999999999999999999999999999 678875431 11111222
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
........+..++..+.+++.+||..+|++||++.++++.|
T Consensus 219 -~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 -KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 12222234555677788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=328.82 Aligned_cols=269 Identities=27% Similarity=0.359 Sum_probs=209.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|....... ........+|+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDK--EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCC--cccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 3579999999999999999997643210 111234679999987653 34456788899999999 7999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEE
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNIL 242 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 242 (441)
.....++||||+.+|+|.+++..... ...+++..++.++.|++.||.|||+ .|++||||||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nil 172 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVL 172 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHHheE
Confidence 99999999999999999999976431 1358899999999999999999996 89999999999999
Q ss_pred EcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCc
Q 013519 243 LDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEH 321 (441)
Q Consensus 243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~ 321 (441)
++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---- 248 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 248 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----
Confidence 99999999999999875432111111122234568999999999999999999999999999998 8888854211
Q ss_pred eeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
..+...+........+...+..+.+|+.+||..+|++||++.++++.|+.+..
T Consensus 249 -------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 249 -------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred -------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11111111111223344566778899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=323.06 Aligned_cols=263 Identities=27% Similarity=0.377 Sum_probs=205.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|.+.+.||+|+||.||+|.+.... ....+..|++|...... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRD----GDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCC----CCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 357889999999999999999765311 11146789999887543 3334568889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC---ce
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGS----AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY---NA 249 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~ 249 (441)
....++||||+++++|.+++..... ...+++..++.++.|++.||.|||+ .+++||||||+|||++.++ .+
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchheEEEeccCCCcce
Confidence 9999999999999999999976532 1358899999999999999999997 8999999999999998765 59
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 328 (441)
||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---------- 228 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---------- 228 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----------
Confidence 9999999985421111111112233567999999999999999999999999999997 99998643211
Q ss_pred cccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
.+............+..++..+.+++.+||+.+|++||++.+++++|+
T Consensus 229 -------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 -------EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111111122334555677889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=326.94 Aligned_cols=270 Identities=25% Similarity=0.359 Sum_probs=210.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
..+|.+.+.||+|+||.||+|....... .....+..||+|...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4578899999999999999996532110 111235689999887543 34457788999999999 7999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEE
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNIL 242 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 242 (441)
.....++||||+.+|+|.+++.+... ...+++..++.++.|++.||.|||+ .||+||||||+|||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nil 169 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS--QKCIHRDLAARNVL 169 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH--CCeeecccccceEE
Confidence 99999999999999999999976421 2357888999999999999999997 89999999999999
Q ss_pred EcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCc
Q 013519 243 LDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEH 321 (441)
Q Consensus 243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~ 321 (441)
++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---- 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----
Confidence 99999999999999976432222222223345678999999999899999999999999999998 7777754311
Q ss_pred eeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
.. +...+........+..++..+.+|+.+||..+|++||++.++++.|+.+...
T Consensus 246 ------------~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 ------------EE-LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ------------HH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 01 1111111111223445667789999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=319.85 Aligned_cols=250 Identities=27% Similarity=0.378 Sum_probs=211.0
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 179 (441)
-|.++.+||+|+||.||+| .++.+|+.+|||++..+. .++++..|+.||+++..|+||++|+.|.....
T Consensus 34 VFDi~~KLGEGSYGSV~KA---------IH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKA---------IHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHhcCCcchHHHHH---------HHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence 3566778999999999999 666679999999987664 46788999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
++||||||..|++.++++.+. ++|.+.++..++...++||.|||- ..-||||||..||||+.+|..||+|||.|..
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~--~~KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHD--LKKIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHH--HHHHHhhcccccEEEcccchhhhhhccccch
Confidence 999999999999999987654 689999999999999999999995 7789999999999999999999999999975
Q ss_pred CCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhh
Q 013519 260 GPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339 (441)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (441)
... .-....++.|||.|||||++..-.|+.++||||||++..||..|++||..-.+.....++--
T Consensus 179 LTD--TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT------------- 243 (502)
T KOG0574|consen 179 LTD--TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT------------- 243 (502)
T ss_pred hhh--hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC-------------
Confidence 332 22234568899999999999999999999999999999999999999976655332222110
Q ss_pred hcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+|...-.-|...+.++.++++.||-.+|++|.|+.++++|
T Consensus 244 --~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 244 --KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred --CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 0111112355566778899999999999999999999986
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=321.72 Aligned_cols=277 Identities=28% Similarity=0.393 Sum_probs=208.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEe--
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE-- 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-- 176 (441)
..|++.+.||+|+||.||+|.... .....+..|++|.+........+.+.+|+++++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 468889999999999999996532 2334578999999887776667789999999999999999999998754
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...+++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||. .||+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeEEECCCcc
Confidence 346899999999999999986543 358899999999999999999996 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceE-eeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSHVT-TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++........... ....++..|+|||++.+..++.++|||||||++|||++|..++.................... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 233 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI-VY 233 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccc-hH
Confidence 9865332221111 112234569999999988999999999999999999998776533211100000000000000 01
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
.+...+........+..++..+.+|+.+||..+|++|||+.++++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11122222222223345567789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=319.30 Aligned_cols=253 Identities=28% Similarity=0.416 Sum_probs=204.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-----hHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-----IQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
++|.+.+.||+|+||.||+|.. ..+++.+++|.+.... ......+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~---------~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYD---------VDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEEE---------cCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 5788999999999999999944 3347899999875432 1234568889999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+.++..+++|+||+++++|.+++...+ .+++..+..++.|++.||.|||. .+|+|+||+|+||+++.++.++|+|
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEee
Confidence 999999999999999999999987643 47889999999999999999996 9999999999999999999999999
Q ss_pred ccCCCCCCCCCCcc-eEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 254 FGLAKLGPIDGNSH-VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 254 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
||+++......... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------------- 212 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--------------- 212 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---------------
Confidence 99987532211111 11235678899999999999999999999999999999999999854311
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
................+...+..+.+++.+||..+|++||++.+++++
T Consensus 213 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 213 -MAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -HHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011111112222233455666778899999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=357.81 Aligned_cols=267 Identities=30% Similarity=0.431 Sum_probs=216.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+..+.+.||+|.||.||.|....... ......||||.+... +.+...+|.+|..+|+.++|||||+++|++.+.
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~----~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPG----SVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCC----CccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 455667899999999999998765421 111456999988776 456678899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcC----CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKG----SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
...+|++|||.||+|..+|+... ....+...+.+.++.|||+|+.||++ +++|||||...|+||+....|||+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~--~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES--KHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh--CCCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999998652 13568899999999999999999997 9999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccc
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
||+|+...............-...|||||.+..+.++.|+|||||||+|||++| |..||.....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--------------- 910 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--------------- 910 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch---------------
Confidence 999994322211111111233468999999999999999999999999999999 7788864322
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
.+.+..++... +-..|..|+..+.+|+..||+.+|++||++..|++.+..+...
T Consensus 911 -~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 911 -FEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred -HHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 12222233333 4566888999999999999999999999999999988776544
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=332.94 Aligned_cols=267 Identities=27% Similarity=0.375 Sum_probs=205.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||+||+|.+... ....+++.||||.+.... ......+.+|+.+|.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccC----CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 35799999999999999999975432 123457899999987643 33456788899999999 5899999999876
Q ss_pred eC-CeEEEEEeecCCCCHHHHHHhcCC-----------------------------------------------------
Q 013519 176 ED-RQFLLVYEYMQKGSLENHLFRKGS----------------------------------------------------- 201 (441)
Q Consensus 176 ~~-~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 201 (441)
.. ..+++|||||++|+|.+++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 568999999999999999865321
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEe
Q 013519 202 -----------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT 270 (441)
Q Consensus 202 -----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 270 (441)
...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 1236788889999999999999997 999999999999999999999999999997543222111122
Q ss_pred eeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccC
Q 013519 271 RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQY 349 (441)
Q Consensus 271 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (441)
...++..|+|||++.+..++.++||||||+++|+|++ |..||...... ..+...+........
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~ 303 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----------------EEFCRRLKEGTRMRA 303 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----------------HHHHHHHhccCCCCC
Confidence 2345678999999999999999999999999999997 88888543211 001111111111122
Q ss_pred ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 350 PIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 350 ~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
+...+..+.+++.+||+.+|++||++.+|+++|+.+-
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3334556889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=336.24 Aligned_cols=265 Identities=25% Similarity=0.292 Sum_probs=201.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
..+|.+.+.||+|+||.||+|..... ..+..|++|.+.... ...+|+.+|+.++||||+++++++...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~-------~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGD-------EQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCC-------ccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 45799999999999999999865322 236789999876542 345799999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..+++|||++. ++|.+++... ..+++..++.++.|++.||.|||. .||+||||||+|||++.++.++|+|||++
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccCccc
Confidence 99999999995 6888888433 468999999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-ee-----------c
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LV-----------D 325 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~-----------~ 325 (441)
+...............||+.|+|||++.+..++.++|||||||++|||++|+.||.......... +. .
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 76443322223345679999999999999999999999999999999999999996543321000 00 0
Q ss_pred ccccccch-hhhhhhhcCccccccC-------ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 326 FARPSLTD-KRRLKKIMDPRLEEQY-------PIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 326 ~~~~~~~~-~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+....... ...+.. +.......+ ....+..+.++|.+||..||++||++.|+|.+
T Consensus 313 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 313 FPQNGSTNLCKHFKQ-YAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cCCccchhHHHHHHh-hcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 000000 000011000 11234568899999999999999999999987
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=321.35 Aligned_cols=256 Identities=25% Similarity=0.347 Sum_probs=202.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
..+|++.+.||+|+||.||+|... .+++.||+|++..........+.+|+.++++++||||+++++++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNL---------HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEEC---------CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 357999999999999999999543 34789999998765544556788899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCccc
Confidence 9999999999999999988654 357899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+...... .......|++.|+|||.+. ...++.++|||||||++|||++|..||....+........ ...
T Consensus 154 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~--~~~---- 225 (267)
T cd06646 154 AKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS--KSN---- 225 (267)
T ss_pred eeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee--cCC----
Confidence 7542211 1123356889999999884 3457789999999999999999999986443221111100 000
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
...+.. ......+..+.+|+.+||..+|++||++++++++|
T Consensus 226 -----~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 -----FQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -----CCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000000 01123345688999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=324.22 Aligned_cols=266 Identities=24% Similarity=0.363 Sum_probs=206.0
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
..++|.+.+.||+|+||.||+|..... .....+..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEecc----CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 357899999999999999999965432 111235689999876543 233456788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC-------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS-------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
+....++||||+++|+|.+++.+... ...+.+..+..++.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCCChheEEEcCCCc
Confidence 99999999999999999999975321 2345677889999999999999997 99999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeeccc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 327 (441)
++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---------- 227 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------- 227 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----------
Confidence 99999999975322211111122345678999999999999999999999999999998 6778754211
Q ss_pred ccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 328 RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
......+..... ...+..++..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 228 ------~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 228 ------EQVLKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ------HHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111111111 122334456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.98 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=204.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||.||+|.... ++.||+|.+..... ..+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN----------TTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC----------CeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 3568899999999999999996532 46799999876543 245688899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+.+++|.+++.... ...+++..+..++.|++.||.|||. .+|+||||||+||+++.++.++|+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 150 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLA 150 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceE
Confidence 99999999999999999986643 3468899999999999999999996 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+....... ........+..|+|||++.+..++.++||||||+++|||++ |+.||...... ..
T Consensus 151 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----------------~~ 213 (261)
T cd05068 151 RVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----------------EV 213 (261)
T ss_pred EEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----------------HH
Confidence 76432111 11111223457999999999899999999999999999999 99998643210 01
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
...+ ........+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 214 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 214 LQQV-DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHH-HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 1111 11111122344566788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=331.23 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=198.3
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKF-SHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 180 (441)
++||+|+||+||+|... ..++.||+|++.... ......+.+|+.++.++ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK---------KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 37999999999999544 347899999987642 23455678899999888 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
|+||||+++|+|..++...+ .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 99999999999998886543 58999999999999999999997 89999999999999999999999999998742
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
.. ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ........+
T Consensus 147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~---------~~~~~~~~~ 215 (327)
T cd05617 147 LG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN---------TEDYLFQVI 215 (327)
T ss_pred cC--CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc---------cHHHHHHHH
Confidence 21 1222345689999999999999999999999999999999999999996432211100 000011111
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS------MEEVLET 381 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~eil~~ 381 (441)
... ...+|...+..+.+++.+||+.||++|++ +.++++|
T Consensus 216 ~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 216 LEK--PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HhC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 111 11245556677889999999999999998 4677765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=331.02 Aligned_cols=248 Identities=27% Similarity=0.391 Sum_probs=198.6
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCC-CCCccceEEEEE
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFS-HPNLVKLIGYCW 175 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~ 175 (441)
+|.+.++||+|+||+||+|.. ..+++.||+|++.... ....+.+..|..++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAER---------KGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 367788999999999999944 3458899999886542 223456778889998886 578888999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+.+.+|+||||+++|+|.+++.+.+ .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeccc
Confidence 9999999999999999999986643 48899999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..
T Consensus 147 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----------------~~ 208 (323)
T cd05615 147 MCKEHMVD--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----------------DE 208 (323)
T ss_pred cccccCCC--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----------------HH
Confidence 98753221 1223346799999999999999999999999999999999999999965321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM-----EEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~eil~~ 381 (441)
....+.... ..+|...+..+.+++.+||+.+|.+|++. .+++++
T Consensus 209 ~~~~i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 209 LFQSIMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred HHHHHHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 111222111 12345566778899999999999999974 555554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=321.01 Aligned_cols=262 Identities=23% Similarity=0.382 Sum_probs=203.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
..+|++.+.||+|+||+||+|.+.... ......||+|.+... .......+.+|+.++..+.||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDG-----ENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCC-----CccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 357888999999999999999765431 112346899988754 33345678899999999999999999998875
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCCCc
Confidence 45789999999999999986543 358899999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------------~ 218 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----------------R 218 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----------------H
Confidence 986533222111112234678999999999999999999999999999998 8888854321 1
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
.+...+........+..++..+.+++.+||+.||++||++.++++.|+.+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 219 EIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred HHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111111111111223345667889999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=323.96 Aligned_cols=260 Identities=24% Similarity=0.383 Sum_probs=203.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcC-CCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKF-SHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 176 (441)
++|.+.++||+|+||.||+|+..... ....+++|.+... .....+.+.+|+.++.++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-------LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-------CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 47889999999999999999664321 1235788877643 334456788999999999 69999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcC-------------CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKG-------------SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
...+++||||+++++|.+++.... ....+++..++.++.|++.||.|||+ .||+||||||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nill 152 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLV 152 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcceEEE
Confidence 999999999999999999996532 12358889999999999999999996 999999999999999
Q ss_pred cCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCce
Q 013519 244 DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHV 322 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~ 322 (441)
+.++.+||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---- 225 (297)
T cd05089 153 GENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---- 225 (297)
T ss_pred CCCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 99999999999998642110 01111223457999999998899999999999999999997 99998643211
Q ss_pred eecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
.....+ ........+..++..+.+|+.+||+.+|.+||++.++++.|+.+..
T Consensus 226 ------------~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 226 ------------ELYEKL-PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred ------------HHHHHH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011111 1112222344566778899999999999999999999999876653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=325.79 Aligned_cols=267 Identities=25% Similarity=0.301 Sum_probs=204.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++.+.||+|+||.||++... .++..+++|.+.... ......+.+|++++++++||||+++++++.++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHR---------PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEc---------CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 36889999999999999999543 347889999887552 33445688899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+ ..+++|+||||+|||++.++.+||+|||++
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-hCCEEECCCChHHEEEecCCcEEEccCCCc
Confidence 9999999999999999999765 358899999999999999999996 358999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc-----
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT----- 332 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 332 (441)
...... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||....................
T Consensus 148 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 148 GQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred cccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 753221 12345789999999999888899999999999999999999999864332111100000000000
Q ss_pred ---------------hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 333 ---------------DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 333 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.....................+..+.+|+.+||..+|++||++.+++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00001111110000001112456788999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=317.33 Aligned_cols=251 Identities=26% Similarity=0.421 Sum_probs=199.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++|.+.+.||+|+||.||++.+.. +..+|+|.+..... ....+.+|+.+|++++||||+++++++....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 458888999999999999996643 35789998765432 2356788999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCcc
Confidence 9999999999999999986543 258899999999999999999996 999999999999999999999999999987
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
...... ........++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ..+
T Consensus 149 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~----------------~~~ 211 (256)
T cd05114 149 YVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY----------------EVV 211 (256)
T ss_pred ccCCCc-eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH----------------HHH
Confidence 532111 111112235568999999998899999999999999999999 88998643211 111
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
..+.. ......+...+..+.+++.+||..+|++||++.++++.|
T Consensus 212 ~~i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 212 EMISR-GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHC-CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11111 111112333455688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=326.88 Aligned_cols=253 Identities=22% Similarity=0.273 Sum_probs=197.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||+||+++.. .+++.||+|++.... ......+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK---------NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 46899999999999999999543 347899999986421 223456788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+++.+|+||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEECCCCHHHEEECCCCCEEEEECC
Confidence 9999999999999999999997543 358899999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccc
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 330 (441)
++....... ........||+.|+|||++.. ..++.++|||||||++|+|++|+.||......
T Consensus 148 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------------ 214 (331)
T cd05597 148 SCLRLLADG-TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------------ 214 (331)
T ss_pred ceeecCCCC-CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------------
Confidence 986532221 112223569999999999873 45778999999999999999999999653211
Q ss_pred cchhhhhhhhcCccccccC---ChhhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 013519 331 LTDKRRLKKIMDPRLEEQY---PIKGALLAGQIIIKCLEAEPKN--RPSMEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~--Rps~~eil~~ 381 (441)
.....+......... ....+..+.+|+.+||..++++ |+++.+++++
T Consensus 215 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 215 ----ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ----HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111111111000011 1235667889999988764444 7899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=323.23 Aligned_cols=271 Identities=27% Similarity=0.396 Sum_probs=209.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccc-------cccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccc
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLA-------PTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVK 169 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~ 169 (441)
.++|++.+.||+|+||.||+|........ ......+..||+|.+.... ......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 35799999999999999999976542211 1233345679999987653 345667889999999999999999
Q ss_pred eEEEEEeCCeEEEEEeecCCCCHHHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcE
Q 013519 170 LIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS--------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNI 241 (441)
Q Consensus 170 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 241 (441)
+++++..+...++||||+.+++|.+++.+... ...+++..++.++.|++.||.|||+ .+|+||||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCccccccchhce
Confidence 99999999999999999999999999976431 2368899999999999999999997 8999999999999
Q ss_pred EEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCC
Q 013519 242 LLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT--GLRALDTNRPSG 319 (441)
Q Consensus 242 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--g~~p~~~~~~~~ 319 (441)
|++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ- 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence 999999999999999975432222222334456788999999998899999999999999999998 56676432210
Q ss_pred Cceeecccccccchhhhhhhhc---CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 320 EHVLVDFARPSLTDKRRLKKIM---DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
..+ ......+ ........+..++.++.+|+.+||+.||++||++.++++.|+
T Consensus 241 -~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 -QVI-----------ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -HHH-----------HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 000 0000110 001111123345567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=318.67 Aligned_cols=259 Identities=27% Similarity=0.373 Sum_probs=198.7
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC-
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED- 177 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 177 (441)
|.+.+.||+|+||.||+|.+.... ....+|+|.++.. .....+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccCC-------CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 356789999999999999765421 1236899987654 344567788999999999999999999987532
Q ss_pred -----CeEEEEEeecCCCCHHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 178 -----RQFLLVYEYMQKGSLENHLFRKG---SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 178 -----~~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
...++||||+.+|+|.+++.... ....+++..++.++.|++.||.|||. ++|+||||||+|||++.++.+
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~ 151 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNV 151 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCCCE
Confidence 24689999999999999875322 23458899999999999999999996 999999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 328 (441)
||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---------- 221 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---------- 221 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH----------
Confidence 9999999986432221111122345678999999999999999999999999999999 78888643211
Q ss_pred cccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
.....+... .....+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 222 ------~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 222 ------EIYDYLRQG-NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ------HHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001111111 11122334556688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=331.31 Aligned_cols=241 Identities=28% Similarity=0.358 Sum_probs=189.9
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHH-HHHhcCCCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEV-KFLGKFSHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~ 180 (441)
+.||+|+||+||+|+.. .+++.||+|++..... .....+..|. .+++.++||||+++++++...+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHK---------AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 37999999999999544 3478999998865321 1223334444 457889999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 72 YFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred EEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 99999999999999986543 47788889999999999999997 99999999999999999999999999999753
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
.. ........+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+..+
T Consensus 147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------~~~~~i 208 (325)
T cd05602 147 IE--HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----------------EMYDNI 208 (325)
T ss_pred cc--CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH----------------HHHHHH
Confidence 22 112234567999999999999999999999999999999999999999643211 111112
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil 379 (441)
..... ..+...+..+.+++.+||+.||.+||++.+.+
T Consensus 209 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 209 LNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HhCCc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 11111 22334566788999999999999999877443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=344.98 Aligned_cols=267 Identities=22% Similarity=0.329 Sum_probs=193.1
Q ss_pred HHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCC------CCcc
Q 013519 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSH------PNLV 168 (441)
Q Consensus 95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h------pniv 168 (441)
....++|++.++||+|+||+||+|+.. ..++.||||+++... .....+..|+.+++.++| ++|+
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~---------~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 194 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDR---------KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLM 194 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEc---------CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCccee
Confidence 344678999999999999999999543 347899999986432 223445667777776654 5588
Q ss_pred ceEEEEEeC-CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 169 KLIGYCWED-RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 169 ~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
.++++|... ..+++|||++ +++|.+++.+.+ .+++..+..++.|++.||.|||+ +.|||||||||+|||++.++
T Consensus 195 ~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~-~~gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 195 KIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHT-ELHLMHTDLKPENILMETSD 269 (467)
T ss_pred eeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCHHHEEEecCC
Confidence 888888764 5789999988 778988887653 58899999999999999999995 25999999999999998765
Q ss_pred ----------------ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCC
Q 013519 248 ----------------NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRA 311 (441)
Q Consensus 248 ----------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p 311 (441)
.+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.|
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 49999999886421 223456899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCceeeccccc----ccc------hhhhhhhhc---Cccccc-----------cCChhhHHHHHHHHHHhccc
Q 013519 312 LDTNRPSGEHVLVDFARP----SLT------DKRRLKKIM---DPRLEE-----------QYPIKGALLAGQIIIKCLEA 367 (441)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~----~~~------~~~~~~~~~---~~~~~~-----------~~~~~~~~~~~~li~~~l~~ 367 (441)
|................. .+. ....+.... .+.... .........+.+||.+||+.
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 976442111000000000 000 000000000 000000 00001234577999999999
Q ss_pred CCCCCCCHHHHHHH
Q 013519 368 EPKNRPSMEEVLET 381 (441)
Q Consensus 368 dp~~Rps~~eil~~ 381 (441)
||++|||++|+|+|
T Consensus 425 dP~~R~ta~e~L~H 438 (467)
T PTZ00284 425 DRQKRLNARQMTTH 438 (467)
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999986
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=317.93 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=207.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||.|+||.||+|... .++..++||.+... .......+.+|+.+++.+.||||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL---------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec---------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 46888899999999999999543 34789999977543 2334567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.++..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECcc
Confidence 9999999999999999999886422 23468899999999999999999996 99999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|++....... .......|+..|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 151 g~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------------- 214 (267)
T cd08229 151 GLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-------------- 214 (267)
T ss_pred hhhhccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--------------
Confidence 9987543221 122345688999999999998999999999999999999999999864321100
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
.....+.........+...+..+.+++.+||..+|++|||+.+|++.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 215 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 000011111111112234566788999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=340.15 Aligned_cols=252 Identities=25% Similarity=0.413 Sum_probs=209.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
+-|.|+..||.|+||+||+|..+ .++-..|-|++.....+.++.+.-||.||..+.||+||++++.|+.++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nk---------et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNK---------ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcc---------cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 45777888999999999999444 346667788888888888899999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.++|++|||.||-+..++...+ ..|.+..+..+++|++.||.|||+ ++|||||||..|||++-+|.++|+|||.+-
T Consensus 103 kLwiliEFC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEEEecCcEeeecccccc
Confidence 9999999999999999887766 579999999999999999999997 999999999999999999999999999985
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
.. ........++.|||+|||||++.. .+|+.++||||||++|.||..+.+|-....+
T Consensus 179 Kn--~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---------------- 240 (1187)
T KOG0579|consen 179 KN--KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---------------- 240 (1187)
T ss_pred cc--hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----------------
Confidence 32 122334567899999999999854 5899999999999999999999888754332
Q ss_pred hhhhhhhcCcccc-ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 334 KRRLKKIMDPRLE-EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 334 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+.+.++...... -.-|...+..+.+|+.+||..||..||++.++|+|
T Consensus 241 MRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 241 MRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2222233221111 12255566678899999999999999999999985
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=320.76 Aligned_cols=248 Identities=26% Similarity=0.362 Sum_probs=194.1
Q ss_pred ecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 107 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
||+|+||.||++... .+++.||+|.+..... .....+..|++++++++||||+++++++..+..+++|
T Consensus 1 lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVK---------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEc---------cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 799999999999543 3588999998864322 1223456699999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
|||+++++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++.....
T Consensus 72 ~e~~~g~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~- 147 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD- 147 (277)
T ss_pred EecCCCCCHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCC-
Confidence 999999999988865432 458889999999999999999997 9999999999999999999999999999875422
Q ss_pred CCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCc
Q 013519 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDP 343 (441)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (441)
........|++.|+|||++.+..++.++|||||||++|||++|..||....... ............
T Consensus 148 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~------------~~~~~~~~~~~~ 213 (277)
T cd05607 148 --GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV------------AKEELKRRTLED 213 (277)
T ss_pred --CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh------------hHHHHHHHhhcc
Confidence 122334578999999999999999999999999999999999999996432110 001111111111
Q ss_pred cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 344 RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 344 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
... ......+.++.+|+.+||+.||++||++.|+++.+
T Consensus 214 ~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 214 EVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 111 01123456788999999999999999997766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=322.36 Aligned_cols=270 Identities=24% Similarity=0.389 Sum_probs=203.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCcc-----ccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTL-----APTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIG 172 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~ 172 (441)
.+|++.+.||+|+||.||+|+...... ..........||+|.+.... ......+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 579999999999999999986643210 00111223468999987653 334567889999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhcCC---------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 173 YCWEDRQFLLVYEYMQKGSLENHLFRKGS---------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 173 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
++...+..++||||+.+++|.+++..... ...+++..++.++.|++.||.|||+ .+++|+||||+|||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nill 162 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFVHRDLATRNCLV 162 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCeeccccChhhEEE
Confidence 99999999999999999999999865321 1246788999999999999999997 999999999999999
Q ss_pred cCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCCCc
Q 013519 244 DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT--GLRALDTNRPSGEH 321 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--g~~p~~~~~~~~~~ 321 (441)
+.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~--~ 240 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--Q 240 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--H
Confidence 9999999999999975432221111223345678999999999999999999999999999998 55666532210 0
Q ss_pred eeecccccccchhhhhhhhcC---ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 322 VLVDFARPSLTDKRRLKKIMD---PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
.. ....+... .......+...+..+.+|+.+||+.+|++||++.+|++.|+
T Consensus 241 ~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VI-----------ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HH-----------HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 00 00001111 00111123345567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=324.48 Aligned_cols=269 Identities=24% Similarity=0.360 Sum_probs=208.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|....... ........+|+|.+.... ......+..|+.+++.+ .||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 3578899999999999999996532110 112235679999887543 34466788999999999 5999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEE
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNIL 242 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 242 (441)
+...+++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+ .||+||||||+|||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nil 166 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAARNVL 166 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeeccccceeEE
Confidence 99999999999999999999976421 2358899999999999999999996 99999999999999
Q ss_pred EcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCc
Q 013519 243 LDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEH 321 (441)
Q Consensus 243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~ 321 (441)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--- 243 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--- 243 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999975432111111122234567999999999899999999999999999999 88888543211
Q ss_pred eeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
. +............+..++..+.+++.+||..+|++||++.++++.|+.+..
T Consensus 244 -------------~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 244 -------------E-LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -------------H-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 0 111111111112344556678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=327.37 Aligned_cols=253 Identities=22% Similarity=0.266 Sum_probs=198.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||.||+++.. .+++.||+|.+.... ......+.+|+.++..++|+||+++++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK---------HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 47899999999999999999544 347899999886532 223445788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+.+..|+||||++||+|.+++.+.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEecc
Confidence 9999999999999999999997643 358889999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccc
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 330 (441)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 148 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------------ 214 (331)
T cd05624 148 SCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------------ 214 (331)
T ss_pred ceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------------
Confidence 9975432211 12233579999999999876 46788999999999999999999999643211
Q ss_pred cchhhhhhhhcCccccccCC---hhhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 013519 331 LTDKRRLKKIMDPRLEEQYP---IKGALLAGQIIIKCLEAEPKN--RPSMEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~--Rps~~eil~~ 381 (441)
.....+........++ ...+..+.+++.+||..++.+ |+++++++++
T Consensus 215 ----~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 215 ----ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1111222111111111 224567889999999876654 4689999886
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=322.24 Aligned_cols=252 Identities=29% Similarity=0.407 Sum_probs=201.7
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
|+..++||+|+||.||+|... .+++.||+|.+..... .....+.+|+.+++.++|+||+.+++.+.+.
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK 72 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEc---------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC
Confidence 677789999999999999544 4578999998765422 2234567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+.+++|.+++...+. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 73 DALCLVLTLMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred CEEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 999999999999999998865432 458899999999999999999997 99999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
....... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....... .....
T Consensus 150 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-------------~~~~~ 213 (285)
T cd05630 150 VHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-------------KREEV 213 (285)
T ss_pred eecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-------------hHHHH
Confidence 7532211 1223478999999999999999999999999999999999999996532110 00111
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-----MEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~eil~~ 381 (441)
..+.. .....++...+..+.+|+.+||+.||++||| +.+++++
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 214 ERLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred Hhhhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 11111 1111234445667889999999999999999 8999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=314.58 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=207.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||.||+|... .+++.|++|.+... .......+.+|+.++++++|+||+++++++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL---------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc---------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 57899999999999999999554 34789999987542 2233567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
+.+..++||||+++++|.+++.... ....+++..++.++.+++.||.|||+ .||+|+||||+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEecc
Confidence 9999999999999999999886532 23458899999999999999999997 99999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|++....... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||....... .
T Consensus 151 ~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~ 214 (267)
T cd08224 151 GLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--------------Y 214 (267)
T ss_pred ceeeeccCCC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH--------------H
Confidence 9987543211 11233568899999999999899999999999999999999999985432110 0
Q ss_pred hhhhhhcCccccccCCh-hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 335 RRLKKIMDPRLEEQYPI-KGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
.....+.. ......+. ..+..+.++|.+||..+|++||++.+|++.|+.+.
T Consensus 215 ~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 215 SLCKKIEK-CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHhhhhc-CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00001111 11111222 45567889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=316.11 Aligned_cols=252 Identities=29% Similarity=0.410 Sum_probs=200.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++|.+.+.||+|+||+||+|.+.. +..+|+|.+..... ....+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 468888999999999999996543 34699998875433 2356889999999999999999999999888
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.+++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||+++
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~~ 148 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSR 148 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCccce
Confidence 9999999999999999987643 258899999999999999999997 899999999999999999999999999987
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
...... ........++..|+|||++.+..++.++|||||||++|+|++ |..||...... ...
T Consensus 149 ~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----------------~~~ 211 (256)
T cd05113 149 YVLDDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----------------ETV 211 (256)
T ss_pred ecCCCc-eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----------------HHH
Confidence 542211 111112235567999999998889999999999999999999 99898543211 011
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
..+... .....+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 212 ~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 212 EKVSQG-LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHhcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111111 111223334567889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=318.89 Aligned_cols=275 Identities=28% Similarity=0.424 Sum_probs=206.9
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC-
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED- 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 177 (441)
-|.+.+.||+|+||.||+|.+.. ....++..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhceecCCCCceeEEEEEEcc-----CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 46788999999999999997642 233457899999987653 34456789999999999999999999998875
Q ss_pred -CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 178 -RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 178 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.++|+|||+
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCEEECCCcc
Confidence 56899999999999999986543 358899999999999999999996 9999999999999999999999999999
Q ss_pred CCCCCCCCCc-ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNS-HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++........ .......++..|+|||++.+..++.++|||||||++|+|+++..|+............. .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 234 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGP-THGQMTVTR 234 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccc-ccccccHHH
Confidence 9864322211 11223557778999999998899999999999999999999876643211100000000 000000001
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
.. ..+........+..++..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 235 ~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LV-RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH-HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 11111111222345667899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=314.85 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=210.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
-++|..+++||+|.||+|-++ +.+.+++.||+|+++++.. ..+..-..|-++|+..+||.+..+...|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~---------rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILC---------REKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred cchhhHHHHhcCCccceEEEE---------eecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 467889999999999999999 6677899999999987643 2334455688999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
+.++.+|+||||..||.|+-+|.+. +.+++...+.+..+|+.||.|||+ ++||+||||.+|+|+|.+|++||+||
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEeeec
Confidence 9999999999999999999988764 458888999999999999999998 99999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+++.... ....+.++||||.|+|||++....|+.++|+|.+||++|||++|+.||.....
T Consensus 313 GLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh----------------- 373 (516)
T KOG0690|consen 313 GLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH----------------- 373 (516)
T ss_pred ccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-----------------
Confidence 99986433 33456789999999999999999999999999999999999999999965422
Q ss_pred hhhhh-hcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 335 RRLKK-IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 335 ~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
+.+.. ++-.. -.+|...+++++.|+..+|..||.+|. .+.||.++
T Consensus 374 ~kLFeLIl~ed--~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 374 EKLFELILMED--LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hHHHHHHHhhh--ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 11111 11111 246778888999999999999999996 46666654
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=324.34 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=202.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcC-CCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKF-SHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 176 (441)
++|.+.+.||+|+||.||+|.+.... ....+++|.+... .......+.+|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCC-------ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 57888999999999999999764321 1235677776643 334456788999999999 79999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
.+.+++||||+++++|.+++.+.+. ...+++..++.++.|++.||.|||+ .||+||||||+|||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Nili 157 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILV 157 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEe
Confidence 9999999999999999999975431 2357899999999999999999996 999999999999999
Q ss_pred cCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCce
Q 013519 244 DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHV 322 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~ 322 (441)
+.++.+||+|||+++.... ........++..|+|||++.+..++.++|||||||++|||+| |..||......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 230 (303)
T cd05088 158 GENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---- 230 (303)
T ss_pred cCCCcEEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH----
Confidence 9999999999999863211 111111234567999999988889999999999999999998 99998543211
Q ss_pred eecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
... ..+........+...+..+.+|+.+||+.+|++||++.+++..|+.+.
T Consensus 231 ------------~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 231 ------------ELY-EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred ------------HHH-HHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000 111111111223344567889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=319.97 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=199.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++.++||+|+||.||+|.. ..+++.||+|.+... .......+.+|+.++.+++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEE---------cCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 3678889999999999999944 345789999988654 334456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred CEEEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 9999999999999986542 36788899999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
..... .......||..|+|||++.+..++.++|||||||++|+|++|+.||.......... ......
T Consensus 143 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~---------~~~~~~ 209 (279)
T cd06619 143 TQLVN----SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL---------MPLQLL 209 (279)
T ss_pred eeccc----ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc---------chHHHH
Confidence 75321 12234578999999999999999999999999999999999999996532211110 000111
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+.+...........+..+.+++.+||+.+|++||++.+++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 210 QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111111111122345568899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=326.77 Aligned_cols=238 Identities=29% Similarity=0.390 Sum_probs=188.8
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHH-HHHhcCCCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEV-KFLGKFSHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~ 180 (441)
++||+|+||.||+|+.. .+++.||+|++..... .....+..|. .+++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK---------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 37999999999999543 4478999998865422 2233444554 467889999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
++||||+++|+|...+.+. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 72 YFVLDYVNGGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred EEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9999999999999888654 347888999999999999999997 99999999999999999999999999998753
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
... .......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+
T Consensus 147 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------~~~~~~i 208 (321)
T cd05603 147 VEP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV----------------SQMYDNI 208 (321)
T ss_pred CCC--CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH----------------HHHHHHH
Confidence 211 1223456799999999999999999999999999999999999999965321 0111112
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCCHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSME 376 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 376 (441)
.... ..++...+..+.+++.+||+.||.+||++.
T Consensus 209 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 209 LHKP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred hcCC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1111 123444566788999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=313.74 Aligned_cols=249 Identities=26% Similarity=0.369 Sum_probs=198.3
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
.||+|+||.||+|.+... .++..+|+|++.... ....+.+.+|+.+++.+.||||+++++++. ....++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK-------KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEecC-------CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 689999999999976432 246789999886543 334567889999999999999999999875 4567899
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
|||+++++|.+++.... .+++..+..++.|++.||.|||. ++|+||||||.|||++.++.+||+|||+++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 74 MELAELGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 99999999999986543 58899999999999999999996 99999999999999999999999999999764322
Q ss_pred CCcce-EeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhhc
Q 013519 264 GNSHV-TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341 (441)
Q Consensus 264 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (441)
..... .....++..|+|||.+....++.++|||||||++|||++ |..||...... .+...+
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~~~~i 211 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----------------EVTQMI 211 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHH
Confidence 21111 112234578999999988889999999999999999998 99998643211 111111
Q ss_pred CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 342 DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
........+..++..+.++|.+||+.||++||++.+|.+.|+.
T Consensus 212 ~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 212 ESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 2222223455667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=313.96 Aligned_cols=251 Identities=28% Similarity=0.401 Sum_probs=204.8
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|.+.+.||+|+||.||+|... .+++.|++|.+... .......+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK---------ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc---------CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 4778889999999999999554 34789999987643 334566788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||. .+|+|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEcccccc
Confidence 99999999999999999987642 3568899999999999999999996 89999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
+..... ........|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ....
T Consensus 149 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~~~ 210 (256)
T cd08529 149 KLLSDN--TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----------------GALI 210 (256)
T ss_pred eeccCc--cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----------------HHHH
Confidence 754322 1222345788999999999999999999999999999999999999964321 0111
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+... .....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 211 ~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 211 LKIIRG-VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHcC-CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111111 1112233456678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=334.83 Aligned_cols=245 Identities=27% Similarity=0.420 Sum_probs=208.0
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYE 185 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 185 (441)
+||+|.||+||-| ++..+...+|||.+...+....+.+..||.+.++|+|.|||+++|.+.+++.+-|.||
T Consensus 582 VLGKGTYG~VYA~---------RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAA---------RDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEee---------ccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 7999999999999 4445578899999988877778889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCC--CHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE-cCCCceEEecccCCCCCCC
Q 013519 186 YMQKGSLENHLFRKGSAEPL--PWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL-DGSYNAKLSDFGLAKLGPI 262 (441)
Q Consensus 186 ~~~~g~L~~~l~~~~~~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill-~~~~~~kl~DFGla~~~~~ 262 (441)
-++||+|.++|...- .++ .+.++-.+..||++||.|||. +.|||||||-+|||+ +-.|.+||+|||-++...
T Consensus 653 qVPGGSLSsLLrskW--GPlKDNEstm~fYtkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA- 727 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA- 727 (1226)
T ss_pred cCCCCcHHHHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccchhhc-
Confidence 999999999997654 345 778899999999999999995 999999999999999 467899999999998642
Q ss_pred CCCcceEeeeccccccCcchhhhcC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 263 DGNSHVTTRIMGTYGYAAPEYVATG--HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
+-...+.++.||..|||||++..+ +|+.++|||||||++.||.||++||........ .+.++
T Consensus 728 -ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------------AMFkV 791 (1226)
T KOG4279|consen 728 -GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------------AMFKV 791 (1226)
T ss_pred -cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------------hhhhh
Confidence 344567778999999999999765 688999999999999999999999965432111 11111
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~ 380 (441)
---.....+|...+.+++.+|.+|+.+||.+||++.++|.
T Consensus 792 GmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 792 GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1122334568888999999999999999999999999996
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=325.41 Aligned_cols=253 Identities=22% Similarity=0.265 Sum_probs=198.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||.||++.... +++.+|+|.+.... ......+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 468899999999999999995543 47889999886432 122345788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+...+++||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999997643 358899999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccc
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 330 (441)
++...... ........+||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 148 ~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------------- 213 (332)
T cd05623 148 SCLKLMED-GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------------- 213 (332)
T ss_pred hheecccC-CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------------
Confidence 98653221 112223457999999999986 34678999999999999999999999965321
Q ss_pred cchhhhhhhhcCccccccCC---hhhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 013519 331 LTDKRRLKKIMDPRLEEQYP---IKGALLAGQIIIKCLEAEPKN--RPSMEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~--Rps~~eil~~ 381 (441)
......+........+| ...+..+.+|+.+||..++++ |+++.+++++
T Consensus 214 ---~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 214 ---VETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---HHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111222111111111 235677889999999765554 6899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=330.31 Aligned_cols=239 Identities=31% Similarity=0.398 Sum_probs=189.4
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHH-HHhcCCCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVK-FLGKFSHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~ 180 (441)
++||+|+||+||+|.. ..+++.||+|++.... ......+..|.. +++.++||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKR---------KLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 4699999999999954 3458899999886542 122334455554 57789999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
++||||+.+|+|..++.+. ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 72 YFVLDFVNGGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred EEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9999999999999888654 358899999999999999999997 99999999999999999999999999998743
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
.. ........+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+
T Consensus 147 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----------------~~~~~~ 208 (325)
T cd05604 147 IA--QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----------------EMYDNI 208 (325)
T ss_pred CC--CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH----------------HHHHHH
Confidence 21 122234567999999999999999999999999999999999999999643211 111112
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHH
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEE 377 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 377 (441)
..... ..+...+..+.+++.+||+.+|.+||++.+
T Consensus 209 ~~~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 209 LHKPL--VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HcCCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 21111 122335566889999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=314.16 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=203.4
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
+|.+.+.||+|+||.||++... .+++.+++|.+... .....+.+.+|+.+++.++||||+++++.+.+.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHV---------NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEc---------CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 4788899999999999999443 45789999987543 3344567888999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.+++||||+++++|.+++.... ...++...++.++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||+++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCcce
Confidence 9999999999999999886532 2457899999999999999999996 999999999999999999999999999997
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
..... ........|++.|+|||++.+..++.++||||||+++|+|++|..||...... ....
T Consensus 149 ~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----------------~~~~ 210 (255)
T cd08219 149 LLTSP--GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK----------------NLIL 210 (255)
T ss_pred eeccc--ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH----------------HHHH
Confidence 54321 12223467899999999999888999999999999999999999999643210 1111
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+... .....+...+..+.+|+.+||+.||++||++.+++..
T Consensus 211 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 211 KVCQG-SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhcC-CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11111 1112334455678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.31 Aligned_cols=266 Identities=23% Similarity=0.302 Sum_probs=197.3
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
..++|.+.+.||+|+||.||+|.. ..+++.||+|++... .......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFD---------TVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF 89 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEE---------cCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 457899999999999999999944 345889999998643 233456678899999999999999999998
Q ss_pred EeCC------eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 175 WEDR------QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 175 ~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
.... .+|+||||+.+ +|...+. ..++...+..++.|++.||.|||+ .||+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~~~~~~ 161 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT 161 (359)
T ss_pred ccCCCccccceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCC
Confidence 6543 57999999976 5666553 237788999999999999999997 89999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce--eecc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--LVDF 326 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~~~~ 326 (441)
+||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ....
T Consensus 162 ~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 238 (359)
T cd07876 162 LKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 238 (359)
T ss_pred EEEecCCCcccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999975321 122234578999999999999999999999999999999999999997543211000 0000
Q ss_pred cccccchhh----hhhhhcC--ccc-----c-----------ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 327 ARPSLTDKR----RLKKIMD--PRL-----E-----------EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 327 ~~~~~~~~~----~~~~~~~--~~~-----~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
..+...... ....... +.. . .......+..+.+||.+||..||++|||+.|+|++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 239 GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred CCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000000000 0000000 000 0 001112345688999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=319.65 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=205.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||.||+|..... .....+..||+|.+.... ......+.+|+.+++++.||||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 35789999999999999999975421 112246789999887653 3445678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcC-------------------CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKG-------------------SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFK 237 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlk 237 (441)
....++||||+++|+|.+++.... ....+++..++.++.|++.||.|||. .+++|||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~H~dl~ 157 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLA 157 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCeeccccc
Confidence 999999999999999999997432 12347888999999999999999997 899999999
Q ss_pred CCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 013519 238 ASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNR 316 (441)
Q Consensus 238 p~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~ 316 (441)
|+|||++.++.++|+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999875322211111122334667999999999999999999999999999998 877875321
Q ss_pred CCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 317 PSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
. ......+.+... ...+...+..+.+|+.+||+.+|++||++.|+++.|++
T Consensus 238 ~----------------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 H----------------EEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H----------------HHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 111111111111 12234456778899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=334.41 Aligned_cols=266 Identities=26% Similarity=0.374 Sum_probs=198.8
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|.+.+.||+|+||.||+|.. ..+++.||||++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTD---------PRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEE---------CCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 478889999999999999944 345889999988653 233456788999999999999999999999877
Q ss_pred C-----eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEe
Q 013519 178 R-----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252 (441)
Q Consensus 178 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 252 (441)
. .+|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili~~~~~~kL~ 145 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKIC 145 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHHEEECCCCCEEec
Confidence 6 7899999996 5788877543 358899999999999999999997 899999999999999999999999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-c-cccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-D-FARP 329 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-~-~~~~ 329 (441)
|||+++...... ........+|+.|+|||++.+. .++.++|||||||++|||++|+.||....+......+ . ...+
T Consensus 146 Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~ 224 (372)
T cd07853 146 DFGLARVEEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224 (372)
T ss_pred cccceeecccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999997543221 1122334678999999999874 4789999999999999999999999765432110000 0 0000
Q ss_pred ccchhh----hhhh-hcCcc-----ccc--cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKR----RLKK-IMDPR-----LEE--QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~----~~~~-~~~~~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...... .... +.... ... ......+..+.+||.+||+.||++|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 0000 00000 000 1122335678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=317.82 Aligned_cols=265 Identities=23% Similarity=0.338 Sum_probs=208.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|.+.++||+|+||.||+|.+.... ...+..|++|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~-----~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEK-----PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCC-----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 467889999999999999999765421 123578999987654 34456678899999999999999999998776
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 177 -DRQFLLVYEYMQKGSLENHLFRKGSA-----EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 177 -~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
+...+++++|+.+++|.+++...... ..+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+|
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCCCcEE
Confidence 56789999999999999998764332 468899999999999999999996 9999999999999999999999
Q ss_pred EecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeeccccc
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 329 (441)
|+|||+++...............++..|+|||++.+..++.++|||||||++||+++ |+.||....+.
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------- 226 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF----------- 226 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-----------
Confidence 999999985432221111122345678999999999899999999999999999999 99998653221
Q ss_pred ccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
.+...+........+..++..+.+++.+||..+|++|||+.++++.|+.+.
T Consensus 227 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 227 ------EMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 011111111111123345567889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=313.25 Aligned_cols=254 Identities=31% Similarity=0.487 Sum_probs=206.0
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-HHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-GLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
+.||+|+||.||+|...... ..+..+++|.+...... ..+.+.+|+.++..++|+||+++++++.....+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 46999999999999765321 23678999998876543 367888999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCC------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 184 YEYMQKGSLENHLFRKGS------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
|||+++++|.+++..... ...+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEEcccccc
Confidence 999999999999976521 2568999999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
................++..|+|||.+....++.++||||||+++|+|++ |..||...... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~ 216 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE----------------EV 216 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH----------------HH
Confidence 86543322222334567889999999988899999999999999999999 58898654210 01
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
...+.. ......+..++..+.+++.+||..+|++|||+.+++++|+
T Consensus 217 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 217 LEYLRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111111 1122334555677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=319.68 Aligned_cols=270 Identities=23% Similarity=0.368 Sum_probs=204.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCcccc-------ccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccce
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAP-------TKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKL 170 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~-------~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~ 170 (441)
++|++.+.||+|+||.||++......... .....+..+|+|.+.... ......+.+|+.+|+.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998654311000 112234579999987653 3445678899999999999999999
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEE
Q 013519 171 IGYCWEDRQFLLVYEYMQKGSLENHLFRKGS--------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNIL 242 (441)
Q Consensus 171 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 242 (441)
++++......++||||+++++|.+++..... ...+++..++.++.|++.||.|||+ .+|+|+||||+|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dlkp~Nil 162 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFVHRDLATRNCL 162 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCeecccCChheEE
Confidence 9999999999999999999999999876432 1246788999999999999999997 89999999999999
Q ss_pred EcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCCC
Q 013519 243 LDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT--GLRALDTNRPSGE 320 (441)
Q Consensus 243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--g~~p~~~~~~~~~ 320 (441)
++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~- 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ- 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH-
Confidence 99999999999999975432221111222344678999999988899999999999999999998 667775432110
Q ss_pred ceeecccccccchhhhhhhhcCc---cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 321 HVLVDFARPSLTDKRRLKKIMDP---RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
.+ ......+.. ......+..++..+.+|+.+||+.||++||++.+|++.|+
T Consensus 242 -~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 -VI-----------ENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred -HH-----------HHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00 000000000 0011123345577889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=313.26 Aligned_cols=251 Identities=29% Similarity=0.462 Sum_probs=205.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||.|+||.||+|... ++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 357889999999999999999543 67899999877654 467788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+++++|.+++..... ..+++..++.++.|++.||.|||. .+++|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEcccccc
Confidence 999999999999999999876432 358899999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+..... .....++..|+|||++....++.++||||||+++|+|++ |..||...... .
T Consensus 150 ~~~~~~-----~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~ 207 (256)
T cd05039 150 KEASQG-----QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------D 207 (256)
T ss_pred cccccc-----cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----------------H
Confidence 864211 112334567999999988889999999999999999997 98888543211 1
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
+............+...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 208 VVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1111111112223445567788999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.36 Aligned_cols=267 Identities=24% Similarity=0.364 Sum_probs=199.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|.+.+.||+|+||.||+|+.. .++..||+|.+..... .....+.+|+.++++++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSK---------LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEEec---------CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 57899999999999999999543 3478899998865432 2233567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++ +|.+++...+ ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 77 KSLTLVFEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred CeEEEEEeCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECccccc
Confidence 999999999975 8888876543 357889999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-c-ccc------
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-D-FAR------ 328 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-~-~~~------ 328 (441)
+...... .......+|+.|+|||++.+ ..++.++|||||||++|+|+||+.||......+..... . +..
T Consensus 152 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 152 RAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229 (309)
T ss_pred eecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 7532211 12233467899999998865 45789999999999999999999999754322110000 0 000
Q ss_pred cccchhhhhhhhcCccccc----cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 PSLTDKRRLKKIMDPRLEE----QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+.+...........+.... ......+.++.+||.+||+.||.+|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000000000000000 0112345678899999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=315.16 Aligned_cols=251 Identities=28% Similarity=0.405 Sum_probs=199.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG----------KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC----------CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 358888999999999999996542 45789998765432 2346778999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHhhEEECCCCcEEECCcccce
Confidence 9999999999999999997644 258899999999999999999997 899999999999999999999999999997
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...
T Consensus 149 ~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~~ 211 (256)
T cd05059 149 YVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----------------EVV 211 (256)
T ss_pred eccccc-ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----------------HHH
Confidence 532111 111111223457999999999999999999999999999999 78888643211 001
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.. .........+..++..+.+++.+||..+|++||++.++++.|
T Consensus 212 ~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 212 ES-VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HH-HHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11 111112233445677799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=329.42 Aligned_cols=262 Identities=23% Similarity=0.346 Sum_probs=194.1
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
...+|++.+.||+|+||.||+|... .++..||+|...... ...|+.++++++||||+++++++..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKP---------GQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEEC---------CCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEe
Confidence 3457999999999999999999554 347789999865432 2458999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
....++|||++. ++|.+++.... ..+++..++.++.|++.||.|||. .+|+||||||+|||++.++.+||+|||+
T Consensus 129 ~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~ 203 (357)
T PHA03209 129 GAITCMVLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGA 203 (357)
T ss_pred CCeeEEEEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEecCcc
Confidence 999999999995 58888886543 468999999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC-Ccee-------ec---
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSG-EHVL-------VD--- 325 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~-~~~~-------~~--- 325 (441)
++.... ........||+.|+|||++.+..++.++|||||||++|||+++..++....+.. .... ..
T Consensus 204 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~ 280 (357)
T PHA03209 204 AQFPVV---APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280 (357)
T ss_pred cccccc---CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence 974221 122334679999999999999999999999999999999999765553322211 0000 00
Q ss_pred ---ccccccc---hhhhhhhhcCc--cccc---cC----ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 326 ---FARPSLT---DKRRLKKIMDP--RLEE---QY----PIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 326 ---~~~~~~~---~~~~~~~~~~~--~~~~---~~----~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+. .......++.. .... .+ ....+..+.+||.+||+.||++|||+.|+|+|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000000 00000000000 0000 00 01234456689999999999999999999986
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=315.50 Aligned_cols=260 Identities=23% Similarity=0.427 Sum_probs=204.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+|++.+.||+|+||.||+|.+.... ..+..|+||.+... .......+..|+.+++.++||||+++++++.++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPG------KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCC------CCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 45788899999999999999765321 12357999998765 344567889999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .|++|+||||+|||++.++.+||+|||++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~dfg~~ 153 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLS 153 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECCCccc
Confidence 99999999999999999987543 358899999999999999999996 99999999999999999999999999998
Q ss_pred CCCCCCCCcceEee-ec--cccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccch
Q 013519 258 KLGPIDGNSHVTTR-IM--GTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 258 ~~~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
.............. .. .+..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------------- 218 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------------- 218 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---------------
Confidence 75432211111111 11 2357999999999999999999999999999886 99998543211
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
.....+ ........+..++..+.+++.+||..+|++||++.+++..|+.+
T Consensus 219 -~~~~~i-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 219 -DVINAI-EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -HHHHHH-HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 001111 11111122344566788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=312.21 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=202.5
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
++||+|+||.||+|.+... ......||||.+..... ...+.+.+|+.++++++||||+++++++.+ ..+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTS------GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecC------CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 3689999999999977542 11234799999988766 567789999999999999999999999988 889999
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
|||+++++|.+++..... ..+++..++.++.|++.||.|||. .+++|+||||+|||++.++.+||+|||+++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 74 TELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh--CCccccccCcccEEEecCCEEEecccccccccccc
Confidence 999999999999976543 468999999999999999999997 89999999999999999999999999999865332
Q ss_pred CCc-ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhhc
Q 013519 264 GNS-HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341 (441)
Q Consensus 264 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (441)
... .......++..|+|||++.+..++.++|||||||++|+|++ |+.||...... .....+.
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----------------~~~~~~~ 214 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS----------------QILKKID 214 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHH
Confidence 211 11123457788999999999999999999999999999999 99998543211 1111111
Q ss_pred CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 342 DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
........+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 215 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 215 KEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred hcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111111223345567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=321.08 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=203.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|.+.+.||+|+||.||+|.. ...++.|++|.+..........+.+|+.+++.+.||||+++++.+....
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~---------~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMD---------VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEE---------CCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 5789999999999999999954 3347899999887765555677889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||+++++|.+++... .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.++|+|||++.
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred EEEEeecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECccccch
Confidence 999999999999999988542 47889999999999999999997 899999999999999999999999999987
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
...... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+..... .
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~---------------~ 227 (296)
T cd06654 165 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---------------L 227 (296)
T ss_pred hccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH---------------H
Confidence 532211 11223468899999999998889999999999999999999999996543211100 0
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...........+...+..+.+++.+||..+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0000100111233445668899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=313.09 Aligned_cols=249 Identities=28% Similarity=0.430 Sum_probs=200.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEE-eC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCW-ED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~ 177 (441)
.+|.+.+.||+|+||.||++... +..+++|....... .+.+.+|+.++++++|+||+++++++. .+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 47888999999999999998543 66789998865532 456889999999999999999999765 45
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCccc
Confidence 678999999999999999876442 357899999999999999999997 89999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+..... .....++..|+|||++.+..++.++|||||||++|+|++ |+.||..... ..
T Consensus 150 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----------------~~ 207 (256)
T cd05082 150 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KD 207 (256)
T ss_pred eecccc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------------HH
Confidence 753221 122344567999999998899999999999999999998 8888854211 00
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
+...+........+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 208 VVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1111111112223445567788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.80 Aligned_cols=257 Identities=21% Similarity=0.279 Sum_probs=198.9
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
....+|++++.||+|+||+||+|+.. .++..+|+|.+... .......+..|+.+|+.|+|||||+++++
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk---------~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHK---------RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEEC---------CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 34578999999999999999999543 45789999987654 23345678899999999999999999998
Q ss_pred EEe--CCeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCC-----CCeeecCCCCCcEEEcC
Q 013519 174 CWE--DRQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSE-----KSVIYRDFKASNILLDG 245 (441)
Q Consensus 174 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~ivHrDlkp~Nill~~ 245 (441)
|.. ...+||||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.. .+||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 865 457899999999999999987532 2346899999999999999999999622 45999999999999964
Q ss_pred -----------------CCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc--CCCCccccchhHHHHHHHHH
Q 013519 246 -----------------SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLLEML 306 (441)
Q Consensus 246 -----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~ell 306 (441)
.+.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||||||||+|+
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 234899999999754221 22334579999999999865 45789999999999999999
Q ss_pred hCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 307 TGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 307 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
||..||...... ..+...+.... .......+..+.+||..||..+|.+||++.++|.+
T Consensus 238 TGk~PF~~~~~~----------------~qli~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 238 SGKTPFHKANNF----------------SQLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HCCCCCCcCCcH----------------HHHHHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 999999643210 00111111000 00112235668899999999999999999999954
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=315.30 Aligned_cols=262 Identities=26% Similarity=0.385 Sum_probs=207.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-HHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-GLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|.+.+.||.|+||.||+|+..... .....+.+++|.+...... ....+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIE----EEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCC----cCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 57888999999999999999875431 2334678999988765443 467789999999999999999999999998
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCC------CCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSA------EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
...++||||+++|+|.+++...... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN--ARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh--cCcccCcCccceEEEeCCCcEEE
Confidence 9999999999999999999765422 258999999999999999999996 89999999999999999999999
Q ss_pred ecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccc
Q 013519 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPS 330 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 330 (441)
+|||+++..... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 159 ~~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~------------- 224 (275)
T cd05046 159 SLLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD------------- 224 (275)
T ss_pred cccccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------------
Confidence 999998643211 1111223356778999999988889999999999999999999 7788853211
Q ss_pred cchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
...+............+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 225 ---EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---HHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111111111112223455667889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=313.58 Aligned_cols=260 Identities=24% Similarity=0.425 Sum_probs=205.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+|++.+.||+|+||.||+|.+.... ..+..+|+|.+.... ......+.+|+.++++++||||+++++++..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPG------KREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCC------CCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 57888999999999999999654221 124579999887643 33456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+++++|.+++.+.. ..+++.+++.++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeehhhchhcEEECCCCeEEeCCCCcc
Confidence 99999999999999999997653 357899999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcce-EeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhh
Q 013519 258 KLGPIDGNSHV-TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 258 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
........... .....++..|+|||++.+..++.++|||||||++|++++ |..||...... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~----------------~ 217 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ----------------D 217 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH----------------H
Confidence 86432221111 111223567999999998899999999999999999886 99998653211 0
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
....+.+ ......+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 218 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 218 VIKAIEE-GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111111 111122334556788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=318.50 Aligned_cols=254 Identities=26% Similarity=0.351 Sum_probs=199.5
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
+.+.|++.+.||+|+||.||+|... .+++.||+|.+..... ....+..|+.++.++ +||||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEc---------CCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 4567888999999999999999543 3478999998865432 235678899999998 6999999999987
Q ss_pred eC------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 176 ED------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 176 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
.. ..+++||||+.+++|.+++.... ...+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCE
Confidence 53 46899999999999999987533 2458899999999999999999997 899999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV 324 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~ 324 (441)
+|+|||+++..... ........|++.|+|||++. ...++.++|||||||++|||++|..||....+..
T Consensus 151 ~l~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----- 223 (272)
T cd06637 151 KLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----- 223 (272)
T ss_pred EEccCCCceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----
Confidence 99999999753221 11223467899999999986 3467889999999999999999999995432110
Q ss_pred cccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 325 DFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..............+..++..+.+|+.+||..+|.+|||+.+++++
T Consensus 224 -----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 224 -----------ALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -----------HHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0000111111111223445678899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=325.42 Aligned_cols=270 Identities=26% Similarity=0.364 Sum_probs=208.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 176 (441)
.+|.+.+.||+|+||.||+|....... ........||+|.+.... ......+.+|+.+++++ +||||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDK--DKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCC--ccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 468999999999999999996543210 111224578999887543 34467788999999999 79999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcC-------------CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKG-------------SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
...+++||||+++|+|.+++.+.. ....+++..++.++.|++.||.|||. .||+||||||+|||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nill 167 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRDLAARNVLV 167 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEE
Confidence 999999999999999999997642 12357889999999999999999997 999999999999999
Q ss_pred cCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCce
Q 013519 244 DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHV 322 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~ 322 (441)
+.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 242 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----- 242 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence 9999999999999975432111111122334567999999999999999999999999999998 8888854321
Q ss_pred eecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 013519 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVIE 389 (441)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~~ 389 (441)
.. ....+........+..++..+.+|+.+||+.+|++||++.++++.|+.+....
T Consensus 243 -----------~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 -----------EE-LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -----------HH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 01 11111111122234455667889999999999999999999999998876443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=318.04 Aligned_cols=253 Identities=27% Similarity=0.400 Sum_probs=204.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+.|++.+.||.|+||.||+|... .+++.+++|.+........+.+.+|+.+++.++||||+++++++..+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNK---------ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEEC---------CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 367999999999999999999544 34789999999877777778889999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+++++|..++.+.. ..+++..++.++.|++.+|.|||. .+++||||||+||+++.++.++|+|||++
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 157 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVS 157 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEEcCCCCEEEccCccc
Confidence 99999999999999988876543 358899999999999999999996 89999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
..... .........+++.|+|||++. ...++.++|||||||++|+|++|..||......
T Consensus 158 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------------- 221 (292)
T cd06644 158 AKNVK--TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------------- 221 (292)
T ss_pred eeccc--cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------------
Confidence 64221 112223456889999999885 345678999999999999999999998643211
Q ss_pred hhhhhhhhcCccc-cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPRL-EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+..... ....+...+..+.+++.+||..+|++||++.+++++
T Consensus 222 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 222 --RVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --HHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 01111111100 111233445568899999999999999999999985
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=332.26 Aligned_cols=246 Identities=29% Similarity=0.387 Sum_probs=201.8
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.|.-++.||.|+||-||-| .++.+...||||++.... .+..+.+..|+..|++++|||+|.+.++|..
T Consensus 27 lf~dLrEIGHGSFGAVYfA---------rd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred HHHHHHHhcCCccceeEEe---------eccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 3555678999999999999 444558899999987764 3456778899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
+...+||||||- |+-.|++.-.. +++.+.++..|+.+.+.||+|||+ .+.||||||..||||++.|.|||+|||.
T Consensus 98 e~TaWLVMEYCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 98 EHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred cchHHHHHHHHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEecCCCeeeeccccc
Confidence 999999999995 57777776544 578899999999999999999998 8899999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
|.+.. ...+++|||+|||||++. .+.|+-++|||||||+..||.-.++|+...+.
T Consensus 173 Asi~~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA---------------- 230 (948)
T KOG0577|consen 173 ASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------------- 230 (948)
T ss_pred hhhcC------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----------------
Confidence 97532 245689999999999985 46899999999999999999999998754321
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+..|....-.-......+..+..|+..||+.-|.+|||.+++|+|
T Consensus 231 MSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 231 MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111111111111111234567778899999999999999999999875
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=317.28 Aligned_cols=252 Identities=26% Similarity=0.385 Sum_probs=202.8
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 179 (441)
.|++.+.||.|+||.||+|... .++..+++|.+..........+.+|+.+++.++||||+++++++...+.
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 76 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNK---------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN 76 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEEC---------CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE
Confidence 3677889999999999999544 3477899999877666667788899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
.++||||+++++|..++.+.. .++++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEcccccccc
Confidence 999999999999998876532 468999999999999999999997 8999999999999999999999999999875
Q ss_pred CCCCCCcceEeeeccccccCcchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 260 GPIDGNSHVTTRIMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
.... ........|++.|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 153 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---------------- 214 (282)
T cd06643 153 NTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---------------- 214 (282)
T ss_pred cccc--ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH----------------
Confidence 3221 12223457899999999984 445778999999999999999999998643211
Q ss_pred hhhhhhcCcc-ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 335 RRLKKIMDPR-LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 335 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.....+.... .....+...+..+.+||.+||+.+|++||++.+++++-
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 215 RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred HHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 1111111100 01112334556788999999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=311.08 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=197.8
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVY 184 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 184 (441)
.||+|+||.||+|.+... ..+..||+|.+..... ...+.+.+|+.++++++||||+++++++. ....++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~-------~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR-------KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecC-------CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence 489999999999976422 1256799998876543 33466889999999999999999999875 45789999
Q ss_pred eecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCC
Q 013519 185 EYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG 264 (441)
Q Consensus 185 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 264 (441)
||+++++|.+++.... ..+++..++.++.|++.||.|||. .|++||||||+|||++.++.+||+|||+++......
T Consensus 74 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 74 EMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred EeCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence 9999999999986433 468899999999999999999997 899999999999999999999999999997543222
Q ss_pred Ccce-EeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhhcC
Q 013519 265 NSHV-TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD 342 (441)
Q Consensus 265 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (441)
.... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...... .+...+.
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~ 212 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----------------EVMSFIE 212 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----------------HHHHHHH
Confidence 1111 111223578999999988889999999999999999996 99998643211 1111111
Q ss_pred ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 343 PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 343 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
.......+..++..+.+++.+||..+|++||++.+|++.|+.+
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 213 QGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1122234556677889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=332.10 Aligned_cols=266 Identities=22% Similarity=0.295 Sum_probs=197.7
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
...++|.+.+.||+|+||.||+|.. ...++.||||++... .......+.+|+.+++.++||||++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 84 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYD---------AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEe---------cCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeee
Confidence 3457899999999999999999943 335789999988754 23345667789999999999999999998
Q ss_pred EEeC------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 174 CWED------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 174 ~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
+... ..+++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ .||+||||||+|||++.++
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~ 156 (355)
T cd07874 85 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDC 156 (355)
T ss_pred eeccccccccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCC
Confidence 8643 357999999975 66666632 37788999999999999999997 9999999999999999999
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce--eec
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--LVD 325 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~~~ 325 (441)
.+||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... +..
T Consensus 157 ~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (355)
T cd07874 157 TLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233 (355)
T ss_pred CEEEeeCcccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999975321 222334578999999999999999999999999999999999999996543111000 000
Q ss_pred ccc--cccchh--hhhhhhcC----------c-----c---ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 326 FAR--PSLTDK--RRLKKIMD----------P-----R---LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 326 ~~~--~~~~~~--~~~~~~~~----------~-----~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
... +.+... .....+.. + . .....+...+..+.+||.+||..||++|||+.|+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 000000 00000000 0 0 0001122234567899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=312.62 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=201.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||.||+|.... +..+|+|.+..... ....+.+|+.++++++||||+++++++. .
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E 72 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence 3578999999999999999995542 45689998876433 2356889999999999999999999875 4
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+++++|.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceee
Confidence 56899999999999999986543 2458899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||...... ..
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----------------~~ 212 (260)
T cd05070 150 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----------------EV 212 (260)
T ss_pred eeccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH----------------HH
Confidence 75432211 11122335567999999988899999999999999999999 88888643210 11
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
... +........+...+..+.+|+.+||..+|++|||+.++++.|+.
T Consensus 213 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 213 LEQ-VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHH-HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111 11111222344556678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=317.06 Aligned_cols=252 Identities=33% Similarity=0.497 Sum_probs=201.7
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHH--HHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR--EWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
|++.+.||+|+||+||++.. ...++.+|+|.+......... ...+|+.++++++||||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~---------~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKN---------KKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEE---------TTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEEE---------CCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 56788999999999999944 445789999999887654322 3456999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||+.+++|.+++... ..+++..++.++.|++.||.+||+ .+|+|+||||+|||++.++.++|+|||.+.
T Consensus 72 ~~~~v~~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEEEEEETTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred ccccccccccccccccccccc---cccccccccccccccccccccccc--cccccccccccccccccccccccccccccc
Confidence 999999999999999999743 358899999999999999999997 899999999999999999999999999987
Q ss_pred CCCCCCCcceEeeeccccccCcchhhh-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVA-TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
.. ...........++..|+|||++. +..++.++||||||+++|+|++|..||..... ......+
T Consensus 147 ~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-------------~~~~~~~ 211 (260)
T PF00069_consen 147 KL--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-------------DDQLEII 211 (260)
T ss_dssp ES--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-------------HHHHHHH
T ss_pred cc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------------hhhhhhh
Confidence 43 12233345567899999999998 78899999999999999999999999975310 0111111
Q ss_pred hhhcCccccccCC--hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIMDPRLEEQYP--IKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
............. ......+.+++.+||+.||++||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 212 EKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111111111 1123678899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=317.79 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=200.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++|.+.+.||+|+||.||+|... .+++.||+|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNV---------NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEc---------CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 57888899999999999999443 347899999987665555566888999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.+++||||+++++|.+++...+ .+++..++.++.|++.||.|||+ .||+|+||||+||+++.++.++|+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcceeee
Confidence 9999999999999999986544 58899999999999999999997 899999999999999999999999999986
Q ss_pred CCCCCCCcceEeeeccccccCcchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
..... ........|+..|+|||++. ...++.++|||||||++|+|++|..||....+........ .
T Consensus 155 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~--~------- 223 (267)
T cd06645 155 QITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT--K------- 223 (267)
T ss_pred EccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh--c-------
Confidence 53221 11223457899999999874 4568899999999999999999999985433211100000 0
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+... .....+..+.+++.+||..+|++||++.+++++
T Consensus 224 --~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 224 --SNFQPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --cCCCCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000000000 011234557899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=330.16 Aligned_cols=265 Identities=22% Similarity=0.276 Sum_probs=196.9
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
..++|.+.+.||+|+||.||+|.. ...++.||||++... .......+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~ 92 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYD---------AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEE---------CCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceee
Confidence 357899999999999999999944 334788999998653 233455677899999999999999999987
Q ss_pred EeC------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 175 WED------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 175 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
... ..+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ +||+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~ 164 (364)
T cd07875 93 TPQKSLEEFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT 164 (364)
T ss_pred cccccccccCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCc
Confidence 543 357999999975 67776632 37788999999999999999997 89999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce--eecc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--LVDF 326 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~~~~ 326 (441)
+||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... +...
T Consensus 165 ~kL~DfG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 241 (364)
T cd07875 165 LKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241 (364)
T ss_pred EEEEeCCCccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999975322 122334578999999999999999999999999999999999999997543211000 0000
Q ss_pred cccccchhhhh-------------------hhhcCcc---ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 327 ARPSLTDKRRL-------------------KKIMDPR---LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 327 ~~~~~~~~~~~-------------------~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+.......+ ...+... .........+..+++||.+||+.||.+|||+.++|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 0000000 0001111234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=313.09 Aligned_cols=260 Identities=24% Similarity=0.424 Sum_probs=204.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|...+.||+|+||.||+|...... .....+++|.+.... ....+.+..|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPG------RKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCC------CCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 46788899999999999999764321 123479999887653 34456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCccc
Confidence 99999999999999999986543 358899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceE-eeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhh
Q 013519 258 KLGPIDGNSHVT-TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 258 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
............ .....+..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----------------~~ 218 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----------------HE 218 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----------------HH
Confidence 754322211111 11223457999999998899999999999999999998 9999854321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
....+. .......+..++..+.+++.+||..+|++||++.+|++.|+++
T Consensus 219 ~~~~i~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 219 VMKAIN-DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111111 1111122334566788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=310.39 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=199.5
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
+.||+|+||.||+|.+.... ..+..+|+|.+..... ...+.+.+|+.+++.+.||||+++++++. ....++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKS------GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccC------CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 46999999999999764321 1347899999876644 34567889999999999999999999876 4568999
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
|||+++++|.+++.... .+++..++.++.|++.||.|||. .+++|+||||+|||++.++.+||+|||+++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 74 MELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred EEeCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 99999999999997654 58899999999999999999996 89999999999999999999999999999764322
Q ss_pred CCcce-EeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhhc
Q 013519 264 GNSHV-TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341 (441)
Q Consensus 264 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (441)
..... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .+...+
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-----------------~~~~~~ 211 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-----------------EVIAML 211 (257)
T ss_pred CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-----------------HHHHHH
Confidence 21111 111223467999999998999999999999999999998 99998643211 011111
Q ss_pred CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 342 DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
........+..++..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 212 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 212 ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111112234455677889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=317.89 Aligned_cols=252 Identities=29% Similarity=0.393 Sum_probs=200.2
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
|+..+.||+|+||+||+|.+. .+++.+|+|.+..... .....+.+|+.+|+.++|+||+.+++++..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence 667789999999999999554 3478999998865432 2234567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+.+++|.+++...+. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 999999999999999988865442 468999999999999999999997 99999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
...... .......|+..|+|||++.+..++.++|||||||++|+|++|..||....... ....+
T Consensus 150 ~~~~~~---~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-------------~~~~~ 213 (285)
T cd05632 150 VKIPEG---ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-------------KREEV 213 (285)
T ss_pred eecCCC---CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-------------HHHHH
Confidence 653221 11234578999999999999999999999999999999999999996432110 00001
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-----MEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~eil~~ 381 (441)
.... ......++...+..+.+|+.+||+.||++||+ +.+++.+
T Consensus 214 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 214 DRRV-LETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHhh-hccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0000 00111233445566889999999999999999 6777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=315.84 Aligned_cols=276 Identities=28% Similarity=0.377 Sum_probs=210.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-HHHHHHHHHHHHhcCCCCCccceEEEEEe-
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-GLREWQAEVKFLGKFSHPNLVKLIGYCWE- 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 176 (441)
..|.+.+.||+|+||.||+|.+... ...++..+|||.+...... ....+.+|+.+++.+.||||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPL-----GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCC-----CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 4577788999999999999976532 2335789999998766543 56789999999999999999999999887
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 177 -DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 177 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||. .+++|+||||+|||++.++.++|+|||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg 154 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFG 154 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccc
Confidence 567899999999999999997644 258899999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcce-EeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 256 LAKLGPIDGNSHV-TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
++........... .....++..|+|||.+.+..++.++||||||+++|||++|..|+............. . ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~-~~~~~~ 232 (284)
T cd05038 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-A-QGQMIV 232 (284)
T ss_pred cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-c-cccccH
Confidence 9986542211111 112344567999999998899999999999999999999999885432211100000 0 000001
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
..+...+........+..++..+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111222222222223445567788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=319.64 Aligned_cols=266 Identities=24% Similarity=0.363 Sum_probs=193.1
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcC---CCCCccceEEEE
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKF---SHPNLVKLIGYC 174 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~~~~~~ 174 (441)
+|++.+.||+|+||+||+|.. ..+++.||+|.+..... .....+.+|+.+++.+ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARD---------PHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEE---------CCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 488889999999999999954 34588999998765321 1123445677777665 699999999988
Q ss_pred Ee-----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 175 WE-----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 175 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
.. ...+++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~ 147 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQV 147 (288)
T ss_pred ccccCCCCceEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCE
Confidence 64 2458999999975 8888886543 2458999999999999999999997 899999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-eeccc-
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LVDFA- 327 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~- 327 (441)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... +....
T Consensus 148 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~ 224 (288)
T cd07863 148 KLADFGLARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224 (288)
T ss_pred EECccCccccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence 99999999754321 12233568999999999999999999999999999999999999986543211000 00000
Q ss_pred ---ccccchhhhh-hhhcCcc---ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 ---RPSLTDKRRL-KKIMDPR---LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ---~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+...... ...+.+. .........+..+.+|+.+||+.||++|||+.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 0000000 0001112345668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.56 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=202.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.++||+|+||.||+|... .++.||+|.+...... ...+.+|+.++++++||||+++++++. .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVT-Q 72 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCCc-HHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence 467899999999999999999643 2578999988765432 357888999999999999999999874 4
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCcce
Confidence 57899999999999999986543 2468899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
....... ........++..|+|||++....++.++||||||+++|||++ |+.||...... .
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------~- 211 (260)
T cd05067 150 RLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP----------------E- 211 (260)
T ss_pred eecCCCC-cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH----------------H-
Confidence 7543211 111122345678999999998899999999999999999999 99999643211 0
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
....+........+...+..+.+++.+||+.+|++||++++++..|+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 212 VIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 001111111112334455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=329.79 Aligned_cols=265 Identities=23% Similarity=0.327 Sum_probs=196.0
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
...++|.+.+.||.|+||+||+|.. ..+++.||||++..... .....+.+|+.+|+.++||||++++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYD---------TRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEE---------CCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhh
Confidence 3457899999999999999999944 34578999999875432 234567789999999999999999998
Q ss_pred EEeC------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 174 CWED------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 174 ~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
+... ...|++++++ +++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~~~~~ 155 (343)
T cd07878 83 FTPATSIENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDC 155 (343)
T ss_pred hcccccccccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEECCCC
Confidence 7543 3578999988 7799887743 358899999999999999999997 9999999999999999999
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-eec
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LVD 325 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~ 325 (441)
.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +..
T Consensus 156 ~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 230 (343)
T cd07878 156 ELRILDFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIME 230 (343)
T ss_pred CEEEcCCccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 999999999985322 1234578999999999877 568899999999999999999999996543211000 000
Q ss_pred c---cccccch---hhhhhhhcC--cccc----ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 326 F---ARPSLTD---KRRLKKIMD--PRLE----EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 326 ~---~~~~~~~---~~~~~~~~~--~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ..+.... ......... +... .......+..+.+|+.+||..||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 231 VVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000 000000000 0000 00001223457799999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=349.48 Aligned_cols=261 Identities=24% Similarity=0.332 Sum_probs=201.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.++||+|+||.||+|.. ..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d---------~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYD---------PVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEE---------CCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 5799999999999999999954 3458899999986542 233457889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS--------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
+++..++||||++||+|.+++..... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~dg 150 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFG 150 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEEcCCC
Confidence 99999999999999999998864211 2345667889999999999999997 8999999999999999999
Q ss_pred ceEEecccCCCCCCCCCC----------------cceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCC
Q 013519 248 NAKLSDFGLAKLGPIDGN----------------SHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRA 311 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p 311 (441)
.++|+|||+++....... .......+||+.|+|||++.+..++.++|||||||++|||+||..|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999999976421100 0111235799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcc
Q 013519 312 LDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-SMEEVLETLQNI 385 (441)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~eil~~L~~i 385 (441)
|......... ... ....+... ......+..+.+++.+||..||++|| +++++++.|+.+
T Consensus 231 F~~~~~~ki~-----------~~~---~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 231 YRRKKGRKIS-----------YRD---VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred CCCcchhhhh-----------hhh---hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9653221100 000 00000000 00123445678999999999999996 566676766654
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=312.63 Aligned_cols=251 Identities=26% Similarity=0.418 Sum_probs=202.0
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---------HHHHHHHHHHHHHhcCCCCCccce
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---------QGLREWQAEVKFLGKFSHPNLVKL 170 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~~ 170 (441)
+|.+...||.|+||.||+|... ..++.+|+|.+..... ...+.+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNA---------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEEec---------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 4778889999999999999543 3478899998754321 223568889999999999999999
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 171 IGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 171 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
++++.+....++||||+++++|.+++...+ .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~--~~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHN--RGIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHh--cCcccccCCHHHEEEcCCCCEE
Confidence 999999999999999999999999996543 57889999999999999999996 8999999999999999999999
Q ss_pred EecccCCCCCCCCCC----cceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecc
Q 013519 251 LSDFGLAKLGPIDGN----SHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF 326 (441)
Q Consensus 251 l~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 326 (441)
|+|||+++....... ........|+..|+|||.+.+..++.++|||||||++|+|++|+.||.....
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------- 217 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--------- 217 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---------
Confidence 999999976432111 1112235688999999999988899999999999999999999999964321
Q ss_pred cccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 327 ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+..+.. ......+...+..+.++|.+||+.||++||++.+++++
T Consensus 218 -------~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 218 -------LQAIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -------HHHHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 011111111 11223344556778899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=304.19 Aligned_cols=253 Identities=25% Similarity=0.335 Sum_probs=203.2
Q ss_pred HhcCCCCC-ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEEE
Q 013519 97 ATKNFRPD-TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 174 (441)
++++|.+. ++||-|-.|+|..+ .++.+++.+|+|++... ...++|+++.-... |||||.++++|
T Consensus 59 itedY~is~qvLG~GinGkV~~C---------~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQC---------VHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred chhhheehhhhhccccCCceEEE---------EeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence 45677765 68999999999998 55566899999988654 34467888766665 99999999988
Q ss_pred Ee----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC---C
Q 013519 175 WE----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS---Y 247 (441)
Q Consensus 175 ~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~ 247 (441)
.. ...+.+|||.++||.|+..+..++. ..+++.++..|+.||..|+.|||+ .+|.||||||+|+|...+ .
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~--~nIAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHS--MNIAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHh--cchhhccCChhheeeecCCCCc
Confidence 64 4568899999999999999988875 679999999999999999999997 999999999999999644 4
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
.+||+|||+|+... ......+.|-||+|.|||++....|+...|+||+||++|.|++|.+||....... .
T Consensus 202 ~lKLtDfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--i----- 271 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--I----- 271 (400)
T ss_pred ceEecccccccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--C-----
Confidence 69999999998532 2334566789999999999999999999999999999999999999997654311 0
Q ss_pred ccccchhhhhhhhcCc--cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTDKRRLKKIMDP--RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+.+ -..+... .+........++.++++|+++|..+|.+|.|+.+++++
T Consensus 272 spgM-----k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 272 SPGM-----KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ChhH-----HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0111 1112211 12222334678889999999999999999999999986
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=319.30 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=204.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
..+|.+.+.||.|+||.||+|.. ..+++.||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAID---------IATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEE---------CCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 46899999999999999999943 345789999998766555556788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+++++|.+++.+. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred CEEEEeecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEECcCccc
Confidence 9999999999999999988542 47889999999999999999997 89999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
....... .......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+........ .
T Consensus 163 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~--~--------- 229 (297)
T cd06656 163 AQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--T--------- 229 (297)
T ss_pred eEccCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec--c---------
Confidence 7532221 11233568899999999999899999999999999999999999996543321111000 0
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
........+...+..+.+|+.+||..+|++||++.+++++
T Consensus 230 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 230 ----NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ----CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000011233445667899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=320.88 Aligned_cols=266 Identities=22% Similarity=0.311 Sum_probs=189.4
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEe--CCeEE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE--DRQFL 181 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 181 (441)
.++||+|+||+||+|..... ..++.||+|.+..... ...+.+|+.+|++++||||+++++++.. +..++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~-------~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG-------KDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEccC-------CCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 45899999999999965421 2367899998875532 2346789999999999999999999864 45689
Q ss_pred EEEeecCCCCHHHHHHhcC------CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE----cCCCceEE
Q 013519 182 LVYEYMQKGSLENHLFRKG------SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL----DGSYNAKL 251 (441)
Q Consensus 182 lv~e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~kl 251 (441)
+||||+. ++|.+++.... ....+++..+..++.|++.||.|||+ .||+||||||+|||+ +.++.+||
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 77 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence 9999996 48888775321 12358899999999999999999997 899999999999999 45678999
Q ss_pred ecccCCCCCCCCCC-cceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-----
Q 013519 252 SDFGLAKLGPIDGN-SHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV----- 324 (441)
Q Consensus 252 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~----- 324 (441)
+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||............
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence 99999976432211 1122346789999999999874 5889999999999999999999999654322110000
Q ss_pred ------cccccccchhhhhhhh---------cCc-cc--------cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013519 325 ------DFARPSLTDKRRLKKI---------MDP-RL--------EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380 (441)
Q Consensus 325 ------~~~~~~~~~~~~~~~~---------~~~-~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~ 380 (441)
....+..........+ +.. .. ........+..+.+||.+||+.||++|||++|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000000000 000 00 00001112345789999999999999999999997
Q ss_pred H
Q 013519 381 T 381 (441)
Q Consensus 381 ~ 381 (441)
+
T Consensus 314 h 314 (317)
T cd07868 314 D 314 (317)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=328.86 Aligned_cols=242 Identities=26% Similarity=0.340 Sum_probs=188.1
Q ss_pred ecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcC---CCCCccceEEEEEeCCeE
Q 013519 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKF---SHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 107 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~ 180 (441)
||+|+||+||+|+. ..+++.||||++..... .....+..|..++..+ .||||+++++++.....+
T Consensus 1 lG~G~~g~Vy~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRK---------KDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEE---------CCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 79999999999944 34588999999864322 1233344566666655 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
|+||||+.+|+|.+++.+.+ .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 72 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred EEEEcCCCCChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 99999999999999887543 58899999999999999999997 99999999999999999999999999998753
Q ss_pred CCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (441)
... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... .....
T Consensus 147 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~----------------~~~~~ 208 (330)
T cd05586 147 LTD--NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ----------------QMYRN 208 (330)
T ss_pred CCC--CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH----------------HHHHH
Confidence 221 1223456799999999998765 4789999999999999999999999653210 11111
Q ss_pred hcCccccccCChhhHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 013519 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP----SMEEVLET 381 (441)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~eil~~ 381 (441)
+...... ......+..+.+|+.+||+.||.+|| ++.+++++
T Consensus 209 i~~~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 209 IAFGKVR-FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHcCCCC-CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 1111110 01123456688999999999999998 67787775
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=311.57 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=200.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||.||+|.+.. ...|++|.+..... ....+.+|+.+++.++||||+++++++. .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence 3569999999999999999996543 23599999876433 2356888999999999999999999874 4
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+++|+|.+++.+.. ...+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCce
Confidence 56899999999999999997542 2457899999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...... ..
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----------------~~ 212 (262)
T cd05071 150 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----------------EV 212 (262)
T ss_pred eecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----------------HH
Confidence 75432211 11122346678999999998999999999999999999999 78888543211 11
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
...+.. ......+...+..+.+|+.+||+.+|++||++.++++.|+.
T Consensus 213 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 213 LDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred HHHHhc-CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 111111 11112233456678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=316.01 Aligned_cols=253 Identities=27% Similarity=0.414 Sum_probs=205.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||.|+||.||+|.... ++..+++|............+.+|+.++++++||||+++++++..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC---------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 4578999999999999999996543 4789999998877666677888999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCccc
Confidence 99999999999999999986643 358999999999999999999997 89999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
...... ........|++.|+|||++. ...++.++|||||||++|+|++|+.||......
T Consensus 151 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------------- 214 (280)
T cd06611 151 AKNKST--LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------------- 214 (280)
T ss_pred hhhccc--ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------------
Confidence 653221 12223457899999999985 345678999999999999999999999653211
Q ss_pred hhhhhhhhcCcc-ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPR-LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+..+.... .....+..++..+.+++.+||+.+|.+||++.+++++
T Consensus 215 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 215 --RVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --HHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1111111100 0111233455678899999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=312.47 Aligned_cols=261 Identities=23% Similarity=0.390 Sum_probs=206.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+|++.+.||+|+||.||+|.+.... ......+++|...... ......+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEG-----EKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCC-----CCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 56888999999999999999764321 1123479999887654 3445678899999999999999999999887
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCCccc
Confidence 78899999999999999997643 348899999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...............++..|+|||.+....++.++||||||+++|||++ |+.||...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~ 219 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-----------------E 219 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-----------------H
Confidence 86542222111112223568999999988899999999999999999999 99998653211 1
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
+...+........+..++..+.+++.+||..+|++||++.++++.|..+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 220 IPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111111112223445567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=310.90 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=205.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||.|+||.||+|... .+++.+++|.+........+.+.+|+.++++++||||+++++++.+.
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 72 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDI---------ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR 72 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEec---------CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC
Confidence 357899999999999999999543 34678999998776655667889999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..++++|||+.+++|.+++.... ..+++..+..++.|++.||.|||. .+|+|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~~l~~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 148 (262)
T cd06613 73 DKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVS 148 (262)
T ss_pred CEEEEEEeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECccccc
Confidence 99999999999999999886642 358899999999999999999996 89999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATG---HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
...... ........++..|+|||.+.+. .++.++||||||+++|+|++|..||....+....
T Consensus 149 ~~~~~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~------------- 213 (262)
T cd06613 149 AQLTAT--IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL------------- 213 (262)
T ss_pred hhhhhh--hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-------------
Confidence 753221 1122345788899999999777 8889999999999999999999999653321100
Q ss_pred hhhhh-hcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKK-IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..... .+.+ .....+...+..+.+++.+||..+|.+||++.+++.+
T Consensus 214 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 214 FLISKSNFPP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHhccCCC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000 0111233456678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=317.09 Aligned_cols=268 Identities=24% Similarity=0.294 Sum_probs=199.6
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.+++.++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK---------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEEC---------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 4788899999999999999543 3478999998765422 2235678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..+++||||+. ++|.+++........+++..++.++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECcccce
Confidence 99999999997 5898888665444578999999999999999999997 99999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee--eccc---c---
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL--VDFA---R--- 328 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~--~~~~---~--- 328 (441)
...... ........+++.|+|||++.+. .++.++|||||||++|+|+||+.||........... ..+. .
T Consensus 149 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd07861 149 RAFGIP--VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226 (285)
T ss_pred eecCCC--cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 753221 1122234578899999988654 578899999999999999999999975432110000 0000 0
Q ss_pred cccchhhhhhhhcCc---cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 PSLTDKRRLKKIMDP---RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+.............. ..........+.++.++|.+||+.||++|||+.+|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000000 00001122356678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=311.65 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=201.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+++.....||+|+||.||+|... .++..|++|.+........+.+.+|+.+++.++||||+++++++..+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDL---------STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN 77 (268)
T ss_pred cccCCceEEEecCCceEEEEeEec---------CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC
Confidence 445555678999999999999543 34788999998877766677899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC-CCceEEecccC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG-SYNAKLSDFGL 256 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DFGl 256 (441)
+..++|+||+++++|.+++.........++..+..++.|++.||.|||+ .+|+||||||+||+++. ++.++|+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 9999999999999999999764321122788889999999999999997 99999999999999976 67899999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH--LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+...... ........|++.|+|||++.... ++.++||||||+++|+|++|..||.........
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~------------- 220 (268)
T cd06624 156 SKRLAGI--NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA------------- 220 (268)
T ss_pred heecccC--CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-------------
Confidence 8753211 11223346889999999986643 788999999999999999999998643211000
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
............++...+..+.+++.+||+.+|++||++.+++.+
T Consensus 221 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 221 --MFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --HhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000000011122344566778899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=311.54 Aligned_cols=257 Identities=24% Similarity=0.317 Sum_probs=191.7
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
+.||+|+||.||+|.+... .++..+++|.+..... .....+.+|+.++++++||||+++++++.+...+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG-------YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcCC-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 3699999999999976432 2356799998876542 3345688899999999999999999999998999999
Q ss_pred EeecCCCCHHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKGS--AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP 261 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~ 261 (441)
|||+++|+|.+++..... ....++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999999999975332 2345677888999999999999997 999999999999999999999999999997532
Q ss_pred CCCCcceEeeeccccccCcchhhhcC-------CCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccch
Q 013519 262 IDGNSHVTTRIMGTYGYAAPEYVATG-------HLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
............|+..|+|||++.+. .++.++||||||+++|||++ |..||.......... . ..
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~-----~~ 223 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---Y-----TV 223 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---H-----Hh
Confidence 21111112234578889999998642 35789999999999999996 999996432211000 0 00
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
......+..+ ......+..+.+++.+|| .+|++|||+++|+..|+
T Consensus 224 ~~~~~~~~~~----~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 224 REQQLKLPKP----RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hcccCCCCCC----ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0000001111 112234456778999998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=311.73 Aligned_cols=260 Identities=25% Similarity=0.360 Sum_probs=205.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+|.+.+.||+|+||.||+|.+.... .....|+||...... ....+.+.+|+.+++.+.||||+++++++.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCC------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence 46888899999999999999764321 124578999887664 4556678999999999999999999998875
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+++|+|.+++.+.. ..+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCcee
Confidence 45789999999999999997643 358899999999999999999997 99999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...... ........++..|+|||.+....++.++||||||+++|||++ |..||....... .
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----------------~ 217 (270)
T cd05056 155 RYLEDES-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND----------------V 217 (270)
T ss_pred eeccccc-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH----------------H
Confidence 7543221 111122234567999999988889999999999999999996 999986542210 0
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
...+. .......+..++..+.+++.+||..+|++|||+.++++.|+.+..
T Consensus 218 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 218 IGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11110 011112344556778999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=316.38 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=202.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++.+.||+|+||.||+|... ..+..||+|.+... .......+.+|+.++++++||||+++++++..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHR---------PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEc---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 36888999999999999999554 34789999987654 333456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+++++|..++........+++..+..++.|++.||.|||. ..+|+|+||||+|||++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 9999999999999999888654323468999999999999999999995 369999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccccc
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATG------HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
..... .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.......
T Consensus 151 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------------ 214 (286)
T cd06622 151 GNLVA----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN------------ 214 (286)
T ss_pred ccccC----CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh------------
Confidence 75321 122334688899999998554 34789999999999999999999996432110
Q ss_pred chhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+..+... .....+..++..+.+||.+||+.+|++||++.+++.+
T Consensus 215 -~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 215 -IFAQLSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -HHHHHHHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00111112211 1122344567778899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=323.97 Aligned_cols=252 Identities=27% Similarity=0.346 Sum_probs=206.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCC--CchHHHHHHHHHHHHHhcCC-CCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP--DSIQGLREWQAEVKFLGKFS-HPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~ 175 (441)
..|++++.||.||.+.||++.... .+.||+|++.. .+...+.-+..|+.+|.+|+ |.+||++++|-.
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 579999999999999999985543 35677776543 34566788999999999997 999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
.++.+||||||- ..+|..+|.+.... .+...+..+..|++.|+.++|. .||||.||||.|+|+-. |.+||+|||
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~--~gIVHSDLKPANFLlVk-G~LKLIDFG 504 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQ--HGIVHSDLKPANFLLVK-GRLKLIDFG 504 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHH--hceeecCCCcccEEEEe-eeEEeeeec
Confidence 999999999976 45999999876542 3323788899999999999996 99999999999999975 589999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCC-----------CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH-----------LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV 324 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~ 324 (441)
+|.....+...-.....+||+.||+||.+.... .+.++||||||||||+|+.|+.||...
T Consensus 505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--------- 575 (677)
T KOG0596|consen 505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--------- 575 (677)
T ss_pred hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---------
Confidence 999877777777777889999999999995432 557899999999999999999999642
Q ss_pred cccccccchhhhhhhhcCccccccCChhhHH-HHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 325 DFARPSLTDKRRLKKIMDPRLEEQYPIKGAL-LAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+..+.+|...-.||..-.. ++.++++.||..||++||++.++|++
T Consensus 576 ------~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 576 ------INQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ------HHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1233456667777555455443322 28899999999999999999999986
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=318.52 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=204.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|.+.+.||.|+||.||+|. ...+++.|++|.+..........+.+|+.+++.++||||+++++++....
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~---------~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAI---------DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEE---------EcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 468889999999999999994 33458899999887655555667889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.+++|+||+++++|..++... .+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.+||+|||++.
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~--~~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccch
Confidence 999999999999999988543 47899999999999999999997 899999999999999999999999999987
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
...... .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....+.. ...
T Consensus 164 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~----------------~~~ 225 (296)
T cd06655 164 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----------------ALY 225 (296)
T ss_pred hccccc--ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHH
Confidence 533221 11233568899999999998889999999999999999999999996543211 000
Q ss_pred hhc-CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 339 KIM-DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 339 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+. ........+...+..+.++|.+||..||++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 226 LIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 110 0000111234456678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=311.57 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=196.1
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKF-SHPNLVKLIGYCWEDRQFLL 182 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 182 (441)
++||+|+||.||+|.+.... ....+++|.+... .....+.+.+|+.++.++ +||||+++++++...+.+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-------CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 36999999999999664321 1235788887753 334456788999999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 183 VYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 183 v~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili~~~~~~ 151 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVA 151 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEEcCCCeE
Confidence 9999999999999875431 2347899999999999999999996 999999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 328 (441)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |..||......
T Consensus 152 kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---------- 218 (270)
T cd05047 152 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------- 218 (270)
T ss_pred EECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH----------
Confidence 99999998632111 11111233567999999988899999999999999999997 99998543210
Q ss_pred cccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
..... +........+...+..+.+|+.+||..+|.+|||+.++++.|+.+
T Consensus 219 ------~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 219 ------ELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ------HHHHH-HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00111 111111122334556688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=328.53 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=210.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
...|.+.+.||+|.|++|.+| ....++..||||.+.+... ..++.+.+|+++|..|+|||||+++.+..
T Consensus 55 vg~y~i~~tig~g~f~~V~La---------~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLA---------RHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE 125 (596)
T ss_pred ccceeeeeeeccceeEEEEee---------EecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee
Confidence 357899999999999999999 4445689999999887643 34566889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
....+|+||||+.+|.++++|.+.+. ....++..++.|++.|++|||+ ++|||||||++||||+.+.++||+|||
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhh--cceeccccchhhcccccccceeeeccc
Confidence 99999999999999999999998875 4458889999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
++..+. ......++||++.|.|||++.+..|+ +.+|+||+|++||-|+.|..||++..-.. ...+.
T Consensus 201 fS~~~~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~------Lr~rv---- 267 (596)
T KOG0586|consen 201 FSTFFD---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE------LRPRV---- 267 (596)
T ss_pred cceeec---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc------ccchh----
Confidence 998754 34456778999999999999998887 89999999999999999999998643211 00000
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
+...+ .+|...+.++.++|+++|.++|.+|++++++.++-
T Consensus 268 ------l~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 268 ------LRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred ------eeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 11111 23445556688999999999999999999999853
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=308.89 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=194.2
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEE-eCCeEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW-EDRQFLL 182 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~l 182 (441)
+.||+|+||.||+|.+... ......+|+|.+... .......+.+|+.+++.++||||+++++++. .++..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDS------DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecC------CCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 3689999999999976432 123568999988543 3445677889999999999999999999776 4566899
Q ss_pred EEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCC
Q 013519 183 VYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPI 262 (441)
Q Consensus 183 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~ 262 (441)
||||+.+|+|.+++.+.. ..+++..++.++.|++.||.|||. .+++||||||+|||++.++.+||+|||+++....
T Consensus 75 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~ 150 (262)
T cd05058 75 VLPYMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGLARDIYD 150 (262)
T ss_pred EEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccccccccC
Confidence 999999999999997543 245677888999999999999996 8999999999999999999999999999975322
Q ss_pred CCCc--ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCCceeecccccccchhhhhhh
Q 013519 263 DGNS--HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG-LRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339 (441)
Q Consensus 263 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (441)
.... .......++..|+|||.+.+..++.++|||||||++|||++| ..||..... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----------------~~~~~~ 214 (262)
T cd05058 151 KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS----------------FDITVY 214 (262)
T ss_pred CcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH----------------HHHHHH
Confidence 1110 111223457789999999988999999999999999999995 455543211 000111
Q ss_pred hcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
+... .....+...+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 215 ~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 215 LLQG-RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HhcC-CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1111 111122334566889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=309.86 Aligned_cols=252 Identities=28% Similarity=0.440 Sum_probs=198.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-----chHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-----SIQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
.+|...+.||+|+||.||+|.. ..++..|++|.+... .......+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~---------~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYD---------VDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEEEE---------cCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 4688999999999999999943 345789999987543 22345678899999999999999999998
Q ss_pred EEe--CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 174 CWE--DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 174 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
+.+ ...+++++||+++++|.+++.... .+++...+.++.|++.||.|||. .+|+||||||+||+++.++.++|
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l 147 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKL 147 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEE
Confidence 876 367899999999999999986543 47889999999999999999996 89999999999999999999999
Q ss_pred ecccCCCCCCCCC-CcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccc
Q 013519 252 SDFGLAKLGPIDG-NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330 (441)
Q Consensus 252 ~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 330 (441)
+|||+++...... .........++..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------------- 214 (266)
T cd06651 148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------------- 214 (266)
T ss_pred ccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------------
Confidence 9999987542211 11112235688999999999988899999999999999999999999964311
Q ss_pred cchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+...........++...+..+.+++ +||..+|++||++++++++
T Consensus 215 ---~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 215 ---MAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ---HHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 1111111111112233445556677888 6888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=313.66 Aligned_cols=249 Identities=26% Similarity=0.355 Sum_probs=203.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|.+.+.||.|+||.||+|... .++..|++|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK---------RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC---------CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 36888899999999999999543 347899999887653 34456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..+++|+||+++++|.+++... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999999998643 68899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
+...... .......|++.|+|||++.+..++.++|||||||++|+|+||..||....+.. ..
T Consensus 146 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~----------------~~ 207 (274)
T cd06609 146 GQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR----------------VL 207 (274)
T ss_pred eeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH----------------HH
Confidence 7643221 22234578889999999999899999999999999999999999996533210 00
Q ss_pred hhhcCccccccCChh-hHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIMDPRLEEQYPIK-GALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+. .......+.. .+..+.+++.+||..+|++||++++++++
T Consensus 208 ~~~~-~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 208 FLIP-KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHhh-hcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0000 0111111122 55668899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=311.78 Aligned_cols=257 Identities=28% Similarity=0.406 Sum_probs=199.4
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVY 184 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 184 (441)
.||+|+||.||+|.+.... .....++.+++|.+.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~---~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDIL---GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccc---cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 6999999999999765421 112234689999876543 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcC----CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC-----ceEEeccc
Q 013519 185 EYMQKGSLENHLFRKG----SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY-----NAKLSDFG 255 (441)
Q Consensus 185 e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-----~~kl~DFG 255 (441)
||+++++|.+++.+.. ....+++..++.++.|++.||.|||+ .+++|+||||+|||++.++ .++|+|||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999997532 12347889999999999999999997 8999999999999999877 89999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---------------- 220 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---------------- 220 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH----------------
Confidence 9975422211111222345678999999999999999999999999999998 99998643210
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
. .............+...+..+.+++.+||..+|.+||++.++++.|+.
T Consensus 221 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 221 E-VLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred H-HHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 111111111112344556778899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=309.89 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=201.4
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEe-
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE- 176 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 176 (441)
+|++.+.||+|+||.||++... ..++.+++|++.... ....+.+.+|+.++++++||||+++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR---------TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc---------CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 4888999999999999999543 347789999886542 3345668889999999999999999998764
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
+..+++||||+++++|.+++.... ...+++.+++.++.+++.||.+||+ .+|+|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~~ 148 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGI 148 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEecccc
Confidence 456899999999999999987532 2458999999999999999999996 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...... ........|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ...
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----------------~~~ 210 (257)
T cd08223 149 ARVLENQ--CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM----------------NSL 210 (257)
T ss_pred eEEeccc--CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----------------HHH
Confidence 9754321 1223345789999999999999999999999999999999999999864211 001
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+.... ....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 211 ~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 211 VYRIIEGK-LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHhcC-CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11111111 112334556678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=307.21 Aligned_cols=248 Identities=29% Similarity=0.461 Sum_probs=197.7
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-HHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-GLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
++||+|+||.||+|... . ++.|++|.+...... ....+.+|+.+++++.||||+++++++.+....++|
T Consensus 1 ~~lg~g~~g~v~~~~~~---------~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK---------G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEe---------C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 36999999999999543 2 688999988765433 556788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
|||+.+++|.+++.... ..+++..++.++.+++.+|.|||+ ++++||||||+|||++.++.++|+|||+++.....
T Consensus 71 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 71 MELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred EEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 99999999999986643 357889999999999999999996 99999999999999999999999999999753211
Q ss_pred CCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhhcC
Q 013519 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD 342 (441)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (441)
..........++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .......
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-----------------~~~~~~~ 209 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-----------------QTRERIE 209 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-----------------HHHHHHh
Confidence 11111111233567999999998899999999999999999999 78888543211 0111111
Q ss_pred ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 343 PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 343 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
.......+...+..+.+++.+||..+|++||++.|+++.|+
T Consensus 210 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 210 SGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11112234455667899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=316.15 Aligned_cols=266 Identities=23% Similarity=0.317 Sum_probs=206.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++.+.||+|+||+||++... ..++.||+|++.... ......+.+|+++++.++||||+++++++...
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHI---------PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEc---------CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 56888899999999999999544 347889999876543 33456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..+++||||+++++|.+++.+.+ .+++..+..++.+++.+|.|||+ ..+++||||||+||+++.++.++|+|||++
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH-hcCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence 99999999999999999886543 58899999999999999999995 358999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
..... .......|+..|+|||++.+..++.++|||||||++|+|++|..||........... . .......+
T Consensus 152 ~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~---~--~~~~~~~~ 222 (284)
T cd06620 152 GELIN----SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD---D--PMGILDLL 222 (284)
T ss_pred cchhh----hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh---h--hhHHHHHH
Confidence 64321 112345789999999999888999999999999999999999999975433211000 0 00000111
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
..+.............+..+.+|+.+||+.||++||++.|++++...+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 223 QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 1111111111111225567889999999999999999999999754444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=314.78 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=191.5
Q ss_pred eecccCceEEEEEEecCCcc---------------ccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccce
Q 013519 106 MLGEGGFGRVFKGWVDHKTL---------------APTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKL 170 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~---------------~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 170 (441)
.||+|+||.||+|.+..... ..........|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997643211 001222345689999877665556678889999999999999999
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC---
Q 013519 171 IGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY--- 247 (441)
Q Consensus 171 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~--- 247 (441)
++++.++...++||||+++|+|..++.+.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLED--KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHc--CCccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999886533 357899999999999999999996 8999999999999997644
Q ss_pred ----ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHH-hCCCCCCCCCCCCCc
Q 013519 248 ----NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEML-TGLRALDTNRPSGEH 321 (441)
Q Consensus 248 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~ell-tg~~p~~~~~~~~~~ 321 (441)
.+|++|||++..... .....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred CccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 389999999864211 122357788999998865 56889999999999999984 78888865322110
Q ss_pred eeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
...+... ...+......+.++|.+||+.+|++||++.++++.|
T Consensus 231 ----------------~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ----------------ERFYEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ----------------HHHHHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 0011000 011222334578999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=310.21 Aligned_cols=255 Identities=28% Similarity=0.456 Sum_probs=204.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|.+.+.||+|+||.||+|.... ++.++||.+..... ....+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 4689999999999999999996542 46799998876543 245688999999999999999999999988
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+++++|.+++.... ...+++..+..++.|++.||.|||. .+++|+||||+||+++.++.++|+|||++
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~--~~i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred CceEEEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcchheEEEcCCCCEEECccccc
Confidence 99999999999999999997643 2458899999999999999999996 89999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...... ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ...
T Consensus 151 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----------------~~~ 213 (261)
T cd05034 151 RLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----------------REV 213 (261)
T ss_pred eeccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----------------HHH
Confidence 7543211 111112234568999999998899999999999999999999 9999854321 111
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
+..+. .......+...+..+.+++.+||..+|++||+++++++.|+.
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 214 LEQVE-RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11111 111112233446678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=309.08 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=192.5
Q ss_pred ceecccCceEEEEEEecCCcccc---ccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAP---TKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFL 181 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~---~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 181 (441)
+.||+|+||.||+|.+....... ........+++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 36899999999999865332100 111234568999887765555667888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc-------eEEecc
Q 013519 182 LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN-------AKLSDF 254 (441)
Q Consensus 182 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-------~kl~DF 254 (441)
+||||+++++|..++.+.. ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999998886543 358899999999999999999997 99999999999999987664 899999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhh-cCCCCccccchhHHHHHHHHH-hCCCCCCCCCCCCCceeecccccccc
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA-TGHLYVKSDVYGFGVVLLEML-TGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|++..... .....++..|+|||++. +..++.++|||||||++|||+ +|..||......
T Consensus 157 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------------- 216 (262)
T cd05077 157 GIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-------------- 216 (262)
T ss_pred CCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--------------
Confidence 99864321 12345788999999886 467889999999999999998 577777543211
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.. ..+...... .....+..+.+|+.+||+.||++||++.+|++.|
T Consensus 217 ~~---~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 217 EK---ERFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HH---HHHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 011111111 1122345678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=317.07 Aligned_cols=261 Identities=23% Similarity=0.390 Sum_probs=202.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|+..+.||+|+||.||+|.+.... ......+|+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEG-----ETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCC-----CcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 56888899999999999999765421 11134689998876533 3344688899999999999999999998754
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||++
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhh--cCeeccccccceeeecCCCceEEcccccc
Confidence 4679999999999999987643 357889999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...............++..|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-----------------~ 219 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-----------------E 219 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------H
Confidence 86432222111222345678999999999999999999999999999997 88888543210 0
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
...+.........+..++..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 220 IPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111111123334566889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=320.15 Aligned_cols=267 Identities=22% Similarity=0.345 Sum_probs=198.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|.+.+.||.|+||.||+|... .+++.||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSK---------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEc---------CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 57899999999999999999543 3478999998865432 2234567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 151 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLA 151 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHHHEEECCCCcEEECcCcch
Confidence 99999999997 58988886543 357889999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ecc-c---c---
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VDF-A---R--- 328 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~~-~---~--- 328 (441)
....... .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||........... ... . .
T Consensus 152 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 229 (301)
T cd07873 152 RAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229 (301)
T ss_pred hccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc
Confidence 7532211 112234578999999998764 578899999999999999999999975432110000 000 0 0
Q ss_pred cccchhhhhhhhcCcccc----ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 PSLTDKRRLKKIMDPRLE----EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+.+...........+... .......+..+.+||.+||+.||.+|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000000000000000 01112345678899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=307.58 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=204.9
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|+..++||.|+||.||.+... .++..+++|.+... .......+.+|+.++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT---------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEc---------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 4888999999999999998443 45788999987654 234456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+++++|.+++.+.. ...+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEEeCCCCEEECcCcce
Confidence 99999999999999999997653 2468899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ...
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~ 210 (256)
T cd08221 149 KILGSEY--SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL----------------NLV 210 (256)
T ss_pred EEccccc--ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH----------------HHH
Confidence 7543222 1223456899999999998888999999999999999999999998643211 111
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
..+...... ..+...+..+.+++.+||..+|++||++.++++++
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 211 VKIVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHcCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 111111111 12234556788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=304.70 Aligned_cols=247 Identities=28% Similarity=0.456 Sum_probs=196.1
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
++||+|+||.||+|... .+..+|+|.+..... .....+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 36999999999999543 257899998876543 3344688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
|||+++++|.+++.... ..+++..++.++.|++.+|.|||. .+++|+||||+||+++.++.+||+|||++......
T Consensus 71 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 71 MELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred EECCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 99999999999886543 357899999999999999999996 89999999999999999999999999998743211
Q ss_pred CCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhhcC
Q 013519 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD 342 (441)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (441)
. ........++..|+|||++.+..++.++||||||+++|+|++ |..||...... ..... ..
T Consensus 147 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----------------~~~~~-~~ 208 (250)
T cd05085 147 I-YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----------------QAREQ-VE 208 (250)
T ss_pred c-cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----------------HHHHH-HH
Confidence 1 111112234567999999998899999999999999999998 98898643211 00001 11
Q ss_pred ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 343 PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 343 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
.......+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 209 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 209 KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11112234445677889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=308.11 Aligned_cols=251 Identities=28% Similarity=0.408 Sum_probs=204.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++|++.+.||.|+||.||+|.+.. .++.+++|.+..... ...+.+|+.+++.++||||+++++++....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 578999999999999999996543 368899999876533 578899999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.+++++||+.+++|.+++.... ..+++..++.++.|++.||.|||. .+++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEcccccch
Confidence 9999999999999999986543 468999999999999999999996 899999999999999999999999999987
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
...... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||....+....... .
T Consensus 148 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------------~ 212 (256)
T cd06612 148 QLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------------P 212 (256)
T ss_pred hcccCc--cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------------c
Confidence 543221 1223356889999999999999999999999999999999999999654322111000 0
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ........+...+..+.+++.+||+.+|++||++.+++++
T Consensus 213 ~--~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 213 N--KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred c--CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0 0000011233345668899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=307.83 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=199.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++|++...||+|+||.||+|.+.. +..+++|.+..... ..+.+.+|+.+++.++||||+++++++. .+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence 468889999999999999996543 23589998765432 2356788999999999999999998875 45
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||+.+++|.+++.... ...+++..+..++.|++.||.|||. .+++|+||||+|||++.++.++|+|||+++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccce
Confidence 6899999999999999997543 2457899999999999999999996 899999999999999999999999999997
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||...... ...
T Consensus 151 ~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----------------~~~ 213 (260)
T cd05069 151 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----------------EVL 213 (260)
T ss_pred EccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHH
Confidence 5422111 11122345678999999998899999999999999999999 88898643211 111
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
..+. .......+...+..+.+++.+||..||++||+++++++.|+.
T Consensus 214 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 214 EQVE-RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHH-cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111 111112234456678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=330.12 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=198.2
Q ss_pred CCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCC----CchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 103 PDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP----DSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 103 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
...+||+|+|-+||+|.... +|..||--.++. .....++.|..|+.+|+.|+|||||++|++|.+..
T Consensus 44 ~~evLGrGafKtVYka~De~---------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEE---------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred hhhhcccccceeeeeccccc---------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence 34589999999999996543 355555332222 13345688999999999999999999999998755
Q ss_pred --eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC-CceEEeccc
Q 013519 179 --QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS-YNAKLSDFG 255 (441)
Q Consensus 179 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~DFG 255 (441)
.+.+|+|++..|+|..|+.+.+. +....+..|++||++||.|||+++..|||||||.+||||+.+ |.|||+|+|
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchh
Confidence 48899999999999999988764 778999999999999999999999999999999999999754 899999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
||+... ........|||.|||||++. ..|+..+||||||++++||+|+.+||..... ...
T Consensus 192 LAtl~r----~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n---------------~AQ 251 (632)
T KOG0584|consen 192 LATLLR----KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN---------------PAQ 251 (632)
T ss_pred HHHHhh----ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC---------------HHH
Confidence 998643 23345589999999999775 8899999999999999999999999965321 122
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+.++........+..--.+++++||.+||.. ..+|||+.|+|++
T Consensus 252 IYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 252 IYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 23333333333333333456788999999999 9999999999985
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=308.48 Aligned_cols=252 Identities=27% Similarity=0.385 Sum_probs=200.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-----chHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-----SIQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
.+|++.+.||+|+||.||+|... .++..|+||.+... .....+.+.+|+.+++++.||||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA---------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc---------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 47889999999999999999543 34789999987532 12345678899999999999999999998
Q ss_pred EEeC--CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 174 CWED--RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 174 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
+.+. ..+++||||+++++|.+++.+.. .+++..++.++.|++.||.|||+ .+|+|+||||+|||++.++.++|
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l 147 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKL 147 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEE
Confidence 8763 56889999999999999987543 47888899999999999999997 89999999999999999999999
Q ss_pred ecccCCCCCCCCCC-cceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccc
Q 013519 252 SDFGLAKLGPIDGN-SHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330 (441)
Q Consensus 252 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 330 (441)
+|||+++....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------------- 214 (265)
T cd06652 148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------------- 214 (265)
T ss_pred CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-------------
Confidence 99999875322111 1112335688999999999988899999999999999999999999864211
Q ss_pred cchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
................+...+..+.+++.+||. +|++||++++++++
T Consensus 215 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 215 ---MAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---HHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111111111112223455566778899999994 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=319.41 Aligned_cols=267 Identities=20% Similarity=0.240 Sum_probs=195.2
Q ss_pred CCceeccc--CceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 103 PDTMLGEG--GFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 103 ~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++++||+| +|++||++.. ..+++.||+|.+.... ......+++|+.+++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARY---------KPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEEee---------cccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 45689999 7899999944 4458999999987652 334567888999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.++++||+.+.
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEEecCCcEEEcccchhh
Confidence 99999999999999999865432 358899999999999999999997 999999999999999999999999998654
Q ss_pred CCCCCCCc-----ceEeeeccccccCcchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ecccccc
Q 013519 259 LGPIDGNS-----HVTTRIMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VDFARPS 330 (441)
Q Consensus 259 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~ 330 (441)
........ .......++..|+|||++.+ ..++.++|||||||++|||++|+.||........... .....+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 229 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccc
Confidence 32111100 01122356778999999976 4688999999999999999999999964321110000 0000000
Q ss_pred cch-----hhhh-------------hh------h---cCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 331 LTD-----KRRL-------------KK------I---MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 331 ~~~-----~~~~-------------~~------~---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+ .... .. . .............+..+.+|+.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 0000 00 0 00000001122345678899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=309.26 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=189.6
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVY 184 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 184 (441)
.||+|+||.||+|..... .....+++|.+.... ......+.+|+.+++.++||||+++++++.....+++||
T Consensus 2 ~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~ 74 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL 74 (269)
T ss_pred cCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence 699999999999965432 124678999876543 233456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCC
Q 013519 185 EYMQKGSLENHLFRKGS--AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPI 262 (441)
Q Consensus 185 e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~ 262 (441)
||+++|+|.+++..... ....++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYP 152 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--cCEecccccHhheEecCCCcEEEecccccccccc
Confidence 99999999999976432 2234677889999999999999997 8999999999999999999999999999864322
Q ss_pred CCCcceEeeeccccccCcchhhhc-------CCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchh
Q 013519 263 DGNSHVTTRIMGTYGYAAPEYVAT-------GHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
...........++..|+|||++.. ..++.++|||||||++|||++ |..||......
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---------------- 216 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---------------- 216 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH----------------
Confidence 111111122345678999998753 356789999999999999999 77787543211
Q ss_pred hhhhhhcC----ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 335 RRLKKIMD----PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 335 ~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
..+..... .......+...+..+.+++..|| .||++||++++|++.|.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 217 QVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 00111000 00111223345566778898998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=324.72 Aligned_cols=258 Identities=27% Similarity=0.441 Sum_probs=219.8
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEE
Q 013519 93 DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIG 172 (441)
Q Consensus 93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 172 (441)
.++-...+.....+||-|.||.||.|.|+.. .-.||||.++.+. ..+++|..|..+|+.++|||+|+|++
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKky---------slTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLG 330 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLG 330 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeecc---------ceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhh
Confidence 3333444566678999999999999999865 3579999988664 44788999999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEe
Q 013519 173 YCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252 (441)
Q Consensus 173 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 252 (441)
+|..+..+|||+|||..|+|.+||.+... ..++.-..+.++.||..|+.||.. +++|||||...|+|+.++..||++
T Consensus 331 VCT~EpPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEk--knFIHRDLAARNCLVgEnhiVKvA 407 (1157)
T KOG4278|consen 331 VCTHEPPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHIVKVA 407 (1157)
T ss_pred hhccCCCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHH--hhhhhhhhhhhhccccccceEEee
Confidence 99999999999999999999999987653 567788889999999999999995 999999999999999999999999
Q ss_pred cccCCCCCCCCCCcceEeeecc---ccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMG---TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 328 (441)
||||++++..+. .+...| ...|.|||-+....++.|+|||+|||+|||+.| |..||.+-
T Consensus 408 DFGLsRlMtgDT----YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi------------- 470 (1157)
T KOG4278|consen 408 DFGLSRLMTGDT----YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI------------- 470 (1157)
T ss_pred ccchhhhhcCCc----eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-------------
Confidence 999999854322 222233 467999999999999999999999999999998 66777542
Q ss_pred cccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
+..++..++...++..-|..|++.+.+|++.||+++|.+||++.|+-+.|+.
T Consensus 471 ----dlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 471 ----DLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ----cHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 2344556677777888899999999999999999999999999999887764
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=314.09 Aligned_cols=260 Identities=27% Similarity=0.351 Sum_probs=202.4
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCccc
Q 013519 91 LQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLVK 169 (441)
Q Consensus 91 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~ 169 (441)
+.++....+.|++.+.||.|+||.||+|... ..++.+|+|....... ....+..|+.++.++ +||||++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~ 77 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIAT 77 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEc---------CCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEE
Confidence 4455556788999999999999999999543 3478999998865533 335678899999998 6999999
Q ss_pred eEEEEEe------CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 170 LIGYCWE------DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 170 ~~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
+++++.. ...+++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+ .+|+|+||||+||++
T Consensus 78 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dl~~~nili 154 (282)
T cd06636 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA--HKVIHRDIKGQNVLL 154 (282)
T ss_pred EeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE
Confidence 9999853 457899999999999999886543 2457888899999999999999997 899999999999999
Q ss_pred cCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 013519 244 DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPS 318 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~ 318 (441)
+.++.++|+|||++....... .......|++.|+|||++. ...++.++|||||||++|+|++|..||....+.
T Consensus 155 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~ 232 (282)
T cd06636 155 TENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232 (282)
T ss_pred CCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH
Confidence 999999999999987532111 1123456899999999886 356788999999999999999999999643221
Q ss_pred CCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 319 GEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.. ...+............++..+.+||.+||..||.+||++.+++++
T Consensus 233 ~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 233 RA----------------LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hh----------------hhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 10 001111111111122345678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=309.41 Aligned_cols=252 Identities=25% Similarity=0.421 Sum_probs=199.4
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch----------HHHHHHHHHHHHHhcCCCCCccc
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI----------QGLREWQAEVKFLGKFSHPNLVK 169 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~ 169 (441)
+|.+.+.||.|+||.||+|.. ..+++.+|+|.+..... ...+.+.+|+.+++.++||||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~---------~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALN---------VTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEee---------cCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 577889999999999999943 34578999998753211 12346788999999999999999
Q ss_pred eEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 170 LIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 170 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
+++++...+..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHS--KGILHRDLKADNLLVDADGIC 147 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh--CCeeecCCChhhEEEcCCCeE
Confidence 999999999999999999999999999765 358889999999999999999997 899999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH--LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
+|+|||+++...............|+..|+|||++.... ++.++||||||+++|+|++|..||......
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------- 218 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--------- 218 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---------
Confidence 999999997543221122233456889999999987755 789999999999999999999998532211
Q ss_pred ccccchhhhhhhhc----CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTDKRRLKKIM----DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+.+.. ...+........+..+.+++.+||..+|++||++.+++++
T Consensus 219 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 219 -------AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -------HHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0000110 1111111222345678899999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=314.73 Aligned_cols=262 Identities=27% Similarity=0.351 Sum_probs=202.1
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCccc
Q 013519 91 LQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLVK 169 (441)
Q Consensus 91 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~ 169 (441)
++.+..+.++|++.+.||+|+||.||+|... ..++.+++|.+..... ....+.+|+.+++.+ +||||++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~ 79 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNK---------KNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVK 79 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEEC---------CCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeee
Confidence 3455566789999999999999999999543 3478999998765432 235677899999999 6999999
Q ss_pred eEEEEE-----eCCeEEEEEeecCCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 170 LIGYCW-----EDRQFLLVYEYMQKGSLENHLFRK-GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 170 ~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
+++++. ....+++||||+++++|.+++... .....+++..+..++.|++.||.|||+ .+|+||||||+||++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili 157 (286)
T cd06638 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV--NKTIHRDVKGNNILL 157 (286)
T ss_pred eeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh--CCccccCCCHHhEEE
Confidence 999874 345789999999999999987642 223467889999999999999999997 899999999999999
Q ss_pred cCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 013519 244 DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPS 318 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~ 318 (441)
+.++.++|+|||+++..... ........|++.|+|||++.. ..++.++|||||||++|+|++|+.||......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~ 235 (286)
T cd06638 158 TTEGGVKLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235 (286)
T ss_pred CCCCCEEEccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence 99999999999998754221 112233468999999998853 45788999999999999999999998654321
Q ss_pred CCceeecccccccchhhhhhhhcC-ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 319 GEHVLVDFARPSLTDKRRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.. +..... .......+..++..+.+|+.+||+.||++|||+.|+++++
T Consensus 236 ~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 236 RA----------------LFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HH----------------HhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 10 000000 0000111223445688999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=313.19 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=200.3
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.|...+.||+|+||.||+|... ..+..||+|.+.... ......+.+|+.++++++||||+++++++..++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDN---------RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEc---------CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 4556678999999999999544 347789999887543 344567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEccccccc
Confidence 99999999999999998853 357889999999999999999997 999999999999999999999999999997
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
..... ........|+..|+|||++.+..++.++|||||||++|||++|..||....+... .
T Consensus 150 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------------~- 210 (277)
T cd06642 150 QLTDT--QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV----------------L- 210 (277)
T ss_pred cccCc--chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH----------------H-
Confidence 54321 1112234688999999999998999999999999999999999999864322110 0
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...........+...+..+.+++.+||..+|++||++.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 211 FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred hhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0011111112233455668899999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=308.11 Aligned_cols=251 Identities=28% Similarity=0.441 Sum_probs=201.0
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc------hHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
+|++.+.||.|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 4788899999999999998542 36789999876432 2234568899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+.+...+++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~d 145 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLID 145 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHhEEECCCCeEEecc
Confidence 999999999999999999999997643 47889999999999999999996 8999999999999999999999999
Q ss_pred ccCCCCCCCCC----CcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 254 FGLAKLGPIDG----NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 254 FGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
||++....... .........|+..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---------- 215 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---------- 215 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH----------
Confidence 99987532111 1112234568999999999999899999999999999999999999996432110
Q ss_pred ccchhhhhhhhcCc-cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKRRLKKIMDP-RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+... ......+...+..+.++|.+||..+|++||++.+++++
T Consensus 216 ------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 216 ------AMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ------HHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000 11112344556678899999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=309.44 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=203.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
..|...+.||.|+||.||+|... ..+..||+|.+.... ......+.+|+.+++++.||||+++++++.++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDN---------RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEc---------cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 35777889999999999999544 347899999876543 34566788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+++++|.+++.. .++++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEcccccc
Confidence 999999999999999998853 347888999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
...... ........++..|+|||++.+..++.++|||||||++|||++|..||....+... .
T Consensus 149 ~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------------~ 210 (277)
T cd06640 149 GQLTDT--QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV----------------L 210 (277)
T ss_pred eeccCC--ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH----------------h
Confidence 754321 1122335688899999999988999999999999999999999999865432110 0
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
...........+...+..+.+++.+||+.+|++||++.+++++-
T Consensus 211 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 211 -FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred -hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 00111111233445667788999999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=307.41 Aligned_cols=255 Identities=24% Similarity=0.447 Sum_probs=203.0
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc------hHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
+|...+.||+|+||.||+|.. ..+++.+|+|.+.... ....+.+.+|+.++++++||||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~---------~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARD---------VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEE---------cCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 477889999999999999943 3457899999886532 1235678899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC-ceEEe
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY-NAKLS 252 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~ 252 (441)
+.+.+.+++||||+++++|.+++.+.+ ++++..++.++.|++.||.|||+ .|++|+||||+||+++.++ .++|+
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~ 146 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIA 146 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEc
Confidence 999999999999999999999987543 58899999999999999999997 8999999999999998776 59999
Q ss_pred cccCCCCCCCCCC--cceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccc
Q 013519 253 DFGLAKLGPIDGN--SHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330 (441)
Q Consensus 253 DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 330 (441)
|||++........ ........|+..|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---------- 216 (268)
T cd06630 147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---------- 216 (268)
T ss_pred ccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----------
Confidence 9999875432211 1112235688999999999888999999999999999999999999864321110
Q ss_pred cchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
................+...+..+.+++.+||..+|++||++.+++++
T Consensus 217 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 217 ---LALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ---HHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 011111111111223445566778899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.55 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=201.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|.+.+.||+|+||.||+|.... +..+++|.+.... .....+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 4678999999999999999996442 4569999887543 234678889999999999999999999887
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+++++|.+++.+.. ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCcce
Confidence 77899999999999999997643 2457888999999999999999996 89999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
....... ........++..|+|||++....++.++|||||||++|++++ |..||....... .
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----------------~ 212 (260)
T cd05073 150 RVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----------------V 212 (260)
T ss_pred eeccCCC-cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH----------------H
Confidence 7543211 111122345677999999998889999999999999999999 899986432110 0
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
. ...........+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 213 ~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 213 I-RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred H-HHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 0001111112233445668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=307.75 Aligned_cols=260 Identities=28% Similarity=0.409 Sum_probs=199.9
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
|.+.++||+|+||.||+|.+... ..+++.+|||.+... .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSE------DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeecc------CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 56778999999999999976532 234789999988654 3344667889999999999999999999886532
Q ss_pred ------eEEEEEeecCCCCHHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 179 ------QFLLVYEYMQKGSLENHLFRKG---SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 179 ------~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
..+++++|+.+|+|.+++.... ....+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcCCCCE
Confidence 2478999999999998875322 12347888999999999999999997 899999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 328 (441)
||+|||+++...............+++.|++||.+....++.++|||||||++|+|++ |..||......
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---------- 222 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---------- 222 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH----------
Confidence 9999999985432221111223345678999999999899999999999999999999 88888543210
Q ss_pred cccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
.....+... .....+...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 223 ------~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 223 ------EIYNYLIKG-NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ------HHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000001110 01112233456788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=306.97 Aligned_cols=259 Identities=27% Similarity=0.373 Sum_probs=205.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++.+.||.|+||+||+|.... .+..+++|++.... ......+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 468899999999999999995433 47789999886543 23567789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++|||++++++|.+++........+++..+..++.|++.||.|||+ .||+|+||||+||++++++.++|+|||++
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 9999999999999999999764333468899999999999999999996 99999999999999999999999999998
Q ss_pred CCCCCCCCc--ceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 258 KLGPIDGNS--HVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 258 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
......... .......|+..|+|||++... .++.++|||||||++|+|++|+.||........ ....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~-------- 219 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLT-------- 219 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHH--------
Confidence 764432222 122345789999999999877 788999999999999999999999965432110 0000
Q ss_pred hhhhhhcCccccccC-ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQY-PIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ....+.+.... ....+..+.+++.+||..||++||++.+++++
T Consensus 220 --~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 220 --L-QNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred --h-cCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 00001111100 12445678899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=306.23 Aligned_cols=254 Identities=25% Similarity=0.366 Sum_probs=203.4
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEe-
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE- 176 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 176 (441)
+|.+.+.||.|+||.||++... .+++.+++|.+... .....+.+..|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRK---------SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeeec---------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 4788899999999999999543 34789999987653 23445678889999999999999999998764
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccC---CCCeeecCCCCCcEEEcCCCceEE
Q 013519 177 -DRQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSS---EKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 177 -~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~---~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
...++++|||+++++|.+++.... ....+++..++.++.|++.||.|||.. ..+|+|+||||+||+++.++.+||
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl 151 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL 151 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence 456899999999999999987532 235689999999999999999999922 389999999999999999999999
Q ss_pred ecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccccc
Q 013519 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
+|||++...... ........|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 152 ~d~g~~~~~~~~--~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------------- 215 (265)
T cd08217 152 GDFGLAKILGHD--SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------------- 215 (265)
T ss_pred ecccccccccCC--cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--------------
Confidence 999999864322 1213345789999999999988899999999999999999999999965321
Q ss_pred chhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+............+...+..+.+++.+||+.+|++||++.+|+++
T Consensus 216 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 216 ---LQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00111111111223445566778899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=306.53 Aligned_cols=247 Identities=30% Similarity=0.488 Sum_probs=198.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++|.+.+.||+|+||.||++.. .++.||+|....... ...+.+|+.+++.++||||+++++++..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 5688999999999999998742 367899998866532 35688899999999999999999998765
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||. .|++||||||+|||++.++.+||+|||+++
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCccce
Confidence 4799999999999999997653 2457899999999999999999996 999999999999999999999999999987
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
..... ......+..|+|||.+.+..++.++|||||||++|+|++ |+.||....... .
T Consensus 149 ~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----------------~ 206 (254)
T cd05083 149 VGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----------------V 206 (254)
T ss_pred ecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----------------H
Confidence 53211 112234567999999998899999999999999999998 999986432110 0
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
............+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 207 KECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11111111222234456678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=311.27 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=193.2
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVY 184 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 184 (441)
+.||.|+||.||+|....... ........+++|.+........+.+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGD--YGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeeccccc--ccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 369999999999997643210 011234568888887665555677889999999999999999999999989999999
Q ss_pred eecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc--------eEEecccC
Q 013519 185 EYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN--------AKLSDFGL 256 (441)
Q Consensus 185 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--------~kl~DFGl 256 (441)
||+++|+|.+++...+ ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++. ++++|||+
T Consensus 79 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 79 EYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred ecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999997654 357889999999999999999996 99999999999999987765 69999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCC-CCCCCCCCCCCceeecccccccchh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGL-RALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++|. .||....+.
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~---------------- 212 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ---------------- 212 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH----------------
Confidence 864321 2235688899999999864 5789999999999999999995 554332110
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
. ....... ...++......+.+|+.+||+.+|++|||++++++.|+
T Consensus 213 ~-~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 213 K-KLQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred H-HHHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0001111 11233344456889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=295.84 Aligned_cols=250 Identities=27% Similarity=0.411 Sum_probs=198.6
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCC-CCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFS-HPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 177 (441)
+.+.+..||.|+.|.|++++.. .+|..+|||.+... +.+..+.+...+.++.... +|+||+++++|..+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~r---------s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFR---------STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEc---------ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 3445668999999999999554 45889999988765 4455667777787776665 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..++|.||.|.. -++.++.+.. .++++..+-++...++.||.||-. +++|+|||+||+|||+|..|++||||||++
T Consensus 164 ~dV~IcMelMs~-C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 164 TDVFICMELMST-CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred chHHHHHHHHHH-HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeeccccc
Confidence 999999999843 4555554433 568899999999999999999986 789999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
.... .+...+...|-+.|||||-+.- ..|+.++||||||+.|+||.||..||.+..- +-
T Consensus 240 Grlv---dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t---------------dF 301 (391)
T KOG0983|consen 240 GRLV---DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT---------------DF 301 (391)
T ss_pred ceee---cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc---------------cH
Confidence 7543 2233455679999999998853 4688999999999999999999999976532 22
Q ss_pred hhhhhhcCccccccCC--hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYP--IKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+.+.++++... ...+ ..+++.+.+|+..||..|+.+||...++|+|
T Consensus 302 e~ltkvln~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 302 EVLTKVLNEEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHHhcCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 33334443221 1111 2267778899999999999999999999986
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=315.83 Aligned_cols=255 Identities=27% Similarity=0.377 Sum_probs=203.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||.||+|... .+++.||+|.+..... ...+.+..|+++++.++||||+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLK---------GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEc---------CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 36888899999999999999543 3578999998876532 24567888999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
.....++||||+.+++|.+++.+.. ...+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecc
Confidence 9999999999999999999886532 3568999999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCc---------------------------ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhC
Q 013519 256 LAKLGPIDGNS---------------------------HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG 308 (441)
Q Consensus 256 la~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg 308 (441)
++......... .......||..|+|||++.+..++.++||||||+++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 98653221100 011134688999999999998999999999999999999999
Q ss_pred CCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 013519 309 LRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS----MEEVLET 381 (441)
Q Consensus 309 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~eil~~ 381 (441)
..||...... ..+..+.............+..+.+++.+||..||++||+ +++++.+
T Consensus 229 ~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 229 TTPFKGSNRD----------------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCCCchH----------------HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 9999654221 1111122111111111124667899999999999999999 8888775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=320.80 Aligned_cols=262 Identities=28% Similarity=0.430 Sum_probs=215.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.+...+.+.||+|.||.||+|..... ++...-.||||..+.+ ..+..+.|..|..+|+.++|||||+++|+|.+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~-----~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDP-----EKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEeccc-----ccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 34455667899999999999987653 2344567999998875 34557889999999999999999999999965
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...+||||+++.|.|..+|..+. ..++......++.||+.||+|||+ ..+|||||...|||+.+.--|||+|||+
T Consensus 463 -~P~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred -cceeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeecccch
Confidence 46899999999999999998765 468889999999999999999998 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++....... ...+...-...|||||.+....++.++|||-|||++||++. |..||.+-...+...
T Consensus 538 SR~~ed~~y-YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~------------- 603 (974)
T KOG4257|consen 538 SRYLEDDAY-YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG------------- 603 (974)
T ss_pred hhhccccch-hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------------
Confidence 998654332 22333344578999999999999999999999999999886 889997643322111
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
.+...-+-..|..|++.+..|+.+||..+|.+||.+.++...|..+..
T Consensus 604 ----~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 ----HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ----EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 112223335688899999999999999999999999999998876644
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=304.89 Aligned_cols=249 Identities=29% Similarity=0.433 Sum_probs=201.8
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-----hHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-----IQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
+|+..+.||+|+||+||+|... .++..|++|.+.... .+..+.+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL---------DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEEc---------CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 4777889999999999999554 347899999875432 23456788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+...+++|+||+++++|.+++.+.. .+++..++.++.|++.||.|||+ .+|+|+||+|+||+++.++.+||+||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccC
Confidence 99999999999999999999986543 57899999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH-LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
|++....... ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||......
T Consensus 147 ~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--------------- 208 (258)
T cd06632 147 GMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--------------- 208 (258)
T ss_pred ccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH---------------
Confidence 9987532221 234467899999999987776 889999999999999999999998643210
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...............+...+..+.+++.+||..+|++||++.+++.+
T Consensus 209 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 209 -AAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -HHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 00111111011122344556778899999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=311.72 Aligned_cols=246 Identities=28% Similarity=0.412 Sum_probs=202.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||.||++.... .++.+|+|.+.... ......+.+|+++|+++.||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 368889999999999999996543 47899999876532 234566888999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+.+.+++||||+++++|.+++.+. ..++...+..++.|++.||.|||+ .||+|+||+|.|||++.++.+||+|||
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCC
Confidence 999999999999999999998765 358899999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+++..... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ..
T Consensus 147 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~ 205 (290)
T cd05580 147 FAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----------------IQ 205 (290)
T ss_pred CccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----------------HH
Confidence 99764322 2345789999999999888889999999999999999999999864321 01
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
....+... ...++...+..+.+++.+||..||.+|+ ++++++++
T Consensus 206 ~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 206 IYEKILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHHHhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11111111 1123444567788999999999999999 78888865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=305.28 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=202.9
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|++.+.||+|+||.||++... ..++.|++|.+... .......+.+|+.++++++||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK---------EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc---------CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 4888999999999999999543 34789999987643 233456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+.+++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||+|+|||++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 999999999999999998865432 357889999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
...... ........|++.|+|||++.+..++.++|||||||++|+|++|..||..... ....
T Consensus 149 ~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----------------~~~~ 210 (256)
T cd08218 149 RVLNST--VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM----------------KNLV 210 (256)
T ss_pred eecCcc--hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH----------------HHHH
Confidence 753221 1112234688899999999988999999999999999999999999854211 1111
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+.... ....+...+..+.++|.+||+.+|++||++.+++++
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 211 LKIIRGS-YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHhcCC-CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111111 112344556678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=304.90 Aligned_cols=252 Identities=27% Similarity=0.449 Sum_probs=199.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|++.+.||+|+||.||+|.+.. +..+++|.+..... ....+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 467888999999999999996542 45799998865432 2346788999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||+.+++|.+++.... ..+++..++.++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||+++
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLES--SNVIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccccceEEEcCCCeEEECCCccee
Confidence 9999999999999999986543 357889999999999999999997 899999999999999999999999999987
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
...... ........++..|+|||++.+..++.++||||||+++|||++ |..||...... ...
T Consensus 149 ~~~~~~-~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----------------~~~ 211 (256)
T cd05112 149 FVLDDQ-YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS----------------EVV 211 (256)
T ss_pred ecccCc-ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH----------------HHH
Confidence 532211 111112234568999999998899999999999999999998 89998643210 011
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
..+ ........+...+..+.+|+.+||+.+|++||++.++++.|.
T Consensus 212 ~~~-~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 212 ETI-NAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHH-hCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 111 111111123334567889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=304.34 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=189.1
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVY 184 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 184 (441)
.||+|+||+||+|..... .....+++|.+.... ......+.+|+.+++.++||||+++++.+.+....++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTD-------TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcC-------CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence 699999999999965322 123467778766543 344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 185 EYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 185 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
||+++|+|.+++.+... ...+++..++.++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE 152 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEecccccccccCcc
Confidence 99999999999976432 2346677888999999999999996 89999999999999999999999999998642211
Q ss_pred CCcceEeeeccccccCcchhhhc-------CCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCCceeecccccccchhh
Q 013519 264 GNSHVTTRIMGTYGYAAPEYVAT-------GHLYVKSDVYGFGVVLLEMLTG-LRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
..........++..|+|||++.. ..++.++|||||||++|||+++ ..||...... .
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----------------~ 216 (268)
T cd05086 153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR----------------E 216 (268)
T ss_pred hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH----------------H
Confidence 11112234568899999998743 2457899999999999999974 6677532210 1
Q ss_pred hhhhhcCc----cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 336 RLKKIMDP----RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 336 ~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
.+..+... ......+...+..+.+++..|| .+|++||++.+|++.|.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 217 VLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111000 0111222335566788999999 68999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=302.44 Aligned_cols=256 Identities=30% Similarity=0.480 Sum_probs=202.2
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-HHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-GLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 179 (441)
+.+.+.||.|+||.||+|.+.... ...+..+|+|.+...... ....+..|+.++..++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLS-----GEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCC-----CCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 356789999999999999765421 123488999998766543 56788899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
.++||||+++++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++.
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~--~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhc--CCeeecccccceEEEccCCeEEEcccCCcee
Confidence 9999999999999999875432 228899999999999999999997 8999999999999999999999999999976
Q ss_pred CCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 260 GPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .....
T Consensus 153 ~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----------------~~~~~ 215 (258)
T smart00219 153 LYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----------------EEVLE 215 (258)
T ss_pred cccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHH
Confidence 43221111 112236789999999988889999999999999999998 7788754211 00011
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.+.. ......+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 216 ~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 216 YLKK-GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHhc-CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111 111122334566788999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.36 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=215.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHH-HHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.+...+.+.||+|-||.|.+|.... +..||+|+++...... ...|.+|+++|.+|+|||||+++++|..
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~ 606 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ 606 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence 4567788999999999999996653 5799999999886544 4789999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++.+++|+||++.|+|..++.++... .+.......|+.||+.|++||.+ .++|||||.+.|+|++.++++||+|||+
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes--~nfVHrd~a~rNcLv~~e~~iKiadfgm 683 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLES--LNFVHRDLATRNCLVDGEFTIKIADFGM 683 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHh--hchhhccccccceeecCcccEEecCccc
Confidence 99999999999999999999876432 23456677899999999999998 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCCCceeecccccccchh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT--GLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
++..-.........+.+-...|||||.+.-++++.++|||+||+++||+++ ...||....... . .
T Consensus 684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--v-----------v 750 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--V-----------V 750 (807)
T ss_pred ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--H-----------H
Confidence 996544445555556677789999999999999999999999999999875 567775432110 0 0
Q ss_pred hhhhhhcCc---cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 335 RRLKKIMDP---RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 335 ~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
+....+++. ......|..|+..+.+++.+||..|-++||+++++..+|+..
T Consensus 751 en~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 751 ENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111122222 122245778889999999999999999999999999998754
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=313.76 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=200.3
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 179 (441)
.|.....||+|+||.||++... ..+..||||.+........+.+.+|+.+++.++||||+++++.+...+.
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEK---------HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEEC---------CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 3444567999999999999543 3478999999876655556778899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
.++||||+++++|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++..
T Consensus 94 ~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred EEEEEeCCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 9999999999999998743 247889999999999999999997 8999999999999999999999999999875
Q ss_pred CCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhh
Q 013519 260 GPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339 (441)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (441)
..... .......|+..|+|||.+.+..++.++||||||+++|||++|..||....... ....+..
T Consensus 168 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------------~~~~~~~ 232 (292)
T cd06658 168 VSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-------------AMRRIRD 232 (292)
T ss_pred ccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------------HHHHHHh
Confidence 32211 12234578999999999988899999999999999999999999986432110 0011111
Q ss_pred hcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+.+... .....+..+.+++.+||..||.+|||+++++++
T Consensus 233 ~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 233 NLPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111111 112345568899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=303.81 Aligned_cols=256 Identities=24% Similarity=0.364 Sum_probs=201.4
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC----------chHHHHHHHHHHHHHhc-CCCCCcc
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD----------SIQGLREWQAEVKFLGK-FSHPNLV 168 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~E~~~l~~-l~hpniv 168 (441)
.|.+.+.||+|+||.||+|..... .++.+|+|.+... .......+.+|+.++.+ ++||||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 477888999999999999976542 3678999976532 22344567788888875 7899999
Q ss_pred ceEEEEEeCCeEEEEEeecCCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 169 KLIGYCWEDRQFLLVYEYMQKGSLENHLFRK-GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 169 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
++++++..++..++||||+++++|.+++... .....+++..++.++.|++.+|.|||+ ..+++|+||||+|||++.++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-CCceeecCCCHHHEEECCCC
Confidence 9999999999999999999999999987542 223468899999999999999999995 36899999999999999999
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
.++|+|||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 152 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------- 219 (269)
T cd08528 152 KVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------- 219 (269)
T ss_pred cEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---------
Confidence 99999999997643221 234467899999999999888999999999999999999999998543110
Q ss_pred ccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 328 RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
.....+.............+..+.+++.+||+.||++||++.|+..+++
T Consensus 220 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 -------SLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -------HHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0011111111111112234567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=307.84 Aligned_cols=255 Identities=29% Similarity=0.384 Sum_probs=200.4
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
..++|++.+.||.|+||.||+|... .+++.+++|.+...... ...+.+|+.+++++ .||||+++++++.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHK---------KTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEEC---------CCCcEEEEEEEecCchh-HHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 4578999999999999999999543 34788999988765543 35788999999999 6999999999997
Q ss_pred eCC------eEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 176 EDR------QFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 176 ~~~------~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
... .+++||||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~~~~~~ 151 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAE 151 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEEccCCe
Confidence 644 4899999999999999886532 23468899999999999999999997 89999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~ 323 (441)
++|+|||++...... ........|+..|+|||++.. ..++.++|||||||++|+|++|..||......
T Consensus 152 ~~l~d~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----- 224 (275)
T cd06608 152 VKLVDFGVSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM----- 224 (275)
T ss_pred EEECCCccceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-----
Confidence 999999998753221 122234568999999998854 34678899999999999999999999643211
Q ss_pred ecccccccchhhhhhhhcCccc-cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 324 VDFARPSLTDKRRLKKIMDPRL-EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+..+..... ....+...+..+.+|+.+||..||++|||+.+++++
T Consensus 225 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 225 -----------RALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -----------HHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 01111111100 111122355678899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=303.28 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=201.9
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|++.+.||+|+||.||+|... .+++.+++|.+.... ......+.+|+.+|+.++||||+++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK---------ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEc---------CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 5888899999999999999554 347899999876542 33456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC-CceEEecccC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS-YNAKLSDFGL 256 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~DFGl 256 (441)
+..++||||+++++|.+++.... ...+++..+..++.+++.+|.|||+ ++|+|+||||+||+++.+ +.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 99999999999999999997643 2458899999999999999999997 999999999999999855 4589999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||...... ..
T Consensus 149 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----------------~~ 209 (256)
T cd08220 149 SKILSSK---SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----------------AL 209 (256)
T ss_pred ceecCCC---ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH----------------HH
Confidence 9754322 1223356889999999999888999999999999999999999998643211 01
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+.... ....+...+..+.+++.+||..+|++|||+.+++.+
T Consensus 210 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 210 VLKIMSGT-FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHhcC-CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11111111 112334456678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=314.76 Aligned_cols=266 Identities=23% Similarity=0.297 Sum_probs=195.7
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|.+.+.||+|+||.||+|... .+|+.+++|.+..... .....+.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~---------~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC---------CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 4788899999999999999543 4578999998865322 2234567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..+++|+||+. ++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccchh
Confidence 99999999997 47888776533 358999999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee--ec-ccccccch
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGH-LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL--VD-FARPSLTD 333 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~--~~-~~~~~~~~ 333 (441)
+...... .......+++.|+|||++.+.. ++.++|||||||++|+|+||..||........... .. ...+....
T Consensus 147 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07839 147 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEES 224 (284)
T ss_pred hccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHH
Confidence 7532211 1123346788999999987754 68999999999999999999988643221110000 00 00000000
Q ss_pred hhhhhhhcCcc----cc-----ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 334 KRRLKKIMDPR----LE-----EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 334 ~~~~~~~~~~~----~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+....+.. .. .......+..+.+||.+||+.||.+|||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000000 00 01112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=314.92 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=188.2
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEe--CCeEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE--DRQFLL 182 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 182 (441)
.+||+|+||+||+|..... ..+..||+|.+..... ...+.+|+.+|+.++||||+++++++.. +..+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~-------~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDG-------KDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eEeccCCCeeEEEEEecCC-------CccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 5899999999999965432 2367899998876532 2356789999999999999999998854 567899
Q ss_pred EEeecCCCCHHHHHHhcC------CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE----cCCCceEEe
Q 013519 183 VYEYMQKGSLENHLFRKG------SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL----DGSYNAKLS 252 (441)
Q Consensus 183 v~e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~kl~ 252 (441)
||||+.+ +|.+++.... ....+++..++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 9999965 7777764321 12357889999999999999999997 899999999999999 566789999
Q ss_pred cccCCCCCCCCCC-cceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee------
Q 013519 253 DFGLAKLGPIDGN-SHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV------ 324 (441)
Q Consensus 253 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~------ 324 (441)
|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||+||+.||............
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence 9999986432211 1122345789999999998764 5789999999999999999999999654321110000
Q ss_pred -----cccccccchhhhh---------hhhcC------ccc---cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 325 -----DFARPSLTDKRRL---------KKIMD------PRL---EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 325 -----~~~~~~~~~~~~~---------~~~~~------~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+.......+ ...+. ... ........+..+.+|+.+||+.||.+|||+.|+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000000 00000 000 000111223457789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=315.84 Aligned_cols=249 Identities=28% Similarity=0.384 Sum_probs=207.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH---HHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ---GLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.+.|+.-++||+||||.||-+ ....+|+.||+|.+.+.... .......|-.||.+++.++||.+-..|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~ac---------qvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCAC---------QVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred ccceeeeEEEecccccceeEE---------EEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 356888899999999999998 55567999999987654332 233456799999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
+..+.+++||..|.||+|.-+|...+. ..+++..++.++.+|+.||.+||. .+||+|||||+|||||+.|+++|+|+
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHh--cceeeccCChhheeeccCCCeEeecc
Confidence 999999999999999999999988775 679999999999999999999997 99999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|||..+... ......+||.+|||||++.++.|+...|+|||||+||||+.|+.||...... ...
T Consensus 332 GLAvei~~g---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-------------vk~ 395 (591)
T KOG0986|consen 332 GLAVEIPEG---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-------------VKR 395 (591)
T ss_pred ceEEecCCC---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-------------hhH
Confidence 999865432 2233348999999999999999999999999999999999999999643211 111
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM 375 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 375 (441)
+.+.... ......++...++++++|...+|..||++|...
T Consensus 396 eEvdrr~-~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 396 EEVDRRT-LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHH-hcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1111111 123346788889999999999999999999754
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.08 Aligned_cols=264 Identities=29% Similarity=0.337 Sum_probs=203.9
Q ss_pred ccCHHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCC
Q 013519 88 MFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPN 166 (441)
Q Consensus 88 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpn 166 (441)
.+++.++..+.++|.+.+.||+|+||.||+|.. ..+++.+|+|.+..... ....+.+|+.+++++ +|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~---------~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~n 80 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTN---------KKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPN 80 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEE---------CCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCC
Confidence 345566666788999999999999999999944 34588999998865432 235677899999999 7999
Q ss_pred ccceEEEEEeC-----CeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCc
Q 013519 167 LVKLIGYCWED-----RQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASN 240 (441)
Q Consensus 167 iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~N 240 (441)
|+++++++... ..+++||||+++++|.+++.... ....+++..++.++.|++.||.|||. .+++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~n 158 (291)
T cd06639 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNN 158 (291)
T ss_pred eEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHH
Confidence 99999998754 35899999999999999886421 23468899999999999999999997 899999999999
Q ss_pred EEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC-----CCCccccchhHHHHHHHHHhCCCCCCCC
Q 013519 241 ILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-----HLYVKSDVYGFGVVLLEMLTGLRALDTN 315 (441)
Q Consensus 241 ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~elltg~~p~~~~ 315 (441)
|+++.++.+||+|||++....... .......|+..|+|||++... .++.++|||||||++|+|++|+.||...
T Consensus 159 ili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 159 ILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEEcCCCCEEEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999987533211 112234688999999988643 3678999999999999999999998643
Q ss_pred CCCCCceeecccccccchhhhhhhhcCc-cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 316 RPSGEHVLVDFARPSLTDKRRLKKIMDP-RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+. ..+..+... ......+......+.+||.+||+.+|++||++.+++++
T Consensus 237 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 237 HPV----------------KTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cHH----------------HHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 211 001111100 00011123344568899999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=311.74 Aligned_cols=255 Identities=22% Similarity=0.346 Sum_probs=199.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||.||++.. ..+++.|++|.+..... .....+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~---------~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRH---------KETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEE---------CCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 3688899999999999999944 34578999998876532 33556788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
.++.+++||||++|++|.+++...+ .+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHEEECCCCCEEEeeCC
Confidence 9999999999999999999996543 58899999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCc-------------ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce
Q 013519 256 LAKLGPIDGNS-------------HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV 322 (441)
Q Consensus 256 la~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~ 322 (441)
+++........ .......|+..|+|||.+.+..++.++|||||||++|||++|..||......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---- 222 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---- 222 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 98742111000 0111246788999999999889999999999999999999999999643211
Q ss_pred eecccccccchhhhhhhhcCccc-cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 323 LVDFARPSLTDKRRLKKIMDPRL-EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
........... ....+...+..+.++|.+||+.+|++||++.++++.|+
T Consensus 223 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 223 ------------ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ------------HHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 00111111100 00111235566889999999999999998655555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=344.79 Aligned_cols=259 Identities=25% Similarity=0.310 Sum_probs=215.8
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCc
Q 013519 91 LQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNL 167 (441)
Q Consensus 91 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpni 167 (441)
+.+++.-.++|+++++||+|+||.|.++ +.+.+++.||+|++++- ......-|..|-.+|..-+.+-|
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lV---------r~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wi 137 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALV---------RHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWI 137 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEE---------EeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHH
Confidence 3445556789999999999999999998 55566899999998762 12234568889999999999999
Q ss_pred cceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 168 VKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 168 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
++++..|++++++|+||||++||+|..++.+.+ .+|+..++.++..|+.||.-||+ .|+|||||||+|||||..|
T Consensus 138 v~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~--mgyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 138 VQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHS--MGYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred HHHHHHhcCccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHh--ccceeccCCcceeEecccC
Confidence 999999999999999999999999999997665 68999999999999999999997 9999999999999999999
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV 322 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~ 322 (441)
++||+|||.+-....++ .-.....+|||.|++||++.. +.|+..+|+||+||++|||+.|..||....
T Consensus 213 HikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------ 285 (1317)
T KOG0612|consen 213 HIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------ 285 (1317)
T ss_pred cEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------
Confidence 99999999986544333 223455789999999999953 568899999999999999999999996532
Q ss_pred eecccccccchhhhhhhhcCccccccCC--hhhHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 013519 323 LVDFARPSLTDKRRLKKIMDPRLEEQYP--IKGALLAGQIIIKCLEAEPKNRPS---MEEVLET 381 (441)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps---~~eil~~ 381 (441)
-.+.+.+|++..-.-.+| ...+..+++||.+.+ -+|+.|.. ++++-.|
T Consensus 286 ----------lveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 286 ----------LVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ----------HHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 124455666654444555 457888999999977 57889988 9999876
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=310.23 Aligned_cols=267 Identities=28% Similarity=0.356 Sum_probs=198.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR---------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC---------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 36888999999999999999544 347899999875432 1223457789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...+++||||++++.|..++... ..+++..++.++.|++.+|.|||+ .+|+|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred CCEEEEEEeccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECcccc
Confidence 99999999999998887776433 358899999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeec-ccccccchh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD-FARPSLTDK 334 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~ 334 (441)
+........ ......++..|+|||++.+ ..++.++||||||+++|+|++|..||............. .........
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07847 147 ARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224 (286)
T ss_pred ceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 976432211 1223467889999999876 457899999999999999999999997543221110000 000000000
Q ss_pred -------hhhhhhcCccccccC-----ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 -------RRLKKIMDPRLEEQY-----PIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 -------~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
........+...... ....+..+.+|+.+||+.+|++||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000000000 01235668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=296.02 Aligned_cols=268 Identities=25% Similarity=0.369 Sum_probs=208.5
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccc
Q 013519 91 LQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVK 169 (441)
Q Consensus 91 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~ 169 (441)
+.++-..++ ++||+|+|+.|--+ +...++..||||++.+...-....+.+|++++.+.+ |+||++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtc---------v~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilq 140 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTC---------VSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQ 140 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeee---------eeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHH
Confidence 455544444 48999999999887 566679999999998876666678889999999997 999999
Q ss_pred eEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC--
Q 013519 170 LIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY-- 247 (441)
Q Consensus 170 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-- 247 (441)
++++|+++..+|||||.+.||+|...|.++. .+++.++..++.+|+.||.|||. +||.||||||+|||.....
T Consensus 141 LiefFEdd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~--kgIAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 141 LIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHT--KGIAHRDLKPENILCESPNKV 215 (463)
T ss_pred HHHHhcccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhh--cCcccccCCccceeecCCCCc
Confidence 9999999999999999999999999998764 58899999999999999999996 9999999999999996544
Q ss_pred -ceEEecccCCCCCCCCC-----CcceEeeeccccccCcchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 013519 248 -NAKLSDFGLAKLGPIDG-----NSHVTTRIMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLLEMLTGLRALDTNR 316 (441)
Q Consensus 248 -~~kl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~ 316 (441)
-||||||.|..-..... ......+.+|+..|||||++. ...|+.+.|.||||||||.||+|..||.+.-
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 48999999875322211 112234578999999999873 2468899999999999999999999997654
Q ss_pred CCCCceeecccccccchh---hhhhhhcCcc--ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 317 PSGEHVLVDFARPSLTDK---RRLKKIMDPR--LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+ ..|.+...... ..+..|.+.. +...-....+.++++++..+|..|+..|.++..++.+
T Consensus 296 g~d----CGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 296 GAD----CGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CCc----CCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 321 12222222111 1112222211 1222234567889999999999999999999999984
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=310.00 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=203.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|.+.+.||.|+||.||++... ..++.|++|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDV---------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEc---------CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 57899999999999999999443 347789999987655455567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++|+||+++++|.+++.+. .+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++.
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~--~gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh--CCEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 999999999999999998643 47789999999999999999996 999999999999999999999999999886
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
...... .......|++.|+|||.+....++.++|||||||++|+|++|+.||............. .
T Consensus 164 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~--~---------- 229 (293)
T cd06647 164 QITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--T---------- 229 (293)
T ss_pred cccccc--cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh--c----------
Confidence 533221 12233568899999999988889999999999999999999999997543321111000 0
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
........+...+..+.+++.+||..+|++||++.+++.+
T Consensus 230 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 230 ---NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ---CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000001122344568899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=304.86 Aligned_cols=254 Identities=29% Similarity=0.385 Sum_probs=203.3
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
+|+..+.||.|+||.||+|... ..++.+++|.+.... ......+.+|+.+++++.||||+++++++...+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHR---------PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEc---------CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC
Confidence 5778889999999999999544 347899999887653 244567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.+++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~-~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcC-CCCeecCCCCHHHEEECCCCCEEEeecccch
Confidence 9999999999999999987643 468899999999999999999995 3799999999999999999999999999986
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|..||......... ....+.
T Consensus 150 ~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----------~~~~~~ 214 (265)
T cd06605 150 QLVNS----LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-----------IFELLQ 214 (265)
T ss_pred hhHHH----HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-----------HHHHHH
Confidence 53211 111267889999999999999999999999999999999999999643211000 001111
Q ss_pred hhcCccccccCChh-hHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 339 KIMDPRLEEQYPIK-GALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 339 ~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+..... ...+.. .+..+.++|.+||..+|++||++.+++.+
T Consensus 215 ~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 215 YIVNEPP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHhcCCC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111111 111222 56678899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=307.23 Aligned_cols=253 Identities=28% Similarity=0.373 Sum_probs=193.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHH-HhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKF-LGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~ 176 (441)
++|.+.+.||+|+||.||+|.. ..+++.||+|.+..... .....+..|+.+ ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRH---------VPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEE---------cCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 3688899999999999999944 34589999998876432 222344456654 666789999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHhhhccCCC-CeeecCCCCCcEEEcCCCceEEecc
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRK-GSAEPLPWNTRLKIAIDAAKDLTFLHSSEK-SVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
++..++||||++ |+|.+++... .....+++..++.++.|++.||.|||+ + +++||||||+|||++.++.+||+||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999996 6888877642 223568999999999999999999996 5 8999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhc----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccc
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT----GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 330 (441)
|+++..... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 149 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------------ 213 (283)
T cd06617 149 GISGYLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------------ 213 (283)
T ss_pred ccccccccc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------------
Confidence 999754221 11223468899999998865 45688999999999999999999998532110
Q ss_pred cchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+...............++..+.++|.+||..+|++||++.+++++
T Consensus 214 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 214 ---FQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ---HHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111111111111112345678899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=311.71 Aligned_cols=268 Identities=26% Similarity=0.362 Sum_probs=201.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++.+.||+|+||.||+|... .+++.|++|+++... ......+.+|+++++.++||||+++++++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~---------~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNK---------ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeC---------CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 36888999999999999999554 347899999876542 2234678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
.+..++||||++++.+..++.+. ..+++..+..++.|++.||.|||. .+++|+||+|+||+++.++.+||+|||+
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEEeeec
Confidence 99999999999987766555332 348899999999999999999996 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch--
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD-- 333 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 333 (441)
+........ .......++..|+|||++.+. .++.++||||||+++|+|++|+.||..................+..
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07833 147 ARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSH 225 (288)
T ss_pred ccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 976433221 122345788999999999888 8889999999999999999999998654221100000000000000
Q ss_pred ------hh-----hhhhhcCc-cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 334 ------KR-----RLKKIMDP-RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 334 ------~~-----~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.. .......+ .....++..++..+.+||.+||..+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 00000000 01112333446778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=301.38 Aligned_cols=254 Identities=28% Similarity=0.396 Sum_probs=206.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++.+.||.|+||.||+|... .+++.|++|++..... .....+.+|+.++.+++||||+++++++...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~---------~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHK---------PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEc---------CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence 36888999999999999999443 4588999999877654 4457788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..+++||||+++++|.+++... ..+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~-~~~~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHT-KRHIIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhc-cCCCccCCCCHHHEEECCCCCEEEccCccc
Confidence 9999999999999999999765 458899999999999999999993 289999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
....... .......++..|+|||.+....++.++||||||+++|+|++|..||...... ......
T Consensus 148 ~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-------------~~~~~~ 212 (264)
T cd06623 148 KVLENTL--DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-------------SFFELM 212 (264)
T ss_pred eecccCC--CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-------------CHHHHH
Confidence 7643222 1123456889999999999999999999999999999999999999654320 001111
Q ss_pred hhhcCccccccCChh-hHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIMDPRLEEQYPIK-GALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+..... ...+.. .+..+.++|.+||..+|++||++.+++++
T Consensus 213 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 213 QAICDGPP-PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHhcCCC-CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111111 122333 56678899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=353.03 Aligned_cols=255 Identities=26% Similarity=0.353 Sum_probs=207.6
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.+-+|.-...||.|.||.||-| ....+|...|+|.++.. .......+.+|+.+|..++|||+|+++++=
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYta---------vN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE 1303 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTA---------VNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE 1303 (1509)
T ss_pred ceeeeccccccCCcceeeeEEe---------ecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCcee
Confidence 4557777889999999999999 55566999999976543 344566788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
...+.++|.||||++|+|.+.+...+ .+++.....+..|++.|++|||. .|||||||||+||||+.+|.+|++||
T Consensus 1304 vHRekv~IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~--~gIVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1304 VHREKVYIFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHE--HGIVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred ecHHHHHHHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHh--cCceecCCCccceeeecCCcEEeecc
Confidence 99999999999999999999886543 36667777889999999999996 99999999999999999999999999
Q ss_pred cCCCCCCCCC--CcceEeeeccccccCcchhhhcC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 255 GLAKLGPIDG--NSHVTTRIMGTYGYAAPEYVATG---HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 255 Gla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
|.|....... -........||+.|||||++.+. +..-++||||||||++||+||+.||...+..
T Consensus 1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne----------- 1447 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE----------- 1447 (1509)
T ss_pred cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-----------
Confidence 9997643221 01112346899999999999764 4567899999999999999999999654221
Q ss_pred ccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+...+...-...+|...+.+..+||.+||+.||++|+++.|++++
T Consensus 1448 -----~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1448 -----WAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----hHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11111122223345677788899999999999999999999999987
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=310.50 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=197.8
Q ss_pred CCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 013519 102 RPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFL 181 (441)
Q Consensus 102 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 181 (441)
.....||+|+||.||+|... ..++.||+|.+..........+.+|+.+++.+.||||+++++++..++..+
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 94 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREK---------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELW 94 (297)
T ss_pred HhhhhcCCCCceeEEEEEEc---------CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEE
Confidence 33457999999999999543 347899999986654444567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCC
Q 013519 182 LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP 261 (441)
Q Consensus 182 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~ 261 (441)
+||||+++++|..++.. ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++....
T Consensus 95 iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred EEEecCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence 99999999999987743 347899999999999999999997 899999999999999999999999999986532
Q ss_pred CCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhc
Q 013519 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341 (441)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (441)
.. ........|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...+....
T Consensus 169 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------------~~~~~~~~ 233 (297)
T cd06659 169 KD--VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-------------MKRLRDSP 233 (297)
T ss_pred cc--cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHhccC
Confidence 21 1122346789999999999988999999999999999999999999964321100 00000000
Q ss_pred CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 342 DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+. ...+...+..+.+++.+||+.+|++||++.+++++
T Consensus 234 ~~~--~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 234 PPK--LKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCC--ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 01122344567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=307.41 Aligned_cols=267 Identities=26% Similarity=0.331 Sum_probs=200.2
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|++.+.||+|+||.||+|... .+++.|++|++.... ......+.+|+.++++++||||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR---------ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC---------CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 5888899999999999999543 347899999886654 23346788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..+++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHA--NGIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 9999999999 999999986544 568999999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce--eeccccc-----
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--LVDFARP----- 329 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~~~~~~~----- 329 (441)
........ .......|+..|+|||++.+. .++.++|||||||++|+|++|..||.......... +..+..+
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07832 147 RLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETW 225 (286)
T ss_pred ccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHH
Confidence 76433221 112335689999999988654 46899999999999999999987775432110000 0000000
Q ss_pred -ccchhhhhhhhcCccc----cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 -SLTDKRRLKKIMDPRL----EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 -~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+........+..+.. ........+..+.+|+.+||..+|++||++++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000000 000112334678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=307.25 Aligned_cols=244 Identities=30% Similarity=0.422 Sum_probs=205.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCC-CCCccceEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFS-HPNLVKLIGY 173 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~~~~~ 173 (441)
..+|.++.+||+|+||+|.+| ..+.+...+|||+++.+.. +.++--..|-++|.... -|.+++++..
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLa---------erkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred ecccceEEEeccCccceeeee---------cccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence 467899999999999999999 4455678999999887633 22333345777887764 7899999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
|+.-+.+|+||||+.||+|...+.+.+. +.+..+..++.+|+.||-|||+ +|||+||||.+|||||.+|++||+|
T Consensus 419 FQTmDRLyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~--kgIiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 419 FQTMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred hhhhhheeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhc--CCeeeeeccccceEeccCCceEeee
Confidence 9999999999999999999999988775 6678889999999999999997 9999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
||+++..... ...+.++||||.|+|||++..++|+..+|+||+||+||||+.|..||++.+.
T Consensus 494 FGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---------------- 555 (683)
T KOG0696|consen 494 FGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---------------- 555 (683)
T ss_pred cccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH----------------
Confidence 9999864332 3346779999999999999999999999999999999999999999987532
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM 375 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 375 (441)
.+....+++.. -.+|...+.++..+....|...|.+|...
T Consensus 556 ~elF~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 556 DELFQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred HHHHHHHHHcc--CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence 22333344332 25788888999999999999999999643
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=303.42 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=200.6
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
-|.+.+.||.|+||.||+|... ..+..+|+|...... ......+.+|+.++++++||||+++++++..+.
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN---------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC---------CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 4777889999999999999543 347899999876543 334567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||+++++|.+++.. ..+++..+..++.|++.+|.|||. .+++|+||||+||+++.++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeecccce
Confidence 99999999999999998853 347899999999999999999996 999999999999999999999999999987
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
..... ........|+..|+|||.+.+..++.++|||||||++|+|++|..||...... ....
T Consensus 150 ~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----------------~~~~ 211 (277)
T cd06641 150 QLTDT--QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM----------------KVLF 211 (277)
T ss_pred ecccc--hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH----------------HHHH
Confidence 54221 11123356888999999998888999999999999999999999998543211 0000
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+ ........+...+..+.+++.+||..+|++||++.+++++
T Consensus 212 ~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 212 LI-PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HH-hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01 1111112233455668899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=321.89 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=213.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-HHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-GLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++..+.++||+|.||+|++|.|.... .+-..||||.+..+... ....|.+|+.+|.+|+|||+++||++..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~ps------gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPS------GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD- 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCC------CcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence 45566789999999999999997532 22457999999887554 67889999999999999999999999987
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...-||||+++.|+|.+.|.+ .....|.......++.||+.|+.||.+ +++|||||...|+||-....|||+||||.
T Consensus 183 qp~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred chhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeecccce
Confidence 678899999999999999987 334678889999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEee-eccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhh
Q 013519 258 KLGPIDGNSHVTTR-IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 258 ~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+.+........+.. ..-...|+|||.+....++.++|||+|||+|||||| |..||.+... .
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~ 322 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------I 322 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------H
Confidence 97665544443332 223457999999999999999999999999999999 5778865432 2
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
++.+.++..-+-..|..|++.++++++.||..+|++||++..|.+.
T Consensus 323 qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 323 QILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 2333344444445688999999999999999999999999999743
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=301.63 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=190.5
Q ss_pred ceecccCceEEEEEEecCCccc-cccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLA-PTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
+.||+|+||.||+|.+...... .........+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 3699999999999977643200 001122346788877655433 5678899999999999999999999988 778999
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC-------ceEEecccC
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY-------NAKLSDFGL 256 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-------~~kl~DFGl 256 (441)
|||+++|+|.+++..... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhh--CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976542 68899999999999999999996 9999999999999999887 799999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcC--CCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccch
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATG--HLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||........
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~------------- 215 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK------------- 215 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-------------
Confidence 975321 2234567789999999876 78899999999999999999 5667754321100
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.. ..... ...+......+.+++.+||..+|++||++.++++.|
T Consensus 216 -~~--~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 216 -ER--FYQDQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -HH--HHhcC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 00000 011111125678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=309.81 Aligned_cols=267 Identities=22% Similarity=0.354 Sum_probs=195.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|.+.+.||.|+||.||+|... ..++.||||.+..... .....+.+|+.+++.++||||+++++++.++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSK---------LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEc---------CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 57899999999999999999543 3478999998765422 1223456799999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+.+ +|.+++.+.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~lv~e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 150 (291)
T cd07844 76 KTLTLVFEYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLA 150 (291)
T ss_pred CeEEEEEecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCHHHEEEcCCCCEEECccccc
Confidence 999999999975 8999887654 368899999999999999999997 89999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee--eccc-cc---c
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL--VDFA-RP---S 330 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~--~~~~-~~---~ 330 (441)
+...... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||........... .... .+ .
T Consensus 151 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07844 151 RAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228 (291)
T ss_pred cccCCCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh
Confidence 7432211 11122346889999999876 4578999999999999999999999965431100000 0000 00 0
Q ss_pred cchhhhhhh-------hc-CccccccCC-hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 331 LTDKRRLKK-------IM-DPRLEEQYP-IKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~-------~~-~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+........ .. ...+....+ ......+.+++.+||+.+|++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000000 00 000000000 1112567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=309.12 Aligned_cols=266 Identities=24% Similarity=0.306 Sum_probs=197.8
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-----HHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-----GLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
+|.+.+.||+|+||.||+|... .+++.|+||.+...... ....+..|+.+++.++||||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK---------ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC---------CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 4778889999999999999543 34789999998765322 234567899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+.+..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||. .+|+|+||||+|||++.++.++|+||
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCChhhEEEcCCCCEEEccc
Confidence 9999999999999 899999986543 368999999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce--eeccccccc
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--LVDFARPSL 331 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~ 331 (441)
|+++...... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.......... ......+..
T Consensus 147 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (298)
T cd07841 147 GLARSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE 224 (298)
T ss_pred eeeeeccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCch
Confidence 9997543221 11223356788999998865 457899999999999999999977776443211000 000000000
Q ss_pred chh---hhhhhhcCccc-----cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 332 TDK---RRLKKIMDPRL-----EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 332 ~~~---~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
... ........... ........+..+.++|.+||..+|++|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 00000000000 001112345678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=304.20 Aligned_cols=260 Identities=27% Similarity=0.333 Sum_probs=201.0
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeC-
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWED- 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 177 (441)
+|+..+.||.|++|.||+|.... +++.+|+|.+..... .....+.+|++++++++||||++++++|.+.
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKN---------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES 72 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECC---------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence 57788999999999999995543 478999998875432 3456788999999999999999999988653
Q ss_pred -CeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 178 -RQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 178 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
..+++||||+++++|.+++.... ....++...+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~dfg 150 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFG 150 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeecc
Confidence 47899999999999998876422 23457889999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++...... ......++..|+|||.+.+..++.++|||||||++|+|++|..||.......... .....
T Consensus 151 ~~~~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--------~~~~~ 218 (287)
T cd06621 151 VSGELVNS----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP--------IELLS 218 (287)
T ss_pred cccccccc----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh--------HHHHH
Confidence 98753221 1223567889999999999999999999999999999999999997542200000 00000
Q ss_pred hhhhhcCccccccCC--hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYP--IKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.+.....+.+....+ ...+..+.+|+.+||..+|++|||+.|++++-
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 219 YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred HHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 010101111111111 23456788999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=304.17 Aligned_cols=249 Identities=28% Similarity=0.366 Sum_probs=203.7
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
+|.+.+.||.|+||.||+|... .+++.|++|.+.... ....+.+.+|++++++++||||+++++++.+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR---------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc---------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 4788899999999999999543 347899999886543 2346778899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...+++|+||+.+++|.+++... .++++..+..++.|++.||.|||. .+++|+||+|+||++++++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 99999999999999999998665 358899999999999999999996 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+....... ......|+..|+|||++.+..++.++||||||+++|+|++|..||....... ...
T Consensus 147 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------------~~~ 209 (258)
T cd05578 147 ATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--------------RDQ 209 (258)
T ss_pred ccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--------------HHH
Confidence 87543221 2234568899999999998889999999999999999999999997543210 111
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM--EEVLE 380 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~--~eil~ 380 (441)
+...... .....+...+..+.++|.+||..||.+||++ .|+++
T Consensus 210 ~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 210 IRAKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1111111 2223445566788899999999999999999 77664
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=300.56 Aligned_cols=252 Identities=28% Similarity=0.401 Sum_probs=201.2
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|.+.+.||+|+||.||+|... ..++.|++|.+..... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL---------DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC---------CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 5788899999999999999543 3478999998876544 3677899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++|+||+++++|.+++.... .+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEcccccc
Confidence 99999999999999999986543 47888999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcce--EeeeccccccCcchhhhcCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 258 KLGPIDGNSHV--TTRIMGTYGYAAPEYVATGH---LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 258 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
........... .....++..|+|||++.+.. ++.++||||||+++|+|++|..||....... .
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~------------~ 214 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF------------Q 214 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH------------H
Confidence 76433222111 12356788999999998766 8899999999999999999999996432110 0
Q ss_pred hhhhhhhhcCccccccCCh--hhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPI--KGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ...+.. ......|. ..+..+.+++.+||+.+|++||++.+++.+
T Consensus 215 ~---~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 215 I---MFHVGA-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred H---HHHHhc-CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000000 11111222 235667899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=299.82 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=202.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-----chHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-----SIQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
.+|++.+.||+|+||.||+|... .+++.|++|.+... .......+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDA---------DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEc---------CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 47899999999999999999543 45889999986432 22345678899999999999999999999
Q ss_pred EEeC--CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 174 CWED--RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 174 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
+.+. ..+++|+||+++++|.+++...+ .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l 147 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKL 147 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEE
Confidence 8764 46889999999999999986543 47888999999999999999997 89999999999999999999999
Q ss_pred ecccCCCCCCCCCC-cceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccc
Q 013519 252 SDFGLAKLGPIDGN-SHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330 (441)
Q Consensus 252 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 330 (441)
+|||+++....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------- 214 (264)
T cd06653 148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------------- 214 (264)
T ss_pred CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-------------
Confidence 99999975422111 1112345689999999999988899999999999999999999999864211
Q ss_pred cchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+.+.........+|...+..+.+++.+||. +|..||++.+++.|
T Consensus 215 ---~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 215 ---MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---HHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111222222223334566677889999999999 57999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=327.89 Aligned_cols=281 Identities=19% Similarity=0.239 Sum_probs=190.4
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCcccccc------ccCCc----EEEEEEcCCCchHHHHHHHHHHHHHhcCCCC
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTK------VGVGK----AVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~------~~~~~----~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp 165 (441)
...++|++++.||+|+||+||+|.+......... ...+. .++.|.+.. .......+.+|+.+|++++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence 3467899999999999999999865432110000 00001 111222221 122345688999999999999
Q ss_pred CccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS--AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 166 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
||+++++++...+..|+|++++. ++|..++..... ........++.++.|++.||.|||+ ++||||||||+|||+
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHrDLKP~NILl 300 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHRDIKLENIFL 300 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE
Confidence 99999999999999999999995 577777654221 1223456778899999999999997 899999999999999
Q ss_pred cCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCC-CCCCCCce
Q 013519 244 DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDT-NRPSGEHV 322 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~-~~~~~~~~ 322 (441)
+.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|..++.. ........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 999999999999997643221 1122346799999999999999999999999999999999998754432 21111000
Q ss_pred eec------ccccccch-hhhhhhhcCcc-c---cccC-----ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 323 LVD------FARPSLTD-KRRLKKIMDPR-L---EEQY-----PIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 323 ~~~------~~~~~~~~-~~~~~~~~~~~-~---~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+.. .....+.+ ...+...+... + .... ....+..+.++|.+||+.||.+|||+.|+|.+
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 00000000 00011111000 0 0000 01123456788999999999999999999986
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=326.71 Aligned_cols=260 Identities=24% Similarity=0.444 Sum_probs=219.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
....+.++||.|.||.||+|+++... .....||||.++.... ....+|..|+.||.+++||||++|.++....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pg------kre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPG------KREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hheEEEEEEecccccceecccccCCC------CcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 34567799999999999999887532 2357899999988644 4567899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..+.||.|||++|+|+.+|+.+. ..+.+.++..+++.|+.|+.||-. .++|||||...|||++.+...|++||||+
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsd--m~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSD--MNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhh--cCchhhhhhhhheeeccceEEEeccccce
Confidence 99999999999999999998765 458899999999999999999985 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeecc--ccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchh
Q 013519 258 KLGPIDGNSHVTTRIMG--TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|....+.. ...++..| ...|.|||.+...+++.++||||+||++||.++ |..||.... .
T Consensus 779 Rvledd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----------------N 840 (996)
T KOG0196|consen 779 RVLEDDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----------------N 840 (996)
T ss_pred eecccCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----------------h
Confidence 97654432 22222223 468999999999999999999999999999887 888885432 1
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
..+.+.+...++-..|..|+..+.+|+..||++|-.+||.+.+|+.+|.++-
T Consensus 841 QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 841 QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 2333444556666678899999999999999999999999999999998764
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=303.20 Aligned_cols=249 Identities=30% Similarity=0.464 Sum_probs=198.2
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCC---CCCccceEEEEE
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFS---HPNLVKLIGYCW 175 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~ 175 (441)
.|.+.+.||.|+||.||+|... .+++.|++|.+... .......+.+|+.+++.+. ||||+++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV---------PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc---------CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 4777889999999999999543 34789999988654 2344567888999999986 999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
.....++||||+++++|.+++... .+++..++.++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEccCC
Confidence 999999999999999999988542 58899999999999999999996 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
++....... .......|+..|+|||.+.+. .++.++|||||||++|+|++|..||...........
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~----------- 213 (277)
T cd06917 147 VAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML----------- 213 (277)
T ss_pred ceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-----------
Confidence 997643322 222345689999999988654 568999999999999999999999965432111000
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+.....+.+. ....+..+.+++.+||+.||++||++.+++++
T Consensus 214 --~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 214 --IPKSKPPRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --cccCCCCCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0000001110 11244568899999999999999999999985
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=314.85 Aligned_cols=265 Identities=22% Similarity=0.292 Sum_probs=197.6
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
..++|.+.+.||+|+||.||+|.. ..+++.||||.+... .......+.+|+.++++++||||++++++|
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYD---------TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEE---------CCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 457899999999999999999944 345889999988643 233445677899999999999999999988
Q ss_pred EeC------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 175 WED------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 175 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
... ...|+||||+.+ +|.+.+.. .++...+..++.|++.||.|||+ .||+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~ 156 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT 156 (353)
T ss_pred ccCCCccccCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCC
Confidence 644 357999999964 88887743 27788999999999999999997 89999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce--eecc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--LVDF 326 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~~~~ 326 (441)
+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++|+.||.......... ...+
T Consensus 157 ~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 233 (353)
T cd07850 157 LKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233 (353)
T ss_pred EEEccCccceeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 999999999754221 11233568899999999999999999999999999999999999996543110000 0000
Q ss_pred cccccc--h-----------------hhhhhhhcCc----cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 327 ARPSLT--D-----------------KRRLKKIMDP----RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 327 ~~~~~~--~-----------------~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+... . ...+.+.+.. ......+...+..+.++|.+||+.||++|||+.|+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0 0000000000 00001122345678899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=307.31 Aligned_cols=248 Identities=30% Similarity=0.380 Sum_probs=197.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
+.|.+.+.||+|+||.||+|... ..++.|++|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDV---------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEc---------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 56888999999999999999543 34789999987643 2334567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+.+..++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEECCCCCEEEeecC
Confidence 9999999999997 57777765433 358899999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
++..... .....|++.|+|||++. ...++.++||||||+++|||++|..||.......
T Consensus 161 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------------- 221 (307)
T cd06607 161 SASLVSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------------- 221 (307)
T ss_pred cceecCC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------------
Confidence 9875322 12346888999999874 3568899999999999999999999985432110
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
....+.........+..++..+.+++.+||..+|++||++.+++.+.
T Consensus 222 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 222 ---ALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ---HHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00011100111111223456788999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=303.17 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=200.1
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 179 (441)
.|...+.||+|++|.||++... ..++.+++|++........+.+.+|+.+++.+.||||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDK---------STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEEC---------CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 3444579999999999999543 3478899998876555555678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
.++|+||+.+++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred EEEEEeccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 9999999999999999865 247889999999999999999997 8999999999999999999999999998865
Q ss_pred CCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhh
Q 013519 260 GPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339 (441)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (441)
..... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+. .....+..
T Consensus 165 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------------~~~~~~~~ 229 (285)
T cd06648 165 VSKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------------QAMKRIRD 229 (285)
T ss_pred hccCC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------------HHHHHHHh
Confidence 32221 1223356899999999999888999999999999999999999998643211 00011111
Q ss_pred hcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+.. ..+...+..+.+++.+||..+|++||++.+++++
T Consensus 230 ~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 230 NLPPKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCCCC--cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 100111 1122345678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=307.97 Aligned_cols=268 Identities=23% Similarity=0.309 Sum_probs=195.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-HHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-GLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
+++|.+.+.||+|+||.||+|... ..+..|++|.+...... ....+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISR---------INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEc---------CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 468999999999999999999543 34789999988654322 22356789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
+...++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||+
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 149 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFGL 149 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEEcCCCcEEEecccc
Confidence 999999999996 67777765432 347788899999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecc---cccccc
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF---ARPSLT 332 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~---~~~~~~ 332 (441)
++...... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.......+.....+ ..+.-.
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07870 150 ARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227 (291)
T ss_pred ccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence 97532211 112234578999999998764 578899999999999999999999975432111100000 000000
Q ss_pred hh---hhhh----hhcCc----cccccC-ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DK---RRLK----KIMDP----RLEEQY-PIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~---~~~~----~~~~~----~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.. ..+. ..... ...... ....+..+.+++.+||..||.+|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 0000 00000 000000 00124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=309.79 Aligned_cols=266 Identities=26% Similarity=0.364 Sum_probs=198.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|.+.+.||+|+||.||+|.+.. .++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 368889999999999999996543 378999998754322 234567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
+...++||||+++++|..+.... ..+++..++.++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCcEEEEeeee
Confidence 99999999999998888776443 248899999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-eecccccccchh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LVDFARPSLTDK 334 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~ 334 (441)
+....... .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.......... +.... ..+...
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~ 223 (286)
T cd07846 147 ARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCL-GNLIPR 223 (286)
T ss_pred eeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHh-CCCchh
Confidence 87542221 22233567899999999875 346789999999999999999999886432110000 00000 000000
Q ss_pred --------hhhhhhcCcccc-----ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 --------RRLKKIMDPRLE-----EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 --------~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
........+... .......+..+.+|+.+||..+|++||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000000 00122345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.90 Aligned_cols=253 Identities=28% Similarity=0.422 Sum_probs=207.5
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|.+.+.||+|++|.||+|... .+++.|++|.+..... ...+.+.+|+.++++++||||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK---------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC---------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 4777889999999999999554 3478999998876543 4567888999999999999999999999988
Q ss_pred --CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 178 --RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 178 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
..+++|+||+++++|.+++.... .+++..++.++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~ 146 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFG 146 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEcccc
Confidence 89999999999999999987653 68999999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
.+................++..|+|||.+.+..++.++||||||+++|+|++|..||...... ..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------------~~ 211 (260)
T cd06606 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---------------MA 211 (260)
T ss_pred cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---------------HH
Confidence 997644332211133456889999999998888999999999999999999999999654310 01
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+.........+...+..+.+++.+||+.+|++||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 212 ALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1111221122233455557789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=303.02 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=204.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+.|...+.||+|+||.||+|.... .+..+++|.+..... ....+.+|+.+++.++|+||+++++++...
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 87 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG 87 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence 4568888899999999999996543 478899999876654 456788899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++|+||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+|+||+|+||+++.++.++|+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccchh
Confidence 99999999999999999997754 368999999999999999999997 99999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
....... .......++..|+|||++.+..++.++|||||||++|+|++|+.||....+.. ..
T Consensus 164 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~----------------~~ 225 (286)
T cd06614 164 AQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR----------------AL 225 (286)
T ss_pred hhhccch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH----------------HH
Confidence 6532211 12233457889999999998889999999999999999999999986432110 00
Q ss_pred hhhcCcccc-ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIMDPRLE-EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+...... ...+..++..+.++|.+||+.+|.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011110000 01122245678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=321.74 Aligned_cols=203 Identities=33% Similarity=0.467 Sum_probs=174.6
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC--
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED-- 177 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 177 (441)
|...+.||+|+||.||+| +.+.+|..||||.++... ....+.+-+|+++|++|+|||||+++++=.+.
T Consensus 15 W~~~e~LG~Ga~g~V~rg---------rnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRG---------RNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred eeehhhhcCCccceeeee---------cccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 455678999999999999 455569999999988753 34456778999999999999999999875543
Q ss_pred ----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc--CCC--ce
Q 013519 178 ----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD--GSY--NA 249 (441)
Q Consensus 178 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~--~~~--~~ 249 (441)
....+|||||.||+|...|.+-.+...|++.+.+.++.+++.||.|||. +|||||||||.||++- .+| ..
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~Iy 163 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQSIY 163 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCceEE
Confidence 3568999999999999999987777889999999999999999999995 9999999999999992 323 47
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRP 317 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~ 317 (441)
||+|||.|+.... .....++.||+.|++||++.. ..|+..+|.|||||++|+.+||..||.....
T Consensus 164 KLtDfG~Arel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 164 KLTDFGAARELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred eeecccccccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 9999999996543 336788999999999999984 7888999999999999999999999965443
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=295.04 Aligned_cols=278 Identities=23% Similarity=0.299 Sum_probs=199.4
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH--HHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--GLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
....|+.+..||+|.||.||+|...+.. -.-.+.+|||+++..... .-...-+|+.+++.++||||+.+..+|
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n-----~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vf 96 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTN-----DKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVF 96 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCC-----cccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHH
Confidence 4468999999999999999999554332 111457999998776221 112345799999999999999999998
Q ss_pred Ee-CCeEEEEEeecCCCCHHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC----C
Q 013519 175 WE-DRQFLLVYEYMQKGSLENHLFRK--GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS----Y 247 (441)
Q Consensus 175 ~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~----~ 247 (441)
.. +..+++++||.+. +|...|.-+ ...+.++...+..|+.||+.|+.|||+ +-|+||||||.|||+..+ |
T Consensus 97 l~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG 173 (438)
T KOG0666|consen 97 LSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERG 173 (438)
T ss_pred hccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccC
Confidence 87 7889999999987 888887632 224678999999999999999999997 999999999999999887 8
Q ss_pred ceEEecccCCCCCCCCCCcc-eEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce---
Q 013519 248 NAKLSDFGLAKLGPIDGNSH-VTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--- 322 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--- 322 (441)
.|||+|||+++++...-..- ....++-|.+|+|||++.+. .|+.+.|||++|||+.||+|-.+.|.+....-...
T Consensus 174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf 253 (438)
T KOG0666|consen 174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF 253 (438)
T ss_pred eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence 99999999999864332211 22346779999999999986 57788999999999999999888775432111000
Q ss_pred --------e--------ecccc-cccchh-hhhhhhcCcc-----ccccC--ChhhHHHHHHHHHHhcccCCCCCCCHHH
Q 013519 323 --------L--------VDFAR-PSLTDK-RRLKKIMDPR-----LEEQY--PIKGALLAGQIIIKCLEAEPKNRPSMEE 377 (441)
Q Consensus 323 --------~--------~~~~~-~~~~~~-~~~~~~~~~~-----~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~e 377 (441)
+ .+|+. ..+.+. ..+..+-... +...+ ...-++...+|+.+||+.||.+|.|+++
T Consensus 254 q~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q 333 (438)
T KOG0666|consen 254 QHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ 333 (438)
T ss_pred hHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence 0 01110 000000 0111110000 00000 0011223779999999999999999999
Q ss_pred HHHHH
Q 013519 378 VLETL 382 (441)
Q Consensus 378 il~~L 382 (441)
+|++.
T Consensus 334 Aleh~ 338 (438)
T KOG0666|consen 334 ALEHP 338 (438)
T ss_pred Hhccc
Confidence 99874
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=308.99 Aligned_cols=272 Identities=24% Similarity=0.325 Sum_probs=197.8
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
+|.+.+.||+|+||.||+|..... ..+..||+|.+.... ......+.+|+.++..++||||+++++++.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 478889999999999999965431 147899999987632 2334567789999999999999999999998
Q ss_pred C--CeEEEEEeecCCCCHHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC----CCc
Q 013519 177 D--RQFLLVYEYMQKGSLENHLFRKGS--AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG----SYN 248 (441)
Q Consensus 177 ~--~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~----~~~ 248 (441)
. ..+++||||+.+ +|.+++..... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.
T Consensus 74 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 74 HADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred CCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEEcCCCCccce
Confidence 8 789999999975 67776653322 2368899999999999999999997 89999999999999999 899
Q ss_pred eEEecccCCCCCCCCCC-cceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee--
Q 013519 249 AKLSDFGLAKLGPIDGN-SHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-- 324 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-- 324 (441)
+||+|||+++....... ........+++.|+|||++.+. .++.++|||||||++|+|++|+.||............
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 230 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence 99999999986433222 1112335678999999988764 5789999999999999999999999755433200000
Q ss_pred ---------cccccccchh------hhhhhhcCccccccCC---------h--hhHHHHHHHHHHhcccCCCCCCCHHHH
Q 013519 325 ---------DFARPSLTDK------RRLKKIMDPRLEEQYP---------I--KGALLAGQIIIKCLEAEPKNRPSMEEV 378 (441)
Q Consensus 325 ---------~~~~~~~~~~------~~~~~~~~~~~~~~~~---------~--~~~~~~~~li~~~l~~dp~~Rps~~ei 378 (441)
.+..+..... .......+......++ . ..+..+.+++.+||+.||++|||+.++
T Consensus 231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei 310 (316)
T cd07842 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA 310 (316)
T ss_pred HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 0000000000 0000000000000011 1 344568899999999999999999999
Q ss_pred HHH
Q 013519 379 LET 381 (441)
Q Consensus 379 l~~ 381 (441)
+++
T Consensus 311 l~~ 313 (316)
T cd07842 311 LEH 313 (316)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=293.61 Aligned_cols=249 Identities=30% Similarity=0.442 Sum_probs=204.1
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 179 (441)
+|.+.+.||+|+||.||++.... .++.+++|++..........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 47788899999999999995543 478999999887765556788999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
.++++||+++++|.+++.... ..+++..+..++.|++.+|.+||. .+++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 999999999999999987643 468999999999999999999997 9999999999999999999999999999976
Q ss_pred CCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhh
Q 013519 260 GPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339 (441)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (441)
...... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...... .....
T Consensus 148 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~ 208 (253)
T cd05122 148 LSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM----------------KALFK 208 (253)
T ss_pred cccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH----------------HHHHH
Confidence 432211 34467889999999999888999999999999999999999998643211 00000
Q ss_pred hcCccccccC--ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 340 IMDPRLEEQY--PIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 340 ~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
... ...... +...+..+.+++.+||+.||++|||+.+++++
T Consensus 209 ~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 209 IAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 011111 11225668899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=305.88 Aligned_cols=267 Identities=24% Similarity=0.325 Sum_probs=196.5
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|++.+.||.|+||.||+|... .+++.|+||++..... .....+.+|++++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK---------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC---------CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 4788899999999999999543 4578999998865432 2235678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+. ++|..++.... ...+++..++.++.|++.||+|||. .+++|+||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccch
Confidence 99999999996 58888886543 2468899999999999999999997 89999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-eeccc-c------
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGH-LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LVDFA-R------ 328 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~-~------ 328 (441)
+...... .......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||.......... ..... .
T Consensus 148 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 148 RAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred hhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 7532211 1122345788999999887644 5789999999999999999999996543210000 00000 0
Q ss_pred cccchhhhhhhhcCccc---cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 PSLTDKRRLKKIMDPRL---EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+.+.........+.... ........+..+.++|.+||+.||++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000000000 000112244567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=298.66 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=200.8
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|.+.+.||.|+||.||+|... ..+..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK---------SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc---------CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 4778899999999999999554 347889999876542 12345678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc-eEEecccC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN-AKLSDFGL 256 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-~kl~DFGl 256 (441)
...++|+||+++++|.+++.+... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++. +||+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEeccccc
Confidence 999999999999999999876432 357899999999999999999997 89999999999999988864 69999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...... ........|++.|+|||++.+..++.++||||||+++|+|++|..||..... ...
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------------~~~ 210 (257)
T cd08225 149 ARQLNDS--MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL----------------HQL 210 (257)
T ss_pred chhccCC--cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----------------HHH
Confidence 8754321 1222335689999999999888899999999999999999999999864321 111
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.......... ..+...+..+.+++.+||..+|++|||+.+++++
T Consensus 211 ~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 211 VLKICQGYFA-PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHhcccCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111111111 1223345568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=297.89 Aligned_cols=244 Identities=27% Similarity=0.360 Sum_probs=198.8
Q ss_pred ecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 107 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
||.|+||.||+|... .+++.+++|.+..... ...+.+.+|+.+++.++||||+++++++.++..+++|
T Consensus 1 lg~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVK---------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEEC---------CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 799999999999554 3478999998865432 3346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
|||+++++|.+++.+.. .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++.....
T Consensus 72 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 72 MEYCLGGELWTILRDRG---LFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred EecCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 99999999999996643 48899999999999999999997 99999999999999999999999999999864322
Q ss_pred CCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCc
Q 013519 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDP 343 (441)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (441)
. ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... .......+...
T Consensus 147 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------------~~~~~~~~~~~ 209 (262)
T cd05572 147 Q---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--------------PMEIYNDILKG 209 (262)
T ss_pred c---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--------------HHHHHHHHhcc
Confidence 1 223357889999999998888999999999999999999999999654310 11112222221
Q ss_pred cccccCChhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 013519 344 RLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-----MEEVLET 381 (441)
Q Consensus 344 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~eil~~ 381 (441)
.....+|...+..+.+++.+||..+|++||+ ++|++++
T Consensus 210 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 210 NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 2222344445677899999999999999999 8888874
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=304.20 Aligned_cols=268 Identities=25% Similarity=0.376 Sum_probs=199.3
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
+|++.+.||.|++|.||+|... .++..||||.+..... .....+.+|+.++++++||||+++++++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR---------TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC---------CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 4788899999999999999543 3578999998876532 22355678999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||+.+ +|.+++........+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||+++
T Consensus 72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 99999999985 888888765544568999999999999999999997 899999999999999999999999999997
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce--eecccccccchhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--LVDFARPSLTDKR 335 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~ 335 (441)
...... .......++..|++||++.+. .++.++|||||||++|+|++|+.||.......... +.....+......
T Consensus 149 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07836 149 AFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP 226 (284)
T ss_pred hhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHH
Confidence 532211 112234578899999998664 56889999999999999999999996543211000 0000000000000
Q ss_pred hhhhh--cCccc-------cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKI--MDPRL-------EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~--~~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+... ..... ........+..+.+++.+||+.||.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 227 GISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 00000 001112345668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=306.20 Aligned_cols=267 Identities=21% Similarity=0.283 Sum_probs=198.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++.+.||.|+||.||+|... .+++.+++|.++.... .....+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDK---------KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEEC---------CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 57888999999999999999554 3478899998865432 122356689999999999999999999987
Q ss_pred C--CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 177 D--RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 177 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
. ..+|+||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.++|+||
T Consensus 76 ~~~~~~~lv~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~~l~d~ 150 (293)
T cd07843 76 SNLDKIYMVMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDF 150 (293)
T ss_pred cCCCcEEEEehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCcEEEeec
Confidence 7 889999999975 8988886643 368999999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce--eeccccccc
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--LVDFARPSL 331 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~ 331 (441)
|++....... .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.......... ...+..+..
T Consensus 151 g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (293)
T cd07843 151 GLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE 228 (293)
T ss_pred CceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence 9987643321 122334578899999998764 46899999999999999999999996543211000 000000000
Q ss_pred chh-----------hhhhhhcCccccccCChh-hHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 332 TDK-----------RRLKKIMDPRLEEQYPIK-GALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 332 ~~~-----------~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
... ..........+...++.. .+..+.++|.+||+.+|++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 000000001111222322 46678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=304.98 Aligned_cols=249 Identities=29% Similarity=0.375 Sum_probs=197.7
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.|...+.||+|+||.||+|... ..+..+|+|.+... .......+.+|+.+++.++|||++++++++.+
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDV---------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEc---------CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4777889999999999999543 34789999987643 23345678889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
+...++||||+.+ +|.+++.... .++++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||+
T Consensus 97 ~~~~~lv~e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 97 EHTAWLVMEYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred CCeEEEEEeCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCC
Confidence 9999999999975 7877775543 458899999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
+..... .....|++.|+|||++. ...++.++|||||||++|+|++|..||......
T Consensus 172 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------------- 230 (317)
T cd06635 172 ASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------------- 230 (317)
T ss_pred ccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---------------
Confidence 875321 22346889999999984 456889999999999999999999998543110
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
.....+.............+..+.+++.+||+.+|.+||++.++++++..
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 231 -SALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred -HHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 11111111111111223445668899999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.76 Aligned_cols=255 Identities=27% Similarity=0.396 Sum_probs=193.8
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.-..+|+.+++||+||||.||++ +.+-+|..||||++.... ......+.+|+.+|.+|+|||||+++..|
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkV---------RNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW 546 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKV---------RNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW 546 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEE---------eecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence 34567888999999999999999 445569999999987763 34456788999999999999999998754
Q ss_pred E------------------------------------------------------------------------------e
Q 013519 175 W------------------------------------------------------------------------------E 176 (441)
Q Consensus 175 ~------------------------------------------------------------------------------~ 176 (441)
. +
T Consensus 547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded 626 (1351)
T KOG1035|consen 547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED 626 (1351)
T ss_pred hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence 2 0
Q ss_pred ---------------------------------C--------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHH
Q 013519 177 ---------------------------------D--------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215 (441)
Q Consensus 177 ---------------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 215 (441)
+ ..+||-||||+...|.+++.++.... .....+++++
T Consensus 627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFr 704 (1351)
T KOG1035|consen 627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFR 704 (1351)
T ss_pred ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHH
Confidence 0 23689999999988877776544211 3678999999
Q ss_pred HHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCC----------------CCCCcceEeeeccccccC
Q 013519 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP----------------IDGNSHVTTRIMGTYGYA 279 (441)
Q Consensus 216 ~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~ 279 (441)
+|+.||.|+|. +|||||||||.||+|++.+.|||+|||+|+... ...+....+..+||.-|+
T Consensus 705 eIlEGLaYIH~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYv 782 (1351)
T KOG1035|consen 705 EILEGLAYIHD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYV 782 (1351)
T ss_pred HHHHHHHHHHh--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeee
Confidence 99999999996 999999999999999999999999999998611 001112345678999999
Q ss_pred cchhhhcCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCcccccc--CChhhH
Q 013519 280 APEYVATGH---LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQ--YPIKGA 354 (441)
Q Consensus 280 aPE~~~~~~---~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 354 (441)
|||++.+.. |+.|+|+|||||||+||+. ||.... .....+..+-++.+... +.....
T Consensus 783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM---------------ERa~iL~~LR~g~iP~~~~f~~~~~ 844 (1351)
T KOG1035|consen 783 APELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM---------------ERASILTNLRKGSIPEPADFFDPEH 844 (1351)
T ss_pred cHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH---------------HHHHHHHhcccCCCCCCcccccccc
Confidence 999997654 9999999999999999985 564321 11122222222222222 122222
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 355 LLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 355 ~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..-..+|.+||+.||.+|||+.|+|+.
T Consensus 845 ~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 845 PEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred hHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 334589999999999999999999973
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=305.64 Aligned_cols=253 Identities=28% Similarity=0.355 Sum_probs=194.6
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCC-CCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFS-HPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 177 (441)
+|...+.||+|+||.||++... .+++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHK---------PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEEC---------CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 4556678999999999999543 347899999887543 234557888999999996 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHh--cCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 178 RQFLLVYEYMQKGSLENHLFR--KGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
...+++|||+.. +|.++... ......+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||
T Consensus 76 ~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg 153 (288)
T cd06616 76 GDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFG 153 (288)
T ss_pred CcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeccCCCHHHEEEccCCcEEEeecc
Confidence 999999999864 55544321 1112468899999999999999999995 3599999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG---HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
+++..... .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||......
T Consensus 154 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------------- 216 (288)
T cd06616 154 ISGQLVDS---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-------------- 216 (288)
T ss_pred hhHHhccC---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH--------------
Confidence 98753221 112334688999999999776 6889999999999999999999999643210
Q ss_pred hhhhhhhhcC---ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMD---PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+..... +.+....+...+..+.+|+.+||+.+|++|||+++++++
T Consensus 217 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 217 -FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -HHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111111 111112223456678899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=294.60 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=206.4
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|.+.+.||.|+||.||++.... ++..+++|.+..... .....+.+|+++++.++|||++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 47888999999999999996543 478999999876533 4566788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...++|+||+++++|.+++.+.. ....+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHHeEEcCCCcEEECCccc
Confidence 99999999999999999987642 13568999999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+....... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ..
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------------~~ 211 (258)
T cd08215 150 SKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL----------------EL 211 (258)
T ss_pred eeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH----------------HH
Confidence 97643221 2334457899999999999989999999999999999999999998643210 01
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....... .....+...+..+.+++.+||..+|++||++.+++++
T Consensus 212 ~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 212 ALKILKG-QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111 1122344556778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=301.16 Aligned_cols=243 Identities=24% Similarity=0.346 Sum_probs=187.9
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHH---HHhcCCCCCccceEEEEEeCCe
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVK---FLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~---~l~~l~hpniv~~~~~~~~~~~ 179 (441)
+||+|+||.||++... .+++.+|+|.+..... .....+.+|.. ++....||||+.+++++...+.
T Consensus 1 ~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEEC---------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 4899999999999543 3478999998754321 11122334443 3444579999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
.++||||+++++|.+++...+ .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++..
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred EEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 999999999999999886543 58999999999999999999997 8999999999999999999999999999864
Q ss_pred CCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 260 GPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
.... ......|++.|+|||.+.. ..++.++|||||||++|+|++|..||........ ..+.
T Consensus 147 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~ 208 (279)
T cd05633 147 FSKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--------------HEID 208 (279)
T ss_pred cccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--------------HHHH
Confidence 3211 1223468999999999864 5688999999999999999999999965422110 0111
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
.. ........+...+..+.++|.+||..||.+|| ++.+++++
T Consensus 209 ~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 209 RM-TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HH-hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11 01112233455667788999999999999999 69999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=300.22 Aligned_cols=246 Identities=30% Similarity=0.403 Sum_probs=194.9
Q ss_pred ecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 107 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
||+|+||+||+|... .+++.|++|.+..... .....+..|+.+|+.++||||+++++++...+.+|+|
T Consensus 1 lg~g~~g~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVK---------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEc---------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 689999999999544 3478999998765322 2244567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
|||+++++|.+++.+... ..+++..++.++.|++.||.|||. .+++||||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~- 147 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG- 147 (277)
T ss_pred EecCCCCcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-
Confidence 999999999999876543 468899999999999999999997 8999999999999999999999999999875322
Q ss_pred CCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCc
Q 013519 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDP 343 (441)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (441)
........++..|+|||++.+..++.++|||||||++|+|++|+.||....... ....+.....
T Consensus 148 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------------~~~~~~~~~~- 211 (277)
T cd05577 148 --GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-------------EKEELKRRTL- 211 (277)
T ss_pred --CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-------------cHHHHHhccc-
Confidence 112233467889999999988889999999999999999999999996543210 0011111100
Q ss_pred cccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 344 RLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 344 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
......+...+..+.++|.+||+.+|++|| ++.+++.+
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 212 EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 111123444567788999999999999999 77777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=297.21 Aligned_cols=251 Identities=23% Similarity=0.274 Sum_probs=193.6
Q ss_pred HHHHHHhcCCCCCcee--cccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCcc
Q 013519 92 QDLRAATKNFRPDTML--GEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLV 168 (441)
Q Consensus 92 ~~~~~~~~~y~~~~~l--G~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv 168 (441)
.+.....++|.+.+.+ |.|+||.||++.. ..++..+++|.......... |+.+...+ +||||+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv 72 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKH---------KPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFI 72 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEE---------cCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEE
Confidence 3444455677877776 9999999999943 34578999998865432211 22222222 699999
Q ss_pred ceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC-
Q 013519 169 KLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY- 247 (441)
Q Consensus 169 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~- 247 (441)
++++++...+.+++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++||||||+||+++.++
T Consensus 73 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~ 147 (267)
T PHA03390 73 KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKD 147 (267)
T ss_pred EEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEeCCCC
Confidence 99999999999999999999999999996653 68999999999999999999997 8999999999999999988
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
.++|+|||+++.... .....|+..|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 148 ~~~l~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-------- 213 (267)
T PHA03390 148 RIYLCDYGLCKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-------- 213 (267)
T ss_pred eEEEecCccceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--------
Confidence 999999999875321 123468899999999999899999999999999999999999997432211
Q ss_pred ccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 013519 328 RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-MEEVLET 381 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~eil~~ 381 (441)
+. ...+...... ....+...+..+.++|.+||+.+|.+||+ ++++|++
T Consensus 214 ---~~-~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 214 ---LD-LESLLKRQQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---hh-HHHHHHhhcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00 0011111111 11223346677889999999999999995 6999875
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.20 Aligned_cols=269 Identities=23% Similarity=0.313 Sum_probs=195.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCC-CCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFS-HPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||.||+|... .+++.||+|....... .....+.+|+.+++.+. ||||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK---------NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC---------CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 36888999999999999999554 3478999998765432 12356778999999996 699999999988
Q ss_pred eCCe-----EEEEEeecCCCCHHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC-CC
Q 013519 176 EDRQ-----FLLVYEYMQKGSLENHLFRKGS--AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG-SY 247 (441)
Q Consensus 176 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~ 247 (441)
.... .|+||||+++ +|.+++..... ...+++..++.++.|++.||.|||. .+|+||||||+|||++. ++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~~ 148 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKG 148 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCCC
Confidence 7655 8999999986 78888865432 2468999999999999999999997 89999999999999998 88
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ec
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VD 325 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~ 325 (441)
.+||+|||+++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||........... ..
T Consensus 149 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 226 (295)
T cd07837 149 LLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226 (295)
T ss_pred eEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 999999999875422111 1122356889999998865 4578999999999999999999999965432110000 00
Q ss_pred -cccc---ccchhhhhhhhc-----CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 326 -FARP---SLTDKRRLKKIM-----DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 326 -~~~~---~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+ .+.......... .+..........+..+.+||.+||..||.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 000000000000 0000000112345668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=301.04 Aligned_cols=263 Identities=17% Similarity=0.209 Sum_probs=186.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHH-----------HHHHHHHHHHhcCCCCC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGL-----------REWQAEVKFLGKFSHPN 166 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpn 166 (441)
.++|.+.++||+|+||+||+|.+.... ..+..+++|.......... .....+...+..+.|+|
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~------~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDH------CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCc------ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 368999999999999999999765421 1144566775433321110 11223445566778999
Q ss_pred ccceEEEEEeCC----eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEE
Q 013519 167 LVKLIGYCWEDR----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNIL 242 (441)
Q Consensus 167 iv~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 242 (441)
|+++++.+.... ..+++++++. .++.+.+... ...++..+..++.|++.||.|||+ .+|+||||||+|||
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nil 158 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIM 158 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEE
Confidence 999998765543 3478888874 3666666443 235678889999999999999997 89999999999999
Q ss_pred EcCCCceEEecccCCCCCCCCCCc-----ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 013519 243 LDGSYNAKLSDFGLAKLGPIDGNS-----HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP 317 (441)
Q Consensus 243 l~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~ 317 (441)
++.++.++|+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999764322111 112235799999999999999999999999999999999999999976432
Q ss_pred CCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 318 SGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
....... . ....+..+..... ....++..+.+++..|+..+|++||++.++++.|
T Consensus 239 ~~~~~~~--~-----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 239 NGNLIHA--A-----KCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred chHHHHH--h-----HHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 2111000 0 0000111111111 1223456788999999999999999999999876
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=300.33 Aligned_cols=263 Identities=23% Similarity=0.310 Sum_probs=191.4
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCC-CCCccceEEEEEeC-
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFS-HPNLVKLIGYCWED- 177 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~- 177 (441)
|++.+.||+|+||.||+|... .+++.||+|.+..... .......+|+.++.++. ||||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR---------KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEEc---------CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 667889999999999999543 3478999998765421 11223446888999886 99999999999987
Q ss_pred -CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 178 -RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 178 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
+.+++||||+. ++|.+.+.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++. +.+||+|||+
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~dfg~ 145 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGS 145 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEeccc
Confidence 88999999997 58888776533 358999999999999999999997 89999999999999999 9999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ecccccccch-
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VDFARPSLTD- 333 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~- 333 (441)
++...... ......++..|+|||++.. ..++.++|||||||++|||++|..||......+.... ..........
T Consensus 146 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 222 (282)
T cd07831 146 CRGIYSKP---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV 222 (282)
T ss_pred ccccccCC---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 97543221 1223467899999998754 4568899999999999999999999965432110000 0000000000
Q ss_pred hhhh--hhhcCcccc-------ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 334 KRRL--KKIMDPRLE-------EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 334 ~~~~--~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.... ......... .......+..+.+||.+||+.+|++||++.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 223 LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 000000000 00112346778999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=292.16 Aligned_cols=249 Identities=28% Similarity=0.457 Sum_probs=204.2
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|.+.+.||+|++|.||+|... ..++.|++|.+..... .....+.+|++++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL---------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc---------CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 4788899999999999999543 3478899999877654 4567889999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++++|.+++... ..+++..++.++.|++.+|.|||+ .||+||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEeccccc
Confidence 9999999999999999998765 358899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
....... .......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ...
T Consensus 147 ~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----------------~~~ 208 (254)
T cd06627 147 TKLNDVS--KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----------------AAL 208 (254)
T ss_pred eecCCCc--ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----------------HHH
Confidence 7643221 1123456889999999998888899999999999999999999998643210 001
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.... .......+...+..+.+++.+||..+|++||++.+++.+
T Consensus 209 ~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 209 FRIV-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHh-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 0111 011122344556778899999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=306.70 Aligned_cols=267 Identities=25% Similarity=0.323 Sum_probs=195.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.++++++|+||+++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDT---------TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEEC---------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 367999999999999999999543 3478999998764422 11234567999999999999999999987
Q ss_pred eC--CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 176 ED--RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 176 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
.. +.+++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~kL~d 151 (309)
T cd07845 77 GKHLDSIFLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIAD 151 (309)
T ss_pred cCCCCeEEEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECc
Confidence 65 568999999975 8888886543 468999999999999999999997 8999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-eecccc---
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LVDFAR--- 328 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~--- 328 (441)
||++....... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......... +.....
T Consensus 152 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07845 152 FGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN 229 (309)
T ss_pred cceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99997643221 11122345788999999875 457899999999999999999999996543211000 000000
Q ss_pred ----cccchhhhhhhhc-C----ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 ----PSLTDKRRLKKIM-D----PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ----~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+.+........+. . ..+... ....+..+.++|.+||+.||++|||+.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhchhhhcccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000000 0 000000 01135667899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=294.93 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=203.1
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|++.+.||+|+||.||++... .+++.+++|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL---------SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC---------CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 4788899999999999999543 347899999886542 23355677899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...++||||+++++|.+++.+... ...+++..++.++.|++.||.|||+ .|++|+||+|.||+++.++.+||+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEEecCCcEEEeeccc
Confidence 999999999999999999866321 2468899999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
++..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... ..
T Consensus 150 ~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----------------~~ 209 (256)
T cd08530 150 SKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----------------DL 209 (256)
T ss_pred hhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 9764332 222346889999999999999999999999999999999999999643210 00
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+. .......+...+..+.+++.+||..+|++||++.+++++
T Consensus 210 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 210 RYKVQ-RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHh-cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00111 111112334566778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=310.50 Aligned_cols=266 Identities=23% Similarity=0.332 Sum_probs=195.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|.+.+.||+|+||.||+|... .+++.||+|.+.... ......+.+|+.++++++||||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHK---------PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEc---------CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 468999999999999999999543 457899999886532 2344567789999999999999999998764
Q ss_pred C-----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 177 D-----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 177 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
. ...++|+||+.+ +|..++.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill~~~~~~kl 147 (336)
T cd07849 75 PSFESFNDVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKI 147 (336)
T ss_pred ccccccceEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEE
Confidence 3 358999999964 88777743 358899999999999999999997 89999999999999999999999
Q ss_pred ecccCCCCCCCCCC-cceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-eecccc
Q 013519 252 SDFGLAKLGPIDGN-SHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LVDFAR 328 (441)
Q Consensus 252 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~ 328 (441)
+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +.....
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~ 227 (336)
T cd07849 148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227 (336)
T ss_pred CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 99999875432111 111233578999999998765 468899999999999999999999996532110000 000000
Q ss_pred cccchhhhhhhhcCcc---------cccc-----CChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 PSLTDKRRLKKIMDPR---------LEEQ-----YPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~---------~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
... ...+..+.... .... .....+..+.+|+.+||+.+|++||++.+++++
T Consensus 228 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 228 TPS--QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCC--HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00000000000 0000 011234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=306.43 Aligned_cols=265 Identities=22% Similarity=0.302 Sum_probs=193.5
Q ss_pred ceeccc--CceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 013519 105 TMLGEG--GFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 180 (441)
..||.| +||+||+|. +..+++.||+|.+... .....+.+.+|+.+++.++||||++++++|......
T Consensus 4 ~~ig~g~~~~~~v~~a~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLAR---------HTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEE---------EcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 356766 999999994 4445899999998654 234457788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
++||||+.+++|.+++.+... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++++||+.+...
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred EEEEecccCCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 999999999999998876532 458889999999999999999997 89999999999999999999999999865322
Q ss_pred CCCCCcc-e----EeeeccccccCcchhhhcC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc----
Q 013519 261 PIDGNSH-V----TTRIMGTYGYAAPEYVATG--HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP---- 329 (441)
Q Consensus 261 ~~~~~~~-~----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~---- 329 (441)
....... . .....++..|+|||++.+. .++.++|||||||++|+|++|+.||........ .......+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~ 230 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSP 230 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCC
Confidence 1111000 0 0112346679999999764 478999999999999999999999965432110 00000000
Q ss_pred ----ccchhhh-----------------h-----hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 330 ----SLTDKRR-----------------L-----KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 330 ----~~~~~~~-----------------~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.+..... . .......+....+..++..+.+|+.+||+.||++|||+.+++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0000000 0 000011111122344667789999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=300.42 Aligned_cols=268 Identities=22% Similarity=0.301 Sum_probs=195.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++.+.||+|+||.||+|... .+++.|++|.+..... .....+.+|+.++++++||||+++++++.+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR---------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec---------CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 46889999999999999999543 3478999998765432 233567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC-CCceEEeccc
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG-SYNAKLSDFG 255 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DFG 255 (441)
....++||||++ ++|.+++..... ..+++..+..++.|++.||.|||+ ++++|+||||+||+++. ++.+||+|||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEcccc
Confidence 999999999996 578887755432 345788888999999999999997 89999999999999985 5679999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee--eccccc---
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL--VDFARP--- 329 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~--~~~~~~--- 329 (441)
++...... ........+++.|+|||++.+. .++.++|||||||++|+|+||..||......+...- ..+..+
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (294)
T PLN00009 149 LARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226 (294)
T ss_pred cccccCCC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99753221 1112334678899999998764 578999999999999999999999965432110000 000000
Q ss_pred ccc---hhhhhhhhc---CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLT---DKRRLKKIM---DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~---~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+. ......... ............+..+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000000000 0000001122345668899999999999999999999975
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=295.52 Aligned_cols=243 Identities=28% Similarity=0.439 Sum_probs=194.2
Q ss_pred ecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 107 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
||.|+||.||+|... .+++.+++|.+..... .....+.+|++++++++||||+++++.+......++|
T Consensus 1 lg~g~~~~vy~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKK---------STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEEC---------CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 689999999999554 3478999999876543 4456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
|||+++++|.+++.+.+ .+++..+..++.|++.||.|||. .+++|+||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 72 MEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 99999999999997654 58899999999999999999996 99999999999999999999999999998753322
Q ss_pred CC------cceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 264 GN------SHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 264 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
.. ........++..|+|||.+....++.++||||||+++|+|++|..||...... ...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------------~~~ 210 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----------------EIF 210 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----------------HHH
Confidence 11 11223456888999999998888999999999999999999999999643211 111
Q ss_pred hhhcCccccccCChh--hHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIMDPRLEEQYPIK--GALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+..... ..+.. .+..+.+++.+||+.+|++||++..+.+.
T Consensus 211 ~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~ 254 (265)
T cd05579 211 QNILNGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI 254 (265)
T ss_pred HHHhcCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence 11111111 11222 25678899999999999999999444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=301.67 Aligned_cols=266 Identities=21% Similarity=0.266 Sum_probs=196.2
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
|++.+.||.|++|.||+|... .++..|++|++..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK---------LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEc---------CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 667889999999999999544 3478999998865432 22356778999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||++ ++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 9999999995 689998865442 458899999999999999999997 899999999999999999999999999997
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-eccccccc-----
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VDFARPSL----- 331 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~----- 331 (441)
...... .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||........... ........
T Consensus 148 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07835 148 AFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP 225 (283)
T ss_pred ccCCCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 532221 112223568899999988664 568899999999999999999999965432110000 00000000
Q ss_pred --chhhhhhhhcC---ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 332 --TDKRRLKKIMD---PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 332 --~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.........+. ...........+..+.++|.+||+.+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 000001122344668899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=299.51 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=196.3
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVY 184 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 184 (441)
.+||+|+||.||++... .++..||||++..........+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 ~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 26 IKIGEGSTGIVCIATVK---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred HHcCCCCCeEEEEEEEc---------CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence 57999999999999544 348899999986655555567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCC
Q 013519 185 EYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG 264 (441)
Q Consensus 185 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~ 264 (441)
||+++++|.+++.. ..+++..+..++.|++.+|.|||+ .|++|+||||+||+++.++.++|+|||++.......
T Consensus 97 e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~--~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 97 EFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred ecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence 99999999987743 247889999999999999999997 899999999999999999999999999986533211
Q ss_pred CcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCcc
Q 013519 265 NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344 (441)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (441)
.......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ....+.......
T Consensus 171 --~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-------------~~~~~~~~~~~~ 235 (292)
T cd06657 171 --PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------------AMKMIRDNLPPK 235 (292)
T ss_pred --ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------------HHHHHHhhCCcc
Confidence 12234568899999999988889999999999999999999999986432110 000011111111
Q ss_pred ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 345 LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 345 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+. .....+..+.+++.+||..+|.+||++.+++++
T Consensus 236 ~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 236 LK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 11 112345567899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=309.00 Aligned_cols=269 Identities=22% Similarity=0.322 Sum_probs=198.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
..+|.+.+.||.|+||.||+|.. ..+++.|++|++.... ......+.+|+.+|+.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~---------~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 74 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAID---------TRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR 74 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEE---------cCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence 36899999999999999999944 4458899999886542 233556778999999999999999999876
Q ss_pred e----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 176 E----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 176 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
. ...+++||||+. ++|.+++... ..+++..++.++.|++.||.|||. .+|+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 75 PPGADFKDVYVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred ccCCCCceEEEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEe
Confidence 3 356899999995 5898888543 348999999999999999999997 89999999999999999999999
Q ss_pred ecccCCCCCCCCCC--cceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee----
Q 013519 252 SDFGLAKLGPIDGN--SHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV---- 324 (441)
Q Consensus 252 ~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~---- 324 (441)
+|||+++....... ........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||............
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 228 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHh
Confidence 99999975432211 111234578999999999866 45889999999999999999999999654321100000
Q ss_pred cccccccch---hhhhhhhcCc-ccccc-----CChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 325 DFARPSLTD---KRRLKKIMDP-RLEEQ-----YPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 325 ~~~~~~~~~---~~~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+...+.. ...+...... ..... .....+..+.++|.+||+.+|++||++.+++.+
T Consensus 229 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 229 GSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred CCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000 0000000000 00000 112346678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=304.83 Aligned_cols=270 Identities=27% Similarity=0.356 Sum_probs=193.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|... .+++.||||.+..... .....+.+|+.++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHK---------KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 81 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEEC---------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence 457999999999999999999543 3588999998754321 12234567999999999999999999987
Q ss_pred eCC--------eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 176 EDR--------QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 176 ~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
... ..++||||+.+ +|.+++.... ..+++.+++.++.|++.||.|||+ .+++|+||||+|||++.++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~ 156 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHR--NKILHRDMKAANILITKDG 156 (310)
T ss_pred cccccccCCCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEECCCC
Confidence 643 45999999964 8888775543 358899999999999999999997 8999999999999999999
Q ss_pred ceEEecccCCCCCCCCCCc--ceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee
Q 013519 248 NAKLSDFGLAKLGPIDGNS--HVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV 324 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~ 324 (441)
.+||+|||++......... .......++..|+|||++.+. .++.++||||||+++|+|++|..||............
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~ 236 (310)
T cd07865 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236 (310)
T ss_pred cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999754322211 112234678899999988664 4688999999999999999999998654321100000
Q ss_pred c-----ccc---cccchhhhhhhhcCcc-----ccc-cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 325 D-----FAR---PSLTDKRRLKKIMDPR-----LEE-QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 325 ~-----~~~---~~~~~~~~~~~~~~~~-----~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ... +.............+. ... ..+...+..+.+||.+||..||++|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 000 0000000000000000 000 0011123457799999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=289.08 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=203.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcC-CCCCccceEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKF-SHPNLVKLIGY 173 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~ 173 (441)
.++|.++++||+|+|++|.+++ .+.+.+.||+|+++++ ..+.+..++.|-.+..+. +||++|.++..
T Consensus 249 l~df~ll~vigrgsyakvl~~~---------~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVR---------LKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred cccceeeeeecCcchhhhhhee---------hcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence 3579999999999999999984 4456889999988764 334566777888888887 49999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
|+.+..+++|.||++||+|.-.+.+. +.++++.++.+..+|+.||.|||+ .|||+||||.+|||||..|++||+|
T Consensus 320 fqtesrlffvieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~--rgiiyrdlkldnvlldaeghikltd 394 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTD 394 (593)
T ss_pred hcccceEEEEEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhh--cCeeeeeccccceEEccCCceeecc
Confidence 99999999999999999998777554 469999999999999999999997 9999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
+|+++.... ....++++||||.|.|||++.+..|...+|+|+|||+++||+.|+.||+--. ...+....
T Consensus 395 ygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg---------m~n~d~nt 463 (593)
T KOG0695|consen 395 YGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG---------MDNPDMNT 463 (593)
T ss_pred cchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec---------CCCcccch
Confidence 999986433 3345678999999999999999999999999999999999999999996322 11111111
Q ss_pred hhhhhh-hcCccccccCChhhHHHHHHHHHHhcccCCCCCCC
Q 013519 334 KRRLKK-IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS 374 (441)
Q Consensus 334 ~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 374 (441)
..-+.+ ++...+ .+|...+..+..+++..|+.||.+|..
T Consensus 464 edylfqvilekqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 464 EDYLFQVILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred hHHHHHHHhhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 111222 222222 346666667778999999999999964
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=296.20 Aligned_cols=243 Identities=24% Similarity=0.356 Sum_probs=188.1
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH---HHHHHHHH---HHHHhcCCCCCccceEEEEEeCCe
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ---GLREWQAE---VKFLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E---~~~l~~l~hpniv~~~~~~~~~~~ 179 (441)
+||+|+||.||+|... .+++.||+|.+...... ....+..| +.+++...||||+.+++++...+.
T Consensus 1 ~ig~g~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEe---------cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 4899999999999443 34789999987654221 11122233 344555679999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
+++||||+.|++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||+++.
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred EEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 99999999999999988654 358999999999999999999997 8999999999999999999999999999875
Q ss_pred CCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 260 GPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
.... ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||......... ...
T Consensus 147 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--------------~~~ 208 (278)
T cd05606 147 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------------EID 208 (278)
T ss_pred cCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--------------HHH
Confidence 3221 12235789999999998754 6889999999999999999999999654221100 000
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
... .......+...+..+.+++.+||..+|.+|| ++.+++++
T Consensus 209 ~~~-~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 209 RMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHh-hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 000 0111223444567789999999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=307.94 Aligned_cols=266 Identities=23% Similarity=0.330 Sum_probs=197.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
..+|.+.+.||+|+||+||+|.. ..+++.||||.+... .......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKN---------SETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEe---------cCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 35799999999999999999944 345889999987653 2223456678999999999999999999876
Q ss_pred eC-----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 176 ED-----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 176 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
.. ...++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+|
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~~~~~~~k 148 (337)
T cd07858 75 PPHREAFNDVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLK 148 (337)
T ss_pred cccccccCcEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEE
Confidence 54 35899999996 6888888654 358899999999999999999997 8999999999999999999999
Q ss_pred EecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ecccc
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VDFAR 328 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~~~~ 328 (441)
|+|||+++...... .......++..|+|||++.. ..++.++|||||||++|+|++|+.||........... .....
T Consensus 149 L~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 226 (337)
T cd07858 149 ICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLG 226 (337)
T ss_pred ECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence 99999997543221 22234567899999998865 4688999999999999999999999965421100000 00000
Q ss_pred c-------ccc--hhhhhhhhc----CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 P-------SLT--DKRRLKKIM----DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~-------~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ... ......+.. ..... ......+..+.+|+.+||+.+|++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 000 000000000 00001 1112356678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.53 Aligned_cols=245 Identities=29% Similarity=0.375 Sum_probs=193.5
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
|...+.||+|+||+||+|... .++..|++|.+... .......+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 93 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNS---------HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE 93 (313)
T ss_pred hhcceeeccCCCeEEEEEEEC---------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence 666778999999999999543 34789999987643 223456788899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+. |+|.+++.... .++++..++.++.|++.+|.|||+ .|++|+||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 94 HTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred CEEEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCCC
Confidence 99999999996 57877776543 458899999999999999999997 89999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
.... ......|+..|+|||++. ...++.++|||||||++|+|++|..||.......
T Consensus 169 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--------------- 227 (313)
T cd06633 169 SKSS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------------- 227 (313)
T ss_pred cccC------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---------------
Confidence 6421 122456889999999984 4568889999999999999999999986432110
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+.............+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 228 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 228 -ALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -HHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001110011111122234457899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=311.29 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=211.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++..+..||-||||.|-++..+.. ...+|+|.+++.+ ....+.+..|-+||..++.|+||++|-.|.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr 490 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR 490 (732)
T ss_pred hhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence 4556677899999999999866543 2247777776653 345567888999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
++.++|++||-|-||.|...|..+++ +...+...++..+++|+.|||+ +|||+|||||+|+||+.+|-+||.|||
T Consensus 491 d~kyvYmLmEaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 491 DSKYVYMLMEACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred cchhhhhhHHhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHh--cCceeccCChhheeeccCCceEEeehh
Confidence 99999999999999999999988875 7788999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+|+.. .....+.++||||.|.|||+++....+.++|.||||+++|||++|.+||.+.++. .
T Consensus 566 FAKki---~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm----------------k 626 (732)
T KOG0614|consen 566 FAKKI---GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM----------------K 626 (732)
T ss_pred hHHHh---ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH----------------H
Confidence 99864 3456688999999999999999999999999999999999999999999765432 1
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-----MEEVLETL 382 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~eil~~L 382 (441)
.+..++...-...+|......+.+||++++..+|.+|.. +.+|-+|-
T Consensus 627 tYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 627 TYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred HHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 122233333333566677777889999999999999986 67777763
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=298.04 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=204.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCC-CCCccceEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFS-HPNLVKLIGYC 174 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 174 (441)
++|.+.+.||.|+||.||+|... .+++.|++|++.... ......+.+|+.+++++. ||||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK---------ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc---------CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 46889999999999999999554 348899999886532 233466788999999998 99999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
...+..++||||+.+++|.+++.+.+ .+++..++.++.|++.||.|||. .+++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCC
Confidence 99999999999999999999997653 58999999999999999999996 89999999999999999999999999
Q ss_pred cCCCCCCCCCC------------------cceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 013519 255 GLAKLGPIDGN------------------SHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNR 316 (441)
Q Consensus 255 Gla~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~ 316 (441)
|++........ ........|+..|+|||++....++.++||||||+++++|++|..||....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 99875432211 012233567899999999988889999999999999999999999996542
Q ss_pred CCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 013519 317 PSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM----EEVLET 381 (441)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~eil~~ 381 (441)
. ...+..+. .....++...+..+.+|+.+||+.+|++||++ .+++++
T Consensus 227 ~----------------~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 227 E----------------YLTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred H----------------HHHHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1 01111111 11123344456678899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=292.05 Aligned_cols=241 Identities=24% Similarity=0.329 Sum_probs=187.4
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHH-HhcCCCCCccceEEEEEeCCeE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKF-LGKFSHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~ 180 (441)
+.||.|+||.||+|.. ...++.||+|.+..... .....+..|..+ .....||||+++++++..++.+
T Consensus 2 ~~l~~g~~~~v~~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKK---------RSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEe---------cCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 4799999999999944 34578999999865432 222334445544 4455899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
++||||+++++|.+++...+ .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++..
T Consensus 73 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred EEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 99999999999999986543 58899999999999999999997 89999999999999999999999999998753
Q ss_pred CCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 261 PIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
.. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+
T Consensus 148 ~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~ 205 (260)
T cd05611 148 LE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD----------------AVFDNI 205 (260)
T ss_pred cc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHH
Confidence 21 23356889999999998888899999999999999999999999643211 000011
Q ss_pred c--CccccccCChhhHHHHHHHHHHhcccCCCCCCCHH---HHHHH
Q 013519 341 M--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSME---EVLET 381 (441)
Q Consensus 341 ~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~---eil~~ 381 (441)
. ...........++..+.+++.+||+.+|++||++. |++.+
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 206 LSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 0 00111112234566788999999999999999664 55543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.78 Aligned_cols=249 Identities=28% Similarity=0.356 Sum_probs=195.9
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.|...+.||+|+||.||+|... ..+..+++|.+... .......+.+|+.+++.++|||++++++++..
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 86 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEc---------CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence 4666788999999999999543 34788999987642 23345567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
....++||||+. |+|.+++.... .++++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||+
T Consensus 87 ~~~~~lv~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~ 161 (308)
T cd06634 87 EHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGS 161 (308)
T ss_pred CCeeEEEEEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCccc
Confidence 999999999996 58877775443 458899999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
+..... .....|++.|+|||++. ...++.++|||||||++|+|++|..||......
T Consensus 162 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------------- 220 (308)
T cd06634 162 ASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------------- 220 (308)
T ss_pred ceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---------------
Confidence 875321 12346889999999985 346788999999999999999999998543110
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
.....+.........+...+..+.+||.+||..+|++||++.+++++...
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 221 -SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred -HHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 00011111111111123455668899999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=308.12 Aligned_cols=268 Identities=29% Similarity=0.377 Sum_probs=197.4
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcC-CCCCccceEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKF-SHPNLVKLIGY 173 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~ 173 (441)
..++|.+.+.||+|+||.||+|... .+++.+|+|++... .......+.+|+.+++++ +||||++++++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~ 75 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDR---------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV 75 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEc---------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence 4568999999999999999999554 34788999987542 223345677899999999 99999999999
Q ss_pred EEeC--CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 174 CWED--RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 174 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
+... ..+++||||+. ++|..++... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl 148 (337)
T cd07852 76 IKAENDKDIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKL 148 (337)
T ss_pred eccCCCceEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEE
Confidence 8653 46899999997 5898888543 57888999999999999999997 99999999999999999999999
Q ss_pred ecccCCCCCCCCCCc---ceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ecc
Q 013519 252 SDFGLAKLGPIDGNS---HVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VDF 326 (441)
Q Consensus 252 ~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~~ 326 (441)
+|||+++........ .......||..|+|||++.+ ..++.++||||||+++|+|++|+.||........... ...
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~ 228 (337)
T cd07852 149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228 (337)
T ss_pred eeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999764332221 22334578999999998765 4578899999999999999999999965332110000 000
Q ss_pred -cccccchhhh-----hhhhcC-------ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 327 -ARPSLTDKRR-----LKKIMD-------PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 327 -~~~~~~~~~~-----~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+....... ...++. ....... ...+..+.++|.+||+.+|++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000 000000 0001111 1246678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=297.58 Aligned_cols=266 Identities=26% Similarity=0.330 Sum_probs=196.7
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC-
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED- 177 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 177 (441)
|.+.+.||.|+||.||+|.... .++.+++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 6678899999999999995543 47899999987653 23345678899999999999999999999988
Q ss_pred -CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 178 -RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 178 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...++||||+++ +|.+++.... ..+++..++.++.|++.||.|||. .+++|+||||+|||+++++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g~ 146 (287)
T cd07840 72 KGSIYMVFEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGL 146 (287)
T ss_pred CCcEEEEeccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEccccc
Confidence 899999999975 8888886543 468899999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ecc-------c
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VDF-------A 327 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~~-------~ 327 (441)
+........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........... ... .
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07840 147 ARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN 225 (287)
T ss_pred eeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Confidence 976433221 11223456788999998765 4578999999999999999999999965432110000 000 0
Q ss_pred ccccchhhhh-----hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTDKRRL-----KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+.+...... .......+...+...++..+.+++.+||..+|++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000000 00000000111112235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=304.77 Aligned_cols=271 Identities=22% Similarity=0.293 Sum_probs=199.7
Q ss_pred CHHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCc
Q 013519 90 TLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNL 167 (441)
Q Consensus 90 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpni 167 (441)
...++....++|.+.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.++++++||||
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i 78 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDT---------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEc---------CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcc
Confidence 34566667899999999999999999999543 347899999887542 2234567789999999999999
Q ss_pred cceEEEEEeC------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcE
Q 013519 168 VKLIGYCWED------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNI 241 (441)
Q Consensus 168 v~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 241 (441)
+++++++... ...+++++++ +++|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||||+||
T Consensus 79 v~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NI 151 (345)
T cd07877 79 IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNL 151 (345)
T ss_pred cceeeeeeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHE
Confidence 9999988643 3468888887 7899887743 248899999999999999999997 9999999999999
Q ss_pred EEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCC
Q 013519 242 LLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGE 320 (441)
Q Consensus 242 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~ 320 (441)
+++.++.+||+|||+++.... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 152 ll~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 226 (345)
T cd07877 152 AVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226 (345)
T ss_pred EEcCCCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999875321 1234568899999999876 5678999999999999999999999964332110
Q ss_pred cee-ec---ccc----cccch--hhhhhhhcCcccc---ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 321 HVL-VD---FAR----PSLTD--KRRLKKIMDPRLE---EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 321 ~~~-~~---~~~----~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
... .. ... ..+.. .......+..... .......+..+.+||.+||+.||.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 00 000 00000 0000000000000 00011235568899999999999999999999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=298.59 Aligned_cols=270 Identities=27% Similarity=0.329 Sum_probs=196.2
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
...++|.+.+.||+|+||.||+|.... .++.||+|.+..... .....+.+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~ 74 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKD---------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECC---------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehe
Confidence 345789999999999999999996543 478899998865432 223456789999999999999999999
Q ss_pred EEeCC----------eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 174 CWEDR----------QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 174 ~~~~~----------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
+.+.. .+++|+||+++ +|..++... ...+++..++.++.|++.||.|||+ .+|+|+||||+||++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili 149 (302)
T cd07864 75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILL 149 (302)
T ss_pred ecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE
Confidence 87654 78999999986 777777543 2468899999999999999999997 899999999999999
Q ss_pred cCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce
Q 013519 244 DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV 322 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~ 322 (441)
++++.+||+|||++........ .......++..|+|||++.+. .++.++|||||||++|+|++|+.||..........
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~ 228 (302)
T cd07864 150 NNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228 (302)
T ss_pred CCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 9999999999999976433221 111223457889999988653 56889999999999999999999996533211000
Q ss_pred ee-ccc-c------cccchhhhhh-----hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 323 LV-DFA-R------PSLTDKRRLK-----KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 323 ~~-~~~-~------~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.. ... . +.+....... ......... .....+..+.+++.+||..+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHHhCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 000 0 0000000000 000000000 111235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=298.57 Aligned_cols=265 Identities=23% Similarity=0.254 Sum_probs=191.9
Q ss_pred CCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 013519 103 PDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 103 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 180 (441)
+.+.+|.|+++.||++ ..+++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 6 i~~~~~~~~~v~~~~~-----------~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~ 74 (314)
T cd08216 6 IGKCFEDLMIVHLAKH-----------KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSEL 74 (314)
T ss_pred hhHhhcCCceEEEEEe-----------cCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeE
Confidence 3344555555555544 225889999998654 344567899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||.+...
T Consensus 75 ~~~~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~ 151 (314)
T cd08216 75 YVVSPLMAYGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM 151 (314)
T ss_pred EEEEeccCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCcceEEEecCCceEEecCccceee
Confidence 999999999999999876432 358889999999999999999997 89999999999999999999999999988643
Q ss_pred CCCCC-----cceEeeeccccccCcchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee--eccccc--
Q 013519 261 PIDGN-----SHVTTRIMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL--VDFARP-- 329 (441)
Q Consensus 261 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~--~~~~~~-- 329 (441)
..... ........++..|+|||++.. ..++.++|||||||++|||++|+.||..........- ......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (314)
T cd08216 152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLL 231 (314)
T ss_pred ccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccc
Confidence 21111 111223457788999999876 3588999999999999999999999975432110000 000000
Q ss_pred ---ccch-hhhhhh----hcC----ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 ---SLTD-KRRLKK----IMD----PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ---~~~~-~~~~~~----~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.... ...... ... ...........+..+.+|+.+||..||++|||+.++|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 000000 000 001112233455678899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=294.88 Aligned_cols=256 Identities=29% Similarity=0.401 Sum_probs=199.2
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch----HHHHHHHHHHHHHhcC-CCCCccceEEEE
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI----QGLREWQAEVKFLGKF-SHPNLVKLIGYC 174 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 174 (441)
+|++.+.||.|+||.||+|.... ...++..||+|.+..... ...+.+.+|+.++.++ +||||+++++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~------~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVS------GHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEecc------CCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 47788999999999999996542 123478999998865322 2345678899999999 599999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
..+..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~df 149 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDF 149 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEeeC
Confidence 9999999999999999999999764 357889999999999999999997 99999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG--HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|+++...... ........|+..|+|||.+... .++.++||||||+++|+|++|..||....... .
T Consensus 150 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------------~ 216 (290)
T cd05613 150 GLSKEFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN------------S 216 (290)
T ss_pred ccceeccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc------------c
Confidence 9997543221 1122345689999999998753 46789999999999999999999986432110 0
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
.......+... ...++...+..+.+++.+||+.+|++|| ++.+++++
T Consensus 217 ~~~~~~~~~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 217 QAEISRRILKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHHhhcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00111111111 1123445566788999999999999997 78888875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=305.45 Aligned_cols=268 Identities=24% Similarity=0.334 Sum_probs=194.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
..+|.+.+.||+|+||.||+|... .+++.||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDK---------RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeC---------CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 478999999999999999999543 347899999876432 222356778999999999999999999987
Q ss_pred eC------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 176 ED------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 176 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
.. ..+++|+||+.. +|..++. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dlkp~NIll~~~~~~ 156 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCEL 156 (342)
T ss_pred ccccCCCCceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCE
Confidence 54 346999999964 6766541 358899999999999999999997 899999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ec--
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VD-- 325 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~-- 325 (441)
||+|||+++..... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||........... ..
T Consensus 157 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 231 (342)
T cd07879 157 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 231 (342)
T ss_pred EEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999753221 123467889999999876 4688999999999999999999999975432110000 00
Q ss_pred -ccccccchh------hhhhhhcCcccccc---CChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhcccc
Q 013519 326 -FARPSLTDK------RRLKKIMDPRLEEQ---YPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET--LQNISV 387 (441)
Q Consensus 326 -~~~~~~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~--L~~i~~ 387 (441)
...+.+... .............. .....+..+.+||.+||+.||++||++.+++.+ ++.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000000 00000000000000 011234568899999999999999999999976 655543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=295.67 Aligned_cols=254 Identities=27% Similarity=0.372 Sum_probs=194.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCC-CCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFS-HPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|.+. .+++.||||.+.... ......+..|+.++.++. ||||+++++++.
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFK---------KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEEC---------CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 357889999999999999999554 347899999986543 233445666777666665 999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+...+++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+ ..+|+||||+|+||+++.++.+||+|||
T Consensus 85 ~~~~~~~v~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~-~~~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 85 TDSDVFICMELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred cCCeEEEEeeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-hCCEecCCCcHHHEEEcCCCCEEECccc
Confidence 9999999999985 47777765533 368899999999999999999995 3589999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccccc
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH----LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
++....... ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||......
T Consensus 161 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------- 224 (296)
T cd06618 161 ISGRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------------- 224 (296)
T ss_pred cchhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------------
Confidence 987532211 112335788999999987554 788999999999999999999998642111
Q ss_pred chhhhhhhhcCccccc-cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 332 TDKRRLKKIMDPRLEE-QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 332 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
...+..++...... .....++..+.+|+.+||..||++||++.+++.+.
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 225 --FEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred --HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 01111111111110 11113456788999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=294.42 Aligned_cols=265 Identities=22% Similarity=0.295 Sum_probs=198.8
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH--HHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--GLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
|.+.+.||.|++|.||+|... ..++.+++|.+...... ....+.+|+.++++++||||+++++++..+.
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK---------LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEEcC---------CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 567789999999999999543 34789999988665332 3456788999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.+++|+||+++ +|.+++.... ..+++..++.++.|++.||.|||. .+|+|+||||+||+++.++.++|+|||.+.
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHH--CCeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 99999999975 8888876643 468899999999999999999997 899999999999999999999999999987
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee--ecccccccchhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL--VDFARPSLTDKR 335 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~ 335 (441)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||........... .....+......
T Consensus 147 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd05118 147 SFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWP 224 (283)
T ss_pred ecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcc
Confidence 643322 122234678899999999877 788999999999999999999999965432110000 000000000000
Q ss_pred hhh--------hhcCc--cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLK--------KIMDP--RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~--------~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
... .+... ..........+..+.++|.+||+.||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 00000 00001122356778999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=294.32 Aligned_cols=259 Identities=27% Similarity=0.378 Sum_probs=200.5
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch----HHHHHHHHHHHHHhcC-CCCCccceEEEE
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI----QGLREWQAEVKFLGKF-SHPNLVKLIGYC 174 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 174 (441)
+|.+.+.||+|+||.||++.... ....+..||||.+..... .....+.+|+.++.++ +||||+++++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVG------GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEec------cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 47788999999999999986542 123467899998764321 2345677899999999 599999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
..+...++||||+.+++|.+++... ..+++..+..++.|++.+|.|||. .+++||||||.||+++.++.++|+||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df 149 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLTDF 149 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEEEC
Confidence 9999999999999999999998654 358889999999999999999996 99999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH--LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|+++...... ........|+..|+|||.+.+.. ++.++||||||+++|+|++|..||....... .
T Consensus 150 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------------~ 216 (288)
T cd05583 150 GLSKEFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN------------S 216 (288)
T ss_pred cccccccccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc------------h
Confidence 9987643221 11223356899999999987665 7789999999999999999999985322110 0
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
.......+... ....+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 217 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 217 QSEISRRILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 00001111111 112344456678899999999999999998877766654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=303.61 Aligned_cols=272 Identities=24% Similarity=0.328 Sum_probs=201.9
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|.+.+.||.|+||.||+|... ..++.|+||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK---------RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC---------CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 5788899999999999999543 347899999887643 33456788999999999999999999998876
Q ss_pred C-----eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEe
Q 013519 178 R-----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252 (441)
Q Consensus 178 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 252 (441)
. .+|+||||+. ++|.+++.+.. .+++..++.++.|++.||.|||+ .||+|+||||+|||++.++.++|+
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~--~gi~H~dlkp~nili~~~~~~~L~ 145 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKIC 145 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEc
Confidence 5 7899999997 48888886543 68999999999999999999997 899999999999999999999999
Q ss_pred cccCCCCCCCCCC-cceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ec-ccc
Q 013519 253 DFGLAKLGPIDGN-SHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VD-FAR 328 (441)
Q Consensus 253 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~-~~~ 328 (441)
|||++........ ........+++.|+|||++.+. .++.++||||||+++|+|++|..||........... .. ...
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 225 (330)
T cd07834 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225 (330)
T ss_pred ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCC
Confidence 9999976433211 0122345678999999999888 789999999999999999999999965432100000 00 000
Q ss_pred cccc-----hhhhhhhhc---Cccc---cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhccc
Q 013519 329 PSLT-----DKRRLKKIM---DPRL---EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET--LQNIS 386 (441)
Q Consensus 329 ~~~~-----~~~~~~~~~---~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~--L~~i~ 386 (441)
+... ......... .... ........+..+.++|.+||+.+|++||++.+++.+ |+.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0000 000000000 0000 000112245678899999999999999999999986 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=293.66 Aligned_cols=269 Identities=26% Similarity=0.384 Sum_probs=201.2
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC--CCCCccceEEEEEeCC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF--SHPNLVKLIGYCWEDR 178 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~~~~~~~~~~ 178 (441)
..+.++||+|.||.||+|.++ ++.||||++...+ .+.|+.|-+|.... +|+||++++++-....
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-----------CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 445678999999999999665 5799999997654 45677888877764 6999999998765444
Q ss_pred ----eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhcc-------CCCCeeecCCCCCcEEEcCCC
Q 013519 179 ----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS-------SEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 179 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-------~~~~ivHrDlkp~Nill~~~~ 247 (441)
.++||++|.+.|+|.++|..+. ++|....+|+..+++||+|||. ++.+|+|||||..||||.+++
T Consensus 278 ~~~~eywLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl 353 (534)
T KOG3653|consen 278 ADRMEYWLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL 353 (534)
T ss_pred ccccceeEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence 7999999999999999997654 8999999999999999999996 467899999999999999999
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCC-CC-----ccccchhHHHHHHHHHhCCCCCCC-CCCCCC
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH-LY-----VKSDVYGFGVVLLEMLTGLRALDT-NRPSGE 320 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwSlG~il~elltg~~p~~~-~~~~~~ 320 (441)
+..|+|||||..+............+||.+|||||++.+.. +. .+.||||+|.|||||++.-..++. ..+...
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 99999999998766554444455589999999999986642 11 468999999999999997554432 111111
Q ss_pred ceeeccc--ccccchhhhhhhhcCccccccCCh-----hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 013519 321 HVLVDFA--RPSLTDKRRLKKIMDPRLEEQYPI-----KGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVIE 389 (441)
Q Consensus 321 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~~ 389 (441)
..+.... .|.+.+-. .-++....+..+|. .....+.+.+..||..||+.|.|+.=+.+++..+....
T Consensus 434 lpfe~evG~hPt~e~mq--~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQ--ELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CchhHHhcCCCCHHHHH--HHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1111000 12221111 11122222222222 33456789999999999999999999998887766544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=340.28 Aligned_cols=262 Identities=30% Similarity=0.495 Sum_probs=201.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
...|...++||+|+||.||+|... ..+..||||++...... ...|+.++++++|||||++++++.+.
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSI---------KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEEC---------CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 456778889999999999999543 34789999988654321 23468899999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccC-CCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSS-EKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...++||||+++|+|.+++. .++|..+..++.|++.||.|||.. ..+|+||||||+||+++.++..++. ||.
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 99999999999999999994 378999999999999999999953 4799999999999999999888775 666
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||+...... ..+..|...... ...
T Consensus 829 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~-~~~ 900 (968)
T PLN00113 829 PGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYS-DCH 900 (968)
T ss_pred cccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC-CcHHHHHHHhcC-ccc
Confidence 543211 122368899999999999999999999999999999999999995432211 111222211111 111
Q ss_pred hhhhcCcccccc--CChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 337 LKKIMDPRLEEQ--YPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 337 ~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
...++++.+... .+.....++.+++.+||+.||++||++.++++.|+.+..
T Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 223344443222 233455667899999999999999999999999987653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=305.46 Aligned_cols=246 Identities=24% Similarity=0.288 Sum_probs=199.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.-|..++.||-|+||.|.++ .+..+...||.|.+.+.+. ..+..++.|-.||.....+-||+||..|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv---------~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLV---------RKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred cceEEEeeecccccceeEEE---------eecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 34777889999999999998 5555678999998877644 34566888999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+++.+|+||+|++||++..+|.+.+- |++..++.++.++..|+.+.|. .|+|||||||+|||||.+|++||+|||
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHk--mGFIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHh--ccceecccCccceEEccCCceeeeecc
Confidence 99999999999999999999988774 7889999999999999999995 999999999999999999999999999
Q ss_pred CCCCCCCCCCc----------------------------------------ceEeeeccccccCcchhhhcCCCCccccc
Q 013519 256 LAKLGPIDGNS----------------------------------------HVTTRIMGTYGYAAPEYVATGHLYVKSDV 295 (441)
Q Consensus 256 la~~~~~~~~~----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 295 (441)
|++-+....++ ......+||+.|+|||++....|+.-+|+
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw 854 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW 854 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence 99643221110 01123589999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC
Q 013519 296 YGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP 373 (441)
Q Consensus 296 wSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 373 (441)
||.|||||||+.|+.||....+.+.+..+..++ ..+ .-.+....+.++.+||.+++ .++++|.
T Consensus 855 ws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~----------~~l----~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 855 WSVGVILYEMLVGQPPFLADTPGETQYKVINWR----------NFL----HIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred hHhhHHHHHHhhCCCCccCCCCCcceeeeeehh----------hcc----ccccccccCHHHHHHHHHHh-cChhhhh
Confidence 999999999999999998887766544321111 111 11223445667788887754 5677786
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=305.31 Aligned_cols=267 Identities=24% Similarity=0.286 Sum_probs=194.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC-
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED- 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 177 (441)
.+|.+.+.||.|+||.||+|.. ..+++.|++|++........+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~---------~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 75 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVD---------SDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSG 75 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEE---------CCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence 6799999999999999999944 345889999988766555667788999999999999999999776543
Q ss_pred -------------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc
Q 013519 178 -------------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD 244 (441)
Q Consensus 178 -------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 244 (441)
...++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+ .||+||||||+|||++
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~Nili~ 148 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFIN 148 (342)
T ss_pred cccccccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEc
Confidence 35799999997 588887743 248899999999999999999997 8999999999999997
Q ss_pred C-CCceEEecccCCCCCCCCCC-cceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCc
Q 013519 245 G-SYNAKLSDFGLAKLGPIDGN-SHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321 (441)
Q Consensus 245 ~-~~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~ 321 (441)
. ++.+||+|||+++....... ........|+..|+|||++.. ..++.++|||||||++|+|++|+.||....+....
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4 56789999999975321111 111122357889999998755 56788999999999999999999999654321110
Q ss_pred eee--cccccccchhhhh----hhhcC-ccccc-----cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 322 VLV--DFARPSLTDKRRL----KKIMD-PRLEE-----QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 322 ~~~--~~~~~~~~~~~~~----~~~~~-~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
... ..+.......... ..... ..... ......+.++.+|+.+||+.||++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 0000000000000 00000 00000 0112345668899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.09 Aligned_cols=268 Identities=23% Similarity=0.278 Sum_probs=195.0
Q ss_pred hcCCCC-CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHH--------------HHHHHHHHHHHhcC
Q 013519 98 TKNFRP-DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG--------------LREWQAEVKFLGKF 162 (441)
Q Consensus 98 ~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--------------~~~~~~E~~~l~~l 162 (441)
.++|.. .+.||.|+||+||+|... ..++.||||++....... ...+.+|+.+++.+
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 77 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDT---------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI 77 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEEC---------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC
Confidence 456664 578999999999999543 347899999876542211 12467899999999
Q ss_pred CCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEE
Q 013519 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNIL 242 (441)
Q Consensus 163 ~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 242 (441)
+||||+++++++...+..++||||+. |+|.+++.... .+++.....++.|++.||.|||+ .+|+|+||||+|||
T Consensus 78 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nil 151 (335)
T PTZ00024 78 KHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIF 151 (335)
T ss_pred CCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeE
Confidence 99999999999999999999999997 58998886543 48899999999999999999997 99999999999999
Q ss_pred EcCCCceEEecccCCCCCCCCC------------CcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCC
Q 013519 243 LDGSYNAKLSDFGLAKLGPIDG------------NSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGL 309 (441)
Q Consensus 243 l~~~~~~kl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~ 309 (441)
++.++.++|+|||+++...... .........+++.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 231 (335)
T PTZ00024 152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231 (335)
T ss_pred ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999997543110 01111223568899999998764 4689999999999999999999
Q ss_pred CCCCCCCCCCCcee-ecc-cc---cccchhhhhh------hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 013519 310 RALDTNRPSGEHVL-VDF-AR---PSLTDKRRLK------KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEV 378 (441)
Q Consensus 310 ~p~~~~~~~~~~~~-~~~-~~---~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ei 378 (441)
.||........... ... .. ..+....... ........ ......+..+.++|.+||+.+|++||+++++
T Consensus 232 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 310 (335)
T PTZ00024 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEA 310 (335)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence 99975432110000 000 00 0000000000 00000000 0112335668899999999999999999999
Q ss_pred HHH
Q 013519 379 LET 381 (441)
Q Consensus 379 l~~ 381 (441)
+.+
T Consensus 311 l~~ 313 (335)
T PTZ00024 311 LKH 313 (335)
T ss_pred hcC
Confidence 986
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=290.44 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=194.5
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCC---C--chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP---D--SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~---~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
+|.+.+.||+|+||.||++..... +..+++|.++. . .......+..|+.+++.++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA---------VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC---------CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 488889999999999999965432 33344444332 1 112234566799999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRK-GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
.+....++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .|++|+||||+||+++. +.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~~-~~~~l~d 148 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLKN-NLLKIGD 148 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH--cCccccCCChhheEeec-CCEeecc
Confidence 9999999999999999999988652 223568999999999999999999996 99999999999999975 5699999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
||+++..... ........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 149 ~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---------------- 210 (260)
T cd08222 149 FGVSRLLMGS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---------------- 210 (260)
T ss_pred cCceeecCCC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----------------
Confidence 9998764321 1223345688999999999888899999999999999999999999853211
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+.. ......+...+..+.++|.+||..+|++||++.+++++
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 211 LSVVLRIVE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHHHc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 011111111 11112344566778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=302.48 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=195.4
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
..++|.+.+.||+|+||.||+|... .++..||||++... .......+.+|+.+|+.++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDR---------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEEC---------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 4678999999999999999999543 34789999987543 222345678899999999999999999998
Q ss_pred EeCC------eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 175 WEDR------QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 175 ~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
.... .+++||||+ +++|.+++.. ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~--~gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCE 156 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCC
Confidence 7653 458999999 7799888753 358899999999999999999997 99999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-eecc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LVDF 326 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~ 326 (441)
++|+|||++..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ....
T Consensus 157 ~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~ 231 (343)
T cd07880 157 LKILDFGLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV 231 (343)
T ss_pred EEEeeccccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999975322 1223467899999999876 457899999999999999999999996542210000 0000
Q ss_pred ccc---ccch------hhhhhhhcCc---cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 327 ARP---SLTD------KRRLKKIMDP---RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 327 ~~~---~~~~------~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
... .+.. .......+.. ..........+..+.++|.+||+.||++|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 232 TGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred cCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000 0000000000 00001112345568899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=302.39 Aligned_cols=266 Identities=25% Similarity=0.323 Sum_probs=196.6
Q ss_pred HHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEE
Q 013519 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIG 172 (441)
Q Consensus 95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~ 172 (441)
..++++|.+.+.||.|+||.||+|.. ..+++.||+|++.... ....+.+.+|+.+++.++||||+++++
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 76 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARD---------QLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEE---------CCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEee
Confidence 34578899999999999999999944 3458899999875432 223456778999999999999999999
Q ss_pred EEEe-CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 173 YCWE-DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 173 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
++.. ...+++||||+ +++|..++.. ..++...+..++.|++.||.|||+ .+|+||||||.|||++.++.++|
T Consensus 77 ~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili~~~~~~~l 149 (328)
T cd07856 77 IFISPLEDIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKI 149 (328)
T ss_pred eEecCCCcEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeECCCCCEEe
Confidence 9876 56789999998 5688887743 247788889999999999999997 89999999999999999999999
Q ss_pred ecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-eecccc-
Q 013519 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LVDFAR- 328 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~- 328 (441)
+|||++..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +.....
T Consensus 150 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 224 (328)
T cd07856 150 CDFGLARIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT 224 (328)
T ss_pred CccccccccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999874321 1223467889999998766 568899999999999999999999996543210000 000000
Q ss_pred c------ccchhhhhhhhcCccccccCC-----hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 P------SLTDKRRLKKIMDPRLEEQYP-----IKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+ .........-+.........+ ...+..+.++|.+||+.+|++||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 225 PPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000000000000001111 1345678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=302.02 Aligned_cols=246 Identities=25% Similarity=0.357 Sum_probs=196.9
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFL 181 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 181 (441)
.++||.|.||+||-| ++..+|+.||||++.+... +....+++|+.||..+.||.||.+...|+..+.+|
T Consensus 569 devLGSGQFG~VYgg---------~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGG---------KHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeecc---------eecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 479999999999999 4555699999999876532 33467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC---CceEEecccCCC
Q 013519 182 LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS---YNAKLSDFGLAK 258 (441)
Q Consensus 182 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~kl~DFGla~ 258 (441)
+|||.+.|.-|+-+|.... ..|++.....++.||+.||.|||- ++|+|.||||+|||+.+. -.+||||||+|+
T Consensus 640 VVMEKl~GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~--knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 640 VVMEKLHGDMLEMILSSEK--GRLPERITKFLVTQILVALRYLHF--KNIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred EEehhhcchHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhh--cceeeccCCchheeeccCCCCCceeecccccee
Confidence 9999996644444443322 358888889999999999999996 999999999999999654 359999999999
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
+.. ......+.+|||.|+|||+++...|+..-|+||+|||+|.-++|..||.......++. +-.
T Consensus 716 iIg---EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI-------------QNA 779 (888)
T KOG4236|consen 716 IIG---EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI-------------QNA 779 (888)
T ss_pred ecc---hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh-------------hcc
Confidence 753 3445667899999999999999999999999999999999999999996542211110 000
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.++-| .......+..+.+||..+|+..-.+|.|++..|.+
T Consensus 780 aFMyP---p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 780 AFMYP---PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ccccC---CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 11111 11123455678899999999999999999999875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=290.19 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=193.3
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcC---CCCCccceEEEEE
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKF---SHPNLVKLIGYCW 175 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~~~~~~~ 175 (441)
|++.+.||+|+||.||+|.... +++.||+|.+..... .....+.+|+.+++++ .||||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 5678899999999999996543 478999998864322 1233456687777665 5999999999998
Q ss_pred eCCe-----EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 176 EDRQ-----FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 176 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
.... .+++|||+.+ +|.+++.+... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++
T Consensus 72 ~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~--~~i~h~~l~~~nili~~~~~~~ 147 (287)
T cd07838 72 GPRTDRELKLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQVK 147 (287)
T ss_pred eccCCCCceeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhEEEccCCCEE
Confidence 8776 9999999975 89888866432 358999999999999999999997 8999999999999999999999
Q ss_pred EecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce--e-----
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--L----- 323 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~----- 323 (441)
|+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||.......... .
T Consensus 148 l~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07838 148 IADFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGL 224 (287)
T ss_pred EeccCcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCC
Confidence 99999997643221 1223457889999999999999999999999999999999999987543211000 0
Q ss_pred ---ecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 324 ---VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 324 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+................... .......+..+.+++.+||+.||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 225 PSEEEWPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CChHhcCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000000000000000000 01112345667899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=308.22 Aligned_cols=243 Identities=24% Similarity=0.287 Sum_probs=198.2
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++.|.+...+|.|+|+.|-.+ ....+++..++|++.... .+..+|+.++... +||||+++.+.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~---------~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYC---------ESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred cchhhccccccCCCCccceeee---------eccccccchhheeccccc----cccccccchhhhhcCCCcceeecceec
Confidence 4678899999999999999988 455568899999987662 2234577666665 5999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE-cCCCceEEecc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL-DGSYNAKLSDF 254 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill-~~~~~~kl~DF 254 (441)
+....|+|||++.|+.|.+.+.... ....++..|+.+++.|+.|||. +|+|||||||+|||+ ++.++++|+||
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrltyF 460 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTYF 460 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEEe
Confidence 9999999999999999988886544 2236778899999999999997 999999999999999 68899999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|.++..... ..+.+-|..|.|||++...+|+.++||||||++||+||+|+.||...... .
T Consensus 461 G~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---------------~ 520 (612)
T KOG0603|consen 461 GFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---------------I 520 (612)
T ss_pred chhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---------------H
Confidence 999864322 33456789999999999999999999999999999999999999754322 1
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.....+..+ .+....+..+++|+.+||+.||.+||++.+++.+-
T Consensus 521 ei~~~i~~~----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 521 EIHTRIQMP----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred HHHHhhcCC----ccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 111111111 22356677899999999999999999999999863
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=297.63 Aligned_cols=269 Identities=27% Similarity=0.319 Sum_probs=192.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH--HHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--GLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|.+.+.||.|+||.||+|... .+++.+++|.+...... ....+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQI---------KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEEC---------CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 468999999999999999999543 34788999987543221 1235678999999999999999999875
Q ss_pred eC--------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 176 ED--------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 176 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
+. ..+++||||+.+ +|...+.... ..+++..+..++.|++.||.|||+ .||+|+||||+|||++.++
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~~~~~ 152 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQG 152 (311)
T ss_pred cccccccccCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCC
Confidence 43 347999999965 6777665432 468999999999999999999997 8999999999999999999
Q ss_pred ceEEecccCCCCCCCCCCc---------ceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 013519 248 NAKLSDFGLAKLGPIDGNS---------HVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRP 317 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~ 317 (441)
.++|+|||+++........ .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999754322111 111234678899999988654 578999999999999999999999965432
Q ss_pred CCCcee-ecc----cccccchhhhhhhhc--------CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 318 SGEHVL-VDF----ARPSLTDKRRLKKIM--------DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 318 ~~~~~~-~~~----~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...... ... ....+.....+.... .+.+... .......+.+++.+||+.||++|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 233 IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 110000 000 000000000000000 0000000 01223567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=298.93 Aligned_cols=268 Identities=24% Similarity=0.296 Sum_probs=191.8
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCC-CCCccceEEEEEe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFS-HPNLVKLIGYCWE 176 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 176 (441)
+|.+.+.||+|+||.||++..... ..+..||+|.+... .....+.+.+|+.+++++. ||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET-------SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC-------CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 477889999999999999965432 11678999987643 2223456778999999994 9999999987543
Q ss_pred C----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEe
Q 013519 177 D----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252 (441)
Q Consensus 177 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 252 (441)
. ..++++++|+. ++|.+++... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+
T Consensus 74 ~~~~~~~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~kl~ 147 (332)
T cd07857 74 FPGNFNELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKIC 147 (332)
T ss_pred ccccCCcEEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCEEeC
Confidence 2 45789999986 6898888543 458899999999999999999997 999999999999999999999999
Q ss_pred cccCCCCCCCCCC--cceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce--eeccc
Q 013519 253 DFGLAKLGPIDGN--SHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--LVDFA 327 (441)
Q Consensus 253 DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~~~~~ 327 (441)
|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... .....
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 9999975432211 111234578999999998866 468899999999999999999999986533110000 00000
Q ss_pred ccc------c-chh-hhhhhhc----CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPS------L-TDK-RRLKKIM----DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~------~-~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+. + ... ....... ...+. ......+..+.+|+.+||+.||++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 0 000 0000000 00000 0111235568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=321.62 Aligned_cols=146 Identities=29% Similarity=0.382 Sum_probs=130.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||+||+|+.. ..++.||||++.... ......+..|+.++..++||||+++++++.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~---------~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKK---------NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 57899999999999999999554 347899999986532 334567888999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
....+||||||+.+++|.+++...+ .+++..++.++.||+.||.|||. .+||||||||+||||+.++.+||+|||
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~--~gIiHrDLKP~NILl~~~g~vkL~DFG 149 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHR--HGIIHRDLKPDNMLISNEGHIKLTDFG 149 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCccHHHEEEcCCCCEEEEeCC
Confidence 9999999999999999999986543 47889999999999999999997 899999999999999999999999999
Q ss_pred CCC
Q 013519 256 LAK 258 (441)
Q Consensus 256 la~ 258 (441)
+++
T Consensus 150 ls~ 152 (669)
T cd05610 150 LSK 152 (669)
T ss_pred CCc
Confidence 986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=291.34 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=194.7
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCC-CCCccceEEEEEeCC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFS-HPNLVKLIGYCWEDR 178 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 178 (441)
|.+.+.||.|+||+||+|.... +++.|+||.+..... .......+|+..+++++ ||||+++++++.+++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 6678899999999999995543 378899998765422 12223456999999999 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||+ +|+|.+++.... ...+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||+++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeecccce
Confidence 999999999 789998886643 2458899999999999999999997 899999999999999999999999999997
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-eecc----cccccc
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LVDF----ARPSLT 332 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~----~~~~~~ 332 (441)
...... ......++..|+|||++.. ..++.++||||||+++++|++|+.||.......... .... ....+.
T Consensus 148 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07830 148 EIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP 224 (283)
T ss_pred eccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence 543211 1233568889999998754 457899999999999999999999996543211000 0000 000000
Q ss_pred hhhhhhhhcCcc--------ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPR--------LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
............ +....+ ..+..+.++|.+||+.+|++||++.|++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 225 EGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hHhhhhccccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000 000111 124668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=310.83 Aligned_cols=261 Identities=28% Similarity=0.420 Sum_probs=212.8
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccc
Q 013519 91 LQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVK 169 (441)
Q Consensus 91 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~ 169 (441)
++.+...+..|++.++||.|.+|.||++ +.+.+++..|+|+...+... -++++.|.+||+.+. |||++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~---------k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~ 80 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKG---------RHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVAT 80 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEE---------eeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcce
Confidence 3444455678999999999999999999 45556888899988776543 256778999999985 999999
Q ss_pred eEEEEEe-----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc
Q 013519 170 LIGYCWE-----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD 244 (441)
Q Consensus 170 ~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 244 (441)
++++|.. +++++||||||.||+..|++.... ...+.|..+..|++.++.||.+||. ..++|||||-.|||++
T Consensus 81 fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~--nkviHRDikG~NiLLT 157 (953)
T KOG0587|consen 81 FYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN--NKVIHRDIKGQNVLLT 157 (953)
T ss_pred EEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh--cceeeecccCceEEEe
Confidence 9999874 468999999999999999987654 5778999999999999999999996 8899999999999999
Q ss_pred CCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC-----CCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 013519 245 GSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-----HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSG 319 (441)
Q Consensus 245 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~elltg~~p~~~~~~~~ 319 (441)
.++.|||+|||++.... .......+..|||.|||||++... .|+..+|+||||++..||--|.+|+....+.-
T Consensus 158 ~e~~VKLvDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr 235 (953)
T KOG0587|consen 158 ENAEVKLVDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR 235 (953)
T ss_pred ccCcEEEeeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence 99999999999987532 333345568899999999999643 57789999999999999999999997665432
Q ss_pred CceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 320 EHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+ .-+|...-..|...+.++.++|..||..|-++||++.++|+|
T Consensus 236 aLF~I---------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 ALFLI---------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhccC---------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 21111 112333334466777888899999999999999999999975
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=292.07 Aligned_cols=265 Identities=23% Similarity=0.307 Sum_probs=199.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC--CC----CccceE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS--HP----NLVKLI 171 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--hp----niv~~~ 171 (441)
+++|.+...||+|.||.|-.++.+.. +..||||+++.... ..+..+-|+++|.++. -| -+|++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~---------~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRET---------KEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCC---------CceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 68999999999999999999966543 68999999875432 2344556999999994 23 377888
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC------
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG------ 245 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~------ 245 (441)
+||.-.+..+||+|.+ |-+++++|..+. ..+++...++.++.|++.+++|||. .+++|-||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~--~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHD--LKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHh--cceeecCCChheEEEeccceEEE
Confidence 8899999999999998 669999997654 5789999999999999999999996 99999999999999931
Q ss_pred --------------CCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCC
Q 013519 246 --------------SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRA 311 (441)
Q Consensus 246 --------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p 311 (441)
+..|+|+|||.|+.... .....+.|.-|+|||++++-+++..+||||+||||+||+||...
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 33589999999986322 22567889999999999999999999999999999999999999
Q ss_pred CCCCCCCCCceeecccccccc----hhh--------------------hhhhhcCcccc----ccCChhhHHHHHHHHHH
Q 013519 312 LDTNRPSGEHVLVDFARPSLT----DKR--------------------RLKKIMDPRLE----EQYPIKGALLAGQIIIK 363 (441)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~----~~~--------------------~~~~~~~~~~~----~~~~~~~~~~~~~li~~ 363 (441)
|..........+.+..-..++ .+. ......++... ..........+.+|+.+
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 987653321111000000000 000 00111111000 01112334568899999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 013519 364 CLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 364 ~l~~dp~~Rps~~eil~~ 381 (441)
||..||.+|+|+.|+|.|
T Consensus 389 mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSH 406 (415)
T ss_pred HHccCccccccHHHHhcC
Confidence 999999999999999986
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=302.82 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=196.7
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
..++|.+.+.||+|+||.||+|.... +++.||+|++... .......+.+|+.+++.+.||||+++++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTK---------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECC---------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 35789999999999999999995543 4789999987653 223345677899999999999999999988
Q ss_pred EeCCe------EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 175 WEDRQ------FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 175 ~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
..... +++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+ .||+||||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCE 156 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCC
Confidence 76554 89999999 6799988854 358899999999999999999997 89999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-eecc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LVDF 326 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~ 326 (441)
++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... +.+.
T Consensus 157 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~ 231 (343)
T cd07851 157 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL 231 (343)
T ss_pred EEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Confidence 999999999753221 233467889999999865 367899999999999999999999996543211000 0000
Q ss_pred c---ccccchh---hhhhhhcC---ccccc---cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 327 A---RPSLTDK---RRLKKIMD---PRLEE---QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 327 ~---~~~~~~~---~~~~~~~~---~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. .+.+... .....++. ..... ......+..+.++|.+||+.+|++|||+.+|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 0000000 00000000 00000 0011235678899999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=289.72 Aligned_cols=264 Identities=29% Similarity=0.396 Sum_probs=196.9
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
|++.+.||+|+||.||+|.. ..+++.+++|.+.... ......+..|+.+++.++||||+++++++.+..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARD---------KKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEeee---------cCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 56678899999999999944 3458899999887653 223456778999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||+. ++|.+++.+.. ..+++..++.++.|++.||.|||. .+|+||||+|+||+++.++.++|+|||+++
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChheEEEcCCCCEEEecCCccc
Confidence 9999999997 58999997653 358899999999999999999997 899999999999999999999999999997
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-eecccc-c---ccc
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LVDFAR-P---SLT 332 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~-~---~~~ 332 (441)
....... ......++..|+|||.+.+. .++.++|||||||++|||++|..||.......... +..... + .+.
T Consensus 147 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07829 147 AFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP 224 (282)
T ss_pred ccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHH
Confidence 6432211 12234567889999998776 78899999999999999999999986543110000 000000 0 000
Q ss_pred h-------hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 D-------KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ...............++ ..+..+.++|.+||..+|++||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 225 GVTKLPDYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred hhcccccccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0 00000000000001111 225568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=282.28 Aligned_cols=241 Identities=32% Similarity=0.430 Sum_probs=195.6
Q ss_pred ecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 107 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
||.|+||.||++... ..++.+++|.+..... .....+..|+.+++.++||||+++++.+..+...++|
T Consensus 1 lg~G~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKK---------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEEC---------CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 699999999999543 3478999998766432 2456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
|||+.+++|.+++.... .+++..+..++.|++.||.|||. .+++|+||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 72 LEYAPGGELFSHLSKEG---RFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 99999999999997653 58899999999999999999997 99999999999999999999999999999754322
Q ss_pred CCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCc
Q 013519 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDP 343 (441)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (441)
. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+..
T Consensus 147 ~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----------------~~~~~~~~~- 207 (250)
T cd05123 147 G--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----------------KEIYEKILK- 207 (250)
T ss_pred C--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHhc-
Confidence 1 123445688899999999888889999999999999999999999964321 011111111
Q ss_pred cccccCChhhHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 013519 344 RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM---EEVLET 381 (441)
Q Consensus 344 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~eil~~ 381 (441)
....++...+..+.+++.+||..||++||++ .+++++
T Consensus 208 -~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 208 -DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 1123344456678899999999999999999 566543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=292.84 Aligned_cols=261 Identities=25% Similarity=0.388 Sum_probs=203.1
Q ss_pred HHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-------HHHHHHHHHHHHHhcCCCCCc
Q 013519 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-------QGLREWQAEVKFLGKFSHPNL 167 (441)
Q Consensus 95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~hpni 167 (441)
....++|-++.+||+|||+.||+|+ +....+.||||+-..... ...+...+|.+|.+.|.||.|
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAF---------Dl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRI 529 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAF---------DLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRI 529 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhc---------ccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCccee
Confidence 3345688899999999999999994 344478999997544321 123446689999999999999
Q ss_pred cceEEEEE-eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc--
Q 013519 168 VKLIGYCW-EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD-- 244 (441)
Q Consensus 168 v~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~-- 244 (441)
|++|++|. +.+.+|-|+|||+|.+|.-+|..+. .+++.+++.|+.||+.||.||..-...|||-||||.||||.
T Consensus 530 VKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G 606 (775)
T KOG1151|consen 530 VKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG 606 (775)
T ss_pred eeeeeeeeeccccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC
Confidence 99999986 4567999999999999999997664 58899999999999999999987678999999999999994
Q ss_pred -CCCceEEecccCCCCCCCCCCc-----ceEeeeccccccCcchhhhcC----CCCccccchhHHHHHHHHHhCCCCCCC
Q 013519 245 -GSYNAKLSDFGLAKLGPIDGNS-----HVTTRIMGTYGYAAPEYVATG----HLYVKSDVYGFGVVLLEMLTGLRALDT 314 (441)
Q Consensus 245 -~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~elltg~~p~~~ 314 (441)
..|.+||+||||++++..+... ..+....||.+|++||.+.-+ .++.|+||||+|||+|..+.|+.||..
T Consensus 607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 4578999999999987654333 335567899999999988543 567899999999999999999999975
Q ss_pred CCCCCCceeecccccccchhhhhhhhcCccccccCC--hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 315 NRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYP--IKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+..... + -....++..... .+| +..+.++++||++||++--++|..+.++...
T Consensus 687 nqsQQd-I------------LqeNTIlkAtEV-qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 687 NQSQQD-I------------LQENTILKATEV-QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred chhHHH-H------------Hhhhchhcceec-cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 432211 0 011112211111 122 3455678899999999999999998887653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=282.68 Aligned_cols=249 Identities=27% Similarity=0.344 Sum_probs=192.2
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKF-SHPNLVKLIGYCWEDRQFL 181 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 181 (441)
+..||.|+||+|++- .++.+|+..|||++...+. ...+++..|.+...+- +.||||++||.+..++..+
T Consensus 69 lg~iG~G~fG~V~KM---------~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKM---------LHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred HHHhcCCcchhhhhh---------hcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 457999999999997 5566799999999987765 4456677788755554 6999999999999999999
Q ss_pred EEEeecCCCCHHHHHHh--cCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 182 LVYEYMQKGSLENHLFR--KGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 182 lv~e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
|.||+|+ .+|..+... ......+++..+-.|....+.||.||-. +..|||||+||+||||+..|.|||||||++..
T Consensus 140 iCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 140 ICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 9999995 466655432 1112458888888999999999999986 68899999999999999999999999999864
Q ss_pred CCCCCCcceEeeeccccccCcchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 260 GPIDGNSHVTTRIMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
.. .+...+.-.|-..|||||-+.. ..|+.++||||||++|||+.||..|+..... .-+++
T Consensus 218 Lv---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---------------vfeql 279 (361)
T KOG1006|consen 218 LV---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---------------VFEQL 279 (361)
T ss_pred HH---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---------------HHHHH
Confidence 32 2333445678899999999854 4689999999999999999999999964321 11222
Q ss_pred hhhcCccccc-cCC---hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIMDPRLEE-QYP---IKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~-~~~---~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+....... ..+ ...+..+..+|.-||..|-.+||...+++++
T Consensus 280 ~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 280 CQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2222211111 111 2345668899999999999999999999874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=259.07 Aligned_cols=266 Identities=23% Similarity=0.318 Sum_probs=196.3
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH--HHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--GLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+|.-.++||+|.||+||+|+ ...++..||+|.++.+..+ ......+|+-+|+.++|.|||+++++...+
T Consensus 3 ~ydkmekigegtygtvfkar---------n~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKAR---------NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEecc---------cCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 45556789999999999994 4445889999988765332 234567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+-+|+|||.. +|..+..... ..++...+..++.|+++||.|+|+ +++.||||||.|+||+.+|++||+|||++
T Consensus 74 kkltlvfe~cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 74 KKLTLVFEFCDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred ceeEEeHHHhhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccchh
Confidence 999999999965 7888876533 358889999999999999999998 88999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCC-CCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeeccc--ccccch
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGH-LYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFA--RPSLTD 333 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~--~~~~~~ 333 (441)
+.+.. ........+-|.+|.+|.++.+.. |+...|+||-|||+.||.. |++.|.+..-.+....+.+. .+.-..
T Consensus 149 rafgi--pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~ 226 (292)
T KOG0662|consen 149 RAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ 226 (292)
T ss_pred hhcCC--ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence 97543 233344556789999999998875 5688899999999999987 55555554322211111000 000000
Q ss_pred hhhhhhhcCccccccCCh---------hhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPI---------KGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+..+.+.-+-.....+|. .....-++|+.++|.-+|..|.++++++++
T Consensus 227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111111111111111221 222335689999999999999999999886
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=280.59 Aligned_cols=225 Identities=20% Similarity=0.222 Sum_probs=179.0
Q ss_pred cCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEeecCC
Q 013519 110 GGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQK 189 (441)
Q Consensus 110 G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 189 (441)
|.||+||+++ +..+++.||+|.+..... +..|...+....||||+++++++.+....++||||+++
T Consensus 4 g~~~~v~~~~---------~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVM---------DTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEE---------EccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 8999999994 444588999999876532 23455555566799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceE
Q 013519 190 GSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269 (441)
Q Consensus 190 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 269 (441)
|+|.+++.+.. .+++..+..++.|++.||.|||. .+|+||||||+||+++.++.++|+|||++..... ..
T Consensus 70 ~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~ 139 (237)
T cd05576 70 GKLWSHISKFL---NIPEECVKRWAAEMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SC 139 (237)
T ss_pred CCHHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----cc
Confidence 99999987643 48899999999999999999996 9999999999999999999999999998764321 12
Q ss_pred eeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccC
Q 013519 270 TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQY 349 (441)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (441)
....++..|+|||.+.+..++.++||||+|+++|||++|+.|+....... . .......
T Consensus 140 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~----------~~~~~~~ 197 (237)
T cd05576 140 DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N----------THTTLNI 197 (237)
T ss_pred ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c----------cccccCC
Confidence 23456778999999988889999999999999999999998875321100 0 0000112
Q ss_pred ChhhHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 013519 350 PIKGALLAGQIIIKCLEAEPKNRPSM-----EEVLE 380 (441)
Q Consensus 350 ~~~~~~~~~~li~~~l~~dp~~Rps~-----~eil~ 380 (441)
+...+..+.++|.+||+.||++||++ +++++
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 233 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKS 233 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHc
Confidence 33445668899999999999999986 55554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=309.40 Aligned_cols=268 Identities=26% Similarity=0.415 Sum_probs=215.0
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCC-CCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFS-HPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 174 (441)
..++..+.+.||+|.||.|++|......... ......||||.++... ....+.+..|+.+|+.+. ||||+.+++++
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred chhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3445566679999999999999876533211 1235789999987653 356678999999999995 99999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcC---------C--C--CCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcE
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKG---------S--A--EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNI 241 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------~--~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 241 (441)
...+.+++|+|||..|+|.++|...+ . . ..++....+.++.||+.|+.||++ ..+|||||...||
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--VPCVHRDLAARNV 449 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh--CCccchhhhhhhE
Confidence 99999999999999999999998765 0 1 238899999999999999999997 8899999999999
Q ss_pred EEcCCCceEEecccCCCCCCCCCCcceEeeecc--ccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 013519 242 LLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG--TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPS 318 (441)
Q Consensus 242 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~ 318 (441)
|+..+..+||+|||+|+......... ...-.| ...|||||.+....|+.++|||||||+||||+| |..||.+-
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~--- 525 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI--- 525 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC---
Confidence 99999999999999998533322221 121222 345999999999999999999999999999999 66777541
Q ss_pred CCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 319 GEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
.....+.+.+....+...|..|+.++.++++.||+.+|++||++.++.+.|+..
T Consensus 526 -------------~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 -------------PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -------------CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111222334555556677888899999999999999999999999999998873
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=302.60 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=215.4
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 179 (441)
.+..++||.|+||+||+|.|-.+ ......+||||++... ..+.-.++.+|+-+|.+++|||++++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pe-----ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPE-----GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecC-----CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 44567999999999999988653 2234568999987665 3445678899999999999999999999998765
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
+-||++|+++|.|.++++.+. ..+-....+.|..||++|+.|||. +.+|||||...|||+.+-..+||+|||+++.
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~--qrlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEE--QRLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHh--cchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 789999999999999998755 457788999999999999999995 9999999999999999999999999999998
Q ss_pred CCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 260 GPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
...+..........-.+.|||-|.+....|+.++|||||||++|||+| |..|+++.. .+.+.
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-----------------~~eI~ 910 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-----------------AEEIP 910 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-----------------HHHhh
Confidence 766655544444444678999999999999999999999999999998 777876532 23344
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
+++....+-..|..++.++..++.+||..|+..||+++++...+.+
T Consensus 911 dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 911 DLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred HHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 5555555556688899999999999999999999999999887643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=280.13 Aligned_cols=263 Identities=28% Similarity=0.445 Sum_probs=199.1
Q ss_pred HHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhc--CCCCCccceEE
Q 013519 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGK--FSHPNLVKLIG 172 (441)
Q Consensus 95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~ 172 (441)
+....+..+.+.||+|.||.||+|.|+ |..||||++..... +.+.+|.+|.+. |+|+||+.+++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIa 272 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIA 272 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-----------CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhh
Confidence 445678889999999999999999998 77899999977654 456677777775 58999999998
Q ss_pred EEEeC----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhcc------CCCCeeecCCCCCcEE
Q 013519 173 YCWED----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS------SEKSVIYRDFKASNIL 242 (441)
Q Consensus 173 ~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~------~~~~ivHrDlkp~Nil 242 (441)
.=..+ .+++||.+|.+.|+|+|||.+. .++....++++..++.||++||. .+..|.|||||..|||
T Consensus 273 aD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 273 ADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred ccccCCCceEEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 75433 2689999999999999999764 48899999999999999999995 2567999999999999
Q ss_pred EcCCCceEEecccCCCCCCCCCCc--ceEeeeccccccCcchhhhcCC------CCccccchhHHHHHHHHHhC------
Q 013519 243 LDGSYNAKLSDFGLAKLGPIDGNS--HVTTRIMGTYGYAAPEYVATGH------LYVKSDVYGFGVVLLEMLTG------ 308 (441)
Q Consensus 243 l~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~elltg------ 308 (441)
+.+++...|+|+|||-......+. ......+||..|||||++...- -...+||||||.|+||+...
T Consensus 349 VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi 428 (513)
T KOG2052|consen 349 VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGI 428 (513)
T ss_pred EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence 999999999999999654332111 1123468999999999985532 22468999999999999874
Q ss_pred ----CCCCCCCCCCCCceeecccccccchhhhhhhh-cCccccccCC-----hhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 013519 309 ----LRALDTNRPSGEHVLVDFARPSLTDKRRLKKI-MDPRLEEQYP-----IKGALLAGQIIIKCLEAEPKNRPSMEEV 378 (441)
Q Consensus 309 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~ei 378 (441)
+.||.+.-+.+ |++. .+.++ ....++..+| ......+.+|++.||..+|.-|.|+-.+
T Consensus 429 ~eey~~Pyyd~Vp~D---------Ps~e---eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 429 VEEYQLPYYDVVPSD---------PSFE---EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred ehhhcCCcccCCCCC---------CCHH---HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 35664332221 1111 12221 1122222222 2344557789999999999999999999
Q ss_pred HHHHhcccc
Q 013519 379 LETLQNISV 387 (441)
Q Consensus 379 l~~L~~i~~ 387 (441)
-+.|.++..
T Consensus 497 KKtl~~l~~ 505 (513)
T KOG2052|consen 497 KKTLAKLSN 505 (513)
T ss_pred HHHHHHHhc
Confidence 998887764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=274.42 Aligned_cols=271 Identities=25% Similarity=0.341 Sum_probs=197.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH--HHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--GLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
..|+-..+||+|.||.||+| ....+++.||+|++-.++.. .-....+|+.+|..|+|+|++.++++|..
T Consensus 17 ~~yek~~kigqGtfgeVFkA---------r~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKA---------RSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred hHHHHHHhcCCchHHHHHHH---------hhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 45666779999999999999 44455888999875443221 12234579999999999999999987753
Q ss_pred --------CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 177 --------DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 177 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
...+|+||++|+. +|.-+|.... ..++..++.+++.++..||.|+|. ..|+|||+||+|+||+.+|.
T Consensus 88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr--~kilHRDmKaaNvLIt~dgi 162 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHR--NKILHRDMKAANVLITKDGI 162 (376)
T ss_pred ccCCcccccceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHH--hhHHhhcccHhhEEEcCCce
Confidence 3458999999976 7887775432 458899999999999999999997 88999999999999999999
Q ss_pred eEEecccCCCCCCCCCCc--ceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeec
Q 013519 249 AKLSDFGLAKLGPIDGNS--HVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD 325 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~ 325 (441)
+||+|||+++.+....+. ...+..+-|.+|++||.+.+. .|+++.|||.-|||+.||+|+.+.+.++......-++.
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 999999999875433221 223345669999999999875 68899999999999999999988887765433222111
Q ss_pred -----ccc---cccchhhhhhhhcCccccc---------cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 326 -----FAR---PSLTDKRRLKKIMDPRLEE---------QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 326 -----~~~---~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
+.. |....-..+..+-.+.+.. .-|..-++++.+|+.++|..||.+|+++.+++.+.-
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 111 1111111111111110100 012223456789999999999999999999998743
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.76 Aligned_cols=269 Identities=20% Similarity=0.231 Sum_probs=170.8
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEE---
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGY--- 173 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~--- 173 (441)
..++|.+.+.||+|+||.||+|+..... ...+..||+|++...... +.+..| .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~-----~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQ-----SKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCc-----cccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 5678999999999999999999665421 123789999987654321 111111 1222222233222221
Q ss_pred ---EEeCCeEEEEEeecCCCCHHHHHHhcCCC-----------------CCCCHHHHHHHHHHHHHHHhhhccCCCCeee
Q 013519 174 ---CWEDRQFLLVYEYMQKGSLENHLFRKGSA-----------------EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIY 233 (441)
Q Consensus 174 ---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH 233 (441)
......+++||||+.+++|.+++...... .......+..++.|++.||.|||+ .+|+|
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~--~gIiH 278 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS--TGIVH 278 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH--CCEEe
Confidence 23456799999999999999988654210 011123456799999999999997 89999
Q ss_pred cCCCCCcEEEcC-CCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC----------------------CCC
Q 013519 234 RDFKASNILLDG-SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG----------------------HLY 290 (441)
Q Consensus 234 rDlkp~Nill~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~ 290 (441)
|||||+|||++. ++.+||+|||+|+...... ........||+.|+|||.+... .++
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 999999999985 5799999999997543221 2233457899999999976432 234
Q ss_pred ccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccc----cccC--ChhhHHHHHHHHHHh
Q 013519 291 VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRL----EEQY--PIKGALLAGQIIIKC 364 (441)
Q Consensus 291 ~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~~~~~li~~~ 364 (441)
.++|||||||+||||+++..++...... ....+...... .........+.. ...+ .........+||.+|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~---~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQ---FNRQLKRNDYD-LVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHH---HHHHHHhcCCc-HHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 5679999999999999976554321000 00000000000 000001111110 0000 011123456899999
Q ss_pred cccCCCCCCCHHHHHHH
Q 013519 365 LEAEPKNRPSMEEVLET 381 (441)
Q Consensus 365 l~~dp~~Rps~~eil~~ 381 (441)
|+.||++|||+.++|+|
T Consensus 434 L~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 434 MRFKGRQRISAKAALAH 450 (566)
T ss_pred ccCCcccCCCHHHHhCC
Confidence 99999999999999987
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=271.25 Aligned_cols=266 Identities=21% Similarity=0.292 Sum_probs=196.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-----C---CCccce
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-----H---PNLVKL 170 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~~ 170 (441)
.+|.+.++||.|.|++||+|+... ..+.||+|+.+.... ..+....||++|++++ | ..||+|
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred ceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 689999999999999999996543 368999999876543 2345567999999884 2 369999
Q ss_pred EEEEEe----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC
Q 013519 171 IGYCWE----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS 246 (441)
Q Consensus 171 ~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 246 (441)
++.|.. ..+++||+|++ |.+|..+|.+.. .+.++...+..|++|++.||.|||. +.||||-||||+|||+..+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLLCST 224 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeeeecc
Confidence 999975 45899999999 778999887654 4679999999999999999999998 7899999999999998200
Q ss_pred --------------------------------------------------------------------------------
Q 013519 247 -------------------------------------------------------------------------------- 246 (441)
Q Consensus 247 -------------------------------------------------------------------------------- 246 (441)
T Consensus 225 e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n 304 (590)
T KOG1290|consen 225 EIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYN 304 (590)
T ss_pred ccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 013519 247 -------------------------------------------------------------------------------- 246 (441)
Q Consensus 247 -------------------------------------------------------------------------------- 246 (441)
T Consensus 305 ~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~ 384 (590)
T KOG1290|consen 305 NEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDI 384 (590)
T ss_pred cccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCC
Confidence
Q ss_pred ------CceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC-
Q 013519 247 ------YNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSG- 319 (441)
Q Consensus 247 ------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~- 319 (441)
..+||+|||-|+.. ....+.-..|..|+|||++.+..|+..+||||++|++|||+||...|+......
T Consensus 385 ~~~~~di~vKIaDlGNACW~-----~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y 459 (590)
T KOG1290|consen 385 PLPECDIRVKIADLGNACWV-----HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENY 459 (590)
T ss_pred CCCccceeEEEeeccchhhh-----hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence 01455555555431 122333467899999999999999999999999999999999999997544321
Q ss_pred ---Ccee-------ecccc----------cccchhhhhhhhcCccc---------cccCChhhHHHHHHHHHHhcccCCC
Q 013519 320 ---EHVL-------VDFAR----------PSLTDKRRLKKIMDPRL---------EEQYPIKGALLAGQIIIKCLEAEPK 370 (441)
Q Consensus 320 ---~~~~-------~~~~~----------~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~ 370 (441)
+..+ ..+++ ..+...+.+..|-.-.+ .-.++.....++.+|+.-||+.+|+
T Consensus 460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe 539 (590)
T KOG1290|consen 460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE 539 (590)
T ss_pred CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence 1110 11111 11111111111111111 1135667778899999999999999
Q ss_pred CCCCHHHHHHHH
Q 013519 371 NRPSMEEVLETL 382 (441)
Q Consensus 371 ~Rps~~eil~~L 382 (441)
+|||+.++|++-
T Consensus 540 KR~tA~~cl~hP 551 (590)
T KOG1290|consen 540 KRPTAAQCLKHP 551 (590)
T ss_pred ccccHHHHhcCc
Confidence 999999999873
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=261.44 Aligned_cols=238 Identities=32% Similarity=0.432 Sum_probs=192.0
Q ss_pred CceEEEEEEecCCccccccccCCcEEEEEEcCCCchHH-HHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEeecCC
Q 013519 111 GFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQK 189 (441)
Q Consensus 111 ~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 189 (441)
+||.||+|.+.. +++.+++|++....... ...+.+|++++++++|+||+++++++......++++||+.+
T Consensus 1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 589999996543 47899999987765443 67889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceE
Q 013519 190 GSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269 (441)
Q Consensus 190 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 269 (441)
++|.+++.... .+++..++.++.+++.++.+||. .+++|+||+|.||+++.++.++|+|||++....... ..
T Consensus 72 ~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~ 143 (244)
T smart00220 72 GDLFDLLKKRG---RLSEDEARFYARQILSALEYLHS--NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LL 143 (244)
T ss_pred CCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---cc
Confidence 99999986543 27889999999999999999997 899999999999999999999999999997643221 23
Q ss_pred eeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccC
Q 013519 270 TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQY 349 (441)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (441)
....++..|++||.+.+..++.++||||||+++++|++|..||..... ...+............
T Consensus 144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----------------~~~~~~~~~~~~~~~~ 207 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----------------LLELFKKIGKPKPPFP 207 (244)
T ss_pred ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----------------HHHHHHHHhccCCCCc
Confidence 445688899999999988899999999999999999999999864211 0111111111111111
Q ss_pred Chh--hHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 350 PIK--GALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 350 ~~~--~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
... .+..+.+++.+||..+|++||++.+++++
T Consensus 208 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 208 PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred cccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 111 45668899999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=284.65 Aligned_cols=278 Identities=20% Similarity=0.191 Sum_probs=184.8
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccc-------cccccCCcEEEEEEcCCCchHHHHH--------------HHHH
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLA-------PTKVGVGKAVAVKKSNPDSIQGLRE--------------WQAE 155 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vaiK~~~~~~~~~~~~--------------~~~E 155 (441)
..++|.+.++||+|+||+||+|........ ......++.||||++........+. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999975322110 0122346789999987654322222 2346
Q ss_pred HHHHhcCCCCCc-----cceEEEEEe--------CCeEEEEEeecCCCCHHHHHHhcCC---------------------
Q 013519 156 VKFLGKFSHPNL-----VKLIGYCWE--------DRQFLLVYEYMQKGSLENHLFRKGS--------------------- 201 (441)
Q Consensus 156 ~~~l~~l~hpni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------- 201 (441)
+.++.+++|.++ ++++++|.. ....++||||+.+++|.+++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766554 666776643 3568999999999999998864211
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcc
Q 013519 202 AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAP 281 (441)
Q Consensus 202 ~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 281 (441)
...+++..++.++.|++.+|.|||. .+|+||||||+|||++.++.+||+|||+++....... .......+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 1234677889999999999999997 8999999999999999999999999999975322111 111123357899999
Q ss_pred hhhhcCC--------------------CC--ccccchhHHHHHHHHHhCCC-CCCCCCCCCCceeecccccccchhhhhh
Q 013519 282 EYVATGH--------------------LY--VKSDVYGFGVVLLEMLTGLR-ALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 282 E~~~~~~--------------------~~--~~~DvwSlG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
|++.... |+ .+.||||+||++|+|++|.. ||........ .+..+ -.......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~~----~~~~~~~r 454 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQY----DNDLNRWR 454 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhhc----cchHHHHH
Confidence 9885432 12 24799999999999999875 6643211000 00000 00000000
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCC---CCCCCHHHHHHHH
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEP---KNRPSMEEVLETL 382 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~Rps~~eil~~L 382 (441)
...............+..+++|+.+||..+| .+|+|+.|+|+|-
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 0111111111223456778899999999766 6899999999873
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=249.39 Aligned_cols=203 Identities=28% Similarity=0.370 Sum_probs=165.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.+....+..||+|+||.|-+- ++..+|+..|+|.+... +.+....+.+|+.+..+. .+|++|.+|+.+.
T Consensus 45 ad~L~~i~elGrGayG~vekm---------rh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKM---------RHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred hhhhhhhhhhcCCccchhhhe---------eeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 344555678999999999776 55567999999998765 334445667788876665 5999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHh-cCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFR-KGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
+...++|.||.|+- +|..+..+ ......+++..+-+|+..++.||.|||+ +..+||||+||+||||+.+|.||+|||
T Consensus 116 regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-kL~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 116 REGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-KLSVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred ccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-HhhhhhccCCcceEEEccCCcEEEccc
Confidence 99999999999964 77766543 1223568899999999999999999998 789999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhc----CCCCccccchhHHHHHHHHHhCCCCCCC
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT----GHLYVKSDVYGFGVVLLEMLTGLRALDT 314 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlG~il~elltg~~p~~~ 314 (441)
|++..... +-..+-..|...|||||.+.. ..|+.++||||||+.++||.+++.||+.
T Consensus 194 GIsG~L~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 194 GISGYLVD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ccceeehh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 99975422 111222467889999998843 4789999999999999999999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=266.75 Aligned_cols=267 Identities=24% Similarity=0.373 Sum_probs=200.3
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+.+..+.||.|+||+||.+ ++..+|+.|++|++... +....+.+-+|+.+|..++|.|++..+++.+..
T Consensus 54 Di~PDRPIGYGAFGVVWsV---------TDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPp 124 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSV---------TDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPA 124 (449)
T ss_pred cCCCCCcccccceeEEEec---------cCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCC
Confidence 3455679999999999988 55556999999988654 233456778899999999999999999987654
Q ss_pred C-----eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEe
Q 013519 178 R-----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252 (441)
Q Consensus 178 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 252 (441)
. ++|+|+|++.. +|.++|.. ..+++...+.-+++||++||.|||+ .+|.||||||.|+|++++..+|||
T Consensus 125 h~dfFqEiYV~TELmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHs--A~ILHRDIKPGNLLVNSNCvLKIC 198 (449)
T KOG0664|consen 125 NPSFFQELYVLTELMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHT--ANILHRDIKPGNLLVNSNCILKIC 198 (449)
T ss_pred CchHHHHHHHHHHHHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhh--cchhhccCCCccEEeccCceEEec
Confidence 3 46788898854 78877743 4578889999999999999999998 999999999999999999999999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-ccc-cc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-DFA-RP 329 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-~~~-~~ 329 (441)
|||+++....+... .++..+-|.+|+|||++.+. .|+.++||||+|||+.||+..+..|....+.....++ +.. .+
T Consensus 199 DFGLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTP 277 (449)
T KOG0664|consen 199 DFGLARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTP 277 (449)
T ss_pred ccccccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCC
Confidence 99999975443332 34445678999999999886 5789999999999999999999999876665433321 111 11
Q ss_pred ccchhh-----hhhhhcCcc-----ccccC----ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 330 SLTDKR-----RLKKIMDPR-----LEEQY----PIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 330 ~~~~~~-----~~~~~~~~~-----~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.....+ .-..++... +...+ +.....+...++.++|..||++|.+..+++.++
T Consensus 278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111110 001111111 11111 122334566889999999999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=251.06 Aligned_cols=261 Identities=17% Similarity=0.291 Sum_probs=197.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 176 (441)
.++|++.+.+|+|-|+.||.| ....+...++||++++... +.+.+|+.||..|. ||||++++++..+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg---------~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEG---------INITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred cchHHHHHHHcCccHhhHhcc---------cccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 468999999999999999999 5555678999999987643 56789999999998 9999999999987
Q ss_pred C--CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC-CceEEec
Q 013519 177 D--RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS-YNAKLSD 253 (441)
Q Consensus 177 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~D 253 (441)
. ....+|+||+++.+...+. +.++...+..++.+++.||.|||+ .||.|||+||.|++||.. -.++|+|
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmIdh~~rkLrlID 176 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMIDHELRKLRLID 176 (338)
T ss_pred ccccCchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeeechhhceeeeee
Confidence 5 4578999999998877665 347778899999999999999998 999999999999999865 4699999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ec------
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VD------ 325 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~------ 325 (441)
+|+|.+...... ....+.+..|.-||++.. ..|+..-|+|||||+|..|+..+.||.......+++. +.
T Consensus 177 WGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~ 253 (338)
T KOG0668|consen 177 WGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD 253 (338)
T ss_pred cchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH
Confidence 999987654332 233456788999998865 5678999999999999999999999954433322221 00
Q ss_pred ----cc-ccccchhhhhhhhcCccccc--------cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 326 ----FA-RPSLTDKRRLKKIMDPRLEE--------QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 326 ----~~-~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+. .-.+.-...+..++....+. ....-.++++.+|+.++|..|-.+|+|+.|++.|
T Consensus 254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00 00000001111111111100 0111234678899999999999999999999986
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=259.67 Aligned_cols=271 Identities=23% Similarity=0.301 Sum_probs=215.8
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccce
Q 013519 92 QDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKL 170 (441)
Q Consensus 92 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~ 170 (441)
.++.....++++..++-+|.||.||.|.|.+.. .-...+.|.+|.++.. +.-++..+..|..+|..+.|||++++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEd----t~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREED----TYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccC----CcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 344455677888899999999999999887653 2223456777876554 44456778889999999999999999
Q ss_pred EEEEEeC-CeEEEEEeecCCCCHHHHHH-----hcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc
Q 013519 171 IGYCWED-RQFLLVYEYMQKGSLENHLF-----RKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD 244 (441)
Q Consensus 171 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 244 (441)
.+++.++ ...++++.+..-|+|..+|. +....+.+...+...++.|++.|+.|||. .+|||.||...|++||
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~--~~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN--HGVIHKDIAARNCVID 430 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh--cCcccchhhhhcceeh
Confidence 9987654 56789999999999999997 33334557777888999999999999997 9999999999999999
Q ss_pred CCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCcee
Q 013519 245 GSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVL 323 (441)
Q Consensus 245 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~ 323 (441)
+...|||+|=.++|..-..........-.....||+||.+....|+.++|||||||+||||+| |+.|+..-+
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID------- 503 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID------- 503 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-------
Confidence 999999999999986432222221222234567999999999999999999999999999999 778875432
Q ss_pred ecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
...+...+....+-..|..|++++..++.-||...|++||++.++..-|.++
T Consensus 504 ----------PfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 504 ----------PFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ----------HHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 2234444555566667899999999999999999999999999999887654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=273.05 Aligned_cols=270 Identities=21% Similarity=0.244 Sum_probs=204.6
Q ss_pred HHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC------CCCcc
Q 013519 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS------HPNLV 168 (441)
Q Consensus 95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~------hpniv 168 (441)
+..-.+|.+....|+|-|++|..|.. ...|..||||++....... +.=.+|++||++|+ --+++
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D---------~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARD---------QARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccc---------cCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHH
Confidence 34457899999999999999999944 4447799999998765432 33457999999995 34899
Q ss_pred ceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC-
Q 013519 169 KLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY- 247 (441)
Q Consensus 169 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~- 247 (441)
+++..|...+++|||+|-+ ..+|.+.|.+.|..-.|....+..++.|+..||..|-. .||+|.||||.|||+++..
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~--c~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK--CGVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh--cCeeecccCccceEeccCcc
Confidence 9999999999999999988 45999999999988889999999999999999999986 8999999999999998764
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
.+||||||.|..... ...+.+.-+..|.|||++++.+|+...|+||+||+||||.||+..|.+.......-+..-.
T Consensus 575 iLKLCDfGSA~~~~e----neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 575 ILKLCDFGSASFASE----NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred eeeeccCcccccccc----ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 589999999975322 2233345577899999999999999999999999999999999998765432211110000
Q ss_pred ccc-----------------------------cchhhh--hhhhcCc------cccc--cCC---hhhHHHHHHHHHHhc
Q 013519 328 RPS-----------------------------LTDKRR--LKKIMDP------RLEE--QYP---IKGALLAGQIIIKCL 365 (441)
Q Consensus 328 ~~~-----------------------------~~~~~~--~~~~~~~------~~~~--~~~---~~~~~~~~~li~~~l 365 (441)
... ++.... +...+.| .+.. .+| ......+.+|+.+||
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 000 000000 0000001 0000 122 233456889999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 013519 366 EAEPKNRPSMEEVLET 381 (441)
Q Consensus 366 ~~dp~~Rps~~eil~~ 381 (441)
.+||++|.|+.++|+|
T Consensus 731 ~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 731 ILDPEKRITVNQALKH 746 (752)
T ss_pred ccChhhcCCHHHHhcC
Confidence 9999999999999987
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=286.33 Aligned_cols=246 Identities=28% Similarity=0.391 Sum_probs=186.7
Q ss_pred CCCceecccCce-EEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEEEEeCCe
Q 013519 102 RPDTMLGEGGFG-RVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 102 ~~~~~lG~G~~g-~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 179 (441)
...+++|.|+-| .||+|... ++.||||.+-.... ...++|+..|+.-+ |||||++++.-.++..
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF 577 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQF 577 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCce
Confidence 344679999876 68999766 67999998865543 34568999999986 9999999999889999
Q ss_pred EEEEEeecCCCCHHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC---C--CceEEec
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSA-EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG---S--YNAKLSD 253 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~--~~~kl~D 253 (441)
.||..|+|. .+|.+++...+.. ........+.++.|++.||++||+ .+||||||||.||||+. + ..++|+|
T Consensus 578 ~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~iSD 654 (903)
T KOG1027|consen 578 LYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKISD 654 (903)
T ss_pred EEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEecc
Confidence 999999995 5999999764111 111113457789999999999998 99999999999999965 2 4699999
Q ss_pred ccCCCCCCCCCCcc-eEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCCceeeccccccc
Q 013519 254 FGLAKLGPIDGNSH-VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG-LRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 254 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
||+++.......+. ......||-+|+|||++....-+.++||||||||+|+.++| ..||...-..+..++..
T Consensus 655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~------ 728 (903)
T KOG1027|consen 655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG------ 728 (903)
T ss_pred cccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC------
Confidence 99998765443322 23457799999999999999888999999999999999997 89996543221111100
Q ss_pred chhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ..+....+.... ++.+||.+|++++|..||++.+||.|
T Consensus 729 --~--------~~L~~L~~~~d~-eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 729 --N--------YTLVHLEPLPDC-EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred --c--------cceeeeccCchH-HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0 001111111111 68899999999999999999999975
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=255.59 Aligned_cols=263 Identities=23% Similarity=0.317 Sum_probs=194.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
..+|.-++.+|.|.- .|..| .+...++.||+|++... +....+...+|..++..+.|+||++++.+|.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a---------~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ft 85 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAA---------FDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFT 85 (369)
T ss_pred eeeeeeecccCCCCc-eEEec---------chhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccC
Confidence 356777888999987 55555 44456889999986543 2334456778999999999999999999986
Q ss_pred eC------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 176 ED------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 176 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
-. ..+|+||||+.. +|...+.. .++-.++..|+.|++.|+.|||+ .||+||||||+||++..++.+
T Consensus 86 P~~~l~~~~e~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~l 157 (369)
T KOG0665|consen 86 PQKTLEEFQEVYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCTL 157 (369)
T ss_pred ccccHHHHHhHHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhhe
Confidence 43 357999999964 88877752 35567889999999999999998 999999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee--c--
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV--D-- 325 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~--~-- 325 (441)
||.|||+|+.... ....+.++.|..|.|||++.+..|...+||||+||++.||++|+..|.+....+..... .
T Consensus 158 Ki~dfg~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lg 234 (369)
T KOG0665|consen 158 KILDFGLARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLG 234 (369)
T ss_pred eeccchhhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhc
Confidence 9999999985322 23456678999999999999999999999999999999999999998755432211100 0
Q ss_pred ccccccchh-----h------------hhhhhc-Cccccc--cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 326 FARPSLTDK-----R------------RLKKIM-DPRLEE--QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 326 ~~~~~~~~~-----~------------~~~~~~-~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
-+.+.+... + .....+ |..+.. ..+......+.+++.+||..||++|.|++++|.|
T Consensus 235 tpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 235 TPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000000 0 000000 000000 1112334568899999999999999999999987
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=269.94 Aligned_cols=197 Identities=23% Similarity=0.327 Sum_probs=169.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH---H-----HHHHHHHHHHHhcCC---CCCc
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ---G-----LREWQAEVKFLGKFS---HPNL 167 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~-----~~~~~~E~~~l~~l~---hpni 167 (441)
.+|..++.||+|+||.|++|..+ .....|+||.+.++..- . +-.+-.||.||..|+ |+||
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K---------~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHK---------ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred ccceeeeeccccccceEEEeeec---------ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 46889999999999999999544 34788999988765431 1 112456999999997 9999
Q ss_pred cceEEEEEeCCeEEEEEeec-CCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC
Q 013519 168 VKLIGYCWEDRQFLLVYEYM-QKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS 246 (441)
Q Consensus 168 v~~~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 246 (441)
++++++|++++.+||+||-. +|.+|+++|..+. .+++.++..|+.|++.|+++||. .||||||||-+||.++.+
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~--~~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHD--QGIVHRDIKDENVIVDSN 706 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccc--cCceecccccccEEEecC
Confidence 99999999999999999986 5679999997765 48899999999999999999996 999999999999999999
Q ss_pred CceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCC
Q 013519 247 YNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALD 313 (441)
Q Consensus 247 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~p~~ 313 (441)
|-+||+|||.|... .+.....++||..|.|||++.+..|- ..-|||+||++||.++....||.
T Consensus 707 g~~klidfgsaa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CeEEEeeccchhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999998653 22335678999999999999998886 66799999999999999888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=279.57 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=204.2
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
..++|+++..+|.|+||.||++ +++.+++..|+|+++........-++.|+-+++..+|||||.+++.|..
T Consensus 13 P~ddyellqrvgsgTygdvyKa---------Rd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKA---------RDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred CccchhheeeecCCcccchhhh---------cccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh
Confidence 3468999999999999999999 5556689999999988877777788899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...++|+||||.||+|.+..+-.+ ++++.++..+.+..+++|.|||+ .|-+|||||-.|||++..|.+|++|||.
T Consensus 84 ~dklwicMEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs--~gk~hRdiKGanilltd~gDvklaDfgv 158 (829)
T KOG0576|consen 84 RDKLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILLTDEGDVKLADFGV 158 (829)
T ss_pred hcCcEEEEEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhc--CCcccccccccceeecccCceeecccCc
Confidence 999999999999999999775444 58888999999999999999998 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhh---hcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYV---ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
+-.+.. .......+.||++|||||+- ..+.|...+|||++|+...||---..|.....+.....+.
T Consensus 159 saqita--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm--------- 227 (829)
T KOG0576|consen 159 SAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM--------- 227 (829)
T ss_pred hhhhhh--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh---------
Confidence 854322 22234568999999999986 4568999999999999999998766665433221111110
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~ 380 (441)
....+++.- -.-+......+-+|++.+|..+|++||+++.+|.
T Consensus 228 ---TkS~~qpp~-lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 228 ---TKSGFQPPT-LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ---hccCCCCCc-ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 000111110 0112334555779999999999999999988876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=253.39 Aligned_cols=272 Identities=22% Similarity=0.306 Sum_probs=201.1
Q ss_pred HHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEE
Q 013519 94 LRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIG 172 (441)
Q Consensus 94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~ 172 (441)
.....+.|..+++||+|.|++||++..... ......||+|.+...+.. ..+..|+++|..+. +.||+++.+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhh------ccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchh
Confidence 455667899999999999999999966541 224789999998776543 46788999999996 999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC-CCceEE
Q 013519 173 YCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG-SYNAKL 251 (441)
Q Consensus 173 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl 251 (441)
.+..++.+.+||||++.....+++. .++...+..+++.++.||.++|. +|||||||||.|+|.+. .+.-.|
T Consensus 103 ~~rnnd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 103 CFRNNDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred hhccCCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhc--cCccccCCCccccccccccCCceE
Confidence 9999999999999999999988884 36688999999999999999997 99999999999999964 467899
Q ss_pred ecccCCCCCC-----------------C-CC------------------------CcceEeeeccccccCcchhhhcC-C
Q 013519 252 SDFGLAKLGP-----------------I-DG------------------------NSHVTTRIMGTYGYAAPEYVATG-H 288 (441)
Q Consensus 252 ~DFGla~~~~-----------------~-~~------------------------~~~~~~~~~gt~~y~aPE~~~~~-~ 288 (441)
+|||+|.... . .+ .........||++|.|||++... .
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~ 254 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR 254 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence 9999996210 0 00 00011224799999999999764 5
Q ss_pred CCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee---------------------eccccc---ccchhhh-hhhh---
Q 013519 289 LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL---------------------VDFARP---SLTDKRR-LKKI--- 340 (441)
Q Consensus 289 ~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~---------------------~~~~~~---~~~~~~~-~~~~--- 340 (441)
.++++||||.|||++.+++++.||.....+-..+. .-|... ...+... ...+
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~ 334 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE 334 (418)
T ss_pred cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence 67899999999999999999999964432221110 001100 0000000 0000
Q ss_pred -cCc-----cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 341 -MDP-----RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 341 -~~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+.+ ..........+..+.+|+.+||+.||.+|.|++++|+|
T Consensus 335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 000 01111222345578899999999999999999999987
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=234.02 Aligned_cols=212 Identities=39% Similarity=0.603 Sum_probs=181.8
Q ss_pred ecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-HHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 013519 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-GLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYE 185 (441)
Q Consensus 107 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 185 (441)
||+|++|.||++.... .++.+++|........ ....+.+|+.+++.+.|++|+++++++......++++|
T Consensus 1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 6899999999995543 4789999998876543 34678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC-CCceEEecccCCCCCCCCC
Q 013519 186 YMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG-SYNAKLSDFGLAKLGPIDG 264 (441)
Q Consensus 186 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DFGla~~~~~~~ 264 (441)
++.+++|.+++.... ..+++..++.++.+++.+|.+||. .+++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 72 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 72 YCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred cCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 999999999987542 357899999999999999999997 89999999999999999 8999999999997543221
Q ss_pred CcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCc
Q 013519 265 NSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDP 343 (441)
Q Consensus 265 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (441)
. ......+...|++||.+... .++.++|+|+||+++++|
T Consensus 148 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------- 187 (215)
T cd00180 148 S--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------- 187 (215)
T ss_pred c--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------
Confidence 1 12335678899999999877 788999999999999998
Q ss_pred cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 344 RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 344 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
..+.+++.+|+..+|++||++.++++++
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1256899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=234.78 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=185.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEE-EE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGY-CW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~-~~ 175 (441)
.+.|.+.+.||+|.||.+-++ .+..+...+++|.+.... ...++|.+|...--.|. |.||+.-|++ |+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~---------eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLA---------EHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ 92 (378)
T ss_pred hhhhhHHHHhcccceeeEEee---------eccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence 457999999999999999999 444557899999886654 34678999998777776 9999998875 66
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE-c-CCCceEEec
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL-D-GSYNAKLSD 253 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill-~-~~~~~kl~D 253 (441)
..+.++++|||++.|+|..-+...| +-+.....++.|++.||.|||+ +++||||||.+|||| + +..+|||||
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKlcD 166 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKLCD 166 (378)
T ss_pred cCceEEEeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEeee
Confidence 6778899999999999988775544 6678889999999999999998 999999999999999 3 334799999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcC-----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccc
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-----HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 328 (441)
||+.+.... .....--+..|.+||+.... ...+.+|||.||+|+|.++||..||......+.
T Consensus 167 FG~t~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-------- 233 (378)
T KOG1345|consen 167 FGLTRKVGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-------- 233 (378)
T ss_pred cccccccCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc--------
Confidence 999874221 11223345679999987543 234678999999999999999999974322111
Q ss_pred cccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.........+-..+.+...+ ...+..+..+.++-|..++++|--+.++-++
T Consensus 234 -~Y~~~~~w~~rk~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 234 -PYWEWEQWLKRKNPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred -hHHHHHHHhcccCccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 11111111111112221111 2234557789999999999999555555544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=230.30 Aligned_cols=200 Identities=33% Similarity=0.462 Sum_probs=171.7
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-HHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-GLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 179 (441)
|.+.+.||.|++|.||++.... .++.+++|.+...... ....+.+|+..++.++|+|++++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 5667899999999999995543 4688999998876554 56788899999999999999999999999899
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
.++++||+++++|.+++..... .+++..+..++.+++.+|.+||. .+++|+||+|.||+++.++.++|+|||++..
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHS--LGIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred eEEEEeccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 9999999999999999876432 17889999999999999999997 8999999999999999999999999999976
Q ss_pred CCCCCCcceEeeeccccccCcchhh-hcCCCCccccchhHHHHHHHHHhCCCCCCC
Q 013519 260 GPIDGNSHVTTRIMGTYGYAAPEYV-ATGHLYVKSDVYGFGVVLLEMLTGLRALDT 314 (441)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~elltg~~p~~~ 314 (441)
...... .......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 148 ~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 148 IHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 433210 122345678899999998 666778899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=273.30 Aligned_cols=197 Identities=19% Similarity=0.266 Sum_probs=139.1
Q ss_pred cCCC-CCccceEEEE-------EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCee
Q 013519 161 KFSH-PNLVKLIGYC-------WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVI 232 (441)
Q Consensus 161 ~l~h-pniv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~iv 232 (441)
.++| +||++++++| .....++++|||+ +++|.++|.... ..+++.+++.++.||+.||.|||+ +||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHS--QGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHh--CCee
Confidence 3455 5788888877 3334678889987 669999996432 458999999999999999999997 9999
Q ss_pred ecCCCCCcEEEcCC-------------------CceEEecccCCCCCCCCCC--------------cceEeeeccccccC
Q 013519 233 YRDFKASNILLDGS-------------------YNAKLSDFGLAKLGPIDGN--------------SHVTTRIMGTYGYA 279 (441)
Q Consensus 233 HrDlkp~Nill~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~ 279 (441)
||||||+||||+.. +.+|++|||+++....... .......+||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4456666666653210000 00011246899999
Q ss_pred cchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHH
Q 013519 280 APEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQ 359 (441)
Q Consensus 280 aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (441)
|||++.+..|+.++|||||||+||||++|..|+...... +.. .....+.+.. . .....+.+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~------------~~~--~~~~~~~~~~----~-~~~~~~~~ 243 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT------------MSS--LRHRVLPPQI----L-LNWPKEAS 243 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH------------HHH--HHHhhcChhh----h-hcCHHHHH
Confidence 999999999999999999999999999988776421100 000 0000111110 0 11223558
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 013519 360 IIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 360 li~~~l~~dp~~Rps~~eil~~ 381 (441)
++.+||+.+|.+||++.|++++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8899999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=209.65 Aligned_cols=166 Identities=20% Similarity=0.196 Sum_probs=125.2
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceE
Q 013519 190 GSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269 (441)
Q Consensus 190 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 269 (441)
|+|.+++...+ ..+++..++.++.|++.||.|||+ .+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~--~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHR--QA------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh--cC------CcccEeEcCccceee--ccceEeeccc------
Confidence 68999997643 469999999999999999999997 44 999999999999999 9998753221
Q ss_pred eeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccc--
Q 013519 270 TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEE-- 347 (441)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 347 (441)
...||+.|+|||++.+..++.++|||||||++|||+||+.||......... ...+..........
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~------------~~~~~~~~~~~~~~~~ 129 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI------------LEILLNGMPADDPRDR 129 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH------------HHHHHHHhccCCcccc
Confidence 126899999999999999999999999999999999999999643221100 00010101110000
Q ss_pred cCChhhHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 348 QYPIKGAL--LAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 348 ~~~~~~~~--~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
..+..... .+.+++.+||..+|++||++.++++++..+.
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 11222233 5889999999999999999999999986543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=220.76 Aligned_cols=262 Identities=23% Similarity=0.247 Sum_probs=195.9
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCC----CCccceEEEE-
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSH----PNLVKLIGYC- 174 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~~~~~~- 174 (441)
+|.+.+.||+|+||.||+|...... ...+|+|............+..|+.++..+.. +++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 7999999999999999999554321 35788887665432222256778888888873 6899999988
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC-----Cce
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS-----YNA 249 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-----~~~ 249 (441)
..+...||||+.+ |.+|.++..... ...++..+.+.|+.|++.+|.+||+ .|++||||||+|+++... ..+
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCcccceE
Confidence 4777889999998 889999876655 5679999999999999999999996 999999999999999755 469
Q ss_pred EEecccCCCCCC--CCCCc----c-e-EeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCc
Q 013519 250 KLSDFGLAKLGP--IDGNS----H-V-TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321 (441)
Q Consensus 250 kl~DFGla~~~~--~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~ 321 (441)
.|.|||+++... ..... . . ...+.||..|+++.+..+...+.+.|+||++.++.+|+.|..||........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~- 245 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL- 245 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-
Confidence 999999998322 22211 0 1 2335699999999999999999999999999999999999999955432111
Q ss_pred eeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
...+................+..+.++...+-..+...+|....+...|+...
T Consensus 246 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 246 ------------KSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred ------------HHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 11111111111111122333455667777777799999999999999876554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=221.72 Aligned_cols=169 Identities=19% Similarity=0.137 Sum_probs=129.0
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-----chHHHHHHHHHHHHHhcCCCCCccce
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-----SIQGLREWQAEVKFLGKFSHPNLVKL 170 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~ 170 (441)
....+|.+.+.||+|+||+||+|+.... .+..+|||++... .......+.+|+++|++++|+||+..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD--------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC--------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 3457899999999999999999965432 2667899986533 12235668999999999999999964
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCC-CCCcEEEcCCCce
Q 013519 171 IGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDF-KASNILLDGSYNA 249 (441)
Q Consensus 171 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDl-kp~Nill~~~~~~ 249 (441)
+.. .+..|+|||||+|++|.. +. . .. ...++.+++.+|.|||+ .||+|||| ||+|||++.++.+
T Consensus 87 l~~---~~~~~LVmE~~~G~~L~~-~~--~----~~---~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 87 LLA---TGKDGLVRGWTEGVPLHL-AR--P----HG---DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred EEE---cCCcEEEEEccCCCCHHH-hC--c----cc---hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCE
Confidence 332 245799999999999963 21 1 11 14678899999999997 99999999 9999999999999
Q ss_pred EEecccCCCCCCCCCCcce------EeeeccccccCcchhhhcC
Q 013519 250 KLSDFGLAKLGPIDGNSHV------TTRIMGTYGYAAPEYVATG 287 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 287 (441)
||+|||+|+.......... .....+++.|+|||.+...
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999999986543321111 1356788999999988543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=243.86 Aligned_cols=262 Identities=22% Similarity=0.259 Sum_probs=191.9
Q ss_pred CCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcC----C-Cch-HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 102 RPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSN----P-DSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 102 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~----~-~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
....++|.|++|.|+.+.... ..+.++.|... . ... .....+..|+-+-..+.|||++..+..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~---------~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRS---------DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEecC---------CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 456789999999777763322 22333333222 1 111 12222667888888899999998888877
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+....+-+||||++ +|+.++.+.+ .+...++..++.|++.|+.|||. .||.||||||+|++++.+|.+||+|||
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~~~~g~lki~Dfg 465 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLVTENGILKIIDFG 465 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEEecCCceEEeecC
Confidence 77666666999999 9999997653 47778999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCc--ceEeeeccccccCcchhhhcCCCCc-cccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 256 LAKLGPIDGNS--HVTTRIMGTYGYAAPEYVATGHLYV-KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 256 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
.+..+...... .....++|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+.............
T Consensus 466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~ 545 (601)
T KOG0590|consen 466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN 545 (601)
T ss_pred cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc
Confidence 99876554444 5567789999999999999999995 57999999999999999999965544332210000000000
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcccc
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE--TLQNISV 387 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~--~L~~i~~ 387 (441)
+ ..-....-...+...+.+|.+||++||.+|.|+++|++ +++.+..
T Consensus 546 -------~--~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 546 -------I--FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred -------c--ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 0 00000112234556778999999999999999999997 4555543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=197.32 Aligned_cols=255 Identities=20% Similarity=0.241 Sum_probs=193.7
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEEEEeCC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGYCWEDR 178 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 178 (441)
.|+++++||+|.||+++.| ...-+++.||||.-...+. .-+++.|.+..+.|. .++|..++.+.....
T Consensus 29 hyrVGkKIGeGsFG~lf~G---------~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLG---------KNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred cceeccccccCcceeeecc---------cccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 6999999999999999999 5566789999997544322 134566888887775 799999988888888
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC-----ceEEec
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY-----NAKLSD 253 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-----~~kl~D 253 (441)
+-.||||++ |-+|+|++.-.+ +.|+.+++..++.|++.-+.|+|. +.+|+|||||+|+||..-+ .|.|+|
T Consensus 98 ~NiLVidLL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~--k~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHE--KDLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHh--cceeecccCccceeecCCCCCCCceEEEEe
Confidence 889999998 789999987776 469999999999999999999997 8999999999999996433 489999
Q ss_pred ccCCCCCCCCCCc-----ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccc
Q 013519 254 FGLAKLGPIDGNS-----HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 254 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 328 (441)
||+|+.+...... ....+..||..||+-...++.+.+.+-|+-|||-+++++|-|..||.+....
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~---------- 242 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD---------- 242 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc----------
Confidence 9999976544322 2245578999999999999999999999999999999999999999865321
Q ss_pred cccchhhhhhhhcCcccc---ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 329 PSLTDKRRLKKIMDPRLE---EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
+.+....+|-+..-. ...-...+.++..-+.-.-..+-++-|..+-+...+.
T Consensus 243 ---tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~ 297 (449)
T KOG1165|consen 243 ---TNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFD 297 (449)
T ss_pred ---chHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 222333333222110 0111223444545555555667777888776665543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-24 Score=206.31 Aligned_cols=258 Identities=34% Similarity=0.493 Sum_probs=194.6
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH---HHHHHHHHHHHHhcCCCC-CccceEEEEEe
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ---GLREWQAEVKFLGKFSHP-NLVKLIGYCWE 176 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp-niv~~~~~~~~ 176 (441)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++++.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 667789999999999999554 57888887665332 467788999999999988 79999999987
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC-ceEEeccc
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY-NAKLSDFG 255 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DFG 255 (441)
....+++++++.++++.+++........+.......++.|++.++.|+|. .+++||||||+||+++..+ .++++|||
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeecCCCCeEEEeccC
Confidence 78889999999999999766543311257889999999999999999997 8899999999999999988 79999999
Q ss_pred CCCCCCCCCCc----ceEeeeccccccCcchhhhc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccc
Q 013519 256 LAKLGPIDGNS----HVTTRIMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 256 la~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 328 (441)
+++........ .......||..|+|||.+.+ ..+....|+||+|++++++++|..||...... .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---------~ 218 (384)
T COG0515 148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---------S 218 (384)
T ss_pred cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---------c
Confidence 99754332221 13456789999999999988 57889999999999999999999997544321 0
Q ss_pred cccchhhhhhhhcCccccccCC----hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYP----IKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
........+.....+....... ......+.+++.+|+..+|..|.+..+....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 219 ATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000000000000010111 1122457799999999999999998887764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-26 Score=200.95 Aligned_cols=247 Identities=22% Similarity=0.334 Sum_probs=194.5
Q ss_pred CCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 013519 102 RPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 102 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 179 (441)
.+..+|.+...|..|+|+|... .++.|+++... ...-+.|..|.-.|+-+.||||+.+++.|.....
T Consensus 193 nl~tkl~e~hsgelwrgrwqgn-----------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGN-----------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred hhhhhhccCCCcccccccccCc-----------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 3455788999999999999854 35556554432 2234578889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEe--cccCC
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS--DFGLA 257 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~--DFGla 257 (441)
+.+|..|++.|+|+..|..... -.++..++.+++.++++|++|||+.+.-|.---|....++||++.+.+|. |--++
T Consensus 262 lv~isq~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred ceEeeeeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee
Confidence 9999999999999999976543 34566789999999999999999976667777899999999999887774 32111
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCC---ccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY---VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
- ......-.|.||+||.++..+-+ .++|+|||.++||||.|...||....+..
T Consensus 341 f---------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme--------------- 396 (448)
T KOG0195|consen 341 F---------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME--------------- 396 (448)
T ss_pred e---------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh---------------
Confidence 0 11112346899999999887655 57899999999999999999997543321
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
--.++.-..++..+|...+..+.+|+.-|++.||.+||.+..|+-.|+++
T Consensus 397 -cgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 397 -CGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred -hhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 11233445566677888888889999999999999999999999998865
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=192.07 Aligned_cols=258 Identities=20% Similarity=0.231 Sum_probs=193.5
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGYCW 175 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~ 175 (441)
...+|++++.||.|+||.+|.| .....|..||||.-...... ..+..|..+.+.|+ ...|..+..+..
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~---------~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLG---------ISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eccceEEEEeecCCchhheeee---------eeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhcc
Confidence 3578999999999999999999 55667999999986554321 24556888888887 467777777788
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC---CceEEe
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS---YNAKLS 252 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~kl~ 252 (441)
+...-.+||+++ |-+|++++.-.. +.++..+++-++-|++.-+.|+|. +++|||||||+|+|+.-+ ..+.|+
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHh--hccccccCCccceeeccccccceEEEE
Confidence 888889999998 789999876443 458899999999999999999996 999999999999999543 459999
Q ss_pred cccCCCCCCCCCCc-----ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 253 DFGLAKLGPIDGNS-----HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 253 DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
|||+|+.+...... .......||..|.+--...+...+.+-|+-|+|.+|.++.-|..||.+....
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~--------- 227 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA--------- 227 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh---------
Confidence 99999875432221 1224478999999998888888899999999999999999999999875432
Q ss_pred ccccchhhhhhhhcCcccc---ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 328 RPSLTDKRRLKKIMDPRLE---EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
+......++...... +..-...|.++.-.+.-|-..--++-|+..-+-+.+.
T Consensus 228 ----tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 228 ----TKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred ----hHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 112222222222111 1112233445556777787777788888766665543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=216.98 Aligned_cols=236 Identities=27% Similarity=0.369 Sum_probs=185.4
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH--HHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEE
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--GLREWQAEVKFLGKFS-HPNLVKLIGYCWEDRQFLL 182 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l 182 (441)
++|+|.||.|++++-- .....+..+|+|+.++.... .......|..++..++ ||.+|++...++.+..+++
T Consensus 1 vlg~g~~gkvfLvrk~------~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKA------GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHh------ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 4799999999987322 23345778888877654321 1113445788888887 9999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCC
Q 013519 183 VYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPI 262 (441)
Q Consensus 183 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~ 262 (441)
+++|..||.|...+.... .+.+.....+...++.++.++|. .+|+|||+|++||+++.+|++++.|||+++....
T Consensus 75 ~ld~~rgg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~--l~iiyrd~k~enilld~~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHK--LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK 149 (612)
T ss_pred hhhhcccchhhhccccCC---chHHHHHHHHHHHHHHHHhhcch--hHHHHhcccccceeecccCccccCCchhhhHhHh
Confidence 999999999988886544 36667777888899999999996 9999999999999999999999999999986432
Q ss_pred CCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcC
Q 013519 263 DGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD 342 (441)
Q Consensus 263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (441)
... .|||..|||||++. ....++|+||||++++||+||..||.. ..+..++.
T Consensus 150 ~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~ 201 (612)
T KOG0603|consen 150 EKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILK 201 (612)
T ss_pred hhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhh
Confidence 211 19999999999998 678899999999999999999999864 11112222
Q ss_pred ccccccCChhhHHHHHHHHHHhcccCCCCCCCH--HHHHHHH
Q 013519 343 PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM--EEVLETL 382 (441)
Q Consensus 343 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~--~eil~~L 382 (441)
. .-..|......+.+++..++..+|..|.-. ..+.++.
T Consensus 202 ~--~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 202 A--ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred h--ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 1 224577778889999999999999999754 4444443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=191.85 Aligned_cols=172 Identities=12% Similarity=0.118 Sum_probs=133.4
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHH---HHH------HHHHHHHHhcCCCCCc
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG---LRE------WQAEVKFLGKFSHPNL 167 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~------~~~E~~~l~~l~hpni 167 (441)
...+|++.++||.|+||.||++.. .+..+|||.+.+..... ... +.+|+..+.++.||+|
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI 97 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGL 97 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCC
Confidence 568999999999999999998522 15579999987653322 222 6789999999999999
Q ss_pred cceEEEEEeC--------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCC
Q 013519 168 VKLIGYCWED--------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKAS 239 (441)
Q Consensus 168 v~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~ 239 (441)
..+.+++... ...+|||||++|.+|.++.. ++. ....+++.+|..||. .|++|||+||+
T Consensus 98 ~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~--~gi~H~Dikp~ 164 (232)
T PRK10359 98 ASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ--HGMVSGDPHKG 164 (232)
T ss_pred CcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH--cCCccCCCChH
Confidence 9999987643 35789999999999987631 222 245689999999996 99999999999
Q ss_pred cEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh
Q 013519 240 NILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307 (441)
Q Consensus 240 Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt 307 (441)
||+++.+| ++|+|||..+....... ...++....|..++|+|+||+++..+..
T Consensus 165 Nili~~~g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 165 NFIVSKNG-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred HEEEeCCC-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence 99999988 99999999874321110 0114556677889999999999876654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-23 Score=181.41 Aligned_cols=138 Identities=12% Similarity=0.153 Sum_probs=106.6
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH--H------------------------HHHHHHHHH
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--G------------------------LREWQAEVK 157 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~E~~ 157 (441)
...||+|+||.||+|... +|+.||||+++..... . ......|+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 468999999999999442 4889999998654210 0 112345999
Q ss_pred HHhcCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhh-ccCCCCeeecCC
Q 013519 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL-HSSEKSVIYRDF 236 (441)
Q Consensus 158 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~ivHrDl 236 (441)
+|.++.++++.....+... ..+|||||++|+++...+... ..++...+..++.|++.+|.++ |. .||+||||
T Consensus 72 ~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDl 144 (190)
T cd05147 72 NLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQD--CRLVHADL 144 (190)
T ss_pred HHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCC
Confidence 9999988887554443322 238999999998776543322 3578899999999999999999 65 89999999
Q ss_pred CCCcEEEcCCCceEEecccCCCC
Q 013519 237 KASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 237 kp~Nill~~~~~~kl~DFGla~~ 259 (441)
||+|||++ ++.++|+|||+|..
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CHHHEEEE-CCcEEEEEcccccc
Confidence 99999998 47899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-23 Score=216.41 Aligned_cols=247 Identities=24% Similarity=0.286 Sum_probs=177.6
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHH---HHHHHHhcCCCCCccceEEEEE
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQ---AEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~---~E~~~l~~l~hpniv~~~~~~~ 175 (441)
+|...+.||.+.|=+|.+|..++ | .|+||++-... .-.++.+. +|++ ...++|||.+++.-+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----------G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----------G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----------c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 67788899999999999986554 3 48888764433 22233333 3444 55668999999988877
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
.+...|||-+|... +|+|.|..+. -+..-+...|+.|++.||..+|. .||+|||||.+||||++-.-+.|+||.
T Consensus 92 t~kAAylvRqyvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~--~gVcHGDIKsENILiTSWNW~~LtDFA 165 (1431)
T KOG1240|consen 92 TDKAAYLVRQYVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHK--LGVCHGDIKSENILITSWNWLYLTDFA 165 (1431)
T ss_pred hhHHHHHHHHHHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHH--cCccccccccceEEEeeechhhhhccc
Confidence 78888999999865 8999885443 46677889999999999999996 999999999999999999999999998
Q ss_pred CCCCC--CCCCCcc---eEeeeccccccCcchhhhcC----------C-CCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 013519 256 LAKLG--PIDGNSH---VTTRIMGTYGYAAPEYVATG----------H-LYVKSDVYGFGVVLLEMLT-GLRALDTNRPS 318 (441)
Q Consensus 256 la~~~--~~~~~~~---~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlG~il~ellt-g~~p~~~~~~~ 318 (441)
..+.. +.+.... ...+...-.+|+|||-+... . .+++.||||+||+++||++ |++||....
T Consensus 166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-- 243 (1431)
T KOG1240|consen 166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-- 243 (1431)
T ss_pred ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH--
Confidence 87642 2222111 12222333579999988542 1 5678899999999999998 467774321
Q ss_pred CCceeeccccc-ccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 319 GEHVLVDFARP-SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 319 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
+..+... .......+.++-+. .++.||..|++.||.+|.++++.|+.-
T Consensus 244 ----L~aYr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 244 ----LLAYRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ----HHhHhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence 1111111 11112223333332 366899999999999999999999863
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=181.80 Aligned_cols=233 Identities=19% Similarity=0.280 Sum_probs=147.2
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCC----------CCc
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSH----------PNL 167 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h----------pni 167 (441)
+...+.||.|+|+.||.+ ++..+++.+|+|+.... .....+.+++|.-....+.+ -.+
T Consensus 14 l~~~~~i~~g~~~~v~~v---------~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~ 84 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEV---------TDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRF 84 (288)
T ss_dssp EEEEEEEEEETTEEEEEE---------EETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred EEEccccccCCceEEEEE---------EEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceE
Confidence 344678999999999999 56667999999975332 22346677777755555432 123
Q ss_pred cceEEEEE---------eC---C-----eEEEEEeecCCCCHHHHHH---hcCCC-CCCCHHHHHHHHHHHHHHHhhhcc
Q 013519 168 VKLIGYCW---------ED---R-----QFLLVYEYMQKGSLENHLF---RKGSA-EPLPWNTRLKIAIDAAKDLTFLHS 226 (441)
Q Consensus 168 v~~~~~~~---------~~---~-----~~~lv~e~~~~g~L~~~l~---~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~ 226 (441)
+-.++... .. . ..+++|+-+ .++|.+++. ..... ..+....++.+..|+++.+++||.
T Consensus 85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~ 163 (288)
T PF14531_consen 85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS 163 (288)
T ss_dssp ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh
Confidence 33333322 11 1 236788877 458877654 22221 223345567777999999999997
Q ss_pred CCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC--------CCCccccchhH
Q 013519 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG--------HLYVKSDVYGF 298 (441)
Q Consensus 227 ~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwSl 298 (441)
.|++|+||||+|+|++.+|.++|+||+..... .........+..|.+||..... .++.+.|.|+|
T Consensus 164 --~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~-----g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L 236 (288)
T PF14531_consen 164 --YGLVHGDIKPENFLLDQDGGVFLGDFSSLVRA-----GTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL 236 (288)
T ss_dssp --TTEEEST-SGGGEEE-TTS-EEE--GGGEEET-----TEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred --cceEecccceeeEEEcCCCCEEEcChHHHeec-----CceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence 99999999999999999999999999987642 1111113456789999977442 46788999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCC
Q 013519 299 GVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR 372 (441)
Q Consensus 299 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 372 (441)
|++||.|.+|..||....+...... .+. ... ..++.++.||..+|+.||++|
T Consensus 237 G~~ly~lWC~~lPf~~~~~~~~~~~--------------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 237 GITLYSLWCGRLPFGLSSPEADPEW--------------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHSS-STCCCGGGSTSGG--------------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHccCCCCCCCccccccc--------------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999999975432111000 111 222 567778999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=171.43 Aligned_cols=186 Identities=16% Similarity=0.091 Sum_probs=138.3
Q ss_pred CCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH----HHHHHHHHHHHHhcCC-CCCccceEEEEEeC
Q 013519 103 PDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ----GLREWQAEVKFLGKFS-HPNLVKLIGYCWED 177 (441)
Q Consensus 103 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 177 (441)
+...|++|+||+||.+.. .+..++.+.+...... ....+.+|+++|++|. |++|.+++++
T Consensus 6 ~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---- 70 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---- 70 (218)
T ss_pred cceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----
Confidence 456899999999997632 2567777776655431 1225789999999996 5889999886
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCC-CCCcEEEcCCCceEEecccC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDF-KASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDl-kp~Nill~~~~~~kl~DFGl 256 (441)
+..+++|||+.|.+|...+.. ....++.|++.+|.++|. .||+|||| ||+|||++.++.++|+|||+
T Consensus 71 ~~~~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~--~GIvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 71 DGRHLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHR--CGVAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred cCEEEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHH--CcCccCCCCCcceEEEcCCCCEEEEECCC
Confidence 346999999999998654311 113477899999999997 99999999 79999999999999999999
Q ss_pred CCCCCCCCCc----ce-------EeeeccccccCcchhhhcC-CCC-ccccchhHHHHHHHHHhCCCCCCCC
Q 013519 257 AKLGPIDGNS----HV-------TTRIMGTYGYAAPEYVATG-HLY-VKSDVYGFGVVLLEMLTGLRALDTN 315 (441)
Q Consensus 257 a~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlG~il~elltg~~p~~~~ 315 (441)
|......... .. ......++.|++|+...-. ..+ ...++++.|+-+|.++|+..+....
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 9854322110 00 0112367889999865432 334 6789999999999999998887544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=172.92 Aligned_cols=140 Identities=15% Similarity=0.149 Sum_probs=109.2
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH--------------------------HHHHHHHHHH
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--------------------------GLREWQAEVK 157 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~E~~ 157 (441)
...||+|+||.||+|... +|+.||||+++..... ....+..|+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05145 2 NGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR 71 (190)
T ss_pred CceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH
Confidence 468999999999999532 4889999987754210 0122467999
Q ss_pred HHhcCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCC
Q 013519 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFK 237 (441)
Q Consensus 158 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlk 237 (441)
.+.++.|++|.....+.... .+|||||++|+++....... ..++......++.|++.++.++|. ..||+|||||
T Consensus 72 ~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~-~~givHrDlk 145 (190)
T cd05145 72 NLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQ-EAGLVHGDLS 145 (190)
T ss_pred HHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCC
Confidence 99999999986655544433 48999999988654432222 246778899999999999999994 4899999999
Q ss_pred CCcEEEcCCCceEEecccCCCCC
Q 013519 238 ASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 238 p~Nill~~~~~~kl~DFGla~~~ 260 (441)
|+|||++ ++.++|+|||+++..
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceec
Confidence 9999999 889999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-22 Score=204.71 Aligned_cols=209 Identities=24% Similarity=0.356 Sum_probs=146.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
..+|..+++|..|+||-||.+ .++.+.+.+|+| +++.+.-. + + ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylv---------rh~~trqrfa~k-iNkq~lil-R---n---ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLV---------RHKETRQRFAMK-INKQNLIL-R---N---ILTFAGNPFVV--------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeee---------eccccccchhhc-ccccchhh-h---c---cccccCCccee---------
Confidence 357899999999999999998 444557889984 44333210 1 0 34444455444
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
|+-...+...+ +++... +.++.|||+ .||+|||+||+|+||+.-|++|++|||++
T Consensus 136 ------------gDc~tllk~~g---~lPvdm--------vla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 136 ------------GDCATLLKNIG---PLPVDM--------VLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLS 190 (1205)
T ss_pred ------------chhhhhcccCC---CCcchh--------hHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhh
Confidence 33334443222 343332 778999997 99999999999999999999999999999
Q ss_pred CCCCCCCCc-------------ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee
Q 013519 258 KLGPIDGNS-------------HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV 324 (441)
Q Consensus 258 ~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~ 324 (441)
+........ .....++|||.|+|||++....|+..+|||++|+|+||.+-|..||.+..+..
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee----- 265 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE----- 265 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-----
Confidence 753211110 11234699999999999999999999999999999999999999998764421
Q ss_pred cccccccchhhhhhhhcCc-cccccCChhhHHHHHHHHHHhcccCCCCCC
Q 013519 325 DFARPSLTDKRRLKKIMDP-RLEEQYPIKGALLAGQIIIKCLEAEPKNRP 373 (441)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 373 (441)
.+..++.. ....+-....+.+++++|.++|+.+|..|.
T Consensus 266 -----------lfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 266 -----------LFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -----------HHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 11111111 111111344556788999999999999996
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-22 Score=193.32 Aligned_cols=175 Identities=26% Similarity=0.383 Sum_probs=132.6
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.+||.|++|...+|.++|.++......++...+.++.|++.|+.| ++.+|+|+||.||++..+..+||.|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhee
Confidence 589999999999999999877777788899999999999999998 789999999999999999999999999987
Q ss_pred CCCCCC----CcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCCceeecccccccch
Q 013519 259 LGPIDG----NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG-LRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 259 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
...... .....+...||..||+||++.+..|+.++||||||+||+||+.- ..+|..
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------------------- 465 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------------------- 465 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-------------------
Confidence 544332 12234557899999999999999999999999999999999982 122211
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEV 378 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ei 378 (441)
...+..+-+..+...+-...+. -..|+.+||.+.|.+||++.+.
T Consensus 466 ~~t~~d~r~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 466 IATLTDIRDGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHhhhhhhcCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHHHH
Confidence 1111111111111111112222 3379999999999999954443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=204.64 Aligned_cols=200 Identities=20% Similarity=0.250 Sum_probs=160.8
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC---CCCccc
Q 013519 93 DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS---HPNLVK 169 (441)
Q Consensus 93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~ 169 (441)
++......|.|.+.||+|+||+||+|... . |+.||+|+-++.+.. +|.--.+++.+|+ -+-|..
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~---------~-~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~ 758 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHS---------N-GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMH 758 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecC---------C-CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHH
Confidence 33445678899999999999999999433 2 899999998877642 1222234445554 344555
Q ss_pred eEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc-----
Q 013519 170 LIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD----- 244 (441)
Q Consensus 170 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~----- 244 (441)
+...+.-.+.-+||+||.+.|+|.+++. ..+.+++..+..++.|++..+..||. .+|||+||||+|+||.
T Consensus 759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~--~~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 759 ISSAHVFQNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA--MGIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred HHHHHccCCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh--cceecccCCcceeEeecccCC
Confidence 5555666777899999999999999996 34568899999999999999999996 9999999999999993
Q ss_pred --CCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCC
Q 013519 245 --GSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLR 310 (441)
Q Consensus 245 --~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~ 310 (441)
...-++|+|||.+-.+............++|-.+-.+|+..+..+++.+|.|.|+.+++.||.|++
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 234599999999965544445556777889999999999999999999999999999999999964
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=167.93 Aligned_cols=134 Identities=14% Similarity=0.167 Sum_probs=103.8
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-----CCCCccceEEEEEeCC
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-----SHPNLVKLIGYCWEDR 178 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~ 178 (441)
.++||+|+||.||. ... ++.. +||++........+.+.+|+.+++.+ .||||++++++++++.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~---------~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~ 74 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPE---------DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC 74 (210)
T ss_pred cceecCCCceEEEE--CCC---------CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC
Confidence 46899999999995 111 1333 68988765444556789999999999 5799999999999873
Q ss_pred ---eEE-EEEee--cCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHH-hhhccCCCCeeecCCCCCcEEEcC----CC
Q 013519 179 ---QFL-LVYEY--MQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDL-TFLHSSEKSVIYRDFKASNILLDG----SY 247 (441)
Q Consensus 179 ---~~~-lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~lH~~~~~ivHrDlkp~Nill~~----~~ 247 (441)
.++ +|||| +.+++|.+++.+. .+++. ..++.+++.++ .|||+ ++|+||||||+|||++. ++
T Consensus 75 g~g~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~--~~IvhrDlKp~NILl~~~~~~~~ 146 (210)
T PRK10345 75 GTGYVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLD--NRIVTMELKPQNILCQRISESEV 146 (210)
T ss_pred CCeEEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEeccCCCCC
Confidence 434 78999 5689999999552 24444 35678888888 89997 99999999999999974 34
Q ss_pred ceEEecccCC
Q 013519 248 NAKLSDFGLA 257 (441)
Q Consensus 248 ~~kl~DFGla 257 (441)
.++|+||+-+
T Consensus 147 ~~~LiDg~G~ 156 (210)
T PRK10345 147 IPVVCDNIGE 156 (210)
T ss_pred cEEEEECCCC
Confidence 7999995444
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.4e-21 Score=186.02 Aligned_cols=215 Identities=27% Similarity=0.412 Sum_probs=158.6
Q ss_pred HhcCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCC
Q 013519 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKA 238 (441)
Q Consensus 159 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp 238 (441)
|+.+.|.|+.++++.+.+....++|.+||..|+|.+.+.... ..+++.....++++++.||.|||....+ .|+.|++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~i~-~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSPIG-YHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCcce-eeeeecc
Confidence 467889999999999999999999999999999999997633 4688899999999999999999973333 9999999
Q ss_pred CcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCC-------CCccccchhHHHHHHHHHhCCCC
Q 013519 239 SNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH-------LYVKSDVYGFGVVLLEMLTGLRA 311 (441)
Q Consensus 239 ~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlG~il~elltg~~p 311 (441)
.|+++|....+||+|||+.................-..-|.|||.+.... .+.+.||||||++++|+++...|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987643211111111122345699999987642 35679999999999999999999
Q ss_pred CCCCCCCCCc-eeecccccccchhhhhhhhcCccccccCC-h-hhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 312 LDTNRPSGEH-VLVDFARPSLTDKRRLKKIMDPRLEEQYP-I-KGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 312 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
|+........ .++ ..+.+.-...++.... . .....+..++..||..+|++||+++.+-..++.+.
T Consensus 158 ~~~~~~~~~~~eii----------~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 158 FDLRNLVEDPDEII----------LRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cccccccCChHHHH----------HHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9764332211 000 0011101111111111 1 33346789999999999999999999988776544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-20 Score=171.27 Aligned_cols=195 Identities=23% Similarity=0.310 Sum_probs=140.2
Q ss_pred CCCCccceEEEEE---------------------------eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHH
Q 013519 163 SHPNLVKLIGYCW---------------------------EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215 (441)
Q Consensus 163 ~hpniv~~~~~~~---------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 215 (441)
+|||||++..+|. .+..+|+||..++. +|..++..+. .+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 5999999998764 23468999999865 8999996543 45667778999
Q ss_pred HHHHHHhhhccCCCCeeecCCCCCcEEE--cCCC--ceEEecccCCCCCCCC----CCcceEeeeccccccCcchhhhcC
Q 013519 216 DAAKDLTFLHSSEKSVIYRDFKASNILL--DGSY--NAKLSDFGLAKLGPID----GNSHVTTRIMGTYGYAAPEYVATG 287 (441)
Q Consensus 216 ~i~~~l~~lH~~~~~ivHrDlkp~Nill--~~~~--~~kl~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~ 287 (441)
|+++|+.|||. +||.|||+|.+|||| |.++ .+.|+|||++-..... ......-...|...-||||+....
T Consensus 349 QlLEav~hL~~--hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 349 QLLEAVTHLHK--HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHH--ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999996 999999999999999 3333 4789999987431110 011112235688899999987543
Q ss_pred C------CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHH
Q 013519 288 H------LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQII 361 (441)
Q Consensus 288 ~------~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 361 (441)
+ -..|+|.|+.|.+.||+++...||..... ..+. .+.+.+ ..-...|..++..+++|+
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe---m~L~---------~r~Yqe----~qLPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE---MLLD---------TRTYQE----SQLPALPSRVPPVARQLV 490 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccch---heec---------hhhhhh----hhCCCCcccCChHHHHHH
Confidence 2 23689999999999999999999975221 1110 111111 111234667778899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 013519 362 IKCLEAEPKNRPSMEEVLE 380 (441)
Q Consensus 362 ~~~l~~dp~~Rps~~eil~ 380 (441)
...|+.||.+|++..-+..
T Consensus 491 ~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred HHHhcCCccccCCccHHHh
Confidence 9999999999998755444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=165.36 Aligned_cols=144 Identities=17% Similarity=0.154 Sum_probs=109.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH------------------------HHHHHH
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ------------------------GLREWQ 153 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------------------------~~~~~~ 153 (441)
.--|.+.+.||+|+||.||+|..+ ..+|+.||+|.+...... ....+.
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~--------~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDF--------DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAE 98 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEec--------CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHH
Confidence 335888999999999999999511 224889999987643210 112356
Q ss_pred HHHHHHhcCCCCC--ccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCC-
Q 013519 154 AEVKFLGKFSHPN--LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKS- 230 (441)
Q Consensus 154 ~E~~~l~~l~hpn--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~- 230 (441)
+|+.++.++.+.. +.+++++ ...++||||+.|++|...+... ..+.......++.|++.+|.+||. .|
T Consensus 99 ~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~g~ 169 (237)
T smart00090 99 KEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYK--EGE 169 (237)
T ss_pred HHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHh--cCC
Confidence 8999999997633 3333332 2358999999998887654322 234556678899999999999997 88
Q ss_pred eeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 231 VIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 231 ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
|+||||||+||+++ ++.++|+|||++..
T Consensus 170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 170 LVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 99999999999999 88999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.2e-19 Score=160.18 Aligned_cols=134 Identities=21% Similarity=0.346 Sum_probs=112.2
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--------HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--------QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
+.||+|++|.||+|.+. +..+++|+...... .....+.+|+.++..+.|++|.....++.+
T Consensus 2 ~~l~~G~~~~vy~~~~~-----------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL-----------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEeeC-----------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 57999999999999653 56788887554321 112357789999999999999888888888
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
....++||||++|++|.+++.... . .+..++.+++.+|.++|+ .+++|+|++|.|||++ ++.++|+|||+
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG------M-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE-CCCEEEEECCc
Confidence 888999999999999999885422 2 788899999999999997 9999999999999999 78899999999
Q ss_pred CCC
Q 013519 257 AKL 259 (441)
Q Consensus 257 a~~ 259 (441)
++.
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 863
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=156.34 Aligned_cols=130 Identities=19% Similarity=0.302 Sum_probs=106.1
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--------hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--------IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.||+|+||.||+|.+. +..+++|...... ......+.+|++++..+.|+++.....++...
T Consensus 1 ~ig~G~~~~vy~~~~~-----------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-----------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeecC-----------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 4899999999999643 5678888754321 11235677899999999998877666666677
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||++|++|.+++.... . .++.+++.+|.+||+ .|++|+|++|.||+++ ++.++++|||++
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGN-------D---ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcH-------H---HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 77899999999999998874321 0 788999999999997 9999999999999999 789999999998
Q ss_pred CC
Q 013519 258 KL 259 (441)
Q Consensus 258 ~~ 259 (441)
+.
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 74
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=179.20 Aligned_cols=139 Identities=19% Similarity=0.271 Sum_probs=111.0
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEc-----CCCc---hHHHHHHHHHHHHHhcCCCCCc
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKS-----NPDS---IQGLREWQAEVKFLGKFSHPNL 167 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~-----~~~~---~~~~~~~~~E~~~l~~l~hpni 167 (441)
.....|...++||+|+||+||+|.+... .+++|+. .... ......+.+|++++..++|++|
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-----------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 398 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-----------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGV 398 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc-----------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCC
Confidence 3345567789999999999999866432 2222221 1111 1123567899999999999999
Q ss_pred cceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 168 VKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 168 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
+....++......++||||++|++|.+++. ....++.+++.+|.+||+ .+++||||||+|||+ .++
T Consensus 399 ~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~--~giiHrDlkp~NILl-~~~ 464 (535)
T PRK09605 399 PTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK--AGIVHGDLTTSNFIV-RDD 464 (535)
T ss_pred CeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh--CCCccCCCChHHEEE-ECC
Confidence 988888877778899999999999998874 356789999999999997 999999999999999 577
Q ss_pred ceEEecccCCCC
Q 013519 248 NAKLSDFGLAKL 259 (441)
Q Consensus 248 ~~kl~DFGla~~ 259 (441)
.++|+|||+++.
T Consensus 465 ~~~liDFGla~~ 476 (535)
T PRK09605 465 RLYLIDFGLGKY 476 (535)
T ss_pred cEEEEeCccccc
Confidence 899999999974
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.5e-18 Score=152.44 Aligned_cols=142 Identities=17% Similarity=0.097 Sum_probs=108.2
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch----------------------HHHH
Q 013519 93 DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI----------------------QGLR 150 (441)
Q Consensus 93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------------------~~~~ 150 (441)
++......|.+.+.||.|+||.||+|... +++.||||++..... ....
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRL 78 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHH
Confidence 33343445888899999999999998543 378999998654320 0112
Q ss_pred HHHHHHHHHhcCCCCC--ccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCC
Q 013519 151 EWQAEVKFLGKFSHPN--LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSE 228 (441)
Q Consensus 151 ~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 228 (441)
....|+.++..+.|++ +..+++ ....++||||++|++|...... .....++.+++.++.++|.
T Consensus 79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~-- 143 (198)
T cd05144 79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK-- 143 (198)
T ss_pred HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH--
Confidence 3567899999998774 444443 2456899999999998765421 2356788899999999997
Q ss_pred CCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 229 KSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 229 ~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
.||+||||||+||+++.++.++|+|||++..
T Consensus 144 ~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 144 HGIIHGDLSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred CCCCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence 9999999999999999999999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.8e-20 Score=186.93 Aligned_cols=260 Identities=25% Similarity=0.292 Sum_probs=192.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCC-CCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFS-HPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~ 175 (441)
..|.+.+.||+|+|+.|-....... ....+|.|.+.... ......+..|..+-..+. |+|++.+++...
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~--------~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~ 91 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRD--------PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS 91 (601)
T ss_pred ccccccccccccccchhhhhhhcCC--------CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC
Confidence 3577788899999999987643222 24456666554432 233445566888888887 999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC-ceEEecc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY-NAKLSDF 254 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DF 254 (441)
+.+..+++++|..|+++.+-+.. ......+....-.++.|+..++.|+|. ..++.|+||||+|.+++..+ .+++.||
T Consensus 92 ~~~~~~~~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~df 169 (601)
T KOG0590|consen 92 SPRSYLLSLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIADF 169 (601)
T ss_pred CCcccccccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCCc
Confidence 99999999999999999887731 111245566778899999999999993 39999999999999999999 9999999
Q ss_pred cCCCCCCC-CCCcceEeeecc-ccccCcchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccccc
Q 013519 255 GLAKLGPI-DGNSHVTTRIMG-TYGYAAPEYVATGHL-YVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 255 Gla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
|+|..+.. .+........+| ++.|+|||...+..| ....|+||.|+++.-+++|..||........... .|...
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-~~~~~-- 246 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-SWKSN-- 246 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-eeccc--
Confidence 99987766 455555566788 999999999988545 4789999999999999999999976543321111 01000
Q ss_pred chhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ................+++.+++..+|..|.+.+++-..
T Consensus 247 ---~-------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 247 ---K-------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ---c-------cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 0 000011122333446689999999999999999888653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.6e-16 Score=133.00 Aligned_cols=134 Identities=19% Similarity=0.162 Sum_probs=110.9
Q ss_pred CCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCC--CCccceEEEEEeCCeE
Q 013519 103 PDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSH--PNLVKLIGYCWEDRQF 180 (441)
Q Consensus 103 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~ 180 (441)
+.+.||.|.++.||++... +..+++|....... ...+.+|+.++..+.| .++.+++.++...+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 3568999999999998543 35789998876543 4567889999999986 5899999888877889
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccC-CCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 181 LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSS-EKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 181 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
+++|||+.++.+..+ +......++.+++.+|.+||.. ..+++|+||+|.|||++..+.++++|||.++.
T Consensus 69 ~~v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 69 YLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999999998777543 3456677889999999999962 14799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.6e-16 Score=141.98 Aligned_cols=134 Identities=20% Similarity=0.167 Sum_probs=100.1
Q ss_pred ceec-ccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-------------hHHHHHHHHHHHHHhcCCCCCc--c
Q 013519 105 TMLG-EGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-------------IQGLREWQAEVKFLGKFSHPNL--V 168 (441)
Q Consensus 105 ~~lG-~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpni--v 168 (441)
..|| .||.|+||.+... +..++||...... ......+.+|+.++..|.|++| +
T Consensus 37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 4677 7888888887443 5577887664311 1123457789999999998875 6
Q ss_pred ceEEEEEeC-C---eEEEEEeecCC-CCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 169 KLIGYCWED-R---QFLLVYEYMQK-GSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 169 ~~~~~~~~~-~---~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
..+++.... . ..++|||+++| .+|.+++... +++.. .+.+++.+|.+||. .||+||||||.|||+
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~--~GI~HrDlkp~NILv 175 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHD--AGVYHADLNAHNILL 175 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHH--CCCCCCCCCchhEEE
Confidence 677664432 2 23599999997 6898887532 34443 35689999999996 999999999999999
Q ss_pred cCCCceEEecccCCCC
Q 013519 244 DGSYNAKLSDFGLAKL 259 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~ 259 (441)
+.++.++|+|||.++.
T Consensus 176 ~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 176 DPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCCCCEEEEECCCccc
Confidence 9989999999999874
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.5e-16 Score=138.08 Aligned_cols=135 Identities=19% Similarity=0.189 Sum_probs=95.2
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH--HHHH----------------------HHHHHHHH
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--GLRE----------------------WQAEVKFL 159 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~----------------------~~~E~~~l 159 (441)
.+.||+|+||+||+|... .++.||||++...... .... ...|...+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence 468999999999999543 3789999987653211 1111 13566666
Q ss_pred hcCCCCC--ccceEEEEEeCCeEEEEEeecCCCCHHHH-HHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCC
Q 013519 160 GKFSHPN--LVKLIGYCWEDRQFLLVYEYMQKGSLENH-LFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDF 236 (441)
Q Consensus 160 ~~l~hpn--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDl 236 (441)
..+.+.. +.+++++ ...++||||++++.+... +.... . ...+..++.+++.++.++|. ..+|+|+||
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~-~~~~~~~~~~~~~~l~~lh~-~~~ivH~Dl 141 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----L-LEDPEELYDQILELMRKLYR-EAGLVHGDL 141 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh----h-cccHHHHHHHHHHHHHHHhh-ccCcCcCCC
Confidence 6665432 4444443 245899999999543221 11111 1 15678899999999999995 389999999
Q ss_pred CCCcEEEcCCCceEEecccCCCC
Q 013519 237 KASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 237 kp~Nill~~~~~~kl~DFGla~~ 259 (441)
||+||+++ ++.++|+|||.+..
T Consensus 142 ~p~Nili~-~~~~~liDfg~a~~ 163 (187)
T cd05119 142 SEYNILVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred ChhhEEEE-CCcEEEEECccccc
Confidence 99999999 88999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.5e-15 Score=147.03 Aligned_cols=253 Identities=24% Similarity=0.257 Sum_probs=180.2
Q ss_pred cCCCCCceecc--cCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCC-CCCccceEEE
Q 013519 99 KNFRPDTMLGE--GGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFS-HPNLVKLIGY 173 (441)
Q Consensus 99 ~~y~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~ 173 (441)
..|.+...+|. |.+|.||.+.... ...+..+|+|+-+.. .......-.+|+...+.++ |+|.++.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~-------~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTN-------SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred hhcccccccccCCCCCceeecccCCc-------ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 35666778999 9999999984411 345788898873322 1111122245777777776 9999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHH----HHhhhccCCCCeeecCCCCCcEEEcCC-Cc
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK----DLTFLHSSEKSVIYRDFKASNILLDGS-YN 248 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~lH~~~~~ivHrDlkp~Nill~~~-~~ 248 (441)
+...+.+|+-+|+|. .+|..+..... ..++...++..+.+... ||.++|+ .+++|-|+||+||++..+ ..
T Consensus 187 ~e~~~~lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 187 WEGSGILFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred cccCCcceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheecccccce
Confidence 999999999999995 67777765433 34777888888888888 9999998 999999999999999999 88
Q ss_pred eEEecccCCCCCCCCCCc---ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeec
Q 013519 249 AKLSDFGLAKLGPIDGNS---HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD 325 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~ 325 (441)
.+++|||+........-. ....+..|...|++||++ ..-++...|||+||.++.+..++..+....-.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-------- 332 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN-------- 332 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC--------
Confidence 999999998765433211 222334678899999965 56788999999999999999998665432200
Q ss_pred ccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 326 FARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..|.. +...+ +...+-...+..+..++..|++.+|-.|++...++.+
T Consensus 333 ---~~W~~---~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 333 ---SSWSQ---LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ---CCccc---ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 01111 11111 1111222223334458899999999999999888764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.5e-15 Score=134.35 Aligned_cols=206 Identities=25% Similarity=0.324 Sum_probs=141.3
Q ss_pred HHHhcCCCCCccceEEEEEeC-----CeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCCC
Q 013519 157 KFLGKFSHPNLVKLIGYCWED-----RQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEKS 230 (441)
Q Consensus 157 ~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ 230 (441)
.-|-++-|.|||+++.|+.+. ....+++||+..|+|..+|++.. ....+......+|+-||+.||.|||+++..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 344456699999999988654 35789999999999999998633 245677788889999999999999999999
Q ss_pred eeecCCCCCcEEEcCCCceEEecccCCCCCCCC--CCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhC
Q 013519 231 VIYRDFKASNILLDGSYNAKLSDFGLAKLGPID--GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG 308 (441)
Q Consensus 231 ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg 308 (441)
|+|+++...-|++..+|-+|+.--.-....... ........-.+-++|.|||.-.....+.++|||+||+..+||..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999988887522111100000 000111223467899999977766777899999999999999987
Q ss_pred CCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 309 LRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 309 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
..--...... ......+....- .+. ...-+.++.+|++..|..||++++++-|.
T Consensus 279 Eiq~tnseS~------------~~~ee~ia~~i~-~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 279 EIQSTNSESK------------VEVEENIANVII-GLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eeccCCCcce------------eehhhhhhhhee-ecc-------CccccCcCcccccCCCCCCcchhhhhcCc
Confidence 5432111000 000000101000 000 00112688999999999999999998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.7e-14 Score=139.23 Aligned_cols=139 Identities=19% Similarity=0.234 Sum_probs=94.4
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHH---------------------------------
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR--------------------------------- 150 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~--------------------------------- 150 (441)
.+.||.|++|.||+|+.. +|+.||||+.++.....+.
T Consensus 122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 368999999999999664 3789999998765321110
Q ss_pred -------HHHHHHHHHhcC----C-CCCccceEEEEE-eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHH
Q 013519 151 -------EWQAEVKFLGKF----S-HPNLVKLIGYCW-EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217 (441)
Q Consensus 151 -------~~~~E~~~l~~l----~-hpniv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i 217 (441)
++.+|...+.++ + +++| .+-.++. .....+|||||++|++|.++...... .. ....++..+
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~ 265 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENL 265 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHH
Confidence 133455444444 2 3333 3222332 23456999999999999887643211 12 223455555
Q ss_pred HH-HHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 218 AK-DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 218 ~~-~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
+. .+..+|. .|++|+|+||.||+++.++.++|+|||++...
T Consensus 266 ~~~~l~ql~~--~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 266 ARSFLNQVLR--DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHHHHHh--CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 55 3567785 89999999999999999999999999999753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.2e-13 Score=132.07 Aligned_cols=168 Identities=19% Similarity=0.226 Sum_probs=128.2
Q ss_pred ccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCH
Q 013519 128 TKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPW 207 (441)
Q Consensus 128 ~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~ 207 (441)
..+..+.+|.|...+..+........+-+.-|+.++||||+++++.++.++.+|||+|.+. .|..++.+.+ .
T Consensus 32 t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------~ 103 (690)
T KOG1243|consen 32 TRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------K 103 (690)
T ss_pred ceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------H
Confidence 3444577788877766655445567788999999999999999999999999999999985 6777776544 4
Q ss_pred HHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC
Q 013519 208 NTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG 287 (441)
Q Consensus 208 ~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 287 (441)
......+.||+.||.|||. +.+++|++|.-..|+++..|+.||++|.++........ ......---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 5677788999999999996 78999999999999999999999999998864322111 11111112236666644322
Q ss_pred CCCccccchhHHHHHHHHHhC
Q 013519 288 HLYVKSDVYGFGVVLLEMLTG 308 (441)
Q Consensus 288 ~~~~~~DvwSlG~il~elltg 308 (441)
. -..|.|-|||++++++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 456999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-13 Score=135.85 Aligned_cols=251 Identities=20% Similarity=0.168 Sum_probs=173.8
Q ss_pred HHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHH--HHHHHHHHhcCC-CCCccceE
Q 013519 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE--WQAEVKFLGKFS-HPNLVKLI 171 (441)
Q Consensus 95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~E~~~l~~l~-hpniv~~~ 171 (441)
..-..+|.++..||.|.|+.|+....+. ..+..|++|.+.........+ -..|+.+...+. |.+++.++
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~--------~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRP--------EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecC--------CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 3345678889999999999999875331 236788888765443222121 124666666664 99999998
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC-CceE
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS-YNAK 250 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~k 250 (441)
..|......|+-.|||.++++...+... ..+.....+.+..|++.++.++|+ +.++|+|+||+||++..+ +.-+
T Consensus 333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s--~~~~~~d~~psni~i~~~~~~~~ 407 (524)
T KOG0601|consen 333 SSWSQLRQGYIPLEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHS--KLFVHLDVKPSNILISNDGFFSK 407 (524)
T ss_pred CCccccccccCchhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccc--hhhhcccccccceeeccchhhhh
Confidence 8888888888999999999988766322 346678889999999999999997 999999999999999886 7889
Q ss_pred EecccCCCCCCCCCCcceEeeecccccc-CcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGY-AAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
+.|||+.+.+.... .....++..| .++.......+..++|++|||.-+.+.+++...-.....
T Consensus 408 ~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------ 471 (524)
T KOG0601|consen 408 LGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------ 471 (524)
T ss_pred ccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc------------
Confidence 99999986321111 1111223334 355555556777999999999999999998543221100
Q ss_pred ccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
...+..... ...+.. ...+..+.+.++..++..||.+.++..+.+
T Consensus 472 -------~~~i~~~~~-p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 472 -------SLTIRSGDT-PNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -------ceeeecccc-cCCCch-HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 000111100 011112 255678889999999999999998877654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.5e-13 Score=137.25 Aligned_cols=144 Identities=16% Similarity=0.177 Sum_probs=92.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHH-----------------------------
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG----------------------------- 148 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~----------------------------- 148 (441)
...|.. +.||.|++|.||+|+... +|+.||||+..+.-...
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~ 188 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPRE 188 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHH
Confidence 456776 799999999999996653 38899999987652110
Q ss_pred -----HHH------HHHHHHHHhcC----CCCCccceEEEEEe-CCeEEEEEeecCCCCHHHH--HHhcCC-CCCCCHHH
Q 013519 149 -----LRE------WQAEVKFLGKF----SHPNLVKLIGYCWE-DRQFLLVYEYMQKGSLENH--LFRKGS-AEPLPWNT 209 (441)
Q Consensus 149 -----~~~------~~~E~~~l~~l----~hpniv~~~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~~-~~~l~~~~ 209 (441)
.+. +.+|+..+.++ .+.+.+.+-.++.+ ....+|||||+.|+.|.++ +...+. ...+....
T Consensus 189 ~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~ 268 (537)
T PRK04750 189 VVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG 268 (537)
T ss_pred HHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH
Confidence 111 23333333333 23334444444433 3456899999999999874 322221 01122222
Q ss_pred HHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC----ceEEecccCCCCC
Q 013519 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY----NAKLSDFGLAKLG 260 (441)
Q Consensus 210 ~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~----~~kl~DFGla~~~ 260 (441)
+..++.|++ ..|++|+|+||.||+++.++ .++++|||++...
T Consensus 269 v~~~~~Qif---------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 269 VEVFFTQVF---------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHHHHHH---------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 333333332 27899999999999999888 9999999999754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.6e-13 Score=115.28 Aligned_cols=128 Identities=20% Similarity=0.150 Sum_probs=93.8
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccc-eEEEEEeCCeEEE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVK-LIGYCWEDRQFLL 182 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-~~~~~~~~~~~~l 182 (441)
.+.|+.|.++.||++... +..|++|........ ...+..|+.+++.+.+.++++ ++.+ .....++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTEL-LINRENEAENSKLAAEAGIGPKLYYF--DPETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEEC-----------CeEEEEEeCCCCccc-ccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeE
Confidence 357899999999998532 568999987654321 234578999999987655543 4433 3334589
Q ss_pred EEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCC-----eeecCCCCCcEEEcCCCceEEecccCC
Q 013519 183 VYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKS-----VIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 183 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-----ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
||||++|.++.... . ....++.+++.+|+.||. .+ ++|+|++|.||+++ ++.++++|||.+
T Consensus 69 v~e~i~G~~l~~~~--------~---~~~~~~~~l~~~l~~LH~--~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a 134 (170)
T cd05151 69 ITEFIEGSELLTED--------F---SDPENLEKIAKLLKKLHS--SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA 134 (170)
T ss_pred EEEecCCCcccccc--------c---cCHHHHHHHHHHHHHHhC--CCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence 99999998875420 0 112356789999999997 44 59999999999999 668999999998
Q ss_pred CC
Q 013519 258 KL 259 (441)
Q Consensus 258 ~~ 259 (441)
..
T Consensus 135 ~~ 136 (170)
T cd05151 135 GM 136 (170)
T ss_pred cC
Confidence 63
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.3e-14 Score=145.75 Aligned_cols=250 Identities=21% Similarity=0.286 Sum_probs=175.7
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
..+.+.+.+.+-.|.|+.++.+ ....++...++|...... ....+....+-.++-...+|.++.....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~---------~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s 872 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPA---------SPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS 872 (1205)
T ss_pred CCccceecccccCCCCcccccC---------CccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC
Confidence 3466777888889999999987 333445455555433221 1122333344445545566777776666
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+......++|++|+.+++|...|...+ ..+..-....+..+..++.+||+ ..+.|+|++|.|+|+..++..+++|
T Consensus 873 ~~~rsP~~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~~~~gh~~l~~ 947 (1205)
T KOG0606|consen 873 FPCRSPLPLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLIAYDGHRPLTD 947 (1205)
T ss_pred CCCCCCcchhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhcccc--chhhcccccccchhhcccCCcccCc
Confidence 666778899999999999999887655 34445566677788899999996 5689999999999999999999999
Q ss_pred ccCCCCCCCC----C-------------------------CcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHH
Q 013519 254 FGLAKLGPID----G-------------------------NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLE 304 (441)
Q Consensus 254 FGla~~~~~~----~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~e 304 (441)
||........ . .........||+.|.+||.+.+......+|+|++|++++|
T Consensus 948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen 948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence 9844321100 0 0011234679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccc-cccCChhhHHHHHHHHHHhcccCCCCCCCHH
Q 013519 305 MLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRL-EEQYPIKGALLAGQIIIKCLEAEPKNRPSME 376 (441)
Q Consensus 305 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 376 (441)
.++|..||....+... + ..+..... ...-+...+..+++++.+.+..+|.+|..+.
T Consensus 1028 ~l~g~pp~na~tpq~~--f--------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETPQQI--F--------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhcCCCCCCCcchhhh--h--------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999976544311 1 11111111 1112344556688999999999999998776
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.2e-11 Score=105.56 Aligned_cols=142 Identities=11% Similarity=0.090 Sum_probs=95.7
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc----------------------hHHHHHH----HHHHHH
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS----------------------IQGLREW----QAEVKF 158 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~~~----~~E~~~ 158 (441)
..||.|-=+.||.|...... .....+..+|||+.+... ......+ ++|++.
T Consensus 3 g~i~~GKEa~V~~~~~~~~~---~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~ 79 (197)
T cd05146 3 GCISTGKESVVLHANGGSNE---TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHN 79 (197)
T ss_pred CccccCcceEEEEEecCccc---ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHH
Confidence 47899999999999543210 011135689999643210 0112223 379999
Q ss_pred HhcCCC--CCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhh-ccCCCCeeecC
Q 013519 159 LGKFSH--PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL-HSSEKSVIYRD 235 (441)
Q Consensus 159 l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~ivHrD 235 (441)
|.++.. -++..++++ ..-+|||||+.+..+..-..+. ..++......+..+++.+|..| |. .||||+|
T Consensus 80 L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~--~glVHGD 150 (197)
T cd05146 80 LKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKE--CNLVHAD 150 (197)
T ss_pred HHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHh--CCeecCC
Confidence 999863 455556653 4568999999765442211111 1244456677889999999998 75 8999999
Q ss_pred CCCCcEEEcCCCceEEecccCCCC
Q 013519 236 FKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 236 lkp~Nill~~~~~~kl~DFGla~~ 259 (441)
|++.|||++ ++.+.|+|||.+..
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCcee
Confidence 999999997 46799999998863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.8e-11 Score=101.70 Aligned_cols=130 Identities=22% Similarity=0.309 Sum_probs=98.6
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---ch--H---HHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SI--Q---GLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~--~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+++|+=+.+|.+.+. |..+++|.--+. .. + ......+|+++|.++.--.|...+=+..+.
T Consensus 3 ~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~ 71 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP 71 (204)
T ss_pred hhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC
Confidence 5789999999998553 444666642211 11 1 123456799999999876777767677888
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
....|+|||++|-.|.+.+... ...++..+-.-+.-||. .||||+||.++||++..+. +.++||||+
T Consensus 72 ~~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~--~givHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 72 DNGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHK--AGIVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred CCCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHh--cCeecCCCccceEEEeCCc-EEEEECCcc
Confidence 8889999999999998888543 23456666677788996 9999999999999998765 999999998
Q ss_pred CC
Q 013519 258 KL 259 (441)
Q Consensus 258 ~~ 259 (441)
..
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 73
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.4e-10 Score=98.50 Aligned_cols=143 Identities=19% Similarity=0.222 Sum_probs=106.7
Q ss_pred CCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---ch-----HHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 103 PDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SI-----QGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 103 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.+.+|-+|+-+.|+++.+. |+..+||.-... .. -......+|+++|.++.--.|.-..-++
T Consensus 11 ~l~likQGAEArv~~~~~~-----------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-----------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeeccC-----------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 4567889999999998665 667777743221 11 1245677899999998766666666677
Q ss_pred EeCCeEEEEEeecCC-CCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC---ceE
Q 013519 175 WEDRQFLLVYEYMQK-GSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY---NAK 250 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~k 250 (441)
.+...-.|+|||++| -++.+++......... ......++..|-..+.-||. .+|||+||..+||+|..++ .+.
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~--ndiiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHD--NDIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhh--CCeecccccccceEEecCCCcCceE
Confidence 788888999999987 4788888765543222 23336788888899999996 9999999999999996554 468
Q ss_pred EecccCCCC
Q 013519 251 LSDFGLAKL 259 (441)
Q Consensus 251 l~DFGla~~ 259 (441)
++|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999999853
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.5e-10 Score=105.37 Aligned_cols=141 Identities=20% Similarity=0.298 Sum_probs=103.4
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCC--CCccceEEEEEeC---C
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSH--PNLVKLIGYCWED---R 178 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~---~ 178 (441)
+.|+.|.++.||++... .|..+++|....... .....+..|+.++..+.+ .++.+++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~----------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEec----------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 57899999999998442 157899998765432 134567889999999975 4456777766553 2
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccC-------------------------------
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSS------------------------------- 227 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------------------------------- 227 (441)
..++||||++|.++.+.+.. ..++......++.+++.+|..||+.
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS 149 (223)
T ss_pred CceEEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence 56899999999887665421 2355566666777777777777741
Q ss_pred -----------------------CCCeeecCCCCCcEEEcC--CCceEEecccCCCC
Q 013519 228 -----------------------EKSVIYRDFKASNILLDG--SYNAKLSDFGLAKL 259 (441)
Q Consensus 228 -----------------------~~~ivHrDlkp~Nill~~--~~~~kl~DFGla~~ 259 (441)
...++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.9e-10 Score=107.42 Aligned_cols=217 Identities=18% Similarity=0.230 Sum_probs=149.7
Q ss_pred ceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEE----eCCeEEEEEeec
Q 013519 112 FGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCW----EDRQFLLVYEYM 187 (441)
Q Consensus 112 ~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~~~~~lv~e~~ 187 (441)
-.+.|+++. ..+|..|++|++.............-+++++++.|+|||++.++|. .+..+++|++|+
T Consensus 289 ~~Ttyk~~s---------~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy 359 (655)
T KOG3741|consen 289 SITTYKATS---------NVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY 359 (655)
T ss_pred cceeEeeee---------ccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence 357888844 3458999999995543333323344678899999999999999886 356789999999
Q ss_pred CC-CCHHHHHHhcC------------CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 188 QK-GSLENHLFRKG------------SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 188 ~~-g~L~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
++ ++|.++..... .....++..+|.++.|+..||.++|+ .|+.-+-|.|.+||++.+.+++|...
T Consensus 360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIriS~C 437 (655)
T KOG3741|consen 360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIRISGC 437 (655)
T ss_pred CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEEEecc
Confidence 76 57777554321 13457789999999999999999997 89988999999999999988999877
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|.......+. .+| +.. -.+-|.=.||.+++.|.||..--... .....
T Consensus 438 ~i~Dvl~~d~--------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~--------------d~~~~ 484 (655)
T KOG3741|consen 438 GIMDVLQEDP--------------TEP--LES---QQQNDLRDLGLLLLALATGTENSNRT--------------DSTQS 484 (655)
T ss_pred cceeeecCCC--------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccccccc--------------cchHH
Confidence 7665432211 011 111 13568889999999999984321100 00000
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
..+ ..+....+.++++++.-....++++ -++.+++.++
T Consensus 485 s~~---------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 485 SHL---------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHH---------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 001 1123345556778888888888887 6788887654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.6e-08 Score=96.26 Aligned_cols=263 Identities=15% Similarity=0.184 Sum_probs=159.7
Q ss_pred CCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCccceEEE----EE--
Q 013519 103 PDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLVKLIGY----CW-- 175 (441)
Q Consensus 103 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~----~~-- 175 (441)
+.+.||+|+-+.+|-.-. .+..| -|+....-..... ..+..|... .||-+-.-+.| .+
T Consensus 15 ~gr~LgqGgea~ly~l~e-----------~~d~V-AKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~ 79 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE-----------VRDQV-AKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGG 79 (637)
T ss_pred CCccccCCccceeeecch-----------hhchh-heeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCC
Confidence 456899999999996410 12222 3443332221111 122333333 46644331221 11
Q ss_pred eCC-eEEEEEeecCCCC-HHHHH---HhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 176 EDR-QFLLVYEYMQKGS-LENHL---FRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 176 ~~~-~~~lv~e~~~~g~-L~~~l---~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
+.. ..-++|..+.|.. +..++ .++.+.....|...+++++.++.+.+.||. .|.+-+|+.++|+|+.+++.|.
T Consensus 80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~--~Gh~vGDVn~~~~lVsd~~~V~ 157 (637)
T COG4248 80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE--HGHVVGDVNQNSFLVSDDSKVV 157 (637)
T ss_pred CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh--cCCcccccCccceeeecCceEE
Confidence 222 3678888887753 22222 234556778999999999999999999996 8999999999999999999999
Q ss_pred EecccCCCCCCCCCCcceEeeeccccccCcchhhh-----cCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCCc---
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLLEMLTG-LRALDTNRPSGEH--- 321 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg-~~p~~~~~~~~~~--- 321 (441)
|.|=....+ ..+.......+|...|.+||.-. +..-+...|.|.||+++++|+.| +.||.+-......
T Consensus 158 LVdsDsfqi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p 234 (637)
T COG4248 158 LVDSDSFQI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP 234 (637)
T ss_pred EEcccceee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence 998654432 13444455578999999999654 23445778999999999999987 8999654321110
Q ss_pred eeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhccc--CCCCCCCHHHHHHHHhcc
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEA--EPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--dp~~Rps~~eil~~L~~i 385 (441)
.-.++....+....+-..-..+......-...+..+..|+.+|+.. ++.-|||++..+..|..+
T Consensus 235 ~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 235 LETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred chhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 0001111111111110000111111111223456677889999975 367899999888776544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.4e-09 Score=97.32 Aligned_cols=123 Identities=15% Similarity=0.122 Sum_probs=89.7
Q ss_pred CcEEEEEEcCCCchH-HHH----------HHHHHHHHHhcCCCCCc--cceEEEEEe-----CCeEEEEEeecCCC-CHH
Q 013519 133 GKAVAVKKSNPDSIQ-GLR----------EWQAEVKFLGKFSHPNL--VKLIGYCWE-----DRQFLLVYEYMQKG-SLE 193 (441)
Q Consensus 133 ~~~vaiK~~~~~~~~-~~~----------~~~~E~~~l~~l~hpni--v~~~~~~~~-----~~~~~lv~e~~~~g-~L~ 193 (441)
|+.|.||........ ..+ .+.+|...+.+|..-+| ..++++... ....+||||++++- +|.
T Consensus 45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~ 124 (268)
T PRK15123 45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE 124 (268)
T ss_pred CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence 678999976544321 111 36789988888753333 344555543 23578999999886 798
Q ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC-------CCceEEecccCCC
Q 013519 194 NHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG-------SYNAKLSDFGLAK 258 (441)
Q Consensus 194 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-------~~~~kl~DFGla~ 258 (441)
+++.... ..+.+......++.+++..+.-||. .||+|+|+++.|||++. ++.+.|+||+.++
T Consensus 125 ~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~--~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 125 DYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA--AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 8875322 1334566778899999999999996 99999999999999975 4679999999885
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.7e-08 Score=88.71 Aligned_cols=98 Identities=20% Similarity=0.237 Sum_probs=63.4
Q ss_pred HHHHHHHHHHhcCCCC--CccceEEEEEeCCeEEEEEeecC--CCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhh-h
Q 013519 150 REWQAEVKFLGKFSHP--NLVKLIGYCWEDRQFLLVYEYMQ--KGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF-L 224 (441)
Q Consensus 150 ~~~~~E~~~l~~l~hp--niv~~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-l 224 (441)
...++|++.|.++..- ++.+++++ .. -+|||||++ |..+..+.... +.......++.+++..+.. +
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~--~~--~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~ 123 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDY--NR--NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKML 123 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEE--ET--TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEE--eC--CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHH
Confidence 3567899999999865 45555543 23 379999998 65554433211 1123445566677775555 4
Q ss_pred ccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 225 H~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
|. .||+|+||.+.|||++.+ .+.|+|||.+..
T Consensus 124 ~~--~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 124 HK--AGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp HC--TTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred Hh--cCceecCCChhhEEeecc-eEEEEecCccee
Confidence 65 899999999999999987 899999998853
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=6.5e-10 Score=111.71 Aligned_cols=152 Identities=18% Similarity=0.229 Sum_probs=106.1
Q ss_pred HHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcc-------eEeeeccccccCcchhhhc
Q 013519 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSH-------VTTRIMGTYGYAAPEYVAT 286 (441)
Q Consensus 214 ~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 286 (441)
+.+++.||.|+|. ..++||+.|.|++|.++.++.+||+.|+++.......... ...-..-...|.|||++.+
T Consensus 105 l~~v~dgl~flh~-sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHR-SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhcc-CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455589999998 5899999999999999999999999999875432211100 0011234568999999999
Q ss_pred CCCCccccchhHHHHHHHHH-hCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhc
Q 013519 287 GHLYVKSDVYGFGVVLLEML-TGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCL 365 (441)
Q Consensus 287 ~~~~~~~DvwSlG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 365 (441)
...+.++|+|||||++|.+. .|+..+........ .......+..-...+....+.++++=+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~--------------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS--------------YSFSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcch--------------hhhhhcccccccccccccCcHHHHHHHHHHh
Confidence 88889999999999999999 55555443322110 0000111111122344566777889999999
Q ss_pred ccCCCCCCCHHHHHH
Q 013519 366 EAEPKNRPSMEEVLE 380 (441)
Q Consensus 366 ~~dp~~Rps~~eil~ 380 (441)
..++..||++.+++.
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.1e-07 Score=85.48 Aligned_cols=105 Identities=19% Similarity=0.178 Sum_probs=81.4
Q ss_pred HHHHHHHHHHhcCCC--CCccceEEEEEeC----CeEEEEEeecCCC-CHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHh
Q 013519 150 REWQAEVKFLGKFSH--PNLVKLIGYCWED----RQFLLVYEYMQKG-SLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222 (441)
Q Consensus 150 ~~~~~E~~~l~~l~h--pniv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~ 222 (441)
....+|...+..|.. =.+..++++.... ...+||+|++++. +|.+++..... .+......++.+++..+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 356678887777753 3345566665543 2458999999884 78888865322 455677889999999999
Q ss_pred hhccCCCCeeecCCCCCcEEEcCCC---ceEEecccCCCC
Q 013519 223 FLHSSEKSVIYRDFKASNILLDGSY---NAKLSDFGLAKL 259 (441)
Q Consensus 223 ~lH~~~~~ivHrDlkp~Nill~~~~---~~kl~DFGla~~ 259 (441)
-||. .||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 133 ~lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9996 9999999999999998887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=8.3e-08 Score=86.99 Aligned_cols=146 Identities=18% Similarity=0.131 Sum_probs=97.3
Q ss_pred cCHHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc----------------------h
Q 013519 89 FTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS----------------------I 146 (441)
Q Consensus 89 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----------------------~ 146 (441)
..+..+..-..-+.+...||-|-=+.||.|... .|..+|||.-+... .
T Consensus 81 LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~ 150 (304)
T COG0478 81 LALHALVKRGIVEAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLY 150 (304)
T ss_pred HHHHHHHHcChHHhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhh
Confidence 334444444444667789999999999999554 37889999532210 0
Q ss_pred HHHHHHHHHHHHHhcCCCC--CccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhh
Q 013519 147 QGLREWQAEVKFLGKFSHP--NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224 (441)
Q Consensus 147 ~~~~~~~~E~~~l~~l~hp--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~l 224 (441)
-.....++|.++|.+|.-. .|.+.++ .+...+||||++|-.|...-. .......++..+.+. +..+
T Consensus 151 ~sRl~A~rEf~~L~~L~~~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~---~~~~ 218 (304)
T COG0478 151 VSRLAAEREFEALQRLYPEGVKVPKPIA----WNRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEE---VRKA 218 (304)
T ss_pred hHHHHHHHHHHHHHHhhhcCCCCCCccc----cccceeeeehcccceeecccC-----cccCHHHHHHHHHHH---HHHH
Confidence 1233467899999999744 6666665 345689999999976654221 112233333333332 2222
Q ss_pred ccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 225 H~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
-. .||||+|+.+=|||++++|.+.++||--+.
T Consensus 219 ~~--~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 219 YR--RGIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred HH--cCccccCCchheEEEecCCCEEEEeCcccc
Confidence 22 889999999999999999999999996654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.2e-07 Score=81.27 Aligned_cols=138 Identities=17% Similarity=0.118 Sum_probs=98.6
Q ss_pred ecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc------hHHHHHHHHHHHHHhcCCC--CCccceEEEEE-e-
Q 013519 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREWQAEVKFLGKFSH--PNLVKLIGYCW-E- 176 (441)
Q Consensus 107 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~-~- 176 (441)
-|+||.+.|+..... |+.+-+|.-...- ......|.+|+..|.+|.. -.+.++. ++. .
T Consensus 26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k 93 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVK 93 (216)
T ss_pred cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeec
Confidence 456888889886443 3467788654211 1234578899999998853 2244444 222 1
Q ss_pred ---CCeEEEEEeecCC-CCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc--eE
Q 013519 177 ---DRQFLLVYEYMQK-GSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN--AK 250 (441)
Q Consensus 177 ---~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--~k 250 (441)
.-..+||+|-+.| -+|.+++.... ..+.+......++.+++..+.-||. .|+.|+|+.+.|||++.++. ++
T Consensus 94 ~~~~~rA~LVTe~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~ 170 (216)
T PRK09902 94 IEGEWRALLVTEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHS--VNRQHGCCYVRHIYVKTEGKAEAG 170 (216)
T ss_pred cCCceEEEEEEEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHhheeecCCCCeeEE
Confidence 1246899997754 58888875432 2345677778999999999999996 99999999999999986667 99
Q ss_pred EecccCCCC
Q 013519 251 LSDFGLAKL 259 (441)
Q Consensus 251 l~DFGla~~ 259 (441)
++||.-++.
T Consensus 171 lIDlEk~r~ 179 (216)
T PRK09902 171 FLDLEKSRR 179 (216)
T ss_pred EEEhhccch
Confidence 999987763
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.3e-06 Score=79.74 Aligned_cols=139 Identities=16% Similarity=0.173 Sum_probs=84.4
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCC--ccceEEEEEeCCeEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN--LVKLIGYCWEDRQFLL 182 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~l 182 (441)
..||.|..+.||+. .+..+++|....... ...+.+|.++++.+..-. +.+++++....+...+
T Consensus 7 ~~i~~G~t~~~y~~-------------~~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTH-------------KTGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEe-------------cCCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 47899999999984 134577888765432 244678999999886433 4667777777778899
Q ss_pred EEeecCCCC-HH--------------HHHHh-----cC-CCCCCCHHHHHHHHH-----------HHHH-HHhhh--ccC
Q 013519 183 VYEYMQKGS-LE--------------NHLFR-----KG-SAEPLPWNTRLKIAI-----------DAAK-DLTFL--HSS 227 (441)
Q Consensus 183 v~e~~~~g~-L~--------------~~l~~-----~~-~~~~l~~~~~~~i~~-----------~i~~-~l~~l--H~~ 227 (441)
|||+++|.. +. ..+.+ +. ............-.. .+.. ...+| +..
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 999999963 11 11110 00 000111111100000 0000 01111 222
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 228 EKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 228 ~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
...++|+|+.|.||++++++ +.|+||+.+..
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 35679999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.7e-06 Score=77.01 Aligned_cols=137 Identities=13% Similarity=0.109 Sum_probs=89.3
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHH---------HHHHHHHhcCC---C
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREW---------QAEVKFLGKFS---H 164 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~---------~~E~~~l~~l~---h 164 (441)
...+|.+.+++-......|.+-.. .++.+++|..........+.| .+.+..+.++. -
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-----------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~ 97 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-----------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGF 97 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-----------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCc
Confidence 456788888888777777766433 267899998877654322222 23333333332 2
Q ss_pred CCccceEEEEEe-----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCC
Q 013519 165 PNLVKLIGYCWE-----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKAS 239 (441)
Q Consensus 165 pniv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~ 239 (441)
-.+..++.+... -...+|||||++|..|.++.. ++. .+...++.++.-||. .|++|+|..|.
T Consensus 98 ~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~--~G~~HGD~hpg 164 (229)
T PF06176_consen 98 TEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK--HGFYHGDPHPG 164 (229)
T ss_pred cccccceeeeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH--cCCccCCCCcC
Confidence 223333333222 235679999999988866531 222 244556677899996 99999999999
Q ss_pred cEEEcCCCceEEecccCCC
Q 013519 240 NILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 240 Nill~~~~~~kl~DFGla~ 258 (441)
|++++.++ ++++||+..+
T Consensus 165 NFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 165 NFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred cEEEECCc-EEEEECcccc
Confidence 99998655 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=6e-07 Score=90.62 Aligned_cols=140 Identities=17% Similarity=0.219 Sum_probs=88.6
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHH------------------------------H----H
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG------------------------------L----R 150 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~------------------------------~----~ 150 (441)
..|+.++-|.||+|.++. |+.||||+..+.-... + +
T Consensus 131 ~PiAsASIaQVH~A~L~s----------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLKS----------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEecC----------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 589999999999997764 8999999977632211 0 0
Q ss_pred ------HHHHHHHHHhcCC-----CCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Q 013519 151 ------EWQAEVKFLGKFS-----HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219 (441)
Q Consensus 151 ------~~~~E~~~l~~l~-----hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~ 219 (441)
++.+|..-+.+++ .|+|.-..=++.-...-.|+|||++|..+.+...... ..++...+.....++.-
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f~ 278 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAFL 278 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHHH
Confidence 1233444444332 3333222222223456789999999999988743221 12333333322222221
Q ss_pred HHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCC
Q 013519 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLG 260 (441)
Q Consensus 220 ~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~ 260 (441)
-.- + ..|++|.|..|.||+++.+|.+.+.|||+....
T Consensus 279 ~q~-~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 279 RQL-L---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HHH-H---hcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 111 1 278999999999999999999999999998753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.8e-08 Score=100.52 Aligned_cols=186 Identities=19% Similarity=0.120 Sum_probs=129.4
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCC-ccceEEEEEeCCe
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN-LVKLIGYCWEDRQ 179 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~ 179 (441)
|....-+++|+++++||.+-.. .+....+.+... ....-++++|.+++||| .+..++-+..+..
T Consensus 244 s~~fh~fvK~altknpKkRpta----------eklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTA----------EKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCCh----------hhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 3444568899999999863321 122224443322 23445889999999999 7777777777888
Q ss_pred EEEEEeecCCC-CHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 180 FLLVYEYMQKG-SLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 180 ~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++|+++.++ +-..... .....+..-....+.+.-+++|+++|+ .--+|+| ||+..+ +..+..||+...
T Consensus 309 ~~i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~--~~~~~~d----~~l~s~-~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHS--SYKVHRD----NILGSE-EEVKLLDFAVPP 379 (829)
T ss_pred cchhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccc--ccccCcc----cccccc-cccccccccCCc
Confidence 99999999887 2211110 011112233445566777889999996 3348888 777766 579999999986
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCC
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALD 313 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~ 313 (441)
.+.... ......+|+.|+|||+.....+....|+|++|+-..++--|..|-.
T Consensus 380 ~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 380 QLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 543221 3455789999999999999999999999999987777777766653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.1e-06 Score=73.05 Aligned_cols=129 Identities=18% Similarity=0.179 Sum_probs=88.1
Q ss_pred CCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 013519 103 PDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLL 182 (441)
Q Consensus 103 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 182 (441)
..+.|++|++|.||+|.|. +..+|+|+-..++. ...+..|+++|..+.--++.+=+-.+ +.-++
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i 89 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFY---GEDFI 89 (201)
T ss_pred hhhhhhcccccEEEEeecc-----------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEe---chhhh
Confidence 4568999999999999876 55899998777654 36788899999999866665433222 12356
Q ss_pred EEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCC-CCcEEEcCCCceEEecccCCCC
Q 013519 183 VYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFK-ASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 183 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlk-p~Nill~~~~~~kl~DFGla~~ 259 (441)
.|||+.|-.|.+.-... +...++ .++...--|- ..||-|..|. |..++|.+++.+.|+||..|+.
T Consensus 90 ~me~i~G~~L~~~~~~~------~rk~l~----~vlE~a~~LD--~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG------DRKHLL----RVLEKAYKLD--RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcCcchhhhhhcc------cHHHHH----HHHHHHHHHH--HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 69999998887655211 122333 3333333333 3677777774 5556666666999999999874
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.34 E-value=6.9e-06 Score=75.92 Aligned_cols=140 Identities=16% Similarity=0.119 Sum_probs=83.0
Q ss_pred eecccCc-eEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEE
Q 013519 106 MLGEGGF-GRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 106 ~lG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv 183 (441)
.|-.|.. ..||+.... +..+.+|...... ...+.+|+++++.+. +--+.+++++....+..++|
T Consensus 5 ~~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 70 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLL 70 (244)
T ss_pred ecCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEE
Confidence 3445555 789987221 3468888876543 234567898888885 44455677777666678999
Q ss_pred EeecCCCCHHHHH-------------------HhcCC-CCCCCH--HHHHHH-----------------------HHHHH
Q 013519 184 YEYMQKGSLENHL-------------------FRKGS-AEPLPW--NTRLKI-----------------------AIDAA 218 (441)
Q Consensus 184 ~e~~~~g~L~~~l-------------------~~~~~-~~~l~~--~~~~~i-----------------------~~~i~ 218 (441)
||+++|.+|.... +.... ..++.. ...... ..++.
T Consensus 71 ~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (244)
T cd05150 71 TSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELY 150 (244)
T ss_pred EEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHH
Confidence 9999998776431 00000 001110 000000 11111
Q ss_pred HHHhhhc--cCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 219 KDLTFLH--SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 219 ~~l~~lH--~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
..|.... .....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 151 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 151 AELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 1111110 1135689999999999999987788999998763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.29 E-value=6.7e-06 Score=75.10 Aligned_cols=142 Identities=18% Similarity=0.182 Sum_probs=82.3
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCC--CccceEEEEEe---CC
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP--NLVKLIGYCWE---DR 178 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~~---~~ 178 (441)
++.|+.|..+.||+.... +..+++|..... .....+.+|..+++.+... .+.+++.+... ..
T Consensus 2 i~~l~~G~~n~~~~v~~~-----------~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~ 68 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD-----------DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG 68 (239)
T ss_dssp EEEEEESSSSEEEEEEET-----------TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS
T ss_pred CccCCCCCeeeEEEEEEC-----------CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc
Confidence 357899999999997433 248999987665 3456677899888888533 34566654432 34
Q ss_pred eEEEEEeecCCCCHHH----------------HHH---hc-CCCCCCCHHHH---------HHH------------HHHH
Q 013519 179 QFLLVYEYMQKGSLEN----------------HLF---RK-GSAEPLPWNTR---------LKI------------AIDA 217 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~----------------~l~---~~-~~~~~l~~~~~---------~~i------------~~~i 217 (441)
..+++|++++|..+.. .+. .. ....++..... ... ...+
T Consensus 69 ~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (239)
T PF01636_consen 69 FPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEEL 148 (239)
T ss_dssp EEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred cceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHH
Confidence 5799999999988777 111 11 11111111110 000 0011
Q ss_pred HH-HHhhhcc-----CCCCeeecCCCCCcEEEc-CCCceEEecccCCC
Q 013519 218 AK-DLTFLHS-----SEKSVIYRDFKASNILLD-GSYNAKLSDFGLAK 258 (441)
Q Consensus 218 ~~-~l~~lH~-----~~~~ivHrDlkp~Nill~-~~~~~kl~DFGla~ 258 (441)
.. .+..++. ....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 149 EERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 11 2222221 247799999999999999 66777899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.23 E-value=9.5e-06 Score=73.08 Aligned_cols=152 Identities=20% Similarity=0.185 Sum_probs=98.2
Q ss_pred ccCHHHHHHHhcCCCCCceec---ccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-----------------
Q 013519 88 MFTLQDLRAATKNFRPDTMLG---EGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ----------------- 147 (441)
Q Consensus 88 ~~~~~~~~~~~~~y~~~~~lG---~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------------- 147 (441)
..++..+.....+..+..+.| .|--+.||+|.. ..+..+|+|+.......
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~----------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~ 103 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAET----------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNS 103 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc----------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcC
Confidence 345666777777777766655 466668999743 23678999986543211
Q ss_pred -------HHHHHHHHHHHHhcCC--CCCccceEEEEEeCCeEEEEEeecCCCC-HHHHHHhcCCCCCCCHHHHHHHHHHH
Q 013519 148 -------GLREWQAEVKFLGKFS--HPNLVKLIGYCWEDRQFLLVYEYMQKGS-LENHLFRKGSAEPLPWNTRLKIAIDA 217 (441)
Q Consensus 148 -------~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~l~~~~~~~i~~~i 217 (441)
......+|+.-|.++. +=.+.+.+.+. .-.|||||+.... -.-.|.. .++...+...+..++
T Consensus 104 ~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~ 175 (268)
T COG1718 104 RSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDV 175 (268)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHH
Confidence 0112446777777774 44445555443 3489999995431 1111111 112223566667777
Q ss_pred HHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 218 ~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
++.+.-|-. ..++||+||..=|||+. ++.+.|+|||-|..
T Consensus 176 v~~~~~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 176 VEYMRRLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred HHHHHHHHH-hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence 777777764 48899999999999999 88999999998864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1e-05 Score=81.57 Aligned_cols=138 Identities=20% Similarity=0.301 Sum_probs=85.9
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHH-------------------------------HH---
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-------------------------------LR--- 150 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------------------------~~--- 150 (441)
+.||.-+.|.||+|+.+. |+.||||+-++.-... .+
T Consensus 167 ~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred chhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 589999999999997664 8899999866532110 01
Q ss_pred ---HHHHHHHHHh----cCCCCCcc---ceEEEEEe-CCeEEEEEeecCCCCHHHH--HHhcCCCCCCCHHHHHHHHHHH
Q 013519 151 ---EWQAEVKFLG----KFSHPNLV---KLIGYCWE-DRQFLLVYEYMQKGSLENH--LFRKGSAEPLPWNTRLKIAIDA 217 (441)
Q Consensus 151 ---~~~~E~~~l~----~l~hpniv---~~~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~~~~~l~~~~~~~i~~~i 217 (441)
+|.+|.+-.. .+.|-++. .+=.++++ ...-.|+||||+|..+.+. |.+.+ ++...+..-+.++
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g----i~~~~i~~~l~~~ 312 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG----ISPHDILNKLVEA 312 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC----CCHHHHHHHHHHH
Confidence 1223332222 22344411 12233333 3456899999999877654 44444 4444444444443
Q ss_pred HHHHhhhccCCCCeeecCCCCCcEEEcC----CCceEEecccCCCCC
Q 013519 218 AKDLTFLHSSEKSVIYRDFKASNILLDG----SYNAKLSDFGLAKLG 260 (441)
Q Consensus 218 ~~~l~~lH~~~~~ivHrDlkp~Nill~~----~~~~kl~DFGla~~~ 260 (441)
..-+-+ ..|++|.|-.|.||++.. ++.+.+.|||+....
T Consensus 313 ~~~qIf----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 313 YLEQIF----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHHHHH----hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 322222 267999999999999983 678999999998753
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.5e-05 Score=73.26 Aligned_cols=32 Identities=19% Similarity=0.273 Sum_probs=27.1
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 228 EKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 228 ~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
..+++|+|+.|.|||++.+...-|+||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 35689999999999998776567999998864
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.13 E-value=6.4e-05 Score=66.67 Aligned_cols=132 Identities=19% Similarity=0.318 Sum_probs=89.0
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc----------------hHHHHHHHHHHHHHhcCC----
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS----------------IQGLREWQAEVKFLGKFS---- 163 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~E~~~l~~l~---- 163 (441)
...||+|+.-.||.-= .....+||+..... ....++..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~HP------------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP------------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEECC------------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 3579999999999631 13457788877766 112344555665555444
Q ss_pred --CCCccceEEEEEeCCeEEEEEeecCC------CCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecC
Q 013519 164 --HPNLVKLIGYCWEDRQFLLVYEYMQK------GSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRD 235 (441)
Q Consensus 164 --hpniv~~~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrD 235 (441)
+.+|.+++|+.+.+.-.-+|+|.+.. -+|.+++.... ++. .....+.++.. ||-. ..|+.+|
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~L~~f~~---~l~~--~~Iv~~d 143 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQALDEFKR---YLLD--HHIVIRD 143 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHHHHHHHH---HHHH--cCCeecC
Confidence 88999999999999889999998643 26788884432 444 45555555544 4432 6799999
Q ss_pred CCCCcEEEcCC---C-ceEEec-ccCC
Q 013519 236 FKASNILLDGS---Y-NAKLSD-FGLA 257 (441)
Q Consensus 236 lkp~Nill~~~---~-~~kl~D-FGla 257 (441)
|+|.||++... . .+.|+| ||..
T Consensus 144 l~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 144 LNPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred CCcccEEEEecCCCceEEEEEeCCCCc
Confidence 99999999433 2 577777 3443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.4e-05 Score=67.90 Aligned_cols=125 Identities=26% Similarity=0.369 Sum_probs=89.0
Q ss_pred cCCCCCceecccCc-eEEEEEEecCCccccccccCCcEEEEEEcC---CCch------------------HHHHHHHHHH
Q 013519 99 KNFRPDTMLGEGGF-GRVFKGWVDHKTLAPTKVGVGKAVAVKKSN---PDSI------------------QGLREWQAEV 156 (441)
Q Consensus 99 ~~y~~~~~lG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~---~~~~------------------~~~~~~~~E~ 156 (441)
.+++.++.||.|.- |.||++... |+.||+|.+. .... .....|..|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-----------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-----------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-----------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 68889999999999 999998765 6799999821 1110 1123577888
Q ss_pred HHHhcCC---CCCc--cceEEEEEeC------------------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHH
Q 013519 157 KFLGKFS---HPNL--VKLIGYCWED------------------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKI 213 (441)
Q Consensus 157 ~~l~~l~---hpni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i 213 (441)
+...+|+ +.++ |++++|..-. ....||.||.+... .+... -
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~ 169 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----D 169 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----H
Confidence 8877775 5566 8999987422 12367888876543 12222 3
Q ss_pred HHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 214 ~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.++.+-+..+|. .||+-+|+++.|.. .-||+|||.+
T Consensus 170 ~~~~~~dl~~~~k--~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 170 IPQMLRDLKILHK--LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHH--CCeeeccCcccccc-----CCEEEecccC
Confidence 4466667788996 99999999999986 3489999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.2e-05 Score=81.81 Aligned_cols=81 Identities=19% Similarity=0.278 Sum_probs=55.2
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCC-CCCc--cceEEEEEeC--
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFS-HPNL--VKLIGYCWED-- 177 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-hpni--v~~~~~~~~~-- 177 (441)
.+.|+.|.+..+|+....... ....+++|+..... ......+.+|+++|+.+. |++| .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~-------~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG-------SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC-------cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 457899999999987543210 01357777765432 122346789999999996 6665 6777777654
Q ss_pred -CeEEEEEeecCCCC
Q 013519 178 -RQFLLVYEYMQKGS 191 (441)
Q Consensus 178 -~~~~lv~e~~~~g~ 191 (441)
+..|+||||++|..
T Consensus 116 ~G~~flVME~v~G~~ 130 (822)
T PLN02876 116 IGTAFYIMEYLEGRI 130 (822)
T ss_pred CCCceEEEEecCCcc
Confidence 46789999999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.00 E-value=2e-05 Score=84.29 Aligned_cols=199 Identities=22% Similarity=0.233 Sum_probs=134.9
Q ss_pred HHHHHHHHHHHhcCCCCCccceEEEEEeCCe----EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhh
Q 013519 149 LREWQAEVKFLGKFSHPNLVKLIGYCWEDRQ----FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224 (441)
Q Consensus 149 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~l 224 (441)
+.....|+..+..+.|+|++.++.|...... ..+..++|..-++...+...+ ..+....+.+..++..||.|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHH
Confidence 3445567888888999999999998765432 345667888888888886554 477889999999999999999
Q ss_pred ccCCCCeeecCCCCC---cEEEcCCCceEEe--cccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCcc--ccchh
Q 013519 225 HSSEKSVIYRDFKAS---NILLDGSYNAKLS--DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVK--SDVYG 297 (441)
Q Consensus 225 H~~~~~ivHrDlkp~---Nill~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DvwS 297 (441)
|. ....|.-|-.. +...+..+.+.++ ||+.++....... .....-+..|.+||......+..+ .|+|.
T Consensus 303 h~--~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 303 HS--LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred HH--hccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHH
Confidence 97 43444333333 3333555667777 9988875433222 222334566888888877666644 79999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHH
Q 013519 298 FGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEE 377 (441)
Q Consensus 298 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 377 (441)
+|.++..+..|..+-... .....+++ ........++..+|+..++++|+++.+
T Consensus 378 lgll~~~~~~~~~i~~~~-------------------~~~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKS-------------------AVPVSLLD--------VLSTSELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred HHHHHhhhhhcCcccccc-------------------cchhhhhc--------cccchhhhhhhhhhcchhhhhccchhh
Confidence 999999999875432111 00011111 111113557889999999999999999
Q ss_pred HHHHH
Q 013519 378 VLETL 382 (441)
Q Consensus 378 il~~L 382 (441)
++.+.
T Consensus 431 ll~~~ 435 (1351)
T KOG1035|consen 431 LLTHP 435 (1351)
T ss_pred hhhch
Confidence 99873
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.9e-05 Score=68.47 Aligned_cols=102 Identities=25% Similarity=0.244 Sum_probs=78.7
Q ss_pred HHHHHHhcCCC-CCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccC-CCCe
Q 013519 154 AEVKFLGKFSH-PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSS-EKSV 231 (441)
Q Consensus 154 ~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~i 231 (441)
.|.-+|+.+.+ +++.+++|+|- -++|.||...+++.............+|..+.+|+.+++..+.+|+.. ...+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888998975 69999999993 377999998776642100000112367999999999999999999742 2347
Q ss_pred eecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 232 IYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 232 vHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
.-.|++|+|+-+++++++|++|...+-.
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 7889999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=2.6e-06 Score=92.82 Aligned_cols=176 Identities=12% Similarity=-0.032 Sum_probs=123.2
Q ss_pred EEEEEEcCCCchHH-----HHHHHHHHHHHhcCCCCCccceEEEEEe--CCeEEEEEeecCCCCHHHHHHhcCC-CCCCC
Q 013519 135 AVAVKKSNPDSIQG-----LREWQAEVKFLGKFSHPNLVKLIGYCWE--DRQFLLVYEYMQKGSLENHLFRKGS-AEPLP 206 (441)
Q Consensus 135 ~vaiK~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~ 206 (441)
.+.+|+.+.-..+. .+....|..-++.+.|+++.....-... ....+.+++|+.+|.+++.|.+... ..++.
T Consensus 1254 ~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld 1333 (2724)
T KOG1826|consen 1254 WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLD 1333 (2724)
T ss_pred eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcch
Confidence 34555554433322 2233445556666789998877654443 3457899999999999999876332 23333
Q ss_pred HHHHHHHHHHHHHHHhhhccC---CCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchh
Q 013519 207 WNTRLKIAIDAAKDLTFLHSS---EKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEY 283 (441)
Q Consensus 207 ~~~~~~i~~~i~~~l~~lH~~---~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 283 (441)
..-+.....+.+.+..-+|+. ..-.+|++||+.|.+|..+.++|+.++|+.++.. ..........+++.|++|++
T Consensus 1334 ~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli 1411 (2724)
T KOG1826|consen 1334 RSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLI 1411 (2724)
T ss_pred hchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHH
Confidence 344444444446667776652 2335899999999999999999999999998421 12223344678889999999
Q ss_pred hhcCCCCccccchhHHHHHHHHHhCCCCC
Q 013519 284 VATGHLYVKSDVYGFGVVLLEMLTGLRAL 312 (441)
Q Consensus 284 ~~~~~~~~~~DvwSlG~il~elltg~~p~ 312 (441)
...-.++.++|+|..|+.+|++..|..+|
T Consensus 1412 ~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1412 KNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 98889999999999999999998887665
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00016 Score=66.38 Aligned_cols=142 Identities=20% Similarity=0.212 Sum_probs=79.3
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCcc-ceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLV-KLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv 183 (441)
+.|..|-...+|+...... .++.|++|+....... .....+|+.+++.+...+++ +++..+ + + .+|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~--------~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~-~-~--~~l 70 (235)
T cd05157 4 KRFTGGITNKLVKVSNKED--------NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATF-Q-N--GLI 70 (235)
T ss_pred EEcCCcccceEEEEEcCCC--------CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEe-C-C--cEE
Confidence 4677788889998732210 1457888876543221 12335788889888643443 344332 2 2 489
Q ss_pred EeecCCCCHHHH--------------HH---hcCCC--------CCC-CHHHHHHHH-----------------------
Q 013519 184 YEYMQKGSLENH--------------LF---RKGSA--------EPL-PWNTRLKIA----------------------- 214 (441)
Q Consensus 184 ~e~~~~g~L~~~--------------l~---~~~~~--------~~l-~~~~~~~i~----------------------- 214 (441)
|||++|.++... +. ..... ... .+..+..+.
T Consensus 71 ~e~i~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (235)
T cd05157 71 YEFIPGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFE 150 (235)
T ss_pred EEeeCCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHH
Confidence 999998765321 11 11100 011 122221211
Q ss_pred --HHHHHHHh-hhcc--CCCCeeecCCCCCcEEEcC-CCceEEecccCCCC
Q 013519 215 --IDAAKDLT-FLHS--SEKSVIYRDFKASNILLDG-SYNAKLSDFGLAKL 259 (441)
Q Consensus 215 --~~i~~~l~-~lH~--~~~~ivHrDlkp~Nill~~-~~~~kl~DFGla~~ 259 (441)
.+.+..|. .+-. ....++|+|+.+.|||++. ++.+.|+||..|..
T Consensus 151 ~l~~~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 151 QLRDEISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 11111111 1111 1357999999999999998 57899999988763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00015 Score=67.57 Aligned_cols=138 Identities=18% Similarity=0.116 Sum_probs=76.3
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCcc-ceEEEEEeCCeEEEEE
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLV-KLIGYCWEDRQFLLVY 184 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~ 184 (441)
.+..|-...+|+... .+..+++|..........-...+|..+++.+....++ +++... . -++||
T Consensus 3 ~~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~ 67 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLV 67 (256)
T ss_pred cCCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEE
Confidence 345677778888631 2567888876543222101346799999988643333 333332 2 37899
Q ss_pred eecCCCCHHH--------------HHHh---cC-CCCCCCHHH-HHHHH------------HHHHHHHhhhc---cCCCC
Q 013519 185 EYMQKGSLEN--------------HLFR---KG-SAEPLPWNT-RLKIA------------IDAAKDLTFLH---SSEKS 230 (441)
Q Consensus 185 e~~~~g~L~~--------------~l~~---~~-~~~~l~~~~-~~~i~------------~~i~~~l~~lH---~~~~~ 230 (441)
||++|..+.. .+.+ .. ...++.... +..+. ..+...+.... .....
T Consensus 68 e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (256)
T TIGR02721 68 EWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLA 147 (256)
T ss_pred EeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCe
Confidence 9999876531 1111 11 011222211 11111 11111111110 01246
Q ss_pred eeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 231 VIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 231 ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
++|+|+.|.||+++.++ +.|+||..+..
T Consensus 148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 148 PLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 89999999999999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00075 Score=64.27 Aligned_cols=76 Identities=12% Similarity=0.012 Sum_probs=52.3
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCC---CCccceEEEEEe---C
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSH---PNLVKLIGYCWE---D 177 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~~~~~~~~---~ 177 (441)
.+.||.|..+.||..... +..+.+|..+... ....+..|...|+.|.- -.+.++++++.. .
T Consensus 19 ~~~i~~G~~~~vy~~~~~-----------~~~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 19 VECISEQPYAALWALYDS-----------QGNPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred eeecCCccceeEEEEEcC-----------CCCEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 457999999999985221 2245666643311 12467789999988853 357778877754 3
Q ss_pred CeEEEEEeecCCCCH
Q 013519 178 RQFLLVYEYMQKGSL 192 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L 192 (441)
+..+||||+++|+++
T Consensus 86 g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 86 GPDVLLLERLRGVSV 100 (297)
T ss_pred CCeEEEEeccCCEec
Confidence 668999999998754
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0035 Score=60.37 Aligned_cols=32 Identities=28% Similarity=0.365 Sum_probs=27.4
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 228 EKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 228 ~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
..++||+|+.|.|||++.+...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 36899999999999999765568999999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00063 Score=64.99 Aligned_cols=81 Identities=17% Similarity=0.190 Sum_probs=48.1
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCcc-ceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLV-KLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv 183 (441)
+.|..|--..||+....... .....++.+++|+..... .......+|+.++..+....+. +++.++. + .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 34556666789987543211 122335788999866543 2223456788888888633333 4444442 2 468
Q ss_pred EeecCCCCHH
Q 013519 184 YEYMQKGSLE 193 (441)
Q Consensus 184 ~e~~~~g~L~ 193 (441)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0032 Score=59.85 Aligned_cols=142 Identities=17% Similarity=0.121 Sum_probs=80.9
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCC--ccceEE------EEE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN--LVKLIG------YCW 175 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~------~~~ 175 (441)
.+.|..|....+|+.... +..+++|+..... ...+..|+.++..|.+-+ +.+++. +..
T Consensus 19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEeC-----------CCcEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 346777777889986322 3468889876522 244566888887775322 444433 123
Q ss_pred eCCeEEEEEeecCCCCHHH-----------HH---HhcCC--C------CCCCHHHHH----------HHHHHHHHHHhh
Q 013519 176 EDRQFLLVYEYMQKGSLEN-----------HL---FRKGS--A------EPLPWNTRL----------KIAIDAAKDLTF 223 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~-----------~l---~~~~~--~------~~l~~~~~~----------~i~~~i~~~l~~ 223 (441)
..+..++|++|++|..+.. .+ +.... . ....|.... .....+..++.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 3456789999999876421 11 11000 0 011111110 001112222333
Q ss_pred hc-----cCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 224 LH-----SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 224 lH-----~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
+. ....+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 32 1236799999999999999987778999998863
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0037 Score=59.90 Aligned_cols=156 Identities=15% Similarity=0.142 Sum_probs=84.7
Q ss_pred HHHHHHHhcCCCC-----CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCC
Q 013519 91 LQDLRAATKNFRP-----DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165 (441)
Q Consensus 91 ~~~~~~~~~~y~~-----~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp 165 (441)
.+++....+.|.+ ++.++.|.-..+|+.... +..+++|+...... ...+..|+.++..|...
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~-----------~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~ 75 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD-----------VGRYILTLYEKRVK--AEELPFFLALTTHLAAR 75 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEeC-----------CCcEEEEEecCCCC--HHHHHHHHHHHHHHHHC
Confidence 3455555555654 355667767789986321 23577887655321 22344566777666421
Q ss_pred --CccceEEE------EEeCCeEEEEEeecCCCCHH-----------HH---HHhcCCC--CC-------CCHHHHHH--
Q 013519 166 --NLVKLIGY------CWEDRQFLLVYEYMQKGSLE-----------NH---LFRKGSA--EP-------LPWNTRLK-- 212 (441)
Q Consensus 166 --niv~~~~~------~~~~~~~~lv~e~~~~g~L~-----------~~---l~~~~~~--~~-------l~~~~~~~-- 212 (441)
.+.+++.. ....+..++|++|++|..+. .. ++..... .+ -.|.....
T Consensus 76 g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~ 155 (307)
T TIGR00938 76 GLPVPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKC 155 (307)
T ss_pred CCCCCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhh
Confidence 13333331 12245678999999986431 11 1110000 00 01111000
Q ss_pred ----------HHHHHHHHHhhhcc-----CCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 213 ----------IAIDAAKDLTFLHS-----SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 213 ----------i~~~i~~~l~~lH~-----~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
....+...+.++.. ...++||+|+.+.||+++.++.+.|+||+.+..
T Consensus 156 ~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 156 FEAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hhcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 01112223444421 247899999999999999888778999998863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0042 Score=61.21 Aligned_cols=76 Identities=24% Similarity=0.260 Sum_probs=50.8
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC------c-hHHHHHHHHHHHHHhcCC---CCCccceEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD------S-IQGLREWQAEVKFLGKFS---HPNLVKLIGYC 174 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~------~-~~~~~~~~~E~~~l~~l~---hpniv~~~~~~ 174 (441)
+.||.|.+..||++..... ++.++||.-.+. . .........|.+.|..+. -.++.+++.+
T Consensus 32 ~elggGn~N~VyrV~~~~g---------~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~- 101 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEG---------GKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY- 101 (401)
T ss_pred eEcCCCceEEEEEEEeCCC---------CeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence 4799999999999854321 257999974421 1 123455667888888763 2345666654
Q ss_pred EeCCeEEEEEeecCCCC
Q 013519 175 WEDRQFLLVYEYMQKGS 191 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~ 191 (441)
+....++||||+++..
T Consensus 102 -D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 -DEELAVTVMEDLSDHK 117 (401)
T ss_pred -CCCCCEEEEecCCCcc
Confidence 5566789999998744
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0039 Score=60.67 Aligned_cols=144 Identities=19% Similarity=0.192 Sum_probs=80.5
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCcc-ceEEEEEeCCeEEEEE
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLV-KLIGYCWEDRQFLLVY 184 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~ 184 (441)
.|-.|-.-.+|++.+.... ...++.|++|.........+ ...+|..+++.+..-++. ++++.+. +. .|.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~-----~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~ 112 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKE-----GNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFP-NG---RVE 112 (344)
T ss_pred EcCCcccceeEEEEeCCCC-----CCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEEC-Cc---eEE
Confidence 4545667789987543211 11246888998765432222 236788888888644443 4455442 22 589
Q ss_pred eecCCCCHHHH--------------H---HhcC---CCCCCCHHHHHHHHHHHH--------------------HHHh-h
Q 013519 185 EYMQKGSLENH--------------L---FRKG---SAEPLPWNTRLKIAIDAA--------------------KDLT-F 223 (441)
Q Consensus 185 e~~~~g~L~~~--------------l---~~~~---~~~~l~~~~~~~i~~~i~--------------------~~l~-~ 223 (441)
+|+++.+|... + +... ......+..+..+..++. ..|. .
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987665321 1 1100 011122333333322211 1111 1
Q ss_pred hc--cCCCCeeecCCCCCcEEEcC-CCceEEecccCCCC
Q 013519 224 LH--SSEKSVIYRDFKASNILLDG-SYNAKLSDFGLAKL 259 (441)
Q Consensus 224 lH--~~~~~ivHrDlkp~Nill~~-~~~~kl~DFGla~~ 259 (441)
+. .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 12357899999999999986 46899999988863
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.00094 Score=62.61 Aligned_cols=134 Identities=16% Similarity=0.111 Sum_probs=87.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--------------------chH--HHHHHHHHH
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--------------------SIQ--GLREWQAEV 156 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--------------------~~~--~~~~~~~E~ 156 (441)
.-+.+++.||-|--+.||.+-... |...++|.-... +.. ..-...+|+
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~----------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEf 161 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEE----------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEF 161 (465)
T ss_pred hhhhhccccccccccceEEEecCC----------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHH
Confidence 346678899999999999985443 667777742211 000 011245688
Q ss_pred HHHhcCC-CCC-ccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeec
Q 013519 157 KFLGKFS-HPN-LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYR 234 (441)
Q Consensus 157 ~~l~~l~-hpn-iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHr 234 (441)
..|+.|. |-. |.+.+ +.+..++|||++.|-.|...-. .....++..-+..+ +.-|- ..|+||+
T Consensus 162 afmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~---Iv~la--~~GlIHg 226 (465)
T KOG2268|consen 162 AFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGL---IVRLA--NHGLIHG 226 (465)
T ss_pred HHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeee------cCChHHHHHHHHHH---HHHHH--HcCceec
Confidence 8888885 333 33333 3456789999999987754321 12233433333333 33343 3899999
Q ss_pred CCCCCcEEEcCCCceEEecccCC
Q 013519 235 DFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 235 Dlkp~Nill~~~~~~kl~DFGla 257 (441)
|..-=||++++++.++++||--.
T Consensus 227 DFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 227 DFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred ccchheeEEecCCCEEEeechHh
Confidence 99999999999999999999654
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0016 Score=57.76 Aligned_cols=103 Identities=17% Similarity=0.136 Sum_probs=67.9
Q ss_pred EEEEEEcCCCchH-HHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHH
Q 013519 135 AVAVKKSNPDSIQ-GLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKI 213 (441)
Q Consensus 135 ~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i 213 (441)
...+|++..-... ....+..+.+++.++. .|+++..- ..-.+-+|+|+|-.... . . ..+
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~---~-~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------N---F-SNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------c---h-hHH
Confidence 3445555443222 2345677888888764 46666521 23356799999943211 1 1 112
Q ss_pred HHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 214 ~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.--+.+|.-.|+...+.+|+|-.|+||+-|..|.+||.|=+..
T Consensus 147 i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 147 ITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 22225678888977899999999999999999999999998754
|
The function of this family is unknown. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.01 Score=56.52 Aligned_cols=33 Identities=24% Similarity=0.500 Sum_probs=29.5
Q ss_pred CCeeecCCCCCcEEEcCCCceEEecccCCCCCC
Q 013519 229 KSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP 261 (441)
Q Consensus 229 ~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~ 261 (441)
..++|+|+.+.||+++.++.+-|+||+++....
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 468999999999999999889999999998643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.014 Score=56.46 Aligned_cols=75 Identities=23% Similarity=0.287 Sum_probs=46.4
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCC-------CchHHHHHHHHHHHHHhcCC--CCCccceEEEEEe
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP-------DSIQGLREWQAEVKFLGKFS--HPNLVKLIGYCWE 176 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~ 176 (441)
.||-|....||++.... .++.|+||.-.+ .-.-...+..-|...|+... -|..|+-+ ++.+
T Consensus 2 EigdGnlN~VfrV~~~~---------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~v-y~~D 71 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE---------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRI-FHFD 71 (370)
T ss_pred cCCCCceEEEEEEEcCC---------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeE-EEEc
Confidence 57999999999985321 135799996322 11223344556778787664 45444322 3456
Q ss_pred CCeEEEEEeecCCC
Q 013519 177 DRQFLLVYEYMQKG 190 (441)
Q Consensus 177 ~~~~~lv~e~~~~g 190 (441)
.....+|||+++..
T Consensus 72 ~e~~~~vMEdL~~~ 85 (370)
T TIGR01767 72 TEMAVTVMEDLSHH 85 (370)
T ss_pred cccceehHhhCccc
Confidence 66778999998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.013 Score=55.10 Aligned_cols=31 Identities=26% Similarity=0.397 Sum_probs=26.4
Q ss_pred CCeeecCCCCCcEEEcCCCc-eEEecccCCCC
Q 013519 229 KSVIYRDFKASNILLDGSYN-AKLSDFGLAKL 259 (441)
Q Consensus 229 ~~ivHrDlkp~Nill~~~~~-~kl~DFGla~~ 259 (441)
..++|+|+.|.|||++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 46899999999999997555 46999999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0012 Score=65.47 Aligned_cols=48 Identities=21% Similarity=0.340 Sum_probs=37.5
Q ss_pred HHHHHHHHHhcCCCCCccceEEEEEeC-CeEEEEEeecCCCCHHHHHHhc
Q 013519 151 EWQAEVKFLGKFSHPNLVKLIGYCWED-RQFLLVYEYMQKGSLENHLFRK 199 (441)
Q Consensus 151 ~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~ 199 (441)
.+.-...+++.+.|+|..+++++-... ....+|||++ +.+|++.+..+
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 344567788999999999999877643 4588999999 56999988654
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.0059 Score=59.09 Aligned_cols=141 Identities=17% Similarity=0.176 Sum_probs=83.4
Q ss_pred HHHhcCCCCCceecccCceEEEEEEecCCcccc------ccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCc
Q 013519 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAP------TKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNL 167 (441)
Q Consensus 95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~------~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpni 167 (441)
..+...|.. ..||.|.-+.||+|..+...... .+....+.+|||+..+.....+ ...+.||.-.. -+|+
T Consensus 186 ~eiF~efn~-~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~i---r~Dl~Il~f~Akl~~~ 261 (565)
T KOG1236|consen 186 EEIFSEFNR-EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQI---RLDLGILGFGAKLINN 261 (565)
T ss_pred HHHHHhcCC-cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHH---HHHHHHHhhhhhhhhh
Confidence 333344443 47999999999999765432211 2344567899999887654332 23333433321 1122
Q ss_pred cceEEEE----------------------------------------------EeCCeEEEEEeecCCCCHHHHHHhcCC
Q 013519 168 VKLIGYC----------------------------------------------WEDRQFLLVYEYMQKGSLENHLFRKGS 201 (441)
Q Consensus 168 v~~~~~~----------------------------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~ 201 (441)
|+-..|. .-.....||-+|..|.++..++...+
T Consensus 262 vP~l~wL~l~~~vkqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~- 340 (565)
T KOG1236|consen 262 VPDLSWLSLPLEVKQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKS- 340 (565)
T ss_pred cCccccccCcchHHHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhccc-
Confidence 2111111 01123467778889989988886543
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc
Q 013519 202 AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD 244 (441)
Q Consensus 202 ~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 244 (441)
.++....+++.-.+.||-.+-- -.+++|.|+.|.||++-
T Consensus 341 ---~pe~l~kkva~lg~~AllkMl~-vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 341 ---QPEALVKKVAKLGVNALLKMLI-VDNFVHADLHPGNVLIR 379 (565)
T ss_pred ---ChHHHHHHHHHHHHHHHHHHHH-hhcceecccCCCcEEEE
Confidence 3445556666666666654432 36799999999999994
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.012 Score=56.33 Aligned_cols=72 Identities=21% Similarity=0.237 Sum_probs=56.2
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
.+.|++|++- |++|.- + ..-.+.++..++.+.+..+.-+.. +...=|||+.-.||||+ +|+|-|+||-++
T Consensus 299 ~y~yl~~kdh-gt~is~-i------k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I------KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred eEEEEEEecC-Cceeee-e------ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeee
Confidence 3567777775 445432 2 224478899999998887777764 56789999999999999 999999999999
Q ss_pred CC
Q 013519 258 KL 259 (441)
Q Consensus 258 ~~ 259 (441)
|.
T Consensus 369 Rl 370 (488)
T COG5072 369 RL 370 (488)
T ss_pred ec
Confidence 85
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.026 Score=54.61 Aligned_cols=143 Identities=20% Similarity=0.278 Sum_probs=77.5
Q ss_pred eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCcc-ceEEEEEeCCeEEEEE
Q 013519 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLV-KLIGYCWEDRQFLLVY 184 (441)
Q Consensus 106 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~ 184 (441)
.|..|---.+|+....... ..+..|++|+....... .-.-.+|..+++.+..-++. ++++++ .++ +|.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~------~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~ 89 (330)
T PLN02421 21 RISGGITNLLLKVSVKEEN------GNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQ 89 (330)
T ss_pred EeCCcccceEEEEEecCCC------CCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEe-CCc---Eee
Confidence 4545666778887543210 11347888877554322 22335788888888755553 445444 332 589
Q ss_pred eecCCCCHHH--------------HHHh-cCC-----CCCCCHHHHHHHHHHH-------------------------HH
Q 013519 185 EYMQKGSLEN--------------HLFR-KGS-----AEPLPWNTRLKIAIDA-------------------------AK 219 (441)
Q Consensus 185 e~~~~g~L~~--------------~l~~-~~~-----~~~l~~~~~~~i~~~i-------------------------~~ 219 (441)
+|++|..|.. .+.+ +.. ..+-.+..+..+..++ +.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 9998765421 1111 110 0111233332222221 11
Q ss_pred HHh-hhcc--CCCCeeecCCCCCcEEEcC-CCceEEecccCCCC
Q 013519 220 DLT-FLHS--SEKSVIYRDFKASNILLDG-SYNAKLSDFGLAKL 259 (441)
Q Consensus 220 ~l~-~lH~--~~~~ivHrDlkp~Nill~~-~~~~kl~DFGla~~ 259 (441)
.+. ++.. ...-++|.|+.+.|||+++ ++.++++||..|..
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 1111 1234799999999999974 57899999998863
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.041 Score=52.81 Aligned_cols=137 Identities=12% Similarity=0.146 Sum_probs=88.3
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC------------------------ch-HHH-HHHHHHHH
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD------------------------SI-QGL-REWQAEVK 157 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~------------------------~~-~~~-~~~~~E~~ 157 (441)
...|..|--+.||.|.-. .|..+|||+.+.. +. ..+ -....|++
T Consensus 149 nGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~R 218 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMR 218 (520)
T ss_pred ccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHH
Confidence 345777888899997433 3777999974321 11 111 12346888
Q ss_pred HHhcCCCCCccceEEEEEeCCeEEEEEeecCCCCHH-HHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCC
Q 013519 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLE-NHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDF 236 (441)
Q Consensus 158 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDl 236 (441)
-|.+|+...|.-.--+... ..+|||+|+...... -.| ....++...+..+-.+++.-+.-|.+ ..++||.||
T Consensus 219 NLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkL----Kd~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHADL 291 (520)
T KOG2270|consen 219 NLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKL----KDASLSTSKARELYQQCVRIMRRLYQ-KCRLVHADL 291 (520)
T ss_pred HHHHHHhcCCCCCCceeee--cceEeeeeccCCCCcCccc----ccccCChHHHHHHHHHHHHHHHHHHH-Hhceeccch
Confidence 8888865554433222222 347999999532211 112 12346666777777788777777765 578999999
Q ss_pred CCCcEEEcCCCceEEecccCCC
Q 013519 237 KASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 237 kp~Nill~~~~~~kl~DFGla~ 258 (441)
.-=|+|+.. |.+.|+|-+-+.
T Consensus 292 SEfN~Lyhd-G~lyiIDVSQSV 312 (520)
T KOG2270|consen 292 SEFNLLYHD-GKLYIIDVSQSV 312 (520)
T ss_pred hhhhheEEC-CEEEEEEccccc
Confidence 999999864 579999998775
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.24 Score=47.27 Aligned_cols=31 Identities=23% Similarity=0.375 Sum_probs=26.9
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 228 EKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 228 ~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
..+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 368999999999999987 6789999997753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.027 Score=55.19 Aligned_cols=76 Identities=21% Similarity=0.311 Sum_probs=48.3
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCC------CchHHHHHHHHHHHHHhcCC--CCCccceEEEEE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP------DSIQGLREWQAEVKFLGKFS--HPNLVKLIGYCW 175 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~ 175 (441)
.+.||-|.-.-||++.... .++.|+||.-.+ +-.-...+..-|..+|+.+. -|..|+-+ ++.
T Consensus 34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~v-y~~ 103 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKV-YLF 103 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeE-EEE
Confidence 3578999999999985421 135788885321 11223455666888888764 45444422 245
Q ss_pred eCCeEEEEEeecCC
Q 013519 176 EDRQFLLVYEYMQK 189 (441)
Q Consensus 176 ~~~~~~lv~e~~~~ 189 (441)
+.....+|||+++.
T Consensus 104 D~e~~~~vMEdL~~ 117 (409)
T PRK12396 104 DSVMNCCVMEDLSD 117 (409)
T ss_pred CcHHhhHHHHhCcc
Confidence 66677899999854
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.11 Score=49.63 Aligned_cols=32 Identities=16% Similarity=0.256 Sum_probs=29.1
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 228 EKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 228 ~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
..++||+|+.+.|||++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999999999999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.065 Score=52.86 Aligned_cols=73 Identities=12% Similarity=0.122 Sum_probs=46.2
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-------HHHHHHHHHHHHHhcCC---CCCccceEEE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-------QGLREWQAEVKFLGKFS---HPNLVKLIGY 173 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~---hpniv~~~~~ 173 (441)
.+.||-|....||+.... +..++||.-..... -....-..|...|+.+. -.++.+++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 357899999999996432 34688887542110 12233344666666554 2467777776
Q ss_pred EEeCCeEEEEEeecCC
Q 013519 174 CWEDRQFLLVYEYMQK 189 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~ 189 (441)
+. ...+++||++++
T Consensus 106 de--d~~vlvME~L~~ 119 (418)
T PLN02756 106 DR--TMALIGMRYLEP 119 (418)
T ss_pred CC--CCCEEEEeecCC
Confidence 65 456889999977
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.12 Score=48.82 Aligned_cols=73 Identities=16% Similarity=0.208 Sum_probs=44.6
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC---CCCccceEEEEEeCCeE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS---HPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~ 180 (441)
.+.|+-|....+|+.. ..++.+.||...... ...|..|..-|+.|. --.+.+++++....+..
T Consensus 22 ~~~v~GG~i~~a~~~~-----------~~~~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~ 87 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-----------TDGGSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA 87 (288)
T ss_dssp EEEE--SSSSEEEEEE-----------TTS-EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred eEecCCCChhheEEEE-----------CCCccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence 4578888889999863 236789999876222 245667887777773 44577888888777778
Q ss_pred EEEEeecCCC
Q 013519 181 LLVYEYMQKG 190 (441)
Q Consensus 181 ~lv~e~~~~g 190 (441)
||||||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 9999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.51 Score=42.62 Aligned_cols=58 Identities=24% Similarity=0.279 Sum_probs=41.8
Q ss_pred CcEEEEEEcCCCchHHHHHHHHHHHHHhcCC---CCCccceEEEEEeCCeEEEEEeecCCCCHH
Q 013519 133 GKAVAVKKSNPDSIQGLREWQAEVKFLGKFS---HPNLVKLIGYCWEDRQFLLVYEYMQKGSLE 193 (441)
Q Consensus 133 ~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~e~~~~g~L~ 193 (441)
...+-+|.-... ....|..|+.-|..+. .-+|.+++.+-......|+||||++-+.+.
T Consensus 39 ~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 39 TDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 456777865433 3456777876666654 456778888888899999999999886654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.69 Score=44.61 Aligned_cols=30 Identities=20% Similarity=0.261 Sum_probs=25.5
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 228 EKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 228 ~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
..++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 46789999999999995 3 578999998864
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.23 Score=48.98 Aligned_cols=81 Identities=14% Similarity=0.108 Sum_probs=45.0
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccce-EEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKL-IGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~-~~~~~~~~~~~lv 183 (441)
+.|..|--..+|++...... ......+.|+++..... ....-.-.+|+.+++.+...++.+- ++.+ . -++|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~---~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f-~---~g~l 127 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGD---KDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRF-G---DFTI 127 (383)
T ss_pred EEeCCcccceEEEEEecCCC---CCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEec-C---CEEE
Confidence 45656777889988653221 00001123555543222 1111223568999999976555544 4444 2 2699
Q ss_pred EeecCCCCHH
Q 013519 184 YEYMQKGSLE 193 (441)
Q Consensus 184 ~e~~~~g~L~ 193 (441)
.||++|..|.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999987654
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.15 Score=50.77 Aligned_cols=30 Identities=23% Similarity=0.304 Sum_probs=23.6
Q ss_pred CeeecCCCCCcEEEcCCCc-----eEEecccCCCC
Q 013519 230 SVIYRDFKASNILLDGSYN-----AKLSDFGLAKL 259 (441)
Q Consensus 230 ~ivHrDlkp~Nill~~~~~-----~kl~DFGla~~ 259 (441)
=++|+||...|||.+.++. ..|+||-++..
T Consensus 269 VL~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~ 303 (414)
T PF07914_consen 269 VLVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR 303 (414)
T ss_pred ceecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence 3699999999999987443 57789877654
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.08 E-value=0.44 Score=47.98 Aligned_cols=83 Identities=12% Similarity=0.047 Sum_probs=46.8
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCcc-ceEEEEEeCCeEEE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLV-KLIGYCWEDRQFLL 182 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~l 182 (441)
.+.|..|---.+|++....... ......++.|++++........+ .-.+|..+++.+..-+|- ++++.+. -..
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~-~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~ 183 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETA-NNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGR 183 (442)
T ss_pred EEEecCcccCceEEEEecCCCC-ccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCE
Confidence 3456566667888876542210 01112256788888755433222 345688888877644444 3444442 256
Q ss_pred EEeecCCCCH
Q 013519 183 VYEYMQKGSL 192 (441)
Q Consensus 183 v~e~~~~g~L 192 (441)
|.||++|..|
T Consensus 184 I~efi~g~~l 193 (442)
T PTZ00296 184 IEEWLYGDPL 193 (442)
T ss_pred EEEeeCCccC
Confidence 7899988744
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.03 E-value=0.13 Score=48.18 Aligned_cols=51 Identities=20% Similarity=0.142 Sum_probs=39.3
Q ss_pred HHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 209 TRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 209 ~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
.....+..+-.++.-++....-++|.|+.|.|+|+++.+.++|+||.-|..
T Consensus 133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 334455566666666664225689999999999999999999999988864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 441 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-44 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-37 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 8e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 489 bits (1261), Expect = e-174
Identities = 106/317 (33%), Positives = 167/317 (52%), Gaps = 27/317 (8%)
Query: 81 VTPNYLKMFTLQDLRAATKNFRPDTM------LGEGGFGRVFKGWVDHKTLAPTKVGVGK 134
V+ F+ +L+ T NF + +GEGGFG V+KG+V+
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----------NT 55
Query: 135 AVAVKK----SNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKG 190
VAVKK + + + +++ E+K + K H NLV+L+G+ + LVY YM G
Sbjct: 56 TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115
Query: 191 SLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250
SL + L PL W+ R KIA AA + FLH E I+RD K++NILLD ++ AK
Sbjct: 116 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAK 173
Query: 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLR 310
+SDFGLA+ + +T+RI+GT Y APE + G + KSD+Y FGVVLLE++TGL
Sbjct: 174 ISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLP 232
Query: 311 ALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPK 370
A+D +R +L+D +++ ++ +D ++ + +CL +
Sbjct: 233 AVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKN 289
Query: 371 NRPSMEEVLETLQNISV 387
RP +++V + LQ ++
Sbjct: 290 KRPDIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 466 bits (1202), Expect = e-165
Identities = 114/321 (35%), Positives = 177/321 (55%), Gaps = 14/321 (4%)
Query: 70 GDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTK 129
N S + P L DL AT NF ++G G FG+V+KG +
Sbjct: 10 NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD------- 62
Query: 130 VGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQK 189
G VA+K+ P+S QG+ E++ E++ L HP+LV LIG+C E + +L+Y+YM+
Sbjct: 63 ---GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119
Query: 190 GSLENHLFRKGS-AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248
G+L+ HL+ + W RL+I I AA+ L +LH +++I+RD K+ NILLD ++
Sbjct: 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFV 177
Query: 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG 308
K++DFG++K G +H++T + GT GY PEY G L KSDVY FGVVL E+L
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 309 LRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAE 368
A+ + P L ++A S + +L++I+DP L ++ + G +KCL
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALS 296
Query: 369 PKNRPSMEEVLETLQNISVIE 389
++RPSM +VL L+ ++
Sbjct: 297 SEDRPSMGDVLWKLEYALRLQ 317
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 388 bits (999), Expect = e-134
Identities = 117/309 (37%), Positives = 182/309 (58%), Gaps = 17/309 (5%)
Query: 86 LKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS 145
LK F+L++L+ A+ NF +LG GGFG+V+KG + G VAVK+ +
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD----------GTLVAVKRLKEER 66
Query: 146 IQGL-REWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLF-RKGSAE 203
QG ++Q EV+ + H NL++L G+C + LLVY YM GS+ + L R S
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 204 PLPWNTRLKIAIDAAKDLTFLH-SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPI 262
PL W R +IA+ +A+ L +LH + +I+RD KA+NILLD + A + DFGLAKL
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD- 185
Query: 263 DGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH- 321
++HVTT + GT G+ APEY++TG K+DV+G+GV+LLE++TG RA D R + +
Sbjct: 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 322 -VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+L+D+ + L +++L+ ++D L+ Y + Q+ + C ++ P RP M EV+
Sbjct: 246 VMLLDWVKG-LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 381 TLQNISVIE 389
L+ + E
Sbjct: 305 MLEGDGLAE 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-82
Identities = 75/322 (23%), Positives = 127/322 (39%), Gaps = 42/322 (13%)
Query: 89 FTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG 148
++L + + + G FG V+K + + VAVK IQ
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIF---PIQD 59
Query: 149 LREWQAE--VKFLGKFSHPNLVKLIGYCWEDR----QFLLVYEYMQKGSLENHLFRKGSA 202
+ WQ E V L H N+++ IG L+ + +KGSL + L
Sbjct: 60 KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---- 115
Query: 203 EPLPWNTRLKIAIDAAKDLTFLHS--------SEKSVIYRDFKASNILLDGSYNAKLSDF 254
+ WN IA A+ L +LH + ++ +RD K+ N+LL + A ++DF
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHL-----YVKSDVYGFGVVLLEMLTGL 309
GLA ++ T +GT Y APE + +++ D+Y G+VL E+ +
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 310 RALDTNRPSGEHVLVDF--ARPSLTDKRRL--KKIMDPRLEEQYPIKGALLA-GQIIIKC 364
A D + PSL D + + K P L + + + + I +C
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
Query: 365 LEAEPKNRPSMEEVLETLQNIS 386
+ + + R S V E + +
Sbjct: 296 WDHDAEARLSAGCVGERITQMQ 317
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 1e-65
Identities = 64/340 (18%), Positives = 120/340 (35%), Gaps = 53/340 (15%)
Query: 89 FTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG 148
+ N + ++G G +G V+KG +D + VAVK S
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVF---SFAN 48
Query: 149 LREWQAEVK--FLGKFSHPNLVKLIGYCWED-----RQFLLVYEYMQKGSLENHLFRKGS 201
+ + E + H N+ + I ++LLV EY GSL +L
Sbjct: 49 RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-- 106
Query: 202 AEPLPWNTRLKIAIDAAKDLTFLHS-------SEKSVIYRDFKASNILLDGSYNAKLSDF 254
W + ++A + L +LH+ + ++ +RD + N+L+ +SDF
Sbjct: 107 --TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164
Query: 255 GLAK------LGPIDGNSHVTTRIMGTYGYAAPEY-------VATGHLYVKSDVYGFGVV 301
GL+ L + +GT Y APE + D+Y G++
Sbjct: 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224
Query: 302 LLEMLTGLRALDTNRPSGEHVLVDFA----RPSLTDKRRL--KKIMDPRLEEQYPIKGAL 355
E+ L E+ + P+ D + L ++ P+ E +
Sbjct: 225 YWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLA 284
Query: 356 LA--GQIIIKCLEAEPKNRPSMEEVLETLQNISVIEIEPK 393
+ + I C + + + R + + E + + +I K
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 3e-65
Identities = 80/286 (27%), Positives = 125/286 (43%), Gaps = 39/286 (13%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQG--LREWQAEVKFLGKFS 163
+G G FG V + W G VAVK + E+ EV + +
Sbjct: 45 IGAGSFGTVHRAEWH------------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLR 92
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
HPN+V +G + +V EY+ +GSL L + G+ E L RL +A D AK + +
Sbjct: 93 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEY 283
LH+ +++R+ K+ N+L+D Y K+ DFGL++L + GT + APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPE- 209
Query: 284 VATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK--KI 340
V KSDVY FGV+L E+ T +P G +RL+ +
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATL------QQPWGNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386
++P++ II C EP RPS +++ L+ +
Sbjct: 264 LNPQVA------------AIIEGCWTNEPWKRPSFATIMDLLRPLI 297
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 8e-63
Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 56/299 (18%)
Query: 106 MLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKK-------SNPDSIQGLREWQAEVK 157
+G+GGFG V KG V VA+K + I+ +E+Q EV
Sbjct: 26 QIGKGGFGLVHKGRLVKD----------KSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
+ +HPN+VKL G +V E++ G L + L K P+ W+ +L++ +D
Sbjct: 76 IMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDI 131
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLD-----GSYNAKLSDFGLAKLGPIDGNSHVTTRI 272
A + ++ + +++RD ++ NI L AK++DFGL++ + H + +
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGL 186
Query: 273 MGTYGYAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPS----GEHVLVDF 326
+G + + APE + K+D Y F ++L +LTG D + +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 327 ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
RP++ + PRL +I C +PK RP +++ L +
Sbjct: 247 LRPTIPED------CPPRLRN------------VIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-62
Identities = 71/295 (24%), Positives = 126/295 (42%), Gaps = 48/295 (16%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LG+G FG+ K H+ G+ + +K+ + R + EVK + HPN
Sbjct: 18 LGKGCFGQAIKV--THR-------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
++K IG ++D++ + EY++ G+L + S PW+ R+ A D A + +LHS
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS 126
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL------------GPIDGNSHVTTRIMG 274
++I+RD + N L+ + N ++DFGLA+L + ++G
Sbjct: 127 --MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 275 TYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD---FARPS 330
+ APE + G Y K DV+ FG+VL E++ + A P ++ F
Sbjct: 185 NPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243
Query: 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
P I ++C + +P+ RPS ++ L+ +
Sbjct: 244 CPPN------CPPSF------------FPITVRCCDLDPEKRPSFVKLEHWLETL 280
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 7e-62
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 45/285 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+G G FG V K K VA+K+ +S + + E++ L + +HPN
Sbjct: 16 VGRGAFGVVCKAKWR-----------AKDVAIKQIESESE--RKAFIVELRQLSRVNHPN 62
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
+VKL G C LV EY + GSL N L + + ++ + +LHS
Sbjct: 63 IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 227 SE-KSVIYRDFKASNILLDGSYN-AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
+ K++I+RD K N+LL K+ DFG A T G+ + APE V
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPE-V 174
Query: 285 ATGHLY-VKSDVYGFGVVLLEMLTGL---RALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340
G Y K DV+ +G++L E++T + + + RP L
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN------ 228
Query: 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ +E ++ +C +P RPSMEE+++ + ++
Sbjct: 229 LPKPIES------------LMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-61
Identities = 60/293 (20%), Positives = 113/293 (38%), Gaps = 50/293 (17%)
Query: 105 TMLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQG--LREWQAEVKFLGK 161
T L E G ++KG W G + VK R++ E L
Sbjct: 16 TKLNENHSGELWKGRWQ------------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRI 63
Query: 162 FSHPNLVKLIGYCWE--DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
FSHPN++ ++G C L+ +M GSL N L +G+ + + +K A+D A+
Sbjct: 64 FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMAR 122
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA 279
+ FLH+ E + + ++++D A++S + S + M +
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWV 175
Query: 280 APEYVATGHLYV----KSDVYGFGVVLLEMLTGLRALDTNRPS--GEHVLVDFARPSLTD 333
APE +D++ F V+L E++T G V ++ RP++
Sbjct: 176 APE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234
Query: 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386
+ P + +++ C+ +P RP + ++ L+ +
Sbjct: 235 G------ISPHVS------------KLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 7e-58
Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 54/296 (18%)
Query: 106 MLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQ----GLREWQAEVKFLG 160
++G GGFG+V++ W+ G VAVK + D + + + E K
Sbjct: 14 IIGIGGFGKVYRAFWI------------GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
HPN++ L G C ++ LV E+ + G L L K +P + + A+ A+
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARG 117
Query: 221 LTFLHSS-EKSVIYRDFKASNILLDGSY--------NAKLSDFGLAKLGPIDGNSHVTTR 271
+ +LH +I+RD K+SNIL+ K++DFGLA+ + +
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSA 174
Query: 272 IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331
G Y + APE + SDV+ +GV+L E+LTG P + A
Sbjct: 175 A-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG------EVPFRGIDGLAVAYGVA 227
Query: 332 TDKRRLK--KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+K L +++ C +P +RPS +L+ L I
Sbjct: 228 MNKLALPIPSTCPEPFA------------KLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-56
Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 42/289 (14%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQG--LREWQAEVKFLGKFS 163
+G G FG V+KG W VAVK N + L+ ++ EV L K
Sbjct: 32 IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
H N++ +GY Q +V ++ + SL +HL + + IA A+ + +
Sbjct: 79 HVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDY 135
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPE- 282
LH+ KS+I+RD K++NI L K+ DFGLA SH ++ G+ + APE
Sbjct: 136 LHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 283 --YVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSG---EHVLVDFARPSLTDKRRL 337
+ +SDVY FG+VL E++TG E V P L+ R
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR-- 251
Query: 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386
R++ ++ +CL+ + RPS +L ++ ++
Sbjct: 252 -SNCPKRMKR------------LMAECLKKKRDERPSFPRILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 6e-55
Identities = 54/296 (18%), Positives = 114/296 (38%), Gaps = 51/296 (17%)
Query: 106 MLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQG--LREWQAEVKFLGKF 162
++G+G FG+V+ G W H VA++ + + L+ ++ EV +
Sbjct: 40 LIGKGRFGQVYHGRW--HGE-----------VAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
H N+V +G C ++ + +L + + L N +IA + K +
Sbjct: 87 RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMG 144
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM---GTYGYA 279
+LH+ K ++++D K+ N+ D + ++DFGL + + ++ G +
Sbjct: 145 YLHA--KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 280 APEYVATGHLYV---------KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF-ARP 329
APE + SDV+ G + E+ T + +P
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261
Query: 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+L+ M + + I++ C E + RP+ ++++ L+ +
Sbjct: 262 NLSQIG-----MGKEISD------------ILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-54
Identities = 71/309 (22%), Positives = 122/309 (39%), Gaps = 52/309 (16%)
Query: 106 MLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF--LGKF 162
+G+G +G V++G W G+ VAVK + + + W E +
Sbjct: 15 CVGKGRYGEVWRGSWQ------------GENVAVKIFSS---RDEKSWFRETELYNTVML 59
Query: 163 SHPNLVKLIGYCWEDR----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
H N++ I R Q L+ Y + GSL ++L L + L+I + A
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIA 115
Query: 219 KDLTFLHSSEKS------VIYRDFKASNILLDGSYNAKLSDFGLAKL---GPIDGNSHVT 269
L LH + +RD K+ NIL+ + ++D GLA + +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 270 TRIMGTYGYAAPE------YVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNR----PSG 319
R+ GT Y APE V Y + D++ FG+VL E+ + + P
Sbjct: 176 PRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 320 EHVLVDFARPSLTDKRRLKKIMD--PRLEEQYPIKGALLA-GQIIIKCLEAEPKNRPSME 376
+ V D PS D R++ + P + ++ L + +++ +C P R +
Sbjct: 235 DVVPND---PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291
Query: 377 EVLETLQNI 385
+ +TL I
Sbjct: 292 RIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-53
Identities = 71/308 (23%), Positives = 118/308 (38%), Gaps = 48/308 (15%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF--LGKFS 163
+G+G +G V+ G G+ VAVK W E +
Sbjct: 44 QIGKGRYGEVWMGKWR-----------GEKVAVKVFFT---TEEASWFRETEIYQTVLMR 89
Query: 164 HPNLVKLIGYCWEDR----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
H N++ I + Q L+ +Y + GSL ++L L + LK+A +
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVS 145
Query: 220 DLTFLHSSEK------SVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSH--VTTR 271
L LH+ ++ +RD K+ NIL+ + ++D GLA D N
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 272 IMGTYGYAAPE------YVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNR----PSGEH 321
+GT Y PE Y+ +D+Y FG++L E+ + P +
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 322 VLVDFARPSLTDKRRL--KKIMDPRLEEQYPIKGALLA-GQIIIKCLEAEPKNRPSMEEV 378
V D PS D R + K + P ++ L G+++ +C P +R + V
Sbjct: 266 VPSD---PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 379 LETLQNIS 386
+TL +S
Sbjct: 323 KKTLAKMS 330
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-51
Identities = 70/311 (22%), Positives = 121/311 (38%), Gaps = 54/311 (17%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAE--VKFLGKFS 163
+G+G FG V++G G+ VAVK + + R W E +
Sbjct: 49 SIGKGRFGEVWRGKWR-----------GEEVAVKIFSS---REERSWFREAEIYQTVMLR 94
Query: 164 HPNLVKLIGYCWEDR----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
H N++ I +D Q LV +Y + GSL ++L R + +K+A+ A
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTAS 150
Query: 220 DLTFLHSSEK------SVIYRDFKASNILLDGSYNAKLSDFGLAKL---GPIDGNSHVTT 270
L LH ++ +RD K+ NIL+ + ++D GLA +
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 271 RIMGTYGYAAPE----YVATGHL--YVKSDVYGFGVVLLEMLTGLRALDTNR----PSGE 320
R+ GT Y APE + H + ++D+Y G+V E+ + P +
Sbjct: 211 RV-GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 321 HVLVDFARPSLTDKRRLKKIMDPRLE-----EQYPIKGALLAGQIIIKCLEAEPKNRPSM 375
V D PS+ + R++ R + + +I+ +C A R +
Sbjct: 270 LVPSD---PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM--AKIMRECWYANGAARLTA 324
Query: 376 EEVLETLQNIS 386
+ +TL +S
Sbjct: 325 LRIKKTLSQLS 335
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-42
Identities = 74/294 (25%), Positives = 121/294 (41%), Gaps = 37/294 (12%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LG+G FG V P + G+ VAVKK + + LR+++ E++ L H N
Sbjct: 18 LGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 167 LVKLIGYCWEDRQ--FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
+VK G C+ + L+ EY+ GSL ++L + E + L+ K + +L
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR-----IMGTYGYA 279
+ K I+RD NIL++ K+ DFGL K+ P D I
Sbjct: 131 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY---- 184
Query: 280 APEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339
APE + V SDV+ FGVVL E+ T + + ++ + + + ++
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 340 IMD-PRLE-------EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ + RL E Y I+ +C RPS ++ + I
Sbjct: 245 LKNNGRLPRPDGCPDEIY---------MIMTECWNNNVNQRPSFRDLALRVDQI 289
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-42
Identities = 73/296 (24%), Positives = 121/296 (40%), Gaps = 41/296 (13%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LG+G FG V P + G+ VAVKK + + LR+++ E++ L H N
Sbjct: 49 LGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 167 LVKLIGYCWEDRQ--FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
+VK G C+ + L+ EY+ GSL ++L + E + L+ K + +L
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT-------RIMGTYG 277
+ K I+RD NIL++ K+ DFGL K+ P D +
Sbjct: 162 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY---- 215
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337
APE + V SDV+ FGVVL E+ T + + ++ + + + +
Sbjct: 216 --APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273
Query: 338 KKIMD-PRLE-------EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ + + RL E Y I+ +C RPS ++ + I
Sbjct: 274 ELLKNNGRLPRPDGCPDEIY---------MIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 9e-42
Identities = 73/294 (24%), Positives = 121/294 (41%), Gaps = 58/294 (19%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSH 164
+G G FG VF G T VAVK ++ E + L ++SH
Sbjct: 122 IGRGNFGEVFSGRLRADNT----------LVAVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
PN+V+LIG C + + +V E +Q G L +G L T L++ DAA + +L
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYL 229
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY--AAPE 282
S K I+RD A N L+ K+SDFG+++ + + + APE
Sbjct: 230 ES--KCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTAPE 285
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR---PSLTDKRRLKK 339
+ G +SDV+ FG++L E + P+L++++ +
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFS------------------LGASPYPNLSNQQTREF 327
Query: 340 IMD------PRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ P L + + +++ +C EP RPS + + LQ+I
Sbjct: 328 VEKGGRLPCPELCPDAVF---------RLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-40
Identities = 66/309 (21%), Positives = 121/309 (39%), Gaps = 49/309 (15%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG+G F ++FKG + + V +K + + + K SH
Sbjct: 16 LGQGTFTKIFKGVR---REVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
+LV G C + +LV E+++ GSL+ +L K + + +L++A A + FL
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFL- 129
Query: 226 SSEKSVIYRDFKASNILLDGSYN--------AKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
E ++I+ + A NILL + KLSD G++ + + RI
Sbjct: 130 -EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQERIPWV-- 184
Query: 278 YAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRP----SGEHVLVDFARPSLT 332
PE + + +D + FG L E+ +G +P + L
Sbjct: 185 --PPECIENPKNLNLATDKWSFGTTLWEICSGGD-----KPLSALDSQRKLQ-----FYE 232
Query: 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVIEIEP 392
D+ +L P+ E +I C++ EP +RPS ++ L ++ ++ P
Sbjct: 233 DRHQLPA---PKAAELA---------NLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280
Query: 393 KKKAKARGN 401
+ +
Sbjct: 281 RGSHHHHHH 289
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-40
Identities = 78/302 (25%), Positives = 122/302 (40%), Gaps = 61/302 (20%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF 158
+F+ ++G GGFG+VFK H+ GK +K+ ++ + RE VK
Sbjct: 11 MDFKEIELIGSGGFGQVFK--AKHRID-------GKTYVIKRVKYNNEKAERE----VKA 57
Query: 159 LGKFSHPNLVKLIGYCWEDRQFL-----------------LVYEYMQKGSLENHLFRKGS 201
L K H N+V G CW+ + + E+ KG+LE + K
Sbjct: 58 LAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRR 115
Query: 202 AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP 261
E L L++ K + ++HS K +I RD K SNI L + K+ DFGL
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVT--- 170
Query: 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGE 320
N TR GT Y +PE + Y + D+Y G++L E+L
Sbjct: 171 SLKNDGKRTRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCDTA-------- 221
Query: 321 HVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
F + D + + + K ++ K L +P++RP+ E+L
Sbjct: 222 -----FETSKF-----FTDLRDGIISDIFDKK----EKTLLQKLLSKKPEDRPNTSEILR 267
Query: 381 TL 382
TL
Sbjct: 268 TL 269
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 76/307 (24%), Positives = 141/307 (45%), Gaps = 53/307 (17%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG G +G V++G W + VAVK D+++ + E+ E + + HP
Sbjct: 228 LGGGQYGEVYEGVWKKYSL----------TVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 276
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
NLV+L+G C + F ++ E+M G+L ++L R+ + + + L +A + + +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL- 334
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG-TYGYAAPEYV 284
+K+ I+R+ A N L+ ++ K++DFGL++L + G+++ + APE +
Sbjct: 335 -EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESL 391
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD-- 342
A +KSDV+ FGV+L E+ T P P + + + +
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGM-----SPY----------PGIDLSQVYELLEKDY 436
Query: 343 ----PRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI---SVIEIEPK 393
P E+ Y +++ C + P +RPS E+ + + + S I E +
Sbjct: 437 RMERPEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 487
Query: 394 KKAKARG 400
K+ RG
Sbjct: 488 KELGKRG 494
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 79/297 (26%), Positives = 129/297 (43%), Gaps = 43/297 (14%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHP 165
LGEG FG+V P G+ VAVK P+S + + + E++ L H
Sbjct: 29 LGEGHFGKVELC-----RYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 166 NLVKLIGYCWED--RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
N+VK G C ED L+ E++ GSL+ +L + + +LK A+ K + +
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDY 141
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT-------RIMGTY 276
L S + ++RD A N+L++ + K+ DFGL K D +
Sbjct: 142 LGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY--- 196
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336
APE + Y+ SDV+ FGV L E+LT D++ + ++ +T R
Sbjct: 197 ---APECLMQSKFYIASDVWSFGVTLHELLT-YCDSDSSPMALFLKMIGPTHGQMTVTRL 252
Query: 337 LKKIMD-PRLE-------EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ + + RL E Y Q++ KC E +P NR S + ++E + +
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVY---------QLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-39
Identities = 83/297 (27%), Positives = 122/297 (41%), Gaps = 45/297 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHP 165
LGEG FG+V PT G G+ VAVK D Q W+ E+ L H
Sbjct: 39 LGEGHFGKVSLY-----CYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 166 NLVKLIGYCWEDRQ--FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
+++K G C + LV EY+ GSL ++L + S + L A + + +
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHS---IGLAQLLLFAQQICEGMAY 149
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT-------RIMGTY 276
LH+ + I+RD A N+LLD K+ DFGLAK P +
Sbjct: 150 LHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY--- 204
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336
APE + Y SDV+ FGV L E+LT + P+ L+ A+ +T R
Sbjct: 205 ---APECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRL 260
Query: 337 LKKIMD-PRLE-------EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ + RL E Y ++ C E E RP+ E ++ L+ +
Sbjct: 261 TELLERGERLPRPDKCPAEVY---------HLMKNCWETEASFRPTFENLIPILKTV 308
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-39
Identities = 75/295 (25%), Positives = 125/295 (42%), Gaps = 40/295 (13%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LG+G FG V P G VAVK+ R++Q E++ L
Sbjct: 31 LGKGNFGSVELC-----RYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85
Query: 167 LVKLIGYCWEDRQ--FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
+VK G + + LV EY+ G L + L ++ A L + L + K + +L
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRAR-LDASRLLLYSSQICKGMEYL 143
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR-----IMGTYGYA 279
S + ++RD A NIL++ + K++DFGLAKL P+D + +V I
Sbjct: 144 GS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY---- 197
Query: 280 APEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338
APE ++ +SDV+ FGVVL E+ T ++ + + ++ R R L+
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC--SPSAEFLRMMGCERDVPALSRLLE 255
Query: 339 KIMD-PRLE-------EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ + RL E + +++ C P++RPS + L +
Sbjct: 256 LLEEGQRLPAPPACPAEVH---------ELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 66/312 (21%), Positives = 113/312 (36%), Gaps = 47/312 (15%)
Query: 92 QDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE 151
+ K++ LGEGGF V V+ G A+K+ Q E
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDL--VEGLH-------DGHFYALKRILCHEQQDREE 72
Query: 152 WQAEVKFLGKFSHPNLVKLIGYCWEDR----QFLLVYEYMQKGSLENHL-FRKGSAEPLP 206
Q E F+HPN+++L+ YC +R + L+ + ++G+L N + K L
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132
Query: 207 WNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNS 266
+ L + + + L +H+ K +RD K +NILL L D G I
Sbjct: 133 EDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 267 HVTTRIM-------GTYGYAAPE------YVATGHLYVKSDVYGFGVVLLEMLTGLRALD 313
+ T Y APE + ++DV+ G VL M+ G D
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYD 247
Query: 314 TNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP 373
G+ V ++ + ++ Q++ + +P RP
Sbjct: 248 MVFQKGDSV-----------ALAVQNQLSIPQSPRHSSA----LWQLLNSMMTVDPHQRP 292
Query: 374 SMEEVLETLQNI 385
+ +L L+ +
Sbjct: 293 HIPLLLSQLEAL 304
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-38
Identities = 80/309 (25%), Positives = 140/309 (45%), Gaps = 57/309 (18%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG G +G V++G W + VAVK D+++ + E+ E + + HP
Sbjct: 21 LGGGQYGEVYEGVWKKYSL----------TVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 69
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
NLV+L+G C + F ++ E+M G+L ++L R+ + + + L +A + + +L
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL- 127
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG-NSHVTTRI----MGTYGYAA 280
+K+ I+RD A N L+ ++ K++DFGL++L D +H + A
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------A 180
Query: 281 PEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP----SGEHVLVDFARPSLTDKRR 336
PE +A +KSDV+ FGV+L E+ T P V L R
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGM-----SPYPGIDLSQVY-----ELLEKDYR 230
Query: 337 LKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI---SVIEIE 391
+++ P E+ Y +++ C + P +RPS E+ + + + S I E
Sbjct: 231 MER---PEGCPEKVY---------ELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 278
Query: 392 PKKKAKARG 400
+K+ RG
Sbjct: 279 VEKELGKRG 287
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-38
Identities = 69/307 (22%), Positives = 113/307 (36%), Gaps = 57/307 (18%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSN-PDSIQGLREWQAEVK 157
+F P LG GGFG VF+ +K A+K+ P+ + EVK
Sbjct: 5 TDFEPIQCLGRGGFGVVFE--AKNKVD-------DCNYAIKRIRLPNRELAREKVMREVK 55
Query: 158 FLGKFSHPNLVKLIGYCWED----------RQFLLVY---EYMQKGSLENHLFRKGSAEP 204
L K HP +V+ W + + +Y + +K +L++ + + + E
Sbjct: 56 ALAKLEHPGIVRYFN-AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE 114
Query: 205 LPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL----- 259
+ L I + A+ + FLHS K +++RD K SNI K+ DFGL
Sbjct: 115 RERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 260 -----GPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALD 313
T +GT Y +PE G+ Y K D++ G++L E+L
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLYPFST-- 229
Query: 314 TNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP 373
E V L + + + + K ++ L P RP
Sbjct: 230 ----QMERVRT------------LTDVRNLKFPPLFTQKYPCEY-VMVQDMLSPSPMERP 272
Query: 374 SMEEVLE 380
++E
Sbjct: 273 EAINIIE 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 66/312 (21%), Positives = 118/312 (37%), Gaps = 62/312 (19%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVK 157
+F +LG+G FG+V K + + A+KK + L +EV
Sbjct: 5 ASDFEEIAVLGQGAFGQVVK--ARNALD-------SRYYAIKKIRHTEEK-LSTILSEVM 54
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFL--------------LVYEYMQKGSLENHLFRKGSAE 203
L +H +V+ W +R+ + EY + G+L + + +
Sbjct: 55 LLASLNHQYVVRYYA-AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL-- 111
Query: 204 PLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL---- 259
+ ++ + L+++HS + +I+RD K NI +D S N K+ DFGLAK
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 260 ---------GPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGL 309
+ ++T+ I GT Y A E + Y K D+Y G++ EM+
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF 228
Query: 310 RALDTNRPSGEHVLVDFARPSLTDK-RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAE 368
R ++ K R + P ++ + +II ++ +
Sbjct: 229 ST-------------GMERVNILKKLRSVSIEFPPDFDDNKM----KVEKKIIRLLIDHD 271
Query: 369 PKNRPSMEEVLE 380
P RP +L
Sbjct: 272 PNKRPGARTLLN 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 70/291 (24%), Positives = 111/291 (38%), Gaps = 47/291 (16%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK-----KSNPDSIQGLREWQAE 155
+ D +G G F V+KG +D +T VA K Q +E E
Sbjct: 28 LKFDIEIGRGSFKTVYKG-LDTET--------TVEVAWCELQDRKLTKSERQRFKE---E 75
Query: 156 VKFLGKFSHPNLVKLIGYCWED-----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTR 210
+ L HPN+V+ WE + +LV E M G+L+ +L R +
Sbjct: 76 AEMLKGLQHPNIVRFYD-SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVL 131
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY-NAKLSDFGLAKLGPIDGNSHVT 269
K L FLH+ +I+RD K NI + G + K+ D GLA L +
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFA 187
Query: 270 TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329
++GT + APE + DVY FG+ +LEM T E+ +
Sbjct: 188 KAVIGTPEFMAPEMYEEKYDE-SVDVYAFGMCMLEMAT-----------SEYPYSECQNA 235
Query: 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ +R + ++ +II C+ R S++++L
Sbjct: 236 AQIYRRVTSGVKPASFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 70/286 (24%), Positives = 105/286 (36%), Gaps = 42/286 (14%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEV 156
++F+ + LG G +G VFK V K G+ AVK+S + AEV
Sbjct: 57 QSFQRLSRLGHGSYGEVFK--VRSKE-------DGRLYAVKRSMSPFRGPKDRARKLAEV 107
Query: 157 KFLGK-FSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA 214
K HP V+L WE+ L L E SL+ H G LP
Sbjct: 108 GSHEKVGQHPCCVRLEQ-AWEEGGILYLQTELCG-PSLQQHCEAWG--ASLPEAQVWGYL 163
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
D L LHS + +++ D K +NI L KL DFGL + + G
Sbjct: 164 RDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-G 218
Query: 275 TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334
Y APE + + +DV+ G+ +LE+ + G L
Sbjct: 219 DPRYMAPELLQGSYGT-AADVFSLGLTILEVACNMELPHGG--EGWQQLR---------- 265
Query: 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ + P + +++ LE +PK R + E +L
Sbjct: 266 ---QGYLPPEFTAGLSSE----LRSVLVMMLEPDPKLRATAEALLA 304
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-37
Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 53/300 (17%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK-----KSNPDSIQGLREWQ 153
+ + +G GG +VF+ V ++ + A+K +++ ++ R
Sbjct: 28 RIYSILKQIGSGGSSKVFQ--VLNEK--------KQIYAIKYVNLEEADNQTLDSYRN-- 75
Query: 154 AEVKFLGKFSHPNL--VKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRL 211
E+ +L K + ++L Y D+ +V E L + L +K S + R
Sbjct: 76 -EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS---IDPWERK 130
Query: 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
+ + + +H +++ D K +N L+ KL DFG+A D S V
Sbjct: 131 SYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS 187
Query: 272 IMGTYGYAAPE---------YVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGE 320
+GT Y PE + KSDV+ G +L M G + +
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG-------KTPFQ 240
Query: 321 HVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
++ + +L I+DP E ++P ++ CL+ +PK R S+ E+L
Sbjct: 241 QIINQIS--------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 68/357 (19%), Positives = 130/357 (36%), Gaps = 59/357 (16%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK-----KSNPDSIQGLREWQAEVKFLG 160
+G GG +VF+ ++ + A+K +++ ++ R E+ +L
Sbjct: 16 QIGSGGSSKVFQVL--NEK--------KQIYAIKYVNLEEADNQTLDSYRN---EIAYLN 62
Query: 161 KFSHPNL--VKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
K + ++L Y D+ +V E L + L +K S + R +
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS---IDPWERKSYWKNML 118
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY 278
+ + +H + +++ D K +N L+ KL DFG+A D S V +GT Y
Sbjct: 119 EAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175
Query: 279 AAPEYVATGHLYV------------KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF 326
PE KSDV+ G +L M G + + ++
Sbjct: 176 MPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG-------KTPFQQIINQI 227
Query: 327 ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE----TL 382
+ +L I+DP E ++P ++ CL+ +PK R S+ E+L +
Sbjct: 228 S--------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279
Query: 383 QNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRSQSPLHSKHGDHNNGTRARRY 439
Q V ++ + + N H G+ +N + ++ +
Sbjct: 280 QTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTF 336
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 62/292 (21%), Positives = 113/292 (38%), Gaps = 51/292 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFSHP 165
LG G FG V+KG P V VA+K+ + +E E + +P
Sbjct: 23 LGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
++ +L+G C L+ + M G L +++ + + + L + AK + +L
Sbjct: 78 HVCRLLGICLTS-TVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL- 133
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG------TYGYA 279
++ +++RD A N+L+ + K++DFGLAKL + G
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVPIKWM---- 186
Query: 280 APEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SGEHVLVDFARPSLTDK 334
A E + +SDV+ +GV + E++T G ++P + L
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFG------SKPYDGIPASEISS-----ILEKG 235
Query: 335 RRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
RL + + Y I+ KC + +RP E++ +
Sbjct: 236 ERLPQPPICT--IDVY---------MIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 71/283 (25%), Positives = 122/283 (43%), Gaps = 40/283 (14%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG+G FG V+ G W VA+K P ++ + E + + K H
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-----------VAIKTLKPGTMS-PEAFLQEAQVMKKLRHE 239
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
LV+L E+ +V EYM KGSL + L + + + L + +A A + ++
Sbjct: 240 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYV- 296
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG-TYGYAAPEYV 284
+ ++RD +A+NIL+ + K++DFGLA+L I+ N + + + APE
Sbjct: 297 -ERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 353
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344
G +KSDV+ FG++L E+ T R + E + R+ P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMPC---PP 404
Query: 345 L--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
E + ++ +C EP+ RP+ E + L++
Sbjct: 405 ECPESLH---------DLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 72/295 (24%), Positives = 121/295 (41%), Gaps = 68/295 (23%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
+G+G FG V G + +K VAVK D+ + + AE + + H
Sbjct: 201 IGKGEFGDVMLGDYRGNK------------VAVKCIKNDATA--QAFLAEASVMTQLRHS 246
Query: 166 NLVKLIGYCWEDR-QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
NLV+L+G E++ +V EYM KGSL ++L R L + LK ++D + + +L
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT---YGYAAP 281
+ ++RD A N+L+ AK+SDFGL K ++ + AP
Sbjct: 306 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAP 355
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR---PSLTDKRRLK 338
E + KSDV+ FG++L E+ + F R P + K +
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYS------------------FGRVPYPRIPLKDVVP 397
Query: 339 KIMD------PRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
++ P Y ++ C + RP+ ++ E L++I
Sbjct: 398 RVEKGYKMDAPDGCPPAVY---------DVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 64/336 (19%), Positives = 125/336 (37%), Gaps = 47/336 (13%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEV 156
+ + +GEG FG+ V G+ +K+ N + + E + EV
Sbjct: 24 EKYVRLQKIGEGSFGKAIL--VKSTED-------GRQYVIKEINISRMSSKEREESRREV 74
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAID 216
L HPN+V+ E+ +V +Y + G L + + L +
Sbjct: 75 AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQ 133
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
L +H + +++RD K+ NI L +L DFG+A++ ++ + +GT
Sbjct: 134 ICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTP 189
Query: 277 GYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
Y +PE + Y KSD++ G VL E+ T A + +L
Sbjct: 190 YYLSPE-ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-----------KNL---- 233
Query: 336 RLKKIMD---PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE------TLQNIS 386
+ KI+ P + Y ++ + + P++RPS+ +LE ++
Sbjct: 234 -VLKIISGSFPPVSLHYSYD----LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFL 288
Query: 387 VIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRSQSP 422
++ ++ + + + + S S
Sbjct: 289 SPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISV 324
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 75/297 (25%), Positives = 120/297 (40%), Gaps = 56/297 (18%)
Query: 104 DTMLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVKFLG 160
D LG G FG V KG + K + VAVK K+ + E AE +
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKT--------VAVKILKNEANDPALKDELLAEANVMQ 73
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
+ +P +V++IG C E ++LV E + G L +L ++ + +++ +
Sbjct: 74 QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQN--RHVKDKNIIELVHQVSMG 129
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG------ 274
+ +L E + ++RD A N+LL + AK+SDFGL+K D ++ + G
Sbjct: 130 MKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKW 186
Query: 275 TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SGEHVLVDFARP 329
APE + KSDV+ FGV++ E + G +P G V
Sbjct: 187 Y----APECINYYKFSSKSDVWSFGVLMWEAFSYGQ------KPYRGMKGSEVT-----A 231
Query: 330 SLTDKRRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
L R+ P E Y ++ C + +NRP V L+N
Sbjct: 232 MLEKGERMGCPAGCP--REMY---------DLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 67/290 (23%), Positives = 119/290 (41%), Gaps = 46/290 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-EWQAEVKFLGKFSHP 165
+G G G V G + V A+K + R ++ +E +G+F HP
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPV------AIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
N+++L G R ++V EYM+ GSL+ L + + + + +L
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL- 167
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT---YGYAAPE 282
S+ ++RD A N+L+D + K+SDFGL+++ ++ + G + APE
Sbjct: 168 -SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SGEHVLVDFARPSLTDKRRL 337
+A SDV+ FGVV+ E+L G RP + V+ S+ + RL
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYG------ERPYWNMTNRDVIS-----SVEEGYRL 273
Query: 338 KKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
P + Q+++ C + RP +++ L +
Sbjct: 274 PA---PMGCPHALH---------QLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 61/293 (20%), Positives = 113/293 (38%), Gaps = 53/293 (18%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK-----KSNPDSIQGLREWQAEVKFLG 160
+G GG +VF+ ++ + A+K +++ ++ R E+ +L
Sbjct: 63 QIGSGGSSKVFQVL--NEK--------KQIYAIKYVNLEEADNQTLDSYRN---EIAYLN 109
Query: 161 KFSHPNL--VKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
K + ++L Y D+ +V E L + L +K S + R +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS---IDPWERKSYWKNML 165
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY 278
+ + +H + +++ D K +N L+ KL DFG+A D S V +G Y
Sbjct: 166 EAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222
Query: 279 AAPE---------YVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327
PE + KSDV+ G +L M G + + ++ +
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG-------KTPFQQIINQIS 275
Query: 328 RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+L I+DP E ++P ++ CL+ +PK R S+ E+L
Sbjct: 276 --------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 64/314 (20%), Positives = 110/314 (35%), Gaps = 42/314 (13%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVK 157
+ +LG+G VF+G HK G A+K N S + E +
Sbjct: 9 HLWLLSDILGQGATANVFRGR--HKKT-------GDLFAIKVFNNISFLRPVDVQMREFE 59
Query: 158 FLGKFSHPNLVKLIGYCWED---RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA 214
L K +H N+VKL E+ R +L+ E+ GSL L +A LP + L +
Sbjct: 60 VLKKLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILL----DGSYNAKLSDFGLAKLGPIDGNSHVTT 270
D + L +++R+ K NI+ DG KL+DFG A+ ++ + +
Sbjct: 119 RDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVS 174
Query: 271 RIMGTYGYAAPEYVATGHLYV--------KSDVYGFGVVLLEMLTG------LRALDTNR 316
GT Y P+ L D++ GV TG N+
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 317 PSGEHVLV-----DFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKN 371
++ + + + D + +L ++ LEA+ +
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
Query: 372 RPSMEEVLETLQNI 385
++ +I
Sbjct: 294 CWGFDQFFAETSDI 307
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 73/297 (24%), Positives = 127/297 (42%), Gaps = 72/297 (24%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
+G+G FG V G + +K VAVK D+ + + AE + + H
Sbjct: 29 IGKGEFGDVMLGDYRGNK------------VAVKCIKNDATA--QAFLAEASVMTQLRHS 74
Query: 166 NLVKLIGYCWEDR-QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
NLV+L+G E++ +V EYM KGSL ++L R L + LK ++D + + +L
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG-NSHVTTRI----MGTYGYA 279
+ ++RD A N+L+ AK+SDFGL K + ++ T ++
Sbjct: 134 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT------ 181
Query: 280 APEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR---PSLTDKRR 336
APE + KSDV+ FG++L E+ + F R P + K
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYS------------------FGRVPYPRIPLKDV 223
Query: 337 LKKIMDP-RLE-------EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ ++ +++ Y +++ C + RPS ++ E L++I
Sbjct: 224 VPRVEKGYKMDAPDGCPPAVY---------EVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 71/283 (25%), Positives = 122/283 (43%), Gaps = 40/283 (14%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG+G FG V+ G W VA+K P ++ + E + + K H
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-----------VAIKTLKPGTMS-PEAFLQEAQVMKKLRHE 322
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
LV+L E+ +V EYM KGSL + L + + + L + +A A + ++
Sbjct: 323 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYV- 379
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG-TYGYAAPEYV 284
+ ++RD +A+NIL+ + K++DFGLA+L I+ N + + + APE
Sbjct: 380 -ERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 436
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344
G +KSDV+ FG++L E+ T R + E + R+ P
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMPC---PP 487
Query: 345 L--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
E + ++ +C EP+ RP+ E + L++
Sbjct: 488 ECPESLH---------DLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 68/319 (21%), Positives = 113/319 (35%), Gaps = 52/319 (16%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVK 157
+ +LG+G VF+G HK G A+K N S + E +
Sbjct: 9 HLWLLSDILGQGATANVFRGR--HKKT-------GDLFAIKVFNNISFLRPVDVQMREFE 59
Query: 158 FLGKFSHPNLVKLIGYCWED---RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA 214
L K +H N+VKL E+ R +L+ E+ GSL L +A LP + L +
Sbjct: 60 VLKKLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILL----DGSYNAKLSDFGLAKLGPIDGNSHVTT 270
D + L +++R+ K NI+ DG KL+DFG A+ ++ + +
Sbjct: 119 RDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVS 174
Query: 271 RIMGTYGYAAPEYVATGHLYV--------KSDVYGFGVVLLEMLTG-------------- 308
GT Y P+ L D++ GV TG
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 309 --LRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLE 366
+ + T +PSG V + + D + +L ++ LE
Sbjct: 234 EVMYKIITGKPSGAISGV-----QKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE 288
Query: 367 AEPKNRPSMEEVLETLQNI 385
A+ + ++ +I
Sbjct: 289 ADQEKCWGFDQFFAETSDI 307
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 73/309 (23%), Positives = 128/309 (41%), Gaps = 69/309 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LGEG FG+VF + + K+ VAVK ++ +++Q E + L H +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKM----LVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHL-------------FRKGSAEPLPWNTRLKI 213
+VK G C + ++V+EYM+ G L L + + L + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM 273
A A + +L + + ++RD N L+ + K+ DFG+++ D S R+
Sbjct: 139 ASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 192
Query: 274 G--------TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-------GLRALDTNRPS 318
G PE + +SDV+ FGV+L E+ T L S
Sbjct: 193 GHTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL--------S 240
Query: 319 GEHVLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSME 376
V+ +T R L++ PR+ +E Y +++ C + EP+ R +++
Sbjct: 241 NTEVIE-----CITQGRVLER---PRVCPKEVY---------DVMLGCWQREPQQRLNIK 283
Query: 377 EVLETLQNI 385
E+ + L +
Sbjct: 284 EIYKILHAL 292
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-35
Identities = 78/289 (26%), Positives = 125/289 (43%), Gaps = 52/289 (17%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
+G G FG V G W++ VA+K ++ ++ E + + K SHP
Sbjct: 16 IGSGQFGLVHLGYWLNKDK-----------VAIKTIREGAMS-EEDFIEEAEVMMKLSHP 63
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
LV+L G C E LV E+M+ G L ++L + T L + +D + + +L
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL- 120
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT---YGYAAPE 282
E VI+RD A N L+ + K+SDFG+ + + + + T GT +A+PE
Sbjct: 121 -EEACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPE 175
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP----SGEHVLVDFARPSLTDKRRLK 338
+ KSDV+ FGV++ E+ + + P S V+ ++ RL
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGK-----IPYENRSNSEVV-----EDISTGFRLY 225
Query: 339 KIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
K PRL Y QI+ C P++RP+ +L L I
Sbjct: 226 K---PRLASTHVY---------QIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-35
Identities = 76/294 (25%), Positives = 131/294 (44%), Gaps = 62/294 (21%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG G FG V+ G + H VAVK S+ + AE + + H
Sbjct: 21 LGAGQFGEVWMGYYNGHTK-----------VAVKSLKQGSMS-PDAFLAEANLMKQLQHQ 68
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
LV+L ++ ++ EYM+ GSL + L + S L N L +A A+ + F+
Sbjct: 69 RLVRLYAVVTQEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI- 125
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGN---SHVTTRIMGTYGYAAPE 282
E++ I+RD +A+NIL+ + + K++DFGLA+L I+ N + + + APE
Sbjct: 126 -EERNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFP--IKWTAPE 180
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR---PSLTDKRRLKK 339
+ G +KSDV+ FG++L E++T R P +T+ ++
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT------------------HGRIPYPGMTNPEVIQN 222
Query: 340 IMD------PRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ P EE Y Q++ C + P++RP+ + + L++
Sbjct: 223 LERGYRMVRPDNCPEELY---------QLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-35
Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 52/289 (17%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG G FG V G W VA+K S+ E+ E K + SH
Sbjct: 32 LGTGQFGVVKYGKWRGQYD-----------VAIKMIKEGSMS-EDEFIEEAKVMMNLSHE 79
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
LV+L G C + R ++ EYM G L N+L + L++ D + + +L
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL- 136
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT---YGYAAPE 282
K ++RD A N L++ K+SDFGL++ + + + T +G+ ++ PE
Sbjct: 137 -ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSPPE 191
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP----SGEHVLVDFARPSLTDKRRLK 338
+ KSD++ FGV++ E+ + + P + + RL
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETA-----EHIAQGLRLY 241
Query: 339 KIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ P L E+ Y I+ C + RP+ + +L + ++
Sbjct: 242 R---PHLASEKVY---------TIMYSCWHEKADERPTFKILLSNILDV 278
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-35
Identities = 75/289 (25%), Positives = 126/289 (43%), Gaps = 52/289 (17%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG G FG V G W VAVK S+ E+ E + + K SHP
Sbjct: 16 LGSGQFGVVKLGKWKGQYD-----------VAVKMIKEGSMS-EDEFFQEAQTMMKLSHP 63
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
LVK G C ++ +V EY+ G L N+L + + L + L++ D + + FL
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL- 120
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT---YGYAAPE 282
I+RD A N L+D K+SDFG+ + + + +V++ GT ++APE
Sbjct: 121 -ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSV--GTKFPVKWSAPE 175
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP----SGEHVLVDFARPSLTDKRRLK 338
KSDV+ FG+++ E+ + + P + V+ ++ RL
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGK-----MPYDLYTNSEVV-----LKVSQGHRLY 225
Query: 339 KIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ P L + Y QI+ C P+ RP+ +++L +++ +
Sbjct: 226 R---PHLASDTIY---------QIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-35
Identities = 76/306 (24%), Positives = 128/306 (41%), Gaps = 68/306 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVKFLGKFSH 164
LGEG FG V +G + G VAVK K + S + + E+ +E + FSH
Sbjct: 42 LGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 165 PNLVKLIGYCWEDR-----QFLLVYEYMQKGSLENHLFR---KGSAEPLPWNTRLKIAID 216
PN+++L+G C E + +++ +M+ G L +L + + +P T LK +D
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNS----HVTTRI 272
A + +L S ++ ++RD A N +L ++DFGL+K I ++
Sbjct: 156 IALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--IYSGDYYRQGRIAKM 211
Query: 273 ----MGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-------GLRALDTNRPSGEH 321
+ A E +A KSDV+ FGV + E+ T G+
Sbjct: 212 PVKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV--------QNHE 257
Query: 322 VLVDFARPSLTDKRRLKKIMDPR--LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
+ L RLK+ P L+E Y +I+ C +P +RP+ +
Sbjct: 258 MYD-----YLLHGHRLKQ---PEDCLDELY---------EIMYSCWRTDPLDRPTFSVLR 300
Query: 380 ETLQNI 385
L+ +
Sbjct: 301 LQLEKL 306
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-35
Identities = 80/303 (26%), Positives = 123/303 (40%), Gaps = 58/303 (19%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LGEG FG+VF + K+ VAVK S +++Q E + L H +
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKM----LVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHL------------FRKGSAEPLPWNTRLKIA 214
+V+ G C E R L+V+EYM+ G L L + PL L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
A + +L + ++RD N L+ K+ DFG+++ D S R +G
Sbjct: 165 SQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VG 217
Query: 275 TYG-----YAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SGEHVLV 324
+ PE + +SDV+ FGVVL E+ T G +P S +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------QPWYQLSNTEAI- 270
Query: 325 DFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
+T R L++ PR E Y I+ C + EP+ R S+++V L
Sbjct: 271 ----DCITQGRELER---PRACPPEVY---------AIMRGCWQREPQQRHSIKDVHARL 314
Query: 383 QNI 385
Q +
Sbjct: 315 QAL 317
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 71/289 (24%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-EWQAEVKFLGKFSHP 165
+G G FG V+KG L + VA+K + R ++ E +G+FSH
Sbjct: 52 IGAGEFGEVYKG-----MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
N+++L G + + +++ EYM+ G+L+ L + + + A + +L
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL- 163
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT---YGYAAPE 282
+ + ++RD A NIL++ + K+SDFGL+++ ++ + T G + APE
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPE 220
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SGEHVLVDFARPSLTDKRRL 337
++ SDV+ FG+V+ E++T G RP S V+ ++ D RL
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGE------RPYWELSNHEVM-----KAINDGFRL 269
Query: 338 KKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
MD P Y Q++++C + E RP +++ L +
Sbjct: 270 PTPMDCP--SAIY---------QLMMQCWQQERARRPKFADIVSILDKL 307
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 73/296 (24%), Positives = 123/296 (41%), Gaps = 54/296 (18%)
Query: 104 DTMLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-EWQAEVKFLGK 161
D LG G FG V +G + K VA+K + + E E + + +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQID--------VAIKVLKQGTEKADTEEMMREAQIMHQ 66
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDL 221
+P +V+LIG C + +LV E G L L G E +P + ++ + +
Sbjct: 67 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGM 123
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG------T 275
+L EK+ ++RD A N+LL + AK+SDFGL+K D +S+ T R G
Sbjct: 124 KYL--EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWY 180
Query: 276 YGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SGEHVLVDFARPS 330
APE + +SDV+ +GV + E L+ G +P G V+
Sbjct: 181 ----APECINFRKFSSRSDVWSYGVTMWEALSYG------QKPYKKMKGPEVMA-----F 225
Query: 331 LTDKRRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ +R++ + P E Y ++ C + ++RP V + ++
Sbjct: 226 IEQGKRMECPPECP--PELY---------ALMSDCWIYKWEDRPDFLTVEQRMRAC 270
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 74/294 (25%), Positives = 129/294 (43%), Gaps = 62/294 (21%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
LG G FG V+ + H VAVK P S+ + + AE + H
Sbjct: 196 LGAGQFGEVWMATYNKHTK-----------VAVKTMKPGSMS-VEAFLAEANVMKTLQHD 243
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
LVKL ++ ++ E+M KGSL + L + P + + A+ + F+
Sbjct: 244 KLVKLHAVVTKEP-IYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFI- 300
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT---YGYAAPE 282
+++ I+RD +A+NIL+ S K++DFGLA++ I+ N + T G + APE
Sbjct: 301 -EQRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGAKFPIKWTAPE 355
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR---PSLTDKRRLKK 339
+ G +KSDV+ FG++L+E++T + R P +++ ++
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVT------------------YGRIPYPGMSNPEVIRA 397
Query: 340 IMD------PRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ P EE Y I+++C + P+ RP+ E + L +
Sbjct: 398 LERGYRMPRPENCPEELY---------NIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 46/295 (15%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEV 156
+++ +G G +GR K + K+ GK + K+ + + + +EV
Sbjct: 6 EDYEVLYTIGTGSYGRCQK--IRRKSD-------GKILVWKELDYGSMTEAEKQMLVSEV 56
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQ---FLLVYEYMQKGSLENHL-FRKGSAEPLPWNTRLK 212
L + HPN+V+ DR +V EY + G L + + + L L+
Sbjct: 57 NLLRELKHPNIVRYYD-RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 213 IAIDAAKDLTFLHS---SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269
+ L H +V++RD K +N+ LDG N KL DFGLA++ ++ ++
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFA 173
Query: 270 TRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328
+GT Y +PE Y KSD++ G +L E+ +
Sbjct: 174 KTFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF------------- 219
Query: 329 PSLTDKRRLKKIMD---PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ K KI + R+ +Y + +II + L + +RPS+EE+LE
Sbjct: 220 ---SQKELAGKIREGKFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEILE 267
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 72/288 (25%), Positives = 131/288 (45%), Gaps = 42/288 (14%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-EWQAEVKFLGKFSHP 165
+G G FG V G + + V A+K + R ++ E +G+F HP
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISV------AIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
N+++L G + + ++V EYM+ GSL++ L RK A+ + + A + +L
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQ-FTVIQLVGMLRGIASGMKYL- 163
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT---YGYAAPE 282
S+ ++RD A NIL++ + K+SDFGL ++ ++ + G + +PE
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 283 YVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP----SGEHVLVDFARPSLTDKRRLK 338
+A SDV+ +G+VL E+++ RP S + V+ ++ + RL
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVI-----KAVDEGYRLP 270
Query: 339 KIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
MD P Y Q+++ C + + NRP E+++ L +
Sbjct: 271 PPMDCP--AALY---------QLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 79/338 (23%), Positives = 134/338 (39%), Gaps = 75/338 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVKFLGKFSH 164
LG+G FG V + + + + KV AVK K++ + + E+ E + +F H
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKV------AVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 165 PNLVKLIGYCWEDR------QFLLVYEYMQKGSLENHLFR---KGSAEPLPWNTRLKIAI 215
P++ KL+G R +++ +M+ G L L + LP T ++ +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNS----HVTTR 271
D A + +L S ++ I+RD A N +L ++DFGL++ I ++
Sbjct: 145 DIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--IYSGDYYRQGCASK 200
Query: 272 I----MGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-------GLRALDTNRPSGE 320
+ + A E +A V SDV+ FGV + E++T G+
Sbjct: 201 LPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI--------ENA 246
Query: 321 HVLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEV 378
+ L RLK+ P EE Y ++ +C A+PK RPS +
Sbjct: 247 EIY-----NYLIGGNRLKQ---PPECMEEVY---------DLMYQCWSADPKQRPSFTCL 289
Query: 379 LETLQNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHN 416
L+NI + Y N +R H H+
Sbjct: 290 RMELENI--LGHLSVLSTSQDPLYIN----IERAHHHH 321
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 78/299 (26%), Positives = 120/299 (40%), Gaps = 52/299 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHP 165
LG G FG V++G V P+ + VAVK S Q ++ E + KF+H
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPL----QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHL----FRKGSAEPLPWNTRLKIAIDAAKDL 221
N+V+ IG + ++ E M G L++ L R L L +A D A
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 222 TFLHSSEKSVIYRDFKASNILLDGS---YNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY 278
+L E I+RD A N LL AK+ DFG+A+ D R G
Sbjct: 154 QYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-KGGCAM 206
Query: 279 -----AAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SGEHVLVDFAR 328
PE G K+D + FGV+L E+ + G P S + VL
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQEVL----- 255
Query: 329 PSLTDKRRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386
+T R+ + P Y +I+ +C + +P++RP+ +LE ++ +
Sbjct: 256 EFVTSGGRMDPPKNCP--GPVY---------RIMTQCWQHQPEDRPNFAIILERIEYCT 303
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 77/316 (24%), Positives = 126/316 (39%), Gaps = 59/316 (18%)
Query: 93 DLRAATKNFRPD---------TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP 143
+L A ++ ++G G FG V+ G G AVK N
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNR 63
Query: 144 D-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE-DRQFLLVYEYMQKGSLENHLFRKGS 201
I + ++ E + FSHPN++ L+G C + L+V YM+ G L N + +
Sbjct: 64 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNE 121
Query: 202 AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP 261
+ + AK + +L + K ++RD A N +LD + K++DFGLA+
Sbjct: 122 THNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--- 176
Query: 262 IDGNSHVTTRIMGTYGYA------APEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDT 314
D + G A E + T KSDV+ FGV+L E++T G
Sbjct: 177 -DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA----- 230
Query: 315 NRP----SGEHVLVDFARPSLTDKRRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEP 369
P + + V L RRL + P + Y ++++KC +
Sbjct: 231 -PPYPDVNTFDITV-----YLLQGRRLLQPEYCP--DPLY---------EVMLKCWHPKA 273
Query: 370 KNRPSMEEVLETLQNI 385
+ RPS E++ + I
Sbjct: 274 EMRPSFSELVSRISAI 289
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 65/295 (22%), Positives = 115/295 (38%), Gaps = 33/295 (11%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK---SNPDSIQGLREWQAE 155
NFR + +G G F V++ G VA+KK + + + E
Sbjct: 32 ANFRIEKKIGRGQFSEVYR--AACLLD-------GVPVALKKVQIFDLMDAKARADCIKE 82
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-FRKGSAEPLPWNTRLKIA 214
+ L + +HPN++K ED + +V E G L + K +P T K
Sbjct: 83 IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF 142
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
+ L +HS + V++RD K +N+ + + KL D GL + + ++G
Sbjct: 143 VQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVG 198
Query: 275 TYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333
T Y +PE + Y KSD++ G +L EM ++ + SL
Sbjct: 199 TPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------LYSLCK 248
Query: 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388
K + P + Y + Q++ C+ +P+ RP + V + + +
Sbjct: 249 K-IEQCDYPPLPSDHYSEELR----QLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 69/301 (22%), Positives = 125/301 (41%), Gaps = 58/301 (19%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHP 165
LG+G FG V++G + VA+K N S++ E+ E + +F+
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPET----RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-------FRKGSAEPLPWNTRLKIAIDAA 218
++V+L+G + + L++ E M +G L+++L P + +++A + A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY 278
+ +L + ++RD A N ++ + K+ DFG+ + D R G G
Sbjct: 149 DGMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-KGGKGL 201
Query: 279 -----AAPEYVATGHLYVKSDVYGFGVVLLEMLT-------GLRALDTNRPSGEHVLVDF 326
+PE + G SDV+ FGVVL E+ T GL S E VL
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------SNEQVLR-- 251
Query: 327 ARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384
+ + L K P + + +++ C + PK RPS E++ +++
Sbjct: 252 ---FVMEGGLLDK---PDNCPDMLF---------ELMRMCWQYNPKMRPSFLEIISSIKE 296
Query: 385 I 385
Sbjct: 297 E 297
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-34
Identities = 62/293 (21%), Positives = 115/293 (39%), Gaps = 51/293 (17%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFSH 164
+LG G FG V+KG P V VA+K+ + +E E + +
Sbjct: 22 VLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
P++ +L+G C L+ + M G L +++ + + + L + AK + +L
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG------TYGY 278
++ +++RD A N+L+ + K++DFGLAKL + G
Sbjct: 134 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVPIKWM--- 186
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SGEHVLVDFARPSLTD 333
A E + +SDV+ +GV + E++T G ++P + L
Sbjct: 187 -ALESILHRIYTHQSDVWSYGVTVWELMTFG------SKPYDGIPASEISS-----ILEK 234
Query: 334 KRRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
RL + + Y I++KC + +RP E++ +
Sbjct: 235 GERLPQPPICT--IDVY---------MIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 9e-34
Identities = 70/294 (23%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-EWQAEVKFLGKFSH 164
LGEG FG V++G + +HK G VAVK D + ++ +E + H
Sbjct: 20 LGEGFFGEVYEGVYTNHK-------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFL 224
P++VKLIG E+ ++ E G L ++L + + L T + ++ K + +L
Sbjct: 73 PHIVKLIGII-EEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT-------RIMGTYG 277
+ ++RD NIL+ KL DFGL++ I+ + + M
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVTRLPIKWM---- 181
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SGEHVLVDFARPSLT 332
+PE + SDV+ F V + E+L+ G +P + V+ L
Sbjct: 182 --SPESINFRRFTTASDVWMFAVCMWEILSFG------KQPFFWLENKDVIG-----VLE 228
Query: 333 DKRRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
RL K P Y ++ +C + +P +RP E++ +L ++
Sbjct: 229 KGDRLPKPDLCP--PVLY---------TLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 78/299 (26%), Positives = 122/299 (40%), Gaps = 52/299 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHP 165
LG G FG V++G V P+ + VAVK S Q ++ E + KF+H
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPL----QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHL--FRKGSAEPLPWNTR--LKIAIDAAKDL 221
N+V+ IG + ++ E M G L++ L R ++P L +A D A
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 222 TFLHSSEKSVIYRDFKASNILLDGS---YNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY 278
+L E I+RD A N LL AK+ DFG+A+ D R G
Sbjct: 195 QYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-KGGCAM 247
Query: 279 -----AAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SGEHVLVDFAR 328
PE G K+D + FGV+L E+ + G P S + VL
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQEVL----- 296
Query: 329 PSLTDKRRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386
+T R+ + P Y +I+ +C + +P++RP+ +LE ++ +
Sbjct: 297 EFVTSGGRMDPPKNCP--GPVY---------RIMTQCWQHQPEDRPNFAIILERIEYCT 344
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 76/341 (22%), Positives = 126/341 (36%), Gaps = 62/341 (18%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-H 164
+L EGGF V++ VG G+ A+K+ + + R EV F+ K S H
Sbjct: 35 VLAEGGFAFVYEA---------QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH 85
Query: 165 PNLVKLIGYCWEDRQ--------FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAID 216
PN+V+ ++ FLL+ E KG L L + S PL +T LKI
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA---KLGPIDGNSHVTTRIM 273
+ + +H + +I+RD K N+LL KL DFG A P S ++
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 274 -------GTYGYAAPEYV-ATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323
T Y PE + + + K D++ G +L + +
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK------ 258
Query: 324 VDFARPSLTDKRRLKKIMDPRLEE-QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
+I++ + + + + +I L+ P+ R S+ EV+ L
Sbjct: 259 --------------LRIVNGKYSIPPHDTQYTVFH-SLIRAMLQVNPEERLSIAEVVHQL 303
Query: 383 QNISVI-EIEPKKKAKARGNYNNNSNDNQRGHPHNRRSQSP 422
Q I+ + PK + G+ S+ P
Sbjct: 304 QEIAAARNVNPKSPIT-------ELLEQNGGYGSATLSRGP 337
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 43/288 (14%)
Query: 107 LGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVKFLGKFS 163
LG G FG V KG W+ V +K + Q + + +G
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPV------CIKVIEDKSGR-QSFQAVTDHMLAIGSLD 73
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
H ++V+L+G C LV +Y+ GSL +H+ + L L + AK + +
Sbjct: 74 HAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEY 283
L E +++R+ A N+LL +++DFG+A L P D + + + A E
Sbjct: 131 L--EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 284 VATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SGEHVLVDFARPSLTDKRRLK 338
+ G +SDV+ +GV + E++T G P V L RL
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFG------AEPYAGLRLAEVPD-----LLEKGERLA 237
Query: 339 KIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ + Y +++KC + RP+ +E+ +
Sbjct: 238 QPQICT--IDVY---------MVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 73/293 (24%), Positives = 117/293 (39%), Gaps = 48/293 (16%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA---EVKFLGKFS 163
LG+G FG V +G D + V AVK PD + EV +
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSV------AVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
H NL++L G +V E GSL + L + T + A+ A+ + +
Sbjct: 80 HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT---YGYAA 280
L K I+RD A N+LL K+ DFGL + P + + +V + + A
Sbjct: 137 L--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCA 192
Query: 281 PEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP----SGEHVL--VDFARPSLTDK 334
PE + T SD + FGV L EM T + P +G +L +D +
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKID------KEG 241
Query: 335 RRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386
RL + D P ++ Y ++++C +P++RP+ + + L
Sbjct: 242 ERLPRPEDCP--QDIY---------NVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 68/295 (23%), Positives = 119/295 (40%), Gaps = 50/295 (16%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFL 159
+F P +LG G G + + VAVK+ P+ EV+ L
Sbjct: 25 SFCPKDVLGHGAEGTIVY--RGMFD--------NRDVAVKRILPECFSFADR---EVQLL 71
Query: 160 GKFS-HPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
+ HPN+++ +DRQF + E +L+ ++ +K A + +
Sbjct: 72 RESDEHPNVIRYFCTE-KDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL--EPITLLQQT 127
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILL-----DGSYNAKLSDFGLAK-LGPIDGNSHVTTR 271
L LHS ++++RD K NIL+ G A +SDFGL K L + +
Sbjct: 128 TSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 272 IMGTYGYAAPEYV---ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328
+ GT G+ APE + + D++ G V +++ G H
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE----------GSH------- 228
Query: 329 P--SLTDKRRLKKIMDPRLEEQYPIKG-ALLAGQIIIKCLEAEPKNRPSMEEVLE 380
P ++ + L+ +P K ++A ++I K + +P+ RPS + VL+
Sbjct: 229 PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 72/309 (23%), Positives = 123/309 (39%), Gaps = 65/309 (21%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKF-SH 164
LGEG FG+V + K VAVK D + + L + +E++ + H
Sbjct: 89 LGEGCFGQVVMAEAVG--IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-------------FRKGSAEPLPWNTRL 211
N++ L+G C +D ++ EY KG+L +L + E + + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT- 270
A+ + +L + + I+RD A N+L+ + K++DFGLA+ TT
Sbjct: 207 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 271 -----RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-------GLRALDTNRPS 318
+ M APE + +SDV+ FGV++ E+ T G+
Sbjct: 265 GRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--------P 310
Query: 319 GEHVLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSME 376
E + L + R+ K P E Y ++ C A P RP+ +
Sbjct: 311 VEELF-----KLLKEGHRMDK---PANCTNELY---------MMMRDCWHAVPSQRPTFK 353
Query: 377 EVLETLQNI 385
+++E L I
Sbjct: 354 QLVEDLDRI 362
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-33
Identities = 65/295 (22%), Positives = 120/295 (40%), Gaps = 52/295 (17%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSH 164
++G+G FG V+ G + + A+K + +Q + + E + +H
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQC------AIKSLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 165 PNLVKLIGYCWEDR-QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
PN++ LIG ++ YM G L + + + + A+ + +
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEY 139
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG-----Y 278
L +E+ ++RD A N +LD S+ K++DFGLA+ I + + + + +
Sbjct: 140 L--AEQKFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQ-QHRHARLPVKW 194
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLT-------GLRALDTNRPSGEHVLVDFARPSL 331
A E + T KSDV+ FGV+L E+LT + + L
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--------DPFDLTH-----FL 241
Query: 332 TDKRRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
RRL + P + Y Q++ +C EA+P RP+ ++ ++ I
Sbjct: 242 AQGRRLPQPEYCP--DSLY---------QVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-33
Identities = 72/309 (23%), Positives = 123/309 (39%), Gaps = 65/309 (21%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKF-SH 164
LGEG FG+V + K VAVK D + + L + +E++ + H
Sbjct: 43 LGEGAFGQVVMAEAVG--IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-------------FRKGSAEPLPWNTRL 211
N++ L+G C +D ++ EY KG+L +L + E + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT- 270
A+ + +L + + I+RD A N+L+ + K++DFGLA+ TT
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 271 -----RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-------GLRALDTNRPS 318
+ M APE + +SDV+ FGV++ E+ T G+
Sbjct: 219 GRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--------P 264
Query: 319 GEHVLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSME 376
E + L + R+ K P E Y ++ C A P RP+ +
Sbjct: 265 VEELF-----KLLKEGHRMDK---PANCTNELY---------MMMRDCWHAVPSQRPTFK 307
Query: 377 EVLETLQNI 385
+++E L I
Sbjct: 308 QLVEDLDRI 316
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 75/293 (25%), Positives = 122/293 (41%), Gaps = 48/293 (16%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSH 164
++G G FG V+ G G AVK N I + ++ E + FSH
Sbjct: 96 VIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 165 PNLVKLIGYCWE-DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
PN++ L+G C + L+V YM+ G L N + + + + AK + F
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKF 207
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG-----Y 278
L + K ++RD A N +LD + K++DFGLA+ + + T +
Sbjct: 208 L--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEFDSVH-NKTGAKLPVKW 262
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SGEHVLVDFARPSLTD 333
A E + T KSDV+ FGV+L E++T G P + + V L
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRG------APPYPDVNTFDITV-----YLLQ 311
Query: 334 KRRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
RRL + P + Y ++++KC + + RPS E++ + I
Sbjct: 312 GRRLLQPEYCP--DPLY---------EVMLKCWHPKAEMRPSFSELVSRISAI 353
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-33
Identities = 69/293 (23%), Positives = 115/293 (39%), Gaps = 55/293 (18%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHP 165
+GEG FG V +G + + AVA+K S ++ E + +F HP
Sbjct: 23 IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
++VKLIG E+ ++ E G L + L + L + + A + L +L
Sbjct: 77 HIVKLIGVITEN-PVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL- 132
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT-------RIMGTYGY 278
K ++RD A N+L+ + KL DFGL++ ++ +++ + M
Sbjct: 133 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWM----- 184
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SGEHVLVDFARPSLTD 333
APE + SDV+ FGV + E+L G +P V+ + +
Sbjct: 185 -APESINFRRFTSASDVWMFGVCMWEILMHG------VKPFQGVKNNDVI-----GRIEN 232
Query: 334 KRRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
RL + P Y ++ KC +P RP E+ L I
Sbjct: 233 GERLPMPPNCP--PTLY---------SLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 44/291 (15%)
Query: 104 DTMLGEGGFGRVFKG-WVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-EWQAEVKFLGK 161
D LG G FG V +G + K VA+K + + E E + + +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQID--------VAIKVLKQGTEKADTEEMMREAQIMHQ 392
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDL 221
+P +V+LIG C + +LV E G L L G E +P + ++ + +
Sbjct: 393 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGM 449
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA-- 279
+L EK+ ++R+ A N+LL + AK+SDFGL+K D +S+ T R G +
Sbjct: 450 KYL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWY 506
Query: 280 APEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP----SGEHVLVDFARPSLTDKR 335
APE + +SDV+ +GV + E L+ + +P G V+ + +
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMA-----FIEQGK 556
Query: 336 RLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
R++ + P E Y ++ C + ++RP V + ++
Sbjct: 557 RMECPPECP--PELY---------ALMSDCWIYKWEDRPDFLTVEQRMRAC 596
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 56/338 (16%), Positives = 109/338 (32%), Gaps = 29/338 (8%)
Query: 76 SSGEIVTPNYLKMFTLQ-DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGK 134
L + + + +K +LGEG F +V++ L K +
Sbjct: 41 YPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYE--ATQGDLNDAKNK--Q 96
Query: 135 AVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLEN 194
+K P + ++ L +K +LV E G+L N
Sbjct: 97 KFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLN 156
Query: 195 HL--FRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL--------- 243
+ ++ + +P + A+ + +H +I+ D K N +L
Sbjct: 157 AINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDD 214
Query: 244 --DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGV 300
D S L D G + + + T T G+ E + + + + D +G
Sbjct: 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAA 273
Query: 301 VLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQI 360
+ ML G N F R D + L P L + +
Sbjct: 274 TVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLD--MWNEFFHVML--NIPDCHHLPSLDL 329
Query: 361 IIKCLEAEPKNRPSMEEVLETLQN-ISVIEIEPKKKAK 397
+ + L+ + + + + L+N + V+ +E K+ K
Sbjct: 330 LRQKLKKVFQQHYTNK--IRALRNRLIVLLLECKRSRK 365
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 69/291 (23%), Positives = 114/291 (39%), Gaps = 51/291 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHP 165
+GEG FG V +G + + AVA+K S ++ E + +F HP
Sbjct: 398 IGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
++VKLIG E+ ++ E G L + L + L + + A + L +L
Sbjct: 452 HIVKLIGVITEN-PVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL- 507
Query: 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR-----IMGTYGYAA 280
K ++RD A N+L+ + KL DFGL++ ++ +++ I A
Sbjct: 508 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWM----A 560
Query: 281 PEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SGEHVLVDFARPSLTDKR 335
PE + SDV+ FGV + E+L G +P V+ + +
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHG------VKPFQGVKNNDVI-----GRIENGE 609
Query: 336 RLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
RL + P Y ++ KC +P RP E+ L I
Sbjct: 610 RLPMPPNCP--PTLY---------SLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 72/292 (24%), Positives = 109/292 (37%), Gaps = 32/292 (10%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVKFLGKFSH 164
LG GGFG V + W+ T G+ VA+K+ + RE W E++ + K +H
Sbjct: 21 RLGTGGFGYVLR-WIHQDT--------GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH 71
Query: 165 PNLVKLI------GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
PN+V + LL EY + G L +L + + L + D +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNA---KLSDFGLAKLGPIDGNSHVTTRIMGT 275
L +LH E +I+RD K NI+L K+ D G AK +D T + GT
Sbjct: 132 SALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFV-GT 186
Query: 276 YGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLR-ALDTNRPSGEHVLV-----DFAR 328
Y APE + Y V D + FG + E +TG R L +P H V +
Sbjct: 187 LQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+K A + + L + R + +
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 66/306 (21%), Positives = 118/306 (38%), Gaps = 64/306 (20%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHP 165
LGE FG+V+KG + AVA+K E++ E + HP
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQ----AVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-------------FRKGSAEPLPWNTRLK 212
N+V L+G +D+ +++ Y G L L + L +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 213 IAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRI 272
+ A + +L S V+++D N+L+ N K+SD GL + + + ++
Sbjct: 133 LVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKL 186
Query: 273 MG--------TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----SG 319
+G APE + G + SD++ +GVVL E+ + GL +P S
Sbjct: 187 LGNSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGL------QPYCGYSN 236
Query: 320 EHVLVDFARPSLTDKRRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEV 378
+ V+ + +++ L D P Y ++I+C P RP +++
Sbjct: 237 QDVV-----EMIRNRQVLPCPDDCP--AWVY---------ALMIECWNEFPSRRPRFKDI 280
Query: 379 LETLQN 384
L+
Sbjct: 281 HSRLRA 286
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 78/327 (23%), Positives = 125/327 (38%), Gaps = 96/327 (29%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHP 165
LGEG FG+V K H VAVK + S LR+ +E L + +HP
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYT----TVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHL---------------------FRKGSAEP 204
+++KL G C +D LL+ EY + GSL L
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 205 LPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG 264
L + A ++ + +L +E +++RD A NIL+ K+SDFGL+
Sbjct: 147 LTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLS------- 197
Query: 265 NSHVTTRIMGTYGYAAPEYVATG----------------HLY-VKSDVYGFGVVLLEMLT 307
R + Y YV H+Y +SDV+ FGV+L E++T
Sbjct: 198 ------RDV----YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 308 -------GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAG 358
G+ E + L R+++ P EE Y
Sbjct: 248 LGGNPYPGI--------PPERLF-----NLLKTGHRMER---PDNCSEEMY--------- 282
Query: 359 QIIIKCLEAEPKNRPSMEEVLETLQNI 385
+++++C + EP RP ++ + L+ +
Sbjct: 283 RLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 78/309 (25%), Positives = 125/309 (40%), Gaps = 73/309 (23%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVKFLGKF-S 163
+GEG FG+V K + K G+ A+K K R++ E++ L K
Sbjct: 33 IGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDD-HRDFAGELEVLCKLGH 84
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-------------FRKGSAEPLPWNTR 210
HPN++ L+G C L EY G+L + L +A L
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT 270
L A D A+ + +L S+K I+RD A NIL+ +Y AK++DFGL++ +V
Sbjct: 145 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK 198
Query: 271 RI-------MGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRP----S 318
+ M A E + SDV+ +GV+L E+++ G P +
Sbjct: 199 TMGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLG------GTPYCGMT 246
Query: 319 GEHVLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSME 376
+ L RL+K P +E Y ++ +C +P RPS
Sbjct: 247 CAELY-----EKLPQGYRLEK---PLNCDDEVY---------DLMRQCWREKPYERPSFA 289
Query: 377 EVLETLQNI 385
++L +L +
Sbjct: 290 QILVSLNRM 298
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 78/316 (24%), Positives = 120/316 (37%), Gaps = 74/316 (23%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHP 165
+GEG FGRVF+ VAVK + S ++Q E + +F +P
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFT----MVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHL---------------------FRKGSAEP 204
N+VKL+G C + L++EYM G L L P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 205 LPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA-KLGPID 263
L +L IA A + +L SE+ ++RD N L+ + K++DFGL+ + D
Sbjct: 171 LSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 264 -----GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-------GLRA 311
GN + R M PE + +SDV+ +GVVL E+ + G+
Sbjct: 229 YYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-- 280
Query: 312 LDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEP 369
+ E V+ + + D L P E Y ++ C P
Sbjct: 281 ------AHEEVI-YY----VRDGNILAC---PENCPLELY---------NLMRLCWSKLP 317
Query: 370 KNRPSMEEVLETLQNI 385
+RPS + LQ +
Sbjct: 318 ADRPSFCSIHRILQRM 333
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 57/294 (19%), Positives = 106/294 (36%), Gaps = 30/294 (10%)
Query: 107 LGEGGFGRVFKGWVDHKTLA---PTKVGVGKAVAVKKSNPDSIQGLREWQA---EVKFLG 160
L +G F ++ D+K A K + K KSN D I ++ E++ +
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 161 KFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHL-----FRKGSAEPLPWNTRLKIA 214
+ + G + + ++YEYM+ S+ K +P I
Sbjct: 99 DIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
+++H+ EK++ +RD K SNIL+D + KLSDFG ++ + + G
Sbjct: 158 KSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKIKG-SRG 212
Query: 275 TYGYAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRAL----DTNRPSG-EHVL-VDF 326
TY + PE+ + Y K D++ G+ L M + + ++ +
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN--VVPFSLKISLVELFNNIRTKNI 270
Query: 327 ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
P + + + L P R + E+ L+
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNE--DIDFLKLFLRKNPAERITSEDALK 322
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 76/315 (24%), Positives = 119/315 (37%), Gaps = 77/315 (24%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKF-SH 164
LGEG FG+V L K VAVK D + + L + +E++ + H
Sbjct: 77 LGEGAFGQVVLAEA--IGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL-------------FRKGSAEPLPWNTRL 211
N++ L+G C +D ++ EY KG+L +L E L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
A A+ + +L + K I+RD A N+L+ K++DFGLA+
Sbjct: 195 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD------------ 240
Query: 272 IMGTYGYA------------APEYVATGHLYVKSDVYGFGVVLLEMLT-------GLRAL 312
I Y APE + +SDV+ FGV+L E+ T G+
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--- 297
Query: 313 DTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPK 370
E + L + R+ K P E Y ++ C A P
Sbjct: 298 -----PVEELF-----KLLKEGHRMDK---PSNCTNELY---------MMMRDCWHAVPS 335
Query: 371 NRPSMEEVLETLQNI 385
RP+ ++++E L I
Sbjct: 336 QRPTFKQLVEDLDRI 350
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 74/310 (23%), Positives = 117/310 (37%), Gaps = 67/310 (21%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKF-SH 164
LG G FG+V + K + VAVK + R +E+K L H
Sbjct: 35 LGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 165 PNLVKLIGYC-WEDRQFLLVYEYMQKGSLENHL-------------FRKGSAEPLPWNTR 210
N+V L+G C +++ E+ + G+L +L + L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT 270
+ + AK + FL + + I+RD A NILL K+ DFGLA+ D +
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 271 ------RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-------GLRALDTNRP 317
+ M APE + ++SDV+ FGV+L E+ + G+
Sbjct: 209 DARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-------K 255
Query: 318 SGEHVLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSM 375
E L + R++ P E Y Q ++ C EP RP+
Sbjct: 256 IDEEFC-----RRLKEGTRMRA---PDYTTPEMY---------QTMLDCWHGEPSQRPTF 298
Query: 376 EEVLETLQNI 385
E++E L N+
Sbjct: 299 SELVEHLGNL 308
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-31
Identities = 69/318 (21%), Positives = 111/318 (34%), Gaps = 86/318 (27%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKF-SH 164
LG G FG+V + + VAVK +E+K + H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVL----KVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRK-----------GSAEPLPWNTRLKI 213
N+V L+G C L++ EY G L N L RK + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM 273
+ A+ + FL + K+ I+RD A N+LL + AK+ DFGLA R +
Sbjct: 170 SSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA-------------RDI 214
Query: 274 GTYGYAAPEYVATG----------------HLY-VKSDVYGFGVVLLEMLT-------GL 309
Y+ G +Y V+SDV+ +G++L E+ + G+
Sbjct: 215 ----MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270
Query: 310 RALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEA 367
+ D ++ + P + Y I+ C
Sbjct: 271 -------LVNSKFY-----KLVKDGYQMAQ---PAFAPKNIY---------SIMQACWAL 306
Query: 368 EPKNRPSMEEVLETLQNI 385
EP +RP+ +++ LQ
Sbjct: 307 EPTHRPTFQQICSFLQEQ 324
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-31
Identities = 76/294 (25%), Positives = 131/294 (44%), Gaps = 54/294 (18%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KS---NPDSIQGLREW 152
++F+ +LG+G F V++ T G VA+K K +Q ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRA-ESIHT--------GLEVAIKMIDKKAMYKAGMVQRVQ-- 59
Query: 153 QAEVKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSA--EPLPWNT 209
EVK + HP++++L Y +ED ++ LV E G + +L + E
Sbjct: 60 -NEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE---A 114
Query: 210 RLKIA--IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSH 267
R + I + +LHS +++RD SN+LL + N K++DFGLA + H
Sbjct: 115 RHFMHQIITG---MLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169
Query: 268 VTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF 326
T + GT Y +PE +AT + ++SDV+ G + +L G RP F
Sbjct: 170 YT--LCGTPNYISPE-IATRSAHGLESDVWSLGCMFYTLLIG-------RPP-------F 212
Query: 327 ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
++ K L K++ + + P ++ A +I + L P +R S+ VL+
Sbjct: 213 DTDTV--KNTLNKVV--LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 72/290 (24%), Positives = 115/290 (39%), Gaps = 47/290 (16%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--GLRE-WQAE 155
+ + LG+GGF + F+ D T + A K + RE E
Sbjct: 15 RRYVRGRFLGKGGFAKCFEI-SDADT--------KEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKI 213
+ +H ++V G+ +ED F+ +V E ++ SL R+ + EP R +
Sbjct: 66 ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYL 121
Query: 214 A--IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
+ +LH VI+RD K N+ L+ K+ DFGLA DG
Sbjct: 122 RQIVLG---CQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-- 174
Query: 272 IMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330
+ GT Y APE V + + + DV+ G ++ +L G P F
Sbjct: 175 LCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVG------KPP--------FETSC 219
Query: 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
L K +I + E P +A +I K L+ +P RP++ E+L
Sbjct: 220 L--KETYLRIK--KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 73/311 (23%), Positives = 116/311 (37%), Gaps = 68/311 (21%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKF-SH 164
LG G FG+V + + + VAVK P + +E+K L +H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAM----TVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL---------------FRKGSAEPLPWNT 209
N+V L+G C L++ EY G L N L + L
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269
L + AK + FL + K+ I+RD A NILL K+ DFGLA+ D N V
Sbjct: 147 LLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 270 T------RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-------GLRALDTNR 316
+ M APE + +SDV+ +G+ L E+ + G+
Sbjct: 205 GNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM------- 251
Query: 317 PSGEHVLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPS 374
P + + R+ P E Y I+ C +A+P RP+
Sbjct: 252 PVDSKFY-----KMIKEGFRMLS---PEHAPAEMY---------DIMKTCWDADPLKRPT 294
Query: 375 MEEVLETLQNI 385
+++++ ++
Sbjct: 295 FKQIVQLIEKQ 305
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 63/313 (20%), Positives = 111/313 (35%), Gaps = 63/313 (20%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF 158
+ +LG G G V G+ VAVK+ D E+K
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ--GSFQ--------GRPVAVKRMLIDFCDIALM---EIKL 61
Query: 159 LGKFS-HPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAID 216
L + HPN+++ +FL + E +L++ + K ++ + I
Sbjct: 62 LTESDDHPNVIRYYCSE-TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 217 AAKDLT----FLHSSEKSVIYRDFKASNILLD-------------GSYNAKLSDFGLAKL 259
+ + LHS +I+RD K NIL+ + +SDFGL K
Sbjct: 120 LLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 260 GPIDGNSHVTTRIM----GTYGYAAPE------YVATGHLYVKS-DVYGFGVVLLEMLTG 308
+D + GT G+ APE + T +S D++ G V +L+
Sbjct: 178 --LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 309 LRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEA 367
G+H F + ++ I ++ + A +I + ++
Sbjct: 236 ----------GKH---PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH 282
Query: 368 EPKNRPSMEEVLE 380
+P RP+ +VL
Sbjct: 283 DPLKRPTAMKVLR 295
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 68/297 (22%), Positives = 123/297 (41%), Gaps = 60/297 (20%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK------KSNPDSIQGLREWQAEVKFLG 160
LG GG V+ D + VA+K + +++ + ++ EV
Sbjct: 19 LGGGGMSTVYLA-EDTI--------LNIKVAIKAIFIPPREKEETL---KRFEREVHNSS 66
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
+ SH N+V +I ED + LV EY++ +L ++ G PL +T +
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDG 123
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT--RIMGTYGY 278
+ H + +++RD K NIL+D + K+ DFG+AK + +T ++GT Y
Sbjct: 124 IKHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL---SETSLTQTNHVLGTVQY 178
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP-SGE--------HVLVDFARP 329
+PE +D+Y G+VL EML G P +GE H+
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVG------EPPFNGETAVSIAIKHIQDSVPNV 232
Query: 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-SMEEVLETLQNI 385
+ ++K + L +I++ E + NR +++E+ + L ++
Sbjct: 233 T----TDVRKDIPQSLSN------------VILRATEKDKANRYKTIQEMKDDLSSV 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 74/281 (26%), Positives = 118/281 (41%), Gaps = 47/281 (16%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQAEVKFLGKFS 163
LG+G FG V+ LA + +A+K K+ + + + EV+
Sbjct: 17 LGKGKFGNVY--------LA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLP-WNTRLKIA--IDAAKD 220
HPN+++L GY + + L+ EY G++ L + T I +A
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANA--- 121
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAA 280
L++ HS K VI+RD K N+LL + K++DFG + P + GT Y
Sbjct: 122 LSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDL--CGTLDYLP 175
Query: 281 PEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339
PE + G ++ K D++ GV+ E L G + N T + K+
Sbjct: 176 PE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN----------------TYQETYKR 218
Query: 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
I R+E +P A +I + L+ P RP + EVLE
Sbjct: 219 IS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 66/282 (23%), Positives = 107/282 (37%), Gaps = 39/282 (13%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP 165
+LG+G +G V+ G D +A+K+ + + E+ H
Sbjct: 29 VLGKGTYGIVYAG-RDLSN--------QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH 225
N+V+ +G E+ + E + GSL L K T + L +LH
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 226 SSEKSVIYRDFKASNILLD-GSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
+++RD K N+L++ S K+SDFG +K + G + T GT Y APE +
Sbjct: 140 D--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEII 195
Query: 285 ---ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP---SGEHVLVDFARPSLTDKRRLK 338
G+ +D++ G ++EM TG P GE F
Sbjct: 196 DKGPRGYGK-AADIWSLGCTIIEMATG------KPPFYELGEPQAAMFKVGMFKVH---- 244
Query: 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
P + E + A I+KC E +P R ++L
Sbjct: 245 ----PEIPESM----SAEAKAFILKCFEPDPDKRACANDLLV 278
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 39/370 (10%), Positives = 82/370 (22%), Gaps = 62/370 (16%)
Query: 47 VKDEHERKADDADEGRQLGDGDGGDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTM 106
++D +R+ + R+ + + + N L + +
Sbjct: 11 MRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTV-DSLLSQGERKLKLVEP 69
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQAEVKFLGKFS 163
L G VF D + + A+K +S L +
Sbjct: 70 LRVGDRSVVFLV-RDVER--------LEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 164 HPNLVKLIGYC--------------------------WEDRQFLLVYEYMQKGSLENHL- 196
+ + + +LL+ LE
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFS 179
Query: 197 ---FRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253
F + + L S K +++ F N+ + L D
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQS--KGLVHGHFTPDNLFIMPDGRLMLGD 237
Query: 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRA 311
YA E++ + + G+ + +
Sbjct: 238 VSALWK-----VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
Query: 312 LDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKN 371
P + + L+ L +I + L + +
Sbjct: 293 FGLVTPGIK---------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR 343
Query: 372 RPSMEEVLET 381
R E +ET
Sbjct: 344 RLLPLEAMET 353
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 72/290 (24%), Positives = 115/290 (39%), Gaps = 47/290 (16%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--GLRE-WQAE 155
+ + LG+GGF + F+ D T + A K + RE E
Sbjct: 41 RRYVRGRFLGKGGFAKCFEI-SDADT--------KEVFAGKIVPKSLLLKPHQREKMSME 91
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKI 213
+ +H ++V G+ +ED F+ +V E ++ SL R+ + EP R +
Sbjct: 92 ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYL 147
Query: 214 A--IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
+ +LH VI+RD K N+ L+ K+ DFGLA DG
Sbjct: 148 RQIVLG---CQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-- 200
Query: 272 IMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330
+ GT Y APE V + + + DV+ G ++ +L G P F
Sbjct: 201 LCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVG------KPP--------FETSC 245
Query: 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
L K +I + E P +A +I K L+ +P RP++ E+L
Sbjct: 246 L--KETYLRIK--KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-30
Identities = 66/349 (18%), Positives = 115/349 (32%), Gaps = 84/349 (24%)
Query: 99 KNFRPDTMLGEGGFGRVFKGW--VDHKTLAPTKVGVGKAVAVKKS--------------- 141
+F P +G GGFG VF+ VD A ++ + ++
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 142 --------------------------------NPDSIQGLREWQAEVKFLGKFSHPNLVK 169
S + +++ + FS N V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 170 LIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEK 229
+ + + +K +L++ + R+ S E L I I A+ + FLHS K
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--K 183
Query: 230 SVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT----------TRIMGTYGYA 279
+++RD K SNI K+ DFGL D T +GT Y
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 280 APEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338
+PE G+ Y K D++ G++L E+L E V + +
Sbjct: 244 SPE-QIHGNNYSHKVDIFSLGLILFELLYSF------STQMERVRI------------IT 284
Query: 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET--LQNI 385
+ + + + K ++ L P RP +++E +N+
Sbjct: 285 DVRNLKFPLLFTQKYPQEH-MMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 54/292 (18%), Positives = 102/292 (34%), Gaps = 54/292 (18%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVKFL 159
+ + GG G ++ +D G+ V +K + AE +FL
Sbjct: 82 YEVKGCIAHGGLGWIYLA-LDRNVN-------GRPVVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 160 GKFSHPNLVKLIGYCWEDRQFL-----LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA 214
+ HP++V++ + + +V EY+ SL+ + LP +
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYL 188
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
++ L++LH ++Y D K NI+L KL D G I+ + G
Sbjct: 189 LEILPALSYLH--SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINS----FGYLYG 239
Query: 275 TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334
T G+ APE + V +D+Y G L + L + G +V +
Sbjct: 240 TPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLPTRN-----GRYVDGLPEDDPVLK- 292
Query: 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-SMEEVLETLQNI 385
++ + ++ +P+ R + EE+ L +
Sbjct: 293 ------TYDSYGR------------LLRRAIDPDPRQRFTTAEEMSAQLTGV 326
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 68/281 (24%), Positives = 117/281 (41%), Gaps = 47/281 (16%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQAEVKFLGKFS 163
LG+G FG V+ LA + +A+K KS + + + E++
Sbjct: 22 LGKGKFGNVY--------LA-REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLP-WNTRLKIA--IDAAKD 220
HPN++++ Y + ++ L+ E+ +G L L + G + + DA
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADA--- 126
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAA 280
L + H + VI+RD K N+L+ K++DFG + P T GT Y
Sbjct: 127 LHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP--SLRRRTM--CGTLDYLP 180
Query: 281 PEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339
PE + G + K D++ GV+ E L G P F PS T+ R +
Sbjct: 181 PE-MIEGKTHDEKVDLWCAGVLCYEFLVG------MPP--------FDSPSHTETHR--R 223
Query: 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
I+ ++ ++P + + +I K L P R ++ V+E
Sbjct: 224 IV--NVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 76/295 (25%), Positives = 110/295 (37%), Gaps = 44/295 (14%)
Query: 93 DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREW 152
+ R +G G FG V + D +T G AVKK + +
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRM-KDKQT--------GFQCAVKKVRLEVFR----- 97
Query: 153 QAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLK 212
E+ S P +V L G E + E ++ GSL + + G LP + L
Sbjct: 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG---CLPEDRALY 154
Query: 213 IAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS-YNAKLSDFGLAK-LGPIDGNSHVTT 270
A + L +LH+ + +++ D KA N+LL A L DFG A L P + T
Sbjct: 155 YLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 271 R--IMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRP-SGEHVLVDF 326
I GT + APE V G K D++ ++L ML G P +
Sbjct: 213 GDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLHMLNG------CHPWTQYFRG--- 262
Query: 327 ARPSLTDKRRLKKIM-DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
KI +P + P A L Q I + L EP +R S E+
Sbjct: 263 --------PLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRR 309
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 71/327 (21%), Positives = 111/327 (33%), Gaps = 95/327 (29%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKF-SH 164
LG G FG+V + + VAVK +E+K + + SH
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSI----QVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRK--------------------GSAEP 204
N+V L+G C L++EY G L N+L K
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 205 LPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG 264
L + L A AK + FL KS ++RD A N+L+ K+ DFGLA
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLA------- 219
Query: 265 NSHVTTRIMGTYGYAAPEYVATG----------------HLY-VKSDVYGFGVVLLEMLT 307
R + + YV G +Y +KSDV+ +G++L E+ +
Sbjct: 220 ------RDI----MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
Query: 308 -------GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAG 358
G+ P + + + ++ + P EE Y
Sbjct: 270 LGVNPYPGI-------PVDANFY-----KLIQNGFKMDQ---PFYATEEIY--------- 305
Query: 359 QIIIKCLEAEPKNRPSMEEVLETLQNI 385
I+ C + + RPS + L
Sbjct: 306 IIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 82/330 (24%), Positives = 131/330 (39%), Gaps = 77/330 (23%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVK 157
K + +G+G G V+ +D T G+ VA+++ N E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA-MDVAT--------GQEVAIRQMNLQQQPKKELIINEIL 69
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI-- 215
+ + +PN+V + + +V EY+ GSL + + E +IA
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVC 122
Query: 216 -DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL-AKLGPIDG--NSHVTTR 271
+ + L FLHS VI+RD K+ NILL + KL+DFG A++ P ++ V
Sbjct: 123 RECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--- 177
Query: 272 IMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTG---------LRAL---DTNRPS 318
GT + APE V T Y K D++ G++ +EM+ G LRAL TN
Sbjct: 178 --GTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT- 233
Query: 319 GEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEV 378
P L + +L I L +CLE + + R S +E+
Sbjct: 234 ----------PELQNPEKLSAIFRDFLN----------------RCLEMDVEKRGSAKEL 267
Query: 379 LE------TLQNISVIE-IEPKKKAKARGN 401
L+ S+ I K+A +
Sbjct: 268 LQHQFLKIAKPLSSLTPLIAAAKEATKNNH 297
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 51/311 (16%), Positives = 99/311 (31%), Gaps = 69/311 (22%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSN--PDSIQGLREWQAE 155
T F +G G FG VFK V G A+K+S + E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC-VKRLD--------GCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 156 VKFLGK-FSHPNLVKLIGYCWEDRQFLLVY-EYMQKGSLENHL-FRKGSAEPLPWNTRLK 212
V H ++V+ W + +L+ EY GSL + +
Sbjct: 61 VYAHAVLGQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 213 IAIDAAKDLTFLHSSEKSVIYRDFKASNILLD-------------------GSYNAKLSD 253
+ + + L ++HS S+++ D K SNI + K+ D
Sbjct: 120 LLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRAL 312
G + V G + A E + + + K+D++ + ++
Sbjct: 178 LGHVTR---ISSPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA---- 227
Query: 313 DTNRPSGEHVLVDFARPSLTDKRRLKKIMD---PRLEEQYPIKGALLAGQIIIKCLEAEP 369
P + + +I PR+ + + +++ + +P
Sbjct: 228 ---------------EPLPRNGDQWHEIRQGRLPRIPQVLSQEFT----ELLKVMIHPDP 268
Query: 370 KNRPSMEEVLE 380
+ RPS +++
Sbjct: 269 ERRPSAMALVK 279
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 41/328 (12%), Positives = 86/328 (26%), Gaps = 83/328 (25%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK------------------ 139
+ T+LG+ + T G++ V
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEA---------TDQETGESFEVHVPYFTERPPSNAIKQMKE 122
Query: 140 ----------KSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYC--WEDRQFLLVYEYM 187
N + + + ++++ +Y M
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182
Query: 188 QK--GSLENHLFRKGSA-EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD 244
Q + L S + L + RL++ + + L LH +++ + +I+LD
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLD 240
Query: 245 GSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYV-----------KS 293
L+ F DG V+ + G+ PE A
Sbjct: 241 QRGGVFLTGFEHLVR---DGARVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSF 294
Query: 294 DVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKG 353
D + G+V+ + + P + + I R + P
Sbjct: 295 DAWALGLVIYWIWCA------DLP--------ITKD--AALGGSEWIF--RSCKNIPQ-- 334
Query: 354 ALLAGQIIIKCLEAEPKNRPSMEEVLET 381
++ L ++R + +ET
Sbjct: 335 --PVRALLEGFLRYPKEDRLLPLQAMET 360
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 63/254 (24%), Positives = 105/254 (41%), Gaps = 36/254 (14%)
Query: 66 DGDGGDKNMPSSG--EIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHK 123
DG + + P + +D F+ +LGEG F V
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVV------- 47
Query: 124 TLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGKFSHPNLVKLIGYCWEDRQF 180
LA ++ + A+K I + E + + HP VKL + ++D +
Sbjct: 48 -LA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEK 104
Query: 181 L-LVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIA--IDAAKDLTFLHSSEKSVIYRDF 236
L Y + G L ++ + GS E TR A + A L +LH K +I+RD
Sbjct: 105 LYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAEIVSA---LEYLHG--KGIIHRDL 156
Query: 237 KASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DV 295
K NILL+ + +++DFG AK+ + +GT Y +PE + T KS D+
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKSACKSSDL 215
Query: 296 YGFGVVLLEMLTGL 309
+ G ++ +++ GL
Sbjct: 216 WALGCIIYQLVAGL 229
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 74/305 (24%), Positives = 122/305 (40%), Gaps = 52/305 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK----SNPDSIQGLREWQAEVKFLGKF 162
LG G G VFK V HK P+ G +A K P + E++ L +
Sbjct: 41 LGAGNGGVVFK--VSHK---PS----GLVMARKLIHLEIKPAIRNQI---IRELQVLHEC 88
Query: 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
+ P +V G + D + + E+M GSL+ L + G +P K++I K LT
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLT 145
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPE 282
+L + +++RD K SNIL++ KL DFG++ G + +S + + GT Y +PE
Sbjct: 146 YLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLI-DSMANSFV-GTRSYMSPE 200
Query: 283 YVATGHLY-VKSDVYGFGVVLLEMLTG-----LRALDTNRPSGEHVLVDFARPSLTDKRR 336
G Y V+SD++ G+ L+EM G + A + R
Sbjct: 201 -RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259
Query: 337 LKKIMDPRLEEQYPIKGAL-LAGQI--------------------IIKCLEAEPKNRPSM 375
+ ++ + P L I + KCL P R +
Sbjct: 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 319
Query: 376 EEVLE 380
++++
Sbjct: 320 KQLMV 324
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 67/302 (22%), Positives = 122/302 (40%), Gaps = 70/302 (23%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVK 157
+GEG G V + + G+ VAVK + Q EV
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLA-REKHS--------GRQVAVKMMDLRKQQRRELLFNEVV 94
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI-- 215
+ + H N+V++ + ++ E++Q G+L + + + E +IA
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE-------QIATVC 147
Query: 216 -DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL-AKLGPIDG--NSHVTTR 271
+ L +LH+ + VI+RD K+ +ILL KLSDFG A++ S V
Sbjct: 148 EAVLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV--- 202
Query: 272 IMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTG---------LRAL---DTNRPS 318
GT + APE V + LY + D++ G++++EM+ G ++A+ + P
Sbjct: 203 --GTPYWMAPE-VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP- 258
Query: 319 GEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEV 378
P L + ++ ++ LE + L +P+ R + +E+
Sbjct: 259 ----------PKLKNSHKVSPVLRDFLE----------------RMLVRDPQERATAQEL 292
Query: 379 LE 380
L+
Sbjct: 293 LD 294
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 80/335 (23%), Positives = 125/335 (37%), Gaps = 76/335 (22%)
Query: 73 NMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGV 132
+M S + + + + L+D F ++G G +G+V+KG KT
Sbjct: 1 SMASDSPARSLDEIDLSALRD---PAGIFELVELVGNGTYGQVYKG-RHVKT-------- 48
Query: 133 GKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIG------YCWEDRQFLLVYE 185
G+ A+K + E + E+ L K+S H N+ G D Q LV E
Sbjct: 49 GQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107
Query: 186 YMQKGSLENHLFRKGSAEPLPWNTRLKIAI---DAAKDLTFLHSSEKSVIYRDFKASNIL 242
+ GS+ + L + L IA + + L+ LH VI+RD K N+L
Sbjct: 108 FCGAGSVTD-LIKNTKGNTL---KEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVL 161
Query: 243 LDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-----VKSDVYG 297
L + KL DFG++ +D +GT + APE +A KSD++
Sbjct: 162 LTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS 219
Query: 298 FGVVLLEMLTG---------LRAL---DTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRL 345
G+ +EM G +RAL N P L K+ KK
Sbjct: 220 LGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-----------PRLKSKKWSKKFQS--- 265
Query: 346 EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
I CL RP+ E++++
Sbjct: 266 --------------FIESCLVKNHSQRPATEQLMK 286
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 45/319 (14%), Positives = 93/319 (29%), Gaps = 82/319 (25%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK------KSNPDSIQGLREWQAEVKFL 159
+LG+ + D +T G++ V + ++I+ ++E ++ L
Sbjct: 85 VLGQEDPYAYLEA-TDQET--------GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 160 GKFSHP-------------NLVKLIGYCWEDR-----------QFLLVYEYMQK--GSLE 193
+ +LVK R +Y MQ +
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 194 NHLFRKGSA-EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252
L S + L + RL++ + + L LH +++ + +I+LD L+
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA----------TGHLYVKSDVYGFGVVL 302
F DG S V+ G+A PE A + D + G+ +
Sbjct: 254 GFEHLV---RDGASAVS---PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307
Query: 303 LEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIII 362
+ + P + + + ++
Sbjct: 308 YWIWCA------DLP--------NTDDAALGGSEWIFRSCKNIPQP--------VRALLE 345
Query: 363 KCLEAEPKNRPSMEEVLET 381
L ++R + +ET
Sbjct: 346 GFLRYPKEDRLLPLQAMET 364
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 66/332 (19%), Positives = 112/332 (33%), Gaps = 58/332 (17%)
Query: 69 GGDKNMPSSGEIVTPNYLKMFTLQDLRAATK--NFRPDTMLGEGGFGRVFKGWVDHKTLA 126
G + + P M + R T+ +R ++G GG G V++ D
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEA-EDTVR-- 58
Query: 127 PTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF----------SHPNLVKLIGYCWE 176
+ VA+K + ++ F + P++V + +
Sbjct: 59 ------ERIVALKLMSE-------TLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105
Query: 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDF 236
D Q + + L L R+G PL + I L H +RD
Sbjct: 106 DGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAH--AAGATHRDV 160
Query: 237 KASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT--RIMGTYGYAAPEYVATGHLYVKSD 294
K NIL+ A L DFG+A + +T +GT Y APE + H ++D
Sbjct: 161 KPENILVSADDFAYLVDFGIASAT---TDEKLTQLGNTVGTLYYMAPERFSESHATYRAD 217
Query: 295 VYGFGVVLLEMLTGLRALDTNRPS--GEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIK 352
+Y VL E LTG ++ S G H+ RPS + +
Sbjct: 218 IYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPG-----IPVAFDA----- 267
Query: 353 GALLAGQIIIKCLEAEPKNR-PSMEEVLETLQ 383
+I + + P++R + ++
Sbjct: 268 -------VIARGMAKNPEDRYVTCGDLSAAAH 292
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 72/308 (23%), Positives = 124/308 (40%), Gaps = 75/308 (24%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-EWQAEVKFLGKF-- 162
+LG GG V D + + VAVK LR + + F +F
Sbjct: 19 ILGFGGMSEVHLA-RDLR--------DHRDVAVKV--------LRADLARDPSFYLRFRR 61
Query: 163 --------SHPNLVKLIGYCWEDRQFL----LVYEYMQKGSLENHLFRKGSAEPLPWNTR 210
+HP +V + + +V EY+ +L + + +G P+
Sbjct: 62 EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRA 118
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT 270
+++ DA + L F H + +I+RD K +NI++ + K+ DFG+A+ I + + T
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVT 174
Query: 271 R---IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP-SGE------ 320
+ ++GT Y +PE + +SDVY G VL E+LTG P +G+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG------EPPFTGDSPVSVA 228
Query: 321 --HVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-SMEE 377
HV D PS + + L+ +++K L P+NR + E
Sbjct: 229 YQHVREDPIPPSARHEG-----LSADLDA------------VVLKALAKNPENRYQTAAE 271
Query: 378 VLETLQNI 385
+ L +
Sbjct: 272 MRADLVRV 279
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 68/219 (31%), Positives = 89/219 (40%), Gaps = 25/219 (11%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAE 155
F +LG GGFG VF K GK A KK N + +G + E
Sbjct: 185 DWFLDFRVLGRGGFGEVFA--CQMK-------ATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPL--PWNTRLK 212
K L K +V L Y +E + L LV M G + H++ P
Sbjct: 236 KKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 213 IA-IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
A I + L LH +++IYRD K N+LLD N ++SD GLA T
Sbjct: 295 TAQIVSG--LEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKG 348
Query: 272 IMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGL 309
GT G+ APE + G Y S D + GV L EM+
Sbjct: 349 YAGTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 84/326 (25%), Positives = 140/326 (42%), Gaps = 79/326 (24%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFSHP 165
+G+G FG VFKG +D++T K VA+K + + + + + Q E+ L + P
Sbjct: 30 IGKGSFGEVFKG-IDNRT--------QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI---DAAKDLT 222
+ K G +D + ++ EY+ GS + L E +IA + K L
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET-------QIATILREILKGLD 133
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPE 282
+LHS +K I+RD KA+N+LL KL+DFG+A G + +GT + APE
Sbjct: 134 YLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPE 189
Query: 283 YVATGHLY-VKSDVYGFGVVLLEMLTG---------LRAL---DTNRPSGEHVLVDFARP 329
V Y K+D++ G+ +E+ G ++ L N P
Sbjct: 190 -VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------------ 236
Query: 330 SLTDKRRLKKIMDPRLEEQY--PIKGALLAGQIIIKCLEAEPKNRPSMEEVLE------T 381
P LE Y P+K + + CL EP RP+ +E+L+
Sbjct: 237 -------------PTLEGNYSKPLK------EFVEACLNKEPSFRPTAKELLKHKFILRN 277
Query: 382 LQNISVIE--IEPKKKAKARGNYNNN 405
+ S + I+ K+ KA +++++
Sbjct: 278 AKKTSYLTELIDRYKRWKAEQSHDDS 303
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 72/306 (23%), Positives = 124/306 (40%), Gaps = 71/306 (23%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVK 157
+ + LG+G FG+V+K + +T G A K S + L ++ E++
Sbjct: 18 NEVWEIVGELGDGAFGKVYKA-KNKET--------GALAAAKVIETKSEEELEDYIVEIE 68
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI-- 215
L HP +VKL+G + D + ++ E+ G+++ + L T +I +
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGL---TEPQIQVVC 123
Query: 216 -DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL-AKLGPIDG--NSHVTTR 271
+ L FLHS K +I+RD KA N+L+ + +L+DFG+ AK +S +
Sbjct: 124 RQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--- 178
Query: 272 IMGTYGYAAPEYVATGHL----Y-VKSDVYGFGVVLLEMLTG---------LRAL---DT 314
GT + APE V + Y K+D++ G+ L+EM +R L
Sbjct: 179 --GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 236
Query: 315 NRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS 374
+ P P+L + + L+ P+ RPS
Sbjct: 237 SDP-----------PTLLTPSKWSVEFR----------------DFLKIALDKNPETRPS 269
Query: 375 MEEVLE 380
++LE
Sbjct: 270 AAQLLE 275
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 75/305 (24%), Positives = 123/305 (40%), Gaps = 50/305 (16%)
Query: 92 QDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK----SNPDSIQ 147
Q ++ + +G G +G V K + HK P+ G+ +AVK+ + +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNK--MVHK---PS----GQIMAVKRIRSTVDEKEQK 65
Query: 148 GLREWQAEVKFLGKFS-HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL--FRKGSAEP 204
L ++ + + S P +V+ G + + + E M S + +
Sbjct: 66 QL---LMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDV 121
Query: 205 LPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL-AKLGPID 263
+P KI + K L L +I+RD K SNILLD S N KL DFG+ +L
Sbjct: 122 IPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL---- 176
Query: 264 GNSHVTTRIMGTYGYAAPE---YVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSG 319
+S TR G Y APE A+ Y V+SDV+ G+ L E+ TG
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG----------- 225
Query: 320 EHVLVDFARPSL-TDKRRLKKIMD---PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM 375
F P + +L +++ P+L + + + CL + RP
Sbjct: 226 -----RFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKY 280
Query: 376 EEVLE 380
+E+L+
Sbjct: 281 KELLK 285
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 72/303 (23%), Positives = 117/303 (38%), Gaps = 67/303 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-GLREWQAEVKFLGKFSHP 165
+G G V + VA+K+ N + Q + E E++ + + HP
Sbjct: 23 IGSGATAVVQAA-YCAPK--------KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLK---IAI---DAAK 219
N+V + LV + + GS+ + + A+ + L IA + +
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG----LAKLGPIDGNSHVTTRIMGT 275
L +LH I+RD KA NILL + +++DFG LA G I N T + GT
Sbjct: 133 GLEYLHK--NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GT 189
Query: 276 YGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTG---------LRAL---DTNRPSGEHV 322
+ APE + Y K+D++ FG+ +E+ TG ++ L N P
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP----- 244
Query: 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLA-----GQIIIKCLEAEPKNRPSMEE 377
P LE K L ++I CL+ +P+ RP+ E
Sbjct: 245 --------------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284
Query: 378 VLE 380
+L
Sbjct: 285 LLR 287
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 68/288 (23%), Positives = 112/288 (38%), Gaps = 51/288 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK----SNPDSIQGLREWQAEVKFLGKF 162
+G G G+V+K + T G +AVK+ N + + + ++ + K
Sbjct: 33 MGSGTCGQVWKMR--FR---KT----GHVIAVKQMRRSGNKEENKRI---LMDLDVVLKS 80
Query: 163 S-HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDL 221
P +V+ G + + E M + +K P+P K+ + K L
Sbjct: 81 HDCPYIVQCFGTFITNTDVFIAMELMGTCAE---KLKKRMQGPIPERILGKMTVAIVKAL 137
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL-AKLGPIDGNSHVTTRIMGTYGYAA 280
+L + VI+RD K SNILLD KL DFG+ +L + R G Y A
Sbjct: 138 YYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV----DDKAKDRSAGCAAYMA 192
Query: 281 PE----YVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
PE T Y +++DV+ G+ L+E+ TG + DF
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------DF--------E 237
Query: 336 RLKKIMD---PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
L K++ P L + + + CL + + RP ++LE
Sbjct: 238 VLTKVLQEEPPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 84/285 (29%), Positives = 117/285 (41%), Gaps = 36/285 (12%)
Query: 32 ENKADGLEMAGEINDVKDEHERKADDADEGRQLGDGDGGDKNMPSSGEIVTPNYLKMFTL 91
E + E I V D ++ A G D + E+ T+
Sbjct: 91 ETPEEREEWTTAIQTVADGLKK---QAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTM 147
Query: 92 QDLRAATKNFRPDTMLGEGGFGRVFKGWVDHK---TLAPTKVGVGKAVAVKKSNPDSIQG 148
+ F +LG+G FG+V V K K+ + K V V K
Sbjct: 148 NE-------FEYLKLLGKGTFGKVIL--VKEKATGRYYAMKI-LKKEVIVAKDEVAHTL- 196
Query: 149 LREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLP 206
E + L HP L L Y ++ L V EY G L HL R+ +E
Sbjct: 197 -----TENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR- 249
Query: 207 WNTRLKIA-IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGN 265
R A I +A L +LHS EK+V+YRD K N++LD + K++DFGL K G DG
Sbjct: 250 --ARFYGAEIVSA--LDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304
Query: 266 SHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGL 309
+ GT Y APE V + Y ++ D +G GVV+ EM+ G
Sbjct: 305 T--MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 4e-26
Identities = 55/313 (17%), Positives = 92/313 (29%), Gaps = 55/313 (17%)
Query: 108 GEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--GLREWQAEVKFLGKFSHP 165
G V T G+ V V++ N ++ + Q E+ F+HP
Sbjct: 36 GFEDLMTVNLA-RYKPT--------GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI---DAAKDLT 222
N+V D + +V +M GS + L + + L IA K L
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMN---ELAIAYILQGVLKALD 142
Query: 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG-LAKLGPIDGNSHVTTRIM----GTYG 277
++H ++R KAS+IL+ LS + V
Sbjct: 143 YIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 278 YAAPEYVA-TGHLY-VKSDVYGFGVVLLEMLTG---------LRAL------DTNRPSGE 320
+ +PE + Y KSD+Y G+ E+ G + L
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260
Query: 321 HVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQI-------------IIKCLEA 367
+ + + L P + + +CL+
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320
Query: 368 EPKNRPSMEEVLE 380
P RPS +L
Sbjct: 321 NPDARPSASTLLN 333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 75/283 (26%), Positives = 109/283 (38%), Gaps = 44/283 (15%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAE 155
FR +LG+GGFG V + GK A KK I +G E
Sbjct: 184 NTFRQYRVLGKGGFGEVCA--CQVR-------ATGKMYACKKLEKKRIKKRKGEAMALNE 234
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA 214
+ L K + +V L Y +E + L LV M G L+ H++ G A A
Sbjct: 235 KQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 215 -IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM 273
I L LH + ++YRD K NILLD + ++SD GLA + + R+
Sbjct: 294 EICCG--LEDLHR--ERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRV- 346
Query: 274 GTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGL---RALDTNRPSGEHVLVDFARP 329
GT GY APE V Y S D + G +L EM+ G + E
Sbjct: 347 GTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE--------- 396
Query: 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR 372
++ + E+Y + + A + + L +P R
Sbjct: 397 --VERLVKEV------PEEYSERFSPQARSLCSQLLCKDPAER 431
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 63/221 (28%), Positives = 91/221 (41%), Gaps = 31/221 (14%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAE 155
+F ++G GGFG V+ GK A+K + I QG E
Sbjct: 189 NDFSVHRIIGRGGFGEVYG--CRKA-------DTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 156 VKFLGKFS---HPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTR 210
L S P +V + Y + L + + M G L HL + G +E R
Sbjct: 240 RIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD---MR 295
Query: 211 LKIA-IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269
A I L +H+ + V+YRD K +NILLD + ++SD GLA
Sbjct: 296 FYAAEIILG--LEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 347
Query: 270 TRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGL 309
+GT+GY APE + G Y S D + G +L ++L G
Sbjct: 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 67/289 (23%), Positives = 118/289 (40%), Gaps = 52/289 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK----SNPDSIQGLREWQAEVKFLGKF 162
LG G +G V K + H P+ G+ +AVK+ N + L ++ +
Sbjct: 15 LGRGAYGVVEK--MRHV---PS----GQIMAVKRIRATVNSQEQKRL---LMDLDISMRT 62
Query: 163 S-HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFR-KGSAEPLPWNTRLKIAIDAAKD 220
P V G + + + E M SL+ + + +P + KIA+ K
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL-AKLGPIDGNSHVTTRIMGTYGYA 279
L LHS + SVI+RD K SN+L++ K+ DFG+ L + G Y
Sbjct: 122 LEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV----DDVAKDIDAGCKPYM 176
Query: 280 APE---YVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
APE Y VKSD++ G+ ++E+ + P +
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAIL-----------RFPYDSWGTPF----Q 221
Query: 336 RLKKIMD---PRL-EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+LK++++ P+L +++ + +CL+ K RP+ E+++
Sbjct: 222 QLKQVVEEPSPQLPADKFSAE----FVDFTSQCLKKNSKERPTYPELMQ 266
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 69/277 (24%), Positives = 110/277 (39%), Gaps = 46/277 (16%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGKF 162
+G+G FG+V V K A+K N E + E++ +
Sbjct: 22 AIGKGSFGKVCI--VQKN-------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 163 SHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIA-IDAAK 219
HP LV L Y ++D + + +V + + G L HL + E +L I + A
Sbjct: 73 EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET---VKLFICELVMA- 127
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA 279
L +L + + +I+RD K NILLD + ++DF +A + P T + GT Y
Sbjct: 128 -LDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-RETQITT--MAGTKPYM 181
Query: 280 APEYVAT--GHLYVKS-DVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336
APE ++ G Y + D + GV E+L G RP + S T +
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR------RP--------YHIRSSTSSKE 227
Query: 337 L-KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR 372
+ + YP + ++ K LE P R
Sbjct: 228 IVHTFETTVV--TYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 75/300 (25%), Positives = 124/300 (41%), Gaps = 66/300 (22%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVK 157
+ F LGEG +G V+K + +T G+ VA+K+ + L+E E+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKA-IHKET--------GQIVAIKQVPVE--SDLQEIIKEIS 76
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI-- 215
+ + P++VK G +++ +V EY GS+ + + + + L T +IA
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTL---TEDEIATIL 131
Query: 216 -DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL-AKLGPIDGNSHVTTRIM 273
K L +LH I+RD KA NILL+ +AKL+DFG+ +L D + T I
Sbjct: 132 QSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNTVI- 186
Query: 274 GTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTG---------LRAL---DTNRPSGE 320
GT + APE V Y +D++ G+ +EM G +RA+ TN P
Sbjct: 187 GTPFWMAPE-VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP--- 242
Query: 321 HVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
P+ + +CL P+ R + ++L+
Sbjct: 243 --------PTFRKPELWSDNFT----------------DFVKQCLVKSPEQRATATQLLQ 278
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 100 NFRPDTMLGEGGFGRVF----KGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAE 155
F +LG+G FG+VF D + L KV + KA + + E
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV-LKKATLKVRDRVRTK-------ME 76
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKI 213
L + +HP +VKL Y ++ L L+ ++++ G L L ++ E + +
Sbjct: 77 RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED---VKFYL 132
Query: 214 A-IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRI 272
A + A L LHS +IYRD K NILLD + KL+DFGL+K
Sbjct: 133 AELALA--LDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSF 186
Query: 273 MGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGL 309
GT Y APE V + +S D + FGV++ EMLTG
Sbjct: 187 CGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 73/221 (33%), Positives = 104/221 (47%), Gaps = 31/221 (14%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPT------KVGVGKAVAVKKSNPDSIQGLREW- 152
F +LG+GG+G+VF+ V T A T KV + KA+ V+ +
Sbjct: 18 CFELLRVLGKGGYGKVFQ--VRKVTGANTGKIFAMKV-LKKAMIVRNAK------DTAHT 68
Query: 153 QAEVKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTR 210
+AE L + HP +V LI Y ++ L L+ EY+ G L L R+G E
Sbjct: 69 KAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT---AC 124
Query: 211 LKIA-IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269
+A I A L LH K +IYRD K NI+L+ + KL+DFGL K DG T
Sbjct: 125 FYLAEISMA--LGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--T 178
Query: 270 TRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGL 309
GT Y APE + + ++ D + G ++ +MLTG
Sbjct: 179 HTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 62/251 (24%), Positives = 96/251 (38%), Gaps = 31/251 (12%)
Query: 71 DKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKV 130
DK + + P ++ L+++R +F ++G G F V V K
Sbjct: 36 DKYVADFLQWAEPIVVR---LKEVRLQRDDFEILKVIGRGAFSEVAV--VKMK------- 83
Query: 131 GVGKAVAVKKSNPDSIQGLRE---WQAEVKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEY 186
G+ A+K N + E ++ E L + +L + ++D +L LV EY
Sbjct: 84 QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEY 142
Query: 187 MQKGSLENHLFRKGSAEPLPWNTRLKIA-IDAAKDLTFLHSSEKSVIYRDFKASNILLDG 245
G L L + G P R +A I A + +H ++RD K NILLD
Sbjct: 143 YVGGDLLTLLSKFGERIPAEM-ARFYLAEIVMA--IDSVHR--LGYVHRDIKPDNILLDR 197
Query: 246 SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYG-------F 298
+ +L+DFG DG + GT Y +PE + + YG
Sbjct: 198 CGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256
Query: 299 GVVLLEMLTGL 309
GV EM G
Sbjct: 257 GVFAYEMFYGQ 267
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 78/276 (28%), Positives = 118/276 (42%), Gaps = 31/276 (11%)
Query: 45 NDVKDEHERKADDADEGRQLGDGDGGDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPD 104
+ E E + G GDGG++ + E+ T N + +NF
Sbjct: 4 HHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTG----HAEKVGIENFELL 59
Query: 105 TMLGEGGFGRVF----KGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREW-QAEVKFL 159
+LG G +G+VF D L KV + KA V+K+ E + E + L
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKV-LKKATIVQKAK------TTEHTRTERQVL 112
Query: 160 GKFSH-PNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIA-I 215
P LV L Y ++ L L+ +Y+ G L HL ++ E ++ + I
Sbjct: 113 EHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHE---VQIYVGEI 168
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
A L LH +IYRD K NILLD + + L+DFGL+K + + GT
Sbjct: 169 VLA--LEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGT 223
Query: 276 YGYAAPEYVATGHL-YVKS-DVYGFGVVLLEMLTGL 309
Y AP+ V G + K+ D + GV++ E+LTG
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 75/337 (22%), Positives = 118/337 (35%), Gaps = 66/337 (19%)
Query: 62 RQLGDGDGGDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVD 121
G + TP L + ++ LG G +G V D
Sbjct: 3 HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLS---EMYQRVKKLGSGAYGEVLLC-RD 58
Query: 122 HKTLAPTKVGVGKAVAVK-----KSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176
T A+K + S L E EV L HPN++KL + +
Sbjct: 59 KVT--------HVERAIKIIRKTSVSTSSNSKLLE---EVAVLKLLDHPNIMKLYDFFED 107
Query: 177 DRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAK-------DLTFLHSSE 228
R + LV E + G L + + + E DAA +T+LH
Sbjct: 108 KRNYYLVMECYKGGELFDEIIHRMKFNEV-----------DAAVIIKQVLSGVTYLHK-- 154
Query: 229 KSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA 285
++++RD K N+LL + K+ DFGL+ + N +GT Y APE V
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKERLGTAYYIAPE-VL 210
Query: 286 TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM--DP 343
K DV+ GV+L +L G TD+ L+K+
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFGGQ----------------TDQEILRKVEKGKY 254
Query: 344 RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ + A +I + L+ + + R S ++ LE
Sbjct: 255 TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 76/294 (25%), Positives = 115/294 (39%), Gaps = 66/294 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK------SNPDSIQGLREWQAEVKFLG 160
LG+G FG V D T G+ AVK + L EV+ L
Sbjct: 34 LGKGSFGEVILC-KDKIT--------GQECAVKVISKRQVKQKTDKESLLR---EVQLLK 81
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAK 219
+ HPN++KL + + F LV E G L + + + +E DAA+
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----------DAAR 130
Query: 220 -------DLTFLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVT 269
+T++H +++RD K N+LL N ++ DFGL+ + + +
Sbjct: 131 IIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMK 186
Query: 270 TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP-SGEHVLVDFAR 328
+I GT Y APE V G K DV+ GV+L +L+G P +G
Sbjct: 187 DKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC------PPFNGA-------- 230
Query: 329 PSLTDKRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ LKK+ E K + A +I K L P R S + L+
Sbjct: 231 ---NEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 85/328 (25%), Positives = 133/328 (40%), Gaps = 56/328 (17%)
Query: 59 DEGRQLGDGDGGDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKG 118
+ Q G G ++ + + LQD F ++G G + +V
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQD-------FDLLRVIGRGSYAKVLL- 70
Query: 119 WVDHKT---LAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGK-FSHPNLVKLIGYC 174
V K + +V V K + + D +Q E + +HP LV L C
Sbjct: 71 -VRLKKTDRIYAMRV-VKKELVNDDEDIDWVQ------TEKHVFEQASNHPFLVGLH-SC 121
Query: 175 W--EDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIA-IDAAKDLTFLHSSEKS 230
+ E R F V EY+ G L H+ R+ E R A I A L +LH E+
Sbjct: 122 FQTESRLFF-VIEYVNGGDLMFHMQRQRKLPEEH---ARFYSAEISLA--LNYLH--ERG 173
Query: 231 VIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM-GTYGYAAPEYVATGHL 289
+IYRD K N+LLD + KL+D+G+ K G G+ TT GT Y APE + G
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPE-ILRGED 229
Query: 290 YVKS-DVYGFGVVLLEMLTGL----RALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPR 344
Y S D + GV++ EM+ G ++ P T+ + I++ +
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-----------TEDYLFQVILEKQ 278
Query: 345 LEEQYPIKGALLAGQIIIKCLEAEPKNR 372
+ + P ++ A ++ L +PK R
Sbjct: 279 I--RIPRSLSVKAASVLKSFLNKDPKER 304
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 72/213 (33%), Positives = 97/213 (45%), Gaps = 31/213 (14%)
Query: 106 MLGEGGFGRVFKGWVDHKT---LAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF 162
+LG+G FG+V V K K+ + K V + K E + L
Sbjct: 12 LLGKGTFGKVIL--VREKATGRYYAMKI-LRKEVIIAKDEVAHTV------TESRVLQNT 62
Query: 163 SHPNLVKLIGYCW--EDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIA-IDAA 218
HP L L Y + DR V EY G L HL R+ E R A I +A
Sbjct: 63 RHPFLTALK-YAFQTHDRLCF-VMEYANGGELFFHLSRERVFTEER---ARFYGAEIVSA 117
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM-GTYG 277
L +LHS + V+YRD K N++LD + K++DFGL K G DG T + GT
Sbjct: 118 --LEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPE 170
Query: 278 YAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGL 309
Y APE V + Y ++ D +G GVV+ EM+ G
Sbjct: 171 YLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 61/285 (21%), Positives = 110/285 (38%), Gaps = 45/285 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA----EVKFLGKF 162
LGEG +G+V + +D +T AVK ++ + +A E++ L +
Sbjct: 13 LGEGSYGKVKEV-LDSET--------LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 163 SHPNLVKL--IGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKI---AIDA 217
H N+++L + Y E ++ +V EY G E + + P ID
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
L +LHS + ++++D K N+LL K+S G+A+ G+
Sbjct: 122 ---LEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 278 YAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
+ PE + K D++ GV L + TGL + G+++ L
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE-----GDNI------YKL---- 221
Query: 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ I + P ++ LE EP R S+ ++ +
Sbjct: 222 -FENIG--KGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 67/217 (30%), Positives = 96/217 (44%), Gaps = 30/217 (13%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEV 156
F LG G FGRV V HK G A+K + + L++ + E
Sbjct: 42 QFDRIKTLGTGSFGRVML--VKHK-------ESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIA 214
+ L + P LVKL + ++D L +V EY+ G + +HL R G +EP R A
Sbjct: 93 RILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---ARFYAA 148
Query: 215 -IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM 273
I +LHS +IYRD K N+L+D +++DFG AK T +
Sbjct: 149 QIVLT--FEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLC 199
Query: 274 GTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGL 309
GT APE + Y K+ D + GV++ EM G
Sbjct: 200 GTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 79/277 (28%), Positives = 120/277 (43%), Gaps = 41/277 (14%)
Query: 106 MLGEGGFGRVFKGWVDHKT---LAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGK- 161
++G G + +V V K + KV V K + + D +Q E +
Sbjct: 16 VIGRGSYAKVLL--VRLKKTDRIYAMKV-VKKELVNDDEDIDWVQ------TEKHVFEQA 66
Query: 162 FSHPNLVKLIGYCW--EDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIA-IDA 217
+HP LV L C+ E R F V EY+ G L H+ R+ E R A I
Sbjct: 67 SNHPFLVGLH-SCFQTESRLFF-VIEYVNGGDLMFHMQRQRKLPEEH---ARFYSAEISL 121
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM-GTY 276
A L +LH + +IYRD K N+LLD + KL+D+G+ K G G+ TT GT
Sbjct: 122 A--LNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTP 174
Query: 277 GYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
Y APE + G Y S D + GV++ EM+ G R + V T+
Sbjct: 175 NYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAG-------RSPFDIVGSSDNPDQNTEDY 226
Query: 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR 372
+ I++ ++ + P ++ A ++ L +PK R
Sbjct: 227 LFQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 70/340 (20%), Positives = 119/340 (35%), Gaps = 75/340 (22%)
Query: 69 GGDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPT 128
G +N+ G + P + +++ LG G +G V +
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIG---ESYFKVRKLGSGAYGEVLLC-KEKNG---- 60
Query: 129 KVGVGKAVAVK---KSNPDSIQGLREWQA----------EVKFLGKFSHPNLVKLIGYCW 175
A+K KS D + + + E+ L HPN++KL
Sbjct: 61 ----HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116
Query: 176 EDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKDLT--------FLHS 226
+ + F LV E+ + G L + + E A ++ +LH
Sbjct: 117 DKKYFYLVTEFYEGGELFEQIINRHKFDE------------CDAANIMKQILSGICYLHK 164
Query: 227 SEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEY 283
++++RD K NILL + N K+ DFGL+ + + +GT Y APE
Sbjct: 165 --HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKLRD-RLGTAYYIAPE- 218
Query: 284 VATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP-SGEHVLVDFARPSLTDKRRLKKIM- 341
V K DV+ GV++ +L G P G+ D+ +KK+
Sbjct: 219 VLKKKYNEKCDVWSCGVIMYILLCG------YPPFGGQ-----------NDQDIIKKVEK 261
Query: 342 -DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ + A ++I L + R + EE L
Sbjct: 262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-23
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 30/211 (14%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEVKFLGKF 162
LG G FGRV + + G+ A+K + + L++ + E L
Sbjct: 13 TLGTGSFGRVHL--IRSR-------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 163 SHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIA-IDAAK 219
+HP ++++ ++D Q + ++ +Y++ G L + L + P+ + A + A
Sbjct: 64 THPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV---AKFYAAEVCLA- 118
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA 279
L +LHS K +IYRD K NILLD + + K++DFG AK P VT + GT Y
Sbjct: 119 -LEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYI 170
Query: 280 APEYVATGHLYVKS-DVYGFGVVLLEMLTGL 309
APE V + Y KS D + FG+++ EML G
Sbjct: 171 APE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 77/250 (30%), Positives = 107/250 (42%), Gaps = 39/250 (15%)
Query: 70 GDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKT---LA 126
G K G + N + + F +LG+G FG+V K L
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGIDN-------FEFIRVLGKGSFGKVML--ARVKETGDLY 51
Query: 127 PTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGK-FSHPNLVKLIGYCW--EDRQFLLV 183
KV + K V ++ + + E + L +HP L +L C+ DR F V
Sbjct: 52 AVKV-LKKDVILQDDDVECTM------TEKRILSLARNHPFLTQLF-CCFQTPDRLFF-V 102
Query: 184 YEYMQKGSLENHLFRKGS-AEPLPWNTRLKIA-IDAAKDLTFLHSSEKSVIYRDFKASNI 241
E++ G L H+ + E R A I +A L FLH K +IYRD K N+
Sbjct: 103 MEFVNGGDLMFHIQKSRRFDEAR---ARFYAAEIISA--LMFLHD--KGIIYRDLKLDNV 155
Query: 242 LLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM-GTYGYAAPEYVATGHLYVKS-DVYGFG 299
LLD + KL+DFG+ K G +G TT GT Y APE + LY + D + G
Sbjct: 156 LLDHEGHCKLADFGMCKEGICNGV---TTATFCGTPDYIAPE-ILQEMLYGPAVDWWAMG 211
Query: 300 VVLLEMLTGL 309
V+L EML G
Sbjct: 212 VLLYEMLCGH 221
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 57/229 (24%), Positives = 90/229 (39%), Gaps = 26/229 (11%)
Query: 91 LQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR 150
++ +R ++F ++G G FG V V K K A+K N +
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVAV--VKLK-------NADKVFAMKILNKWEMLKRA 116
Query: 151 E---WQAEVKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLP 206
E ++ E L + L Y ++D L LV +Y G L L + P
Sbjct: 117 ETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE 175
Query: 207 WNTRLKIA-IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGN 265
R +A + A + +H ++RD K NIL+D + + +L+DFG DG
Sbjct: 176 M-ARFYLAEMVIA--IDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230
Query: 266 SHVTTRIMGTYGYAAPEYVATGHL----YVKS-DVYGFGVVLLEMLTGL 309
+ +GT Y +PE + Y D + GV + EML G
Sbjct: 231 VQSSV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-23
Identities = 65/290 (22%), Positives = 107/290 (36%), Gaps = 59/290 (20%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREW-QAEVKFLGKFSHP 165
LGEG +G V V+ T +AVAVK + E + E+ +H
Sbjct: 15 LGEGAYGEVQLA-VNRVT--------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 166 NLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA---------I 215
N+VK G + L EY G L + + + +
Sbjct: 66 NVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLM 115
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
+ +LH + +RD K N+LLD N K+SDFGLA + + + ++ GT
Sbjct: 116 AG---VVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 276 YGYAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333
Y APE + + DV+ G+VL ML G L P + +PS +
Sbjct: 171 LPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG--EL----P--------WDQPSDSC 215
Query: 334 KRRLKKIMDPRLEEQYPIKGALL---AGQIIIKCLEAEPKNRPSMEEVLE 380
+ ++ Y + ++ K L P R ++ ++ +
Sbjct: 216 -QEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 83/353 (23%), Positives = 126/353 (35%), Gaps = 76/353 (21%)
Query: 51 HERKADDADEGRQLGDGDGGDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEG 110
H D + G MP+ G + + L K F +G G
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHG 65
Query: 111 GFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREW---QAEVKFLGKFSHPNL 167
FG V+ D + + VA+KK + Q +W EV+FL K HPN
Sbjct: 66 SFGAVYFA-RDVRN--------SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 168 VKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI---DAAKDLTFL 224
++ G + LV EY + + K PL ++IA A + L +L
Sbjct: 117 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PL---QEVEIAAVTHGALQGLAYL 170
Query: 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR--IMGTYGYAAPE 282
HS ++I+RD KA NILL KL DFG A S + +GT + APE
Sbjct: 171 HS--HNMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPE 220
Query: 283 YVA--TGHLY-VKSDVYGFGVVLLEMLTG---------LRAL---DTNRPSGEHVLVDFA 327
+ Y K DV+ G+ +E+ + AL N
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---------- 270
Query: 328 RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
P+L + + + CL+ P++RP+ E +L+
Sbjct: 271 -PALQSGHWSEYFRN-----------------FVDSCLQKIPQDRPTSEVLLK 305
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 78/257 (30%), Positives = 108/257 (42%), Gaps = 39/257 (15%)
Query: 63 QLGDGDGGDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDH 122
+L + + PS + P+ D F ++G+G FG+V H
Sbjct: 9 ELMNANPAPPPAPSQQINLGPSSNPHAKPSD-------FHFLKVIGKGSFGKVLL--ARH 59
Query: 123 KTLAPTKVGVGKAVAVKKSNPDSIQGLREW---QAEVKFLGK-FSHPNLVKLIGYCW--E 176
K AVK +I +E +E L K HP LV L + +
Sbjct: 60 K-------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTA 111
Query: 177 DRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIA-IDAAKDLTFLHSSEKSVIYR 234
D+ + V +Y+ G L HL R+ EP R A I +A L +LHS +++YR
Sbjct: 112 DKLYF-VLDYINGGELFYHLQRERCFLEPR---ARFYAAEIASA--LGYLHS--LNIVYR 163
Query: 235 DFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM-GTYGYAAPEYVATGHLYVKS 293
D K NILLD + L+DFGL K + TT GT Y APE V Y ++
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTFCGTPEYLAPE-VLHKQPYDRT 219
Query: 294 -DVYGFGVVLLEMLTGL 309
D + G VL EML GL
Sbjct: 220 VDWWCLGAVLYEMLYGL 236
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 70/214 (32%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 106 MLGEGGFGRVFKGWVDHKT---LAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGK- 161
+LG+G FG+V + K L K+ + K V ++ + + E + L
Sbjct: 27 VLGKGSFGKVML--SERKGTDELYAVKI-LKKDVVIQDDDVECTM------VEKRVLALP 77
Query: 162 FSHPNLVKLIGYCW--EDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIA-IDA 217
P L +L C+ DR + V EY+ G L H+ + G EP A I
Sbjct: 78 GKPPFLTQLH-SCFQTMDRLYF-VMEYVNGGDLMYHIQQVGRFKEPH---AVFYAAEIAI 132
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM-GTY 276
L FL S K +IYRD K N++LD + K++DFG+ K DG TT+ GT
Sbjct: 133 G--LFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTP 185
Query: 277 GYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGL 309
Y APE + Y KS D + FGV+L EML G
Sbjct: 186 DYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-23
Identities = 66/297 (22%), Positives = 113/297 (38%), Gaps = 61/297 (20%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQA- 154
++ +LG GGFG V+ G +V VA+K K L
Sbjct: 43 SQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 155 --EVKFLGKFSH--PNLVKLIGYCWEDRQFLLVYEYMQ-KGSLENHLFRKGSAEPLPWNT 209
EV L K S +++L+ + F+L+ E + L + + +G L
Sbjct: 94 PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEEL 150
Query: 210 RLKI---AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY-NAKLSDFGLAKLGPIDGN 265
++A + H+ V++RD K NIL+D + KL DFG L D
Sbjct: 151 ARSFFWQVLEAVR---HCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV 204
Query: 266 SHVTTRIMGTYGYAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323
GT Y+ PE++ H Y + V+ G++L +M+ G + P
Sbjct: 205 YTDFD---GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCG--DI----P------ 248
Query: 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
F ++I+ ++ + + + +I CL P +RP+ EE+
Sbjct: 249 --F--------EHDEEIIRGQVF--FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 9e-23
Identities = 72/351 (20%), Positives = 124/351 (35%), Gaps = 68/351 (19%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREW-QAEVKFLGKFSHP 165
LGEG +G V V+ T +AVAVK + E + E+ +H
Sbjct: 15 LGEGAYGEVQLA-VNRVT--------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 166 NLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA---------I 215
N+VK G + L EY G L + + + +
Sbjct: 66 NVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLM 115
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
+ +LH + +RD K N+LLD N K+SDFGLA + + + ++ GT
Sbjct: 116 AG---VVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 276 YGYAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333
Y APE + + DV+ G+VL ML G L P + +PS +
Sbjct: 171 LPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG--EL----P--------WDQPSDSC 215
Query: 334 KRRLKKIMDPRLEEQYPIKGALL---AGQIIIKCLEAEPKNRPSMEEV---------LET 381
+ ++ Y + ++ K L P R ++ ++ L+
Sbjct: 216 QEYSDWK----EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 271
Query: 382 LQNISVIEIEPKKKAKARGNYNNNSNDNQRGHPHNRRSQSPLHSKHGDHNN 432
+ ++ + + + SN + R+ SK H++
Sbjct: 272 GAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHHHH 322
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 75/299 (25%), Positives = 123/299 (41%), Gaps = 63/299 (21%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQA- 154
+R +LG+GGFG VF G ++ VA+K ++ L +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81
Query: 155 --EVKFL----GKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGS-LENHLFRKGS-AEPLP 206
EV L HP +++L+ + F+LV E L +++ KG E
Sbjct: 82 PLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP- 140
Query: 207 WNTRLKI--AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA-KLSDFGLAKLGPID 263
+R + A + HS + V++RD K NIL+D KL DFG L D
Sbjct: 141 --SRCFFGQVVAAIQ---HCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-D 192
Query: 264 GNSHVTTRIMGTYGYAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321
GT Y+ PE+++ H Y + V+ G++L +M+ G + P
Sbjct: 193 EPYTDFD---GTRVYSPPEWIS-RHQYHALPATVWSLGILLYDMVCG--DI----P---- 238
Query: 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
F R ++I++ L +P + +I +CL +P +RPS+EE+L
Sbjct: 239 ----F--------ERDQEILEAEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 80/292 (27%), Positives = 129/292 (44%), Gaps = 67/292 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQAEVKFLGKFS 163
LG G FG+V G T G VAVK + S+ + + + E++ L F
Sbjct: 19 LGVGTFGKVKIG-EHQLT--------GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 164 HPNLVKLIGY-CWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA------- 214
HP+++KL Y +V EY+ G L +++ + G R++
Sbjct: 70 HPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG---------RVEEMEARRLFQ 118
Query: 215 --IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRI 272
+ A + + H V++RD K N+LLD NAK++DFGL+ + DG T+
Sbjct: 119 QILSA---VDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTS-- 170
Query: 273 MGTYGYAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330
G+ YAAPE V +G LY + D++ GV+L +L G D EHV P+
Sbjct: 171 CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD-----DEHV------PT 218
Query: 331 LTDKRRLKKIMDPRLEEQYPIKGAL--LAGQIIIKCLEAEPKNRPSMEEVLE 380
L KKI + I L +++ L+ +P R +++++ E
Sbjct: 219 L-----FKKI----RGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 70/237 (29%), Positives = 97/237 (40%), Gaps = 37/237 (15%)
Query: 82 TPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKS 141
P+ ++D F MLG+G FG+VF LA K + A+K
Sbjct: 7 RPSLQIKLKIED-------FILHKMLGKGSFGKVF--------LAEFK-KTNQFFAIKAL 50
Query: 142 NPDSIQGLREW---QAEVKFLGK-FSHPNLVKLIGYCW--EDRQFLLVYEYMQKGSLENH 195
D + + E + L + HP L + + ++ F V EY+ G L H
Sbjct: 51 KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFF-VMEYLNGGDLMYH 108
Query: 196 LFRKGS-AEPLPWNTRLKIA-IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253
+ A I L FLHS K ++YRD K NILLD + K++D
Sbjct: 109 IQSCHKFDLS---RATFYAAEIILG--LQFLHS--KGIVYRDLKLDNILLDKDGHIKIAD 161
Query: 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGL 309
FG+ K + T GT Y APE + G Y S D + FGV+L EML G
Sbjct: 162 FGMCKENMLGDA--KTNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 62/325 (19%), Positives = 107/325 (32%), Gaps = 79/325 (24%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK-----KSNPDSIQGLREWQAEVKFLGK 161
+G+G +G V ++++T A+K K + + + + EV+ + K
Sbjct: 34 IGQGSYGVVRVA-IENQT--------RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI------ 215
HPN+ +L +++ LV E G L + L +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 216 ------------------------DAAK-------DLTFLHSSEKSVIYRDFKASNILL- 243
+ L +LH+ + + +RD K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN--QGICHRDIKPENFLFS 202
Query: 244 -DGSYNAKLSDFGLAKL--GPIDGNSHVTTRIMGTYGYAAPEYV-ATGHLY-VKSDVYGF 298
+ S+ KL DFGL+K +G + T GT + APE + T Y K D +
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262
Query: 299 GVVLLEMLTGLRALDTNRP-SGEHVLVDFARPSLTDKRRLKKIM--DPRLEEQYPIKGAL 355
GV+L +L G P G D + +++ E +
Sbjct: 263 GVLLHLLLMGA------VPFPGV-----------NDADTISQVLNKKLCFENPNYNVLSP 305
Query: 356 LAGQIIIKCLEAEPKNRPSMEEVLE 380
LA ++ L R L+
Sbjct: 306 LARDLLSNLLNRNVDERFDAMRALQ 330
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 69/294 (23%), Positives = 123/294 (41%), Gaps = 72/294 (24%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGV----GKAVAVK-----KSNPDSIQGLREWQAEVK 157
+G+G F +V K+ G+ VA+K + NP S+Q L EV+
Sbjct: 23 IGKGNFAKV-------------KLARHILTGREVAIKIIDKTQLNPTSLQKLF---REVR 66
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA--- 214
+ +HPN+VKL ++ L+ EY G + ++L G R+K
Sbjct: 67 IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG---------RMKEKEAR 117
Query: 215 ------IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHV 268
+ A + + H K +++RD KA N+LLD N K++DFG + G
Sbjct: 118 SKFRQIVSA---VQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGFSNE-FTVGGKLD 171
Query: 269 TTRIMGTYGYAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF 326
G YAAPE + G Y + DV+ GV+L +++G D G+++
Sbjct: 172 AF--CGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQNL---- 219
Query: 327 ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
L ++++ + P + ++ + L P R ++E++++
Sbjct: 220 --KEL-----RERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 68/248 (27%), Positives = 106/248 (42%), Gaps = 30/248 (12%)
Query: 71 DKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKV 130
+KN+ + K ++DLR +++ ++G G FG V V HK
Sbjct: 44 NKNIDNFLSRYKDTINK---IRDLRMKAEDYEVVKVIGRGAFGEVQL--VRHK------- 91
Query: 131 GVGKAVAVKKSNPDSIQGLRE---WQAEVKFLGKFSHPNLVKLIGYCWEDRQFL-LVYEY 186
K A+K + + + + E + + P +V+L Y ++D ++L +V EY
Sbjct: 92 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEY 150
Query: 187 MQKGSLENHLFRKGSAEPLPWNTRLKIA-IDAAKDLTFLHSSEKSVIYRDFKASNILLDG 245
M G L N + E R A + A L +HS I+RD K N+LLD
Sbjct: 151 MPGGDLVNLMSNYDVPEKW---ARFYTAEVVLA--LDAIHS--MGFIHRDVKPDNMLLDK 203
Query: 246 SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT---GHLYVKS-DVYGFGVV 301
S + KL+DFG +G T + GT Y +PE + + Y + D + GV
Sbjct: 204 SGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
Query: 302 LLEMLTGL 309
L EML G
Sbjct: 263 LYEMLVGD 270
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 76/294 (25%), Positives = 116/294 (39%), Gaps = 67/294 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK-----KSNPDSIQGLREWQAEVKFLGK 161
LG+G FG V K D T + AVK + + EV+ L K
Sbjct: 30 LGKGSFGEVLKC-KDRIT--------QQEYAVKVINKASAKNKDTSTILR---EVELLKK 77
Query: 162 FSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAK 219
HPN++KL ED +V E G L + + ++ +E DAA+
Sbjct: 78 LDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-----------DAAR 125
Query: 220 -------DLTFLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVT 269
+T++H ++++RD K NILL + + K+ DFGL+ N+ +
Sbjct: 126 IIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMK 181
Query: 270 TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP-SGEHVLVDFAR 328
RI GT Y APE V G K DV+ GV+L +L+G P G+
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG------TPPFYGK-------- 225
Query: 329 PSLTDKRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ LK++ + + A +I K L P R + + LE
Sbjct: 226 ---NEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 75/357 (21%), Positives = 122/357 (34%), Gaps = 93/357 (26%)
Query: 62 RQLGDGDGGDKNMPSSGEI-VTPNYLKMFTLQDLRAATKNFRPDT---------MLGEGG 111
R L + EI ++ + K+F DL ++ P LG G
Sbjct: 98 RPLNNNS----------EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGA 147
Query: 112 FGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA--------EVKFLGKFS 163
G V + KT K VA++ + +A E++ L K +
Sbjct: 148 CGEVKLA-FERKT--------CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKDLT 222
HP ++K+ + + + +V E M+ G L + + E K
Sbjct: 199 HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE------------ATCKLYF 245
Query: 223 --------FLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
+LH +I+RD K N+LL + K++DFG +K I G + +
Sbjct: 246 YQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRT 300
Query: 272 IMGTYGYAAPEYVATGHLYV----KSDVYGFGVVLLEMLTGLRALDTNRP--SGEHVLVD 325
+ GT Y APE V D + GV+L L+G P S
Sbjct: 301 LCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG-------YPPFSEHR---- 348
Query: 326 FARPSLTDKRRLKKIMDPRLEEQYPIKGAL--LAGQIIIKCLEAEPKNRPSMEEVLE 380
T +I + + + A ++ K L +PK R + EE L
Sbjct: 349 ------TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 4e-22
Identities = 85/311 (27%), Positives = 129/311 (41%), Gaps = 41/311 (13%)
Query: 9 VDDGPSKPPSPGSRTGANSLTGKENKADGLEMAGEINDVKDEHERKADDADEGRQLGDGD 68
+ G S+ G L+ +E + + + E ++ +E +K + A G+ G
Sbjct: 260 LSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQ--GTKA 317
Query: 69 GGDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKT---L 125
+K + + L D F +LG+G FG+V + K L
Sbjct: 318 PEEKTANTISKFDNNGNRDRMKLTD-------FNFLMVLGKGSFGKVML--SERKGTDEL 368
Query: 126 APTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGK-FSHPNLVKLIGYCW--EDRQFLL 182
K+ + K V ++ + + E + L P L +L C+ DR +
Sbjct: 369 YAVKI-LKKDVVIQDDDVECTM------VEKRVLALPGKPPFLTQLH-SCFQTMDRLYF- 419
Query: 183 VYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIA-IDAAKDLTFLHSSEKSVIYRDFKASN 240
V EY+ G L H+ + G EP A I L FL S K +IYRD K N
Sbjct: 420 VMEYVNGGDLMYHIQQVGRFKEPH---AVFYAAEIAIG--LFFLQS--KGIIYRDLKLDN 472
Query: 241 ILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM-GTYGYAAPEYVATGHLYVKS-DVYGF 298
++LD + K++DFG+ K DG TT+ GT Y APE + Y KS D + F
Sbjct: 473 VMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAF 528
Query: 299 GVVLLEMLTGL 309
GV+L EML G
Sbjct: 529 GVLLYEMLAGQ 539
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 73/309 (23%), Positives = 119/309 (38%), Gaps = 67/309 (21%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--------KSNPDSIQGL 149
+N+ P +LG G V + + T K AVK + + +Q L
Sbjct: 16 YENYEPKEILGRGVSSVVRRC-IHKPT--------CKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 150 RE-WQAEVKFLGKFS-HPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS----- 201
RE EV L K S HPN+++L E F LV++ M+KG L ++L K +
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE 125
Query: 202 AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP 261
+ ++ ++ + LH ++++RD K NILLD N KL+DFG +
Sbjct: 126 TRKI-----MRALLEV---ICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ-- 173
Query: 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGF-------GVVLLEMLTGLRALDT 314
+D + GT Y APE + + YG GV++ +L G
Sbjct: 174 LDPGEKLREVC-GTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS----- 226
Query: 315 NRP-SGEHVLVDFARPSLTDKRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKN 371
P L+ IM + + + ++ + L +P+
Sbjct: 227 -PPFWHR-----------KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 274
Query: 372 RPSMEEVLE 380
R + EE L
Sbjct: 275 RYTAEEALA 283
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 62/298 (20%), Positives = 108/298 (36%), Gaps = 56/298 (18%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVK 157
T + +G G + + + T AVK + E + ++
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRC-IHKAT--------NMEFAVKIIDKSKRDPTEEIEILLR 71
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAID 216
+ HPN++ L + + +V E M+ G L + + R+ +E + A
Sbjct: 72 YGQ---HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE--------REASA 120
Query: 217 AAKDLT----FLHSSEKSVIYRDFKASNILL----DGSYNAKLSDFGLAKLGPIDGNSHV 268
+T +LH+ + V++RD K SNIL + ++ DFG AK + + +
Sbjct: 121 VLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGL 176
Query: 269 TTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF- 326
T + APE V Y + D++ GV+L MLTG F
Sbjct: 177 LMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTG-------YTP-------FA 221
Query: 327 ARPSLTDKRRLKKIMDPRLEEQYP----IKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
P T + L +I + + A ++ K L +P R + VL
Sbjct: 222 NGPDDTPEEILARIGSGKFSLSGGYWNSVSDT--AKDLVSKMLHVDPHQRLTAALVLR 277
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 77/301 (25%), Positives = 116/301 (38%), Gaps = 54/301 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREWQAEVKFLG 160
+GEG +G VFK + T G+ VA+KK LRE ++ L
Sbjct: 11 IGEGSYGVVFKC-RNRDT--------GQIVAIKKFLESEDDPVIKKIALRE----IRMLK 57
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
+ HPNLV L+ R+ LV+EY ++ + L +P + I +
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQA 114
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL--GPIDGNSH-VTTRIMGTYG 277
+ F H + I+RD K NIL+ KL DFG A+L GP D V TR
Sbjct: 115 VNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----W 167
Query: 278 YAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG----------------LRALDTNRPSGE 320
Y +PE + Y DV+ G V E+L+G + L
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGD--LI-P 224
Query: 321 HVLVDFARPSLTDKRRLKKIMDPR-LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
F+ ++ D LE ++P A ++ CL +P R + E++L
Sbjct: 225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISY-PALGLLKGCLHMDPTERLTCEQLL 283
Query: 380 E 380
Sbjct: 284 H 284
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 78/292 (26%), Positives = 127/292 (43%), Gaps = 67/292 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQAEVKFLGKFS 163
LG G FG+V G T G VAVK + S+ + + + E++ L F
Sbjct: 24 LGVGTFGKVKVG-KHELT--------GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 164 HPNLVKLIGY-CWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA------- 214
HP+++KL Y + +V EY+ G L +++ + G RL
Sbjct: 75 HPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG---------RLDEKESRRLFQ 123
Query: 215 --IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRI 272
+ + + H V++RD K N+LLD NAK++DFGL+ + DG T+
Sbjct: 124 QILSG---VDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTS-- 175
Query: 273 MGTYGYAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330
G+ YAAPE V +G LY + D++ GV+L +L G D +HV P+
Sbjct: 176 CGSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD-----DDHV------PT 223
Query: 331 LTDKRRLKKIMDPRLEEQYPIKGAL--LAGQIIIKCLEAEPKNRPSMEEVLE 380
L KKI + + L ++ L+ +P R +++++ E
Sbjct: 224 L-----FKKI----CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 73/290 (25%), Positives = 114/290 (39%), Gaps = 59/290 (20%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK-----KSNPDSIQGLREWQAEVKFLGK 161
LG+G FG V K D T + AVK + + EV+ L K
Sbjct: 30 LGKGSFGEVLKC-KDRIT--------QQEYAVKVINKASAKNKDTSTILR---EVELLKK 77
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-----AEPLPWNTRLKIAID 216
HPN++KL + F +V E G L + + ++ A + +K
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFS 132
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVTTRIM 273
+T++H ++++RD K NILL + + K+ DFGL+ N+ + RI
Sbjct: 133 G---ITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRI- 184
Query: 274 GTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP-SGEHVLVDFARPSLT 332
GT Y APE V G K DV+ GV+L +L+G P G+
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------PPFYGK-----------N 226
Query: 333 DKRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ LK++ + + A +I K L P R + + LE
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 72/305 (23%), Positives = 118/305 (38%), Gaps = 59/305 (19%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQAEVKFLGKF 162
+LGEG RV ++ T + AVK K + EV+ L +
Sbjct: 20 VLGEGAHARVQTC-INLIT--------SQEYAVKIIEKQPGHIRSRVFR---EVEMLYQC 67
Query: 163 S-HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKD 220
H N+++LI + E+ +F LV+E M+ GS+ +H+ ++ E A +D
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE--------LEASVVVQD 119
Query: 221 LT----FLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAK-LGPIDGNSHVTTRI 272
+ FLH+ K + +RD K NIL + K+ DF L + S ++T
Sbjct: 120 VASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 273 M----GTYGYAAPE----YVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRP--SGEH 321
+ G+ Y APE + +Y K D++ GV+L +L+G P G
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG-------YPPFVGRC 230
Query: 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGA------LLAGQIIIKCLEAEPKNRPSM 375
+ + E +Y A +I K L + K R S
Sbjct: 231 GSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA 290
Query: 376 EEVLE 380
+VL+
Sbjct: 291 AQVLQ 295
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 66/298 (22%), Positives = 115/298 (38%), Gaps = 67/298 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--------KSNPDSIQGLREWQAEVKF 158
+G+G F V + ++ +T G+ AVK S S + L+ E
Sbjct: 32 IGKGPFSVVRRC-INRET--------GQQFAVKIVDVAKFTSSPGLSTEDLKR---EASI 79
Query: 159 LGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSA-----EPLPWNTRLK 212
HP++V+L+ L +V+E+M L + ++ A E
Sbjct: 80 CHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--------A 130
Query: 213 IAIDAAKD----LTFLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGN 265
+A + L + H ++I+RD K +LL + S KL FG+A + +
Sbjct: 131 VASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGES 186
Query: 266 SHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV 324
V +GT + APE V Y DV+G GV+L +L+G P
Sbjct: 187 GLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGC------LP------- 232
Query: 325 DFARPSLTDKRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
F T +R + I+ ++ + + A ++ + L +P R ++ E L
Sbjct: 233 -FYG---TKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 69/288 (23%), Positives = 108/288 (37%), Gaps = 50/288 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HP 165
LGEG F K V K+ +A AVK + ++ E+ L HP
Sbjct: 19 LGEGSFSICRKC-VHKKS--------NQAFAVKIISKRMEANTQK---EITALKLCEGHP 66
Query: 166 NLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKDLT-- 222
N+VKL + LV E + G L + +K +E A + L
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSE--------TEASYIMRKLVSA 118
Query: 223 --FLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
+H V++RD K N+L + + K+ DFG A+L ++ T
Sbjct: 119 VSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLH 174
Query: 278 YAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRP--SGEHVLVDFARPSLTDK 334
YAAPE + + Y +S D++ GV+L ML+G + D + +
Sbjct: 175 YAAPE-LLNQNGYDESCDLWSLGVILYTMLSG-------QVPFQSH----DRSLTCTSAV 222
Query: 335 RRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+KKI D E + + A +I L +P R M +
Sbjct: 223 EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 80/317 (25%), Positives = 119/317 (37%), Gaps = 52/317 (16%)
Query: 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA 154
R F+ + M G+G FG V G + T G +VA+KK D RE Q
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLG-KEKST--------GMSVAIKKVIQDPRFRNRELQ- 68
Query: 155 EVKFLGKFSHPNLVKL--IGYCWEDRQF-----LLVYEYMQKGSLENHL-FRKGSAEPLP 206
++ L HPN+V+L Y +R +V EY+ +L P
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP 127
Query: 207 WNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA-KLSDFGLAK-LGPIDG 264
+ + LH +V +RD K N+L++ + KL DFG AK L P +
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 265 NSH-VTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG-------------- 308
N + +R Y Y APE + Y + D++ G + EM+ G
Sbjct: 188 NVAYICSR----Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 309 --LRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYP---IKGALLAGQIIIK 363
+R L PS E + PS TD L + +K A A ++
Sbjct: 243 EIVRVLGC--PSREV--LRKLNPSHTD-VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA 297
Query: 364 CLEAEPKNRPSMEEVLE 380
L+ P+ R E L
Sbjct: 298 LLQYLPEERMKPYEALC 314
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 70/352 (19%), Positives = 115/352 (32%), Gaps = 81/352 (23%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA--- 154
+ LG G G V + KT K VA+K + +A
Sbjct: 9 RDEYIMSKTLGSGACGEVKLA-FERKT--------CKKVAIKIISKRKFAIGSAREADPA 59
Query: 155 -----EVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWN 208
E++ L K +HP ++K+ + ++ + +V E M+ G L + + E
Sbjct: 60 LNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKE----- 113
Query: 209 TRLKIAIDAAKDLT--------FLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLA 257
K +LH +I+RD K N+LL + K++DFG +
Sbjct: 114 -------ATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
Query: 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYV----KSDVYGFGVVLLEMLTGLRALD 313
K I G + + + GT Y APE V D + GV+L L+G
Sbjct: 165 K---ILGETSLMRTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG----- 215
Query: 314 TNRP--SGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGAL--LAGQIIIKCLEAEP 369
P S T +I + + + A ++ K L +P
Sbjct: 216 --YPPFSEHR----------TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP 263
Query: 370 KNRPSMEEVLE--------TLQNISVIEIEPKKKAKARGNYNNNSNDNQRGH 413
K R + EE L + + E + S +R
Sbjct: 264 KARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPR 315
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-21
Identities = 70/303 (23%), Positives = 106/303 (34%), Gaps = 66/303 (21%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK-----KSNPDSIQGLREW 152
+ N+ LG+G F V + V T G A K K + Q L
Sbjct: 5 SDNYDVKEELGKGAFSVVRRC-VHKTT--------GLEFAAKIINTKKLSARDFQKLER- 54
Query: 153 QAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRL 211
E + K HPN+V+L E+ LV++ + G L + + +E
Sbjct: 55 --EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA------- 105
Query: 212 KIAIDAAK-------DLTFLHSSEKSVIYRDFKASNILLDGSYNA---KLSDFGLAKLGP 261
DA+ + + HS +++R+ K N+LL KL+DFGLA
Sbjct: 106 ----DASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--- 156
Query: 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRP-SG 319
+S GT GY +PE V Y K D++ GV+L +L G P
Sbjct: 157 EVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGY------PPFWD 209
Query: 320 EHVLVDFARPSLTDKRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEE 377
E R +I A +I L PK R + ++
Sbjct: 210 E-----------DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQ 258
Query: 378 VLE 380
L+
Sbjct: 259 ALK 261
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 78/308 (25%), Positives = 121/308 (39%), Gaps = 68/308 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREWQAEVKFLG 160
+GEG +G V K + T G+ VA+KK +RE +K L
Sbjct: 33 VGEGSYGMVMKC-RNKDT--------GRIVAIKKFLESDDDKMVKKIAMRE----IKLLK 79
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
+ H NLV L+ C + +++ LV+E++ ++ + L + L + K
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIING 136
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL--GPIDGNSH-VTTRIMGTYG 277
+ F HS ++I+RD K NIL+ S KL DFG A+ P + V TR
Sbjct: 137 IGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----W 189
Query: 278 YAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG----------------LRALDTNRPSGE 320
Y APE + Y K+ DV+ G ++ EM G + L
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN--LIPR 247
Query: 321 H-----VLVDFAR---PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR 372
H FA P + ++ L++ P+L E + KCL +P R
Sbjct: 248 HQELFNKNPVFAGVRLPEIKEREPLERRY-PKLSEV--------VIDLAKKCLHIDPDKR 298
Query: 373 PSMEEVLE 380
P E+L
Sbjct: 299 PFCAELLH 306
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 8e-21
Identities = 66/289 (22%), Positives = 105/289 (36%), Gaps = 59/289 (20%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQAEVKFLGKFS 163
+G G +G V V T A K K + + ++ E++ +
Sbjct: 17 IGRGSWGEVKIA-VQKGT--------RIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLD 64
Query: 164 HPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-----AEPLPWNTRLKIAIDA 217
HPN+++L ED + LV E G L + K A + +K + A
Sbjct: 65 HPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLSA 118
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
+ + H +V +RD K N L KL DFGLA + T++ G
Sbjct: 119 ---VAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-G 170
Query: 275 TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP-SGEHVLVDFARPSLTD 333
T Y +P+ V G + D + GV++ +L G P S TD
Sbjct: 171 TPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGY------PPFSAP-----------TD 212
Query: 334 KRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ KI E+ + + A +I + L PK R + + LE
Sbjct: 213 SEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 70/312 (22%), Positives = 123/312 (39%), Gaps = 74/312 (23%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK-------KSNPDSIQGLR 150
+ + P ++G G V + V T G AVK + +P+ ++ +R
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRC-VHRAT--------GHEFAVKIMEVTAERLSPEQLEEVR 143
Query: 151 E-WQAEVKFLGKFS-HPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLP 206
E + E L + + HP+++ LI E F+ LV++ M+KG L ++L K + +E
Sbjct: 144 EATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSE--- 199
Query: 207 WNTRLKIAIDAAKDLT--------FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258
+ + FLH+ ++++RD K NILLD + +LSDFG +
Sbjct: 200 ---------KETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSDFGFSC 248
Query: 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGF-------GVVLLEMLTGLRA 311
++ + GT GY APE + + YG GV+L +L G
Sbjct: 249 H--LEPGEKLRELC-GTPGYLAPE-ILKCSMDETHPGYGKEVDLWACGVILFTLLAGS-- 302
Query: 312 LDTNRP-SGEHVLVDFARPSLTDKRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAE 368
P L+ IM + + +I + L+ +
Sbjct: 303 ----PPFWHR-----------RQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVD 347
Query: 369 PKNRPSMEEVLE 380
P+ R + E+ L+
Sbjct: 348 PEARLTAEQALQ 359
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 61/288 (21%), Positives = 103/288 (35%), Gaps = 59/288 (20%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--------KSNPDSIQGLREWQAEVKF 158
LG G FG V+ VD + K V VK + L + E+
Sbjct: 32 LGSGAFGFVWTA-VDKEK--------NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGS-LENHLFRKGS-AEPLPWNTRLKIA-- 214
L + H N++K++ F LV E G L + R EPL
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL---ASYIFRQL 139
Query: 215 IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG 274
+ A + +L K +I+RD K NI++ + KL DFG A + G
Sbjct: 140 VSA---VGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---G 191
Query: 275 TYGYAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332
T Y APE V G+ Y + +++ GV L ++
Sbjct: 192 TIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------------------ 232
Query: 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
L++ ++ + Y + ++ L+ P+ R ++E+++
Sbjct: 233 ----LEETVEAAIHPPYLVSKE--LMSLVSGLLQPVPERRTTLEKLVT 274
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 84/384 (21%), Positives = 138/384 (35%), Gaps = 77/384 (20%)
Query: 12 GPSKPPSPGSRTGANSLTGKENKADGLEMAGEINDVKDEHERKADDADEGRQLGDGDGGD 71
G SKP P + K + ++ G+I K D+ D
Sbjct: 89 GQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDN-------YVFDIWK 141
Query: 72 KNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVG 131
+ P EI + L + + + LG G FG V + + T
Sbjct: 142 QYYPQPVEIKHDHVLDHYDIHEE------------LGTGAFGVVHRV-TERAT------- 181
Query: 132 VGKAVAVK---KSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQ 188
G A K + + +R+ E++ + HP LV L +D + +++YE+M
Sbjct: 182 -GNNFAAKFVMTPHESDKETVRK---EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237
Query: 189 KGSLENHLFRKGSAEPLPWNTRLKIAIDAAK-------DLTFLHSSEKSVIYRDFKASNI 241
G E LF K + E + +A + L +H + ++ D K NI
Sbjct: 238 GG--E--LFEKVADEHNKMSED-----EAVEYMRQVCKGLCHMHE--NNYVHLDLKPENI 286
Query: 242 LL--DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFG 299
+ S KL DFGL +D V GT +AAPE + +D++ G
Sbjct: 287 MFTTKRSNELKLIDFGLTAH--LDPKQSVKV-TTGTAEFAAPEVAEGKPVGYYTDMWSVG 343
Query: 300 VVLLEMLTGLRALDTNRP-SGEHVLVDFARPSLTDKRRLKKIM--DPRLEEQYPIKGALL 356
V+ +L+GL P GE D L+ + D +++ +
Sbjct: 344 VLSYILLSGL------SPFGGE-----------NDDETLRNVKSCDWNMDDSAFSGISED 386
Query: 357 AGQIIIKCLEAEPKNRPSMEEVLE 380
I K L A+P R ++ + LE
Sbjct: 387 GKDFIRKLLLADPNTRMTIHQALE 410
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 71/296 (23%), Positives = 103/296 (34%), Gaps = 71/296 (23%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK-----KSNPDSIQGLREWQAEVKFLGK 161
+G G FG D T + VAVK + +++Q RE +
Sbjct: 28 IGSGNFGVARLM-RDKLT--------KELVAVKYIERGAAIDENVQ--RE----IINHRS 72
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA------- 214
HPN+V+ ++ EY G L + G R
Sbjct: 73 LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG---------RFSEDEARFFFQ 123
Query: 215 --IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY--NAKLSDFGLAKLGPIDGNSHVTT 270
+ +++ HS + +RD K N LLDGS K+ DFG +K + T
Sbjct: 124 QLLSG---VSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 271 RIMGTYGYAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328
GT Y APE V Y +DV+ GV L ML G A P F
Sbjct: 179 ---GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVG--AY----P--------FED 220
Query: 329 PSLTDKRRLKKIMDPRLEEQYPIKGAL----LAGQIIIKCLEAEPKNRPSMEEVLE 380
P R +K + L +Y I + +I + A+P R S+ E+
Sbjct: 221 PEEP--RDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 66/303 (21%), Positives = 103/303 (33%), Gaps = 65/303 (21%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK-----KSNPDSIQGLREW 152
T+ ++ LG+G F V + V G+ A K + Q L
Sbjct: 10 TEEYQLFEELGKGAFSVVRRC-VKVLA--------GQEYAAMIINTKKLSARDHQKLER- 59
Query: 153 QAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRL 211
E + HPN+V+L E+ L+++ + G L + + +E
Sbjct: 60 --EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA------- 110
Query: 212 KIAIDAAK-------DLTFLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGP 261
DA+ + H V++R+ K N+LL KL+DFGLA
Sbjct: 111 ----DASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-- 162
Query: 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRP-SG 319
++G GT GY +PE V Y D++ GV+L +L G P
Sbjct: 163 VEGEQQAWFGFAGTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVGY------PPFWD 215
Query: 320 EHVLVDFARPSLTDKRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEE 377
E R ++I A +I K L P R + E
Sbjct: 216 E-----------DQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAE 264
Query: 378 VLE 380
L+
Sbjct: 265 ALK 267
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 72/292 (24%), Positives = 110/292 (37%), Gaps = 65/292 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQAEVKFLGKFS 163
LG G F VF T GK A+K KS L E+ L K
Sbjct: 17 LGSGAFSEVFLV-KQRLT--------GKLFALKCIKKSPAFRDSSLEN---EIAVLKKIK 64
Query: 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAK--- 219
H N+V L + LV + + G L + + +G E DA+
Sbjct: 65 HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEK-----------DASLVIQ 113
Query: 220 ----DLTFLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVTTRI 272
+ +LH +++RD K N+L + + ++DFGL+K ++ N ++T
Sbjct: 114 QVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTAC 168
Query: 273 MGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRP-SGEHVLVDFARPS 330
GT GY APE V Y K+ D + GV+ +L G P E
Sbjct: 169 -GTPGYVAPE-VLAQKPYSKAVDCWSIGVITYILLCG------YPPFYEE---------- 210
Query: 331 LTDKRRLKKIMDPRLE--EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
T+ + +KI + E + + A I LE +P R + E+ L
Sbjct: 211 -TESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 6e-20
Identities = 78/292 (26%), Positives = 123/292 (42%), Gaps = 68/292 (23%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQAEVKFLGKFS 163
LGEG FG+V +KT + VA+K + + E+ +L
Sbjct: 17 LGEGSFGKVKLA-THYKT--------QQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 164 HPNLVKLIGY-CWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIA------- 214
HP+++KL Y + +V EY G L +++ K R+
Sbjct: 68 HPHIIKL--YDVITTPTDIVMVIEYA-GGELFDYIVEKK---------RMTEDEGRRFFQ 115
Query: 215 --IDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRI 272
I A + + H +++RD K N+LLD + N K++DFGL+ + DGN T+
Sbjct: 116 QIICA---IEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKTS-- 167
Query: 273 MGTYGYAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330
G+ YAAPE V G LY + DV+ G+VL ML G D E + P+
Sbjct: 168 CGSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD-----DEFI------PN 215
Query: 331 LTDKRRLKKIMDPRLEEQYPIKGAL--LAGQIIIKCLEAEPKNRPSMEEVLE 380
L KK+ Y + L A +I + + A+P R +++E+
Sbjct: 216 L-----FKKV----NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 48/235 (20%), Positives = 90/235 (38%), Gaps = 52/235 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---------------KSNPDSIQGLRE 151
+G+G +G V + A+K + P +
Sbjct: 21 IGKGSYGVVKLA-YNEND--------NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 152 WQA-----------EVKFLGKFSHPNLVKLIGYC-WED---RQFLLVYEYMQKGSLENHL 196
E+ L K HPN+VKL +D +V+E + +G +
Sbjct: 72 GCIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV---- 125
Query: 197 FRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256
+ +PL + D K + +LH + +I+RD K SN+L+ + K++DFG+
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH-LYV--KSDVYGFGVVLLEMLTG 308
+ ++ ++ + GT + APE ++ ++ DV+ GV L + G
Sbjct: 184 SNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 70/326 (21%), Positives = 109/326 (33%), Gaps = 63/326 (19%)
Query: 72 KNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVG 131
+M ++ + M N+ LG+G F V + V T
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFS---DNYDVKEELGKGAFSVVRRC-VHKTT------- 53
Query: 132 VGKAVAVK-----KSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEY 186
G A K K + Q L E + K HPN+V+L E+ LV++
Sbjct: 54 -GLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109
Query: 187 MQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKDL----TFLHSSEKSVIYRDFKASNI 241
+ G L + + +E A + + + HS +++R+ K N+
Sbjct: 110 VTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHS--NGIVHRNLKPENL 159
Query: 242 LLDGSYNA---KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYG 297
LL KL+DFGLA +S GT GY +PE V Y D++
Sbjct: 160 LLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWA 215
Query: 298 FGVVLLEMLTGLRALDTNRP-SGEHVLVDFARPSLTDKRRLKKIM--DPRLEEQYPIKGA 354
GV+L +L G P E R +I
Sbjct: 216 CGVILYILLVGY------PPFWDE-----------DQHRLYAQIKAGAYDYPSPEWDTVT 258
Query: 355 LLAGQIIIKCLEAEPKNRPSMEEVLE 380
A +I L PK R + ++ L+
Sbjct: 259 PEAKSLIDSMLTVNPKKRITADQALK 284
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-20
Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 33/214 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-----IQGLREWQAEVKFLGK 161
LG G + V+KG + T G VA+K+ DS +RE + + +
Sbjct: 13 LGNGTYATVYKGL-NKTT--------GVYVALKEVKLDSEEGTPSTAIRE----ISLMKE 59
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQ---KGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
H N+V+L + + LV+E+M K +++ + L N
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTV-GNTPRGLELNLVKYFQWQLL 118
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL--GPIDGNSH-VTTRIMGT 275
+ L F H +++RD K N+L++ KL DFGLA+ P++ S V T
Sbjct: 119 QGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL---- 172
Query: 276 YGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
Y AP+ + Y S D++ G +L EM+TG
Sbjct: 173 -WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG 205
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 76/319 (23%), Positives = 127/319 (39%), Gaps = 65/319 (20%)
Query: 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA 154
R ++ ++G G FG V++ + G+ VA+KK D RE
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQA-KLCDS--------GELVAIKKVLQDKRFKNRE--- 97
Query: 155 EVKFLGKFSHPNLVKLIGY-----CWEDRQFL-LVYEYMQKGSLENHL-FRKGSAEPLPW 207
++ + K H N+V+L + +D +L LV +Y+ + ++ + + LP
Sbjct: 98 -LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP- 154
Query: 208 NTRLKIAI-DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA-KLSDFGLAK-LGPIDG 264
+K+ + + L ++HS + +RD K N+LLD KL DFG AK L +
Sbjct: 155 VIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 265 N-SHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG-------------- 308
N S++ +R Y Y APE + Y S DV+ G VL E+L G
Sbjct: 213 NVSYICSR----Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 309 --LRALDTNRPSGE---HVLVDFARPSL--TDKRRLKKIMDPRLEEQYPIKGALLAGQII 361
++ L T P+ E + ++ K+ PR + A +
Sbjct: 268 EIIKVLGT--PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE--------AIALC 317
Query: 362 IKCLEAEPKNRPSMEEVLE 380
+ LE P R + E
Sbjct: 318 SRLLEYTPTARLTPLEACA 336
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 66/293 (22%), Positives = 107/293 (36%), Gaps = 63/293 (21%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK----KSNPDSIQGLREWQAEVKFLGKF 162
LG G FG V + + G +K + ++ + E++ L
Sbjct: 30 LGSGAFGDVHLV-EERSS--------GLERVIKTINKDRSQVPMEQIEA---EIEVLKSL 77
Query: 163 SHPNLVKLIGYCWEDRQFL-LVYEYMQKGSL-----ENHLFRKGSAEPLPWNTRLKIAID 216
HPN++K+ ED + +V E + G L K +E +
Sbjct: 78 DHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSE--------GYVAE 128
Query: 217 AAKDL----TFLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVT 269
K + + HS + V+++D K NIL K+ DFGLA+L + H T
Sbjct: 129 LMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHST 184
Query: 270 TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP-SGEHVLVDFAR 328
GT Y APE V + K D++ GVV+ +LTG P +G
Sbjct: 185 NAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGC------LPFTGT-------- 228
Query: 329 PSLTDKRRLKKIMDPRLE-EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ + +K A ++ + L +P+ RPS +VL
Sbjct: 229 ---SLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 2e-19
Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 39/227 (17%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREW 152
+ + +GEG +G VFK + +T + VA+K+ D LRE
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAK-NRET--------HEIVALKRVRLDDDDEGVPSSALRE- 51
Query: 153 QAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQ---KGSLENHLFRKGSAEPLPWNT 209
+ L + H N+V+L D++ LV+E+ K ++ L
Sbjct: 52 ---ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC------NGDLDPEI 102
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL--GPIDGNSH 267
K L F HS ++V++RD K N+L++ + KL++FGLA+ P+ S
Sbjct: 103 VKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
Query: 268 -VTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRAL 312
V T Y P+ + LY S D++ G + E+ R L
Sbjct: 161 EVVTL-----WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 72/383 (18%), Positives = 129/383 (33%), Gaps = 64/383 (16%)
Query: 18 SPGSRTGANSLTGKENKADGLEMAGEINDVKDEHERKADDADEGRQLGDGDGGDKNMPSS 77
+ L + ++ +G+ + +E A + L + S+
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNE--AKEVWSNADLTERMPVKSKRTSA 61
Query: 78 GEIVTPNYLKMFTLQDLRAATKNFR------PDTMLGEGGFGRVFKGWVDHKTLAPTKVG 131
+ P F + + A +LG G FG+V K +
Sbjct: 62 LAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHK--CEETAT------ 113
Query: 132 VGKAVAVK---KSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQ 188
G +A K + ++ E+ + + H NL++L +LV EY+
Sbjct: 114 -GLKLAAKIIKTRGMKDKEEVKN---EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169
Query: 189 KGSL------ENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNIL 242
G L E++ + +K + + +H +++ D K NIL
Sbjct: 170 GGELFDRIIDESYNLTELDTILF-----MKQICEG---IRHMHQ--MYILHLDLKPENIL 219
Query: 243 L--DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGV 300
+ K+ DFGLA+ + GT + APE V + +D++ GV
Sbjct: 220 CVNRDAKQIKIIDFGLARR--YKPREKLKV-NFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
Query: 301 VLLEMLTGLRALDTNRP-SGEHVLVDFARPSLTDKRRLKKIM--DPRLEEQYPIKGALLA 357
+ +L+GL P G+ D L I+ LE++ + A
Sbjct: 277 IAYMLLSGL------SPFLGD-----------NDAETLNNILACRWDLEDEEFQDISEEA 319
Query: 358 GQIIIKCLEAEPKNRPSMEEVLE 380
+ I K L E R S E L+
Sbjct: 320 KEFISKLLIKEKSWRISASEALK 342
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 38/222 (17%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-----LREWQ 153
+ + LGEG + V+KG T VA+K+ + +G +RE
Sbjct: 2 ETYIKLDKLGEGTYATVYKGK-SKLT--------DNLVALKEIRLEHEEGAPCTAIRE-- 50
Query: 154 AEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQ---KGSLENHLFRKGSAEPLPWNTR 210
V L H N+V L ++ LV+EY+ K L++ + +
Sbjct: 51 --VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC------GNIINMHNV 102
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL--GPIDGNSH- 267
+ L + H + V++RD K N+L++ KL+DFGLA+ P +
Sbjct: 103 KLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160
Query: 268 VTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
V T Y P+ + Y D++G G + EM TG
Sbjct: 161 VVTL-----WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 80/348 (22%), Positives = 127/348 (36%), Gaps = 71/348 (20%)
Query: 72 KNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTM-------LGEGGFGRVFKGWVDHKT 124
N P +G + P ++ L + K + +G G FG VF+
Sbjct: 6 SNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQA-----K 60
Query: 125 LAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGY-----CWEDRQ 179
L + VA+KK D RE ++ + HPN+V L + +D
Sbjct: 61 LVESDE-----VAIKKVLQDKRFKNRE----LQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111
Query: 180 FL-LVYEYMQKGSLENHL-FRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFK 237
FL LV EY+ + ++ + +P + L ++HS + +RD K
Sbjct: 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIK 168
Query: 238 ASNILLDGSYNA-KLSDFGLAK-LGPIDGNSH-VTTRIMGTYGYAAPEYVATGHLYVKS- 293
N+LLD KL DFG AK L + N + +R Y Y APE + Y +
Sbjct: 169 PQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELIFGATNYTTNI 223
Query: 294 DVYGFGVVLLEMLTG----------------LRALDTNRPSGE---HVLVDFARPSL--T 332
D++ G V+ E++ G ++ L T PS E + ++
Sbjct: 224 DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT--PSREQIKTMNPNYMEHKFPQI 281
Query: 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
K+ PR A +I + LE P R + E L
Sbjct: 282 RPHPFSKVFRPRTPP--------DAIDLISRLLEYTPSARLTAIEALC 321
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSH 164
+G G +G V+K K A+K+ S+ RE + L + H
Sbjct: 29 VGRGTYGHVYKAKRKDG-------KDDKDYALKQIEGTGISMSACRE----IALLRELKH 77
Query: 165 PNLVKLIGYCWE--DRQFLLVYEYMQ---KGSLENHLFRKGSAEPLPWNTRL--KIAIDA 217
PN++ L DR+ L+++Y + ++ H K + +P+ + +
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNA----KLSDFGLAKL--GPIDGNSHVTTR 271
+ +LH+ V++RD K +NIL+ G K++D G A+L P+ + +
Sbjct: 138 LDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 272 IMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
++ T+ Y APE + Y K+ D++ G + E+LT
Sbjct: 196 VV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 40/215 (18%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREWQAEVKFLG 160
+GEG +G V+K G+ VA+K+ D+ +RE + L
Sbjct: 29 VGEGTYGVVYKAK--DSQ--------GRIVALKRIRLDAEDEGIPSTAIRE----ISLLK 74
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQ---KGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
+ HPN+V LI +R LV+E+M+ K L+ + L +
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN------KTGLQDSQIKIYLYQL 128
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL--GPIDGNSH-VTTRIMG 274
+ + H +++RD K N+L++ KL+DFGLA+ P+ +H V T
Sbjct: 129 LRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL--- 183
Query: 275 TYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
Y AP+ + Y S D++ G + EM+TG
Sbjct: 184 --WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 69/341 (20%), Positives = 117/341 (34%), Gaps = 83/341 (24%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVK 157
+K + LG G FG V + D ++ GK A+KK D RE +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEV-FDIES--------GKRFALKKVLQDPRYKNRE----LD 52
Query: 158 FLGKFSHPNLVKLIGY---CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTR---- 210
+ H N++KL+ Y ++ + + + N
Sbjct: 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 211 ---------------LKIAIDAAKDLT----------------FLHSSEKSVIYRDFKAS 239
LK I + + + F+HS + +RD K
Sbjct: 113 LNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--LGICHRDIKPQ 170
Query: 240 NILLDGSYNA-KLSDFGLAK-LGPIDGNSH-VTTRIMGTYGYAAPEYVATGHLYVKS-DV 295
N+L++ N KL DFG AK L P + + + +R + Y APE + Y S D+
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYTPSIDL 225
Query: 296 YGFGVVLLEMLTG----------------LRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339
+ G V E++ G ++ + T P+ E + P T + R
Sbjct: 226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGT--PTKEQ--MIRMNPHYT-EVRFPT 280
Query: 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ + P LA ++ + L EP R + E +
Sbjct: 281 LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 6e-19
Identities = 76/292 (26%), Positives = 113/292 (38%), Gaps = 57/292 (19%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK------KSNPDSIQGLREWQAEVKFLG 160
LG G F V K T GK A K S+ E + EV L
Sbjct: 13 LGSGQFAIVRKC-RQKGT--------GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAK 219
+ HPN++ L +L+ E + G L + L K S E A K
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE--------DEATQFLK 115
Query: 220 D----LTFLHSSEKSVIYRDFKASNILL----DGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
+ +LHS K + + D K NI+L + KL DFG+A I+ +
Sbjct: 116 QILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKN- 170
Query: 272 IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP-SGEHVLVDFARPS 330
I GT + APE V L +++D++ GV+ +L+G P GE
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SPFLGE---------- 214
Query: 331 LTDKRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
T + L I + +E+Y + LA I + L +PK R ++ + LE
Sbjct: 215 -TKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 66/328 (20%), Positives = 121/328 (36%), Gaps = 60/328 (18%)
Query: 71 DKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRP----DTMLGEGGFGRVFKGWVDHKTLA 126
D + + + K + Q + + LG G FG V + V+ T
Sbjct: 19 DGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRC-VEKAT-- 75
Query: 127 PTKVGVGKAVAVK---KSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183
G+ K P ++ E+ + + HP L+ L + + +L+
Sbjct: 76 ------GRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINLHDAFEDKYEMVLI 126
Query: 184 YEYMQKGSLENHLFRKGSA--EPLPWNTRLKIAIDAAKD----LTFLHSSEKSVIYRDFK 237
E++ G L + + + E I+ + L +H S+++ D K
Sbjct: 127 LEFLSGGELFDRIAAEDYKMSE--------AEVINYMRQACEGLKHMHE--HSIVHLDIK 176
Query: 238 ASNILL--DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDV 295
NI+ + + K+ DFGLA ++ + V T +AAPE V + +D+
Sbjct: 177 PENIMCETKKASSVKIIDFGLATK--LNPDEIVKV-TTATAEFAAPEIVDREPVGFYTDM 233
Query: 296 YGFGVVLLEMLTGLRALDTNRP-SGEHVLVDFARPSLTDKRRLKKIM--DPRLEEQYPIK 352
+ GV+ +L+GL P +GE D L+ + D +E
Sbjct: 234 WAIGVLGYVLLSGL------SPFAGE-----------DDLETLQNVKRCDWEFDEDAFSS 276
Query: 353 GALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ A I L+ EP+ R ++ + LE
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALE 304
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 71/293 (24%), Positives = 111/293 (37%), Gaps = 59/293 (20%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK------KSNPDSIQGLREWQAEVKFLG 160
LG G F V K + T G A K E + EV L
Sbjct: 20 LGSGQFAIVKKC-REKST--------GLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAK 219
+ HPN++ L +L+ E + G L + L +K S +E + A K
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------EEATSFIK 122
Query: 220 D----LTFLHSSEKSVIYRDFKASNILL----DGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
+ +LH+ K + + D K NI+L + KL DFGLA I+
Sbjct: 123 QILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKN- 177
Query: 272 IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP--SGEHVLVDFARP 329
I GT + APE V L +++D++ GV+ +L+G G+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-------SPFLGD--------- 221
Query: 330 SLTDKRRLKKIMDPRLE--EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
T + L I + E++ + + LA I K L E + R +++E L
Sbjct: 222 --TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 72/293 (24%), Positives = 112/293 (38%), Gaps = 59/293 (20%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK-----KSNPDSIQGLREW-QAEVKFLG 160
LG G F V K + T G A K +S RE + EV L
Sbjct: 20 LGSGQFAIVKKC-REKST--------GLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAK 219
+ H N++ L +L+ E + G L + L +K S +E + A K
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------EEATSFIK 122
Query: 220 D----LTFLHSSEKSVIYRDFKASNILL----DGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
+ +LH+ K + + D K NI+L + KL DFGLA I+
Sbjct: 123 QILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKN- 177
Query: 272 IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP--SGEHVLVDFARP 329
I GT + APE V L +++D++ GV+ +L+G G+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-------SPFLGD--------- 221
Query: 330 SLTDKRRLKKIMDPRLE--EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
T + L I + E++ + LA I K L E + R +++E L
Sbjct: 222 --TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 40/215 (18%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREWQAEVKFLG 160
+GEG +G V+K + G+ A+KK + +RE + L
Sbjct: 10 IGEGTYGVVYKAQ--NNY--------GETFALKKIRLEKEDEGIPSTTIRE----ISILK 55
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQ---KGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
+ H N+VKL ++ +LV+E++ K L+ L T +
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC------EGGLESVTAKSFLLQL 109
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL--GPIDGNSH-VTTRIMG 274
+ + H + V++RD K N+L++ K++DFGLA+ P+ +H + T
Sbjct: 110 LNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL--- 164
Query: 275 TYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
Y AP+ + Y + D++ G + EM+ G
Sbjct: 165 --WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 50/287 (17%), Positives = 108/287 (37%), Gaps = 55/287 (19%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVKFLGKFSH 164
LG G FG V + V+ + K K K +++ E+ L H
Sbjct: 13 LGRGEFGIVHRC-VETSS--------KKTYMAKFVKVKGTDQVLVKK---EISILNIARH 60
Query: 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSA--EPLPWNTRLKIAIDAAKD-- 220
N++ L + ++++E++ + + E + +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNE--------REIVSYVHQVC 112
Query: 221 --LTFLHSSEKSVIYRDFKASNILLDGSYNA--KLSDFGLAKLGPIDGNSHVTTRIMGTY 276
L FLHS ++ + D + NI+ ++ K+ +FG A+ + + +
Sbjct: 113 EALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRL-LFTAP 167
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP-SGEHVLVDFARPSLTDKR 335
Y APE + +D++ G ++ +L+G+ P E T+++
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAE-----------TNQQ 210
Query: 336 RLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
++ IM + +E+ + ++ A + + L E K+R + E L+
Sbjct: 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 65/299 (21%), Positives = 111/299 (37%), Gaps = 71/299 (23%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-H 164
+LG G G+V + +T G+ A+K + + + EV + S
Sbjct: 36 VLGLGVNGKVLEC-FHRRT--------GQKCALK-----LLYDSPKARQEVDHHWQASGG 81
Query: 165 PNLVKLIGYC----WEDRQFLLVYEYMQKGSLENHLFRKGSA---EPLPWNTRLKIAIDA 217
P++V ++ R L++ E M+ G L + + +G E + A +
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE--------REAAEI 133
Query: 218 AKDLT----FLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVTT 270
+D+ FLHS ++ +RD K N+L + KL+DFG AK + + T
Sbjct: 134 MRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQT 188
Query: 271 RIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRP--SGEHVLVDFA 327
T Y APE V Y KS D++ GV++ +L G P
Sbjct: 189 PC-YTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCG-------FPPFYSN------- 232
Query: 328 RPSLTDKRRLKKIMDPRLEEQYPIKGA------LLAGQIIIKCLEAEPKNRPSMEEVLE 380
T + + QY A Q+I L+ +P R ++ + +
Sbjct: 233 ----TGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 70/292 (23%), Positives = 112/292 (38%), Gaps = 57/292 (19%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK------KSNPDSIQGLREWQAEVKFLG 160
LG G F V K + T G A K + + + EV L
Sbjct: 19 LGSGQFAVVKKC-REKST--------GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAK 219
+ HPN++ L +L+ E + G L + L K S E + A + K
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLK 121
Query: 220 D----LTFLHSSEKSVIYRDFKASNILL----DGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
+ +LHS + + D K NI+L K+ DFGLA ID +
Sbjct: 122 QILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKN- 176
Query: 272 IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP-SGEHVLVDFARPS 330
I GT + APE V L +++D++ GV+ +L+G P G+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SPFLGD---------- 220
Query: 331 LTDKRRLKKIMDPRLE--EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
T + L + E ++Y + LA I + L +PK R ++++ L+
Sbjct: 221 -TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 68/324 (20%), Positives = 120/324 (37%), Gaps = 82/324 (25%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNP-----DSIQGLRE 151
K + T +G G +G V +D ++ G+ VA+KK S P + + RE
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSA-IDKRS--------GEKVAIKKLSRPFQSEIFAKRAYRE 73
Query: 152 WQAEVKFLGKFSHPNLVKLI------GYCWEDRQFLLVYEYM---------QKGSLENHL 196
+ L H N++ L+ F LV +M K S E
Sbjct: 74 ----LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQ 129
Query: 197 FRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256
+ + K L ++HS+ V++RD K N+ ++ K+ DFGL
Sbjct: 130 Y---------------LVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGL 172
Query: 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG------- 308
A+ + +V TR Y APE + + Y ++ D++ G ++ EMLTG
Sbjct: 173 ARHADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227
Query: 309 ---------LRALDTNRPSGE---HVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALL 356
L+ P E + A+ + + + + +P + +
Sbjct: 228 DYLDQLTQILKVTGV--PGTEFVQKLNDKAAKSYIQSLPQTPRK---DFTQLFP-RASPQ 281
Query: 357 AGQIIIKCLEAEPKNRPSMEEVLE 380
A ++ K LE + R + + L
Sbjct: 282 AADLLEKMLELDVDKRLTAAQALT 305
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 65/296 (21%), Positives = 113/296 (38%), Gaps = 66/296 (22%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HP 165
LG G G+V + + +T + A+K +Q + + EV+ + S P
Sbjct: 70 LGLGINGKVLQI-FNKRT--------QEKFALK-----MLQDCPKARREVELHWRASQCP 115
Query: 166 NLVKLIGYC----WEDRQFLLVYEYMQKGSLENHLFRKGSA---EPLPWNTRLKIAIDAA 218
++V+++ + L+V E + G L + + +G E + A +
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE--------REASEIM 167
Query: 219 KDLT----FLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
K + +LHS ++ +RD K N+L + KL+DFG AK ++ +TT
Sbjct: 168 KSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTP 223
Query: 272 IMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRP--SGEHVLVDFAR 328
T Y APE V Y KS D++ GV++ +L G P H
Sbjct: 224 C-YTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCG-------YPPFYSNH------- 267
Query: 329 PSLTDKRRLKKIMDPRLEEQYP----IKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+I + E P + +I L+ EP R ++ E +
Sbjct: 268 GLAISPGMKTRIRMGQYEFPNPEWSEVSEE--VKMLIRNLLKTEPTQRMTITEFMN 321
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 39/224 (17%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREWQ 153
+R T LGEG +G V+K D T + VA+K+ + +RE
Sbjct: 35 RYRRITKLGEGTYGEVYKAI-DTVT--------NETVAIKRIRLEHEEEGVPGTAIRE-- 83
Query: 154 AEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQ---KGSLENHLFRKGSAEPLPWNTR 210
V L + H N+++L + + L++EY + K ++ + +
Sbjct: 84 --VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN-------PDVSMRVI 134
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA-----KLSDFGLAKLGPIDGN 265
+ F HS + ++RD K N+LL S + K+ DFGLA+ I
Sbjct: 135 KSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192
Query: 266 SHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
T I+ T Y PE + Y S D++ + EML
Sbjct: 193 QF-THEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 72/322 (22%), Positives = 126/322 (39%), Gaps = 65/322 (20%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP-----DSIQGLREW 152
+ +F+ ++LGEG +G V T G+ VA+KK P +++ LRE
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSA-THKPT--------GEIVAIKKIEPFDKPLFALRTLRE- 59
Query: 153 QAEVKFLGKFSHPNLVKLI-----GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPW 207
+K L F H N++ + + ++ E M + L R S + L
Sbjct: 60 ---IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLS- 110
Query: 208 NTRLK-IAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA----KLGPI 262
+ ++ + + LH S VI+RD K SN+L++ + + K+ DFGLA +
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 263 DGNSHVTTRIMGTY----GYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRAL----D 313
+ M + Y APE + T Y ++ DV+ G +L E+ R + D
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRD 227
Query: 314 TN-----------RPSGEHVLV----DFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAG 358
P ++ L AR + LE+ +P +
Sbjct: 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAA---PLEKMFP-RVNPKGI 283
Query: 359 QIIIKCLEAEPKNRPSMEEVLE 380
++ + L +P R + +E LE
Sbjct: 284 DLLQRMLVFDPAKRITAKEALE 305
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 76/320 (23%), Positives = 126/320 (39%), Gaps = 69/320 (21%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP-----DSIQGLREW 152
+ + +GEG +G V D+ VA+KK +P + LRE
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSA-YDNLN--------KVRVAIKKISPFEHQTYCQRTLRE- 75
Query: 153 QAEVKFLGKFSHPNLVKLI-----GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPW 207
+K L +F H N++ + + + +V + M E L++ + L
Sbjct: 76 ---IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLS- 126
Query: 208 NTRLK-IAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNS 266
N + + L ++HS+ V++RD K SN+LL+ + + K+ DFGLA++ D +
Sbjct: 127 NDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 267 ------HVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG----------- 308
+V TR Y APE + Y KS D++ G +L EML+
Sbjct: 185 TGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239
Query: 309 -----LRALDTNRPSGE---HVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQI 360
L L + PS E ++ AR L K+ +P A +
Sbjct: 240 QLNHILGILGS--PSQEDLNCIINLKARNYLLSLPHKNKV---PWNRLFP-NADSKALDL 293
Query: 361 IIKCLEAEPKNRPSMEEVLE 380
+ K L P R +E+ L
Sbjct: 294 LDKMLTFNPHKRIEVEQALA 313
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 69/315 (21%), Positives = 119/315 (37%), Gaps = 63/315 (20%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNP-----DSIQGLRE 151
+R +G G +G V VD +T G VA+KK P + + RE
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSA-VDGRT--------GAKVAIKKLYRPFQSELFAKRAYRE 74
Query: 152 WQAEVKFLGKFSHPNLVKLI------GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPL 205
++ L H N++ L+ + F LV +M L + E L
Sbjct: 75 ----LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKL 125
Query: 206 PWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGN 265
+ + K L ++H++ +I+RD K N+ ++ K+ DFGLA+ +
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 183
Query: 266 SHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG---------------- 308
+V TR Y APE + Y ++ D++ G ++ EM+TG
Sbjct: 184 GYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238
Query: 309 LRALDTNRPSGE---HVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCL 365
++ T P E + D A+ + L+K + LA ++ K L
Sbjct: 239 MKVTGT--PPAEFVQRLQSDEAKNYMKGLPELEKK---DFASILT-NASPLAVNLLEKML 292
Query: 366 EAEPKNRPSMEEVLE 380
+ + R + E L
Sbjct: 293 VLDAEQRVTAGEALA 307
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 41/222 (18%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK----SNPDS--IQGLREWQAEVKFLG 160
+G+G FG VFK KT G+ VA+KK + + I LRE +K L
Sbjct: 25 IGQGTFGEVFKA-RHRKT--------GQKVALKKVLMENEKEGFPITALRE----IKILQ 71
Query: 161 KFSHPNLVKLIGYCWEDR--------QFLLVYEYMQ---KGSLENHLFRKGSAEPLPWNT 209
H N+V LI C LV+++ + G L N +
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV------LVKFTLSE 125
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL--GPIDGNSH 267
++ L ++H +++RD KA+N+L+ KL+DFGLA+ + +
Sbjct: 126 IKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 268 VTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
T + T Y PE + Y D++G G ++ EM T
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 62/290 (21%), Positives = 102/290 (35%), Gaps = 55/290 (18%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK-----KSNPDSIQGLREWQAEVKFLGK 161
LG G F V + + T G+ A K + D + E+ L
Sbjct: 37 LGRGKFAVVRQC-ISKST--------GQEYAAKFLKKRRRGQDCRAEILH---EIAVLEL 84
Query: 162 FSH-PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
P ++ L + +L+ EY G E +F E + I K
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSE-NDVIRLIKQ 139
Query: 221 ----LTFLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVTTRIM 273
+ +LH ++++ D K NILL + K+ DFG+++ I + IM
Sbjct: 140 ILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELRE-IM 194
Query: 274 GTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP-SGEHVLVDFARPSLT 332
GT Y APE + + +D++ G++ +LT P GE
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT------SPFVGE-----------D 237
Query: 333 DKRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
++ I + E+ + LA I L P+ RP+ E L
Sbjct: 238 NQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 9e-17
Identities = 67/294 (22%), Positives = 115/294 (39%), Gaps = 69/294 (23%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAV----KKSNPDSIQGLREWQAEVKFLGKF 162
LG G V++ + G K A+ K + ++ E+ L +
Sbjct: 61 LGRGATSIVYRC---------KQKGTQKPYALKVLKKTVDKKIVR------TEIGVLLRL 105
Query: 163 SHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKD 220
SHPN++KL +E + LV E + G L + + KG +E + A DA K
Sbjct: 106 SHPNIIKLKEI-FETPTEISLVLELVTGGELFDRIVEKGYYSE--------RDAADAVKQ 156
Query: 221 ----LTFLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVTTRIM 273
+ +LH +++RD K N+L K++DFGL+K+ ++ + T
Sbjct: 157 ILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVC- 211
Query: 274 GTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332
GT GY APE + G Y D++ G++ +L G
Sbjct: 212 GTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCG-------------------FEPFY 251
Query: 333 DKRRLKKIMDPRLEEQYPIKGA------LLAGQIIIKCLEAEPKNRPSMEEVLE 380
D+R + + L +Y L A ++ K + +PK R + + L+
Sbjct: 252 DERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 67/229 (29%), Positives = 104/229 (45%), Gaps = 36/229 (15%)
Query: 93 DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-------SNPDS 145
D+++ K + LGEG F V+K D T + VA+KK D
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKAR-DKNT--------NQIVAIKKIKLGHRSEAKDG 54
Query: 146 I--QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAE 203
I LRE +K L + SHPN++ L+ LV+++M+ LE + K ++
Sbjct: 55 INRTALRE----IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSL 107
Query: 204 PLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL--GP 261
L + + + L +LH +++RD K +N+LLD + KL+DFGLAK P
Sbjct: 108 VLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165
Query: 262 IDGNSH-VTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
+H V TR Y APE + +Y D++ G +L E+L
Sbjct: 166 NRAYTHQVVTR-----WYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 38/224 (16%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNP-----DSIQGLRE 151
+ ++ + +G G +G V + D KT G VAVKK S P + + RE
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAF-DTKT--------GLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 152 WQAEVKFLGKFSHPNLVKLI------GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPL 205
++ L H N++ L+ E LV M L + L
Sbjct: 79 ----LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKL 129
Query: 206 PWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGN 265
+ + + L ++HS++ +I+RD K SN+ ++ K+ DFGLA+ +
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187
Query: 266 SHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
+V TR Y APE + Y ++ D++ G ++ E+LTG
Sbjct: 188 GYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 49/319 (15%), Positives = 92/319 (28%), Gaps = 88/319 (27%)
Query: 54 KADDADEGRQLGDGDGGDKNMPSSGEIVTPNYLKMFTLQDLRAATKNFRPDTMLGEGGFG 113
A + G Q + + M + ++G G +G
Sbjct: 8 AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYG 67
Query: 114 RVFKGWVDHKTLAPTKVGVGKAVAVKK-SNP-----DSIQGLREWQAEVKFLGKFSHPNL 167
V + D + VA+KK D + LRE + L + +H ++
Sbjct: 68 HVCEA-YDKLE--------KRVVAIKKILRVFEDLIDCKRILRE----IAILNRLNHDHV 114
Query: 168 VKLI-----GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
VK++ + + +V E + K LT
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIAD--------------------SDFKKLFRTPVYLT 154
Query: 223 ----------------FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNS 266
++HS+ +++RD K +N L++ + K+ DFGLA+ N
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 267 HVTTRIMGTYGYAAP--------------EYVAT-----------GHLYVKS-DVYGFGV 300
+ I +V T Y ++ DV+ G
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272
Query: 301 VLLEMLTGLRALDTNRPSG 319
+ E+L ++
Sbjct: 273 IFAELLNMIKENVAYHADR 291
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 6e-16
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 39/219 (17%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREWQAEVKFLG 160
+GEG +G+VFK G+ VA+K+ + + +RE ++ L
Sbjct: 19 IGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLE 69
Query: 161 KFSHPNLVKLI-----GYCWEDRQFLLVYEYMQ---KGSLENHLFRKGSAEPLPWNTRLK 212
F HPN+V+L + + LV+E++ L+ +P T
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-----PEPGVPTETIKD 124
Query: 213 IAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL--GPIDGNSHVTT 270
+ + L FLHS V++RD K NIL+ S KL+DFGLA++ + S V T
Sbjct: 125 MMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182
Query: 271 RIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
Y APE V Y D++ G + EM
Sbjct: 183 L-----WYRAPE-VLLQSSYATPVDLWSVGCIFAEMFRR 215
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 50/262 (19%), Positives = 88/262 (33%), Gaps = 83/262 (31%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNP-----DSIQGLRE 151
N+ ++G G +G V+ D T K VA+KK + D + LRE
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLA-YDKNT--------EKNVAIKKVNRMFEDLIDCKRILRE 75
Query: 152 WQAEVKFLGKFSHPNLVKLI-----GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLP 206
+ L + +++L + + +V E
Sbjct: 76 ----ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD------------------ 113
Query: 207 WNTRLKIAIDAAKDLT----------------FLHSSEKSVIYRDFKASNILLDGSYNAK 250
+ LK LT F+H S +I+RD K +N LL+ + K
Sbjct: 114 --SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVK 169
Query: 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAP---------EYVAT-----------GHLY 290
+ DFGLA+ + ++++ + +V T Y
Sbjct: 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 229
Query: 291 VKS-DVYGFGVVLLEMLTGLRA 311
KS D++ G + E+L L++
Sbjct: 230 TKSIDIWSTGCIFAELLNMLQS 251
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 73/342 (21%), Positives = 107/342 (31%), Gaps = 105/342 (30%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK----------SNP---- 143
+ + G +G V G VD + G VA+K+ N
Sbjct: 21 QSPYTVQRFISSGSYGAVCAG-VDSE---------GIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 144 -DSIQGLREWQAEVKFLGKFSHPNLVKLI-----GYCWEDRQFLLVYEYM---------- 187
+ LRE ++ L F HPN++ L + LV E M
Sbjct: 71 FLCKRVLRE----IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD 126
Query: 188 QKGSLENHLFR-------KGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASN 240
Q+ + + G L LH + V++RD N
Sbjct: 127 QRIVISPQHIQYFMYHILLG--------------------LHVLHEAG--VVHRDLHPGN 164
Query: 241 ILLDGSYNAKLSDFGLAKLGPIDGNS--HVTTRIMGTYGYAAPEYVATGHLYVKS-DVYG 297
ILL + + + DF LA+ D N +VT R Y APE V + K D++
Sbjct: 165 ILLADNNDITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWS 219
Query: 298 FGVVLLEMLTG----------------LRALDTNRPSGE---HVLVDFARPSLTDKRRLK 338
G V+ EM + + T P E AR L +
Sbjct: 220 AGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT--PKIEDVVMFSSPSARDYLRNSLSNV 277
Query: 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
P +A +I K LE P+ R S E+ L
Sbjct: 278 PARA--WTAVVP-TADPVALDLIAKMLEFNPQRRISTEQALR 316
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 65/324 (20%), Positives = 117/324 (36%), Gaps = 70/324 (21%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNP-----DSIQGLRE 151
K ++ +G G G V D + VA+KK S P + + RE
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAA-YDAVL--------DRNVAIKKLSRPFQNQTHAKRAYRE 111
Query: 152 WQAEVKFLGKFSHPNLVKLI------GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPL 205
+ + +H N++ L+ E + LV E M + + + L
Sbjct: 112 ----LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQM----EL 161
Query: 206 PWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGN 265
+ + LHS+ +I+RD K SNI++ K+ DFGLA+
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219
Query: 266 S--HVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG-------------- 308
+V TR Y APE + Y ++ D++ G ++ EM+
Sbjct: 220 MTPYVVTRY-----YRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273
Query: 309 --LRALDTNRPSGEHV--LVDFARPSLTDKRRLKKI--------MDPRLEEQYPIKGALL 356
+ L T P E + L R + ++ + + + ++ A
Sbjct: 274 KVIEQLGT--PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ 331
Query: 357 AGQIIIKCLEAEPKNRPSMEEVLE 380
A ++ K L +P R S+++ L+
Sbjct: 332 ARDLLSKMLVIDPAKRISVDDALQ 355
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 67/325 (20%), Positives = 121/325 (37%), Gaps = 72/325 (22%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNP-----DSIQGLRE 151
K ++ +G G G V D + VA+KK S P + + RE
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAA-YDAIL--------ERNVAIKKLSRPFQNQTHAKRAYRE 74
Query: 152 WQAEVKFLGKFSHPNLVKLI------GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPL 205
+ + +H N++ L+ E + +V E M +L + + L
Sbjct: 75 ----LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NL-CQVIQM----EL 124
Query: 206 PWNTRLK-IAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG 264
+ R+ + + LHS+ +I+RD K SNI++ K+ DFGLA+
Sbjct: 125 -DHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 265 NS--HVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG------------- 308
+V TR Y APE + Y ++ D++ G ++ EM+ G
Sbjct: 182 MMTPYVVTRY-----YRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 235
Query: 309 ---LRALDTNRPSGEHV--LVDFARPSLTDKRRLKKI--------MDPRLEEQYPIKGAL 355
+ L T P E + L R + ++ + + + ++ A
Sbjct: 236 NKVIEQLGT--PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 293
Query: 356 LAGQIIIKCLEAEPKNRPSMEEVLE 380
A ++ K L + R S++E L+
Sbjct: 294 QARDLLSKMLVIDASKRISVDEALQ 318
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 43/222 (19%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---------IQGLREWQAEVK 157
+G G +G V+K D + G VA+K + I +RE ++
Sbjct: 17 IGVGAYGTVYKA-RDPHS--------GHFVALKSVRVPNGGGGGGGLPISTVREVAL-LR 66
Query: 158 FLGKFSHPNLVKLI-----GYCWEDRQFLLVYEYMQ---KGSLENHLFRKGSAEPLPWNT 209
L F HPN+V+L+ + + LV+E++ + L+ LP T
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-----PPPGLPAET 121
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL--GPIDGNSH 267
+ + L FLH+ +++RD K NIL+ KL+DFGLA++ +
Sbjct: 122 IKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV 179
Query: 268 VTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG 308
V T Y APE V Y D++ G + EM
Sbjct: 180 VVTL-----WYRAPE-VLLQSTYATPVDMWSVGCIFAEMFRR 215
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 72/322 (22%), Positives = 119/322 (36%), Gaps = 65/322 (20%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK---SNP-DSIQGLREWQ 153
+ LG GG G VF VD+ K VA+KK ++P LRE
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSA-VDNDC--------DKRVAIKKIVLTDPQSVKHALRE-- 58
Query: 154 AEVKFLGKFSHPNLVKLI--------------GYCWEDRQFLLVYEYMQKGSLENHLFRK 199
+K + + H N+VK+ G E +V EYM E L
Sbjct: 59 --IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANV 111
Query: 200 GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS-YNAKLSDFGLAK 258
PL + L ++HS+ +V++RD K +N+ ++ K+ DFGLA+
Sbjct: 112 LEQGPLLEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 259 -LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTG-------- 308
+ P + + + T Y +P + + + Y K+ D++ G + EMLTG
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229
Query: 309 --------LRALDTNRPSGEHV--LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAG 358
L ++ E L+ + + L + P + A
Sbjct: 230 ELEQMQLILESIPV--VHEEDRQELLSVIPVYIRNDMTEPHK---PLTQLLP-GISREAV 283
Query: 359 QIIIKCLEAEPKNRPSMEEVLE 380
+ + L P +R + EE L
Sbjct: 284 DFLEQILTFSPMDRLTAEEALS 305
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 31/287 (10%), Positives = 74/287 (25%), Gaps = 61/287 (21%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVK 157
+R G + ++ +D + VA+ +P + L+E +
Sbjct: 33 YRLLIFHGGVPPLQFWQA-LDTAL--------DRQVALTFVDPQGVLPDDVLQETLSRTL 83
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
L + P + +++ L+V E+++ GSL+ ++
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSL 138
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
A H V S + + + L+ +
Sbjct: 139 AAAADAAH--RAGVALSIDHPSRVRVSIDGDVVLAYPATM--------PDANPQ------ 182
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALD-TNRPSGEHVLVDFARPSLTDKRR 336
D+ G G L +L L SG +
Sbjct: 183 ---------------DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPAD 227
Query: 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
+ + + ++ + + ++ + R + + Q
Sbjct: 228 IDRDIPFQISA------------VAARSVQGDGGIRSASTLLNLMQQ 262
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 49/227 (21%), Positives = 80/227 (35%), Gaps = 60/227 (26%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFS-H 164
LG G + VF+ + + V VK P + RE +K L
Sbjct: 44 LGRGKYSEVFEAI-NITN--------NEKVVVKILKPVKKKKIKRE----IKILENLRGG 90
Query: 165 PNLVKLIGYCWEDRQF--LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD-- 220
PN++ L + LV+E++ NT K D
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVN-------------------NTDFKQLYQTLTDYD 131
Query: 221 -----------LTFLHSSEKSVIYRDFKASNILLDGSYNA-KLSDFGLAKLG-PIDG-NS 266
L + HS +++RD K N+++D + +L D+GLA+ P N
Sbjct: 132 IRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189
Query: 267 HVTTRIMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRAL 312
V +R Y + PE + +Y S D++ G +L M+
Sbjct: 190 RVASR----Y-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 79/359 (22%), Positives = 125/359 (34%), Gaps = 114/359 (31%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK-SNP-----DSIQGLRE 151
+ + LG+G +G V+K +D +T G+ VAVKK + D+ + RE
Sbjct: 8 LRKYELVKKLGKGAYGIVWKS-IDRRT--------GEVVAVKKIFDAFQNSTDAQRTFRE 58
Query: 152 WQAEVKFLGKFS-HPNLVKL--IGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWN 208
+ L + S H N+V L + DR LV++YM+
Sbjct: 59 ----IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-------------------- 94
Query: 209 TRLKIAIDAAKDLT----------------FLHSSEKSVIYRDFKASNILLDGSYNAKLS 252
T L I A L +LHS +++RD K SNILL+ + K++
Sbjct: 95 TDLHAVI-RANILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVA 151
Query: 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAP--------EYVAT-----------GHLYVKS 293
DFGL++ + +YVAT Y K
Sbjct: 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG 211
Query: 294 -DVYGFGVVLLEMLTG----------------LRALDTNRPSGEHV-------------- 322
D++ G +L E+L G + +D PS E V
Sbjct: 212 IDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDF--PSNEDVESIQSPFAKTMIES 269
Query: 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGA-LLAGQIIIKCLEAEPKNRPSMEEVLE 380
L + ++KR + L + P A ++ K L+ P R S + L+
Sbjct: 270 LKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK 328
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 48/192 (25%), Positives = 76/192 (39%), Gaps = 35/192 (18%)
Query: 203 EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPI 262
+ L + + AK + FL + + I+RD A NILL K+ DFGLA+
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245
Query: 263 DGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-------GLRALDTN 315
D + + APE + ++SDV+ FGV+L E+ + G+
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV------ 299
Query: 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRP 373
E L + R++ P E Y Q ++ C EP RP
Sbjct: 300 -KIDEEFC-----RRLKEGTRMRA---PDYTTPEMY---------QTMLDCWHGEPSQRP 341
Query: 374 SMEEVLETLQNI 385
+ E++E L N+
Sbjct: 342 TFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 26/96 (27%), Positives = 41/96 (42%), Gaps = 7/96 (7%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKF-SH 164
LG G FG+V + K + VAVK + R +E+K L H
Sbjct: 30 LGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 165 PNLVKLIGYC-WEDRQFLLVYEYMQKGSLENHLFRK 199
N+V L+G C +++ E+ + G+L +L K
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 29/183 (15%), Positives = 60/183 (32%), Gaps = 19/183 (10%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEV 156
+ ++ + G +++ TL + ++K + +Q
Sbjct: 42 RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100
Query: 157 KF--------LGKFSHPNLVKLIGY-CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPW 207
K L + +G+ +D+ LV + + SL+ L
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-SALDVSPKHVLSE 158
Query: 208 NTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK--LSDFGLAKLGPIDGN 265
+ L++A L FLH ++ + A NI +D ++ L+ +G A
Sbjct: 159 RSVLQVACRLLDALEFLHE--NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY-CPSG 215
Query: 266 SHV 268
HV
Sbjct: 216 KHV 218
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 54/292 (18%), Positives = 100/292 (34%), Gaps = 79/292 (27%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HP 165
LG G G+V + + +T + A+K +Q + + EV+ + S P
Sbjct: 26 LGLGINGKVLQI-FNKRT--------QEKFALK-----MLQDCPKARREVELHWRASQCP 71
Query: 166 NLVKLIGYC----WEDRQFLLVYEYMQKGSLENHLFRKGSA---EPLPWNTRLKIAIDAA 218
++V+++ + L+V E + G L + + +G E + A +
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE--------REASEIM 123
Query: 219 KDLT----FLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
K + +LHS ++ +RD K N+L + KL+DFG AK T
Sbjct: 124 KSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--------ETTGE 173
Query: 272 IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP-SGEHVLVDFARPS 330
Y + D++ GV++ +L G P H
Sbjct: 174 ---KYDKSC-------------DMWSLGVIMYILLCGY------PPFYSNH-------GL 204
Query: 331 LTDKRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+I + + +I L+ EP R ++ E +
Sbjct: 205 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 49/225 (21%), Positives = 82/225 (36%), Gaps = 37/225 (16%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVK 157
+++ +GEG FG +F+G + + VA+K D+ Q E++
Sbjct: 11 HYKVGRRIGEGSFGVIFEG-TNLLN--------NQQVAIKFEPRRSDAPQLRDEYRTYKL 61
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
G + + + E +LV + + SLE L T A
Sbjct: 62 LAGC---TGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDL-CGRKFSVKTVAMAAKQM 115
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK-----LSDFGLAKL-GPIDGNSHVTTR 271
+ +H KS++YRD K N L+ + + DFG+ K H+ R
Sbjct: 116 LARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 272 ----IMGTYGYAAPEYVATGHLYV----KSDVYGFGVVLLEMLTG 308
+ GT Y + + T HL + D+ G V + L G
Sbjct: 174 EKKNLSGTARYMS---INT-HLGREQSRRDDLEALGHVFMYFLRG 214
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 47/232 (20%), Positives = 86/232 (37%), Gaps = 55/232 (23%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQA--EVKFL-- 159
LG G F V+ D VA+K + + + A E+K L
Sbjct: 26 KLGWGHFSTVWLAK-DMVN--------NTHVAMKIVRGDKVYTE-----AAEDEIKLLQR 71
Query: 160 ------GKFSHP---NLVKLIG---YCWEDRQFL-LVYEYMQKGSLENHLF---RKGSAE 203
K +++KL+ + + + +V+E L +L +K
Sbjct: 72 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHR 126
Query: 204 PLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD------GSYNAKLSDFGLA 257
+P +I+ L ++H +I+ D K N+L++ K++D G A
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
Query: 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTG 308
+ H T I T Y +PE V G + +D++ ++ E++TG
Sbjct: 186 ----CWYDEHYTNSIQ-TREYRSPE-VLLGAPWGCGADIWSTACLIFELITG 231
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPD-SIQGLREWQAEVKFLGKF 162
++G+G FG+V K + D + VA+K K+ Q E V+ L
Sbjct: 61 LIGKGSFGQVVKAY-DRVE--------QEWVAIKIIKNKKAFLNQAQIE----VRLLELM 107
Query: 163 SHP------NLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLF---RKGSAEPLPWNTRLK 212
+ +V L + + R L LV+E L +L+ R + + N K
Sbjct: 108 NKHDTEMKYYIVHLKRH-FMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRK 161
Query: 213 IAIDAAKDLTFLHSSEKSVIYRDFKASNILL--DGSYNAKLSDFGLAKLGPIDGNSHVTT 270
A L FL + E S+I+ D K NILL K+ DFG + +
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQ 217
Query: 271 RIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGL 309
I + Y +PE V G Y + D++ G +L+EM TG
Sbjct: 218 YIQSRF-YRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 54/223 (24%), Positives = 84/223 (37%), Gaps = 35/223 (15%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKF 158
+R +G G FG ++ G D G+ VA+K + L E K
Sbjct: 10 RYRLGRKIGSGSFGDIYLG-TDIAA--------GEEVAIKLECVKTKHPQLH---IESKI 57
Query: 159 LGKFSH-PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
+ + E ++V E + SLE LF + T L +A
Sbjct: 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNF-CSRKFSLKTVLLLADQM 114
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK---LSDFGLAKL-GPIDGNSHVTTR-- 271
+ ++HS K+ I+RD K N L+ + DFGLAK + H+ R
Sbjct: 115 ISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 272 --IMGTYGYAAPEYVATGHLYV----KSDVYGFGVVLLEMLTG 308
+ GT YA+ + T HL + + D+ G VL+ G
Sbjct: 173 KNLTGTARYAS---INT-HLGIEQSRRDDLESLGYVLMYFNLG 211
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 37/217 (17%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPD-SIQGLREWQAEVKFL--- 159
++G+G FG+V K + DHK + VA+K ++ Q E++ L
Sbjct: 104 VIGKGSFGQVVKAY-DHKV--------HQHVALKMVRNEKRFHRQAAE----EIRILEHL 150
Query: 160 ---GKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
K + N++ ++ + R + + +E + +L + +K + K A
Sbjct: 151 RKQDKDNTMNVIHMLEN-FTFRNHICMTFELLSM-NLYELI-KKNKFQGFSLPLVRKFAH 207
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILL--DGSYNAKLSDFGLAKLGPIDGNSHVTTRIM 273
+ L LH + +I+ D K NILL G K+ DFG + + V T I
Sbjct: 208 SILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQ 261
Query: 274 GTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGL 309
+ Y APE V G Y + D++ G +L E+LTG
Sbjct: 262 SRF-YRAPE-VILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 54/225 (24%), Positives = 86/225 (38%), Gaps = 37/225 (16%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVK 157
NFR +G G FG + G + T + VA+K + Q E++ +
Sbjct: 10 NFRVGKKIGCGNFGELRLG-KNLYT--------NEYVAIKLEPMKSRAPQLHLEYRFYKQ 60
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
+ ++ + + +V E + SLE LF T L IAI
Sbjct: 61 LGSG---DGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDL-CDRTFSLKTVLMIAIQL 114
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK-----LSDFGLAKL-GPIDGNSHVTTR 271
+ ++HS K++IYRD K N L+ N + DF LAK + H+ R
Sbjct: 115 ISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 272 ----IMGTYGYAAPEYVATGHLYV----KSDVYGFGVVLLEMLTG 308
+ GT Y + + T HL + D+ G + + L G
Sbjct: 173 EHKSLTGTARYMS---INT-HLGKEQSRRDDLEALGHMFMYFLRG 213
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 35/223 (15%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVK 157
FR +G G FG ++ G + +T + VA+K Q L E + +
Sbjct: 8 KFRLGRKIGSGSFGEIYLG-TNIQT--------NEEVAIKLENVKTKHPQLLYESKI-YR 57
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
L + + + E +LV + + SLE LF + L T L +A
Sbjct: 58 ILQ--GGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNF-CSRKLSLKTVLMLADQM 112
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK---LSDFGLAKL-GPIDGNSHVTTR-- 271
+ F+HS KS ++RD K N L+ A + DFGLAK + H+ R
Sbjct: 113 INRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 272 --IMGTYGYAAPEYVATGHLYV----KSDVYGFGVVLLEMLTG 308
+ GT YA+ V T HL + + D+ G VL+ L G
Sbjct: 171 KNLTGTARYAS---VNT-HLGIEQSRRDDLESLGYVLMYFLRG 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 36/192 (18%), Positives = 68/192 (35%), Gaps = 37/192 (19%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF 158
++ +G+GGFG ++ ++ VG VK D+ E +KF
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSE----SVGSDAPCVVKVEPSDNGPLFTE----LKF 86
Query: 159 LGKFSHPNLV---------------KLIGYCWEDRQFL----LVYEYMQKGSLENHLFRK 199
+ + P + K G D+ ++ + L+ ++
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQ-KIYEA 144
Query: 200 GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK---LSDFGL 256
+ + T L++++ L ++H ++ D KASN+LL N L D+GL
Sbjct: 145 NA-KRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLL-NYKNPDQVYLVDYGL 200
Query: 257 AKLGPIDGNSHV 268
A H
Sbjct: 201 AYR-YCPEGVHK 211
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 3e-08
Identities = 42/253 (16%), Positives = 68/253 (26%), Gaps = 63/253 (24%)
Query: 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEV 156
T+ + +GEG FG VF+ DH +A + + N + E E+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGP---DLVNGSHQKTFEEILPEI 74
Query: 157 KFLGKF---------SHPNLVKLIGYC-------------WE-----------------D 177
+ + L W+ D
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFK 237
Q +V E+ G + K T I L +S + +RD
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEASLR-FEHRDLH 189
Query: 238 ASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA--------------APEY 283
N+LL + KL K I + + I Y + E
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTI-PSCGLQVSI-IDYTLSRLERDGIVVFCDVSMDED 247
Query: 284 VATGHLYVKSDVY 296
+ TG + D+Y
Sbjct: 248 LFTGDGDYQFDIY 260
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 3e-08
Identities = 65/389 (16%), Positives = 109/389 (28%), Gaps = 100/389 (25%)
Query: 91 LQDLRAATKNFRPDTML---GEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ 147
LR A RP + G G G K W +A + V + V+ I
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSG---KTW-----VA---LDVCLSYKVQCKMDFKIF 185
Query: 148 GLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEP-LP 206
W + C L E +QK L + ++
Sbjct: 186 ----W---LNL-------------KNCNSPETVL---EMLQK--LLYQIDPNWTSRSDHS 220
Query: 207 WNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK-LSDFGLAKLGPIDGN 265
N +L+I A+ L S + ++ ++L NAK + F + +
Sbjct: 221 SNIKLRIHSIQAELRRLLKS-------KPYENCLLVLLNVQNAKAWNAF--------NLS 265
Query: 266 SH--VTTRIMGTYGYAAPEYVATGHLYVKSDVYGF----GVVLLEMLTGLR-------AL 312
+TTR + + T H+ + LL R L
Sbjct: 266 CKILLTTRFKQVTDFLSAAT--TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVL 323
Query: 313 DTNRPS-----GEHVLVDFARPS---LTDKRRLKKIMDPRLEEQYP--IKGAL--LA--- 357
TN P E + A + +L I++ L P + L+
Sbjct: 324 TTN-PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP 382
Query: 358 --GQIIIKCLE---AEPKNRPSMEEVLETLQNISVIEIEPKKKAKARGNYNNNSNDNQRG 412
I L + + V+ L S++E +PK+ + +
Sbjct: 383 PSAHIPTILLSLIWFDVIKS-DVMVVVNKLHKYSLVEKQPKESTI----SIPSIYLELKV 437
Query: 413 HPHNRRSQSPLHSKHGDHNNGTRARRYHY 441
N + LH DH N +
Sbjct: 438 KLENEYA---LHRSIVDHYNIPKTFDSDD 463
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 1e-05
Identities = 27/153 (17%), Positives = 51/153 (33%), Gaps = 32/153 (20%)
Query: 288 HLYVKSDV----YGFGVVLLEMLTGL-RALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD 342
H ++ + Y + +L D V D + L+ K + I
Sbjct: 4 HHHMDFETGEHQYQYKDILSVFEDAFVDNFDCK-----DVQ-DMPKSILS-KEEIDHI-- 54
Query: 343 PRLEEQYPIKGALLAGQIIIKCLEAEPKN--RPSMEEVLETLQN----ISVIEIEPKKKA 396
+ + + G L + L ++ + + +EEVL N +S I+ E ++ +
Sbjct: 55 --IMSKDAVSGTLR----LFWTLLSKQEEMVQKFVEEVLR--INYKFLMSPIKTEQRQPS 106
Query: 397 KARGNY----NNNSNDNQRGHPHNRRSQSPLHS 425
Y + NDNQ +N P
Sbjct: 107 MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK 139
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 36/182 (19%), Positives = 63/182 (34%), Gaps = 39/182 (21%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF 158
+ +G GGFG ++ + PT A V K L E+KF
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAF-------PTNKPEKDARHVVKVEYQENGPLFS---ELKF 86
Query: 159 LGKFSHPNLV---------------KLIGY----CWEDRQFLLVYEYMQKGSLENHLFRK 199
+ + + + G +V E + L+ +
Sbjct: 87 YQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQN 145
Query: 200 GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK---LSDFGL 256
G+ +T L++ I L ++H ++ D KA+N+LL G N L+D+GL
Sbjct: 146 GT---FKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLL-GYKNPDQVYLADYGL 199
Query: 257 AK 258
+
Sbjct: 200 SY 201
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 66/375 (17%), Positives = 109/375 (29%), Gaps = 127/375 (33%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNPDSIQGLREWQAEVKFL---- 159
LG G F V+ W D + K VA+K KS + + E++ L
Sbjct: 44 KLGWGHFSTVWLSW-DIQG--------KKFVAMKVVKSAEHYTETALD---EIRLLKSVR 91
Query: 160 -GKFSHPN---LVKLIGY-----------CWEDRQFLLVYEYMQKGSLENHLFRKGSAEP 204
+ PN +V+L+ C +V+E + L K + +
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHIC-------MVFEVLGH-HLL-KWIIKSNYQG 142
Query: 205 LPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL--------------------- 243
LP KI + L +LH+ + +I+ D K NILL
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201
Query: 244 ----------------------------DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
K++D G A + TR
Sbjct: 202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ--- 258
Query: 276 YGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD---------- 325
Y + E + +D++ + E+ TG + + D
Sbjct: 259 --YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316
Query: 326 -----------FARPSLTDKRRLKKIMDPR-------LEEQYPIKG--ALLAGQIIIKCL 365
+++ T K LK I + L E+Y A ++ L
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPML 376
Query: 366 EAEPKNRPSMEEVLE 380
E P+ R + E L
Sbjct: 377 ELIPEKRATAAECLR 391
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 50/244 (20%), Positives = 83/244 (34%), Gaps = 75/244 (30%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNP----------DSIQGLREWQ 153
LGEG FG+V + DH VA+K ++ + ++ ++E
Sbjct: 26 NLGEGTFGKVVECL-DHARG-------KSQVALKIIRNVGKYREAARLEINVLKKIKEKD 77
Query: 154 AE-----VKFLGKFSHPN---LV-KLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEP 204
E V F+ + +L+G +E++ ++ + +P
Sbjct: 78 KENKFLCVLMSDWFNFHGHMCIAFELLGKN--------TFEFL----------KENNFQP 119
Query: 205 LPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA--------------- 249
P +A L FLH E + + D K NIL S
Sbjct: 120 YPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 250 ----KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLE 304
+++DFG A + H TT + + Y PE V + DV+ G +L E
Sbjct: 178 NTSIRVADFGSA----TFDHEHHTTIVATRH-YRPPE-VILELGWAQPCDVWSIGCILFE 231
Query: 305 MLTG 308
G
Sbjct: 232 YYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 55/249 (22%), Positives = 86/249 (34%), Gaps = 81/249 (32%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNP----------DSIQGLREWQ 153
+G+G FGRV K AVK ++ D ++ ++
Sbjct: 42 KMGDGTFGRVLLCQ-HIDN--------KKYYAVKVVRNIKKYTRSAKIEADILKKIQNDD 92
Query: 154 AE----VKFLGKFSHPN---LV-KLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPL 205
VK+ GKF + + L+ + +G +YE + + + +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPLGPS--------LYEIITRNN-----YN-----GF 134
Query: 206 PWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA---------------- 249
I+ K L +L + S+ + D K NILLD Y
Sbjct: 135 HIEDIKLYCIEILKALNYLR--KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192
Query: 250 ---------KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFG 299
KL DFG A + + + I Y APE V + V SD++ FG
Sbjct: 193 IYRTKSTGIKLIDFGCA----TFKSDYHGSIINTRQ-YRAPE-VILNLGWDVSSDMWSFG 246
Query: 300 VVLLEMLTG 308
VL E+ TG
Sbjct: 247 CVLAELYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 73/343 (21%), Positives = 114/343 (33%), Gaps = 103/343 (30%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK--KSNP----------DSIQGLREWQ 153
LGEG FG+V + DHK G+ VAVK K+ ++ L
Sbjct: 21 TLGEGAFGKVVECI-DHKA-------GGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTD 72
Query: 154 AE-----VKFLGKFSHPN---LV-KLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEP 204
V+ L F H +V +L+G Y+++++ N F P
Sbjct: 73 PNSTFRCVQMLEWFEHHGHICIVFELLGLS--------TYDFIKE----NG-FL-----P 114
Query: 205 LPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA--------------- 249
+ K+A K + FLH + + D K NIL S
Sbjct: 115 FRLDHIRKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172
Query: 250 ----KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLE 304
K+ DFG A + H +T + + Y APE V + DV+ G +L+E
Sbjct: 173 NPDIKVVDFGSA----TYDDEHHSTLVSTRH-YRAPE-VILALGWSQPCDVWSIGCILIE 226
Query: 305 MLTGLRALDTNRPSGEHV-------------LVDFAR-------------PSLTDKRRLK 338
G + S EH+ ++ R + R +
Sbjct: 227 YYLGF-TVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVS 285
Query: 339 KIMDPRLEEQYPIKGAL-LAGQIIIKCLEAEPKNRPSMEEVLE 380
+ P E +I K LE +P R ++ E L+
Sbjct: 286 RACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 441 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.12 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.67 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.44 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.26 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.25 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.09 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.58 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.53 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.42 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.35 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.12 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.94 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.77 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.77 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.38 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.99 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.87 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.33 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.66 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 84.07 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.2 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-60 Score=454.46 Aligned_cols=266 Identities=27% Similarity=0.405 Sum_probs=214.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++|.+.++||+|+||+||+|.+... ....+++.||||+++.......+.|.+|+.+|++++|||||+++++|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4677788999999999999987642 233457899999998887777888999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCC------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGS------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS 246 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 246 (441)
.+|||||||++|+|.++|..... ..++++.+++.|+.|++.||.|||+ ++||||||||+||||+.+
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETT
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhEEECCC
Confidence 99999999999999999976432 2468999999999999999999997 899999999999999999
Q ss_pred CceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeec
Q 013519 247 YNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVD 325 (441)
Q Consensus 247 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~ 325 (441)
+.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||.....
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------- 266 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------- 266 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--------
Confidence 9999999999986544333334456789999999999999999999999999999999999 8999965321
Q ss_pred ccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 326 FARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
...+..+. .......|..++..+.+|+.+||+.||++|||+.||+++|+.+..
T Consensus 267 --------~~~~~~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 267 --------TEAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp --------HHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------HHHHHHHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11111111 112234566778889999999999999999999999999988753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-61 Score=453.39 Aligned_cols=266 Identities=26% Similarity=0.386 Sum_probs=219.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++|.+.+.||+|+||+||+|.+... ....++..||||+++.......+.|.+|+.+|++++|||||++++++.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSC----C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCc----ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 5788899999999999999987542 223457899999998877777888999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcC----------CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 179 QFLLVYEYMQKGSLENHLFRKG----------SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
.++||||||++|+|.++|...+ ....+++..++.++.|++.||.|||+ ++||||||||+||||+.++.
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEEECCCCc
Confidence 9999999999999999997643 23579999999999999999999997 89999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeeccc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 327 (441)
+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.....
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---------- 236 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---------- 236 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----------
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----------
Confidence 99999999985432222222233579999999999999999999999999999999999 8999965321
Q ss_pred ccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 328 RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
...+..+.. ......|..++.++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 237 ------~~~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 237 ------NEVIECITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp ------HHHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111111211 11224566778889999999999999999999999999987653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-60 Score=455.52 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=206.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++++.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+|++|+|||||+++++|.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVK---------STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEEE---------ETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEE---------ECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 689999999999999999994 4456899999998654 34456789999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++.+|||||||+||+|.++|...+ ...+++..++.|+.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEEEccccc
Confidence 999999999999999999997654 2457899999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
|+.... ........+||+.|||||++.+..|+.++|||||||+||||+||+.||..... ...
T Consensus 172 a~~~~~--~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~----------------~~~ 233 (350)
T 4b9d_A 172 ARVLNS--TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM----------------KNL 233 (350)
T ss_dssp ESCCCH--HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----------------HHH
T ss_pred ceeecC--CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----------------HHH
Confidence 986321 12233457899999999999999999999999999999999999999965321 112
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+..+..... ...+..++.++.+||.+||+.||++|||+.|+|++
T Consensus 234 ~~~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 234 VLKIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222222221 12345567789999999999999999999999985
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-60 Score=450.25 Aligned_cols=250 Identities=23% Similarity=0.380 Sum_probs=213.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|+++++||+|+||+||+| .+..+++.||||++..... ...+.+.+|+++|++++|||||+++++|.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a---------~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEEE---------EECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 57999999999999999999 4445689999999865422 23567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+++.+|||||||+||+|.++|.+.+ .+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 9999999999999999999998765 48999999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+|+............+.+||+.|||||++.+..|+.++|||||||+||||+||+.||..... ..
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----------------~~ 241 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----------------GL 241 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HH
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----------------HH
Confidence 99876544444455678999999999999999999999999999999999999999965321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~ 380 (441)
.+..+....+ .+|...+.++++||.+||+.||++|||++|++.
T Consensus 242 ~~~~i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 242 IFAKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHHHHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred HHHHHHcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 1222222211 345566778999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-60 Score=448.35 Aligned_cols=265 Identities=23% Similarity=0.379 Sum_probs=215.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++++.+.||+|+||+||+|.+... .....++.||||+++... ....+.|.+|+.+|++++|||||++++++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~----~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGP----APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCC----ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 4567788999999999999987532 233457899999987653 23457899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD 244 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 244 (441)
+.++||||||++|+|.++|..... ...+++..++.|+.||+.||.|||+ ++||||||||+||||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccceEEC
Confidence 999999999999999999975431 2458999999999999999999997 8999999999999999
Q ss_pred CCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCcee
Q 013519 245 GSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVL 323 (441)
Q Consensus 245 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~ 323 (441)
+++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |..||.....
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------ 253 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------ 253 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999986433322333445689999999999999999999999999999999999 8999965321
Q ss_pred ecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
...+..+.. ......|..++..+.+|+.+||+.||++|||+.+|+++|+.+.
T Consensus 254 ----------~~~~~~i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 254 ----------QDVVEMIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp ----------HHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----------HHHHHHHHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 111112221 2223456678888999999999999999999999999998765
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=439.44 Aligned_cols=260 Identities=24% Similarity=0.380 Sum_probs=205.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||+||+|.+. ..||||+++.. .....+.|.+|+.+|++++|||||++++++.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH------------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS------------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC------------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 357888999999999999999653 24899988654 3455778999999999999999999999875
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
++.++||||||+||+|.++|.... ..+++..++.|+.|++.||.|||+ ++||||||||+||||++++.+||+|||
T Consensus 103 -~~~~~iVmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DFG 177 (307)
T 3omv_A 103 -KDNLAIVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFG 177 (307)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred -CCeEEEEEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeecc
Confidence 456899999999999999997543 469999999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG---HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
+|+..............+||+.|||||++.+. .|+.++|||||||+||||+||+.||........
T Consensus 178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------------ 245 (307)
T 3omv_A 178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------------ 245 (307)
T ss_dssp SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------------
T ss_pred CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------------
Confidence 99875443334445567899999999999743 589999999999999999999999975422100
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
....+............+..++..+.+|+.+||+.||++|||+.+|+++|+.++
T Consensus 246 ~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 246 IIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp HHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 000011111111112345567788999999999999999999999999998765
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-60 Score=452.28 Aligned_cols=250 Identities=24% Similarity=0.314 Sum_probs=210.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
+.|++.+.||+|+||+||+|+ +..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~---------~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIAT---------VRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEEE---------ECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 569999999999999999994 44568999999986554444566889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.+|||||||+||+|.+++.+. .+++..+..++.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEecCcCce
Confidence 999999999999999998653 48999999999999999999997 999999999999999999999999999998
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
.... ........+||+.|||||++.+..|+.++|||||||++|||++|+.||...... ..+.
T Consensus 219 ~~~~--~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----------------~~~~ 280 (346)
T 4fih_A 219 QVSK--EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----------------KAMK 280 (346)
T ss_dssp ECCS--SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHH
T ss_pred ecCC--CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----------------HHHH
Confidence 6432 223345689999999999999999999999999999999999999999653211 1111
Q ss_pred hhcCc-cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 339 KIMDP-RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 339 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+... ......+..++.++.+||.+||+.||++|||+.|+|+|
T Consensus 281 ~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 281 MIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111 11112234567789999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=443.61 Aligned_cols=252 Identities=28% Similarity=0.309 Sum_probs=207.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
+.|.+.++||+|+||+||+|+ +..+|+.||||+++.... ..+|+.+|+.++|||||+++++|.+++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~---------~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMK---------DKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hheEeCcEeccCCCeEEEEEE---------ECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 457788899999999999994 445689999999876532 246999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC-ceEEecccCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY-NAKLSDFGLA 257 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DFGla 257 (441)
.+|||||||+||+|.++|.+.+ .+++..++.++.|++.||.|||+ ++||||||||+||||+.+| .+||+|||+|
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~~vKl~DFGla 198 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHA 198 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred EEEEEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence 9999999999999999998765 58999999999999999999997 9999999999999999987 6999999999
Q ss_pred CCCCCCCCcc---eEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 258 KLGPIDGNSH---VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 258 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+......... ....++||+.|||||++.+..|+.++|||||||+||||+||+.||........
T Consensus 199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------------- 264 (336)
T 4g3f_A 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-------------- 264 (336)
T ss_dssp EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--------------
T ss_pred eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--------------
Confidence 8654322111 12346899999999999999999999999999999999999999976433211
Q ss_pred hhhhhhcC-ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 335 RRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 335 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
+..+.. +.....++..++..+.+||.+||+.||++|||+.|++++|...
T Consensus 265 --~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 265 --CLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp --HHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 011111 1111234566778899999999999999999999999988654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-58 Score=432.98 Aligned_cols=246 Identities=25% Similarity=0.389 Sum_probs=200.0
Q ss_pred CCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEe---
Q 013519 102 RPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE--- 176 (441)
Q Consensus 102 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--- 176 (441)
++.++||+|+||+||+|.+. .++..||+|++... .....+.|.+|+.+|++|+|||||+++++|.+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp EEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred EeeeEEecCcCcEEEEEEEC---------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence 56678999999999999544 45889999988643 33456779999999999999999999999875
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCC--eeecCCCCCcEEEcC-CCceEEe
Q 013519 177 -DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKS--VIYRDFKASNILLDG-SYNAKLS 252 (441)
Q Consensus 177 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--ivHrDlkp~Nill~~-~~~~kl~ 252 (441)
+..+|||||||+||+|.+++.+.+ .+++..++.++.||+.||.|||+ ++ ||||||||+||||+. ++.+||+
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~--~~~~IiHRDlKp~NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCCCEEecccChhheeEECCCCCEEEE
Confidence 356899999999999999998754 58999999999999999999997 56 999999999999974 7999999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|||+|+... .......+||+.|||||++.+ .|+.++|||||||+||||+||+.||......
T Consensus 175 DFGla~~~~----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------------- 235 (290)
T 3fpq_A 175 DLGLATLKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------------- 235 (290)
T ss_dssp CTTGGGGCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--------------
T ss_pred eCcCCEeCC----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--------------
Confidence 999998532 233456799999999998864 6999999999999999999999999643211
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+........++...++++.+||.+||+.||++|||+.|+|+|
T Consensus 236 -~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 236 -AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111222111122334445678899999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=454.22 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=211.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+.|++.+.||+|+||+||+|+ +..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~---------~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIAT---------VRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 220 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHhcEeeeEeccCcCcEEEEEE---------ECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence 3579999999999999999994 4456899999998765544456688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+|||||||+||+|.+++... .+++..+..++.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~~~g~vKl~DFGla 294 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC 294 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEecCccc
Confidence 9999999999999999998653 48999999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
+..... .......+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .....+
T Consensus 295 ~~~~~~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------------~~~~~i 359 (423)
T 4fie_A 295 AQVSKE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------------KAMKMI 359 (423)
T ss_dssp EECCSS--CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------------HHHHHH
T ss_pred eECCCC--CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------------HHHHHH
Confidence 864322 23345679999999999999999999999999999999999999999653211 000111
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+. ...+..++..+.+||.+||+.||++|||+.|+|+|
T Consensus 360 ~~~~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 360 RDNLPPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHSCCCC--CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HcCCCCC--CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111111 12234566789999999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-58 Score=427.94 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=195.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||+||+| .+..+++.||||++.... ......+.+|+.+|++++|||||++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLA---------YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEE---------ECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 68999999999999999999 444568999999986543 233567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+++.+||||||| +|+|.+++.+.+ .+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~DFG 157 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFG 157 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEeecC
Confidence 999999999999 679999997754 59999999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+|+.... .....+.+||+.|||||++.+..|+ .++|||||||++|+|+||+.||..... .
T Consensus 158 la~~~~~---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~----------------~ 218 (275)
T 3hyh_A 158 LSNIMTD---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI----------------P 218 (275)
T ss_dssp CC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------H
T ss_pred CCeecCC---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH----------------H
Confidence 9986422 2234567899999999999988874 799999999999999999999965321 1
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+.... ..+|...+..+.+||.+||+.||++|||+.|+++|
T Consensus 219 ~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 219 VLFKNISNGV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHHHHTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHcCC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111121111 12455667789999999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-58 Score=444.79 Aligned_cols=274 Identities=26% Similarity=0.358 Sum_probs=224.7
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCC-CCcc
Q 013519 91 LQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSH-PNLV 168 (441)
Q Consensus 91 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h-pniv 168 (441)
...++...++|++.+.||+|+||+||+|.+... ....+++.||||.+.... ....+.|.+|+.+|.++.| ||||
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCC----CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 344445567899999999999999999987653 233456789999987654 3446779999999999975 9999
Q ss_pred ceEEEEEeC-CeEEEEEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeec
Q 013519 169 KLIGYCWED-RQFLLVYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYR 234 (441)
Q Consensus 169 ~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHr 234 (441)
+++++|.+. +.++||||||++|+|.++|..... ...+++..++.++.||+.||.|||+ ++||||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHR 209 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHR 209 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCS
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecC
Confidence 999999764 578999999999999999975321 3458999999999999999999997 899999
Q ss_pred CCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCC
Q 013519 235 DFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALD 313 (441)
Q Consensus 235 Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~ 313 (441)
||||+|||++.++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654444444556789999999999999999999999999999999998 899997
Q ss_pred CCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 314 TNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
..... ..+...+........|..++.++.+|+.+||+.||++|||+.+|+++|+.+-
T Consensus 290 ~~~~~----------------~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 290 GVKID----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp TCCCS----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHH----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 54221 1111222222233456677788999999999999999999999999998764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=436.27 Aligned_cols=252 Identities=27% Similarity=0.353 Sum_probs=203.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++++.||+|+||+||+|+... ...+++.||||++..... .....+.+|+.+|++++|||||++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKIS------GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECS------STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEcc------CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 579999999999999999996532 223578999999865421 123457789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++.+|||||||+||+|.++|.+.+ .+++..+..++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGl 172 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGL 172 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEeccccc
Confidence 999999999999999999998765 58999999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
|+.... ......+.+||+.|||||++.+..|+.++|||||||+||||+||+.||..... ...
T Consensus 173 a~~~~~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~----------------~~~ 234 (304)
T 3ubd_A 173 SKESID--HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR----------------KET 234 (304)
T ss_dssp EEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHH
T ss_pred ceeccC--CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH----------------HHH
Confidence 985322 22234557899999999999999999999999999999999999999975321 112
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-----MEEVLET 381 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~eil~~ 381 (441)
+..+.... ..+|..++.++.+||.+||+.||++||| ++|+++|
T Consensus 235 ~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 235 MTMILKAK--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHcCC--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 22222221 1345667788999999999999999998 5788875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-56 Score=422.09 Aligned_cols=272 Identities=24% Similarity=0.335 Sum_probs=203.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|.+.+.||+|+||+||+|.+. |+.||||++....... ..++.|+..+.+++|||||++++++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-----------g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~ 70 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-----------TEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence 46788899999999999999653 6789999997654322 23345777778899999999999998754
Q ss_pred ----eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccC------CCCeeecCCCCCcEEEcCCCc
Q 013519 179 ----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSS------EKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 179 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivHrDlkp~Nill~~~~~ 248 (441)
.+|||||||++|+|.++|... .+++..++.++.|++.||+|||+. ..+||||||||+||||+.+++
T Consensus 71 ~~~~~~~lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~ 146 (303)
T 3hmm_A 71 GTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCceEEEEEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC
Confidence 689999999999999999764 489999999999999999999962 239999999999999999999
Q ss_pred eEEecccCCCCCCCCCCc--ceEeeeccccccCcchhhhcC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCCC
Q 013519 249 AKLSDFGLAKLGPIDGNS--HVTTRIMGTYGYAAPEYVATG------HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGE 320 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~ 320 (441)
+||+|||+|+........ ......+||+.|||||++.+. .|+.++|||||||+||||+||..||........
T Consensus 147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~ 226 (303)
T 3hmm_A 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence 999999999864332221 122346899999999999764 467899999999999999999888754432211
Q ss_pred ceeecccccccchhhhhhhhcCccccccCC-----hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 321 HVLVDFARPSLTDKRRLKKIMDPRLEEQYP-----IKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
..................+....++..+| ..++..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 227 -p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 227 -PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp -TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11111111111111111222223322233 2455678899999999999999999999999987754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=423.39 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=192.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++++.||+|+||+||+|+. ..+++.||||++.... ....+.+.+|+.+|++|+|||||+++++|.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKN---------KVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEE---------TTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEE---------CCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 4699999999999999999944 4458999999886543 33456789999999999999999999998764
Q ss_pred C------------eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC
Q 013519 178 R------------QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG 245 (441)
Q Consensus 178 ~------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 245 (441)
+ .+|||||||++|+|.+++...+.....++..++.++.|++.||.|||+ +|||||||||+||||+.
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl~~ 153 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTM 153 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECT
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEECC
Confidence 4 379999999999999999877655566778899999999999999997 99999999999999999
Q ss_pred CCceEEecccCCCCCCCCCCc----------ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 013519 246 SYNAKLSDFGLAKLGPIDGNS----------HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315 (441)
Q Consensus 246 ~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~ 315 (441)
++.+||+|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||...
T Consensus 154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 999999999999865332111 12234689999999999999999999999999999999996 66421
Q ss_pred CCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. .....+..+....+.. .....++.+.+||.+||+.||++|||+.|+|++
T Consensus 231 ~---------------~~~~~~~~~~~~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 231 M---------------ERVRTLTDVRNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp H---------------HHHHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c---------------HHHHHHHHHhcCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 0011111121111111 112233456789999999999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=414.79 Aligned_cols=270 Identities=21% Similarity=0.273 Sum_probs=201.6
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCccceEEEE
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLVKLIGYC 174 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 174 (441)
...++|++.+.||+|+||+||+|+.+. ...+++.||||++..... ...+.+|+++|+.+ +|||||+++++|
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQL------QVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEB------TTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcc------cCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 346789999999999999999996542 223578999998866543 34577899999998 599999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC-CceEEec
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS-YNAKLSD 253 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~D 253 (441)
.+++.+|||||||+||+|.+++. .+++.++..++.|++.||.|||+ +|||||||||+|||++.+ +.+||+|
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred EECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEEECc
Confidence 99999999999999999999982 48899999999999999999997 999999999999999877 7999999
Q ss_pred ccCCCCCCCCCC--------------------------cceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHH
Q 013519 254 FGLAKLGPIDGN--------------------------SHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEML 306 (441)
Q Consensus 254 FGla~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~ell 306 (441)
||+|+....... .......+||+.|+|||++.+. .|+.++||||+||++|||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 999975322110 1123446899999999999876 4889999999999999999
Q ss_pred hCCCCCCCCCCCCCcee-----------------------ecccccccchhhhhhhhc--C---cc---------ccccC
Q 013519 307 TGLRALDTNRPSGEHVL-----------------------VDFARPSLTDKRRLKKIM--D---PR---------LEEQY 349 (441)
Q Consensus 307 tg~~p~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~--~---~~---------~~~~~ 349 (441)
||+.||........... .....+..........+. + +. .....
T Consensus 242 ~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 321 (361)
T 4f9c_A 242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG 321 (361)
T ss_dssp HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred HCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence 99999964332111000 000000000000000000 0 00 00011
Q ss_pred ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 350 PIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 350 ~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+.++.+||.+||+.||++|||++|+|+|
T Consensus 322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 322 WNEVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 23455678999999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=419.76 Aligned_cols=268 Identities=23% Similarity=0.308 Sum_probs=202.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++++.||+|+||+||+|+ +..+|+.||||++... .....+.+.+|+.+|+.|+|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~---------~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 124 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSAR---------RRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRP 124 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCeEEEEEEecccCeEEEEEE---------ECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeec
Confidence 579999999999999999994 4456899999998654 33445678899999999999999999998764
Q ss_pred ------CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 177 ------DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 177 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
.+.+|||||||+ |+|.+++.+. ..+++..+..++.||+.||.|||+ +|||||||||+|||++.++.+|
T Consensus 125 ~~~~~~~~~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~~~~~~~K 198 (398)
T 4b99_A 125 TVPYGEFKSVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLVNENCELK 198 (398)
T ss_dssp SSCTTTCCCEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEE
T ss_pred ccccccCCEEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCccccccCCCCCEE
Confidence 367899999996 6799998654 469999999999999999999997 9999999999999999999999
Q ss_pred EecccCCCCCCCCC--CcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeec--
Q 013519 251 LSDFGLAKLGPIDG--NSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD-- 325 (441)
Q Consensus 251 l~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~-- 325 (441)
|+|||+|+...... ........+||+.|||||++.+. .|+.++||||||||+|||++|+.||.+.........+.
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~ 278 (398)
T 4b99_A 199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278 (398)
T ss_dssp ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 99999998643221 12234567999999999998876 46899999999999999999999997643211100000
Q ss_pred ccccccch--------hhhhhhhcCcccc---ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 326 FARPSLTD--------KRRLKKIMDPRLE---EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 326 ~~~~~~~~--------~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+.... .......+.+... .......+.++.+||.+||..||++|||+.|+|+|
T Consensus 279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 0000000000000 00112345678899999999999999999999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=429.65 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=213.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++++.||+|+||+||+|+ ++.+|+.||+|++........+.+.+|+.+|+.|+|||||+++++|.++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~---------~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVT---------ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEeeccCeEEEEEE---------ECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 4689999999999999999994 4456899999999877766677889999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC--CceEEeccc
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS--YNAKLSDFG 255 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~--~~~kl~DFG 255 (441)
+.+|||||||+||+|.++|.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred CEEEEEEeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEeecc
Confidence 99999999999999999986432 358999999999999999999997 999999999999999754 899999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+|+.... .......+||+.|||||++.+..|+.++|||||||++|||++|..||..... ..
T Consensus 303 ~a~~~~~---~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~----------------~~ 363 (573)
T 3uto_A 303 LTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----------------DE 363 (573)
T ss_dssp SCEECCT---TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----------------HH
T ss_pred ceeEccC---CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----------------HH
Confidence 9986432 3345667999999999999999999999999999999999999999975421 11
Q ss_pred hhhhhcCc--cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDP--RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+..+... .+....+...+..+.+||.+||+.||++|||+.|+|+|
T Consensus 364 ~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 364 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12222221 11122233456778999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=430.26 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=205.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc------hHHHHHHHHHHHHHhcCCCCCccceE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS------IQGLREWQAEVKFLGKFSHPNLVKLI 171 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~ 171 (441)
.++|+++++||+|+||+||+| .+..+|+.||||++.... .......+.++.+++.++|||||+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la---------~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred hHHeEEEEEEecccCeEEEEE---------EECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 367999999999999999999 444568999999986432 12223334557788889999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
++|.+.+.+|||||||+||+|.++|.+.+ .+++..+..++.||+.||.|||+ +|||||||||+||||+.+|++||
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~--~gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHeEEeCCCCEEe
Confidence 99999999999999999999999998765 48999999999999999999997 99999999999999999999999
Q ss_pred ecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccc
Q 013519 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 330 (441)
+|||+|+.... ....+.+||+.|||||++.. ..|+.++|||||||+||||++|..||........
T Consensus 334 ~DFGlA~~~~~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---------- 399 (689)
T 3v5w_A 334 SDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---------- 399 (689)
T ss_dssp CCCTTCEECSS----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH----------
T ss_pred cccceeeecCC----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----------
Confidence 99999986432 22345799999999999974 5799999999999999999999999965322110
Q ss_pred cchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 013519 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-----MEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~eil~~ 381 (441)
......+... ...+|...+.++.+||.+||+.||.+|++ +.||++|
T Consensus 400 ---~~i~~~i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 400 ---HEIDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ---HHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ---HHHHHhhcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 0011111111 12346667788999999999999999998 7899876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=385.68 Aligned_cols=284 Identities=39% Similarity=0.695 Sum_probs=230.2
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceE
Q 013519 92 QDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLI 171 (441)
Q Consensus 92 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 171 (441)
.++....++|.+.+.||+|+||+||+|.+. +++.||||++........+.+.+|+.+++.++||||++++
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 101 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLI 101 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 344456789999999999999999999643 3789999998877666678899999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
+++.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+|
T Consensus 102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~k 179 (321)
T 2qkw_B 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPK 179 (321)
T ss_dssp EECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCSTTEEECTTCCEE
T ss_pred EEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999998865432 2358999999999999999999997 8999999999999999999999
Q ss_pred EecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccc
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 330 (441)
|+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||....+........+....
T Consensus 180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 259 (321)
T 2qkw_B 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259 (321)
T ss_dssp ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence 99999997643322233334467899999999999999999999999999999999999999765443322211111100
Q ss_pred cchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
.....+..++++......+...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 260 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 260 -HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp -HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 011122334445555566778888999999999999999999999999999876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=372.17 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=209.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||+||+|. ...+++.||||++........+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEE---------BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhceeeeeeeccCCCeEEEEEE---------ECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 4689999999999999999994 3445889999998665544456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+++|+|.+++... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999999999999764 48899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...
T Consensus 164 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------------~~~ 225 (297)
T 3fxz_A 164 AQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----------------RAL 225 (297)
T ss_dssp EECCST--TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHH
T ss_pred eecCCc--ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----------------HHH
Confidence 764322 22234568999999999999999999999999999999999999999653211 001
Q ss_pred hhhc-CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 338 KKIM-DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 338 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+. ........+...+..+.+||.+||+.||++|||+.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0110 0111112345566778899999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=376.96 Aligned_cols=289 Identities=40% Similarity=0.697 Sum_probs=231.4
Q ss_pred ccccCHHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-HHHHHHHHHHHHhcCCC
Q 013519 86 LKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-GLREWQAEVKFLGKFSH 164 (441)
Q Consensus 86 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h 164 (441)
...+++.++....++|.+.+.||+|+||.||+|... +++.||||++...... ....+.+|+.+++.++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h 86 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH 86 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGTCCC
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHhccC
Confidence 456788999999999999999999999999999432 3788999998765432 22367899999999999
Q ss_pred CCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCC---CeeecCCCCCc
Q 013519 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEK---SVIYRDFKASN 240 (441)
Q Consensus 165 pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---~ivHrDlkp~N 240 (441)
|||+++++++......++||||+.+|+|.+++.... ....+++..++.++.|++.||.|||+ . ||+||||||+|
T Consensus 87 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~ivH~Dlkp~N 164 (326)
T 3uim_A 87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD--HCDPKIIHRDVKAAN 164 (326)
T ss_dssp TTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH--SSSSCEECCCCSGGG
T ss_pred CCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEeCCCchhh
Confidence 999999999999999999999999999999997654 23468999999999999999999997 6 99999999999
Q ss_pred EEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCC--C
Q 013519 241 ILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP--S 318 (441)
Q Consensus 241 ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~--~ 318 (441)
||++.++.+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|+|++|..||..... .
T Consensus 165 il~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (326)
T 3uim_A 165 ILLDEEFEAVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243 (326)
T ss_dssp EEECTTCCEEECCCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred EEECCCCCEEeccCccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence 99999999999999999864322 22334456799999999999999999999999999999999999999953211 1
Q ss_pred CCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 319 GEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
.......+..... ....+..+.+......++...+..+.+++.+||+.||.+|||+.+++++|+.....
T Consensus 244 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 244 DDVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp SCSBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred cchhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 1111111111111 11223334445555566778888999999999999999999999999999875444
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=374.56 Aligned_cols=260 Identities=29% Similarity=0.452 Sum_probs=206.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
..+|++.+.||+|+||+||+|.+. ++.||||++.... ....+.+.+|+.+|++++||||+++++++.
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-----------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-----------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 468999999999999999999543 6789999986653 345677889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCC--eeecCCCCCcEEEcCCCceEEec
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKS--VIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+...+++||||+++|+|.+++.+.+....+++..++.++.|++.||.|||+ .| |+||||||+|||++.++.+||+|
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT--SSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc--CCCCEECCCCChhhEEEeCCCcEEECC
Confidence 999999999999999999999765433458899999999999999999997 78 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
||+++.... .........||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 183 fg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---------------- 244 (309)
T 3p86_A 183 FGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---------------- 244 (309)
T ss_dssp CC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH----------------
T ss_pred CCCCccccc--cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------------
Confidence 999975322 11223456799999999999999999999999999999999999999965321
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
......+.........+..++..+.+||.+||+.||++|||+.++++.|+.+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 245 AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111111122234556677899999999999999999999999999876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=372.62 Aligned_cols=261 Identities=25% Similarity=0.440 Sum_probs=214.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++|.+.++||+|+||+||+|... .+++.||+|++........+.+.+|+.+|++++||||+++++++.+++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~---------~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 80 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHR---------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred hHeeccceecCCCCEEEEEEEEC---------CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence 57889999999999999999544 348899999987777777788999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred eeEEEEEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeecccce
Confidence 9999999999999999997643 468999999999999999999997 899999999999999999999999999997
Q ss_pred CCCCCCCcc------------eEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecc
Q 013519 259 LGPIDGNSH------------VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF 326 (441)
Q Consensus 259 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 326 (441)
......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-- 234 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-- 234 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--
Confidence 643221110 112467999999999999999999999999999999999999998654332111100
Q ss_pred cccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 327 ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
. ..... ....+..++..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 235 -----~----~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 235 -----N----VRGFL----DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp -----C----HHHHH----HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----h----hhccc----cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 00111 112234445568899999999999999999999999987754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=381.10 Aligned_cols=269 Identities=25% Similarity=0.355 Sum_probs=217.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|.+..... .....+..||||++.... ....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCST--TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccC--cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 3678999999999999999997643210 122346789999997653 34567889999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEE
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNIL 242 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 242 (441)
+.+.+|+||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ +||+||||||+|||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIl 235 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL 235 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchhhEE
Confidence 99999999999999999999986542 2358899999999999999999997 89999999999999
Q ss_pred EcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCc
Q 013519 243 LDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEH 321 (441)
Q Consensus 243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~ 321 (441)
++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--- 312 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 312 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999985433222222233467889999999999999999999999999999999 99999653211
Q ss_pred eeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
.+...+........+..++..+.+||.+||+.||++||++.++++.|+.+..
T Consensus 313 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 313 --------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp --------------GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0111111122233455677789999999999999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=374.63 Aligned_cols=272 Identities=24% Similarity=0.304 Sum_probs=209.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.++||+|+||+||+|.+. ++.||||++...... .....+|+.+|++++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 368999999999999999999543 678999998765433 34456799999999999999999999874
Q ss_pred C----eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCC----------CeeecCCCCCcEEE
Q 013519 178 R----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEK----------SVIYRDFKASNILL 243 (441)
Q Consensus 178 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~----------~ivHrDlkp~Nill 243 (441)
. .+++|||||++|+|.+++... .+++..++.++.|++.||.|||+ . +|+||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~--~~~~l~~~~~~~ivH~Dlkp~Nill 164 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHE--DIPGLKDGHKPAISHRDIKSKNVLL 164 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTC--CEEEETTEEECEEECSCCSGGGEEE
T ss_pred CCCCceEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHh--hccccccccCCCEEeCCCChHhEEE
Confidence 4 479999999999999999653 48999999999999999999997 6 99999999999999
Q ss_pred cCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 013519 244 DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPS 318 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~ 318 (441)
+.++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||......
T Consensus 165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 9999999999999976443332222334679999999999987 35667899999999999999999999765443
Q ss_pred CCceeecccccccchhhhhhhhcCccccccC-----ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 319 GEHVLVDFARPSLTDKRRLKKIMDPRLEEQY-----PIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
....+.......................... ....+..+.+||.+||+.||++|||+.++++.|+.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 2222111101000111111111111111111 22456678999999999999999999999999988764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=375.67 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=208.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||.||+|.. ..+++.||||++... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARH---------ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 36899999999999999999944 445889999998654 3345677889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
..+.+|+||||+++|+|.+++...+ .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG 159 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFG 159 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred ECCEEEEEEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999999999997764 48899999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+++..... ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||..... .
T Consensus 160 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------------~ 220 (328)
T 3fe3_A 160 FSNEFTVG---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL----------------K 220 (328)
T ss_dssp CCGGGSSS---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------H
T ss_pred CceecCCC---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH----------------H
Confidence 99754322 223456899999999999988876 899999999999999999999965321 1
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+.... ...|...+..+.+|+.+||..||.+|||+.+++++
T Consensus 221 ~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 221 ELRERVLRGK--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHHHCC--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHhCC--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111111111 12345566778999999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=373.88 Aligned_cols=249 Identities=28% Similarity=0.389 Sum_probs=208.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||+||+|+. ..+++.||+|++.... ......+.+|+.+|+.++||||+++++++.
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 75 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVRE---------KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence 5799999999999999999944 4458899999986542 123456788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+.+.+|+||||++||+|.+++.+.+ .+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus 76 ~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG 150 (337)
T 1o6l_A 76 THDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999997654 48899999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ..
T Consensus 151 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----------------~~ 212 (337)
T 1o6l_A 151 LCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------------ER 212 (337)
T ss_dssp TCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----------------HH
T ss_pred chhhcccC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH----------------HH
Confidence 99853222 2234557899999999999999999999999999999999999999964321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
....+.... ..+|...+..+.+||.+||+.||++|| ++.++++|
T Consensus 213 ~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 213 LFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 111121111 134556677899999999999999999 89999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=378.54 Aligned_cols=276 Identities=25% Similarity=0.353 Sum_probs=221.7
Q ss_pred CHHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCc
Q 013519 90 TLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNL 167 (441)
Q Consensus 90 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpni 167 (441)
....+....++|++.+.||+|+||.||+|.+... ....+++.||||++.... ....+.+.+|+.+|.++ +||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccc----cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 3445555678999999999999999999976432 234557899999997653 34456789999999999 79999
Q ss_pred cceEEEEEeCC-eEEEEEeecCCCCHHHHHHhcCC---------------------------------------------
Q 013519 168 VKLIGYCWEDR-QFLLVYEYMQKGSLENHLFRKGS--------------------------------------------- 201 (441)
Q Consensus 168 v~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------- 201 (441)
+++++++.+.+ .+++|||||++|+|.+++.....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 99999998765 48999999999999999976432
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCC
Q 013519 202 ------------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263 (441)
Q Consensus 202 ------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~ 263 (441)
...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 1228899999999999999999997 89999999999999999999999999999865443
Q ss_pred CCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhhcC
Q 013519 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD 342 (441)
Q Consensus 264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (441)
..........||+.|+|||++.+..++.++|||||||++|||++ |..||...... ..+...+.
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------------~~~~~~~~ 310 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----------------EEFCRRLK 310 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----------------HHHHHHHH
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh----------------HHHHHHHH
Confidence 33334455678999999999999999999999999999999998 99999654321 01111111
Q ss_pred ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 343 PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 343 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
.......+..++..+.+|+.+||+.||++|||+.+++++|+.+..
T Consensus 311 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 311 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 112223445566778999999999999999999999999987653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=374.46 Aligned_cols=256 Identities=24% Similarity=0.299 Sum_probs=204.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||+||+|... .+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhceeeeEEecCCCEEEEEEEEC---------CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 368999999999999999999543 4588999999865432 234568899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
.+..++|||||++|+|.+++... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGL 151 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEeec
Confidence 99999999999999999988543 358999999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++..............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........
T Consensus 152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------------- 217 (323)
T 3tki_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------------- 217 (323)
T ss_dssp CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--------------
T ss_pred cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--------------
Confidence 975432222233345689999999999988776 68999999999999999999999754322110
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.................+..+.+||.+||+.||++|||+.|++++-
T Consensus 218 -~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 218 -YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp -HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred -HHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 0111111111111234556688999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=369.64 Aligned_cols=264 Identities=24% Similarity=0.394 Sum_probs=212.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||+||+|.+... ...+..||||++... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVP------GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCT------TSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecC------CCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 36789999999999999999976532 123567999998765 34456778999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred CCccEEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEECCCCCEEECCCCc
Confidence 999999999999999999996543 468999999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCc-ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchh
Q 013519 257 AKLGPIDGNS-HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 257 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... .
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----------------~ 261 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----------------R 261 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----------------H
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----------------H
Confidence 9865332211 12223456788999999999999999999999999999999 9999964321 1
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
.....+ ........+..++..+.+||.+||..||++|||+.++++.|+.+...
T Consensus 262 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 262 DVISSV-EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHH-HcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 111111 11122234556677899999999999999999999999999887643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=361.85 Aligned_cols=284 Identities=36% Similarity=0.628 Sum_probs=226.2
Q ss_pred ccccCHHHHHHHhcCCCCC------ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC----chHHHHHHHHH
Q 013519 86 LKMFTLQDLRAATKNFRPD------TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD----SIQGLREWQAE 155 (441)
Q Consensus 86 ~~~~~~~~~~~~~~~y~~~------~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~E 155 (441)
...|++.++..++.+|... +.||+|+||.||+|... ++.||+|++... .....+.+.+|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~E 80 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----------NTTVAVKKLAAMVDITTEELKQQFDQE 80 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-----------SCEEEEEEECCCTTSCTTTHHHHHHHH
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-----------CceEEEEEEecccCcchHHHHHHHHHH
Confidence 3567889999999888877 89999999999999542 678999987653 22345678899
Q ss_pred HHHHhcCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecC
Q 013519 156 VKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRD 235 (441)
Q Consensus 156 ~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrD 235 (441)
+.+++.++||||+++++++.+.+..++||||+++++|.+++.......++++..++.++.|++.||.|||+ .||+|||
T Consensus 81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~d 158 (307)
T 2nru_A 81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRD 158 (307)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSC
T ss_pred HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecCC
Confidence 99999999999999999999999999999999999999999765545679999999999999999999997 8999999
Q ss_pred CCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 013519 236 FKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315 (441)
Q Consensus 236 lkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~ 315 (441)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|+|++|..||...
T Consensus 159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~ 237 (307)
T 2nru_A 159 IKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH 237 (307)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred CCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence 999999999999999999999976443333333344679999999998865 5889999999999999999999999754
Q ss_pred CCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
.... .+..+..........+...++..+ ...+...+..+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 238 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 238 REPQ--LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp BSSS--BTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred cchH--HHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 3221 110000000000111222222222 2345677788999999999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=374.66 Aligned_cols=251 Identities=26% Similarity=0.331 Sum_probs=206.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH------HHHHHHHHHHHHhcCCCCCccceE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ------GLREWQAEVKFLGKFSHPNLVKLI 171 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~ 171 (441)
.++|.+.+.||+|+||+||+|.. ..+++.||+|.+...... ..+.+.+|+.+|+.++||||++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~---------~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCRE---------KSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEE---------CCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 46799999999999999999944 445889999987654321 246788999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC----
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY---- 247 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---- 247 (441)
+++.+...+++||||++||+|.+++... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSC
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCCcc
Confidence 9999999999999999999999999654 358999999999999999999997 8999999999999998777
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
.+||+|||+++..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 157 ~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---------- 223 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---------- 223 (361)
T ss_dssp CEEECCCSSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----------
T ss_pred CEEEEecCCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----------
Confidence 7999999999864322 223456899999999999999999999999999999999999999965321
Q ss_pred ccccchhhhhhhhcCcc--ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTDKRRLKKIMDPR--LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+..+.... +...++...+..+.+||.+||..||++|||+.++++|
T Consensus 224 ------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 224 ------QETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp ------HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ------HHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111121111 1111122345678899999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=376.25 Aligned_cols=250 Identities=28% Similarity=0.393 Sum_probs=204.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcC-CCCCccceEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKF-SHPNLVKLIGY 173 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~ 173 (441)
.++|++.++||+|+||+||+|+.. .+++.||||++.... ......+.+|..+|..+ +||||++++++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 92 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVK---------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEc---------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence 468999999999999999999543 458899999987542 22345677899999988 69999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+.+.+.+|+|||||+||+|.+++.+.+ .+++..++.++.|++.||.|||+ .||+||||||+||||+.++.+||+|
T Consensus 93 ~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL~D 167 (353)
T 3txo_A 93 FQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLAD 167 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEEcc
Confidence 999999999999999999999997754 48999999999999999999997 8999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
||+++.... ........+||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 168 FG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---------------- 229 (353)
T 3txo_A 168 FGMCKEGIC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---------------- 229 (353)
T ss_dssp CTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------
T ss_pred ccceeeccc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH----------------
Confidence 999985322 22334567899999999999999999999999999999999999999965321
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM------EEVLET 381 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~eil~~ 381 (441)
......+.... ..+|...+..+.+||.+||+.||++||++ .++++|
T Consensus 230 ~~~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 230 DDLFEAILNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 11122222211 13455567778999999999999999998 888875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=364.76 Aligned_cols=266 Identities=27% Similarity=0.397 Sum_probs=216.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|.+.+.||+|+||.||+|..... .....+..||||++... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHL----KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETG----GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhheeeeeeecccCCeeEEEEEEecc----CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 46799999999999999999976432 12334689999998765 34556788999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCC---------------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGS---------------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRD 235 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrD 235 (441)
.+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+ .+|+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~d 175 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHRD 175 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--TTEECCC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--CCCcccc
Confidence 9999999999999999999986542 1348899999999999999999997 8999999
Q ss_pred CCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 013519 236 FKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDT 314 (441)
Q Consensus 236 lkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~ 314 (441)
|||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999976433322222233567889999999999999999999999999999999 9999965
Q ss_pred CCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 315 NRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
.... .+...+........+..++..+.+|+.+||+.||++||++.+++++|+.+.
T Consensus 256 ~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 256 IPPE-----------------RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp CCGG-----------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHH-----------------HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3211 111111111222345566778999999999999999999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=378.40 Aligned_cols=267 Identities=26% Similarity=0.347 Sum_probs=212.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|.+.+.||+|+||+||+|.+... ....+++.||||++... .......+.+|+.++++++||||+++++++.+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccC----CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 35789999999999999999976532 13345789999998754 34455678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC---ce
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGS----AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY---NA 249 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~ 249 (441)
....++|||||++|+|.+++..... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999986532 2458899999999999999999997 8999999999999999555 49
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 328 (441)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~----------- 292 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----------- 292 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------
Confidence 9999999964321111222334568999999999999999999999999999999998 9999965321
Q ss_pred cccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
.. +...+........+..++..+.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus 293 -----~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 293 -----QE-VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp -----HH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HH-HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 11 111111111223355566778999999999999999999999999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=358.72 Aligned_cols=258 Identities=25% Similarity=0.374 Sum_probs=207.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|++.+.||+|+||.||+|.. ..+++.||+|.+... .....+.+.+|+.++++++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAED---------TILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEE---------TTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEE---------CCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 36899999999999999999944 345889999987432 344567889999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+.+.+++||||+++++|.+++...+ ++++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999999997664 58999999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+++..... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 156 g~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---------------- 218 (294)
T 4eqm_A 156 GIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV---------------- 218 (294)
T ss_dssp SSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH----------------
T ss_pred CCccccccc-cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----------------
Confidence 999864322 112234467999999999999999999999999999999999999999654211
Q ss_pred hhhhhhcC---ccccccCChhhHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhccc
Q 013519 335 RRLKKIMD---PRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-SMEEVLETLQNIS 386 (441)
Q Consensus 335 ~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~eil~~L~~i~ 386 (441)
........ +......+...+..+.++|.+||+.||++|| ++.++++.|+.+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 219 SIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 00011111 1111223445567788999999999999998 8999999988654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=366.06 Aligned_cols=252 Identities=18% Similarity=0.238 Sum_probs=207.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|.+.+.||+|+||+||+|.. ..+++.||+|.+..... ....+.+|+.+|+.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~---------~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVE---------TSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEE---------CCCCcEEEEEEEecCcc-cHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 46899999999999999999944 44588999999876543 345688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC--CCceEEeccc
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG--SYNAKLSDFG 255 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~--~~~~kl~DFG 255 (441)
+.+++|||||++|+|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++. ++.+||+|||
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~Dfg 149 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred CEEEEEEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence 99999999999999999996543 358999999999999999999997 89999999999999987 7899999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..
T Consensus 150 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------------~~ 210 (321)
T 1tki_A 150 QARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----------------QQ 210 (321)
T ss_dssp TCEECCT---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----------------HH
T ss_pred CCeECCC---CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH----------------HH
Confidence 9986432 2334557899999999999998899999999999999999999999965321 11
Q ss_pred hhhhhcCccc--cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 336 RLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 336 ~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.+..+..... ........+..+.+||.+||..||++|||+.|+|++-
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 1111111111 0001123456788999999999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=379.20 Aligned_cols=259 Identities=27% Similarity=0.412 Sum_probs=211.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|.+.+.||+|+||.||+|.+.. +++.||||.+.... ......+.+|+.+|++++||||+++++++.+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 4678899999999999999996543 47899999987653 3345568899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
.+.+++||||+++|+|.+++...+ ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 999999999999999999997654 358899999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++...............+++.|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----------------~ 322 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----------------Q 322 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----------------H
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------H
Confidence 975321110000111235678999999999999999999999999999998 9999865321 1
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
.....+........+..++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 323 QTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111111122223345566778999999999999999999999999998775
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=373.84 Aligned_cols=271 Identities=27% Similarity=0.355 Sum_probs=219.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||+||+|....... .....+..||||++.... ......+.+|+.+++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSST--TCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccc--cccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 4689999999999999999997643210 122345789999987653 34567788999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEE
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNIL 242 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 242 (441)
+.+.+++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .+|+||||||+|||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCcceEE
Confidence 99999999999999999999986542 2458999999999999999999997 89999999999999
Q ss_pred EcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCc
Q 013519 243 LDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEH 321 (441)
Q Consensus 243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~ 321 (441)
++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---- 299 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 299 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999986543322233344567899999999999999999999999999999999 9999864321
Q ss_pred eeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccc
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVIE 389 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~~ 389 (441)
..+...+........+..++..+.+|+.+||+.||++|||+.+++++|+.+....
T Consensus 300 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 300 -------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp -------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred -------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 1111122222223345566778999999999999999999999999998876443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=365.91 Aligned_cols=279 Identities=26% Similarity=0.386 Sum_probs=214.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||+||+|++.. ....+++.||||++........+.+.+|+.+|++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECT-----TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEec-----ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3679999999999999999997542 23345899999999888777778899999999999999999999998653
Q ss_pred --CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 178 --RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 178 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
..+++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 56899999999999999997654 358899999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCc-ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 256 LAKLGPIDGNS-HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+++........ .......++..|+|||++.+..++.++||||||+++|+|+||..||.................... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~ 238 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-V 238 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH-H
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh-H
Confidence 99864332211 122334577889999999999999999999999999999999988853211000000000000000 0
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
..+...+........+..++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111122222233445667788999999999999999999999999998765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=379.44 Aligned_cols=253 Identities=23% Similarity=0.281 Sum_probs=206.5
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
..++|++.+.||+|+||+||+|. +..+++.+|+|++.... ....+.+.+|+.+|+.++||||+++++++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~---------~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCV---------KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEE---------ETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEE---------ECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 45789999999999999999994 44458999999886543 33456788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc---CCCceEE
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD---GSYNAKL 251 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl 251 (441)
.+.+..|+|||||.||+|.+++...+ .+++..+..++.|++.||.|||+ .||+||||||+|||++ .++.+||
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEE
Confidence 99999999999999999999997654 48999999999999999999997 8999999999999998 5678999
Q ss_pred ecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccccc
Q 013519 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 155 ~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------------- 218 (444)
T 3soa_A 155 ADFGLAIEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-------------- 218 (444)
T ss_dssp CCCSSCBCCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------------
T ss_pred ccCceeEEecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------------
Confidence 999999764322 2223456899999999999999999999999999999999999999964321
Q ss_pred chhhhhhhhcCcc--ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 332 TDKRRLKKIMDPR--LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 332 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+.... +........+..+.+||.+||+.||++|||+.++|++
T Consensus 219 --~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 219 --HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp --HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111111111 1111123456778999999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=375.58 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=207.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcC-CCCCccceEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKF-SHPNLVKLIGY 173 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~ 173 (441)
.++|++.++||+|+||+||+|+.. .+++.||+|++.... ......+.+|..+|.++ +||||++++++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLK---------KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 357999999999999999999544 458899999986542 22334577899999887 79999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+.+.+.+|||||||+||+|..++.+.+ .+++..++.++.|++.||.|||+ .||+||||||+||||+.++.+||+|
T Consensus 122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 122 FQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEee
Confidence 999999999999999999999997754 48999999999999999999997 8999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
||+++.... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...
T Consensus 197 FGla~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~~ 267 (396)
T 4dc2_A 197 YGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTE 267 (396)
T ss_dssp CTTCBCCCC--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCH
T ss_pred cceeeeccc--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hhH
Confidence 999985322 22334567899999999999999999999999999999999999999965432111000 000
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM------EEVLET 381 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~eil~~ 381 (441)
......+... ...+|...+..+.+||.+||+.||++||++ .+|++|
T Consensus 268 ~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 268 DYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HHHHHHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1111111111 123456677789999999999999999985 788775
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=362.43 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=213.4
Q ss_pred ccCHHHHHHHhcC----------CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHH
Q 013519 88 MFTLQDLRAATKN----------FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVK 157 (441)
Q Consensus 88 ~~~~~~~~~~~~~----------y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~ 157 (441)
.++..++..+++. |...+.||+|+||.||+|... .+++.||||++........+.+.+|+.
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~E~~ 94 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK---------HSGRQVAVKMMDLRKQQRRELLFNEVV 94 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCSHHHHHHHHH
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC---------CCCcEEEEEEEeccchhHHHHHHHHHH
Confidence 4567777766654 667789999999999999543 358899999987665555677889999
Q ss_pred HHhcCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCC
Q 013519 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFK 237 (441)
Q Consensus 158 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlk 237 (441)
+++.++||||+++++++...+..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+ .||+|||||
T Consensus 95 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlk 168 (321)
T 2c30_A 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHA--QGVIHRDIK 168 (321)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCS
T ss_pred HHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCC
Confidence 99999999999999999999999999999999999998854 358999999999999999999997 899999999
Q ss_pred CCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 013519 238 ASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP 317 (441)
Q Consensus 238 p~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~ 317 (441)
|+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 169 p~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~ 246 (321)
T 2c30_A 169 SDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246 (321)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred HHHEEECCCCcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999764322 1223456899999999999999999999999999999999999999964321
Q ss_pred CCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 318 SGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
. .....+.....+.+ ..+...+..+.+|+.+||+.||++|||+.+++++-
T Consensus 247 ~-------------~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 247 V-------------QAMKRLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp H-------------HHHHHHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred H-------------HHHHHHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0 00011111111111 11234556788999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=369.79 Aligned_cols=269 Identities=28% Similarity=0.386 Sum_probs=215.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|..... .....+..||||.+.... ....+.+.+|+.+|.++ .||||+++++++.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHceeeeeecCCCCceeEEeeeecc----ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 46899999999999999999976322 123357789999987543 23456788999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCC--------------------CCCCHHHHHHHHHHHHHHHhhhccCCCCeeecC
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSA--------------------EPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRD 235 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrD 235 (441)
..+.+++||||+++|+|.+++...... ..+++..++.++.|++.||.|||+ .||+|||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~D 197 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRD 197 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETT
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCcccCC
Confidence 999999999999999999999765421 347899999999999999999997 8999999
Q ss_pred CCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 013519 236 FKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDT 314 (441)
Q Consensus 236 lkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~ 314 (441)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|+| |..||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999986543333333445678899999999999999999999999999999998 9999965
Q ss_pred CCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 315 NRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
.... ..+...+........+..++..+.+|+.+||..||.+|||+.+++++|+.+...
T Consensus 278 ~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 278 IPVD----------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCCS----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCcH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 4321 111112222222334555677899999999999999999999999999876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=365.29 Aligned_cols=246 Identities=28% Similarity=0.432 Sum_probs=207.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||+||+|+. ..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 76 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRS---------RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence 5799999999999999999954 34588999999865422 23566788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+...+|+||||++||+|.+++.+.+ .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg 151 (318)
T 1fot_A 77 DAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFG 151 (318)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecC
Confidence 9999999999999999999997654 58899999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+++.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ..
T Consensus 152 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------------~~ 210 (318)
T 1fot_A 152 FAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----------------MK 210 (318)
T ss_dssp SCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------------HH
T ss_pred cceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----------------HH
Confidence 9985321 23456899999999999999999999999999999999999999964321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
....+.... ..+|...+..+.+||.+||..||++|| +++++++|
T Consensus 211 ~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 211 TYEKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 122222221 134555677899999999999999999 89999976
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=371.73 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=206.2
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
..++|.+.+.||+|+||.||+|.. ..+++.||+|++... .....+.+.+|+.+++.++||||+++++++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVH---------KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEE---------CCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 457899999999999999999944 345889999998654 334567788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC---ceEE
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY---NAKL 251 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~kl 251 (441)
.+.+..|+|||||.+|+|.+++... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEE
Confidence 9999999999999999999998654 358999999999999999999997 8999999999999997654 5999
Q ss_pred ecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccccc
Q 013519 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 173 ~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------------- 235 (362)
T 2bdw_A 173 ADFGLAIEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------------- 235 (362)
T ss_dssp CCCTTCBCCTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------------
T ss_pred eecCcceEecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------------
Confidence 999999864322 223456899999999999999999999999999999999999999965321
Q ss_pred chhhhhhhhcCccc--cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 332 TDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 332 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+..... ........+..+.+||.+||+.||++||++.++|++
T Consensus 236 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 236 --HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --HHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011111111111 111112446678899999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=367.01 Aligned_cols=261 Identities=23% Similarity=0.374 Sum_probs=205.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++.+.||+|+||+||+|.+.... ......||+|.+.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCC-----ceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 57999999999999999999765321 1123457999886543 24456789999999999999999999999876
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
. .++|+||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred C-eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEccCcce
Confidence 5 789999999999999997754 458999999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...............||+.|+|||++.+..++.++|||||||++|||+| |..||...... .
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~ 227 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------E 227 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------G
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-----------------H
Confidence 76543333333344567889999999999999999999999999999999 99999653211 1
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
+...+........+..++..+.+|+.+||+.||++||++.+++++|+.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 228 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11122222222345556777899999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=368.00 Aligned_cols=268 Identities=25% Similarity=0.381 Sum_probs=216.4
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
..++|++.+.||+|+||.||+|..... ....+++.||||.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCc----CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 457899999999999999999976532 112346899999997653 344677899999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC---------------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeec
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS---------------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYR 234 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHr 234 (441)
+.+.+++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .+|+||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~ivH~ 198 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHR 198 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCS
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecC
Confidence 99999999999999999999976431 1568999999999999999999997 899999
Q ss_pred CCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCC
Q 013519 235 DFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALD 313 (441)
Q Consensus 235 Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~ 313 (441)
||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999975322222222344578999999999999999999999999999999999 999996
Q ss_pred CCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 314 TNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
.... ......+.... ....+..++..+.+|+.+||+.||++||++.+++++|+.+..
T Consensus 279 ~~~~----------------~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 279 GMAH----------------EEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TSCH----------------HHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCh----------------HHHHHHHhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 4321 11111111111 123455667789999999999999999999999999988754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=362.51 Aligned_cols=267 Identities=27% Similarity=0.391 Sum_probs=217.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|.+... ....+++.||+|.+.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 46799999999999999999975431 233457899999987654 34457789999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC---------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS---------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASN 240 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~N 240 (441)
+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .||+||||||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~N 175 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARN 175 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccce
Confidence 99999999999999999999986542 1258999999999999999999997 899999999999
Q ss_pred EEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 013519 241 ILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSG 319 (441)
Q Consensus 241 ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~ 319 (441)
||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~- 254 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD- 254 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-
Confidence 9999999999999999986544333333344567889999999999999999999999999999999 99999654221
Q ss_pred CceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 320 EHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
..+............+...+..+.+|+.+||+.||.+|||+.+++++|+.+.
T Consensus 255 ---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 255 ---------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ---------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------------hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1111111112222334556677899999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=370.34 Aligned_cols=263 Identities=25% Similarity=0.430 Sum_probs=203.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
..+|.+.+.||+|+||.||+|+.... ...+..||||.+... .....+.+.+|+.+|++++||||+++++++.+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLP------SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCT------TSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecC------CCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 35799999999999999999965421 124678999998765 34456779999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
.+.+++||||+++|+|.+++...+ ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred CCceEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 999999999999999999997643 468999999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcc-eEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchh
Q 013519 257 AKLGPIDGNSH-VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 257 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----------------- 256 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------------- 256 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----------------
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----------------
Confidence 98643322111 1122345778999999999999999999999999999998 9999964321
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
..+...+........+..++..+.+|+.+||+.||++||++.++++.|+.+..
T Consensus 257 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 257 QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp HHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 11111122222233445667778999999999999999999999999987643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=370.79 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=209.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|.+.+.||+|+||+||+|.. ..+++.||+|.+..........+.+|+.+|+.++||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~---------~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVE---------KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEE---------CCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 36799999999999999999944 345889999998877665667789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC--CCceEEeccc
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG--SYNAKLSDFG 255 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~--~~~~kl~DFG 255 (441)
..+++|||||.+|+|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++. .+.+||+|||
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEecc
Confidence 99999999999999999986543 358999999999999999999997 89999999999999974 4779999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..
T Consensus 197 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----------------~~ 257 (387)
T 1kob_A 197 LATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----------------LE 257 (387)
T ss_dssp TCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----------------HH
T ss_pred cceecCCC---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----------------HH
Confidence 99864322 234456899999999999999999999999999999999999999965321 01
Q ss_pred hhhhhc--CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+..+. ...+........+..+.+||.+||..||++|||+.++|++
T Consensus 258 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 258 TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111111 1111122233456778999999999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=359.86 Aligned_cols=273 Identities=22% Similarity=0.288 Sum_probs=210.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|.+.++||+|+||+||+|... .+++.||||++.... ....+.+.+|+.+|++++||||+++++++...
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHK---------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CCEEEEEEecCCCCeEEEEEEEC---------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence 57999999999999999999544 357899999987543 23356678999999999999999999999876
Q ss_pred C--eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE----cCCCceEE
Q 013519 178 R--QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL----DGSYNAKL 251 (441)
Q Consensus 178 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~kl 251 (441)
. ..++||||+++++|.+++........+++..++.++.|++.||.|||+ .||+||||||+|||+ +.++.+||
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceEEE
Confidence 5 789999999999999999876555559999999999999999999997 899999999999999 78888999
Q ss_pred ecccCCCCCCCCCCcceEeeeccccccCcchhhh--------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-
Q 013519 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA--------TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV- 322 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~- 322 (441)
+|||+++..... .......||+.|+|||++. +..++.++|||||||++|||++|..||..........
T Consensus 158 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 234 (319)
T 4euu_A 158 TDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (319)
T ss_dssp CCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred ccCCCceecCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence 999999864322 2233467999999999987 5788899999999999999999999996432211000
Q ss_pred -eeccc----ccccchhhhhhh-h--c--CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 323 -LVDFA----RPSLTDKRRLKK-I--M--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 323 -~~~~~----~~~~~~~~~~~~-~--~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
+.... ...+........ . . ........+...+..+.+|+.+||+.||++|||+.|+|++..+.
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 00000 000000000000 0 0 00111234567788899999999999999999999999998653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=368.70 Aligned_cols=250 Identities=28% Similarity=0.384 Sum_probs=208.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcC-CCCCccceEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKF-SHPNLVKLIGY 173 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~~~~~ 173 (441)
.++|++.++||+|+||+||+|... .+++.||||++..... ...+.+..|..+|..+ +||||++++++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 89 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERK---------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 89 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEET---------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE
Confidence 468999999999999999999543 4578999999865421 2345678899999988 79999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+.+.+.+|+||||++||+|.+++.+.+ .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|
T Consensus 90 ~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 90 FQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEEEe
Confidence 999999999999999999999997654 48899999999999999999997 8999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
||+++.... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 165 FG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---------------- 226 (353)
T 2i0e_A 165 FGMCKENIW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---------------- 226 (353)
T ss_dssp CTTCBCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------
T ss_pred CCccccccc--CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH----------------
Confidence 999985322 12234567899999999999999999999999999999999999999965321
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-----MEEVLET 381 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~eil~~ 381 (441)
......+.... ..+|...+..+.+||.+||..||++||+ +.++++|
T Consensus 227 ~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 227 DELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11122222221 1345566778999999999999999995 6888875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=370.16 Aligned_cols=254 Identities=22% Similarity=0.298 Sum_probs=203.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-----HHHHHHHHHHHHHhcCCCCCccceEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-----QGLREWQAEVKFLGKFSHPNLVKLIG 172 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~ 172 (441)
.++|++.+.||+|+||+||+|.. ..+++.||||++..... ...+.+.+|+.+++.++||||+++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 93 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCIN---------RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 35799999999999999999944 44588999998754221 13467889999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc---
Q 013519 173 YCWEDRQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN--- 248 (441)
Q Consensus 173 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--- 248 (441)
++.+++.+|+|||||++++|.+++.... ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~~ 171 (351)
T 3c0i_A 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAP 171 (351)
T ss_dssp EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTCC
T ss_pred EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCCc
Confidence 9999999999999999999998886532 23458899999999999999999997 89999999999999986655
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 328 (441)
+||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 172 vkl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------- 238 (351)
T 3c0i_A 172 VKLGGFGVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----------- 238 (351)
T ss_dssp EEECCCTTCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-----------
T ss_pred EEEecCcceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-----------
Confidence 999999999764322 2223456799999999999999999999999999999999999999965210
Q ss_pred cccchhhhhhhhcCccc--cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 PSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+..... ........+..+.+||.+||..||++|||+.++|++
T Consensus 239 ------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 239 ------RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp ------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01111111110 000012345678899999999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=365.25 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=205.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch------HHHHHHHHHHHHHhcCCCCCccceE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI------QGLREWQAEVKFLGKFSHPNLVKLI 171 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~ 171 (441)
.++|.+.+.||+|+||.||+|.. ..+++.||+|.+..... ...+.+.+|+.+|+.++||||++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 80 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCRE---------KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEE---------TTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEeceEEeeCCCeEEEEEEE---------CCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 35799999999999999999954 34588999998765322 1356788999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC----
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY---- 247 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---- 247 (441)
+++.+...+++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSSC
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCCC
Confidence 9999999999999999999999999654 458999999999999999999997 9999999999999998887
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 156 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------- 223 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------- 223 (326)
T ss_dssp CEEECCCTTCEECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---------
T ss_pred CEEEEECCCCeECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---------
Confidence 7999999999864322 1234467999999999999999999999999999999999999999643210
Q ss_pred ccccchhhhhhhhc--CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTDKRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+..+. ...+........+..+.+||.+||+.||++|||+.++|++
T Consensus 224 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 224 -------ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -------HHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111 1111111122345678899999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=365.62 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=208.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcC-CCCCccceEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKF-SHPNLVKLIGYC 174 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 174 (441)
++|++.+.||+|+||+||+|+.. .+++.||+|++... .......+.+|+.++.++ +||||+++++++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLK---------KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 57899999999999999999543 45889999998654 334566788999999988 799999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+...+|+||||+++|+|.+++.+.+ .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DF 154 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDY 154 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCG
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999997654 48999999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....
T Consensus 155 G~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------~~~~ 225 (345)
T 3a8x_A 155 GMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTED 225 (345)
T ss_dssp GGCBCSCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHH
T ss_pred cccccccCC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-------ccHH
Confidence 999853221 2234557899999999999999999999999999999999999999964322110000 0001
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM------EEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~eil~~ 381 (441)
.....+... ...+|...+..+.+||.+||+.||++||++ .++++|
T Consensus 226 ~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 226 YLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHHHHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 111111111 123455667789999999999999999985 778775
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=362.41 Aligned_cols=265 Identities=26% Similarity=0.384 Sum_probs=197.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||+||+|...... .....||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQED------GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhHeEEeceecccCCeEEEEEEEcccC------CcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 468999999999999999999654321 11237999998765 3345678899999999999999999999998
Q ss_pred eCCeE------EEEEeecCCCCHHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC
Q 013519 176 EDRQF------LLVYEYMQKGSLENHLFRKGS---AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS 246 (441)
Q Consensus 176 ~~~~~------~lv~e~~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 246 (441)
..... ++||||+.+|+|.+++..... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.+
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAED 173 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEEEcCC
Confidence 77655 999999999999999865432 2258999999999999999999997 899999999999999999
Q ss_pred CceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeec
Q 013519 247 YNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVD 325 (441)
Q Consensus 247 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~ 325 (441)
+.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------- 246 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA------- 246 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-------
Confidence 9999999999986433322223334567889999999999999999999999999999999 89999653211
Q ss_pred ccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 326 FARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
.....+.. ......+..++..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 247 ---------~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 247 ---------EIYNYLIG-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp ---------GHHHHHHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------HHHHHHhc-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111111 11123345566778999999999999999999999999987653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=370.37 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=207.0
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcC-CCCCccceEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKF-SHPNLVKLIG 172 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~~~~ 172 (441)
..++|.+.+.||+|+||+||+|... .+++.||||++..... .....+..|..+|..+ +||||+++++
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~ 85 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFK---------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFC 85 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEE
Confidence 3578999999999999999999543 4588999999865421 2345677899999876 8999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEe
Q 013519 173 YCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252 (441)
Q Consensus 173 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 252 (441)
++.+.+.+|+||||++||+|.+++.+.+ .+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 86 TFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEEEe
Confidence 9999999999999999999999997654 48899999999999999999997 899999999999999999999999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 161 DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------------- 223 (345)
T 1xjd_A 161 DFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------------- 223 (345)
T ss_dssp CCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------
T ss_pred EChhhhhcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---------------
Confidence 99999853221 2234567899999999999999999999999999999999999999965321
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSME-EVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-eil~~ 381 (441)
......+... ...+|...+..+.+||.+||..||++||++. ++++|
T Consensus 224 -~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 224 -EELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp -HHHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -HHHHHHHHhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 1111111111 1134555677899999999999999999998 77764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=367.99 Aligned_cols=255 Identities=23% Similarity=0.306 Sum_probs=197.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||+||+|+. ..+++.||||++...... ...+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRD---------KLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEE---------TTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcEEEEEEeccCCCEEEEEEEE---------CCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 36899999999999999999944 445889999998654322 25678999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc--eEEeccc
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN--AKLSDFG 255 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--~kl~DFG 255 (441)
..+++||||+.+|+|.+++...+ .+++..++.++.|++.||.|||+ .||+||||||+|||++.++. +||+|||
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeecC
Confidence 99999999999999999997654 48999999999999999999997 99999999999999987765 9999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCcc-ccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVK-SDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+++.... ........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ..
T Consensus 164 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------------~~ 228 (361)
T 3uc3_A 164 YSKSSVL---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD------------YR 228 (361)
T ss_dssp CC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC------------HH
T ss_pred ccccccc---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH------------HH
Confidence 9974221 222344679999999999998888755 8999999999999999999975432111 11
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
..+..+.............+..+.+||.+||+.||++|||+.++++|-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 229 KTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp HHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred HHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 112222222222112224566788999999999999999999999873
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=364.65 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=200.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.+|++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 75 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNK---------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 75 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEET---------TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred hhcCceeeEecCCCCeEEEEEEEc---------CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 467999999999999999999543 458899999986543 2345778999999999999999999999866
Q ss_pred CC---------------------------------------------------------eEEEEEeecCCCCHHHHHHhc
Q 013519 177 DR---------------------------------------------------------QFLLVYEYMQKGSLENHLFRK 199 (441)
Q Consensus 177 ~~---------------------------------------------------------~~~lv~e~~~~g~L~~~l~~~ 199 (441)
.. .+++|||||++++|.+++.+.
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 155 (332)
T 3qd2_B 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155 (332)
T ss_dssp CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence 43 389999999999999999887
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCc----------ceE
Q 013519 200 GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNS----------HVT 269 (441)
Q Consensus 200 ~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~----------~~~ 269 (441)
......++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++........ ...
T Consensus 156 ~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T 3qd2_B 156 CSLEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233 (332)
T ss_dssp CSGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred cCccchhhHHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence 665667778899999999999999997 89999999999999999999999999999865432211 112
Q ss_pred eeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccC
Q 013519 270 TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQY 349 (441)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (441)
....||+.|+|||++.+..++.++|||||||++|+|++|..|+... ............. ..
T Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------------------~~~~~~~~~~~~~-~~ 294 (332)
T 3qd2_B 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------------------VRIITDVRNLKFP-LL 294 (332)
T ss_dssp CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------------------HHHHHHHHTTCCC-HH
T ss_pred cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------------------HHHHHHhhccCCC-cc
Confidence 3357999999999999999999999999999999999986654210 0111111111110 11
Q ss_pred ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 350 PIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 350 ~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+..+.+||.+||+.||++|||+.+++++
T Consensus 295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 12334567899999999999999999999985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=367.41 Aligned_cols=246 Identities=25% Similarity=0.346 Sum_probs=207.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||.||+|... .+++.||+|++..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHK---------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEEC---------CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 57999999999999999999543 4588999999865422 23567888999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+...+|+||||++||+|.+++.+.+ .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 112 ~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFg 186 (350)
T 1rdq_E 112 DNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEcccc
Confidence 9999999999999999999998754 48899999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+++.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ..
T Consensus 187 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----------------~~ 245 (350)
T 1rdq_E 187 FAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----------------IQ 245 (350)
T ss_dssp TCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HH
T ss_pred cceeccC-----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH----------------HH
Confidence 9985422 13456899999999999999999999999999999999999999964321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-----MEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~eil~~ 381 (441)
....+.... ..+|...+..+.+||.+||+.||.+||+ +.+|++|
T Consensus 246 ~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 246 IYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 122222211 1345566778999999999999999998 8999876
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=380.85 Aligned_cols=259 Identities=22% Similarity=0.278 Sum_probs=208.5
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH---HHHHHHHHHHHHhcCCCCCccc
Q 013519 93 DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ---GLREWQAEVKFLGKFSHPNLVK 169 (441)
Q Consensus 93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~ 169 (441)
++....++|++.++||+|+||+||+|+.. .+++.||+|++...... ....+.+|+.++..++||||++
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~ 138 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLK---------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCC
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEc---------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 33445678999999999999999999554 35789999998643221 1223778999999999999999
Q ss_pred eEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 170 LIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 170 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
++++|.+.+.+|||||||+||+|.+++.+.. ..+++..++.++.|++.||.|||+ .+|+||||||+||||+.++.+
T Consensus 139 l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl~~~g~v 214 (437)
T 4aw2_A 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHI 214 (437)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCE
T ss_pred EEEEEeeCCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeEcCCCCE
Confidence 9999999999999999999999999997632 458999999999999999999997 999999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV 324 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~ 324 (441)
||+|||+++...... .......+||+.|+|||++. ...|+.++|||||||++|||++|+.||.....
T Consensus 215 kL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~------- 286 (437)
T 4aw2_A 215 RLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------- 286 (437)
T ss_dssp EECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-------
T ss_pred EEcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-------
Confidence 999999997543222 22234468999999999997 46789999999999999999999999965321
Q ss_pred cccccccchhhhhhhhcCccccccCC---hhhHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 013519 325 DFARPSLTDKRRLKKIMDPRLEEQYP---IKGALLAGQIIIKCLEAEPKN--RPSMEEVLET 381 (441)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~--Rps~~eil~~ 381 (441)
......++.......+| ...+..+.+||.+||..+|++ ||+++|+++|
T Consensus 287 ---------~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 287 ---------VETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ---------HHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ---------hHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11122222211111222 235677999999999988888 9999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=378.49 Aligned_cols=258 Identities=26% Similarity=0.301 Sum_probs=208.3
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccc
Q 013519 93 DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVK 169 (441)
Q Consensus 93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~ 169 (441)
++....++|++.++||+|+||+||+|+.. .+++.||+|++..... .....+.+|+.+++.++||||++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~ 133 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHK---------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCC
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEEC---------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence 33445678999999999999999999543 4588999999864221 11234778999999999999999
Q ss_pred eEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 170 LIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 170 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
+++++.+...+|||||||+||+|.+++... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+
T Consensus 134 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~i 207 (410)
T 3v8s_A 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHL 207 (410)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCE
T ss_pred EEEEEEECCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeECCCCCE
Confidence 999999999999999999999999998653 48899999999999999999997 899999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeec
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH----LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD 325 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~ 325 (441)
||+|||+++..... ........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.....
T Consensus 208 kL~DFG~a~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------- 278 (410)
T 3v8s_A 208 KLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------- 278 (410)
T ss_dssp EECCCTTCEECCTT-SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------
T ss_pred EEeccceeEeeccC-CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------
Confidence 99999999764322 112234578999999999998765 78999999999999999999999965321
Q ss_pred ccccccchhhhhhhhcCccccccCC--hhhHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 013519 326 FARPSLTDKRRLKKIMDPRLEEQYP--IKGALLAGQIIIKCLEAEPKN--RPSMEEVLETL 382 (441)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~--Rps~~eil~~L 382 (441)
......++.......+| ...+..+.+||.+||..+|.+ ||+++||++|-
T Consensus 279 --------~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 279 --------VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp --------HHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred --------hhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 12222232221111222 245677999999999999988 99999999873
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=351.95 Aligned_cols=258 Identities=28% Similarity=0.378 Sum_probs=210.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||.||+|.+.. +..||+|++...... ...+.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG----------QYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheeeeeeeccCCCceEEEEEecC----------ceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4679999999999999999996542 567999998765432 35688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+++++|.+++...+ ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred CceEEEEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCccc
Confidence 99999999999999999997653 358899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 152 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------------~~~ 214 (268)
T 3sxs_A 152 RYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN----------------SEV 214 (268)
T ss_dssp EECCTTC-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH----------------HHH
T ss_pred eecchhh-hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh----------------HHH
Confidence 7543221 112223456778999999999999999999999999999999 9999964321 111
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
...+. .......+...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 215 ~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 215 VLKVS-QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHH-TTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHH-cCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11111 1111223444566788999999999999999999999999987643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=351.24 Aligned_cols=250 Identities=28% Similarity=0.502 Sum_probs=197.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch----HHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI----QGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
++|.+.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC 75 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 57889999999999999999643 67899999865432 2356788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCC---eeecCCCCCcEEEcC------
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKS---VIYRDFKASNILLDG------ 245 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~---ivHrDlkp~Nill~~------ 245 (441)
.+.+..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+ .+ |+||||||+|||++.
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~~~~i~H~dikp~Nil~~~~~~~~~ 149 (271)
T 3dtc_A 76 LKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHD--EAIVPIIHRDLKSSNILILQKVENGD 149 (271)
T ss_dssp CCC--CEEEEECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHH--SSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred ecCCceEEEEEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCchHHEEEeccccccc
Confidence 999999999999999999998843 358999999999999999999997 77 999999999999986
Q ss_pred --CCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee
Q 013519 246 --SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323 (441)
Q Consensus 246 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~ 323 (441)
++.+||+|||+++..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------ 219 (271)
T 3dtc_A 150 LSNKILKITDFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------ 219 (271)
T ss_dssp CSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------
T ss_pred ccCcceEEccCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------
Confidence 678999999999753221 22345799999999999999999999999999999999999999965321
Q ss_pred ecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
................+..++..+.+++.+||+.||++|||+.+++++|+.+
T Consensus 220 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 220 ----------LAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----------HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----------HHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111122222333344566677899999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=353.65 Aligned_cols=253 Identities=27% Similarity=0.519 Sum_probs=205.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH----H---HHHHHHHHHHHhcCCCCCccceE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ----G---LREWQAEVKFLGKFSHPNLVKLI 171 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~---~~~~~~E~~~l~~l~hpniv~~~ 171 (441)
++|++.+.||+|+||+||+|... .+++.||+|++...... . .+.+.+|+.++++++||||++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLV---------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEET---------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccceehhccccCCceeEEEEEEc---------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 67999999999999999999553 34789999998654321 1 26788999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCC--eeecCCCCCcEEEcCCCc-
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKS--VIYRDFKASNILLDGSYN- 248 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--ivHrDlkp~Nill~~~~~- 248 (441)
+++.+.. ++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++.
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~~ivH~dikp~Nil~~~~~~~ 163 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQN--QNPPIVHRDLRSPNIFLQSLDEN 163 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCSCCSGGGEEESCCCTT
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHh--CCCCeecCCCCcceEEEeccCCC
Confidence 9986655 79999999999999887643 468999999999999999999997 77 999999999999988776
Q ss_pred ----eEEecccCCCCCCCCCCcceEeeeccccccCcchhh--hcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce
Q 013519 249 ----AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV--ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV 322 (441)
Q Consensus 249 ----~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~ 322 (441)
+||+|||+++... .......||+.|+|||++ ....++.++|||||||++|+|++|..||.......
T Consensus 164 ~~~~~kl~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--- 235 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK--- 235 (287)
T ss_dssp CSCCEEECCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH---
T ss_pred CceeEEeCCCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH---
Confidence 9999999997422 234557899999999998 34567899999999999999999999996543211
Q ss_pred eecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
......+.........+..++..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 236 -----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 236 -----------IKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -----------HHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -----------HHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111112222233345566677899999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=353.56 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=210.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||.||+|.+.. ++.||+|++...... .+.+.+|+.++++++||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhhceeeheecCCCccEEEEEEecC----------CCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3578899999999999999996542 567999998765432 35688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred CceEEEEEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEEcCCCCEEecccccc
Confidence 99999999999999999996543 458999999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 154 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~----------------~~~ 216 (269)
T 4hcu_A 154 RFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------------SEV 216 (269)
T ss_dssp GGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHH
T ss_pred ccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH----------------HHH
Confidence 7532211 111223456788999999999999999999999999999999 9999965321 111
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
...+. .......+...+..+.+|+.+||+.||++||++.+++++|+.+..
T Consensus 217 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 217 VEDIS-TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHh-cCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11111 112223344556778899999999999999999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=366.17 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=204.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|.+.+.||+|+||+||+|.. ..+++.||||++..... .....+.+|+.+|+.++||||+++++++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 78 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATH---------YKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 36899999999999999999954 34588999998864321 1234688999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.....+++||||+ +|+|.+++...+ .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus 79 ~~~~~~~lv~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~DF 152 (336)
T 3h4j_B 79 TTPTDIVMVIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADF 152 (336)
T ss_dssp ECSSEEEEEECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEECTTCCEEECCS
T ss_pred EeCCEEEEEEECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEEcCCCCEEEEEe
Confidence 9999999999999 789999887654 48999999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
|+++.... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..........
T Consensus 153 G~s~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------- 218 (336)
T 3h4j_B 153 GLSNIMTD---GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------- 218 (336)
T ss_dssp SCTBTTTT---SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-----------
T ss_pred ccceeccC---CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-----------
Confidence 99986432 222345689999999999988876 689999999999999999999997543211000
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.+.. .....|...+..+.+||.+||+.||.+|||+.|++++-
T Consensus 219 -----~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 219 -----KVNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp -----CCCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred -----HHHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 0000 01123445567788999999999999999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=360.54 Aligned_cols=274 Identities=26% Similarity=0.355 Sum_probs=218.7
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccc
Q 013519 92 QDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVK 169 (441)
Q Consensus 92 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~ 169 (441)
..+....++|++.+.||+|+||+||+|.+... ....+++.||||.+.... ....+.+.+|+.++.++ +||||++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecC----CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 33444567899999999999999999976432 233457899999987653 34456788999999999 6999999
Q ss_pred eEEEEEeCC-eEEEEEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecC
Q 013519 170 LIGYCWEDR-QFLLVYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRD 235 (441)
Q Consensus 170 ~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrD 235 (441)
+++++...+ .+++||||+++++|.+++..... ...+++..++.++.|++.||.|||+ .+|+|||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~d 173 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRD 173 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCCCSC
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCccccc
Confidence 999988754 58999999999999999976542 1237899999999999999999997 8999999
Q ss_pred CCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 013519 236 FKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDT 314 (441)
Q Consensus 236 lkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~ 314 (441)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986544333333445678999999999999999999999999999999998 9999965
Q ss_pred CCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 315 NRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
..... .+...+........+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 254 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 254 VKIDE----------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CCCSH----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhH----------------HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 42210 0111111111122344556678899999999999999999999999987653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=358.78 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=196.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--------------------------HHHHH
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--------------------------QGLRE 151 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~ 151 (441)
.++|.+.+.||+|+||.||+|+. ..+++.||||++..... ...+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYN---------ENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEE---------TTTTEEEEEEEEECC-------------------------------CH
T ss_pred ecceEEEeEEeecCCEEEEEEEE---------CCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence 36799999999999999999954 34588999998865431 12356
Q ss_pred HHHHHHHHhcCCCCCccceEEEEEe--CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCC
Q 013519 152 WQAEVKFLGKFSHPNLVKLIGYCWE--DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEK 229 (441)
Q Consensus 152 ~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 229 (441)
+.+|+.+|++++||||+++++++.+ ...+++||||+++++|.+++. ...+++..++.++.|++.||.|||+ .
T Consensus 83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~--~ 156 (298)
T 2zv2_A 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY--Q 156 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH--T
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH--C
Confidence 8899999999999999999999987 568999999999999987542 2468999999999999999999997 8
Q ss_pred CeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCC---CCccccchhHHHHHHHHH
Q 013519 230 SVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH---LYVKSDVYGFGVVLLEML 306 (441)
Q Consensus 230 ~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~ell 306 (441)
+|+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 157 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred CeeccCCCHHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 9999999999999999999999999999764322 22344568999999999997765 368899999999999999
Q ss_pred hCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 307 TGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 307 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+|..||..... ......+.............+..+.+||.+||+.||++|||+.+++++
T Consensus 235 ~g~~pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 235 FGQCPFMDERI----------------MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HSSCSSCCSSH----------------HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HCCCCCCCccH----------------HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 99999964311 000111111111111123455678899999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=372.03 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=205.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||+||+|.. ..+++.||+|++..... ...+.+.+|+.+|+.++|||||+++++|.
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~---------~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQK---------NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 5799999999999999999954 34588999998865321 23567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+...+|+||||+.||+|.+++...+ .+++..++.++.|++.||.|||+ .||+||||||+||||+.++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG 160 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFN 160 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEeccc
Confidence 9999999999999999999997643 58999999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
+++.... .......+||+.|+|||++.. ..++.++|||||||++|+|++|..||........
T Consensus 161 ~a~~~~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~------------ 225 (384)
T 4fr4_A 161 IAAMLPR---ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS------------ 225 (384)
T ss_dssp TCEECCT---TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH------------
T ss_pred eeeeccC---CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH------------
Confidence 9986432 223456789999999999964 4588999999999999999999999965432110
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-MEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~eil~~ 381 (441)
......+.. ....+|..++..+.+||.+||+.||++||+ +.+++++
T Consensus 226 -~~~~~~~~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 226 -KEIVHTFET--TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp -HHHHHHHHH--CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred -HHHHHHHhh--cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 111111111 112345566778999999999999999998 7777764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=352.35 Aligned_cols=260 Identities=25% Similarity=0.355 Sum_probs=200.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||.||+|..... ...+..||+|..... .....+.+.+|+.++++++||||+++++++ .
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~ 86 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSP------ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecC------CCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-c
Confidence 46799999999999999999976532 123668999998764 334456788999999999999999999987 4
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred cCccEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECcccc
Confidence 567899999999999999997653 358899999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++...... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~----------------~ 225 (281)
T 1mp8_A 163 SRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----------------D 225 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----------------G
T ss_pred ccccCccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH----------------H
Confidence 98643221 112233457889999999999999999999999999999997 99999653211 1
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
....+... .....+..++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 226 ~~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 226 VIGRIENG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp HHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111111 112234566777899999999999999999999999998765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=375.27 Aligned_cols=253 Identities=27% Similarity=0.425 Sum_probs=209.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|.+.+.||+|+||.||+|.+. ++.||||.++... ..+.+.+|+.+|++++||||+++++++.+.
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 467888999999999999999653 5689999987654 346788999999999999999999998876
Q ss_pred C-eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 178 R-QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 178 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
. .+++|||||++|+|.+++...+. ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~ 335 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGL 335 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred CCceEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence 5 79999999999999999987643 347899999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++.... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 336 a~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---------------- 394 (450)
T 1k9a_A 336 TKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------------- 394 (450)
T ss_dssp CEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----------------
T ss_pred cccccc-----cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------
Confidence 985321 1223467889999999999999999999999999999998 999997543211
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
....+ ........|..++..+.+||.+||+.||++|||+.++++.|+.+...
T Consensus 395 ~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 395 VVPRV-EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHH-HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 01111 11122344566778899999999999999999999999999887644
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=360.98 Aligned_cols=253 Identities=28% Similarity=0.391 Sum_probs=200.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc----hHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS----IQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
.++|++.+.||+|+||.||+|+... ...+++.||+|++.... ......+.+|+.+|+.++||||++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVT------GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECS------STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEec------cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 3679999999999999999996532 12458899999987653 2334567889999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+...+.+|+||||+++++|.+++...+ .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~D 164 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTD 164 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEECC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEEe
Confidence 999999999999999999999997654 48899999999999999999997 8999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
||+++.... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 165 fg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------------- 226 (327)
T 3a62_A 165 FGLCKESIH--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---------------- 226 (327)
T ss_dssp CSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----------------
T ss_pred CCccccccc--CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH----------------
Confidence 999975322 12223456799999999999999999999999999999999999999965321
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
...+..+.... ..++...+..+.+||.+||..||++|| ++.++++|
T Consensus 227 ~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 227 KKTIDKILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHHHHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHHHhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11111222111 123455667789999999999999999 88899986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=362.67 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=202.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCC--CCccceEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSH--PNLVKLIGYC 174 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~ 174 (441)
.+|++.+.||+|+||.||+|... .++.||||++... .......+.+|+.+|..++| |||+++++++
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 78 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence 56999999999999999999542 3778999987644 34456788999999999986 9999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+...+++||| +.+++|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+|||++ ++.+||+||
T Consensus 79 ~~~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~DF 151 (343)
T 3dbq_A 79 ITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDF 151 (343)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEECCC
T ss_pred eeCCEEEEEEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEeec
Confidence 99999999999 56889999997653 58899999999999999999997 8999999999999997 578999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-----------GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~ 323 (441)
|+++..............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 152 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------- 224 (343)
T 3dbq_A 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------- 224 (343)
T ss_dssp SSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------
T ss_pred ccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-------
Confidence 99986543333333445789999999999975 678899999999999999999999996421
Q ss_pred ecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.....+..+.++.....++...+..+.+||.+||+.||++|||+.++|++.
T Consensus 225 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 225 --------NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp --------SHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------hHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 112223344444444455666667789999999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=355.83 Aligned_cols=267 Identities=22% Similarity=0.287 Sum_probs=201.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||+||+|... .++.||+|++..... .....+.+|+.+|++++||||+++++++.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 368999999999999999999543 278999999875432 23467889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+...+++||||+++ +|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 90 SERCLTLVFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp CSSCEEEEEECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cCCEEEEEEcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccCc
Confidence 99999999999985 8888886543 458999999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-c----cccc
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-D----FARP 329 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-~----~~~~ 329 (441)
+++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ . ....
T Consensus 165 ~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 242 (311)
T 3niz_A 165 LARAFGIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242 (311)
T ss_dssp TCEETTSC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred CceecCCC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChH
Confidence 99864322 222344678999999999976 56899999999999999999999999765433211100 0 0000
Q ss_pred ccchhhhhhhh-------cCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKRRLKKI-------MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+.....+... +............+.++.+||.+||+.||++|||+.|+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000000000 00000011122345678899999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=362.55 Aligned_cols=278 Identities=26% Similarity=0.355 Sum_probs=218.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEE--e
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCW--E 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~ 176 (441)
++|++.+.||+|+||.||+|.+.. ....+++.||||++........+.+.+|+.++++++||||+++++++. +
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDP-----LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECT-----TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhccCCCCeEEEEEEecc-----CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 579999999999999999997542 234458899999998887777788999999999999999999999987 4
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...+++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred CceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCCEEEccccc
Confidence 567999999999999999997643 258899999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcc-eEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSH-VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... ..........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~~ 251 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM--GCERDVPALS 251 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC--C----CCHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc--ccccccccHH
Confidence 98653322211 12234688889999999999999999999999999999999999864321000000 0000111112
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
.+............+..++..+.+||.+||+.||++|||+.+++++|+.+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2222222333334566677889999999999999999999999999987753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=359.86 Aligned_cols=262 Identities=23% Similarity=0.364 Sum_probs=204.1
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++.++||+|+||+||+|.+.... ......|++|.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTT-----CSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCC-----ceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 67999999999999999999765421 112345788877543 233457788999999999999999999999876
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
. .++|++|+.+|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred C-ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 5 889999999999999997654 458899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----------------~ 227 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------E 227 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------G
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----------------H
Confidence 86543333333344567889999999999999999999999999999999 99999654221 1
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
+...+........+..++..+.+|+.+||..||.+||++.++++.|+.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 228 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111121222223455567778999999999999999999999999987653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=364.71 Aligned_cols=262 Identities=23% Similarity=0.388 Sum_probs=205.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++.+.||+|+||+||+|.+.... ......|++|.+.... ......+.+|+.+++.++||||+++++++. .
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEG-----ESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTT-----CSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hHceeeeeeeecCCceEEEEEEcCCC-----ceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 57899999999999999999765421 1123458888875432 222345678999999999999999999886 4
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
...++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred CccEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEECCCCcc
Confidence 56899999999999999997642 358889999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------- 225 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----------------- 225 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-----------------
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-----------------
Confidence 87654444444455678899999999999999999999999999999999 999997543211
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
+...+........+..++..+.+|+.+||..||++||++.+++++|+.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 226 VPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp HHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111111111122333445557799999999999999999999999987653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=364.43 Aligned_cols=268 Identities=28% Similarity=0.376 Sum_probs=215.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|...... .....+.||+|.+.... ....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLG----KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCS----SSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHceeeeEeccCCCcceEEEEecCCC----cccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 468999999999999999999765431 12234689999987653 34567788999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC-----------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS-----------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD 244 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 244 (441)
+.+.+++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .||+||||||+|||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGCEEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccceEEEC
Confidence 99999999999999999999975421 2457899999999999999999997 8999999999999999
Q ss_pred CCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCcee
Q 013519 245 GSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVL 323 (441)
Q Consensus 245 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~ 323 (441)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|+| |..||......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----- 273 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN----- 273 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-----
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-----
Confidence 999999999999986433333233334567889999999999999999999999999999999 99998653211
Q ss_pred ecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
..+............+..++..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus 274 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 274 -----------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp -----------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 11111111122223344556778899999999999999999999999987653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=360.44 Aligned_cols=270 Identities=25% Similarity=0.360 Sum_probs=215.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|....... .....+..||||++.... ......+.+|+.+++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCST--TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccc--cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3689999999999999999997653210 122457889999987653 34567788999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEE
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNIL 242 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 242 (441)
+.+.+++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .||+||||||+|||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL 189 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCccceEE
Confidence 99999999999999999999976542 2348899999999999999999997 89999999999999
Q ss_pred EcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCc
Q 013519 243 LDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEH 321 (441)
Q Consensus 243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~ 321 (441)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---- 265 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 265 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----
Confidence 99999999999999976433222222333467889999999999999999999999999999999 9999964321
Q ss_pred eeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
..+...+........+..++..+.+|+.+||..||.+||++.++++.|+.+...
T Consensus 266 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 266 -------------EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp -------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 011111111112234455667789999999999999999999999999887543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=376.21 Aligned_cols=259 Identities=22% Similarity=0.259 Sum_probs=207.1
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCcc
Q 013519 92 QDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLV 168 (441)
Q Consensus 92 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv 168 (441)
.+.....++|++.++||+|+||+||+|+. ..+++.||||++..... .....+.+|..+|..++||||+
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~---------~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv 124 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKM---------KQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBC
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCee
Confidence 33444568899999999999999999954 34589999999865322 1233478899999999999999
Q ss_pred ceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 169 KLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 169 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
++++++.+.+.+||||||++||+|.+++.+.+ ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.+++
T Consensus 125 ~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp CEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSC
T ss_pred eEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeeecCCCC
Confidence 99999999999999999999999999998754 358899999999999999999997 99999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhh-------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA-------TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~ 321 (441)
+||+|||+++...... .......+||+.|+|||++. ...|+.++|||||||++|||++|+.||.....
T Consensus 201 vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---- 275 (412)
T 2vd5_A 201 IRLADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---- 275 (412)
T ss_dssp EEECCCTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----
T ss_pred EEEeechhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH----
Confidence 9999999997643322 11223468999999999997 35789999999999999999999999965321
Q ss_pred eeecccccccchhhhhhhhcCcccccc---CChhhHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQ---YPIKGALLAGQIIIKCLEAEPKNR---PSMEEVLET 381 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~R---ps~~eil~~ 381 (441)
......+........ .+...+..+.+||.+||. +|.+| |+++|+++|
T Consensus 276 ------------~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 276 ------------AETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ------------HHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ------------HHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111222221111111 123456779999999999 99998 599999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=362.88 Aligned_cols=270 Identities=22% Similarity=0.350 Sum_probs=214.9
Q ss_pred HHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
....++|.+.+.||+|+||.||+|.+... .....++.||||.+.... ......+.+|+.+++.++||||++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 34457899999999999999999966521 122347889999987653 3445678899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcC-------CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKG-------SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS 246 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 246 (441)
+.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ .||+||||||+|||++.+
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAED 174 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEcCC
Confidence 999999999999999999999987532 12457899999999999999999997 899999999999999999
Q ss_pred CceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeec
Q 013519 247 YNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVD 325 (441)
Q Consensus 247 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~ 325 (441)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------- 246 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------- 246 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--------
Confidence 9999999999975322211111223457889999999999999999999999999999999 8888864321
Q ss_pred ccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 326 FARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
......+.... ....+..++..+.+|+.+||+.||++|||+.+++++|+.+..
T Consensus 247 --------~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 --------EQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --------HHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --------HHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111111111 112345566778999999999999999999999999987643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=366.28 Aligned_cols=246 Identities=24% Similarity=0.326 Sum_probs=198.5
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 183 (441)
.+.||+|+||.||+|.. ..+++.||+|++........+.+.+|+.+|++++||||+++++++.+.+.++||
T Consensus 94 ~~~lG~G~~g~Vy~a~~---------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEE---------TATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEECC-----CEEEEEE---------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEecCcCEEEEEEEE---------cCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 56899999999999944 345889999999887766678899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE--cCCCceEEecccCCCCCC
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL--DGSYNAKLSDFGLAKLGP 261 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill--~~~~~~kl~DFGla~~~~ 261 (441)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 165 ~E~~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp EECCTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 99999999999887543 358899999999999999999997 899999999999999 567899999999998643
Q ss_pred CCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhc
Q 013519 262 IDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341 (441)
Q Consensus 262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (441)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+..+.
T Consensus 241 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----------------~~~~~~i~ 301 (373)
T 2x4f_A 241 PR---EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND----------------AETLNNIL 301 (373)
T ss_dssp TT---CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHHHH
T ss_pred Cc---cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHH
Confidence 22 223345799999999999999999999999999999999999999965321 11111121
Q ss_pred Cccc--cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 342 DPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 342 ~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.... ........+..+.+||.+||+.||.+|||+.++|++
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 302 ACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111 111122345678899999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=377.69 Aligned_cols=251 Identities=27% Similarity=0.381 Sum_probs=199.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|++.+.||+|+||.||+|.. ..+++.||||++... .......+.+|+.+|+.++||||+++++++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 217 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKE---------KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEE---------cCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence 46799999999999999999944 445889999998643 223345677899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+.+.++|||||+++|+|.+++.+.. .+++..++.++.|++.||.|||+ ..||+||||||+||||+.++.+||+||
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCCCGGGEEECSSSCEEECCC
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhh-cCCEEECCCCHHHEEECCCCCEEEccC
Confidence 99999999999999999999997654 58999999999999999999994 378999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+++.... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 294 G~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----------------~ 355 (446)
T 4ejn_A 294 GLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------------E 355 (446)
T ss_dssp CCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------H
T ss_pred CCceeccC--CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----------------H
Confidence 99985322 22234557899999999999999999999999999999999999999964321 1
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
.....+.... ..+|...+..+.+||.+||+.||.+|| ++.++++|
T Consensus 356 ~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 356 KLFELILMEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHhCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1111111111 124555667889999999999999999 99999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=347.54 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=207.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|.+.+.||+|+||.||+|.+. ++.||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS 78 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence 57999999999999999999653 678999998765 34456778999999999999999999999988
Q ss_pred C--CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCC--eeecCCCCCcEEEcCCCceEEe
Q 013519 177 D--RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKS--VIYRDFKASNILLDGSYNAKLS 252 (441)
Q Consensus 177 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--ivHrDlkp~Nill~~~~~~kl~ 252 (441)
. ...++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++.++|+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~~~i~H~dikp~Nil~~~~~~~~l~ 155 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHT--LEPLIPRHALNSRSVMIDEDMTARIS 155 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTT--SSSCCTTCCCSGGGEEECTTSCEEEE
T ss_pred CCCCCeEeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhc--CCCceecCCCccceEEEcCCcceeEE
Confidence 7 78899999999999999997643 2368999999999999999999997 77 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCc---cccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYV---KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
|||++.... .....||+.|+|||++.+..++. ++|||||||++|+|++|..||.....
T Consensus 156 ~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------------ 216 (271)
T 3kmu_A 156 MADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------------ 216 (271)
T ss_dssp GGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------------
T ss_pred eccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------------
Confidence 998875421 12346899999999998765554 79999999999999999999964321
Q ss_pred ccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
................+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 217 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 217 ----MEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ----HHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ----HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11112222222333445666778999999999999999999999999998765
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=366.76 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=202.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCC--CCCccceEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFS--HPNLVKLIGYC 174 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~ 174 (441)
.+|.+.+.||+|+||+||+|... .++.||||++... .......+.+|+.+|+.+. ||||+++++++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 46999999999999999999532 2778999987644 3455678899999999996 59999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
...+.+||||| +.+++|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+|||++ ++.+||+||
T Consensus 126 ~~~~~~~lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~-~~~~kl~DF 198 (390)
T 2zmd_A 126 ITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDF 198 (390)
T ss_dssp ECSSEEEEEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCCGGGEEES-SSCEEECCC
T ss_pred ecCCEEEEEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEEE-CCeEEEEec
Confidence 99999999999 66889999997654 58889999999999999999997 8999999999999996 578999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-----------GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~ 323 (441)
|+++..............+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 199 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------ 272 (390)
T 2zmd_A 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------ 272 (390)
T ss_dssp SSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC------
T ss_pred CccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH------
Confidence 99986543332223445689999999999975 4688999999999999999999999964311
Q ss_pred ecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
....+..++++.....++...+..+.+||.+||+.||++|||+.++|++-
T Consensus 273 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 273 ---------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp ---------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---------HHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 11223334444444444555567789999999999999999999999863
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=355.44 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=200.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++.+.||+|+||+||+|... .+++.||||++.... ......+.+|+.++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEEC---------CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 57899999999999999999543 458899999886542 2345678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++.+++||||+.+ +|.+.+.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 9999999999986 5666555432 458999999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee---cccccccc
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH-LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV---DFARPSLT 332 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~---~~~~~~~~ 332 (441)
++.... .........||+.|+|||++.+.. ++.++|||||||++|+|++|..||............ ....+...
T Consensus 148 ~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~ 225 (292)
T 3o0g_A 148 ARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp CEECCS--CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ceecCC--ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 976432 122234467899999999998766 799999999999999999998886432211100000 00000000
Q ss_pred hhhhhhhhcC---------ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMD---------PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.........+ ...........+..+.+||.+||+.||++|||+.|+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000000 000011223456778899999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=356.46 Aligned_cols=276 Identities=28% Similarity=0.400 Sum_probs=212.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
..|++.+.||+|+||.||+|.+.. ....+++.||+|++..... ...+.+.+|+.+|+.++||||+++++++...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECT-----TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhccCCCCceEEEEEEEcc-----ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 468889999999999999997543 2344689999999875532 3456788999999999999999999999876
Q ss_pred --CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 178 --RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 178 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
..+++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCEEECccc
Confidence 67899999999999999996654 358999999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCc-ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 256 LAKLGPIDGNS-HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+++........ .......||..|+|||++.+..++.++|||||||++|+|++|..|+........... .........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~ 249 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI--GPTHGQMTV 249 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH--CSCCGGGHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhcc--CCcccccCH
Confidence 99865432221 122345688899999999999999999999999999999999988643210000000 000000111
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
..+............+..++..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 112222222223344566778899999999999999999999999999865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=351.31 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=197.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhc--CCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGK--FSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||+||+|.+. ++.||||++..... ..+.+|.+++.. ++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ-----------GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC-----------CEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 468999999999999999999552 67899999876533 344556666655 78999999999876
Q ss_pred eC----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccC------CCCeeecCCCCCcEEEcC
Q 013519 176 ED----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSS------EKSVIYRDFKASNILLDG 245 (441)
Q Consensus 176 ~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivHrDlkp~Nill~~ 245 (441)
.. ..+++||||+++|+|.+++.. ..+++..++.++.|++.||.|||.. ..+|+||||||+|||++.
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~ 148 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK 148 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECT
T ss_pred cccCCCceeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcC
Confidence 53 468999999999999999943 3589999999999999999999921 289999999999999999
Q ss_pred CCceEEecccCCCCCCCCCCcc--eEeeeccccccCcchhhhcC------CCCccccchhHHHHHHHHHhC---------
Q 013519 246 SYNAKLSDFGLAKLGPIDGNSH--VTTRIMGTYGYAAPEYVATG------HLYVKSDVYGFGVVLLEMLTG--------- 308 (441)
Q Consensus 246 ~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~elltg--------- 308 (441)
++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 149 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~ 228 (301)
T 3q4u_A 149 NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228 (301)
T ss_dssp TSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccc
Confidence 9999999999997533222111 12234799999999999876 456799999999999999999
Q ss_pred -CCCCCCCCCCCCceeecccccccchhhhhhhh-cCcccccc-----CChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 309 -LRALDTNRPSGEHVLVDFARPSLTDKRRLKKI-MDPRLEEQ-----YPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 309 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..||......... ...+... ........ .+...+..+.+|+.+||+.||++|||+.++++.
T Consensus 229 ~~~pf~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 229 YKPPFYDVVPNDPS------------FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp CCCTTTTTSCSSCC------------HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccccccCCCCcc------------hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 6666433221100 0111111 11111111 233467789999999999999999999999999
Q ss_pred Hhcc
Q 013519 382 LQNI 385 (441)
Q Consensus 382 L~~i 385 (441)
|+.+
T Consensus 297 L~~i 300 (301)
T 3q4u_A 297 LTKI 300 (301)
T ss_dssp HHHH
T ss_pred Hhcc
Confidence 9875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=366.92 Aligned_cols=277 Identities=20% Similarity=0.245 Sum_probs=207.0
Q ss_pred hcCCCCCceeccc--CceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 98 TKNFRPDTMLGEG--GFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 98 ~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
.++|++.+.||+| +||+||+|... .+++.||||++.... ....+.+.+|+.+|+.++|||||+++++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYK---------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEc---------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 3679999999999 99999999543 458899999986542 4456778899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+.+.+.+++|||||++|+|.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECC
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEcc
Confidence 999999999999999999999997653 2458999999999999999999997 8999999999999999999999999
Q ss_pred ccCCCCCCCCCC-----cceEeeeccccccCcchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecc
Q 013519 254 FGLAKLGPIDGN-----SHVTTRIMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF 326 (441)
Q Consensus 254 FGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 326 (441)
||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..............
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 999854211110 011122478999999999987 6789999999999999999999999976443221110000
Q ss_pred -cccccch-----hhh-------------hhhhc---------CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 013519 327 -ARPSLTD-----KRR-------------LKKIM---------DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEV 378 (441)
Q Consensus 327 -~~~~~~~-----~~~-------------~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ei 378 (441)
..+.+.. ... +.... .......++...+..+.+||.+||+.||++|||+.|+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 0000000 000 00000 0000111234456778999999999999999999999
Q ss_pred HHH--Hhccc
Q 013519 379 LET--LQNIS 386 (441)
Q Consensus 379 l~~--L~~i~ 386 (441)
|++ |+.+.
T Consensus 332 l~hp~f~~~~ 341 (389)
T 3gni_B 332 LNHSFFKQIK 341 (389)
T ss_dssp TTSGGGGGC-
T ss_pred hcCHHHHHHh
Confidence 987 44443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=349.51 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=195.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||+||+|... ..+|+|++... .....+.+.+|+.+|+.++||||++++++.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS------------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred ccceeeeeEecCCCCeEEEEEEEc------------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 357999999999999999999543 24899988654 345567889999999999999999999954
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
.....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred cCCccEEEEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEccce
Confidence 5667899999999999999996543 468999999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
+++...............||+.|+|||++. +..++.++|||||||++|+|++|..||........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------------ 233 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------------ 233 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------------
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------------
Confidence 997644333333345567999999999986 66788999999999999999999999965321100
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
....+...............++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 234 IIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 000000000011111233456677899999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=379.93 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=213.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
..+|.+.+.||+|+||.||+|.+.. .+..||||.+..... ..+.+.+|+.+|++++||||+++++++.+.
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4567888999999999999996543 478999999976543 356789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..++|||||+++|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CcEEEEEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecccc
Confidence 999999999999999999976432 468899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+..... .........+++.|+|||++.+..++.++|||||||+||||+| |..||...... .
T Consensus 366 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----------------~ 427 (495)
T 1opk_A 366 RLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------Q 427 (495)
T ss_dssp ECCTTC-CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------G
T ss_pred eeccCC-ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----------------H
Confidence 864321 1111222346788999999999999999999999999999999 99999653211 1
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
+...+........+..++..+.+||.+||+.||++|||+.+|++.|+.+.
T Consensus 428 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 428 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11112222333456667788999999999999999999999999998764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=361.95 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=191.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||+||+|... .+++.||||++.... ..+.+.+|+.+|++++||||+++++++.+.
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQK---------GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECS
T ss_pred cCcEEEeeEEeeCCCEEEEEEEEC---------CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecC
Confidence 467999999999999999999554 347899999987653 235678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC---CCceEEecc
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG---SYNAKLSDF 254 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~kl~DF 254 (441)
...++||||+++|+|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEccC
Confidence 9999999999999999999654 358999999999999999999997 89999999999999975 889999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+++.... ........||+.|+|||++.+..++.++|||||||++|||++|..||...... .
T Consensus 196 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------------~ 257 (349)
T 2w4o_A 196 GLSKIVEH---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD---------------Q 257 (349)
T ss_dssp C-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH---------------H
T ss_pred ccccccCc---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc---------------H
Confidence 99985422 22234567999999999999999999999999999999999999999643211 0
Q ss_pred hhhhhhcCccc--cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+..... ........+..+.+||.+||+.||++|||+.++|++
T Consensus 258 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 258 FMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111211111 111223456678899999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=351.92 Aligned_cols=256 Identities=25% Similarity=0.368 Sum_probs=206.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||+||+|.+.. +..||+|++...... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETT----------TEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcC----------CCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 4679999999999999999996542 567999998765432 35688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred CCeEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEcccccc
Confidence 99999999999999999997633 358999999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..... ...
T Consensus 168 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----------------~~~ 230 (283)
T 3gen_A 168 RYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----------------SET 230 (283)
T ss_dssp GGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----------------HHH
T ss_pred ccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh----------------hHH
Confidence 7542211 111122456788999999999999999999999999999998 9999965321 111
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
...+. .......+...+..+.+|+.+||+.||++|||+.+++++|+.+.
T Consensus 231 ~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 231 AEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHh-cccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 11111 11222334555677889999999999999999999999998765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=357.57 Aligned_cols=269 Identities=23% Similarity=0.333 Sum_probs=190.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||+||+|.. ..+++.||+|++..... .....+.+|+.+|+.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLN---------KTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEEEC---------SSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEEEE---------CCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 46899999999999999999944 34588999998865432 233567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKG---SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
++.+++||||++ |+|.+++.... ....+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEECc
Confidence 999999999998 59999887532 22458899999999999999999997 8999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ecc----c
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VDF----A 327 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~~----~ 327 (441)
||+++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||........... ... .
T Consensus 152 fg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 229 (317)
T 2pmi_A 152 FGLARAFGIP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229 (317)
T ss_dssp CSSCEETTSC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CccceecCCC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9999764322 1223345789999999999764 689999999999999999999999965432100000 000 0
Q ss_pred ccccchhhhhhhhcCcc------------ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTDKRRLKKIMDPR------------LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+.....+.. +.+. +....+...+..+.+||.+||+.||++|||+.++|++
T Consensus 230 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 230 ESLWPSVTKLPK-YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTTCGGGGGCTT-CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhHhhhhhhhhh-cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000000000 0000 0111122345678899999999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=374.31 Aligned_cols=248 Identities=26% Similarity=0.388 Sum_probs=206.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||+||+|.. ..+++.||||++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~---------~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKH---------ELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEE---------TTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 5799999999999999999944 34588999999865422 23457889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
..+.+++|||||++|+|.+++.+. ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEecc
Confidence 999999999999999999999654 358999999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+++.... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .
T Consensus 162 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----------------~ 222 (476)
T 2y94_A 162 LSNMMSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV----------------P 222 (476)
T ss_dssp SCEECCT---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS----------------H
T ss_pred chhhccc---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH----------------H
Confidence 9986432 223345689999999999988776 6899999999999999999999965321 1
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+..... ..|...+..+.+||.+||+.||++|||+.+++++
T Consensus 223 ~~~~~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 223 TLFKKICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHHHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 11122222211 2344556778999999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=359.98 Aligned_cols=259 Identities=21% Similarity=0.226 Sum_probs=206.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||+||+|.. ..+++.||||.+..... ...+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKN---------LYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEE---------TTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEE---------CCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 35799999999999999999943 34588999998865432 23577899999999 89999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc-----eEE
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN-----AKL 251 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-----~kl 251 (441)
.+..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++. +||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~kl 151 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHI 151 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred CCccEEEEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceEEE
Confidence 99999999999 999999997653 468999999999999999999997 89999999999999998887 999
Q ss_pred ecccCCCCCCCCCCcc-----eEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecc
Q 013519 252 SDFGLAKLGPIDGNSH-----VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF 326 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 326 (441)
+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~------ 225 (330)
T 2izr_A 152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL------ 225 (330)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH------
T ss_pred EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH------
Confidence 9999998643322111 12457899999999999999999999999999999999999999976432210
Q ss_pred cccccchhhhhhhhcCccc---cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 327 ARPSLTDKRRLKKIMDPRL---EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
...+..+..... .......++ .+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 226 -------~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 226 -------KERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp -------HHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -------HHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 001111100000 000111234 7889999999999999999999999998654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=353.03 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=200.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++|++.+.||+|+||+||+|.+. ++.||||.+.... ..+.+.+|+.+|++++||||+++++++. +
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~ 72 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--N 72 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--T
T ss_pred hHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence 57889999999999999999653 5689999987553 3467889999999999999999999876 3
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCC-CCeeecCCCCCcEEEcCCCc-eEEecccC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSE-KSVIYRDFKASNILLDGSYN-AKLSDFGL 256 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-~~ivHrDlkp~Nill~~~~~-~kl~DFGl 256 (441)
..++||||+++|+|.+++........+++..++.++.|++.||.|||+.. +||+||||||+|||++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 47999999999999999986654445788999999999999999999632 68999999999999998886 79999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
++.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...
T Consensus 153 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------------~~~ 213 (307)
T 2eva_A 153 ACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--------------FRI 213 (307)
T ss_dssp -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--------------HHH
T ss_pred cccccc-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--------------HHH
Confidence 975321 1234569999999999999999999999999999999999999996432110 000
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
..... .......+..++..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 214 MWAVH-NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp HHHHH-TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred HHHHh-cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 00010 1111122344566788999999999999999999999999887643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=353.01 Aligned_cols=264 Identities=25% Similarity=0.399 Sum_probs=201.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|..... ..++..||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQE------DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECT------TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HHHeeeccceeecCCeEEEEEEEecc------CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 46789999999999999999966532 224678999998754 3445677899999999999999999999998
Q ss_pred eCC-----eEEEEEeecCCCCHHHHHHhc---CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 176 EDR-----QFLLVYEYMQKGSLENHLFRK---GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 176 ~~~-----~~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
+.. ..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+|+||||||+|||++.++
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCSGGGEEECTTS
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCC
Confidence 754 359999999999999998543 223568999999999999999999997 8999999999999999999
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecc
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDF 326 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 326 (441)
.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------- 256 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-------- 256 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--------
Confidence 999999999976433222222334567889999999999999999999999999999999 88888653211
Q ss_pred cccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 327 ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
.....+.. ......+..++..+.+|+.+||..||++|||+.+++++|+.+.
T Consensus 257 --------~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 257 --------EMYDYLLH-GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp --------GHHHHHHT-TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------HHHHHHHc-CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111111 1112334456677899999999999999999999999998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=366.58 Aligned_cols=244 Identities=27% Similarity=0.348 Sum_probs=194.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHH-HhcCCCCCccceEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKF-LGKFSHPNLVKLIGYC 174 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~-l~~l~hpniv~~~~~~ 174 (441)
++|++.++||+|+||+||+|+.. .+++.||||++..... .....+.+|..+ ++.++||||+++++++
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHK---------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEET---------TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEc---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 57999999999999999999543 4588999999865432 233456667776 5778999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+.+.+|+||||++||+|.+++.+.+ .+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+||
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEeeC
Confidence 99999999999999999999997754 48899999999999999999997 99999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+++.... ........+||+.|+|||++.+..++.++|||||||++|||++|..||..... .
T Consensus 184 G~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----------------~ 245 (373)
T 2r5t_A 184 GLCKENIE--HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----------------A 245 (373)
T ss_dssp CBCGGGBC--CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH----------------H
T ss_pred cccccccc--CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----------------H
Confidence 99975322 12234567899999999999999999999999999999999999999964311 1
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSME 376 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 376 (441)
.....+..... .++...+..+.+||.+||+.||.+||++.
T Consensus 246 ~~~~~i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 246 EMYDNILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHHHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred HHHHHHHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 11222222211 23455667789999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=351.71 Aligned_cols=269 Identities=23% Similarity=0.331 Sum_probs=203.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|++.+.||+|+||.||+|... .+++.||||++... .......+.+|+.+++.++||||+++++++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 101 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACL---------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEET---------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEc---------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 357999999999999999999543 34789999998753 344567788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
...+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~D 179 (310)
T 2wqm_A 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGD 179 (310)
T ss_dssp EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECC
T ss_pred EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEe
Confidence 99999999999999999999986521 23568899999999999999999997 8999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
||+++..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||...... .
T Consensus 180 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------------~ 243 (310)
T 2wqm_A 180 LGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--------------L 243 (310)
T ss_dssp C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC--------------H
T ss_pred ccceeeecCC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh--------------H
Confidence 9999754321 12233457899999999999999999999999999999999999999643211 0
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccccccCch
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVIEIEPK 393 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~~~~~~ 393 (441)
......+.........+..++..+.+|+.+||..||++|||+.++++.|+.+.....++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 244 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp HHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred HHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 011111111111112224456678899999999999999999999999998876654433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=357.39 Aligned_cols=254 Identities=25% Similarity=0.376 Sum_probs=195.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|++.+.||+|+||.||+|.. ..+++.||||++... .......+.+|+.++++++||||+++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARD---------LRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEE---------CCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 36899999999999999999954 345889999998765 334456788999999999999999999998
Q ss_pred EeCC----eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 175 WEDR----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 175 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
.... ..|+||||+++++|.+++...+ .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~k 156 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVK 156 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCEE
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCEE
Confidence 7654 3499999999999999997654 58899999999999999999997 8999999999999999999999
Q ss_pred EecccCCCCCCCCCCc-ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 251 LSDFGLAKLGPIDGNS-HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 251 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----------- 225 (311)
T 3ork_A 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----------- 225 (311)
T ss_dssp ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------
T ss_pred EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----------
Confidence 9999999764332211 2233467999999999999999999999999999999999999999653211
Q ss_pred ccchhhhhhhhcC--ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKRRLKKIMD--PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
........ ..........++..+.+||.+||+.||++||++.+++.+
T Consensus 226 -----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 226 -----SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp -----HHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -----HHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 00001100 000111122355678899999999999999977776654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=350.66 Aligned_cols=259 Identities=26% Similarity=0.426 Sum_probs=214.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|.+.+.||+|+||.||+|.+. .++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEG---------GGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccceeEEeecCCCCceeEEEeEec---------CCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 467999999999999999999554 3478999999876543 356788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+++++|.+++..... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEEcCCCCEEEccCccc
Confidence 999999999999999999976443 568999999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... .
T Consensus 159 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----------------~ 220 (288)
T 3kfa_A 159 RLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------Q 220 (288)
T ss_dssp GTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------G
T ss_pred eeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------H
Confidence 8643222 222334567889999999999999999999999999999999 99998653211 1
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
+...+........+..++..+.+|+.+||..||++|||+.++++.|+.+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 221 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 111111222233455667789999999999999999999999999987643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=356.25 Aligned_cols=274 Identities=30% Similarity=0.422 Sum_probs=213.4
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC--
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED-- 177 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 177 (441)
|++.+.||+|+||+||++.+.. ....+++.||||++.... ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDP-----TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECS-----CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HhhhheecCCCCeEEEEEEEcc-----CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 4889999999999999986643 344568999999988653 34467789999999999999999999999884
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..+++||||+++|+|.+++... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred ceEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCEEECCcccc
Confidence 6789999999999999999654 38899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCc-ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNS-HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....+.... .....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~-~~~~~ 259 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQ-MTVLR 259 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHH-HHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccc-hhHHH
Confidence 865432221 123345688899999999999999999999999999999999999864211000 000000000 01111
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
+............+..++..+.+||.+||+.||++|||+.++++.|+.+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 222222333334456677889999999999999999999999999987754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=360.44 Aligned_cols=249 Identities=29% Similarity=0.372 Sum_probs=202.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
+.|.+.+.||+|+||+||+|.. ..+++.||||++... .....+.+.+|+.+|++++||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARD---------VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEE---------ccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4588899999999999999954 345889999988643 2334567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+++..++||||+. |+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFG 199 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999997 58888876543 468999999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
+++.... .....||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 200 ~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------------- 258 (348)
T 1u5q_A 200 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------------- 258 (348)
T ss_dssp TCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---------------
T ss_pred CceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---------------
Confidence 9976422 23467999999999985 56788999999999999999999999964321
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
...+..+.........+...+..+.+||.+||+.||++|||+.+++++..
T Consensus 259 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 259 -MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp -HHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred -HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 01111111111111223445667889999999999999999999998643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=354.23 Aligned_cols=247 Identities=26% Similarity=0.300 Sum_probs=194.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcC-CCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKF-SHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 174 (441)
.++|++.++||+|+||+||+|... .+++.||||++... .......+..|+..+..+ .||||+++++++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSK---------EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---------TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEEC---------CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 357999999999999999999554 34889999987653 223333444555555544 899999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+.+.+++||||+ +++|.+++...+ ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~DF 201 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDF 201 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECCC
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEccc
Confidence 9999999999999 679999887654 468999999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+++.... ........||+.|+|||++.+ .++.++|||||||++|||++|..|+....
T Consensus 202 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------------------ 259 (311)
T 3p1a_A 202 GLLVELGT---AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------------------ 259 (311)
T ss_dssp TTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------------------
T ss_pred eeeeeccc---CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------------------
Confidence 99975422 222344579999999998875 79999999999999999999976654210
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+........++...+..+.+||.+||+.||++|||+.++|++
T Consensus 260 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 260 -GWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -HHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HHHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0111111111112233455678899999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=354.73 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=206.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|.+.+.||+|+||+||+|....... .....+..||+|.+........+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGD--YGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECG--GGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccc--cccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 3678999999999999999996653210 01112367999999877666678899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc--------e
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN--------A 249 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--------~ 249 (441)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++. +
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999997653 348899999999999999999997 89999999999999998887 9
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 328 (441)
||+|||+++.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..|+.....
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~----------- 223 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD----------- 223 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----------
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----------
Confidence 9999999974311 223568999999999987 6789999999999999999996555432211
Q ss_pred cccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
..... .... .....+...+..+.+|+.+||+.||++|||+.+++++|+.+...
T Consensus 224 ----~~~~~-~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 224 ----SQRKL-QFYE--DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp ----HHHHH-HHHH--TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred ----hHHHH-HHhh--ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 00000 0000 01112233344577999999999999999999999999987643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=350.85 Aligned_cols=261 Identities=17% Similarity=0.189 Sum_probs=208.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||.||+|.. ..+++.||||++..... ...+.+|+.+++.+ +|+||+++++++.+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTN---------LLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEE---------TTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEE---------CCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 35799999999999999999953 34588999998765432 23567899999999 69999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc-----eEE
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN-----AKL 251 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-----~kl 251 (441)
....++||||+ +++|.+++...+ ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++. +||
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred CceeEEEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 99999999999 999999997654 458999999999999999999997 89999999999999987776 999
Q ss_pred ecccCCCCCCCCCCc-----ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecc
Q 013519 252 SDFGLAKLGPIDGNS-----HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF 326 (441)
Q Consensus 252 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 326 (441)
+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----- 227 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----- 227 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-----
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-----
Confidence 999999764332221 1234567999999999999999999999999999999999999999764322110
Q ss_pred cccccchhhhhhhhcCc---cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 327 ARPSLTDKRRLKKIMDP---RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 327 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
..+..+... .........++..+.+|+.+||+.||++||++.+|++.|+.+..
T Consensus 228 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 228 --------QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp --------HHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred --------HHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 011111000 00011122445678899999999999999999999999987653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=361.90 Aligned_cols=261 Identities=22% Similarity=0.244 Sum_probs=201.9
Q ss_pred HHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-----chHHHHHHHHHHHHHhcCCCCCcc
Q 013519 94 LRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-----SIQGLREWQAEVKFLGKFSHPNLV 168 (441)
Q Consensus 94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv 168 (441)
+....++|++.+.||+|+||+||+|... .+++.||+|++... .....+.+.+|+.+|++++||||+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 91 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIEN---------QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhhheeecceeeecCCeEEEEEEEC---------CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3556788999999999999999999543 45889999987543 223456788999999999999999
Q ss_pred ceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCC-------------------------------------CCCCCHHHHH
Q 013519 169 KLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-------------------------------------AEPLPWNTRL 211 (441)
Q Consensus 169 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------~~~l~~~~~~ 211 (441)
++++++.+.+..++|||||++|+|.+++..... ...+++..++
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (345)
T 3hko_A 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS 171 (345)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred eeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence 999999999999999999999999999852100 1123567788
Q ss_pred HHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC--ceEEecccCCCCCCCCC--CcceEeeeccccccCcchhhhc-
Q 013519 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY--NAKLSDFGLAKLGPIDG--NSHVTTRIMGTYGYAAPEYVAT- 286 (441)
Q Consensus 212 ~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~--~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~- 286 (441)
.++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||+++...... .........||+.|+|||++.+
T Consensus 172 ~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 249 (345)
T 3hko_A 172 NIMRQIFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249 (345)
T ss_dssp HHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS
T ss_pred HHHHHHHHHHHHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC
Confidence 999999999999997 8999999999999998776 89999999997542211 1122345679999999999976
Q ss_pred -CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccc--cCChhhHHHHHHHHHH
Q 013519 287 -GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEE--QYPIKGALLAGQIIIK 363 (441)
Q Consensus 287 -~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~ 363 (441)
..++.++|||||||++|+|++|+.||..... ...+..+....... ......+..+.+||.+
T Consensus 250 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 313 (345)
T 3hko_A 250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVND----------------ADTISQVLNKKLCFENPNYNVLSPLARDLLSN 313 (345)
T ss_dssp SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh----------------HHHHHHHHhcccccCCcccccCCHHHHHHHHH
Confidence 6788999999999999999999999965321 11112222111111 1112345678899999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 013519 364 CLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 364 ~l~~dp~~Rps~~eil~~ 381 (441)
||+.||.+||++.++|++
T Consensus 314 ~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 314 LLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HSCSCTTTSCCHHHHHHS
T ss_pred HcCCChhHCCCHHHHhcC
Confidence 999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=366.32 Aligned_cols=270 Identities=25% Similarity=0.330 Sum_probs=193.5
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCC-CCCccceEE
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFS-HPNLVKLIG 172 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~ 172 (441)
...++|++.+.||+|+||+||+|.. ..+++.||||++... .......+.+|+.+|+.+. ||||+++++
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~ 76 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSID---------RRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEE---------TTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred cccCceEEEEEeeeCCCeEEEEEEE---------CCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence 3467899999999999999999944 445889999988643 3445667789999999997 999999999
Q ss_pred EEEeCC--eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 173 YCWEDR--QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 173 ~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
++...+ .+|+|||||. ++|..++... .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+|
T Consensus 77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~k 149 (388)
T 3oz6_A 77 VLRADNDRDVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVK 149 (388)
T ss_dssp EEECTTSSCEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEE
T ss_pred EEecCCCCEEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEE
Confidence 998654 7899999997 5899888653 48899999999999999999997 8999999999999999999999
Q ss_pred EecccCCCCCCCC-------------------CCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCC
Q 013519 251 LSDFGLAKLGPID-------------------GNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLR 310 (441)
Q Consensus 251 l~DFGla~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~ 310 (441)
|+|||+++..... .........+||+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 229 (388)
T 3oz6_A 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229 (388)
T ss_dssp ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence 9999999754221 11122345689999999999987 678999999999999999999999
Q ss_pred CCCCCCCCCCceee--cccccccch--------hh----hhhhhc---Cccccc------------cCChhhHHHHHHHH
Q 013519 311 ALDTNRPSGEHVLV--DFARPSLTD--------KR----RLKKIM---DPRLEE------------QYPIKGALLAGQII 361 (441)
Q Consensus 311 p~~~~~~~~~~~~~--~~~~~~~~~--------~~----~~~~~~---~~~~~~------------~~~~~~~~~~~~li 361 (441)
||.+.........+ ....+.... .. .+.... ...... ..+..++..+.+||
T Consensus 230 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 309 (388)
T 3oz6_A 230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309 (388)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence 99754321100000 000000000 00 000000 000000 01123456788999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 013519 362 IKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 362 ~~~l~~dp~~Rps~~eil~~ 381 (441)
.+||+.||++|||+.|+|+|
T Consensus 310 ~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 310 DKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHCCSSGGGSCCHHHHTTS
T ss_pred HHhhccCcccCCCHHHHhCC
Confidence 99999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=354.67 Aligned_cols=263 Identities=24% Similarity=0.400 Sum_probs=205.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+|.+.+.||+|+||+||+|...... ...+..||||.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSS-----GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCC-----CCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 56778899999999999999765321 1224579999987653 34456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CCcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 99999999999999999997643 468999999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCc-ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhh
Q 013519 258 KLGPIDGNS-HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 258 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----------------~~ 258 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------HE 258 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HH
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH----------------HH
Confidence 864322111 11223456789999999999999999999999999999999 9999964321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
....+. .......+..++..+.+|+.+||+.||++||++.+++++|+.+..
T Consensus 259 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 259 VMKAIN-DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp HHHHHH-TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHH-CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111111 111222345566778999999999999999999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=364.91 Aligned_cols=201 Identities=30% Similarity=0.331 Sum_probs=175.3
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-----CCCccce
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-----HPNLVKL 170 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~ 170 (441)
...++|.+.+.||+|+||+||+|... .+++.||||++.... .....+..|+.+++.+. ||||+++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHI---------DNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEEC---------CCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34578999999999999999999543 457899999987543 34456778999999986 9999999
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC-----
Q 013519 171 IGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG----- 245 (441)
Q Consensus 171 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~----- 245 (441)
++++...+.+++||||+ +++|.+++.+... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccEEEccccccc
Confidence 99999999999999999 9999999976543 458999999999999999999997 99999999999999975
Q ss_pred --------------------CCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHH
Q 013519 246 --------------------SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEM 305 (441)
Q Consensus 246 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el 305 (441)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 78899999999985322 22346799999999999999999999999999999999
Q ss_pred HhCCCCCCCC
Q 013519 306 LTGLRALDTN 315 (441)
Q Consensus 306 ltg~~p~~~~ 315 (441)
++|+.||...
T Consensus 253 l~g~~pf~~~ 262 (360)
T 3llt_A 253 YTGSLLFRTH 262 (360)
T ss_dssp HHSSCSCCCS
T ss_pred HHCCCCCCCC
Confidence 9999999654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=349.80 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=198.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH--HHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--GLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++.+.||+|+||+||+|... +++.||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 57899999999999999999542 3789999998665332 23567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
.+.+++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred CCeEEEEEEecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECcc
Confidence 9999999999986 8998886543 458899999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-----cccccc
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-----DFARPS 330 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-----~~~~~~ 330 (441)
++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||............ ......
T Consensus 147 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (288)
T 1ob3_A 147 ARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224 (288)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCcc--ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhh
Confidence 9753221 1223445789999999999764 5899999999999999999999999654211000000 000000
Q ss_pred cchhhhhhhhcCcc-------ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 331 LTDKRRLKKIMDPR-------LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+....... .+++. ....+....+..+.+||.+||+.||++|||+.+++++
T Consensus 225 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 225 WPNVTELP-KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTGGGST-TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhhccc-ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 00000 0111223456778899999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=364.87 Aligned_cols=254 Identities=21% Similarity=0.297 Sum_probs=192.6
Q ss_pred cCCCCC-ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHh-cCCCCCccceEEEEEe
Q 013519 99 KNFRPD-TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLG-KFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~ 176 (441)
++|.+. ++||+|+||+||+|+. ..+++.||||++... ..+.+|+.++. ..+||||++++++|..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~---------~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFN---------KRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEE---------CCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence 567666 6899999999999954 345889999998643 34567888874 4579999999999876
Q ss_pred ----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC---CCce
Q 013519 177 ----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG---SYNA 249 (441)
Q Consensus 177 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~ 249 (441)
...+|||||||+||+|.+++...+ ...+++..++.++.|++.||.|||+ .||+||||||+|||++. ++.+
T Consensus 127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~ 203 (400)
T 1nxk_A 127 LYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAIL 203 (400)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCE
T ss_pred cccCCcEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccE
Confidence 567899999999999999997643 2468999999999999999999997 89999999999999987 7889
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
||+|||+++.... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .
T Consensus 204 kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~ 273 (400)
T 1nxk_A 204 KLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------P 273 (400)
T ss_dssp EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-------C
T ss_pred EEEecccccccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-------H
Confidence 9999999985322 22234578999999999999999999999999999999999999999754332110 0
Q ss_pred ccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.. ...+.. ....+.......++..+.+||.+||+.||++|||+.+++++-
T Consensus 274 ~~--~~~i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 274 GM--KTRIRM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp SH--HHHHHH-TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HH--HHHHHc-CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00 000000 000111111234567789999999999999999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=361.74 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=202.2
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
..++|.+.+.||+|+||+||+|.. ..+++.||||++..... ...+|+.+|.++ +||||+++++++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIH---------KATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 356799999999999999999944 44588999999866532 234688888887 6999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC----CceEE
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS----YNAKL 251 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~----~~~kl 251 (441)
+...+|+|||||+||+|.+++.+.+ .+++..+..++.|++.||.|||+ .||+||||||+|||+... +.+||
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl 161 (342)
T 2qr7_A 87 DGKYVYVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRI 161 (342)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEE
Confidence 9999999999999999999997653 58999999999999999999997 899999999999998433 35999
Q ss_pred ecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccccc
Q 013519 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 162 ~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------------ 227 (342)
T 2qr7_A 162 CDFGFAKQLRAE--NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT------------ 227 (342)
T ss_dssp CCCTTCEECBCT--TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC------------
T ss_pred EECCCcccCcCC--CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC------------
Confidence 999999864322 223345689999999999998889999999999999999999999997532111
Q ss_pred chhhhhhhhcCc--cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 332 TDKRRLKKIMDP--RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 332 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+..+... .+...++...+..+.+||.+||..||++||++.+++++
T Consensus 228 -~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 228 -PEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp -HHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -HHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01111111111 11122334566779999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=347.35 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=208.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|.+.+.||+|+||+||+|.+... ...+..||+|.+... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNH------KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECT------TCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCC------CCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 36799999999999999999976532 223567999998775 34456778999999999999999999998764
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred -CCCEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCccCC
Confidence 45789999999999999997654 358899999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....... ...
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-------------~~~ 225 (281)
T 3cc6_A 160 SRYIEDED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------------VIG 225 (281)
T ss_dssp GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-------------HHH
T ss_pred Cccccccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-------------HHH
Confidence 97643221 112233567889999999999999999999999999999998 999996432110 001
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
.+.. ......+..++..+.+|+.+||..||++||++.+++++|+.+...
T Consensus 226 ~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 226 VLEK----GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhc----CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 1111 111123445567788999999999999999999999999877543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=373.03 Aligned_cols=196 Identities=21% Similarity=0.324 Sum_probs=154.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||+||+|+. ..+++.||||++... .....+.+.+|+.+|+.++|||||++++++.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYD---------KLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp CTTEEECCC-------CEEEEEE---------CC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEeeEeeecCCeEEEEEEE---------CCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 36899999999999999999944 345889999988653 3445677889999999999999999999985
Q ss_pred eC-----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 176 ED-----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 176 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
.. ..+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+||||+.++.+|
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl~~~~~~k 196 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVK 196 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEE
T ss_pred cCCcccCceEEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEECCCCCEe
Confidence 43 5799999998 56899988654 358999999999999999999997 8999999999999999999999
Q ss_pred EecccCCCCCCCCCCc-------------------------ceEeeeccccccCcchhh-hcCCCCccccchhHHHHHHH
Q 013519 251 LSDFGLAKLGPIDGNS-------------------------HVTTRIMGTYGYAAPEYV-ATGHLYVKSDVYGFGVVLLE 304 (441)
Q Consensus 251 l~DFGla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~e 304 (441)
|+|||+++........ ......+||+.|+|||++ .+..|+.++|||||||||||
T Consensus 197 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp ECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred ecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHH
Confidence 9999999865322110 123456899999999987 45679999999999999999
Q ss_pred HHhC
Q 013519 305 MLTG 308 (441)
Q Consensus 305 lltg 308 (441)
|++|
T Consensus 277 lltg 280 (458)
T 3rp9_A 277 LLNM 280 (458)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 9994
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=352.68 Aligned_cols=266 Identities=26% Similarity=0.348 Sum_probs=200.2
Q ss_pred cCCCCC-ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCccceEEEEEe
Q 013519 99 KNFRPD-TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 176 (441)
+.|.+. +.||+|+||+||+|. ...+++.||||++..........+.+|+.+|.++ +||||+++++++.+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCI---------NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEE---------CSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEE---------EcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 568874 789999999999994 3445889999998766544566788999999985 79999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc---eEEec
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN---AKLSD 253 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---~kl~D 253 (441)
.+.+++||||+++|+|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++. +||+|
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceEEEE
Confidence 999999999999999999997754 58899999999999999999997 89999999999999988776 99999
Q ss_pred ccCCCCCCCCCC-----cceEeeeccccccCcchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee
Q 013519 254 FGLAKLGPIDGN-----SHVTTRIMGTYGYAAPEYVAT-----GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323 (441)
Q Consensus 254 FGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~ 323 (441)
||+++....... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 237 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence 999975432211 111234569999999999975 5688999999999999999999999976543321110
Q ss_pred ecccccccchhhhhhhhcCccccccCC----hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 324 VDFARPSLTDKRRLKKIMDPRLEEQYP----IKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+. ........+..... .++ ...+..+.+||.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~~-~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 238 RGEACPA-CQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp ---CCHH-HHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchh-HHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000000 00001111111111 112 1345678899999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=374.56 Aligned_cols=259 Identities=25% Similarity=0.433 Sum_probs=210.1
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
...++|.+.+.||+|+||+||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~ 253 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT 253 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 345678899999999999999997643 56799999886543 3578899999999999999999999886
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
...+++|||||.+|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 254 -~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 254 -KEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp -SSSCEEEECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred -CCccEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeCC
Confidence 6678999999999999999975421 247889999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+++...... ........+|+.|+|||++....++.++|||||||+||||+| |+.||..... .
T Consensus 330 ~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~----------------~ 392 (454)
T 1qcf_A 330 LARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----------------P 392 (454)
T ss_dssp GGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------------H
T ss_pred CceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH----------------H
Confidence 998643211 111122346788999999999999999999999999999999 9999965321 1
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
... ..+........+..++..+.+||.+||..||++|||+.+|++.|+.+..
T Consensus 393 ~~~-~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 393 EVI-RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHH-HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHH-HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 111 1111112223455677789999999999999999999999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=362.78 Aligned_cols=274 Identities=17% Similarity=0.198 Sum_probs=206.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHH-----------HHHHHHHHHhcCCCCC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-----------EWQAEVKFLGKFSHPN 166 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~E~~~l~~l~hpn 166 (441)
.++|++.+.||+|+||.||+|.+... .....++.||||++......... .+..|+..+..++|||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSS----ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCS----SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCc----cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 35799999999999999999977653 22334789999998766432111 2334666788889999
Q ss_pred ccceEEEEEeC----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEE
Q 013519 167 LVKLIGYCWED----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNIL 242 (441)
Q Consensus 167 iv~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 242 (441)
|+++++++... ...+|||||| +++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Nil 184 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLL 184 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEE
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHEE
Confidence 99999998764 4589999999 999999997643 468999999999999999999997 89999999999999
Q ss_pred Ec--CCCceEEecccCCCCCCCCCCc-----ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 013519 243 LD--GSYNAKLSDFGLAKLGPIDGNS-----HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315 (441)
Q Consensus 243 l~--~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~ 315 (441)
++ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99 8899999999999754322111 1113456999999999999999999999999999999999999999753
Q ss_pred CCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
....... .... ......+..+++..+ .+..++..+.+|+..||..||++||++.+|++.|+.+..
T Consensus 265 ~~~~~~~--~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 265 LKDPKYV--RDSK--IRYRENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp TTCHHHH--HHHH--HHHHHCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCHHHH--HHHH--HHhhhhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 2211100 0000 000011111111111 113345678899999999999999999999999886543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=371.94 Aligned_cols=264 Identities=21% Similarity=0.290 Sum_probs=195.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||+||+|+. ..+++.||||++... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYD---------AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEE---------TTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEEE---------CCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 46899999999999999999944 445889999998754 3345677889999999999999999999997
Q ss_pred eC------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 176 ED------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 176 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
.. ..+||||||++++ |.+.+. ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll~~~~~~ 203 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL 203 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCE
T ss_pred cCCccccCCeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEEeCCCCE
Confidence 54 4679999999764 666663 238899999999999999999997 899999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ec-cc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VD-FA 327 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~-~~ 327 (441)
||+|||+++.... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+......... .. ..
T Consensus 204 kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg 280 (464)
T 3ttj_A 204 KILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280 (464)
T ss_dssp EECCCCCC--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEEEEEeeeecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999986432 2234557899999999999999999999999999999999999999976432110000 00 00
Q ss_pred ccccch----hhhhhhhcCc-------cccccCC-----------hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTD----KRRLKKIMDP-------RLEEQYP-----------IKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~----~~~~~~~~~~-------~~~~~~~-----------~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+.... .......+.. .+...++ ...+..+.+||.+||..||++|||++|+|+|
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000000000 0000111 1125678999999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=346.48 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=204.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||.||+|... .++..+|+|++........+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQK---------GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeC---------CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 467999999999999999999544 44789999998765444567889999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE---cCCCceEEecc
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL---DGSYNAKLSDF 254 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~DF 254 (441)
...++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CeEEEEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 99999999999999999987654 48899999999999999999997 899999999999999 78899999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|++...... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||..... .
T Consensus 154 g~~~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------------~ 213 (277)
T 3f3z_A 154 GLAARFKPG---KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD----------------S 213 (277)
T ss_dssp TTCEECCTT---SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----------------H
T ss_pred ccceeccCc---cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH----------------H
Confidence 999754322 22344679999999998865 489999999999999999999999965321 1
Q ss_pred hhhhhhcCccccccCCh----hhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPI----KGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+..... ..+. ..+..+.+||.+||+.||++|||+.+++++
T Consensus 214 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 214 EVMLKIREGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHhCCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111100 1111 345678899999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=356.39 Aligned_cols=267 Identities=26% Similarity=0.340 Sum_probs=206.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|.+.+.||+|+||.||+|.+... ....++..||||.+... .......+.+|+.++++++||||+++++++.+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCC----CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 36899999999999999999975432 13345789999998754 34455678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC---CCce
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGS----AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG---SYNA 249 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~ 249 (441)
....++||||+++++|.+++..... ...+++..++.++.|++.||.|||+ .||+||||||+|||++. +..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999986542 1458899999999999999999997 89999999999999984 4469
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 328 (441)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|+| |..||.....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----------- 251 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----------- 251 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-----------
Confidence 9999999864322222222234568899999999999999999999999999999998 9899864321
Q ss_pred cccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
......+. .......+..++..+.+||.+||+.||.+||++.+++++|+.+..
T Consensus 252 -----~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 252 -----QEVLEFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -----HHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 01111111 111123345566778999999999999999999999999987653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=344.61 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=205.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||.||+|... .+++.||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHK---------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEc---------CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 468999999999999999999543 45889999987654 3345677889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc---eEEe
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN---AKLS 252 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---~kl~ 252 (441)
+.+..++||||+.+++|.+.+.... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++. +||+
T Consensus 76 ~~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 76 EESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred cCCEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 9999999999999999999887654 48899999999999999999997 89999999999999976655 9999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|||++..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 151 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------------- 212 (284)
T 3kk8_A 151 DFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------------- 212 (284)
T ss_dssp CCTTCEECCS---SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------
T ss_pred eceeeEEccc---CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---------------
Confidence 9999975432 2223446799999999999999999999999999999999999999964321
Q ss_pred hhhhhhhhcCc--cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDP--RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+... ..........+..+.+|+.+||+.||++|||+.+++++
T Consensus 213 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 213 -HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -hHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0111111111 11111123455678899999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=378.96 Aligned_cols=255 Identities=29% Similarity=0.415 Sum_probs=209.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|++.++||+|+||.||+|.. ..+++.||+|++..... .....+.+|+.+|+.++||||+++++++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~---------~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 253 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQV---------RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 253 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 45799999999999999999954 34589999999865322 2345678899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+.+.+|+||||++||+|.+++...+ ...+++..++.++.||+.||.|||+ .||+||||||+||||+.++.+||+||
T Consensus 254 ~~~~~l~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 254 ETKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEec
Confidence 99999999999999999999997654 2458999999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+++..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||........ .
T Consensus 331 Gla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-------------~ 394 (576)
T 2acx_A 331 GLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-------------R 394 (576)
T ss_dssp TTCEECCTT---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-------------H
T ss_pred ccceecccC---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-------------H
Confidence 999864322 234456899999999999999999999999999999999999999975432110 0
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
..+...+. .....++...+..+.+||.+||+.||.+|| ++.||++|
T Consensus 395 ~~i~~~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 395 EEVERLVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11111110 112234556677899999999999999999 78999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=354.46 Aligned_cols=251 Identities=25% Similarity=0.321 Sum_probs=205.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH------HHHHHHHHHHHHhcCCCCCccceE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ------GLREWQAEVKFLGKFSHPNLVKLI 171 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~ 171 (441)
.++|++.+.||+|+||.||+|.. ..+++.||+|.+...... ..+.+.+|+.+++.++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCRE---------KSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hccEEEeeEeeecCCEEEEEEEE---------CCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence 45799999999999999999954 345889999987654221 356788999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC----
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY---- 247 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---- 247 (441)
+++.+...+++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSC
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCcC
Confidence 9999999999999999999999999754 358899999999999999999997 8999999999999999888
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 157 ~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------- 223 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---------- 223 (321)
T ss_dssp CEEECCCTTCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----------
T ss_pred CEEEccCccceecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH----------
Confidence 7999999999764322 123446799999999999999999999999999999999999999964321
Q ss_pred ccccchhhhhhhhcCc--cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTDKRRLKKIMDP--RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+..+... ......+...+..+.+||.+||..||++|||+.+++++
T Consensus 224 ------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 224 ------QETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ------HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ------HHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111111 11111112345668899999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=354.29 Aligned_cols=258 Identities=27% Similarity=0.426 Sum_probs=205.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcE--EEEEEcCCC-chHHHHHHHHHHHHHhcC-CCCCccceEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKA--VAVKKSNPD-SIQGLREWQAEVKFLGKF-SHPNLVKLIGYC 174 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~--vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 174 (441)
++|.+.+.||+|+||.||+|.... ++.. +++|.+... .....+.+.+|+.+|+++ +||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 579999999999999999996543 3554 488987653 233456788999999999 899999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcC-------------CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcE
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKG-------------SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNI 241 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 241 (441)
.+.+.+++||||+++++|.+++.... ....+++..++.++.|++.||.|||+ .||+||||||+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NI 173 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNI 173 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGE
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccceE
Confidence 99999999999999999999997643 23468999999999999999999997 9999999999999
Q ss_pred EEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCC
Q 013519 242 LLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGE 320 (441)
Q Consensus 242 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~ 320 (441)
|++.++.+||+|||+++.... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 174 l~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--- 247 (327)
T 1fvr_A 174 LVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--- 247 (327)
T ss_dssp EECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---
T ss_pred EEcCCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---
Confidence 999999999999999974221 111233457889999999999999999999999999999998 9999965321
Q ss_pred ceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 321 HVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
.. +...+........+..++..+.+||.+||..||++|||+.+++++|+.+..
T Consensus 248 -------------~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 248 -------------AE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp -------------HH-HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------HH-HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 01 111111112223455667789999999999999999999999999987653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=345.91 Aligned_cols=261 Identities=23% Similarity=0.354 Sum_probs=209.3
Q ss_pred cCCCCCc-eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDT-MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|.+.+ .||+|+||.||+|..... ..+..||||++.... ....+.+.+|+.+++.++||||+++++++ .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred HHhhhhhccccccCceeEEEeEeccC-------CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 4566665 999999999999965421 237889999988753 34567789999999999999999999999 5
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECcccc
Confidence 567999999999999999996433 468999999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCc-ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchh
Q 013519 257 AKLGPIDGNS-HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 257 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------------- 220 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---------------- 220 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----------------
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----------------
Confidence 9864322211 11223456889999999999999999999999999999998 99999653211
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
... ..+........+..++..+.+||.+||..||++||++.+++++|+.+...
T Consensus 221 ~~~-~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 221 EVM-AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp HHH-HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH-HHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111 11111112234556677899999999999999999999999999877543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=344.92 Aligned_cols=249 Identities=28% Similarity=0.425 Sum_probs=203.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREK---------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEc---------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence 367999999999999999999544 3478999998854322 1245688999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+....++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Df 153 (279)
T 3fdn_A 79 HDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADF 153 (279)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSC
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEec
Confidence 99999999999999999999997654 48899999999999999999997 99999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|++.... ........||+.|+|||++.+..++.++||||||+++|+|++|..||..... .
T Consensus 154 g~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~ 213 (279)
T 3fdn_A 154 GWSVHAP----SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----------------Q 213 (279)
T ss_dssp CEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------------H
T ss_pred cccccCC----cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH----------------H
Confidence 9986432 1223456799999999999999999999999999999999999999964321 0
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
.....+.. ....++...+..+.+||.+||+.||++|||+.+++++-
T Consensus 214 ~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 214 ETYKRISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp HHHHHHHH--TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred HHHHHHHh--CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 11111111 11223455667788999999999999999999999873
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=350.81 Aligned_cols=267 Identities=25% Similarity=0.336 Sum_probs=198.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++.+.||+|+||+||+|... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNR---------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeC---------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 67999999999999999999543 458899999876543 2335668899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 148 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGF 148 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCeEEEEEEeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence 99999999999999999887654 358999999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc-ccccchh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA-RPSLTDK 334 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~ 334 (441)
++.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............... .......
T Consensus 149 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
T 4agu_A 149 ARLLTG--PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226 (311)
T ss_dssp CEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred chhccC--cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccc
Confidence 976432 1222345679999999999976 56799999999999999999999999654321110000000 0000000
Q ss_pred hh-------hhhhcCcccccc-----CChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RR-------LKKIMDPRLEEQ-----YPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~-------~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.. ......+..... .....+..+.+|+.+||+.||++|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 000000000000 012345668899999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=345.74 Aligned_cols=260 Identities=27% Similarity=0.374 Sum_probs=207.2
Q ss_pred hcCCCCCc-eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDT-MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|.+.+ .||+|+||+||+|.+... ..++.||||++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCC-------CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 35688887 999999999999965422 2478999999876532 3356789999999999999999999998
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
..+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCC
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEccC
Confidence 6677899999999999999997643 48899999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcc-eEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccc
Q 013519 255 GLAKLGPIDGNSH-VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 255 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|+++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------------- 226 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------------- 226 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------------
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---------------
Confidence 9997643322211 1222456789999999999999999999999999999999 9999965321
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
..+...+........+..++..+.+++.+||+.||++||++.++++.|+.+-.
T Consensus 227 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 227 --SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp --HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01111111111223455667789999999999999999999999999987643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=345.21 Aligned_cols=254 Identities=24% Similarity=0.316 Sum_probs=203.0
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQ 179 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 179 (441)
+|....+||+|+||.||+|... .+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDL---------SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEET---------TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEeecCcEEEEEEEEC---------CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 4555669999999999999543 4578999999877665566788999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC-CCceEEecccCCC
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG-SYNAKLSDFGLAK 258 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DFGla~ 258 (441)
.++||||+++++|.+++........+++..+..++.|++.||.|||+ .||+|+||||+|||++. ++.+||+|||+++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSK 171 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeeccccc
Confidence 99999999999999999876544567789999999999999999997 89999999999999987 8999999999997
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGH--LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
..... ........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...... ...
T Consensus 172 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------------~~~ 234 (295)
T 2clq_A 172 RLAGI--NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---------------QAA 234 (295)
T ss_dssp ESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---------------HHH
T ss_pred ccCCC--CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---------------hHH
Confidence 54321 12233467999999999997754 789999999999999999999999542110 000
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.............+..++..+.+||.+||+.||++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 235 MFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000111223455667778999999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=346.78 Aligned_cols=262 Identities=23% Similarity=0.321 Sum_probs=206.6
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.|.+.++||+|+||+||+|.+... ...+..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQ------AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECS------SSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEecC------CCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 456678999999999999976432 123457999988764 3345678899999999999999999999998766
Q ss_pred eE-EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 179 QF-LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 179 ~~-~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
.. ++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 171 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLA 171 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred CCcEEEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCcCCCc
Confidence 54 99999999999999997633 468899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCC--CcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 258 KLGPIDG--NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 258 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+...... .........+|+.|+|||.+.+..++.++|||||||++|+|++|..|+...... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----------------~ 235 (298)
T 3pls_A 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----------------F 235 (298)
T ss_dssp CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----------------G
T ss_pred ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----------------H
Confidence 7543211 111223456889999999999999999999999999999999966665322110 0
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
.+............+..++..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 236 DLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111111111223344556778999999999999999999999999987653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=359.11 Aligned_cols=266 Identities=25% Similarity=0.358 Sum_probs=206.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++.+.||+|+||+||+|... .+++.||+|++... .....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHK---------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred ccceeeeeecCCCCeEEEEEEEC---------CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 57999999999999999999544 45889999998765 334467789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+++++|.+++...+ .+++..+..++.|++.||.|||+ ..||+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred CEEEEEEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 99999999999999999997754 48899999999999999999996 238999999999999999999999999998
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-------------
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV------------- 324 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~------------- 324 (441)
+... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 180 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3eqc_A 180 GQLI----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255 (360)
T ss_dssp HHHH----HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred cccc----cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence 6421 12234468999999999999999999999999999999999999999653311000000
Q ss_pred ----------c---ccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 325 ----------D---FARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 325 ----------~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ...+.......+..+.........+...+..+.+||.+||+.||++|||+.++|+|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0 00000000011111111111112223456678999999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=356.82 Aligned_cols=250 Identities=26% Similarity=0.313 Sum_probs=180.9
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGYCWEDRQFLL 182 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l 182 (441)
.+.||+|+||+||+|... .+++.||||++.... ...+.+|+.+++.+. ||||+++++++.+....|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHK---------KSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEET---------TTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCccccCCCeEEEEEEEC---------CCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 378999999999999543 458899999986543 356778999999997 9999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC---ceEEecccCCCC
Q 013519 183 VYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY---NAKLSDFGLAKL 259 (441)
Q Consensus 183 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~kl~DFGla~~ 259 (441)
||||+++|+|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 84 VMELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EECCCCSCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 999999999999997653 58999999999999999999997 8999999999999997765 899999999975
Q ss_pred CCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhh
Q 013519 260 GPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339 (441)
Q Consensus 260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (441)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ......+..
T Consensus 159 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---------~~~~~~~~~ 227 (325)
T 3kn6_A 159 KPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC---------TSAVEIMKK 227 (325)
T ss_dssp CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C---------CCHHHHHHH
T ss_pred cCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc---------ccHHHHHHH
Confidence 4322 22334567899999999999999999999999999999999999999754321100 001111222
Q ss_pred hcCcccc--ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 340 IMDPRLE--EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 340 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+...... .......+..+.+||.+||+.||++|||+.+++++
T Consensus 228 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 228 IKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 2221111 11112356778999999999999999999999876
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=359.37 Aligned_cols=258 Identities=17% Similarity=0.191 Sum_probs=205.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC---CCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS---HPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~ 174 (441)
.++|.+.+.||+|+||+||+|++... ....+++.||||++..... ..+..|+.++..++ |+||+++++++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDL----NDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCC----cccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 46799999999999999999965432 2344688999999987654 35667777777776 99999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC-------
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKG--SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG------- 245 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~------- 245 (441)
...+..+||||||++|+|.+++.... ....+++..++.++.|++.||.|||+ .+|+||||||+||||+.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGGGTCC--
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999997532 23569999999999999999999997 89999999999999988
Q ss_pred ----CCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCc
Q 013519 246 ----SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321 (441)
Q Consensus 246 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~ 321 (441)
++.+||+|||+|+..............+||+.|+|||++.+..++.++|||||||++|||+||+.||....... .
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~ 293 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-C 293 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-E
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-e
Confidence 89999999999975433333445566789999999999999999999999999999999999999985432110 0
Q ss_pred eeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhccc
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR-PSMEEVLETLQNIS 386 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R-ps~~eil~~L~~i~ 386 (441)
.. ...+. .+ ..+..+.+++..||+.+|.+| |++.++.+.|+.+-
T Consensus 294 ~~------------------~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 294 KP------------------EGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp EE------------------CSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ee------------------chhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 00 00000 01 124457789999999999999 57888887776554
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=367.76 Aligned_cols=201 Identities=23% Similarity=0.343 Sum_probs=167.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||+||+|+. ..+++.||||++... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYD---------KNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEEEE---------CCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 46899999999999999999954 345889999998753 3445677889999999999999999999997
Q ss_pred eC-----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 176 ED-----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 176 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
.. ..+|+||||+. ++|.+++... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+|
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl~~~~~~k 169 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCSVK 169 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEE
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEECCCCCEE
Confidence 76 57999999996 5999998654 358999999999999999999998 8999999999999999999999
Q ss_pred EecccCCCCCCCCCCc--------------------ceEeeeccccccCcchhh-hcCCCCccccchhHHHHHHHHHhCC
Q 013519 251 LSDFGLAKLGPIDGNS--------------------HVTTRIMGTYGYAAPEYV-ATGHLYVKSDVYGFGVVLLEMLTGL 309 (441)
Q Consensus 251 l~DFGla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~elltg~ 309 (441)
|+|||+++........ ......+||+.|+|||++ ....++.++|||||||++|||++|.
T Consensus 170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 9999999864322111 123567899999999986 4566999999999999999999976
Q ss_pred CCCC
Q 013519 310 RALD 313 (441)
Q Consensus 310 ~p~~ 313 (441)
.||.
T Consensus 250 ~p~~ 253 (432)
T 3n9x_A 250 QSHI 253 (432)
T ss_dssp TTTC
T ss_pred cccc
Confidence 6664
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=357.68 Aligned_cols=244 Identities=22% Similarity=0.290 Sum_probs=202.9
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--------HHHHHHHHHHHHHhcCCCCCcc
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--------QGLREWQAEVKFLGKFSHPNLV 168 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv 168 (441)
..++|++.+.||+|+||+||+|.. ..+++.||||++..... .....+.+|+.+|+.++||||+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 92 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVD---------KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEE---------TTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBC
T ss_pred cccceEEEeEEEecCCEEEEEEEE---------CCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEe
Confidence 457899999999999999999944 34588999998765421 1233566799999999999999
Q ss_pred ceEEEEEeCCeEEEEEeecCCC-CHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 169 KLIGYCWEDRQFLLVYEYMQKG-SLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 169 ~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
++++++.+.+.+++||||+.+| +|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDF 167 (335)
T ss_dssp CEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTS
T ss_pred eEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCCC
Confidence 9999999999999999999776 9999987653 58999999999999999999997 8999999999999999999
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecc
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF 326 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 326 (441)
.+||+|||+++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 168 ~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------- 235 (335)
T 3dls_A 168 TIKLIDFGSAAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------- 235 (335)
T ss_dssp CEEECCCTTCEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------
T ss_pred cEEEeecccceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------
Confidence 9999999999864322 22345689999999999998887 7899999999999999999999954211
Q ss_pred cccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 327 ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..... ...+...+..+.+||.+||+.||++|||+.+++++
T Consensus 236 -------------~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 -------------TVEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------------GTTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------------HHhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 01233355668899999999999999999999997
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=347.85 Aligned_cols=273 Identities=23% Similarity=0.336 Sum_probs=200.2
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC--CCCCccceEEE
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF--SHPNLVKLIGY 173 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~~~~~ 173 (441)
...++|++.+.||+|+||.||+|... ++.||||++..... ..+.+|.+++..+ +||||++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~ 99 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAA 99 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEE
Confidence 34578999999999999999999543 67899999864432 3344555665554 89999999999
Q ss_pred EEeC----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccC------CCCeeecCCCCCcEEE
Q 013519 174 CWED----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSS------EKSVIYRDFKASNILL 243 (441)
Q Consensus 174 ~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivHrDlkp~Nill 243 (441)
+... ..+++||||+++|+|.+++... .+++..++.++.|++.||.|||+. ..+|+||||||+|||+
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence 9887 7899999999999999999654 489999999999999999999972 1299999999999999
Q ss_pred cCCCceEEecccCCCCCCCCCCcc--eEeeeccccccCcchhhhcCCCCcc------ccchhHHHHHHHHHhCCCCCCCC
Q 013519 244 DGSYNAKLSDFGLAKLGPIDGNSH--VTTRIMGTYGYAAPEYVATGHLYVK------SDVYGFGVVLLEMLTGLRALDTN 315 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlG~il~elltg~~p~~~~ 315 (441)
+.++.+||+|||+++......... ......||+.|+|||++.+..++.. +|||||||++|||+||..|+...
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 999999999999997543222111 1124579999999999988766654 99999999999999995544321
Q ss_pred CCCCCceeecccccccchhhhhhh-hcCccccccCC-----hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 316 RPSGEHVLVDFARPSLTDKRRLKK-IMDPRLEEQYP-----IKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
..... .+......... ...... .........++ ..++..+.+|+.+||+.||++|||+.+++++|+.+...
T Consensus 256 ~~~~~-p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 256 EEYQL-PYHDLVPSDPS-YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CCCCC-TTTTTSCSSCC-HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccccc-cHhhhcCCCCc-hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 11000 00000000000 011111 11112222222 36778899999999999999999999999999887643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=359.85 Aligned_cols=262 Identities=27% Similarity=0.389 Sum_probs=198.7
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe-C
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE-D 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 177 (441)
.|.+.+.||+|+||+||+|.+.... .....||+|.+... .....+.+.+|+.+|++++||||+++++++.. +
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 163 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETT------TEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred eeecCcEeeeCCCeEEEEEEEECCC------CcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 4677889999999999999764321 12457899988654 33556788999999999999999999998754 5
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred CCeEEEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEeecccc
Confidence 67899999999999999997543 457899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCc--ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchh
Q 013519 258 KLGPIDGNS--HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 258 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+........ .......+|+.|+|||++.+..++.++|||||||++|||+| |..||........
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-------------- 305 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------------- 305 (373)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--------------
T ss_pred ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--------------
Confidence 754322111 11233567889999999999999999999999999999999 6677754322110
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
...+.. ......+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 306 --~~~~~~-~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 306 --TVYLLQ-GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp --HHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --HHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 001111 111123445667789999999999999999999999999876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=346.13 Aligned_cols=254 Identities=25% Similarity=0.344 Sum_probs=197.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|.+.+.||+|+||+||+|... .++..+|+|++.... ....+.+.+|+.+|+.++||||+++++++.+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 91 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEER---------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED 91 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEc---------cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec
Confidence 357999999999999999999543 347899999876543 2235678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE---cCCCceEEe
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL---DGSYNAKLS 252 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~ 252 (441)
....++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ .||+||||||+|||+ +.++.+||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEEE
Confidence 999999999999999999886531 23568999999999999999999997 899999999999999 556789999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|||+++.... ........||+.|+|||++. ..++.++|||||||++|+|++|..||......
T Consensus 170 Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-------------- 231 (285)
T 3is5_A 170 DFGLAELFKS---DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-------------- 231 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------------
T ss_pred eeecceecCC---cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--------------
Confidence 9999975432 22234567999999999875 57899999999999999999999999653210
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..........+... ......+..+.+||.+||+.||++|||+.|+|++
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 232 EVQQKATYKEPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHHHCCCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHhhhccCCcccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000011111111 1111245668899999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=343.83 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=209.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|.+.+.||+|+||.||+|.+.. ++.||+|.+...... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeEecCCCceeEEEEEecC----------CCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3578899999999999999996542 568999998765432 35788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 151 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMT 151 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred CCeEEEEeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEcccccc
Confidence 99999999999999999997653 458899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+..... .........||+.|+|||++.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 152 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------------~~~ 214 (267)
T 3t9t_A 152 RFVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------------SEV 214 (267)
T ss_dssp GGBCCH-HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHH
T ss_pred cccccc-cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH----------------HHH
Confidence 753211 1111123457788999999999999999999999999999999 8999865321 111
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
...+.. ......+...+..+.+|+.+||+.||++||++.+++++|+.+..
T Consensus 215 ~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 215 VEDIST-GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhc-CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111 11222344556778899999999999999999999999987753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=350.64 Aligned_cols=269 Identities=25% Similarity=0.362 Sum_probs=198.0
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-----hHHHHHHHHHHHHHhcCC---CCCcc
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-----IQGLREWQAEVKFLGKFS---HPNLV 168 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~---hpniv 168 (441)
..++|++.+.||+|+||+||+|+ +..+++.||||++.... ......+.+|+.+++.++ ||||+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv 77 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEE---------CTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred cccceEEEEEEecCCCeEEEEEE---------ECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeE
Confidence 35789999999999999999994 34458899999875321 111234556777777664 99999
Q ss_pred ceEEEEEeCC-----eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 169 KLIGYCWEDR-----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 169 ~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
++++++.... .+++||||+. ++|.+++..... ..+++..++.++.|++.||.|||+ .+|+||||||+|||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~ 153 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILV 153 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEEE
T ss_pred EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE
Confidence 9999998765 5899999997 599999876542 448999999999999999999997 899999999999999
Q ss_pred cCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee
Q 013519 244 DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~ 323 (441)
+.++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus 154 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 230 (308)
T 3g33_A 154 TSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 230 (308)
T ss_dssp CTTSCEEECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH
T ss_pred cCCCCEEEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999864322 223456899999999999999999999999999999999999999965432110000
Q ss_pred e-c-c---cccccchhhhh-hhhcCc---cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 324 V-D-F---ARPSLTDKRRL-KKIMDP---RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 324 ~-~-~---~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. . . ....+.....+ ...+.+ ..........+..+.+||.+||+.||++|||+.|+|++
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0 0 0 00000000000 000000 00001112345678899999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=347.19 Aligned_cols=262 Identities=26% Similarity=0.370 Sum_probs=204.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEE-e
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW-E 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~ 176 (441)
.+|++.+.||+|+||+||+|..... ......+|+|.+... .....+.+.+|+.++++++||||+++++++. .
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDN------DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred eehhhcceeeecCCceEEEEEEecC------CCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 4688889999999999999976432 123457899988764 3445677899999999999999999999865 4
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred CCceEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEECcccc
Confidence 567899999999999999997543 457899999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCC--cceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCCceeecccccccch
Q 013519 257 AKLGPIDGN--SHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG-LRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 257 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
++....... ........||+.|+|||++.+..++.++||||||+++|+|++| ..||.......
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-------------- 240 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------------- 240 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--------------
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--------------
Confidence 986432211 1123345678899999999999999999999999999999994 55554332111
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
....+. .......+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 241 --~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 241 --ITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp --HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHh-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000111 111122344456678899999999999999999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=373.77 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=208.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.++||+|+||+||+|+. ..+++.||+|++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~---------~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQM---------KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEE---------CCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 6788899999999999999954 34589999999865432 23456788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
+...+|+||||++||+|.+++..... ...+++..++.++.|++.||.|||+ .||+||||||+||||+.+|.+||+||
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEeec
Confidence 99999999999999999999976542 3468999999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+++..... .......+||+.|+|||++.+..|+.++|||||||++|||++|..||....... ...
T Consensus 334 Gla~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~------------~~~ 399 (543)
T 3c4z_A 334 GLAVELKAG--QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV------------ENK 399 (543)
T ss_dssp TTCEECCTT--CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC------------CHH
T ss_pred ceeeeccCC--CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch------------hHH
Confidence 999864322 122344689999999999999999999999999999999999999997543211 001
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM-----EEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~eil~~ 381 (441)
.....+... ...+|...+..+.+||.+||+.||++||++ .+|++|
T Consensus 400 ~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 400 ELKQRVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp HHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred HHHHHHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 111111111 123455667789999999999999999964 777765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=370.01 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=205.1
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 34678899999999999999997653 35799999886542 24678899999999999999999999866
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
+.+++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~ 326 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGL 326 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred -CceEEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCcc
Confidence 67899999999999999996532 1358899999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++...... ........+++.|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 327 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----------------~~ 389 (452)
T 1fmk_A 327 ARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------RE 389 (452)
T ss_dssp TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HH
T ss_pred ceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH----------------HH
Confidence 98643211 112233457789999999999999999999999999999999 9999964321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
.+..+ ........+..++..+.+||.+||+.||++|||+.++++.|+.+.
T Consensus 390 ~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 390 VLDQV-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp HHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HHHHH-HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11111 112223345667778999999999999999999999999998765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=345.61 Aligned_cols=253 Identities=28% Similarity=0.411 Sum_probs=201.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||+||+|... ++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-----------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 367999999999999999999543 6789999987654 346788999999999999999999997654
Q ss_pred -CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 178 -RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 178 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
+.+++||||+++++|.+++..... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 163 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGL 163 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred CCceEEEEecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeeccc
Confidence 478999999999999999976431 237889999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++.... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...... .
T Consensus 164 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----------------~ 222 (278)
T 1byg_A 164 TKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------D 222 (278)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----------------G
T ss_pred cccccc-----cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----------------H
Confidence 975321 1223467899999999999999999999999999999998 99998643210 0
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
+...+........+..++..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 223 -VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -HHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1111111122234556677789999999999999999999999999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=344.87 Aligned_cols=255 Identities=24% Similarity=0.308 Sum_probs=205.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEEC---------CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence 467999999999999999999543 357899999876432 2345678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 151 (276)
T 2yex_A 77 GNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGL 151 (276)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEEEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeCCC
Confidence 99999999999999999988543 358899999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+................||+.|+|||++.+..+ +.++||||||+++|+|++|..||.........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------- 217 (276)
T 2yex_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------------- 217 (276)
T ss_dssp CEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--------------
T ss_pred ccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--------------
Confidence 975432222222345679999999999988776 68999999999999999999999754321100
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+.............+..+.+||.+||+.||++|||+.+++++
T Consensus 218 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 218 -YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -HHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 001111111111123445678899999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=344.90 Aligned_cols=251 Identities=26% Similarity=0.430 Sum_probs=185.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|.+.+.||+|+||.||+|.. ..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAES---------IHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF 80 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEE---------ccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE
Confidence 36799999999999999999954 33588999999864322 1246788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~df 156 (278)
T 3cok_A 81 EDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADF 156 (278)
T ss_dssp ECSSEEEEEEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEECCC
T ss_pred ccCCeEEEEEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEEee
Confidence 99999999999999999999997543 468999999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|++....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------------- 220 (278)
T 3cok_A 157 GLATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------------- 220 (278)
T ss_dssp TTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------
T ss_pred cceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------------
Confidence 9997643221 122346799999999999999999999999999999999999999965432110
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+..+.... ...+...+..+.+||.+||+.||++|||+.+++++
T Consensus 221 --~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 221 --LNKVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -----CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --HHHHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 00111011 12344456678899999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=353.91 Aligned_cols=265 Identities=24% Similarity=0.327 Sum_probs=206.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEe-
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE- 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 176 (441)
.++|++.+.||+|+||.||+|.. ..+++.||||++........+.+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEG---------LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEE---------TTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEe---------cCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 36899999999999999999954 34588999998877666677889999999999999999999999873
Q ss_pred ---CCeEEEEEeecCCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEe
Q 013519 177 ---DRQFLLVYEYMQKGSLENHLFRK-GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252 (441)
Q Consensus 177 ---~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 252 (441)
....++||||+.+|+|.+++... .....+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEEC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEEE
Confidence 34789999999999999998763 223568999999999999999999997 899999999999999999999999
Q ss_pred cccCCCCCCCCCCcc-------eEeeeccccccCcchhhhcCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCCCce
Q 013519 253 DFGLAKLGPIDGNSH-------VTTRIMGTYGYAAPEYVATGH---LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV 322 (441)
Q Consensus 253 DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~ 322 (441)
|||+++......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.........
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~- 255 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS- 255 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-
Confidence 999987532110000 011245799999999987554 688999999999999999999998532110000
Q ss_pred eecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
+............+...+..+.+||.+||+.||.+|||+.+++++|+.+...
T Consensus 256 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 256 --------------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp --------------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred --------------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 0000001111122334566788999999999999999999999999987644
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=362.53 Aligned_cols=273 Identities=22% Similarity=0.270 Sum_probs=210.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|.+.++||+|+||+||+|... .+++.||||++..... ...+.+.+|+.+|++++||||+++++++...
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHK---------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CceEEEEEEEcCCCeEEEEEEEC---------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC
Confidence 57999999999999999999554 4588999999875432 3356678999999999999999999999876
Q ss_pred C--eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE----cCCCceEE
Q 013519 178 R--QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL----DGSYNAKL 251 (441)
Q Consensus 178 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~kl 251 (441)
. ..++|||||++|+|.+++........+++..++.++.|++.||.|||+ .||+||||||+|||+ +.++.+||
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeEEE
Confidence 5 789999999999999999765544558999999999999999999997 899999999999999 77888999
Q ss_pred ecccCCCCCCCCCCcceEeeeccccccCcchhhhc--------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-
Q 013519 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT--------GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV- 322 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~- 322 (441)
+|||+++.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 158 ~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 234 (396)
T 4eut_A 158 TDFGAARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (396)
T ss_dssp CCGGGCEECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH
T ss_pred ecCCCceEccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH
Confidence 99999976432 222344679999999999875 567889999999999999999999996433211100
Q ss_pred -eeccccccc-chhhhhhhhc--------CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 323 -LVDFARPSL-TDKRRLKKIM--------DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 323 -~~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
+........ .....+.... ........+...+..+.+++.+||+.||++||++.++++.++.+
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 000000000 0000000000 00111133466778899999999999999999999999988664
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=351.63 Aligned_cols=269 Identities=20% Similarity=0.346 Sum_probs=196.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHH--HHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA--EVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~--E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++.+.||+|+||+||+|... ++.||||++..... ..+.. |+..+..++||||+++++.+..
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 78 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDER 78 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEEC-----------CeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccc
Confidence 67999999999999999999542 67999999865543 23333 4444556899999999986543
Q ss_pred -----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCC---------CeeecCCCCCcEE
Q 013519 177 -----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEK---------SVIYRDFKASNIL 242 (441)
Q Consensus 177 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---------~ivHrDlkp~Nil 242 (441)
...+++|||||++|+|.+++.... .++..++.++.|++.||.|||+ . +|+||||||+|||
T Consensus 79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~--~~~~~~~~~~~ivH~Dikp~Nil 152 (336)
T 3g2f_A 79 VTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHT--ELPRGDHYKPAISHRDLNSRNVL 152 (336)
T ss_dssp ECTTSCEEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHC--CBCCGGGCBCCEECSSCSGGGEE
T ss_pred cccCCCceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHh--hhccccccccceeecccccceEE
Confidence 236789999999999999996643 5789999999999999999997 6 9999999999999
Q ss_pred EcCCCceEEecccCCCCCCCCC------CcceEeeeccccccCcchhhhc-------CCCCccccchhHHHHHHHHHhCC
Q 013519 243 LDGSYNAKLSDFGLAKLGPIDG------NSHVTTRIMGTYGYAAPEYVAT-------GHLYVKSDVYGFGVVLLEMLTGL 309 (441)
Q Consensus 243 l~~~~~~kl~DFGla~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~elltg~ 309 (441)
++.++.+||+|||+++...... .........||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 9999999999999997643221 1112234579999999999987 45668899999999999999998
Q ss_pred CCCCCCCCCCCceee-cccccccchhhhhhh-hcCccccccCC------hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 310 RALDTNRPSGEHVLV-DFARPSLTDKRRLKK-IMDPRLEEQYP------IKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 310 ~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.||............ ............... .........++ ..++..+.+||.+||+.||++|||+.|+++.
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 777543322211110 000000000011111 11111111222 2366789999999999999999999999999
Q ss_pred Hhcccc
Q 013519 382 LQNISV 387 (441)
Q Consensus 382 L~~i~~ 387 (441)
|+.+..
T Consensus 313 L~~ll~ 318 (336)
T 3g2f_A 313 MAELMM 318 (336)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 987763
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=348.06 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=203.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|.+.+.||+|+||.||+|... .+++.||+|.+..........+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQR---------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST 78 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccceeeeeccCCCCceEEEEEEC---------CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence 467999999999999999999543 45889999998766544456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE---cCCCceEEecc
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL---DGSYNAKLSDF 254 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~DF 254 (441)
..+++||||+++++|.+++...+ .+++..++.++.|++.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred CEEEEEEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEccC
Confidence 99999999999999999987654 48899999999999999999997 899999999999999 78899999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+++.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .
T Consensus 154 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------------~ 213 (304)
T 2jam_A 154 GLSKMEQN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE----------------S 213 (304)
T ss_dssp STTCCCCC----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH----------------H
T ss_pred CcceecCC----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----------------H
Confidence 99975321 122345799999999999999999999999999999999999999965321 0
Q ss_pred hhhhhhcCc--cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDP--RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+... .+....+...+..+.+||.+||..||++||++.+++++
T Consensus 214 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 214 KLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111111 11112234456778999999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.29 Aligned_cols=267 Identities=21% Similarity=0.290 Sum_probs=193.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH--HHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ--GLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||+||+|.. ..+++.||||++...... ....+.+|+.+|++++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAID---------TVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEE---------CCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 46899999999999999999944 445889999998765432 2456778999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE-----cCCCceE
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL-----DGSYNAK 250 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill-----~~~~~~k 250 (441)
++..+++||||+.+ +|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+|||+ +..+.+|
T Consensus 104 ~~~~~~lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 104 HNHRLHLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp ETTEEEEEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEE
T ss_pred cCCEEEEEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEE
Confidence 99999999999985 9999997654 48899999999999999999997 899999999999999 4555699
Q ss_pred EecccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee--ccc
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV--DFA 327 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~--~~~ 327 (441)
|+|||+++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||............ ...
T Consensus 178 l~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 255 (329)
T 3gbz_A 178 IGDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255 (329)
T ss_dssp ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ECcCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence 9999999753221 2223445789999999999875 4899999999999999999999999654321100000 000
Q ss_pred c---cccchhh-------hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 R---PSLTDKR-------RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~---~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ..+.... .........+....+...+..+.+||.+||+.||++|||+.|+|++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 0000000 0000000011111122245678899999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=346.04 Aligned_cols=251 Identities=28% Similarity=0.406 Sum_probs=205.4
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
...+|.+.+.||+|+||.||+|... .+++.||+|.+..... .+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHR---------IDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDG 75 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEET---------TTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hccccceeeeeccCCceEEEEEEEc---------CCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEec
Confidence 4567999999999999999999554 3478999999876542 45689999999999999999998864
Q ss_pred ----------------CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCc
Q 013519 177 ----------------DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASN 240 (441)
Q Consensus 177 ----------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~N 240 (441)
...+++||||+++++|.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~N 152 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSN 152 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGG
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHH
Confidence 345899999999999999997643 2468899999999999999999997 899999999999
Q ss_pred EEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCC
Q 013519 241 ILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGE 320 (441)
Q Consensus 241 ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~ 320 (441)
||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+...
T Consensus 153 il~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 224 (284)
T 2a19_B 153 IFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----- 224 (284)
T ss_dssp EEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----
T ss_pred EEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----
Confidence 999999999999999997643221 223457999999999999999999999999999999999998876321
Q ss_pred ceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 321 HVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
......+... ..+...+..+.+||.+||+.||++|||+.+++++|+.+...
T Consensus 225 -------------~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 225 -------------SKFFTDLRDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -------------HHHHHHHHTT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -------------HHHHHHhhcc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0111111111 22334456688999999999999999999999999877643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=355.72 Aligned_cols=258 Identities=26% Similarity=0.355 Sum_probs=190.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEEEE--
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGYCW-- 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~-- 175 (441)
.+|++.++||+|+||.||+|... .+++.||||++........+.+.+|+.++.++. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDV---------GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceEEEEEEEccCCceEEEEEEEC---------CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 57999999999999999999543 358899999987766666778899999999996 999999999985
Q ss_pred ------eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCC--eeecCCCCCcEEEcCCC
Q 013519 176 ------EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKS--VIYRDFKASNILLDGSY 247 (441)
Q Consensus 176 ------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--ivHrDlkp~Nill~~~~ 247 (441)
....+++||||+. |+|.+++........+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR--QKPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCCCCCGGGCEECTTS
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCEEEccCCcccEEECCCC
Confidence 3345899999996 6999988764444569999999999999999999997 77 99999999999999999
Q ss_pred ceEEecccCCCCCCCCCCcc----------eEeeeccccccCcchhh---hcCCCCccccchhHHHHHHHHHhCCCCCCC
Q 013519 248 NAKLSDFGLAKLGPIDGNSH----------VTTRIMGTYGYAAPEYV---ATGHLYVKSDVYGFGVVLLEMLTGLRALDT 314 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~il~elltg~~p~~~ 314 (441)
.+||+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999998643322111 11245699999999998 567788999999999999999999999964
Q ss_pred CCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 315 NRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
..... +.........+...+..+.+|+.+||+.||++|||+.+++++|+.+...
T Consensus 256 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 256 GAKLR--------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHH--------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 32110 0000011111122233467899999999999999999999999877643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=384.77 Aligned_cols=251 Identities=28% Similarity=0.382 Sum_probs=210.0
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcC-CCCCccceEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKF-SHPNLVKLIG 172 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~ 172 (441)
..++|.++++||+|+||+||+|... .+++.||||++.... ....+.+..|..+|..+ +||||+++++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~---------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~ 409 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERK---------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEES---------SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEEC---------CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 3568999999999999999999543 458899999986532 12345677899999988 6999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEe
Q 013519 173 YCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252 (441)
Q Consensus 173 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 252 (441)
++.+.+.+||||||++||+|.+++...+ .+++..++.++.||+.||.|||+ .+||||||||+||||+.++.+||+
T Consensus 410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 410 CFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp ECBCSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEEC
T ss_pred EEEeCCEEEEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEEe
Confidence 9999999999999999999999998764 48999999999999999999997 899999999999999999999999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|||+++..... .......+||+.|+|||++.+..|+.++|||||||+||||++|..||....
T Consensus 485 DFGla~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---------------- 546 (674)
T 3pfq_A 485 DFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---------------- 546 (674)
T ss_dssp CCTTCEECCCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----------------
T ss_pred ecceeeccccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC----------------
Confidence 99999853322 223456789999999999999999999999999999999999999996532
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM-----EEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~eil~~ 381 (441)
....+..++... ..+|...+.++.+||.+||+.||++||++ ++|++|
T Consensus 547 ~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 547 EDELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHHHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHHHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 112223333322 23566677889999999999999999997 888765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=354.56 Aligned_cols=267 Identities=23% Similarity=0.343 Sum_probs=195.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHH-HHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++.+.||+|+||+||+|... .+++.||+|++....... ...+.+|+.+|+.++||||+++++++.+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSK---------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEEEC---------CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 57899999999999999999543 457899999987654321 12345799999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+. |+|.+++...+ ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLA 147 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred CEEEEEecccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCccc
Confidence 99999999997 48999887654 468899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-c-------ccc
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-D-------FAR 328 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-~-------~~~ 328 (441)
+.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ . ...
T Consensus 148 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (324)
T 3mtl_A 148 RAKSI--PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225 (324)
T ss_dssp ECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccC--CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhc
Confidence 75322 1222344578999999999977 56889999999999999999999999754321100000 0 000
Q ss_pred cccchhhhhhhhcCcccc----ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 PSLTDKRRLKKIMDPRLE----EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+.............+... .......+..+.+||.+||+.||++|||+.|+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000000 01122345678899999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=342.17 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=199.5
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEe-
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE- 176 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 176 (441)
.|++.+.||+|+||.||+|... .++..||+|.+... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~---------~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEec---------CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence 4778889999999999999544 34789999987654 33456778899999999999999999999875
Q ss_pred ---CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCC--eeecCCCCCcEEEc-CCCceE
Q 013519 177 ---DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKS--VIYRDFKASNILLD-GSYNAK 250 (441)
Q Consensus 177 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--ivHrDlkp~Nill~-~~~~~k 250 (441)
...+++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .+ |+||||||+|||++ .++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 98 VKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred cCCCceEEEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHc--CCCCEEECCCCHHHEEEECCCCCEE
Confidence 456899999999999999997653 48899999999999999999997 67 99999999999997 789999
Q ss_pred EecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccc
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 330 (441)
|+|||++..... .......||+.|+|||++. ..++.++|||||||++|+|++|..||......
T Consensus 173 l~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------ 235 (290)
T 1t4h_A 173 IGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------------ 235 (290)
T ss_dssp ECCTTGGGGCCT----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------------
T ss_pred EeeCCCcccccc----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------------
Confidence 999999975322 2234567999999999876 56899999999999999999999999643211
Q ss_pred cchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+.........+...+..+.+||.+||+.||++|||+.+++++
T Consensus 236 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 236 ---AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111111111111112233344568899999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=354.58 Aligned_cols=278 Identities=26% Similarity=0.375 Sum_probs=214.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|++.+.||+|+||.||+|.+.. ....+++.||||++........+.+.+|+.+++.++||||+++++++...+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECT-----TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred HHceeeeeeccCCCeEEEEEEecc-----ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 568899999999999999997532 133458999999998877677788999999999999999999999987644
Q ss_pred --eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 179 --QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 179 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
.+++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 7899999999999999997654 358899999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcc-eEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSH-VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++......... ......++..|+|||++.+..++.++|||||||++|+|+||..||................... ...
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~-~~~ 270 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM-IVF 270 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH-HHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh-hHH
Confidence 98654322211 1123457788999999999999999999999999999999998875321000000000000000 001
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
.+...+........+..++..+.+||.+||+.||++|||+.++++.|+.+.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111222222222345567778999999999999999999999999998765
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=370.16 Aligned_cols=250 Identities=26% Similarity=0.337 Sum_probs=201.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||+||+|.. ..+++.||||++.... ......+.+|+.+|++++||||+++++++.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 91 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKD---------RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEE---------TTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEE---------CCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence 46899999999999999999954 3458899999975421 123467889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc---CCCceEEe
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD---GSYNAKLS 252 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl~ 252 (441)
+...+++|||||.+|+|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++ .++.+||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 92 DSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEE
Confidence 9999999999999999999987654 48999999999999999999997 8999999999999995 45679999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|||+++.... .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.....
T Consensus 167 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------------- 227 (486)
T 3mwu_A 167 DFGLSTCFQQ---NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------------- 227 (486)
T ss_dssp SCSCTTTBCC---C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------------
T ss_pred ECCcCeECCC---CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------------
Confidence 9999986432 223345689999999998875 599999999999999999999999965321
Q ss_pred hhhhhhhhcCccccc--cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPRLEE--QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+..+....... ......+..+.+||.+||+.||.+|||+.++|++
T Consensus 228 -~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 228 -YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -HHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -HHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111111111111 1123456678899999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=342.74 Aligned_cols=247 Identities=23% Similarity=0.384 Sum_probs=205.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|.+.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREK---------QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEc---------CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 67999999999999999999543 3478999998864322 12456889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+.+..++||||+++++|.+++...+ .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEeccc
Confidence 9999999999999999999997754 48899999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
++..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ..
T Consensus 160 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------------~~ 219 (284)
T 2vgo_A 160 WSVHAPS----LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH----------------TE 219 (284)
T ss_dssp TCEECSS----SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------------HH
T ss_pred ccccCcc----cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH----------------hH
Confidence 9865322 122346799999999999999999999999999999999999999964321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+.... ..++...+..+.+||.+||+.||.+||++.+++++
T Consensus 220 ~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 220 THRRIVNVD--LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHHHTTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHHhccc--cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 111122111 12345566778899999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=345.49 Aligned_cols=262 Identities=27% Similarity=0.384 Sum_probs=201.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||+||+|.+.... ..+..||+|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hHeeeeeeecCCCceeEEEEEeccCC------CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 57999999999999999999764321 123479999887642 245677889999999999999999999997
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
... .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred cCC-ceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEcccc
Confidence 765 899999999999999997653 358899999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcc-eEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccch
Q 013519 256 LAKLGPIDGNSH-VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 256 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
+++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------------- 230 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---------------- 230 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH----------------
Confidence 997653322211 1233567889999999999999999999999999999999 9999965321
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
...+..+.........+..++..+.+++.+||..||++|||+.+++++|+.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 231 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 111122222222223345566779999999999999999999999999987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=344.74 Aligned_cols=260 Identities=22% Similarity=0.269 Sum_probs=200.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|++.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDT---------VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEc---------CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 468999999999999999999543 347899999986542 23456788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
..++.+++||||+++++|.+++...+ .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~Df 178 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDF 178 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSC
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEecC
Confidence 99999999999999999999997654 58899999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|++....... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ...
T Consensus 179 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------------~~~ 244 (309)
T 2h34_A 179 GIASATTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------------VMG 244 (309)
T ss_dssp CC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------------HHH
T ss_pred ccCccccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------------HHH
Confidence 9997543221 12233467999999999999999999999999999999999999999653210 000
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcccc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-SMEEVLETLQNISV 387 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~eil~~L~~i~~ 387 (441)
..+... .......+..++..+.+||.+||+.||++|| +++++++.|+.+-.
T Consensus 245 ~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 245 AHINQA--IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp HHHHSC--CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred HHhccC--CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 000000 0111123445566788999999999999999 99999999986543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=355.99 Aligned_cols=263 Identities=22% Similarity=0.288 Sum_probs=196.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||.||+|.. ..+++.||||++... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVD---------GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEEEE---------TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEEEE---------CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 36799999999999999999944 345889999998543 3344567889999999999999999999998
Q ss_pred eCC------eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 176 EDR------QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 176 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
... .+|+||||+ +++|.+++... .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~ 167 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCEL 167 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCE
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEcCCCCE
Confidence 653 469999999 88999998652 48899999999999999999997 899999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ec-c
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VD-F 326 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~-~ 326 (441)
||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... .. .
T Consensus 168 kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 242 (367)
T 1cm8_A 168 KILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 242 (367)
T ss_dssp EECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEeeeccccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999986322 1344678999999999987 6789999999999999999999999975432110000 00 0
Q ss_pred cccccc--------hhhhhhhhcC---ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 327 ARPSLT--------DKRRLKKIMD---PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 327 ~~~~~~--------~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+... ........+. ...........+..+.+||.+||..||++|||+.++|+|
T Consensus 243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000 0000000000 000111223456778999999999999999999999996
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=370.00 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=198.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||+||+|.. ..++..||+|++.... ......+.+|+.+|+.++||||+++++++.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRD---------KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEE---------TTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEE---------CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 45799999999999999999954 3458899999886543 223466889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC---CceEEe
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS---YNAKLS 252 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~kl~ 252 (441)
+...+++|||||.+|+|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.. +.+||+
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEEE
Confidence 9999999999999999999887654 48899999999999999999997 899999999999999764 459999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|||+++.... .......+||+.|+|||++. ..++.++|||||||++|+|++|..||.....
T Consensus 182 DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------------- 242 (494)
T 3lij_A 182 DFGLSAVFEN---QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--------------- 242 (494)
T ss_dssp CCTTCEECBT---TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------
T ss_pred ECCCCeECCC---CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------------
Confidence 9999976432 22334568999999999876 5799999999999999999999999965321
Q ss_pred hhhhhhhhcCcccc--ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPRLE--EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+..+...... .......+..+.+||.+||+.||.+|||+.++|++
T Consensus 243 -~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 243 -QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -HHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -HHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1111111111111 11112345678899999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=356.73 Aligned_cols=269 Identities=18% Similarity=0.186 Sum_probs=200.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHH-----------HHHHHHHHHHHhcCCCCCc
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-----------LREWQAEVKFLGKFSHPNL 167 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpni 167 (441)
++|.+.+.||+|+||.||+|..... ...+..+|||+........ ...+.+|+.+++.++||||
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNK------PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSS------CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred ceEEEEeeEeecCCeEEEEEEecCC------CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence 5799999999999999999976531 1246789999886653211 1235678899999999999
Q ss_pred cceEEEEEe----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 168 VKLIGYCWE----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 168 v~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
+++++++.. ...+++||||+ +++|.+++...+ .+++..++.++.|++.||.|||+ .+|+||||||+|||+
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll 184 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLL 184 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEE
Confidence 999999988 77899999999 999999987654 68999999999999999999997 899999999999999
Q ss_pred cCCC--ceEEecccCCCCCCCCCCc-----ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 013519 244 DGSY--NAKLSDFGLAKLGPIDGNS-----HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNR 316 (441)
Q Consensus 244 ~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~ 316 (441)
+.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8887 9999999999764321111 11134579999999999999999999999999999999999999996422
Q ss_pred CCCCceeecccccccchhhhhhhhcCccccccC-ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 317 PSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQY-PIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
....... .........+...+.... +..++..+.+||.+||..||++||++.+|++.|+.+..
T Consensus 265 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 KDPVAVQ--------TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TCHHHHH--------HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cccHHHH--------HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1110000 000000000111110000 11455678899999999999999999999999987654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=346.35 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=206.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||.||+|... .+++.||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRK---------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEEC---------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 468999999999999999999543 45889999998654 3345677899999999999999999999886
Q ss_pred e--CCeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccCCCC-----eeecCCCCCcEEEcCCC
Q 013519 176 E--DRQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSSEKS-----VIYRDFKASNILLDGSY 247 (441)
Q Consensus 176 ~--~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-----ivHrDlkp~Nill~~~~ 247 (441)
+ ...+++||||+++++|.+++.... ....+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~ivH~dl~p~NIl~~~~~ 153 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR--RSDGGHTVLHRDLKPANVFLDGKQ 153 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HC------CCCCCSGGGEEECSSS
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc--ccCCCCeeEEeccchhhEEEcCCC
Confidence 5 578999999999999999997633 23458999999999999999999997 67 99999999999999999
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
.+||+|||+++..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 154 ~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------- 221 (279)
T 2w5a_A 154 NVKLGDFGLARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---------- 221 (279)
T ss_dssp CEEECCCCHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------
T ss_pred CEEEecCchheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH----------
Confidence 9999999999753221 1122345789999999999999999999999999999999999999965321
Q ss_pred ccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 013519 328 RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~ 384 (441)
......+... .....+..++..+.+||.+||+.||++||++.++++++..
T Consensus 222 ------~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 222 ------KELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ------HHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------HHHHHHHhhc-ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 0111111111 1123345566778999999999999999999999997654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=365.23 Aligned_cols=244 Identities=15% Similarity=0.179 Sum_probs=191.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHH---HHHhcCCCCCccceE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEV---KFLGKFSHPNLVKLI 171 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~---~~l~~l~hpniv~~~ 171 (441)
.++|.+.+.||+|+||+||+|.. ..+++.||||++... .....+.+.+|+ .+|+.++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATD---------QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC----------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEE---------CCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 36788999999999999999954 345889999998632 334567788999 555566899999998
Q ss_pred -------EEEEeCCe-----------------EEEEEeecCCCCHHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHhh
Q 013519 172 -------GYCWEDRQ-----------------FLLVYEYMQKGSLENHLFRKGSA----EPLPWNTRLKIAIDAAKDLTF 223 (441)
Q Consensus 172 -------~~~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~~----~~l~~~~~~~i~~~i~~~l~~ 223 (441)
+++.+.+. .||||||+ +|+|.+++...+.. ..+++..++.++.|++.||.|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 77665542 88999999 67999999764321 224458888999999999999
Q ss_pred hccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC-----------CCCcc
Q 013519 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-----------HLYVK 292 (441)
Q Consensus 224 lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~ 292 (441)
||+ .||+||||||+|||++.++.+||+|||+++.. .......+| +.|+|||++.+. .++.+
T Consensus 222 LH~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 222 LHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HHH--TTEECSCCCGGGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred HHh--CCeecCCCCHHHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 997 89999999999999999999999999999852 223455678 999999999988 89999
Q ss_pred ccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCC
Q 013519 293 SDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR 372 (441)
Q Consensus 293 ~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 372 (441)
+|||||||++|||++|+.||......... ..+.. ....++..+.+||.+||+.||++|
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~~~~~~----------------~~~~~------~~~~~~~~~~~li~~~L~~dp~~R 351 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDAALGGS----------------EWIFR------SCKNIPQPVRALLEGFLRYPKEDR 351 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------CCS----------------GGGGS------SCCCCCHHHHHHHHHHTCSSGGGC
T ss_pred hhHHHHHHHHHHHHHCCCCCcccccccch----------------hhhhh------hccCCCHHHHHHHHHHcCCCchhC
Confidence 99999999999999999999654321100 00110 112345568899999999999999
Q ss_pred CCHHHHHHH
Q 013519 373 PSMEEVLET 381 (441)
Q Consensus 373 ps~~eil~~ 381 (441)
||+.+++++
T Consensus 352 pt~~e~l~h 360 (377)
T 3byv_A 352 LLPLQAMET 360 (377)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhhC
Confidence 999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=364.46 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=192.0
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--------hHHHHHHHHHHHHHhcCCCCCc
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--------IQGLREWQAEVKFLGKFSHPNL 167 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~hpni 167 (441)
...++|.+.+.||+|+||+||+|+.. .+++.||||++.... ......+.+|+.+|++++||||
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 202 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFER---------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence 45689999999999999999999544 458899999875432 1122347889999999999999
Q ss_pred cceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 168 VKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 168 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
+++++++. .+.+++||||+++|+|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++
T Consensus 203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~ 276 (419)
T 3i6u_A 203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQE 276 (419)
T ss_dssp CCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSS
T ss_pred eeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCC
Confidence 99999875 55689999999999999888544 458999999999999999999997 8999999999999997544
Q ss_pred ---ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCc
Q 013519 248 ---NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321 (441)
Q Consensus 248 ---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~ 321 (441)
.+||+|||+++... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 277 ~~~~~kl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~ 353 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353 (419)
T ss_dssp SSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH
T ss_pred CcceEEEeecccceecC---CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH
Confidence 59999999998643 2233455789999999999853 67889999999999999999999999653221100
Q ss_pred eeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+.... ...........+..+.+||.+||+.||++|||+.++|++
T Consensus 354 ------------~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 354 ------------KDQITSGK-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ------------HHHHHTTC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------------HHHHhcCC-CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000 000001112345668899999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=342.76 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=201.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch------HHHHHHHHHHHHHhcCCCCCccceE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI------QGLREWQAEVKFLGKFSHPNLVKLI 171 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~ 171 (441)
.++|++.+.||+|+||.||+|... .+++.||+|.+..... ...+.+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 74 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQK---------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEc---------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence 357999999999999999999544 3578999998754321 1356788999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC----
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY---- 247 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---- 247 (441)
+++.+....++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~ 149 (283)
T 3bhy_A 75 DIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNP 149 (283)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSC
T ss_pred heecCCCeEEEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCC
Confidence 99999999999999999999999997643 58999999999999999999997 8999999999999998877
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
.+||+|||+++..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 150 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------- 216 (283)
T 3bhy_A 150 RIKLIDFGIAHKIEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---------- 216 (283)
T ss_dssp CEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH----------
T ss_pred ceEEEecccceeccCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch----------
Confidence 7999999999754221 223445799999999999999999999999999999999999999965321
Q ss_pred ccccchhhhhhhhcC--ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTDKRRLKKIMD--PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+.. ...........+..+.+|+.+||..||++||++.+++++
T Consensus 217 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 217 ------QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ------HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ------HHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 011111111 111111112345668899999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=351.54 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=207.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
..+|.+.+.||+|+||.||+|... .+++.||+|++... .....+.+.+|+.+++.++||||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDA---------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 367999999999999999999543 35789999987643 334566788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+.+.+++||||+.+++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCC
T ss_pred ecCCeEEEEEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEeec
Confidence 99999999999999999999987653 58899999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .
T Consensus 186 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------------~ 247 (335)
T 2owb_A 186 GLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----------------K 247 (335)
T ss_dssp TTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----------------H
T ss_pred cCceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH----------------H
Confidence 9997643222 223446799999999999999999999999999999999999999964321 0
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+.... ...+...+..+.+||.+||+.||++||++.+++++
T Consensus 248 ~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 248 ETYLRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHHHHTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHhcCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111111 12344556678899999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=375.44 Aligned_cols=258 Identities=23% Similarity=0.352 Sum_probs=204.2
Q ss_pred CCCCCc-eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 100 NFRPDT-MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 100 ~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++.+.+ .||+|+||.||+|.+... ..+..||||+++... ....+.+.+|+.+|++++|||||++++++..
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECS-------SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred ceeEcCcEEecCCCcEEEEEEEecC-------CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 333444 799999999999976532 235689999987653 2346788999999999999999999999976
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.++||||||.+|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 56899999999999999996543 468999999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCc-ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhh
Q 013519 258 KLGPIDGNS-HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 258 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+........ .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----------------~ 547 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----------------E 547 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----------------H
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----------------H
Confidence 864322211 11122345689999999999999999999999999999998 99999653211 1
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
+...+........+..++..+.+||.+||+.||++||++.+|++.|+.+.
T Consensus 548 -~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 548 -VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp -HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111112223456667788999999999999999999999999998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=369.02 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=200.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-------------HHHHHHHHHHHHHhcCCC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-------------QGLREWQAEVKFLGKFSH 164 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~E~~~l~~l~h 164 (441)
.++|.+.+.||+|+||+||+|.. ..+++.||+|++..... ...+.+.+|+.+|++++|
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 105 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKE---------KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEE---------TTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC
T ss_pred ccceEEEeEecccCCeEEEEEEE---------CCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC
Confidence 57899999999999999999954 34578999998765421 224678899999999999
Q ss_pred CCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc
Q 013519 165 PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD 244 (441)
Q Consensus 165 pniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 244 (441)
|||+++++++.+...+++|||||++|+|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++
T Consensus 106 pniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHK--HNIVHRDIKPENILLE 180 (504)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEES
T ss_pred CCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEEEe
Confidence 999999999999999999999999999999997654 48999999999999999999997 8999999999999998
Q ss_pred CCC---ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCc
Q 013519 245 GSY---NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321 (441)
Q Consensus 245 ~~~---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~ 321 (441)
.++ .+||+|||+++..... ......+||+.|+|||++. ..++.++|||||||++|+|++|..||.....
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---- 252 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---- 252 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred cCCCCccEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 776 6999999999864322 2234567999999999886 5699999999999999999999999965321
Q ss_pred eeecccccccchhhhhhhhcCcccc--ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLE--EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+..+...... .......+..+.+||.+||..||.+|||+.++|++
T Consensus 253 ------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 253 ------------QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ------------HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------------HHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111111111110 00012345678899999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=343.16 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=207.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
..+|.+.+.||+|+||.||+|... .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDA---------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEEC---------CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 367999999999999999999543 34789999987543 234556788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEEec
Confidence 99999999999999999999887653 58899999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .
T Consensus 160 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------------~ 221 (294)
T 2rku_A 160 GLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----------------K 221 (294)
T ss_dssp TTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----------------H
T ss_pred cCceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------------H
Confidence 9997643222 223446799999999999999999999999999999999999999964321 1
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+.... ...+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 222 ~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 222 ETYLRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHhhcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111111111 12344556678899999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=346.48 Aligned_cols=265 Identities=25% Similarity=0.392 Sum_probs=206.0
Q ss_pred HHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhc--CCCCCccceE
Q 013519 94 LRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGK--FSHPNLVKLI 171 (441)
Q Consensus 94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~ 171 (441)
.....++|.+.+.||+|+||.||+|... ++.||||.+.... ...+.+|++++.. ++||||++++
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~ 102 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI 102 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-----------CccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEE
Confidence 3456789999999999999999999552 6799999987543 3456778888877 7899999999
Q ss_pred EEEEeCC----eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccC------CCCeeecCCCCCcE
Q 013519 172 GYCWEDR----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSS------EKSVIYRDFKASNI 241 (441)
Q Consensus 172 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivHrDlkp~Ni 241 (441)
+++.... .+++||||+++|+|.+++.+. .+++..++.++.|++.||.|||.. ..+|+||||||+||
T Consensus 103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NI 178 (342)
T 1b6c_B 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178 (342)
T ss_dssp EEEECCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGE
T ss_pred eeecccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHE
Confidence 9998876 799999999999999999653 488999999999999999999921 28999999999999
Q ss_pred EEcCCCceEEecccCCCCCCCCCCcc--eEeeeccccccCcchhhhcC------CCCccccchhHHHHHHHHHhC-----
Q 013519 242 LLDGSYNAKLSDFGLAKLGPIDGNSH--VTTRIMGTYGYAAPEYVATG------HLYVKSDVYGFGVVLLEMLTG----- 308 (441)
Q Consensus 242 ll~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~elltg----- 308 (441)
|++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 99999999999999997543222111 12345799999999999775 334789999999999999999
Q ss_pred -----CCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCC-----hhhHHHHHHHHHHhcccCCCCCCCHHHH
Q 013519 309 -----LRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYP-----IKGALLAGQIIIKCLEAEPKNRPSMEEV 378 (441)
Q Consensus 309 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~ei 378 (441)
..||........ ........+.........+ ..++..+.+|+.+||+.||++|||+.++
T Consensus 259 ~~~~~~~p~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDP-----------SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp BCCCCCCTTTTTSCSSC-----------CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cccccccCccccCcCcc-----------cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 556643322110 0011111122222222222 3566789999999999999999999999
Q ss_pred HHHHhcccc
Q 013519 379 LETLQNISV 387 (441)
Q Consensus 379 l~~L~~i~~ 387 (441)
+++|+.+..
T Consensus 328 ~~~L~~i~~ 336 (342)
T 1b6c_B 328 KKTLSQLSQ 336 (342)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=352.43 Aligned_cols=259 Identities=21% Similarity=0.273 Sum_probs=204.5
Q ss_pred HHHHhcCCCCC-ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCC-CCCccc
Q 013519 94 LRAATKNFRPD-TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFS-HPNLVK 169 (441)
Q Consensus 94 ~~~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~ 169 (441)
.....++|.+. +.||+|+||+||+|.. ..+++.||+|++..... .....+.+|+.++..+. ||||++
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~ 93 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCIS---------KSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEE---------CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEE
Confidence 34556778887 8999999999999954 34588999998865422 23567889999999995 799999
Q ss_pred eEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC---C
Q 013519 170 LIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG---S 246 (441)
Q Consensus 170 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~ 246 (441)
+++++.+...+++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+ .||+||||||+|||++. +
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 94 LHEVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp EEEEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCBTTB
T ss_pred EEEEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecCCCC
Confidence 9999999999999999999999999885432 3568999999999999999999997 89999999999999987 7
Q ss_pred CceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecc
Q 013519 247 YNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF 326 (441)
Q Consensus 247 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 326 (441)
+.+||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 171 ~~~kL~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------- 240 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIGH---ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------- 240 (327)
T ss_dssp CCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------
T ss_pred CcEEEeeCccccccCC---ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-------
Confidence 8999999999986432 222344679999999999999999999999999999999999999996532100
Q ss_pred cccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 327 ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+.. ............++..+.+||.+||+.||++|||+.++|++
T Consensus 241 ------~~~~i~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 241 ------TYLNISQ-VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ------HHHHHHH-TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ------HHHHHHh-cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0000111 11112222234556778899999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=371.82 Aligned_cols=250 Identities=26% Similarity=0.347 Sum_probs=204.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|++.++||+|+||.||+|.. ..+++.||||++.... ......+.+|+.+|++++||||+++++++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 95 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKD---------KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEE---------CCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 46799999999999999999944 3458899999975432 23456788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE---cCCCceEE
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL---DGSYNAKL 251 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl 251 (441)
.+.+.+++|||||.+|+|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||+ +.++.+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 96 EDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred EeCCEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcEEE
Confidence 99999999999999999999987653 58999999999999999999997 899999999999999 56789999
Q ss_pred ecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccccc
Q 013519 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
+|||+++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.....
T Consensus 171 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------- 232 (484)
T 3nyv_A 171 IDFGLSTHFEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-------------- 232 (484)
T ss_dssp CCTTHHHHBCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------------
T ss_pred EeeeeeEEcccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------------
Confidence 999999754322 22334679999999998866 699999999999999999999999965321
Q ss_pred chhhhhhhhcCccccc--cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 332 TDKRRLKKIMDPRLEE--QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 332 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+..+....... ......+..+.+||.+||+.||.+|||+.++|+|
T Consensus 233 --~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 233 --YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --HHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 11111111111111 1123456778999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=343.24 Aligned_cols=265 Identities=20% Similarity=0.223 Sum_probs=201.7
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEE-E
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYC-W 175 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~ 175 (441)
..++|++.+.||+|+||+||+|.. ..+++.||||++..... ...+.+|+.+++.++|++++..+.++ .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTD---------IAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEE---------cCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence 457899999999999999999953 34588999998654432 13467899999999988877776665 5
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE---cCCCceEEe
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL---DGSYNAKLS 252 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~ 252 (441)
.....++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL~ 150 (296)
T 4hgt_A 76 EGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYII 150 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred CCCceEEEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEEe
Confidence 678889999999 999999997543 358999999999999999999997 899999999999999 788999999
Q ss_pred cccCCCCCCCCCCc-----ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 253 DFGLAKLGPIDGNS-----HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 253 DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--- 227 (296)
T 4hgt_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY--- 227 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH---
T ss_pred cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh---
Confidence 99999764332221 1223467999999999999999999999999999999999999999764332111100
Q ss_pred ccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 328 RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
. ......... ........++..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 228 ----~--~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 228 ----E--RISEKKMST-PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp ----H--HHHHHHHHS-CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----h--hhhcccccc-hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0 000000000 0001112345678899999999999999999999999987653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=344.89 Aligned_cols=251 Identities=27% Similarity=0.378 Sum_probs=206.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.+.|.+.+.||+|+||.||+|.. ..+++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 91 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGID---------NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 91 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEE---------CCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 35789999999999999999954 3458899999886543 2345778899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
...+++||||+++++|.+++.. ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 92 DTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGV 165 (303)
T ss_dssp TTEEEEEEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCeEEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeeccc
Confidence 9999999999999999999853 358999999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...... ........||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..
T Consensus 166 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~ 227 (303)
T 3a7i_A 166 AGQLTDT--QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM----------------KV 227 (303)
T ss_dssp CEECBTT--BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HH
T ss_pred ceecCcc--ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH----------------HH
Confidence 9754321 11234467999999999999999999999999999999999999999643210 00
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
...+ ........+..++..+.+|+.+||+.||++|||+.+++++.
T Consensus 228 ~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 228 LFLI-PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HHHH-HHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred HHHh-hcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 0011 01111223445566788999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=352.38 Aligned_cols=271 Identities=24% Similarity=0.267 Sum_probs=196.9
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-----HHHHHHHHHHHHhcCCCCCccce
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-----GLREWQAEVKFLGKFSHPNLVKL 170 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~ 170 (441)
...++|++.+.||+|+||.||+|.. ..+++.||||++...... ..+.+.+|+.+++.++||||+++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARD---------KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEEC---------SSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCE
T ss_pred HHhcccEEEeEEeecCCEEEEEEEE---------CCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeE
Confidence 3457899999999999999999944 345889999998754321 12457789999999999999999
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 171 IGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 171 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
++++.+....++||||+++ +|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+|
T Consensus 78 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~k 152 (346)
T 1ua2_A 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLK 152 (346)
T ss_dssp EEEECCTTCCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEE
T ss_pred EEEEeeCCceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCEE
Confidence 9999999999999999986 8888886543 458889999999999999999997 8999999999999999999999
Q ss_pred EecccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce--eeccc
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--LVDFA 327 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~~~~~ 327 (441)
|+|||+++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.......... +....
T Consensus 153 l~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~ 230 (346)
T 1ua2_A 153 LADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 230 (346)
T ss_dssp ECCCGGGSTTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEecccceeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999999864322 2223446799999999999764 58899999999999999999999986543110000 00000
Q ss_pred c---cccchhhhhhhhcCccccc-----cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 328 R---PSLTDKRRLKKIMDPRLEE-----QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 328 ~---~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
. ..+................ ......+..+.+||.+||..||++|||+.|+|++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0 0000000000000000000 01133456788999999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=352.44 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=205.5
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--------hHHHHHHHHHHHHHhcC-
Q 013519 92 QDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--------IQGLREWQAEVKFLGKF- 162 (441)
Q Consensus 92 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l- 162 (441)
.......++|.+.+.||+|+||.||+|... .+|+.||||++.... ....+.+.+|+.+++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 157 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHR---------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEEC---------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc
Confidence 344556678999999999999999999543 348899999876543 12245678899999999
Q ss_pred CCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEE
Q 013519 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNIL 242 (441)
Q Consensus 163 ~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 242 (441)
+||||+++++++......++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl 232 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENIL 232 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEE
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEE
Confidence 79999999999999999999999999999999997653 58899999999999999999997 89999999999999
Q ss_pred EcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC------CCCccccchhHHHHHHHHHhCCCCCCCCC
Q 013519 243 LDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG------HLYVKSDVYGFGVVLLEMLTGLRALDTNR 316 (441)
Q Consensus 243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~elltg~~p~~~~~ 316 (441)
++.++.+||+|||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 233 ~~~~~~ikl~DfG~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 233 LDDNMQIRLSDFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp ECTTCCEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECCCCCEEEEecCcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999764322 223456899999999998643 58889999999999999999999996432
Q ss_pred CCCCceeecccccccchhhhhhhhcCcccccc--CChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 317 PSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQ--YPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ...+..+........ .....+..+.+||.+||+.||++|||+.+++++
T Consensus 310 ~----------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 310 Q----------------ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp H----------------HHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H----------------HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 011111111111000 001234568899999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=340.81 Aligned_cols=253 Identities=21% Similarity=0.304 Sum_probs=202.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch----HHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI----QGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
.++|++.+.||+|+||.||+|.. ..+++.||+|++..... .....+.+|+.+++.++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLD---------SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEB---------TTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEE---------CCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 47899999999999999999944 34588999999875432 235678899999999999999999999
Q ss_pred EEe--CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 174 CWE--DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 174 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
+.. ....++||||+.++ |.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~kl 150 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKI 150 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEE
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEEe
Confidence 853 45789999999887 777776543 3568999999999999999999997 89999999999999999999999
Q ss_pred ecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCC--CccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHL--YVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
+|||++................||+.|+|||++.+... +.++||||||+++|+|++|..||.....
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------ 218 (305)
T 2wtk_C 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------------ 218 (305)
T ss_dssp CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------------
T ss_pred eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------------
Confidence 99999986543333334455679999999999976543 6799999999999999999999964321
Q ss_pred ccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+... ....+..++..+.+||.+||+.||++|||+.+++++
T Consensus 219 ----~~~~~~i~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 219 ----YKLFENIGKG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----HHHHHHHHHC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----HHHHHHHhcC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111111111 112344566778899999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=341.72 Aligned_cols=247 Identities=19% Similarity=0.242 Sum_probs=199.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcC-CCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKF-SHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 174 (441)
.++|++.+.||+|+||+||+|... .+++.||||.+... .......+.+|+.++..+ +||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~ 80 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKR---------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEc---------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 468999999999999999999543 35889999988653 233456778899999999 899999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC-------
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGS-AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS------- 246 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~------- 246 (441)
.+.+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC---------
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCcccc
Confidence 999999999999999999999976421 2458999999999999999999997 899999999999999844
Q ss_pred ------------CceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCC
Q 013519 247 ------------YNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALD 313 (441)
Q Consensus 247 ------------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~ 313 (441)
..+||+|||+++..... ....||+.|+|||++.+. .++.++|||||||++|+|++|..++.
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred cccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 47999999999764321 224589999999999876 56689999999999999999987653
Q ss_pred CCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 314 TNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
... ....+... .....+..++..+.+||.+||+.||++|||+.+++++
T Consensus 233 ~~~-------------------~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 233 NGD-------------------QWHEIRQG-RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp SSH-------------------HHHHHHTT-CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred chh-------------------HHHHHHcC-CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 210 01111111 1123344566778999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=341.50 Aligned_cols=256 Identities=26% Similarity=0.420 Sum_probs=206.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||.||+|.... +..||+|.+..... ..+.+.+|+.+|+.++||||+++++++. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 79 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHhhhheeeecCCCCeEEEEEEEcC----------CcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-C
Confidence 4678999999999999999996542 56899999876542 2467889999999999999999999876 4
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCcEEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 56899999999999999986432 1258899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----------------~~~ 219 (279)
T 1qpc_A 157 RLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----------------PEV 219 (279)
T ss_dssp EECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHH
T ss_pred ccccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH----------------HHH
Confidence 7643211 111223456788999999999999999999999999999999 8999864321 111
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
...+. .......+..++..+.+|+.+||..||++|||+.++++.|+.+.
T Consensus 220 ~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 220 IQNLE-RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp HHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHh-cccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 11111 11222334556677899999999999999999999999998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=376.72 Aligned_cols=252 Identities=27% Similarity=0.379 Sum_probs=202.0
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLL 182 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 182 (441)
+.||+|+||+||+|.+... ..++.||||+++.... ...+.+.+|+.+|++++|||||++++++.. +.++|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEECS-------SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CEeccCCCEEEEEEEEcCC-------CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 4799999999999966432 2468999999876432 346789999999999999999999999864 55889
Q ss_pred EEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCC
Q 013519 183 VYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPI 262 (441)
Q Consensus 183 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~ 262 (441)
|||||++|+|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 447 v~E~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred EEEccCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 999999999999997543 58899999999999999999997 8999999999999999999999999999986433
Q ss_pred CCCc-ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 263 DGNS-HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 263 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
.... .......||+.|+|||++.+..++.++|||||||+||||++ |+.||..... ..+...
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----------------~~~~~~ 584 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAM 584 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHH
Confidence 2211 12233457889999999999999999999999999999998 9999965321 111122
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
+........+..++..+.+||.+||+.||++||++.+|++.|+.+-
T Consensus 585 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 585 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2222233456667788999999999999999999999999998653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=358.17 Aligned_cols=267 Identities=23% Similarity=0.332 Sum_probs=197.9
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
...++|.+.+.||+|+||+||+|.. ..+++.||||++..... ...+|+.+|+.++||||+++++++.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~---------~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~ 70 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFD---------IESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFY 70 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEE---------TTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccceEEEEEEEEeccCEEEEEEEE---------CCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheee
Confidence 3457899999999999999999944 44589999998865432 2346999999999999999999985
Q ss_pred e--------------------------------------CCeEEEEEeecCCCCHHHHHHhc-CCCCCCCHHHHHHHHHH
Q 013519 176 E--------------------------------------DRQFLLVYEYMQKGSLENHLFRK-GSAEPLPWNTRLKIAID 216 (441)
Q Consensus 176 ~--------------------------------------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ 216 (441)
. ...+++||||+++ +|.+.+... .....+++..++.++.|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~q 149 (383)
T 3eb0_A 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQ 149 (383)
T ss_dssp EC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence 4 3348999999984 877777541 22356899999999999
Q ss_pred HHHHHhhhccCCCCeeecCCCCCcEEEc-CCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCcccc
Q 013519 217 AAKDLTFLHSSEKSVIYRDFKASNILLD-GSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSD 294 (441)
Q Consensus 217 i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D 294 (441)
++.||.|||+ .||+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+. .++.++|
T Consensus 150 i~~aL~~LH~--~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 224 (383)
T 3eb0_A 150 LFRAVGFIHS--LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSID 224 (383)
T ss_dssp HHHHHHHHHT--TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHHH
T ss_pred HHHHHHHHHH--CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcchh
Confidence 9999999997 9999999999999998 6889999999999854322 223446789999999998875 4899999
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCCCcee-ec-ccccccchhhhh---------hhhcCccccccCChhhHHHHHHHHHH
Q 013519 295 VYGFGVVLLEMLTGLRALDTNRPSGEHVL-VD-FARPSLTDKRRL---------KKIMDPRLEEQYPIKGALLAGQIIIK 363 (441)
Q Consensus 295 vwSlG~il~elltg~~p~~~~~~~~~~~~-~~-~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~li~~ 363 (441)
||||||++|||++|+.||........... .. ...+........ .......+...++...+..+.+||.+
T Consensus 225 iwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 304 (383)
T 3eb0_A 225 LWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ 304 (383)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred hhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence 99999999999999999975432110000 00 000000000000 00001112223455567779999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 013519 364 CLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 364 ~l~~dp~~Rps~~eil~~ 381 (441)
||+.||++|||+.|+|+|
T Consensus 305 ~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 305 ILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HCCSSGGGSCCHHHHHTS
T ss_pred HccCChhhCCCHHHHhcC
Confidence 999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=352.05 Aligned_cols=268 Identities=25% Similarity=0.360 Sum_probs=199.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 94 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNK---------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK 94 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEET---------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEEC---------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence 367999999999999999999543 45889999987543 2334556789999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 95 KKKRWYLVFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred cCCEEEEEEecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEEEEeCC
Confidence 999999999999999998876543 358999999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeec-ccccccch
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD-FARPSLTD 333 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~ 333 (441)
+++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||............. ........
T Consensus 170 ~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (331)
T 4aaa_A 170 FARTLAAP--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247 (331)
T ss_dssp TC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred CceeecCC--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 99753321 2223446799999999999875 78899999999999999999999996543211000000 00000000
Q ss_pred h-------hhhhhhcCccccc-----cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 334 K-------RRLKKIMDPRLEE-----QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 334 ~-------~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ........+.... .....++..+.+||.+||+.||++|||+.|+|++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0000000011100 0112356778999999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=346.30 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=200.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||.||+|... .+++.||+|++........+.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNK---------ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEET---------TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccceeecceeccCCCeEEEEEEEc---------CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 468999999999999999999554 34789999998776655677889999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 99999999999999999987643 358999999999999999999997 89999999999999999999999999987
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
..... .........||+.|+|||++. ...++.++||||||+++|+|++|..||......
T Consensus 165 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------- 228 (302)
T 2j7t_A 165 AKNLK--TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------------- 228 (302)
T ss_dssp HHHHH--HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------------
T ss_pred ccccc--cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--------------
Confidence 53110 111223457999999999984 567889999999999999999999999653210
Q ss_pred hhhhhhhhcCcc-ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPR-LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+.... .....+..++..+.+||.+||..||++|||+.+++++
T Consensus 229 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 229 --RVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --HHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --HHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111111110 1112234556678899999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=358.84 Aligned_cols=200 Identities=22% Similarity=0.301 Sum_probs=172.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC------CCCCccceE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF------SHPNLVKLI 171 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~ 171 (441)
..+|++.++||+|+||+||+|.. ..+++.||||++.... .....+.+|+.+++.+ .|+||++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~---------~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYD---------HKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEE---------TTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred cCcEEEEEEcccCccEEEEEEEE---------CCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 45799999999999999999954 3458899999997653 3345667788888776 578999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc--e
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN--A 249 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--~ 249 (441)
+++...+.+++||||+. ++|.+++..... ..+++..++.++.|++.||.|||+ .+|+||||||+||||+.++. +
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEESSTTSCCE
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEccCCCcce
Confidence 99999999999999996 699998876542 458999999999999999999997 89999999999999999887 9
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNR 316 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~ 316 (441)
||+|||+++.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 242 kL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 242 KVIDFGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EECCCTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEeecccceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999975321 2334689999999999999999999999999999999999999997543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=374.37 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=206.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 3457778899999999999997653 35799999876542 24678899999999999999999999866
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.++|||||+.+|+|.++|.... ...+++..++.++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred ccceEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 67899999999999999996532 1358899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+..... .........++..|+|||++.+..++.++|||||||+||||++ |+.||..... ...
T Consensus 411 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----------------~~~ 473 (535)
T 2h8h_A 411 RLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------REV 473 (535)
T ss_dssp TTCCCH-HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----------------HHH
T ss_pred eecCCC-ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----------------HHH
Confidence 864321 0111122456788999999999999999999999999999999 8999964321 111
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
+..+ ........+..++..+.+||.+||+.||++|||+.+|++.|+.+-
T Consensus 474 ~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 474 LDQV-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp HHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111 112222345567778999999999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=340.80 Aligned_cols=264 Identities=20% Similarity=0.227 Sum_probs=204.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEE-Ee
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYC-WE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~ 176 (441)
.++|++.+.||+|+||.||+|.. ..+++.||||++...... ..+.+|+.+++.++|++++..+.++ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTD---------IAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEE---------cCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 46899999999999999999954 345889999987654322 3577899999999988877766655 56
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE---cCCCceEEec
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL---DGSYNAKLSD 253 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~D 253 (441)
....++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~D 151 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred CCceEEEEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEEee
Confidence 77889999999 999999997543 468999999999999999999997 899999999999999 5888999999
Q ss_pred ccCCCCCCCCCCc-----ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccc
Q 013519 254 FGLAKLGPIDGNS-----HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 254 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 328 (441)
||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---- 227 (296)
T 3uzp_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY---- 227 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH----
T ss_pred CCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh----
Confidence 9999764332211 1124467999999999999999999999999999999999999999764322111000
Q ss_pred cccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
. ......... .....+..++..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 228 ---~--~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 228 ---E--RISEKKMST-PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp ---H--HHHHHHHHS-CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ---h--hhcccccCC-chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 0 000000000 0001123345668899999999999999999999999987653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=350.47 Aligned_cols=270 Identities=23% Similarity=0.300 Sum_probs=198.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++.+.||+|+||+||+|... .+++.||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHR---------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEET---------TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceeEEEEEecCCCcEEEEEEEC---------CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 57999999999999999999543 4588999998865432 223467789999999999999999999987
Q ss_pred --------CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 177 --------DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 177 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
.+.+++||||+.+ +|.+.+.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~ 162 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGV 162 (351)
T ss_dssp C--------CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSC
T ss_pred cccccccCCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCC
Confidence 4568999999975 7777775543 458999999999999999999997 89999999999999999999
Q ss_pred eEEecccCCCCCCCCCC--cceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-
Q 013519 249 AKLSDFGLAKLGPIDGN--SHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV- 324 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~- 324 (441)
+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............
T Consensus 163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999976432211 122344678999999999976 45789999999999999999999999754321100000
Q ss_pred ----cccccccchhhh--hhhhcCccccccCC-------hhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 325 ----DFARPSLTDKRR--LKKIMDPRLEEQYP-------IKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 325 ----~~~~~~~~~~~~--~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
......+..... ....+......... ...+..+.+||.+||+.||++|||+.|+|++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 000000000000 00000000000000 01145588999999999999999999999973
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=351.61 Aligned_cols=264 Identities=22% Similarity=0.276 Sum_probs=192.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|.. ..+++.||||++... .......+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYD---------AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEEEE---------CCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 36899999999999999999944 345889999998653 3445567889999999999999999999998
Q ss_pred eCC------eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 176 EDR------QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 176 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
... .+++||||+++ +|.+++. ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~~ 166 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL 166 (371)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCE
T ss_pred cccccccccceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCE
Confidence 665 78999999975 7888774 248899999999999999999997 899999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce--eeccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--LVDFA 327 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~~~~~ 327 (441)
||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.......... +....
T Consensus 167 kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 243 (371)
T 2xrw_A 167 KILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243 (371)
T ss_dssp EECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CC
T ss_pred EEEEeeccccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999975321 222345689999999999999999999999999999999999999997543210000 00000
Q ss_pred cc--cc----chh-------------hhhhhhcCccccc---cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RP--SL----TDK-------------RRLKKIMDPRLEE---QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~--~~----~~~-------------~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+ .+ ... ..+...+...... ..+...+..+.+||.+||+.||++|||+.++|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00 00 000 0000000000000 0012236778999999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=341.73 Aligned_cols=254 Identities=26% Similarity=0.329 Sum_probs=190.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||+||+|.. ..+++.||+|++..... ...+.+.++...++.++||||+++++++.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRH---------VPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEe---------cCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 46799999999999999999954 34588999999876522 22334555666688899999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHhhhccCCC-CeeecCCCCCcEEEcCCCceEEec
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRK-GSAEPLPWNTRLKIAIDAAKDLTFLHSSEK-SVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+.+..++||||+++ +|.+++... .....+++..++.++.|++.||.|||+ . ||+||||||+|||++.++.+||+|
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~D 153 (290)
T 3fme_A 77 REGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCD 153 (290)
T ss_dssp CSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HSCCCCCCCSGGGCEECTTCCEEBCC
T ss_pred ccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEee
Confidence 99999999999975 887777541 223568999999999999999999997 6 999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhh----hcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV----ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
||+++..... .......||+.|+|||++ .+..++.++|||||||++|+|++|..||.....
T Consensus 154 fg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------ 218 (290)
T 3fme_A 154 FGISGYLVDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------------ 218 (290)
T ss_dssp C------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------------
T ss_pred cCCccccccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------------
Confidence 9999754321 223335799999999996 566788999999999999999999999964211
Q ss_pred ccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+............+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 219 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 219 ---PFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ---HHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---hHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1111112222222222234456778899999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=341.93 Aligned_cols=253 Identities=26% Similarity=0.371 Sum_probs=200.6
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
..++|.+.+.||+|+||.||+|... .+++.||+|.+.... ..+.+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHK---------ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEET---------TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEEC---------CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 3468999999999999999999543 358899999986543 23567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
.+.+++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+|+||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 171 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGV 171 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeeccc
Confidence 999999999999999999987433 468999999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...... ........||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....
T Consensus 172 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------------~~~~ 236 (314)
T 3com_A 172 AGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-------------AIFM 236 (314)
T ss_dssp CEECBTT--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-------------HHHH
T ss_pred chhhhhh--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-------------HHHH
Confidence 9753221 122334579999999999999999999999999999999999999996432100 0000
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+... .......+...+..+.+||.+||..||.+|||+.+++++
T Consensus 237 ~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 237 IPTN--PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHS--CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HhcC--CCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000 111111234456678899999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=349.97 Aligned_cols=255 Identities=26% Similarity=0.362 Sum_probs=197.5
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCccceEEEE
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLVKLIGYC 174 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 174 (441)
...++|++.+.||+|+||.||+|... .+++.||||++..... ....+.+|+.+++++ +||||+++++++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEEC---------CCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 34678999999999999999999543 3478999998865432 235678899999998 799999999999
Q ss_pred Ee------CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 175 WE------DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 175 ~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
.. ...+++||||+++++|.+++.... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCCCC
Confidence 87 468999999999999999997643 2468899999999999999999997 89999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~ 323 (441)
+||+|||++...... ........||+.|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 168 ~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----- 240 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----- 240 (326)
T ss_dssp EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----
T ss_pred EEEeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----
Confidence 999999999754221 12234467999999999987 567889999999999999999999999643210
Q ss_pred ecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+..+.........+..++..+.+||.+||..||++||++.+++++
T Consensus 241 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 241 -----------RALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp -----------HHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -----------HHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111111111111233455678899999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=354.49 Aligned_cols=254 Identities=13% Similarity=0.022 Sum_probs=184.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHH---HHHhcCCCCCccceE-
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEV---KFLGKFSHPNLVKLI- 171 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~---~~l~~l~hpniv~~~- 171 (441)
.+|.+.+.||+|+||+||+|.+. .+++.||||++..... ...+.+.+|+ .+|+. +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDV---------ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred eeeeeeeeccCCCCEEEEEEEEC---------CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 45888999999999999999543 3488999999877542 3456677784 55555 799988755
Q ss_pred ------EEEEeC-----------------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHH------HHHHHHHHHHHh
Q 013519 172 ------GYCWED-----------------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTR------LKIAIDAAKDLT 222 (441)
Q Consensus 172 ------~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~ 222 (441)
+++... ..+|||||||+ |+|.+++...+. .+++..+ +.++.|++.||.
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~ 208 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAA 208 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHH
Confidence 555443 33899999998 899999986432 2344555 678899999999
Q ss_pred hhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc--CCCCccccchhHHH
Q 013519 223 FLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT--GHLYVKSDVYGFGV 300 (441)
Q Consensus 223 ~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~ 300 (441)
|||+ +||+||||||+|||++.++.+||+|||+++... .......+|+.|+|||++.+ ..++.++|||||||
T Consensus 209 ~LH~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~ 281 (371)
T 3q60_A 209 NLQS--KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281 (371)
T ss_dssp HHHH--TTEEETTCSGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred HHHH--CCCccCcCCHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence 9997 999999999999999999999999999998532 22224567799999999987 78999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 013519 301 VLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380 (441)
Q Consensus 301 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~ 380 (441)
++|||++|+.||....+.....+..... ...............++..+.+||.+||+.||++|||+.++|+
T Consensus 282 il~elltg~~Pf~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSL---------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHHSSCSTTBCCTTCTTCCCBCCT---------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHHHhCCCCCCCcCcccccchhhhhh---------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999999999997764432211110000 0000111111112345677889999999999999999999997
Q ss_pred H
Q 013519 381 T 381 (441)
Q Consensus 381 ~ 381 (441)
+
T Consensus 353 h 353 (371)
T 3q60_A 353 T 353 (371)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=345.95 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=196.8
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--------HHHHHHHHHHHHHhcCCCCCcc
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--------QGLREWQAEVKFLGKFSHPNLV 168 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv 168 (441)
..++|.+.+.||+|+||.||+|... .+++.||||.+..... .....+.+|+.+|+.++||||+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 78 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFER---------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBC
T ss_pred hhhceeEeeEEecCCCEEEEEEEEc---------CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCc
Confidence 3568999999999999999999543 4588999999865421 2234578899999999999999
Q ss_pred ceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 169 KLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 169 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
++++++..+. .++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.
T Consensus 79 ~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 79 KIKNFFDAED-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp CEEEEEESSS-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSS
T ss_pred eEeeEEcCCc-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCC
Confidence 9999987655 89999999999999988643 458999999999999999999997 89999999999999987664
Q ss_pred ---eEEecccCCCCCCCCCCcceEeeeccccccCcchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce
Q 013519 249 ---AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV 322 (441)
Q Consensus 249 ---~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~ 322 (441)
+||+|||+++.... ........||+.|+|||++. ...++.++|||||||++|+|++|..||.........
T Consensus 153 ~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~- 228 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL- 228 (322)
T ss_dssp SCCEEECCCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH-
T ss_pred CCeEEEccCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH-
Confidence 99999999975421 22223467999999999974 467889999999999999999999999654321110
Q ss_pred eecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+.... .......+...+..+.+||.+||..||++||++.+++++
T Consensus 229 -----------~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 229 -----------KDQITSGK-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -----------HHHHHHTC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----------HHHHHhCc-cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 00010000 000001112345668899999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=335.47 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=196.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|.+.+.||+|+||.||+|... .+++.||||.+..... .....+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQ---------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEEC---------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 368999999999999999999543 3588999999865422 2345788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
...+..++||||+++++|.+++...+ .+++..++.++.|++.||.|||+ .||+|+||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH--HCSSCCCCCGGGEEECTTSCEEECCC
T ss_pred ecCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChhhEEECCCCCEEEeec
Confidence 99999999999999999999997654 48899999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
|++..... ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 156 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------------- 216 (276)
T 2h6d_A 156 GLSNMMSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---------------- 216 (276)
T ss_dssp CGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------
T ss_pred ccccccCC---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH----------------
Confidence 99976432 122344578999999999988766 5899999999999999999999964311
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+... ....+...+..+.++|.+||+.||++|||+.+++++
T Consensus 217 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 217 PTLFKKIRGG--VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhhcC--cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0011111110 012344456678899999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=338.15 Aligned_cols=251 Identities=27% Similarity=0.319 Sum_probs=203.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---------hHHHHHHHHHHHHHhcCC-CCCc
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---------IQGLREWQAEVKFLGKFS-HPNL 167 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~E~~~l~~l~-hpni 167 (441)
.++|++.+.||+|+||.||+|.. ..+++.||||++.... ....+.+.+|+.+++++. ||||
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i 86 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIH---------KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred hhccceeeeecCCCceEEEEEEE---------cCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence 46899999999999999999954 3458899999986542 123456788999999996 9999
Q ss_pred cceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 168 VKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 168 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
+++++++......++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDM 161 (298)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTC
T ss_pred eeeeeeeccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcCCC
Confidence 999999999999999999999999999997653 58899999999999999999997 8999999999999999999
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhh------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCc
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA------TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~ 321 (441)
.+||+|||++...... .......||+.|+|||++. ...++.++||||||+++|+|++|..||.....
T Consensus 162 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---- 234 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---- 234 (298)
T ss_dssp CEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred cEEEecccchhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH----
Confidence 9999999999754322 2234467999999999985 45678999999999999999999999964321
Q ss_pred eeecccccccchhhhhhhhcCccc--cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+..... ........+..+.+|+.+||+.||++|||+.+++++
T Consensus 235 ------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 235 ------------MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp ------------HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ------------HHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 011111111111 111123456678899999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=353.23 Aligned_cols=265 Identities=21% Similarity=0.251 Sum_probs=201.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC--------CCCccc
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS--------HPNLVK 169 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~ 169 (441)
.++|++.+.||+|+||+||+|+. ..+++.||||++.... ...+.+.+|+.+|+.++ ||||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWD---------IQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred CCeEEEEEEeeecCCeeEEEEEe---------cCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 36899999999999999999944 3458899999997553 34567889999999885 788999
Q ss_pred eEEEEE----eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCC-CeeecCCCCCcEEEc
Q 013519 170 LIGYCW----EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEK-SVIYRDFKASNILLD 244 (441)
Q Consensus 170 ~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivHrDlkp~Nill~ 244 (441)
+++++. ....+++||||+ +++|.+++.... ...+++..++.++.|++.||.|||+ + ||+||||||+||||+
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIll~ 181 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLS 181 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEEEC
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHeeEe
Confidence 999987 456799999999 667777766543 2468999999999999999999997 7 999999999999998
Q ss_pred CCC-------------------------------------------------ceEEecccCCCCCCCCCCcceEeeeccc
Q 013519 245 GSY-------------------------------------------------NAKLSDFGLAKLGPIDGNSHVTTRIMGT 275 (441)
Q Consensus 245 ~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt 275 (441)
.++ .+||+|||+++.... ......||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt 256 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQT 256 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSC
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCC
Confidence 775 799999999975422 13345799
Q ss_pred cccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-------ccccc--------------ccchh
Q 013519 276 YGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-------DFARP--------------SLTDK 334 (441)
Q Consensus 276 ~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-------~~~~~--------------~~~~~ 334 (441)
+.|+|||++.+..++.++|||||||++|||++|+.||............ ..... .+...
T Consensus 257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence 9999999999999999999999999999999999999764432210000 00000 00000
Q ss_pred hhhhhhcCc---------cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 335 RRLKKIMDP---------RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 335 ~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+... ......+...+..+.+||.+||+.||++|||+.|+|++
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000000000 00012355667789999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.57 Aligned_cols=260 Identities=19% Similarity=0.255 Sum_probs=199.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEEEEe-
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGYCWE- 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~- 176 (441)
++|++.+.||+|+||+||+|.. ..+++.||||++..... +.+.+|+.+|+.++ ||||+++++++.+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 103 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAIN---------ITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDP 103 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEECSCCH---HHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CceEEEEEecccCCeEEEEEEE---------CCCCcEEEEEEecccch---HHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence 5799999999999999999954 34588999999986553 56788999999997 9999999999988
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC-ceEEecc
Q 013519 177 -DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY-NAKLSDF 254 (441)
Q Consensus 177 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DF 254 (441)
....++||||+.+++|.+++. .+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .+||+||
T Consensus 104 ~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~~kl~Df 175 (330)
T 3nsz_A 104 VSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDW 175 (330)
T ss_dssp TTCCEEEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCCceEEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence 667899999999999999883 37889999999999999999997 8999999999999999776 8999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeec---ccccc
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD---FARPS 330 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~---~~~~~ 330 (441)
|+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||............. ...+.
T Consensus 176 g~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~ 252 (330)
T 3nsz_A 176 GLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252 (330)
T ss_dssp TTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred CCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCch
Confidence 9997543222 2344578999999999987 678999999999999999999999995432211100000 00000
Q ss_pred cc---------hhhhhhhhcC--------ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 331 LT---------DKRRLKKIMD--------PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 331 ~~---------~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+. .......... .......+...+..+.+||.+||+.||++|||+.|+|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0000000000 000111122356778999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=361.34 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=193.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC-
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED- 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 177 (441)
.+|.+.++||+|+||+||+|... .+++.||||++..... .+.+|+.+|+.++|||||+++++|...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~---------~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLC---------DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEEC---------CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 46888999999999999999554 3488999998865432 234699999999999999999998642
Q ss_pred -----CeEEEEEeecCCCCHHHHHHh-cCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC-CceE
Q 013519 178 -----RQFLLVYEYMQKGSLENHLFR-KGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS-YNAK 250 (441)
Q Consensus 178 -----~~~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~k 250 (441)
..+++||||+++ +|.+.+.. ......+++..++.++.|++.||.|||+ .||+||||||+||||+.+ +.+|
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~~k 197 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLK 197 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTEEE
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCeEE
Confidence 236799999986 56665543 1223568999999999999999999997 999999999999999965 6789
Q ss_pred EecccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-eec-cc
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-LVD-FA 327 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~-~~ 327 (441)
|+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... +.. ..
T Consensus 198 l~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg 274 (420)
T 1j1b_A 198 LCDFGSAKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 274 (420)
T ss_dssp ECCCTTCEECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eccchhhhhcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999864322 122346789999999999765 78999999999999999999999997643211000 000 00
Q ss_pred ccccchhhhhhhhcCc-------------cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTDKRRLKKIMDP-------------RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+. ...+..+ .+ .+...++...+..+.+||.+||..||++||++.|+++|
T Consensus 275 ~p~---~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 275 TPT---REQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp SCC---HHHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCC---HHHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000 0001000 11 01111233456789999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=354.61 Aligned_cols=259 Identities=27% Similarity=0.382 Sum_probs=204.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc----hHHHHHHHHHHHHHhcC-CCCCccceEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS----IQGLREWQAEVKFLGKF-SHPNLVKLIGY 173 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~~~~~ 173 (441)
++|++.+.||+|+||+||+|+... ...+++.||||++.... ......+.+|+.+|+.+ .||||++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKIS------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECS------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEcc------cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 579999999999999999996632 12358899999986532 12234566799999999 69999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+.....+++||||+++|+|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~D 202 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTD 202 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESC
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEEee
Confidence 999999999999999999999997654 48899999999999999999997 8999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccccc
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
||+++..... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 203 fG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---------- 271 (355)
T 1vzo_A 203 FGLSKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---------- 271 (355)
T ss_dssp SSEEEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----------
T ss_pred CCCCeecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH----------
Confidence 9999754221 1222334679999999999986 34789999999999999999999999654321110
Q ss_pred chhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHh
Q 013519 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLETLQ 383 (441)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~L~ 383 (441)
......+.. ....++...+..+.+||.+||..||++|| ++.+++++..
T Consensus 272 --~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 272 --AEISRRILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp --HHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred --HHHHHHHhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 000111111 11234455667788999999999999999 9999998753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=353.70 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=184.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|.. ..+++.||||++... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFD---------TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEE---------TTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEEEE---------CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 46899999999999999999944 345889999998653 3345667889999999999999999999987
Q ss_pred eC------CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 176 ED------RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 176 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
.. ..+|+||||+ +++|.+++.. ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~ 171 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCEL 171 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCE
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCCE
Confidence 54 5689999999 6899888854 358999999999999999999997 999999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ec-c
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VD-F 326 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~-~ 326 (441)
||+|||+++... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... .. .
T Consensus 172 kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 246 (367)
T 2fst_X 172 KILDFGLARHTA-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246 (367)
T ss_dssp EECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEeecccccccc-----ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999998532 12345689999999999987 6789999999999999999999999975432110000 00 0
Q ss_pred cccc------cch--hhhhhhhcCc----cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 327 ARPS------LTD--KRRLKKIMDP----RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 327 ~~~~------~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+. +.. ...+...+.. .+. ......+..+.+||.+||..||++|||+.++|++
T Consensus 247 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHhhhHHHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 000 0000000000 000 0012335668899999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=344.80 Aligned_cols=265 Identities=23% Similarity=0.363 Sum_probs=186.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||.||+|.. ..+++.||||.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYC---------APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEEES
T ss_pred hhhhhhhheeccccceEEEEEEE---------CCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 46899999999999999999944 3347899999887653 2345678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhc-----CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRK-----GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEEE
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCEEE
Confidence 99999999999999999998641 123458999999999999999999997 89999999999999999999999
Q ss_pred ecccCCCCCCCCCC---cceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 252 SDFGLAKLGPIDGN---SHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 252 ~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............ ..
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~ 241 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT-LQ 241 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-HT
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH-hc
Confidence 99999875432211 112234679999999999876 56899999999999999999999999754321100000 00
Q ss_pred ccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ... ..............++..+.+|+.+||+.||.+||++.+++++
T Consensus 242 ~-~~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 N-DPP------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp S-SCC------CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred c-CCC------ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 000 0000000111223445668899999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=349.77 Aligned_cols=273 Identities=23% Similarity=0.290 Sum_probs=189.8
Q ss_pred HHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEE
Q 013519 93 DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIG 172 (441)
Q Consensus 93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 172 (441)
......++|.+.+.||+|+||+||+|... .+++.||||++..... ......+|+..+..++||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~ 86 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEK---------STGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQS 86 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEET---------TTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEE
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHH
Confidence 44566789999999999999999999543 4588999998754422 1234556888888899999999999
Q ss_pred EEEeCCe-------EEEEEeecCCCCHHHHHHh-cCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc
Q 013519 173 YCWEDRQ-------FLLVYEYMQKGSLENHLFR-KGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD 244 (441)
Q Consensus 173 ~~~~~~~-------~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 244 (441)
++..... +++||||+.+ +|...+.. ......+++..+..++.|++.||.|||.+..||+||||||+|||++
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~ 165 (360)
T 3e3p_A 87 YFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN 165 (360)
T ss_dssp EEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE
T ss_pred hhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe
Confidence 9976433 8899999986 45444432 2334568899999999999999999995459999999999999999
Q ss_pred C-CCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCCce
Q 013519 245 G-SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH-LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV 322 (441)
Q Consensus 245 ~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~ 322 (441)
. ++.+||+|||+++..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-- 240 (360)
T 3e3p_A 166 EADGTLKLCDFGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-- 240 (360)
T ss_dssp TTTTEEEECCCTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--
T ss_pred CCCCcEEEeeCCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--
Confidence 6 899999999999864322 2233467899999999997654 89999999999999999999999975432110
Q ss_pred eecccccc-cchhhhhhhhcC---------------ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 323 LVDFARPS-LTDKRRLKKIMD---------------PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 323 ~~~~~~~~-~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+....... ......+..+.. .......+...+..+.+||.+||+.||++|||+.|+|+|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000 000000000000 000011223356789999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=348.79 Aligned_cols=268 Identities=23% Similarity=0.309 Sum_probs=201.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
..+|++.+.||+|+||.||+|+. ..+++.||||++.... ....+.+.+|+.+|++++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYD---------NLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccEEEEEEeecCCCeEEEEEEE---------CCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 35899999999999999999954 3458899999987543 3445778899999999999999999999976
Q ss_pred C-----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 177 D-----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 177 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
. ...++||||+.+ +|.+++... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl 169 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKI 169 (364)
T ss_dssp SSTTTCCCEEEEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEE
T ss_pred CCccccceEEEEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCCCCEEE
Confidence 4 468999999974 899988653 48899999999999999999997 89999999999999999999999
Q ss_pred ecccCCCCCCCCCCc-ceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-c-cc
Q 013519 252 SDFGLAKLGPIDGNS-HVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-D-FA 327 (441)
Q Consensus 252 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-~-~~ 327 (441)
+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||............ . ..
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 249 (364)
T 3qyz_A 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249 (364)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence 999999764322111 112345899999999987654 5899999999999999999999999754322110000 0 00
Q ss_pred ccccch--------hhhh-hhhcCcc--ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTD--------KRRL-KKIMDPR--LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~--------~~~~-~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+.... .... ....... .........+..+.+||.+||+.||++|||+.++|++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000 0000000 0001112345678899999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=339.49 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=200.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCC--CCCccceEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFS--HPNLVKLIGY 173 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~--hpniv~~~~~ 173 (441)
.++|++.+.||+|+||.||+|... .++.||||++... .......+.+|+.++.+++ ||||++++++
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 467999999999999999999543 2778999988644 3445678899999999997 5999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+...+.+++||| +.+++|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+|||+++ +.+||+|
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEEECC
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEEEee
Confidence 999999999999 56889999997653 58899999999999999999997 89999999999999975 8999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-----------GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV 322 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~ 322 (441)
||+++...............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----- 244 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----- 244 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----
Confidence 999986543322223345679999999999875 4788899999999999999999999964311
Q ss_pred eecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 013519 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382 (441)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L 382 (441)
....+..+.++.....++...+..+.+||.+||+.||++||++.+++++-
T Consensus 245 ----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 245 ----------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp ----------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ----------HHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 11222333344333444555567789999999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=355.96 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=192.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|.+.++||+|+||+||+|.... +..+|+|++..... ...+|+.+|+.++||||+++++++....
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~----------~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVE----------SDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred ceEEEeEEEeeCCCeEEEEEEECC----------CCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 579999999999999999996543 23488887654322 1236999999999999999999996543
Q ss_pred ------eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc-CCCceEE
Q 013519 179 ------QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD-GSYNAKL 251 (441)
Q Consensus 179 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~kl 251 (441)
.+++||||++++.+............+++..++.++.|++.||.|||+ .||+||||||+|||++ .++.+||
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~kL 183 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVLKL 183 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEE
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcEEE
Confidence 388999999875444433322233568999999999999999999997 8999999999999999 7999999
Q ss_pred ecccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ec-ccc
Q 013519 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VD-FAR 328 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~-~~~ 328 (441)
+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........... .. ...
T Consensus 184 ~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 260 (394)
T 4e7w_A 184 IDFGSAKILIAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260 (394)
T ss_dssp CCCTTCEECCTT---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeCCCcccccCC---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999864322 223346789999999999765 589999999999999999999999976432110000 00 000
Q ss_pred cccchhhhhh-hhc--------CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 PSLTDKRRLK-KIM--------DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~~~~~~~~~~-~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+......... ... ...+...++...+..+.+||.+||+.||.+|||+.|+++|
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000000 000 0011112333456789999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=358.27 Aligned_cols=259 Identities=21% Similarity=0.266 Sum_probs=203.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCC-CCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSH-PNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~ 176 (441)
.++|++.++||+|+||.||+|.. ..+++.||||++...... ..+.+|+.+++.+.| ++|..+..++..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~---------~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTN---------IQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEE---------TTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEE---------CCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 46899999999999999999954 345889999987654322 346789999999986 556666666777
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE---cCCCceEEec
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL---DGSYNAKLSD 253 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~D 253 (441)
....+|||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+ .+||||||||+|||| +.++.+||+|
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL~D 149 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIID 149 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred CCEEEEEEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEEEe
Confidence 88999999999 999999997543 468999999999999999999997 899999999999999 6889999999
Q ss_pred ccCCCCCCCCCCc-----ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccc
Q 013519 254 FGLAKLGPIDGNS-----HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 254 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 328 (441)
||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||.........
T Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~------- 222 (483)
T 3sv0_A 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK------- 222 (483)
T ss_dssp CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH-------
T ss_pred CCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH-------
Confidence 9999864432221 1123568999999999999999999999999999999999999999764322110
Q ss_pred cccchhhhhhhhcCccc---cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 329 PSLTDKRRLKKIMDPRL---EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
..+..+..... .......++.++.+||.+||+.+|++||++.+|++.|+.+
T Consensus 223 ------~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 223 ------QKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp ------HHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ------HHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111111100 0011123456788999999999999999999999988765
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=346.12 Aligned_cols=201 Identities=26% Similarity=0.308 Sum_probs=172.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CC-----CccceE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HP-----NLVKLI 171 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~~~ 171 (441)
.++|++.+.||+|+||+||+|.. ..+++.||||++.... .....+..|+.+++.+. |+ +|++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYD---------RVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEE---------cCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 46899999999999999999954 3458899999997543 33566778999888875 55 499999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc--CCCce
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD--GSYNA 249 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~--~~~~~ 249 (441)
+++...+.+++||||+. ++|.+++.... ...+++..++.++.|++.||.|||+++.||+||||||+|||++ .++.+
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCE
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcE
Confidence 99999999999999996 59999987653 2458999999999999999999997668999999999999994 57889
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~ 315 (441)
||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 201 kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 201 KIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEeccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999986422 123467999999999999999999999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=351.35 Aligned_cols=272 Identities=21% Similarity=0.296 Sum_probs=184.8
Q ss_pred cCCCC-CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEe-
Q 013519 99 KNFRP-DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE- 176 (441)
Q Consensus 99 ~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 176 (441)
+.|.+ .++||+|+||+||+|..... .+++.||||++...... ..+.+|+.+|+.++||||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~-------~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDG-------KDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSS-------SCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccC-------CCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 44665 55899999999999965421 24788999998765432 457789999999999999999999965
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhcC------CCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE----cC
Q 013519 177 -DRQFLLVYEYMQKGSLENHLFRKG------SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL----DG 245 (441)
Q Consensus 177 -~~~~~lv~e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~ 245 (441)
...+++||||+.+ +|.+++.... ....+++..++.++.|++.||.|||+ .+|+||||||+|||| +.
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 91 ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp TTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSSTT
T ss_pred CCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCCC
Confidence 6789999999975 7888775321 12348999999999999999999997 899999999999999 77
Q ss_pred CCceEEecccCCCCCCCCCC-cceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee
Q 013519 246 SYNAKLSDFGLAKLGPIDGN-SHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323 (441)
Q Consensus 246 ~~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~ 323 (441)
++.+||+|||+++....... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 247 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence 78999999999986432211 1223456899999999999874 589999999999999999999999975433210000
Q ss_pred e-----------ccccc---ccc------hhhhhhhhcCccccc---------cCChhhHHHHHHHHHHhcccCCCCCCC
Q 013519 324 V-----------DFARP---SLT------DKRRLKKIMDPRLEE---------QYPIKGALLAGQIIIKCLEAEPKNRPS 374 (441)
Q Consensus 324 ~-----------~~~~~---~~~------~~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps 374 (441)
. ....+ .+. ....+...+...... ......+..+.+||.+||+.||.+|||
T Consensus 248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t 327 (405)
T 3rgf_A 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327 (405)
T ss_dssp CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence 0 00000 000 000000000000000 001112456789999999999999999
Q ss_pred HHHHHHHH
Q 013519 375 MEEVLETL 382 (441)
Q Consensus 375 ~~eil~~L 382 (441)
+.|+|+|-
T Consensus 328 a~e~L~hp 335 (405)
T 3rgf_A 328 SEQAMQDP 335 (405)
T ss_dssp HHHHHTSG
T ss_pred HHHHhcCh
Confidence 99999973
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=341.79 Aligned_cols=266 Identities=22% Similarity=0.298 Sum_probs=204.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCC------CccceE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP------NLVKLI 171 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp------niv~~~ 171 (441)
.++|++.+.||+|+||+||+|.... ..++.||||++.... ...+.+.+|+.+++.++|+ +|++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHK--------AGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecC--------CCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 3689999999999999999996532 247899999987653 3456788899999988655 599999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC------
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG------ 245 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~------ 245 (441)
+++...+.+++||||+ +++|.+++...+. .++++..++.++.|++.||.|||+ .||+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCEEEE
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEeccccccc
Confidence 9999999999999999 8899999976542 468899999999999999999997 89999999999999987
Q ss_pred -------------CCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCC
Q 013519 246 -------------SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRAL 312 (441)
Q Consensus 246 -------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~ 312 (441)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCCccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 66899999999975322 123467999999999999999999999999999999999999999
Q ss_pred CCCCCCCCceeecccccc---------------------cc----hhhhhhhhcCccc-cccCChhhHHHHHHHHHHhcc
Q 013519 313 DTNRPSGEHVLVDFARPS---------------------LT----DKRRLKKIMDPRL-EEQYPIKGALLAGQIIIKCLE 366 (441)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~---------------------~~----~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~ 366 (441)
.................. +. ..........+.. ....+...+..+.+||.+||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 754321100000000000 00 0000000010000 011234567789999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 013519 367 AEPKNRPSMEEVLET 381 (441)
Q Consensus 367 ~dp~~Rps~~eil~~ 381 (441)
.||.+|||+.|++++
T Consensus 315 ~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 315 YDPAKRITLREALKH 329 (339)
T ss_dssp SSTTTSCCHHHHTTS
T ss_pred cCcccccCHHHHhcC
Confidence 999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=335.06 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=195.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEe-
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE- 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 176 (441)
.++|++.+.||+|+||.||+|.. ..+++.||||.+... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 74 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARN---------ALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLER 74 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred cccchhhheeccCCcEEEEEEEE---------cCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhh
Confidence 46799999999999999999954 345889999998643 3445778899999999999999999998865
Q ss_pred ------------CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc
Q 013519 177 ------------DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD 244 (441)
Q Consensus 177 ------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 244 (441)
...+++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++
T Consensus 75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~~ 150 (303)
T 1zy4_A 75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFID 150 (303)
T ss_dssp CCCCC------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEC
T ss_pred cchhhhhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEEc
Confidence 356899999999999999997643 357789999999999999999997 8999999999999999
Q ss_pred CCCceEEecccCCCCCCCCC------------CcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCC
Q 013519 245 GSYNAKLSDFGLAKLGPIDG------------NSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRA 311 (441)
Q Consensus 245 ~~~~~kl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p 311 (441)
.++.+||+|||+++...... .........||+.|+|||++.+. .++.++|||||||++|+|++ |
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p 227 (303)
T 1zy4_A 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P 227 (303)
T ss_dssp TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence 99999999999997643211 01223446799999999999865 68899999999999999998 4
Q ss_pred CCCCCCCCCceeecccccccchhhhhhhh--cCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 312 LDTNRPSGEHVLVDFARPSLTDKRRLKKI--MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
|.... ........+ ....+...++...+..+.+||.+||+.||.+|||+.+++++
T Consensus 228 ~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 228 FSTGM---------------ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp CSSHH---------------HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCCch---------------hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 42110 000111111 11222333455566778899999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=368.91 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=207.8
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
..++|.+.+.||+|+||+||+|.+.... ..+..||||.+... .....+.+.+|+.+|++++||||+++++++.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPE------NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSS------SCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCC------CccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3467899999999999999999765321 23678999998764 3344567899999999999999999999884
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
++..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEecC
Confidence 566899999999999999997653 358899999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 537 ~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----------------~ 599 (656)
T 2j0j_A 537 LSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----------------N 599 (656)
T ss_dssp CCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------H
T ss_pred CCeecCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH----------------H
Confidence 998643221 122234567889999999999999999999999999999997 9999965321 0
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
..+..+.. ......+..++..+.+||.+||..||++|||+.++++.|+.+.
T Consensus 600 ~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 600 DVIGRIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp HHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHc-CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111111 1112345566778999999999999999999999999998764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=346.56 Aligned_cols=273 Identities=22% Similarity=0.303 Sum_probs=198.1
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-----------hHHHHHHHHHHHHH
Q 013519 91 LQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-----------IQGLREWQAEVKFL 159 (441)
Q Consensus 91 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~E~~~l 159 (441)
+.++....++|.+.+.||+|+||.||+|... .+..||||++.... ....+.+.+|+.+|
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 83 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHH
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHH
Confidence 4567778899999999999999999999542 27899999875421 22347789999999
Q ss_pred hcCCCCCccceEEEEEe-----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeec
Q 013519 160 GKFSHPNLVKLIGYCWE-----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYR 234 (441)
Q Consensus 160 ~~l~hpniv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHr 234 (441)
++++||||+++++++.. ...+++||||+. |+|.+++.... ..+++..++.++.|++.||.|||+ .||+||
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~ 158 (362)
T 3pg1_A 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHE--AGVVHR 158 (362)
T ss_dssp HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCC
T ss_pred HhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CcCEec
Confidence 99999999999999864 236899999998 58888886443 468999999999999999999997 899999
Q ss_pred CCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCC
Q 013519 235 DFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALD 313 (441)
Q Consensus 235 Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~ 313 (441)
||||+|||++.++.+||+|||+++.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 159 DLHPGNILLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp CCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCChHHEEEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999974322 222344679999999999987 678999999999999999999999997
Q ss_pred CCCCCCCce-eec-ccccccch-----hhhhhhhcCcccc-------ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 013519 314 TNRPSGEHV-LVD-FARPSLTD-----KRRLKKIMDPRLE-------EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379 (441)
Q Consensus 314 ~~~~~~~~~-~~~-~~~~~~~~-----~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil 379 (441)
......... +.. ...+.... ............. ...+...+..+.+||.+||+.||++|||+.+++
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 542110000 000 00000000 0000001100000 011223456688999999999999999999999
Q ss_pred HH
Q 013519 380 ET 381 (441)
Q Consensus 380 ~~ 381 (441)
++
T Consensus 316 ~h 317 (362)
T 3pg1_A 316 RH 317 (362)
T ss_dssp TS
T ss_pred cC
Confidence 86
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=339.59 Aligned_cols=268 Identities=25% Similarity=0.316 Sum_probs=195.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEE--
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCW-- 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-- 175 (441)
.++|++.+.||+|+||.||+|... .+++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDN---------DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEET---------TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEEC---------CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 368999999999999999999543 458899999988777777788999999999999999999999873
Q ss_pred ------------eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 176 ------------EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 176 ------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
+....++||||+. |+|.+++.. ..+++..++.++.|++.||.|||+ .||+||||||+|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~ 153 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFI 153 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEE
Confidence 3467899999998 599998853 358899999999999999999997 899999999999999
Q ss_pred c-CCCceEEecccCCCCCCCCCC-cceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCC
Q 013519 244 D-GSYNAKLSDFGLAKLGPIDGN-SHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGE 320 (441)
Q Consensus 244 ~-~~~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~ 320 (441)
+ .++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 233 (320)
T 2i6l_A 154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233 (320)
T ss_dssp ETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 7 567999999999986432111 111233567999999999876 6788999999999999999999999975432110
Q ss_pred ceeecccccccc--hhhhhhhhc--------C-cc-ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 321 HVLVDFARPSLT--DKRRLKKIM--------D-PR-LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 321 ~~~~~~~~~~~~--~~~~~~~~~--------~-~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
........+... ....+...+ . +. .........+..+.+||.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000000000000 000000000 0 00 0001122356678999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=351.59 Aligned_cols=269 Identities=16% Similarity=0.198 Sum_probs=202.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccc---------
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVK--------- 169 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~--------- 169 (441)
++|.+.+.||+|+||.||+|....+... .....++.||+|.+... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~-~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTC-DSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccc-cccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 5799999999999999999976542100 01113789999998754 35678999999999999887
Q ss_pred ------eEEEEEe-CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEE
Q 013519 170 ------LIGYCWE-DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNIL 242 (441)
Q Consensus 170 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 242 (441)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHE--NEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEE
Confidence 6777776 78899999999 999999997642 2468999999999999999999997 89999999999999
Q ss_pred EcCCC--ceEEecccCCCCCCCCCCc-----ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 013519 243 LDGSY--NAKLSDFGLAKLGPIDGNS-----HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315 (441)
Q Consensus 243 l~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~ 315 (441)
++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999764322111 1123357999999999999999999999999999999999999999754
Q ss_pred CCCCCceeecccccccchhhhhhhhcCccccc--cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 316 RPSGEHVLVDFARPSLTDKRRLKKIMDPRLEE--QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
........ .....+.... ..+.. ......+..+.+|+.+||+.||++||++.++++.|+.+.
T Consensus 272 ~~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 272 LPNTEDIM--------KQKQKFVDKP-GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TTCHHHHH--------HHHHHHHHSC-CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CcCHHHHH--------HHHHhccCCh-hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 32111000 0000000000 00100 001234567889999999999999999999999998765
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=344.51 Aligned_cols=268 Identities=24% Similarity=0.341 Sum_probs=199.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|.+.+.||+|+||.||+|... .+++.||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHK---------PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEEC---------CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 468999999999999999999543 358899999987543 3445678899999999999999999998765
Q ss_pred C-----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 177 D-----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 177 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
. ...++||||+. ++|.+++... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~~kl 153 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKV 153 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEE
T ss_pred cccCccceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCcEEE
Confidence 4 67899999997 5899988653 48899999999999999999997 89999999999999999999999
Q ss_pred ecccCCCCCCCCCCc--------ceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce
Q 013519 252 SDFGLAKLGPIDGNS--------HVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV 322 (441)
Q Consensus 252 ~DFGla~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~ 322 (441)
+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 233 (353)
T 2b9h_A 154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233 (353)
T ss_dssp CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999764322111 01223578999999998865 678899999999999999999999997543110000
Q ss_pred ee-cc-cccc------cchhhhhhhhcC--c----cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 323 LV-DF-ARPS------LTDKRRLKKIMD--P----RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 323 ~~-~~-~~~~------~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.. .. ..+. ............ + ..........+..+.+||.+||..||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00 0000 000000000000 0 00001122456678899999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=345.59 Aligned_cols=259 Identities=19% Similarity=0.313 Sum_probs=198.6
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
..++|++.+.||+|+||.||+|... ..+|+|++.... ....+.+.+|+.++++++||||+++++++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~------------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWH------------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEES------------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEc------------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 3578999999999999999999653 248899876542 22234567899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+...+++||||+++++|.+++...+ ..+++..++.++.|++.||.|||+ .||+||||||+|||++ ++.+||+||
T Consensus 99 ~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 99 MSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDF 173 (319)
T ss_dssp ECSSCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECCC
T ss_pred ecCCceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEeec
Confidence 99999999999999999999996543 468899999999999999999997 8999999999999998 679999999
Q ss_pred cCCCCCCCCC---CcceEeeeccccccCcchhhhc---------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce
Q 013519 255 GLAKLGPIDG---NSHVTTRIMGTYGYAAPEYVAT---------GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV 322 (441)
Q Consensus 255 Gla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~ 322 (441)
|+++...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---- 249 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---- 249 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH----
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 9987532111 1112233568999999999875 45788999999999999999999999653210
Q ss_pred eecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
.....+.........+..++..+.+|+.+||..||++|||+.++++.|+.+...
T Consensus 250 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 250 ------------AIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp ------------HHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ------------HHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 111111111111111223445588999999999999999999999999987643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=347.61 Aligned_cols=262 Identities=23% Similarity=0.315 Sum_probs=197.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||+||+|.. ..+++.||||++... .......+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAID---------KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEEEE---------CCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 46899999999999999999944 445889999998764 3344567889999999999999999999998
Q ss_pred eCCeE------EEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 176 EDRQF------LLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 176 ~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
..... ++||||+. ++|.+++. ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~ 183 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCEL 183 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCE
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCCE
Confidence 77654 99999997 58887762 348899999999999999999997 899999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-c-c
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-D-F 326 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-~-~ 326 (441)
||+|||+++... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ . .
T Consensus 184 kL~Dfg~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 258 (371)
T 4exu_A 184 KILDFGLARHAD-----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258 (371)
T ss_dssp EECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEEecCcccccc-----cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 999999997532 12344678999999999987 67899999999999999999999999754311000000 0 0
Q ss_pred ccc------ccch--hhhhhhhcCcccc---ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 327 ARP------SLTD--KRRLKKIMDPRLE---EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 327 ~~~------~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+ .+.. .......+..... .......+..+.+||.+||+.||++|||+.++|++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 0000 0000000000000 01122346678899999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=332.97 Aligned_cols=252 Identities=26% Similarity=0.341 Sum_probs=201.9
Q ss_pred HHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 96 AATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
...++|++.+.||+|+||.||+|... .+++.||+|++.... ......+.+|+.++++++||||++++++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDR---------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEc---------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEE
Confidence 44578999999999999999999543 357899999875432 2345678899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC---CceE
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS---YNAK 250 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~k 250 (441)
+.+...+++||||+.+++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.+ +.+|
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~k 164 (287)
T 2wei_A 90 LEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIK 164 (287)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred EeCCCeEEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEE
Confidence 999999999999999999999887654 48899999999999999999997 899999999999999754 4699
Q ss_pred EecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccc
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 330 (441)
|+|||+++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......
T Consensus 165 L~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------------ 228 (287)
T 2wei_A 165 IIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------------ 228 (287)
T ss_dssp ECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------------
T ss_pred EeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------------
Confidence 99999997543221 2234568999999998865 5899999999999999999999999653210
Q ss_pred cchhhhhhhhcCccccccC--ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 331 LTDKRRLKKIMDPRLEEQY--PIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.....+......... ....+..+.+||.+||..||++|||+.+++++
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 229 ----DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ----HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 011111111111011 12345678899999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=337.60 Aligned_cols=256 Identities=25% Similarity=0.327 Sum_probs=179.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHH-HHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVK-FLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~ 176 (441)
++|++.+.||+|+||.||+|... .+++.||||++.... ......+..|+. +++.++||||+++++++.+
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHK---------PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEET---------TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEc---------CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 67899999999999999999543 458899999986653 233445555655 7888899999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHh--cCCCCCCCHHHHHHHHHHHHHHHhhhccCCC-CeeecCCCCCcEEEcCCCceEEec
Q 013519 177 DRQFLLVYEYMQKGSLENHLFR--KGSAEPLPWNTRLKIAIDAAKDLTFLHSSEK-SVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
.+..++||||+.+ +|.+++.. ......+++..+..++.|++.||.|||+ . ||+||||||+|||++.++.+||+|
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl~D 169 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCD 169 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEEcc
Confidence 9999999999986 78777753 1123568999999999999999999997 7 999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhh----hcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV----ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
||+++..... .......||+.|+|||++ .+..++.++|||||||++|+|++|..||........... ...
T Consensus 170 fg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~-- 243 (327)
T 3aln_A 170 FGISGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT-QVV-- 243 (327)
T ss_dssp CSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C-CCC--
T ss_pred CCCceecccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH-HHh--
Confidence 9999754321 122334799999999998 466789999999999999999999999975322111100 000
Q ss_pred ccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+.+.......++..+.+|+.+||+.||++||++.+++++
T Consensus 244 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 244 ---------KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ---------CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---------cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000111111223455678899999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=336.82 Aligned_cols=268 Identities=25% Similarity=0.377 Sum_probs=199.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcC---CCCCccceEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKF---SHPNLVKLIG 172 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~~~~ 172 (441)
.++|++.+.||+|+||.||+|.... ..++.||+|++..... .....+.+|+.+++.+ .||||+++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~ 81 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 81 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred hhceeeeeeecccccEEEEEEEecC--------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeee
Confidence 4789999999999999999996532 2378999998754321 1112345677766665 8999999999
Q ss_pred EEE-----eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 173 YCW-----EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 173 ~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
++. ....+++||||+. |+|.+++..... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~~~ 157 (326)
T 1blx_A 82 VCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSG 157 (326)
T ss_dssp EEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTC
T ss_pred eeeecccCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcCCC
Confidence 987 4567899999998 599999876542 458999999999999999999997 8999999999999999999
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce-e---
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV-L--- 323 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~--- 323 (441)
.+||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... +
T Consensus 158 ~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 158 QIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp CEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CEEEecCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 999999999975421 122344678999999999999999999999999999999999999997543210000 0
Q ss_pred ------ecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 324 ------VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 324 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..|........... ..........+....+..+.+||.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGS-CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCCcccCccccccchhhh-cccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000000000 0000001112234456778899999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=340.40 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=174.6
Q ss_pred hcCCCCCc-eecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDT-MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|.+.+ +||+|+||+||+|... .+++.||||++..... ...+....++.+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHR---------RTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEEC---------CCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 46788854 6999999999999544 4588999999865421 12223344667789999999999876
Q ss_pred ----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC---CCce
Q 013519 177 ----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG---SYNA 249 (441)
Q Consensus 177 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~ 249 (441)
...+++|||||++|+|.+++..... ..+++..++.++.|++.||.|||+ .||+||||||+|||++. ++.+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~~ 170 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVL 170 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCE
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCceE
Confidence 4558999999999999999976542 468999999999999999999997 89999999999999976 4559
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
||+|||+++... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 171 kl~Dfg~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------ 240 (336)
T 3fhr_A 171 KLTDFGFAKETT----QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG------ 240 (336)
T ss_dssp EECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred EEeccccceecc----ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh------
Confidence 999999997532 1223456789999999999888999999999999999999999999965432210000
Q ss_pred ccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.. ..+ ..............++..+.+||.+||+.||++|||+.+++++
T Consensus 241 -~~--~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 241 -MK--RRI-RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp --------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -HH--Hhh-hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 000 0000011111123456678899999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=338.78 Aligned_cols=264 Identities=17% Similarity=0.242 Sum_probs=199.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-----------CCCc
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-----------HPNL 167 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpni 167 (441)
++|.+.+.||+|+||+||+|.. ..+++.||||++.... .....+.+|+.+++++. ||||
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKD---------MVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CeEEEEEeeeecCCeEEEEEEe---------cCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchH
Confidence 5799999999999999999944 3458899999997643 33466788999999886 8999
Q ss_pred cceEEEEEeCC----eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCC-CeeecCCCCCcEE
Q 013519 168 VKLIGYCWEDR----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEK-SVIYRDFKASNIL 242 (441)
Q Consensus 168 v~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivHrDlkp~Nil 242 (441)
+++++++...+ .+++||||+ +++|.+++..... ..+++..++.++.|++.||.|||+ + ||+||||||+|||
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~NIl 164 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVL 164 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChHHeE
Confidence 99999998654 789999999 8899999976432 458999999999999999999997 7 9999999999999
Q ss_pred Ec------CCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 013519 243 LD------GSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNR 316 (441)
Q Consensus 243 l~------~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~ 316 (441)
++ ..+.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EeccCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 94 445799999999975422 1234579999999999999999999999999999999999999997543
Q ss_pred CCCCce----eec-------ccccccchhhhhhhhcCc-------------------cccccCChhhHHHHHHHHHHhcc
Q 013519 317 PSGEHV----LVD-------FARPSLTDKRRLKKIMDP-------------------RLEEQYPIKGALLAGQIIIKCLE 366 (441)
Q Consensus 317 ~~~~~~----~~~-------~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~li~~~l~ 366 (441)
...... +.. .+...+........++.. .....++...+..+.+||.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 319 (373)
T 1q8y_A 240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 319 (373)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred ccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhc
Confidence 211000 000 000000000000000000 00113456778889999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 013519 367 AEPKNRPSMEEVLET 381 (441)
Q Consensus 367 ~dp~~Rps~~eil~~ 381 (441)
.||++|||+.|+|++
T Consensus 320 ~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 320 LDPRKRADAGGLVNH 334 (373)
T ss_dssp SSTTTCBCHHHHHTC
T ss_pred cCccccCCHHHHhhC
Confidence 999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=342.92 Aligned_cols=266 Identities=19% Similarity=0.265 Sum_probs=202.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-----------------HHHHHHHHHHHHh
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-----------------GLREWQAEVKFLG 160 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~E~~~l~ 160 (441)
.++|++.+.||+|+||.||+|.. +++.||||.+...... ....+.+|+.+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 36899999999999999999955 3789999987643221 1267889999999
Q ss_pred cCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHH------HHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeec
Q 013519 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENH------LFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYR 234 (441)
Q Consensus 161 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHr 234 (441)
.++||||+++++++.+.+.+++||||+++++|.++ +... ....+++..++.++.|++.||.|||+ ..||+||
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~ 176 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHR 176 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECC
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeec
Confidence 99999999999999999999999999999999988 4332 13578999999999999999999995 3899999
Q ss_pred CCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCc-cccchhHHHHHHHHHhCCCCC
Q 013519 235 DFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYV-KSDVYGFGVVLLEMLTGLRAL 312 (441)
Q Consensus 235 Dlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlG~il~elltg~~p~ 312 (441)
||||+|||++.++.+||+|||+++.... .......||+.|+|||++.+. .++. ++|||||||++|+|++|..||
T Consensus 177 dl~p~Nil~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 177 DVKPSNILMDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCChHhEEEcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999975322 134556799999999999887 6665 999999999999999999999
Q ss_pred CCCCCCCCceeeccccc--ccchh-hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 313 DTNRPSGEHVLVDFARP--SLTDK-RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 313 ~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
........ ........ .+... ...................+..+.+||.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 253 SLKISLVE-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp CCSSCSHH-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCcHHH-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 75432110 00000000 00000 00000000000001113456678899999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=339.51 Aligned_cols=262 Identities=24% Similarity=0.323 Sum_probs=196.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|.+.+.||+|+||.||+|.. ..+++.||||++... .......+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAID---------KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEEeeeEecCCCeEEEEEEE---------CCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 36799999999999999999944 345889999998654 3344567889999999999999999999998
Q ss_pred eCCe------EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 176 EDRQ------FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 176 ~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
.... +++||||+. ++|.+++. ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~~ 165 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCEL 165 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCCE
T ss_pred cccccccceeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCcE
Confidence 7654 499999997 58877662 248899999999999999999997 899999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ec-c
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VD-F 326 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~-~ 326 (441)
||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........... .. .
T Consensus 166 kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 240 (353)
T 3coi_A 166 KILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240 (353)
T ss_dssp EECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHH
T ss_pred EEeecccccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999975321 2344678999999999987 6788999999999999999999999975432100000 00 0
Q ss_pred ccc------ccchh--hhhhhhcCcccc---ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 327 ARP------SLTDK--RRLKKIMDPRLE---EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 327 ~~~------~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+ .+... ......+..... .......+..+.+||.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00000 000000000000 11223456778999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=336.04 Aligned_cols=266 Identities=21% Similarity=0.276 Sum_probs=200.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCC------ccceE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN------LVKLI 171 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~~~ 171 (441)
.++|++.+.||+|+||+||+|..... .+..||+|++.... ...+.+.+|+.+++.++|++ ++.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 36899999999999999999965432 13689999987543 34567788999999987665 99999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE--------
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL-------- 243 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill-------- 243 (441)
+++...+.+++||||+ +++|.+++.... ...+++..++.++.|++.||.|||+ .||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCEEEE
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999 667777776543 2468999999999999999999997 899999999999999
Q ss_pred -----------cCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCC
Q 013519 244 -----------DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRAL 312 (441)
Q Consensus 244 -----------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~ 312 (441)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 5678999999999975322 123467999999999999999999999999999999999999999
Q ss_pred CCCCCCCCceeeccccccc-------------------------chhhhhhhhcCccc-cccCChhhHHHHHHHHHHhcc
Q 013519 313 DTNRPSGEHVLVDFARPSL-------------------------TDKRRLKKIMDPRL-EEQYPIKGALLAGQIIIKCLE 366 (441)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~ 366 (441)
................... ...........+.. ........+..+.+||.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 7543211000000000000 00000000000000 011223446678899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 013519 367 AEPKNRPSMEEVLET 381 (441)
Q Consensus 367 ~dp~~Rps~~eil~~ 381 (441)
.||++|||+.+++++
T Consensus 320 ~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 320 FDPAQRITLAEALLH 334 (355)
T ss_dssp SSTTTSCCHHHHTTS
T ss_pred CChhhCcCHHHHhcC
Confidence 999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=335.23 Aligned_cols=245 Identities=29% Similarity=0.456 Sum_probs=193.0
Q ss_pred HHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch------HHHHHHHHHHHHHhcC----CC
Q 013519 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI------QGLREWQAEVKFLGKF----SH 164 (441)
Q Consensus 95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l----~h 164 (441)
....++|++.+.||+|+||.||+|.. ..+++.||||++..... .....+.+|+.++.++ +|
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h 97 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHR---------LTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEEC---------TTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCC
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEE---------ccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCC
Confidence 34457899999999999999999943 34588999999866532 1223455788888888 89
Q ss_pred CCccceEEEEEeCCeEEEEEee-cCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 165 PNLVKLIGYCWEDRQFLLVYEY-MQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 165 pniv~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
|||+++++++...+..++|||| +.+++|.+++...+ .+++..++.++.|++.||.|||+ .+|+||||||+|||+
T Consensus 98 ~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~ 172 (312)
T 2iwi_A 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILI 172 (312)
T ss_dssp SSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH--HTEECCCCSGGGEEE
T ss_pred CCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChhhEEE
Confidence 9999999999999999999999 78999999997754 48999999999999999999997 899999999999999
Q ss_pred c-CCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCCc
Q 013519 244 D-GSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEH 321 (441)
Q Consensus 244 ~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~ 321 (441)
+ .++.+||+|||+++..... ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||....
T Consensus 173 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----- 243 (312)
T 2iwi_A 173 DLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----- 243 (312)
T ss_dssp ETTTTEEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred eCCCCeEEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----
Confidence 9 8899999999999764321 23446799999999999887775 58999999999999999999985321
Q ss_pred eeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
. ... . ...++...+..+.+||.+||+.||++|||+.+++++
T Consensus 244 -------------~-~~~---~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 -------------E-ILE---A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -------------H-HHH---T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------------H-Hhh---h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 0 112344556678899999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=337.92 Aligned_cols=243 Identities=25% Similarity=0.398 Sum_probs=199.1
Q ss_pred HhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH------HHHHHHHHHHHHhcCC--CCCcc
Q 013519 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ------GLREWQAEVKFLGKFS--HPNLV 168 (441)
Q Consensus 97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~--hpniv 168 (441)
..++|++.+.||+|+||.||+|.. ..+++.||||.+...... ....+.+|+.+++++. ||||+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIR---------VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEE---------TTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred ccCceEEEEEEeeCCCeEEEEEEE---------CCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 456899999999999999999954 345889999987654211 1234567999999996 59999
Q ss_pred ceEEEEEeCCeEEEEEeecCC-CCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc-CC
Q 013519 169 KLIGYCWEDRQFLLVYEYMQK-GSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD-GS 246 (441)
Q Consensus 169 ~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~ 246 (441)
++++++...+..++|||++.+ ++|.+++...+ .+++..++.++.|++.||.|||+ .+|+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNR 186 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTT
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeCCC
Confidence 999999999999999999986 89999997654 58899999999999999999997 9999999999999999 78
Q ss_pred CceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCCceeec
Q 013519 247 YNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD 325 (441)
Q Consensus 247 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~ 325 (441)
+.+||+|||+++.... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 187 ~~~kL~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------- 253 (320)
T 3a99_A 187 GELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------- 253 (320)
T ss_dssp TEEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------
T ss_pred CCEEEeeCcccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------
Confidence 9999999999976432 22334679999999999988776 688999999999999999999995321
Q ss_pred ccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 326 FARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..... ...++...+..+.+||.+||+.||++|||+.+++++
T Consensus 254 ---------~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 ---------EIIRG------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ---------HHHHC------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------hhhcc------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 011233445668899999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=328.73 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=181.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||.||+|... .+++.||||++..... ...+.+.++..+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFR---------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp GGGEEEEEEC------CEEEEEET---------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEe---------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 367899999999999999999554 3488999999866532 22334555666788899999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCC-CeeecCCCCCcEEEcCCCceEEecc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEK-SVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
+.+.+++||||+ ++.+..+..... ..+++..++.++.|++.||.|||+ . ||+||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCC
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEEC
Confidence 999999999999 556665554432 458899999999999999999996 5 9999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
|+++.... ........||+.|+|||++. ...++.++|||||||++|+|++|..||......
T Consensus 170 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------- 235 (318)
T 2dyl_A 170 GISGRLVD---DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD----------- 235 (318)
T ss_dssp TTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----------
T ss_pred CCchhccC---CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----------
Confidence 99975322 12233457999999999994 567889999999999999999999999643210
Q ss_pred ccchhhhhhhhcCcccc-ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKRRLKKIMDPRLE-EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+..+...... ......++..+.+||.+||+.||.+||++.+++++
T Consensus 236 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 236 ----FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ----HHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----HHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111111111000 01112345678899999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=344.38 Aligned_cols=253 Identities=24% Similarity=0.301 Sum_probs=185.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 177 (441)
+.|.+.++||+|+||+||.+.. .+++.||||++.... .+.+.+|+.+|+++ +||||+++++++.+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~----------~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS----------FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE----------SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred heeeccCeEeeCCCeEEEEEEE----------ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 3455678999999999986422 247899999886543 34567899999876 899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCC----CCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC-------
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEP----LPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS------- 246 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~----l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~------- 246 (441)
+.++||||||. |+|.+++........ ..+..++.++.|++.||.|||+ .+|+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSCC
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCccccccc
Confidence 99999999996 599999976542111 1233567899999999999997 899999999999999754
Q ss_pred ------CceEEecccCCCCCCCCCCc--ceEeeeccccccCcchhhhc-------CCCCccccchhHHHHHHHHHh-CCC
Q 013519 247 ------YNAKLSDFGLAKLGPIDGNS--HVTTRIMGTYGYAAPEYVAT-------GHLYVKSDVYGFGVVLLEMLT-GLR 310 (441)
Q Consensus 247 ------~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt-g~~ 310 (441)
+.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+| |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 48999999999865432211 11234679999999999976 678899999999999999999 999
Q ss_pred CCCCCCCCCCceeecccccccchhhhhhhhcC-ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 311 ALDTNRPSGEHVLVDFARPSLTDKRRLKKIMD-PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 311 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
||....... ...+..... +......+...+..+.+||.+||+.||.+|||+.+++++
T Consensus 239 Pf~~~~~~~--------------~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 239 PFGDKYSRE--------------SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TTCSTTTHH--------------HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCchhhH--------------HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 996432110 000111111 111112234567889999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=357.35 Aligned_cols=265 Identities=24% Similarity=0.297 Sum_probs=200.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe-
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE- 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 176 (441)
++|++.+.||+|+||.||+| ....+++.||||++... .....+.+.+|+.+|++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla---------~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCC---------CCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCeEEEEEEeeCCCeEEEEE---------EECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 68999999999999999998 44445889999998765 44456778999999999999999999998755
Q ss_pred -----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc---
Q 013519 177 -----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN--- 248 (441)
Q Consensus 177 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--- 248 (441)
.+..++|||||++|+|.+++........+++..++.++.|++.||.|||+ .||+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~~~ 162 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLI 162 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSSCE
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCcee
Confidence 66789999999999999999876655578999999999999999999997 89999999999999987765
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCc-------
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH------- 321 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~------- 321 (441)
+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 163 vKL~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~ 239 (676)
T 3qa8_A 163 HKIIDLGYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 239 (676)
T ss_dssp EEECSCCCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC--
T ss_pred EEEcccccccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcc
Confidence 999999999864322 2234568999999999999999999999999999999999999999653110000
Q ss_pred eeec-ccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHH
Q 013519 322 VLVD-FARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379 (441)
Q Consensus 322 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil 379 (441)
.... ............ ..............+..+.+||.+||..||++|||+.+++
T Consensus 240 ~~~~~~~~~~l~g~~~~--~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKF--SSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp ----CCSCCCCSSSCCC--CSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred cchhhhhhhhhcccccc--ccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0000 000000000000 0000111234456788899999999999999999998854
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=341.61 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=185.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcC-CCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKF-SHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 177 (441)
.+|.+.++||+|+||+||.. ...+++.||||++...... .+.+|+.+|+.+ +|||||++++++.+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~----------~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR----------GMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE----------EESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred EEEecCCeeecCcCEEEEEE----------EEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 46888899999999986542 1224789999998765432 345799999999 799999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC-----CCceEEe
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG-----SYNAKLS 252 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-----~~~~kl~ 252 (441)
..+|||||||. |+|.+++..... .+....++.++.|++.||.|||+ .+|+||||||+|||++. ...+||+
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred CEEEEEEECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 99999999996 599999976542 34445677899999999999997 89999999999999943 2357899
Q ss_pred cccCCCCCCCCCC-cceEeeeccccccCcchhhh---cCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeeccc
Q 013519 253 DFGLAKLGPIDGN-SHVTTRIMGTYGYAAPEYVA---TGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 253 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 327 (441)
|||+++....... ........||+.|+|||++. ...++.++|||||||++|||++ |..||......
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--------- 236 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--------- 236 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---------
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---------
Confidence 9999986432211 12234567999999999997 4567789999999999999999 88998543211
Q ss_pred ccccchhhhhhhhcCc-ccc-ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTDKRRLKKIMDP-RLE-EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
........ ... ...+...+..+.+||.+||+.||++|||+.++++|
T Consensus 237 --------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 237 --------QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp --------HHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --------HHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 00001110 010 11123456668899999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=313.55 Aligned_cols=232 Identities=13% Similarity=0.094 Sum_probs=185.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||.||+|+.. .+++.||||++.... ....+.+.+|+.++..++||||+++++++.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDT---------ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEET---------TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEec---------CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 57999999999999999999543 458899999987653 344577889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+++..|+||||++|++|.+++... ....++..++.|++.||.|||+ .||+||||||+|||++.++.+||+++|
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred ECCcEEEEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEEcCCCCEEEEecc
Confidence 999999999999999999998432 3456788999999999999997 899999999999999999999998543
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee-ecccccccchh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL-VDFARPSLTDK 334 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~ 334 (441)
|++ .++.++|||||||++|||+||+.||........... .........
T Consensus 175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~-- 223 (286)
T 3uqc_A 175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI-- 223 (286)
T ss_dssp ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBC--
T ss_pred ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCC--
Confidence 333 378999999999999999999999976543221100 000000000
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
........++..+.+||.+||+.||++| |+.++++.|+.+...
T Consensus 224 ----------~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 224 ----------EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp ----------CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ----------ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0011123445668899999999999999 999999999877644
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.65 Aligned_cols=241 Identities=24% Similarity=0.390 Sum_probs=191.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||+||+|+.... +++.||||++... .......+.+|+.+|.+++||||+++++++..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 36899999999999999999965431 3789999988654 33455678899999999999999999999987
Q ss_pred CCe-----EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEE
Q 013519 177 DRQ-----FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKL 251 (441)
Q Consensus 177 ~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 251 (441)
.+. .||||||++|++|.+++.. .+++..++.++.|++.||.|||+ .|||||||||+|||++.+ .+||
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSS-CEEE
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEeCC-cEEE
Confidence 655 7999999999999887643 58999999999999999999997 899999999999999885 8999
Q ss_pred ecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccccc
Q 013519 252 SDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 252 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||....... +
T Consensus 223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~ 284 (681)
T 2pzi_A 223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------L 284 (681)
T ss_dssp CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------C
T ss_pred EecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----------c
Confidence 999999864321 345799999999998765 4899999999999999999988875421100 0
Q ss_pred chhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-HHHHHHHHhcc
Q 013519 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-MEEVLETLQNI 385 (441)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~eil~~L~~i 385 (441)
... ......+..+.+||.+||+.||++||+ ++++.+.|..+
T Consensus 285 ~~~-------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 PED-------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp CTT-------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccc-------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 000 001122345779999999999999995 55555555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=312.31 Aligned_cols=228 Identities=21% Similarity=0.326 Sum_probs=178.9
Q ss_pred cCCCCC-ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHH-hcCCCCCccceEEEEEe
Q 013519 99 KNFRPD-TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFL-GKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~ 176 (441)
++|.+. ++||+|+||.||+|.. ..+++.||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFN---------KRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEE---------cCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 567776 7899999999999954 345889999998643 3456788887 56689999999999987
Q ss_pred ----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC---CCce
Q 013519 177 ----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG---SYNA 249 (441)
Q Consensus 177 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~ 249 (441)
...+++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~ 159 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAIL 159 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCE
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCCCcE
Confidence 6779999999999999999987542 468999999999999999999997 99999999999999998 7889
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
||+|||+++... +..++.++|||||||++|+|++|..||.......... ....
T Consensus 160 kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~~~~- 212 (299)
T 3m2w_A 160 KLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKT- 212 (299)
T ss_dssp EECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--CSCC-
T ss_pred EEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--HHHH-
Confidence 999999986321 2457889999999999999999999996543211000 0000
Q ss_pred ccchhhhhhhhcCccccccCC----hhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKRRLKKIMDPRLEEQYP----IKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+.... ...+ ..++..+.+||.+||+.||++|||+.+++++
T Consensus 213 ---------~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 ---------RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ---------SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 0011 2345678899999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=328.93 Aligned_cols=243 Identities=15% Similarity=0.150 Sum_probs=181.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCC-CCc-------
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSH-PNL------- 167 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h-pni------- 167 (441)
.+|...++||+|+||+||+|.+ ..+++.||||++..... ...+.+.+|+.+++.+.| +|+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~---------~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATD---------QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred eeEEEecccccCCCEEEEEEEe---------cCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence 4577788999999999999954 34588999999874332 235678899999999987 221
Q ss_pred --cceEEE------------EEe-----CCeEEEEEeecCCCCHHHHHHh----cCCCCCCCHHHHHHHHHHHHHHHhhh
Q 013519 168 --VKLIGY------------CWE-----DRQFLLVYEYMQKGSLENHLFR----KGSAEPLPWNTRLKIAIDAAKDLTFL 224 (441)
Q Consensus 168 --v~~~~~------------~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~l 224 (441)
+..++. +.. ...++++|+++ +++|.+++.. ......+++..++.++.|++.||.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 111111 111 12357777766 6799988852 12234577889999999999999999
Q ss_pred ccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhh----------hcCCCCcccc
Q 013519 225 HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV----------ATGHLYVKSD 294 (441)
Q Consensus 225 H~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~D 294 (441)
|+ ++|+||||||+||||+.++.+||+|||+++... ......+| +.|+|||++ .+..++.++|
T Consensus 228 H~--~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D 299 (413)
T 3dzo_A 228 HH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD 299 (413)
T ss_dssp HH--TTEECSCCCGGGEEECTTCCEEECCGGGCEETT-----EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred Hh--CCcccCCcccceEEEecCCeEEEEeccceeecC-----CccccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence 97 999999999999999999999999999997532 22455678 999999999 5556888999
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC
Q 013519 295 VYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS 374 (441)
Q Consensus 295 vwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 374 (441)
||||||++|||++|+.||....... ....++.. ....+..+.+||.+||+.||++||+
T Consensus 300 vwSlGvil~elltg~~Pf~~~~~~~----------------~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt 357 (413)
T 3dzo_A 300 TWTLGLAIYWIWCADLPNTDDAALG----------------GSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLL 357 (413)
T ss_dssp HHHHHHHHHHHHHSSCCCCTTGGGS----------------CSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHHHCCCCCCCcchhh----------------hHHHHHhh------cccCCHHHHHHHHHHccCChhhCcC
Confidence 9999999999999999996542211 00011110 1123456889999999999999999
Q ss_pred HHHHHHH
Q 013519 375 MEEVLET 381 (441)
Q Consensus 375 ~~eil~~ 381 (441)
+.+++++
T Consensus 358 ~~~~l~~ 364 (413)
T 3dzo_A 358 PLQAMET 364 (413)
T ss_dssp HHHHTTS
T ss_pred HHHHHhC
Confidence 9999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=326.39 Aligned_cols=242 Identities=16% Similarity=0.134 Sum_probs=183.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--------hHHHHHHHHHHHHHhcCC------
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--------IQGLREWQAEVKFLGKFS------ 163 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~------ 163 (441)
.++|++.+.||+|+||+||+|+. +++.||||++.... ....+.+.+|+.+|+.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 36789999999999999999954 26899999886542 123467788998888875
Q ss_pred ---CCCccceEEEEE------------------------------eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHH
Q 013519 164 ---HPNLVKLIGYCW------------------------------EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTR 210 (441)
Q Consensus 164 ---hpniv~~~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~ 210 (441)
|||||++.+++. +...+|||||||++|++.+.+.+ ..+++..+
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~ 163 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATA 163 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHH
Confidence 888888777643 26789999999999987776643 35889999
Q ss_pred HHHHHHHHHHHhhhc-cCCCCeeecCCCCCcEEEcCCC--------------------ceEEecccCCCCCCCCCCcceE
Q 013519 211 LKIAIDAAKDLTFLH-SSEKSVIYRDFKASNILLDGSY--------------------NAKLSDFGLAKLGPIDGNSHVT 269 (441)
Q Consensus 211 ~~i~~~i~~~l~~lH-~~~~~ivHrDlkp~Nill~~~~--------------------~~kl~DFGla~~~~~~~~~~~~ 269 (441)
+.++.|++.||.||| + .+|+||||||+||||+.++ .+||+|||+|+....
T Consensus 164 ~~i~~qi~~aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------- 234 (336)
T 2vuw_A 164 KSILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------- 234 (336)
T ss_dssp HHHHHHHHHHHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------
T ss_pred HHHHHHHHHHHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------
Confidence 999999999999999 7 8999999999999999887 899999999985321
Q ss_pred eeeccccccCcchhhhcCCCCccccchhHHHH-HHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhh--hcCcccc
Q 013519 270 TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVV-LLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK--IMDPRLE 346 (441)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 346 (441)
...+||+.|+|||++.+.. +.++||||||++ .+++++|..||.... |.. . ....+.. .......
T Consensus 235 ~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---------~~~-~--~~~~~~~~~~~~~~~~ 301 (336)
T 2vuw_A 235 GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---------WLH-Y--LTDKMLKQMTFKTKCN 301 (336)
T ss_dssp TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---------HHH-H--HHHHHHHTCCCSSCCC
T ss_pred CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---------hhh-H--HHHhhhhhhccCcccc
Confidence 2357999999999998766 899999998777 778888988874210 000 0 0000000 0111111
Q ss_pred ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHH-HH
Q 013519 347 EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL-ET 381 (441)
Q Consensus 347 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil-~~ 381 (441)
...+...+..+.+||.+||+.| |+.|+| +|
T Consensus 302 ~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 1123457788999999999976 999999 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.41 Aligned_cols=174 Identities=18% Similarity=0.121 Sum_probs=129.8
Q ss_pred ccccCCcEEEEEEcCCCc----------hHHHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEeecCCCCHHHHH
Q 013519 128 TKVGVGKAVAVKKSNPDS----------IQGLREWQAEVKFLGKF-SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHL 196 (441)
Q Consensus 128 ~~~~~~~~vaiK~~~~~~----------~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l 196 (441)
.....|+.+++|.+.... ....++|.+|+++|+++ .|+||+++++++++++.+|||||||+|++|.++|
T Consensus 254 rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i 333 (569)
T 4azs_A 254 RRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDML 333 (569)
T ss_dssp EEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHH
T ss_pred ccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHH
Confidence 344468899999875531 23456799999999999 5999999999999999999999999999999999
Q ss_pred HhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeecccc
Q 013519 197 FRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276 (441)
Q Consensus 197 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 276 (441)
.+.+ +++.. .|+.||+.||.|+|+ +|||||||||+||||+.+|.+||+|||+|+..... .......+||+
T Consensus 334 ~~~~---~l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~~~~t~vGTp 403 (569)
T 4azs_A 334 AAGE---EIDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CSWPTNLVQSF 403 (569)
T ss_dssp HTTC---CCCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHH
T ss_pred HhCC---CCCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEECCCCCEEEeecccCeeCCCC--CccccCceech
Confidence 7654 45543 588999999999997 99999999999999999999999999999864322 22344578999
Q ss_pred ccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCC
Q 013519 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRAL 312 (441)
Q Consensus 277 ~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~ 312 (441)
.|+|||++.+ .+..++|+||+|+++++|.++..++
T Consensus 404 ~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 404 FVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHHHHC------------------CCCCTTHHHH
T ss_pred hhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 9999998865 5678899999999998887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-30 Score=260.56 Aligned_cols=185 Identities=16% Similarity=0.176 Sum_probs=142.7
Q ss_pred CCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--------HHHHHHHHHHHHHhcCCCCCccceEEE
Q 013519 102 RPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--------QGLREWQAEVKFLGKFSHPNLVKLIGY 173 (441)
Q Consensus 102 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~ 173 (441)
...++||+|+||+||+|.+. +..+++|+...... ...+.+.+|+.+|++++||||+++..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-----------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 407 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-----------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF 407 (540)
T ss_dssp ---------CCEEEEEEECS-----------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-----------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence 44678999999999999433 56788887543211 123458899999999999999976666
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+......|||||||+|++|.+++.. ++.++.|++.||.|||+ ++|+||||||+|||++. .+||+|
T Consensus 408 ~~~~~~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl~~--~~kL~D 472 (540)
T 3en9_A 408 DVDLDNKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIFDK--DLYIID 472 (540)
T ss_dssp EEETTTTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEESS--SEEECC
T ss_pred EEeCCccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEECC--eEEEEE
Confidence 6677888999999999999999854 55799999999999997 89999999999999998 999999
Q ss_pred ccCCCCCCCCCCcc-----eEeeeccccccCcchhhhc--CCCCccccchhHHHHHHHHHhCCCCC
Q 013519 254 FGLAKLGPIDGNSH-----VTTRIMGTYGYAAPEYVAT--GHLYVKSDVYGFGVVLLEMLTGLRAL 312 (441)
Q Consensus 254 FGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~ 312 (441)
||+++......... .....+||+.|+|||++.. ..|+..+|+|+..+-.++-+.++.+|
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99998643211111 1235789999999999987 67888899999999888888776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.2e-26 Score=212.55 Aligned_cols=166 Identities=14% Similarity=0.091 Sum_probs=128.0
Q ss_pred HHHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch------------------HHHHHH
Q 013519 91 LQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI------------------QGLREW 152 (441)
Q Consensus 91 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~ 152 (441)
+..+......|.+.+.||+|+||.||+|.+ .+++.||||.+..... .....+
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~----------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~ 151 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYS----------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 151 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEE----------TTTEEEEEEEECC------CCCC-------CHHHHHHHHH
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEe----------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHH
Confidence 334444556677889999999999999965 2378999999865321 134568
Q ss_pred HHHHHHHhcCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCee
Q 013519 153 QAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVI 232 (441)
Q Consensus 153 ~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~iv 232 (441)
.+|+.+|++++ | +++.+++.. +..++||||++|++|.+ +.. .....++.|++.||.|||+ .||+
T Consensus 152 ~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~--~gii 215 (282)
T 1zar_A 152 RNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH--RGIV 215 (282)
T ss_dssp HHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH--TTEE
T ss_pred HHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH--CCCE
Confidence 89999999999 4 566665433 55699999999999987 411 2345799999999999997 9999
Q ss_pred ecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc----------CCCCccccchhH
Q 013519 233 YRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT----------GHLYVKSDVYGF 298 (441)
Q Consensus 233 HrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DvwSl 298 (441)
||||||+|||++ ++.+||+|||+|+. +..|+|||++.. ..|...+|+|.+
T Consensus 216 HrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 216 HGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp CSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred eCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 999999999999 99999999999862 345899998854 345566677653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.5e-21 Score=179.70 Aligned_cols=137 Identities=18% Similarity=0.101 Sum_probs=104.6
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcE--EEEEEcCCCchH------------------------HHHHHH
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKA--VAVKKSNPDSIQ------------------------GLREWQ 153 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~--vaiK~~~~~~~~------------------------~~~~~~ 153 (441)
-|.+.+.||+|+||.||+|... .+|+. ||||+++..... ....+.
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~---------~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGV---------FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTE 118 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEE---------ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEc---------CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHH
Confidence 3667899999999999999552 23778 999986543211 123578
Q ss_pred HHHHHHhcCCCCCc--cceEEEEEeCCeEEEEEeecCC-C----CHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhc-
Q 013519 154 AEVKFLGKFSHPNL--VKLIGYCWEDRQFLLVYEYMQK-G----SLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLH- 225 (441)
Q Consensus 154 ~E~~~l~~l~hpni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH- 225 (441)
+|+.+|.++.|++| ..++++ ...+|||||+.+ | +|.++... .++..+..++.|++.+|.|||
T Consensus 119 ~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~ 188 (258)
T 1zth_A 119 KEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ 188 (258)
T ss_dssp HHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH
Confidence 89999999988865 333332 356899999942 3 67766532 224467889999999999999
Q ss_pred cCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 226 SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 226 ~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
. .||+||||||+|||++. .++|+|||+|..
T Consensus 189 ~--~givHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 189 E--AELVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp T--SCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred H--CCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 7 89999999999999998 899999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=161.04 Aligned_cols=144 Identities=13% Similarity=0.071 Sum_probs=101.3
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch------------------HHH----
Q 013519 92 QDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI------------------QGL---- 149 (441)
Q Consensus 92 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~---- 149 (441)
..+.....-|.+...||.|+||.||+|... .|+.||||+++.... ...
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~r 157 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSR 157 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHH
Confidence 333333345999999999999999999542 378999998653210 000
Q ss_pred HHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCC
Q 013519 150 REWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEK 229 (441)
Q Consensus 150 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 229 (441)
....+|...|.++.+.++.-..-+.... .+|||||++|++|..+.. ......++.|++.+|.+||. .
T Consensus 158 l~A~kE~~nL~rL~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~--~ 224 (397)
T 4gyi_A 158 LAAIKEFAFMKALYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAK--H 224 (397)
T ss_dssp HHHHHHHHHHHHHHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHH--T
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeccC--ceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHH--C
Confidence 1123577777777655543322222222 379999999988854321 12345688999999999997 8
Q ss_pred CeeecCCCCCcEEEcCCC----------ceEEecccCCC
Q 013519 230 SVIYRDFKASNILLDGSY----------NAKLSDFGLAK 258 (441)
Q Consensus 230 ~ivHrDlkp~Nill~~~~----------~~kl~DFGla~ 258 (441)
|||||||||.|||++.++ .+.|+||+-+.
T Consensus 225 gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 225 GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 999999999999998776 38999999775
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=4.6e-13 Score=123.98 Aligned_cols=146 Identities=14% Similarity=0.062 Sum_probs=111.5
Q ss_pred HHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEE
Q 013519 94 LRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIG 172 (441)
Q Consensus 94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~ 172 (441)
+......|++...++.|+++.||++... +..+++|............+.+|+.+|+.+. +..+.++++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-----------~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~ 77 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-----------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLH 77 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-----------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-----------CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 3445567888888999999999997321 5689999986522112235778999999885 677889999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccC-------------------------
Q 013519 173 YCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSS------------------------- 227 (441)
Q Consensus 173 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------------------------- 227 (441)
++.+.+..|+||||++|.+|.+.+. +......++.+++.+|..||+.
T Consensus 78 ~~~~~~~~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (263)
T 3tm0_A 78 FERHDGWSNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND 149 (263)
T ss_dssp EEEETTEEEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred EEecCCceEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcc
Confidence 9999999999999999999887631 1122346778888888999861
Q ss_pred --------------------------------CCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 228 --------------------------------EKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 228 --------------------------------~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
...++|+|++|.|||++.+..+.|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876556799998875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.3e-11 Score=113.59 Aligned_cols=134 Identities=16% Similarity=0.058 Sum_probs=94.1
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCC--ccceEEEEEeCC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN--LVKLIGYCWEDR 178 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~ 178 (441)
|.+..+.+.|..+.||++... .|..+++|...... ...+.+|+.+++.+.+.+ +.+++++....+
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~ 88 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAG 88 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred CceEecccCCCCceEEEEecC----------CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence 443333345566999997322 25679999876542 235678999998886444 456888888778
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCC------------------------------
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSE------------------------------ 228 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~------------------------------ 228 (441)
..++||||++|.+|. .. ... ...++.+++..|..||+..
T Consensus 89 ~~~~v~e~i~G~~l~--~~------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL--SS------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD 157 (264)
T ss_dssp CEEEEEECCSSEETT--TS------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred CCEEEEEecCCcccC--cC------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence 899999999998874 21 111 1245667777777777521
Q ss_pred --------------------------CCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 229 --------------------------KSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 229 --------------------------~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
..++|+|++|.|||++.++.+.|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 239999999999999877667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=7.6e-11 Score=114.23 Aligned_cols=140 Identities=13% Similarity=0.236 Sum_probs=103.4
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcC--CCc-hHHHHHHHHHHHHHhcCC--CCCccceEEEEEeC-
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSN--PDS-IQGLREWQAEVKFLGKFS--HPNLVKLIGYCWED- 177 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~- 177 (441)
.+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.|. +..+.+++.++.+.
T Consensus 43 ~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~ 111 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES 111 (359)
T ss_dssp EEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT
T ss_pred EEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC
Confidence 467899999999997432 3578888776 332 122346778999999987 45678888888766
Q ss_pred --CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccC----------------------------
Q 013519 178 --RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSS---------------------------- 227 (441)
Q Consensus 178 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---------------------------- 227 (441)
+..|+||||++|..+.+.. ...++......++.+++..|..||+.
T Consensus 112 ~~g~~~~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3dxp_A 112 VIGRAFYIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY 186 (359)
T ss_dssp TTSSCEEEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence 4589999999998774311 13466788888999999999999962
Q ss_pred ----------------------------CCCeeecCCCCCcEEEcCCCc--eEEecccCCCC
Q 013519 228 ----------------------------EKSVIYRDFKASNILLDGSYN--AKLSDFGLAKL 259 (441)
Q Consensus 228 ----------------------------~~~ivHrDlkp~Nill~~~~~--~kl~DFGla~~ 259 (441)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999987753 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.12 E-value=6.4e-11 Score=112.02 Aligned_cols=182 Identities=20% Similarity=0.231 Sum_probs=117.3
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCC--ccceEEEEEeCC--
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPN--LVKLIGYCWEDR-- 178 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~~~~~~~~~~-- 178 (441)
.+.++.|.+..||+. +..+++|..... .....+.+|+.+|+.+. +.. +.+++.......
T Consensus 25 i~~~~~G~~n~v~~v--------------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI--------------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEES--------------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEE--------------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 456899999999986 356888986543 34567889999998874 333 334444332322
Q ss_pred -eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccC------------------------------
Q 013519 179 -QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSS------------------------------ 227 (441)
Q Consensus 179 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------------------------------ 227 (441)
..|+||++++|.+|...... .++..+...++.+++..|..||+.
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR 163 (304)
T ss_dssp SCSCEEEECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred CcceEEEcccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence 34899999999888654321 245566666777777777776641
Q ss_pred --------------------------CCCeeecCCCCCcEEEcC--CCceEEecccCCCCCCCCCCcceEeeecccccc-
Q 013519 228 --------------------------EKSVIYRDFKASNILLDG--SYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY- 278 (441)
Q Consensus 228 --------------------------~~~ivHrDlkp~Nill~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y- 278 (441)
...++|+|++|.|||++. ...+.|+||+.+....... .......+
T Consensus 164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~ 237 (304)
T 3sg8_A 164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDD 237 (304)
T ss_dssp TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTT
T ss_pred cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhc
Confidence 135799999999999988 4568899999986532110 00001111
Q ss_pred --Ccchhhhc-----CC---------CCccccchhHHHHHHHHHhCCCCC
Q 013519 279 --AAPEYVAT-----GH---------LYVKSDVYGFGVVLLEMLTGLRAL 312 (441)
Q Consensus 279 --~aPE~~~~-----~~---------~~~~~DvwSlG~il~elltg~~p~ 312 (441)
..|+.... +. .....+.|+++.++|.+.+|..+|
T Consensus 238 ~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 238 EEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 22322111 00 122358999999999999997766
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=1.6e-07 Score=88.61 Aligned_cols=135 Identities=19% Similarity=0.178 Sum_probs=89.3
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCC---CccceEEEEE-eCCe
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP---NLVKLIGYCW-EDRQ 179 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~~~~~~~-~~~~ 179 (441)
.+.++.|....||+. +..+++|+... ......+.+|+.+|+.|.+. .|.+++.+.. ..+.
T Consensus 24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE--------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE--------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 356888888899986 45688888532 23456788999999998742 2556666664 3456
Q ss_pred EEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhcc---------------------------------
Q 013519 180 FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS--------------------------------- 226 (441)
Q Consensus 180 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--------------------------------- 226 (441)
.++||||++|..|...... .++......++.++...|..||+
T Consensus 88 ~~~v~e~i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~ 162 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFP 162 (306)
T ss_dssp EEEEEECCCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGG
T ss_pred eEEEEeccCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccc
Confidence 7899999999887653211 12223333333333333333332
Q ss_pred -------------------------CCCCeeecCCCCCcEEEcC---CCc-eEEecccCCCC
Q 013519 227 -------------------------SEKSVIYRDFKASNILLDG---SYN-AKLSDFGLAKL 259 (441)
Q Consensus 227 -------------------------~~~~ivHrDlkp~Nill~~---~~~-~kl~DFGla~~ 259 (441)
....++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 163 ~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 163 LLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred ccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1346799999999999987 455 48999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=6.2e-07 Score=82.78 Aligned_cols=134 Identities=16% Similarity=0.090 Sum_probs=90.6
Q ss_pred eecccCce-EEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEE
Q 013519 106 MLGEGGFG-RVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 106 ~lG~G~~g-~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv 183 (441)
.+..|..+ .||+.... ..+..+++|..... ....+.+|..+|+.|. +--|.++++++.+.+..++|
T Consensus 31 ~~~~G~S~~~v~rl~~~---------~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGK---------PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp EEECSSSSCEEEEEECC---------TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred EccCCCcCCeEEEEEec---------CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 34455554 68875322 22567888976543 2356778999998875 33367788888999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccC------------------------------------
Q 013519 184 YEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSS------------------------------------ 227 (441)
Q Consensus 184 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------------------------------------ 227 (441)
||+++|.++.+...... .....+..+++..|..||..
T Consensus 99 me~l~G~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER 171 (272)
T ss_dssp EECCCSEEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred EEeeCCccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence 99999988776543211 12223444444444444431
Q ss_pred --------------------CCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 228 --------------------EKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 228 --------------------~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
...++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999987777899999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1.2e-06 Score=84.46 Aligned_cols=85 Identities=2% Similarity=-0.042 Sum_probs=52.3
Q ss_pred cee-cccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCC-C--CCccceEEEEEeC
Q 013519 105 TML-GEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFS-H--PNLVKLIGYCWED 177 (441)
Q Consensus 105 ~~l-G~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pniv~~~~~~~~~ 177 (441)
+.| +.|....+|+....... .....+..+++|...... ......+.+|+.+|+.|. + -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~---~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQ---DGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEE---TTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EECCCCCccceEEEEEEeccc---CCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 467 78888999986432000 000014578888765432 101134667888888875 3 3466777776554
Q ss_pred ---CeEEEEEeecCCCCH
Q 013519 178 ---RQFLLVYEYMQKGSL 192 (441)
Q Consensus 178 ---~~~~lv~e~~~~g~L 192 (441)
+..|+||||++|..+
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 356899999988654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=5.4e-06 Score=81.05 Aligned_cols=76 Identities=18% Similarity=0.246 Sum_probs=47.9
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-------HHHHHHHHHHHHHhcCCC--CCcc-ceEEE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-------QGLREWQAEVKFLGKFSH--PNLV-KLIGY 173 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~h--pniv-~~~~~ 173 (441)
.+.||.|.++.||++.... .++.++||....... .....+..|.++|+.+.. |..+ +++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 4679999999999984332 256899997543211 112345678888887742 4433 45433
Q ss_pred EEeCCeEEEEEeecCCC
Q 013519 174 CWEDRQFLLVYEYMQKG 190 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g 190 (441)
+....++|||++++.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 455678999999774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.09 E-value=2e-05 Score=75.00 Aligned_cols=31 Identities=16% Similarity=0.228 Sum_probs=28.2
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 228 EKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 228 ~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
...++|+|+++.|||++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 4789999999999999888889999999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.0001 Score=72.57 Aligned_cols=77 Identities=13% Similarity=0.154 Sum_probs=47.4
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeecc--ccccCcchhhhcCC---CCccccchhHHHHH
Q 013519 228 EKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMG--TYGYAAPEYVATGH---LYVKSDVYGFGVVL 302 (441)
Q Consensus 228 ~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DvwSlG~il 302 (441)
...++|+|++|.|||++.++ ++|+||+.+...... ........ ...|++|+...... -....++..+...+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~---~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG---FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH---HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH---HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 47899999999999998876 999999998752210 00000111 13456665443111 11234555777788
Q ss_pred HHHHhC
Q 013519 303 LEMLTG 308 (441)
Q Consensus 303 ~elltg 308 (441)
|+.+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00064 Score=63.85 Aligned_cols=137 Identities=15% Similarity=0.131 Sum_probs=89.1
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC---CCCccceEEEEEeCCeE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS---HPNLVKLIGYCWEDRQF 180 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~ 180 (441)
.+.|+.|....+|+... .+..+++|..... ....+..|+..|+.|. ...+.+++.+....+..
T Consensus 41 ~~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 35789999999999732 2567888986543 2456788998888874 35688888888888889
Q ss_pred EEEEeecCCCCHH--------H---HHHhcCCCC-------------------CCCHHHHH---HHH-------------
Q 013519 181 LLVYEYMQKGSLE--------N---HLFRKGSAE-------------------PLPWNTRL---KIA------------- 214 (441)
Q Consensus 181 ~lv~e~~~~g~L~--------~---~l~~~~~~~-------------------~l~~~~~~---~i~------------- 214 (441)
++||||++|..+. . .|.+..... .-.|.... ++.
T Consensus 107 ~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~ 186 (312)
T 3jr1_A 107 FLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIF 186 (312)
T ss_dssp EEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCC
T ss_pred EEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCCh
Confidence 9999999987641 1 122221100 01343221 011
Q ss_pred ---HHHHHHH-hhh--ccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 215 ---IDAAKDL-TFL--HSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 215 ---~~i~~~l-~~l--H~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
..++..+ ..| |.....+||+|+.+.|++++.++ +.|+||.
T Consensus 187 ~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 187 GNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp SCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1111111 223 22347899999999999999887 8899983
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00022 Score=66.14 Aligned_cols=78 Identities=15% Similarity=0.124 Sum_probs=52.5
Q ss_pred CCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCC---CccceEEEEEeC
Q 013519 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHP---NLVKLIGYCWED 177 (441)
Q Consensus 101 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~~~~~~~~~ 177 (441)
..-.+.+|.|..+.||+.... +|+.|++|+...........+.+|+..|+.|.-. -+.+++++ +.
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~ 84 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD 84 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET
T ss_pred eEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC
Confidence 334567999999999997443 4789999986654333334577899988887421 23444443 33
Q ss_pred CeEEEEEeecCCCCH
Q 013519 178 RQFLLVYEYMQKGSL 192 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L 192 (441)
-++||||++++..
T Consensus 85 --~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 --RTLAMEWVDERPP 97 (288)
T ss_dssp --TEEEEECCCCCCC
T ss_pred --ceEEEEeecccCC
Confidence 3789999987653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00047 Score=60.34 Aligned_cols=99 Identities=14% Similarity=0.073 Sum_probs=66.1
Q ss_pred CCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceE
Q 013519 190 GSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269 (441)
Q Consensus 190 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 269 (441)
-+|.++|...+ .++++.++|.++.|.+.+|.-+-. ...-..+=+-|..|+|..+|.|-+.+ ..+.
T Consensus 33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~-~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAAR-RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhh-cccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 37999998776 589999999999999999877610 01112344567999999999988774 2211
Q ss_pred eeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh
Q 013519 270 TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT 307 (441)
Q Consensus 270 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt 307 (441)
.....+.|||... ...+.+.=|||||++||.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123467888653 455678899999999999876
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00027 Score=66.02 Aligned_cols=136 Identities=12% Similarity=0.101 Sum_probs=74.2
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCc-cceEEEEEeCCeEEE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNL-VKLIGYCWEDRQFLL 182 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~l 182 (441)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+..-.+ .+++.+ +...-++
T Consensus 23 i~~l~gG~tN~~~~~---------------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~ 84 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---------------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVM 84 (301)
T ss_dssp CEEEESCSSEEEEEE---------------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred eeEcCCcccccccee---------------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence 568888999999986 24778876543211 1123468877777653233 344443 4444578
Q ss_pred EEeec-CCCCHHH---------------HHHh-cCCCCCC----CH-HH---------------------HHHHHHHHHH
Q 013519 183 VYEYM-QKGSLEN---------------HLFR-KGSAEPL----PW-NT---------------------RLKIAIDAAK 219 (441)
Q Consensus 183 v~e~~-~~g~L~~---------------~l~~-~~~~~~l----~~-~~---------------------~~~i~~~i~~ 219 (441)
|+||+ +|.+|.. .|.+ +.....+ .. .. ....+..+..
T Consensus 85 v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 85 VTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp EEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred EEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 99999 6644421 0111 0100101 11 11 1111111111
Q ss_pred HHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 220 ~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
.+.- +.....++|+|+.|.||| ..++.+.|+||..+..
T Consensus 165 ~l~~-~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 165 ALAA-HPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHS-SCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHh-cCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 1111 112456899999999999 5667789999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00075 Score=63.50 Aligned_cols=157 Identities=13% Similarity=0.125 Sum_probs=83.3
Q ss_pred cCHHHHHHHhcCCCCC-----ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC
Q 013519 89 FTLQDLRAATKNFRPD-----TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS 163 (441)
Q Consensus 89 ~~~~~~~~~~~~y~~~-----~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~ 163 (441)
++..++.....+|.+. +.|+.|....+|+.... +..+++|...... ....+..|+.++..|.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-----------~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~ 73 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-----------KDPLILTLYEKRV--EKNDLPFFLGLMQHLA 73 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-----------SCCEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-----------CccEEEEEeCCCC--CHHHHHHHHHHHHHHH
Confidence 4456666666667652 34666878899987432 2358889877531 1123455777776653
Q ss_pred -----CCCccceE-E--EEEeCCeEEEEEeecCCCCHHH--------------HHHhcCC--CCC----C---CHHHHHH
Q 013519 164 -----HPNLVKLI-G--YCWEDRQFLLVYEYMQKGSLEN--------------HLFRKGS--AEP----L---PWNTRLK 212 (441)
Q Consensus 164 -----hpniv~~~-~--~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~--~~~----l---~~~~~~~ 212 (441)
-|.++... + +....+..++||+|++|..+.. .++.... ..+ . .|...+.
T Consensus 74 ~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~ 153 (322)
T 2ppq_A 74 AKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWD 153 (322)
T ss_dssp HTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHH
T ss_pred HCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHH
Confidence 34443211 0 1223467799999999865310 1111110 000 1 1211000
Q ss_pred H------------HHHHHHHHhhhcc-----CCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 213 I------------AIDAAKDLTFLHS-----SEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 213 i------------~~~i~~~l~~lH~-----~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
- ...+...+..+.. ...+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 154 KSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0 0012222333321 13679999999999999987656899999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.003 Score=59.50 Aligned_cols=156 Identities=15% Similarity=0.101 Sum_probs=83.5
Q ss_pred CHHHHHHHhcCCCC-----CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCC
Q 013519 90 TLQDLRAATKNFRP-----DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSH 164 (441)
Q Consensus 90 ~~~~~~~~~~~y~~-----~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h 164 (441)
+.+.+......|.+ ...|+ |....||+... ..|+.+++|....... ....+..|..+++.|..
T Consensus 12 ~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~----------~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~ 79 (328)
T 1zyl_A 12 HPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQD----------EDRRRFVVKFYRPERW-TADQILEEHQFALQLVN 79 (328)
T ss_dssp CHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECC----------TTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEc----------CCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHH
Confidence 34444444444432 23566 77789998632 1255799999864321 12455667777776641
Q ss_pred C--CccceEEE-----EEeCCeEEEEEeecCCCCHH-----H------H---HHhcCC------CCCCCHHHH-------
Q 013519 165 P--NLVKLIGY-----CWEDRQFLLVYEYMQKGSLE-----N------H---LFRKGS------AEPLPWNTR------- 210 (441)
Q Consensus 165 p--niv~~~~~-----~~~~~~~~lv~e~~~~g~L~-----~------~---l~~~~~------~~~l~~~~~------- 210 (441)
. .+.+++.. ....+..++||++++|..+. . . ++.... ...+.+...
T Consensus 80 ~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T 1zyl_A 80 DEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKL 159 (328)
T ss_dssp TTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHH
T ss_pred cCCeecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHH
Confidence 1 13333332 22356678999999875431 1 1 111000 011121110
Q ss_pred ---------------HHHHHHHHHHHhhhc--cCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 211 ---------------LKIAIDAAKDLTFLH--SSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 211 ---------------~~i~~~i~~~l~~lH--~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
...+..++..+.-+- .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 160 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 160 FEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 111112222222111 0236789999999999999 4 899999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0026 Score=60.13 Aligned_cols=33 Identities=36% Similarity=0.460 Sum_probs=28.5
Q ss_pred CCCeeecCCCCCcEEEcCC----CceEEecccCCCCC
Q 013519 228 EKSVIYRDFKASNILLDGS----YNAKLSDFGLAKLG 260 (441)
Q Consensus 228 ~~~ivHrDlkp~Nill~~~----~~~kl~DFGla~~~ 260 (441)
...++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4689999999999999874 67999999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0012 Score=63.71 Aligned_cols=147 Identities=15% Similarity=0.128 Sum_probs=80.3
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv 183 (441)
+.|..|-...+|++....... .....+..+++|+.... ......+.+|..+++.|. +.-..++++++. + .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLP--SVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSC--CCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEE
T ss_pred EEcCCcccccEEEEEeCCCcc--ccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccE
Confidence 467677778899975432100 01112468899986432 122445668999998885 332345565543 2 399
Q ss_pred EeecCCCCHHH--------------HHHh-cCC----CCCC--CHHHHHHHHHHHHH-------------------HHhh
Q 013519 184 YEYMQKGSLEN--------------HLFR-KGS----AEPL--PWNTRLKIAIDAAK-------------------DLTF 223 (441)
Q Consensus 184 ~e~~~~g~L~~--------------~l~~-~~~----~~~l--~~~~~~~i~~~i~~-------------------~l~~ 223 (441)
|||++|..|.. .|.+ +.. .+.. .+..+.++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99999865421 1111 111 1112 23444444443321 1111
Q ss_pred ----hc--cCCCCeeecCCCCCcEEEcCC----CceEEecccCCC
Q 013519 224 ----LH--SSEKSVIYRDFKASNILLDGS----YNAKLSDFGLAK 258 (441)
Q Consensus 224 ----lH--~~~~~ivHrDlkp~Nill~~~----~~~kl~DFGla~ 258 (441)
|. .....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 123578999999999999876 789999998875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0014 Score=63.02 Aligned_cols=81 Identities=11% Similarity=0.052 Sum_probs=43.2
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCC-ccceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN-LVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv 183 (441)
+.|+.|..-.+|+......... .....+..+++|+...... .......|..+++.|...+ +.++++.. .+ ++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~-~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETAN-NYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHT-TCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEeCCcccceEEEEEeCCCCcc-cccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 4677788889998754321000 0000135788888755322 1122356888888775333 34566543 22 789
Q ss_pred EeecCCCC
Q 013519 184 YEYMQKGS 191 (441)
Q Consensus 184 ~e~~~~g~ 191 (441)
|||++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0019 Score=63.58 Aligned_cols=80 Identities=15% Similarity=0.025 Sum_probs=48.1
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCc-cceEEEEEeCCeEEE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNL-VKLIGYCWEDRQFLL 182 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~l 182 (441)
.+.|+.|....||++....... .....+..+++|+...... ...+..|+.+++.|...++ .++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~--~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred EEEeCCCcccceEEEEeCCCcc--ccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence 3567888889999985532110 0011246889998744221 1344478888888863333 55665542 2 38
Q ss_pred EEeecCCCC
Q 013519 183 VYEYMQKGS 191 (441)
Q Consensus 183 v~e~~~~g~ 191 (441)
|+||++|..
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999998743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.011 Score=58.37 Aligned_cols=74 Identities=14% Similarity=0.094 Sum_probs=44.7
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCc-cceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNL-VKLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv 183 (441)
+.|+.|-...+|++.... .+..+++|+....... .-...+|..+++.|...++ .++++++ .+ .+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v 179 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRI 179 (458)
T ss_dssp EEECC--CEEEEEEEETT---------TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEE
T ss_pred EEcCCCeEeEEEEEEECC---------CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEE
Confidence 467778888999975432 1367888876443211 1112478888988875445 4566655 22 359
Q ss_pred EeecCCCCH
Q 013519 184 YEYMQKGSL 192 (441)
Q Consensus 184 ~e~~~~g~L 192 (441)
|||++|..|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0096 Score=56.48 Aligned_cols=32 Identities=19% Similarity=0.249 Sum_probs=28.2
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 228 EKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 228 ~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
...++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 36799999999999999888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.87 E-value=0.064 Score=52.37 Aligned_cols=81 Identities=9% Similarity=0.034 Sum_probs=46.5
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv 183 (441)
+.|..|-...+|+........ .....+..+++++..... ...-...+|..+++.|. +.-..++++.+ .+ ++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESM--SLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEcCCCcccceEEEEeCCCcc--cccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence 467677788999986542110 000115678898865432 11122356888888875 33334555433 32 789
Q ss_pred EeecCCCCH
Q 013519 184 YEYMQKGSL 192 (441)
Q Consensus 184 ~e~~~~g~L 192 (441)
|||++|..|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.33 E-value=0.85 Score=39.80 Aligned_cols=115 Identities=10% Similarity=0.061 Sum_probs=78.0
Q ss_pred CCCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHh-hhccCCCCeeecCCCCCcE
Q 013519 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT-FLHSSEKSVIYRDFKASNI 241 (441)
Q Consensus 163 ~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~lH~~~~~ivHrDlkp~Ni 241 (441)
.||++ -..+-.+++.+.|.++.-+++.=+..+. .++...+++++..++.... +++ .-+|--|.|+||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~----~r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSA----RRLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCS----SSEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhh----CceeEEEeCceE
Confidence 57888 4455577788888887764443333442 3668899999999987766 554 367888999999
Q ss_pred EEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCC
Q 013519 242 LLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALD 313 (441)
Q Consensus 242 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~ 313 (441)
+++.++.++|.-.|+-...+ |.=+.+|-+ +-.+=|++..++.++..|+
T Consensus 116 ~f~~~~~p~i~hRGi~~~lp--------------P~e~~ee~f----------l~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESLP--------------PDEWDDERL----------LREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETTTBS--------------SCSCCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCcccCC--------------CCCCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 99999999999888743211 111222222 2245678888888877664
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.66 E-value=0.67 Score=40.33 Aligned_cols=115 Identities=8% Similarity=0.098 Sum_probs=78.5
Q ss_pred CCCCccceEEEEEeCCeEEEEEeecCCC-CHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcE
Q 013519 163 SHPNLVKLIGYCWEDRQFLLVYEYMQKG-SLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNI 241 (441)
Q Consensus 163 ~hpniv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 241 (441)
.||+++.. .+-.+.+.+.|.++.-+.+ ++.. + +.++...+++++..|+....++++ -+|--|.|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceE
Confidence 58988877 5666677777777665432 3322 3 346688999999998887765553 57888999999
Q ss_pred EEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCC
Q 013519 242 LLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALD 313 (441)
Q Consensus 242 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~ 313 (441)
+++.++.+++.-.|+-...++ .=+.+|-+ +-.+=|++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l~P--------------~~~~ee~f----------L~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVDP--------------LPVSEAEF----------LTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTBSC--------------CCCCHHHH----------HHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCCCC--------------CCCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 999999999998877432111 00122222 2245678889999988874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=84.07 E-value=0.53 Score=45.42 Aligned_cols=29 Identities=28% Similarity=0.327 Sum_probs=24.8
Q ss_pred CeeecCCCCCcEEE------cCCCceEEecccCCC
Q 013519 230 SVIYRDFKASNILL------DGSYNAKLSDFGLAK 258 (441)
Q Consensus 230 ~ivHrDlkp~Nill------~~~~~~kl~DFGla~ 258 (441)
.++|+|+.+.|||+ +++..+.++||..|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46899999999999 445679999998886
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.20 E-value=0.15 Score=50.31 Aligned_cols=61 Identities=11% Similarity=0.065 Sum_probs=16.4
Q ss_pred CCceecccCceEEEEEEecCCccccccccCCcEEEE------EEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 103 PDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAV------KKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 103 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vai------K~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
+.+.|| ||.||+|.+... ...||+ |...... .+....+.+|..+++.++|||+++.+.+.
T Consensus 146 l~~~lG---fG~v~~g~~~~~---------~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKK---------HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccccCC---chhhhccccccc---------CCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 446666 999999987642 124555 5544322 23345677889999999999999998876
Q ss_pred E
Q 013519 175 W 175 (441)
Q Consensus 175 ~ 175 (441)
.
T Consensus 214 ~ 214 (463)
T 3cxl_A 214 V 214 (463)
T ss_dssp E
T ss_pred E
Confidence 5
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 441 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-69 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-13 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 5e-69
Identities = 70/290 (24%), Positives = 124/290 (42%), Gaps = 30/290 (10%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFL 159
+G G FG V+KG K AV + + Q L+ ++ EV L
Sbjct: 9 QITVGQRIGSGSFGTVYKG----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 160 GKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
K H N++ +GY Q +V ++ + SL +HL + + IA A+
Sbjct: 59 RKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQ 115
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA 279
+ +LH KS+I+RD K++NI L K+ DFGLA + SH ++ G+ +
Sbjct: 116 GMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 280 APEYVAT---GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336
APE + +SDVY FG+VL E++TG + +
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-----------FMV 222
Query: 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386
+ + P L + + +++ +CL+ + RP ++L +++ ++
Sbjct: 223 GRGYLSPDLSKVRSNCPKAMK-RLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 5e-64
Identities = 69/287 (24%), Positives = 122/287 (42%), Gaps = 32/287 (11%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF 158
+ + LG G FG V+ G+ + VAVK S + AE
Sbjct: 13 ETLKLVERLGAGQFGEVWMGY--YNG--------HTKVAVKSLKQGS-MSPDAFLAEANL 61
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
+ + H LV+L ++ EYM+ GSL + L L N L +A A
Sbjct: 62 MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIA 119
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY 278
+ + F+ ++ I+RD +A+NIL+ + + K++DFGLA+L D +
Sbjct: 120 EGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 176
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338
APE + G +KSDV+ FG++L E++T R + E + + L+
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI------------QNLE 224
Query: 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ + P + Q++ C + P++RP+ + + L++
Sbjct: 225 RGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 8e-64
Identities = 68/314 (21%), Positives = 123/314 (39%), Gaps = 44/314 (14%)
Query: 94 LRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-W 152
+ +F + LG G G VFK + G +A K + + +R
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKV-SHKPS--------GLVMARKLIHLEIKPAIRNQI 51
Query: 153 QAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLK 212
E++ L + + P +V G + D + + E+M GSL+ L + G +P K
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGK 108
Query: 213 IAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRI 272
++I K LT+L + +++RD K SNIL++ KL DFG++ +
Sbjct: 109 VSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSF 163
Query: 273 MGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF------ 326
+GT Y +PE + H V+SD++ G+ L+EM G + ++
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223
Query: 327 --------------------ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLE 366
+RP + L I++ + +L + KCL
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283
Query: 367 AEPKNRPSMEEVLE 380
P R +++++
Sbjct: 284 KNPAERADLKQLMV 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (520), Expect = 2e-63
Identities = 64/314 (20%), Positives = 131/314 (41%), Gaps = 39/314 (12%)
Query: 85 YLKMFTLQDLRAATKNF---------RPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKA 135
++ FT +D A + F + + ++G G FG V G +
Sbjct: 3 FIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIF 56
Query: 136 VAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLEN 194
VA+K + R++ +E +G+F HPN++ L G + +++ E+M+ GSL++
Sbjct: 57 VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 116
Query: 195 HLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254
L + + + A + +L + + ++RD A NIL++ + K+SDF
Sbjct: 117 FLRQNDG--QFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDF 172
Query: 255 GLAKLGPIDGNSHVTTR---IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRA 311
GL++ D + T + APE + SDV+ +G+V+ E+++
Sbjct: 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY--- 229
Query: 312 LDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKN 371
GE D + + + P ++ + Q+++ C + + +
Sbjct: 230 -------GERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH------QLMLDCWQKDRNH 276
Query: 372 RPSMEEVLETLQNI 385
RP +++ TL +
Sbjct: 277 RPKFGQIVNTLDKM 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 7e-63
Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 38/288 (13%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF 158
K + +G+G FG V G D++ G VAVK D+ + + AE
Sbjct: 7 KELKLLQTIGKGEFGDVMLG--DYR---------GNKVAVKCIKNDATA--QAFLAEASV 53
Query: 159 LGKFSHPNLVKLIGYCWEDRQFL-LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
+ + H NLV+L+G E++ L +V EYM KGSL ++L +G L + LK ++D
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDV 112
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
+ + +L + ++RD A N+L+ AK+SDFGL K S
Sbjct: 113 CEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVK 165
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337
+ APE + KSDV+ FG++L E+ + R P + V R+
Sbjct: 166 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------------PRV 213
Query: 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+K + P +++ C + RPS ++ E L++I
Sbjct: 214 EKGYKMDAPDGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-62
Identities = 76/306 (24%), Positives = 115/306 (37%), Gaps = 43/306 (14%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVKF 158
N +LG G FG+V + +K GV VAVK + RE +E+K
Sbjct: 38 NLEFGKVLGSGAFGKVMNA-TAYGI---SKTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 159 LGKF-SHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKG----------------- 200
+ + SH N+V L+G C L++EY G L N+L K
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 201 ---SAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257
L + L A AK + FL KS ++RD A N+L+ K+ DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRP 317
+ D N V + APE + G +KSDV+ +G++L E+ +
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY---- 267
Query: 318 SGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEE 377
P + K++ + P I+ C + + RPS
Sbjct: 268 -----------PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316
Query: 378 VLETLQ 383
+ L
Sbjct: 317 LTSFLG 322
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-62
Identities = 63/287 (21%), Positives = 108/287 (37%), Gaps = 32/287 (11%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF 158
K+ LG G FG V G + VA+K S E+ E K
Sbjct: 4 KDLTFLKELGTGQFGVVKYG--KWRG--------QYDVAIKMIKEGS-MSEDEFIEEAKV 52
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
+ SH LV+L G C + R ++ EYM G L N+L L++ D
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVC 110
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY 278
+ + +L K ++RD A N L++ K+SDFGL++ D + +
Sbjct: 111 EAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRW 167
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338
+ PE + KSD++ FGV++ E+ + + + E
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TA 211
Query: 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ + L P + I+ C + RP+ + +L + ++
Sbjct: 212 EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 1e-61
Identities = 68/317 (21%), Positives = 113/317 (35%), Gaps = 44/317 (13%)
Query: 91 LQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR 150
L L N +GEG FGRVF+ VAVK ++ ++
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEP----FTMVAVKMLKEEASADMQ 60
Query: 151 -EWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-------- 201
++Q E + +F +PN+VKL+G C + L++EYM G L L
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 202 -------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248
PL +L IA A + +L + ++RD N L+ +
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMV 178
Query: 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG 308
K++DFGL++ + PE + +SDV+ +GVVL E+ +
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 309 LRALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAE 368
+ + + + D + P L ++ C
Sbjct: 239 GLQPY---------------YGMAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKL 282
Query: 369 PKNRPSMEEVLETLQNI 385
P +RPS + LQ +
Sbjct: 283 PADRPSFCSIHRILQRM 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-61
Identities = 74/303 (24%), Positives = 113/303 (37%), Gaps = 38/303 (12%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVKF 158
LG G FG+V + + VAVK P + RE +E+K
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDA----AMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 159 LGKFS-HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAE-------------- 203
L H N+V L+G C L++ EY G L N L RK +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 204 -PLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPI 262
L L + AK + FL S K+ I+RD A NILL K+ DFGLA+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 263 DGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV 322
D N V + APE + +SDV+ +G+ L E+ + + P
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256
Query: 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETL 382
K++ P I+ C +A+P RP+ +++++ +
Sbjct: 257 --------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 383 QNI 385
+
Sbjct: 303 EKQ 305
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 3e-61
Identities = 65/284 (22%), Positives = 106/284 (37%), Gaps = 31/284 (10%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVK 157
+++ LGEG +G V V+ T +AVAVK + E + E+
Sbjct: 5 EDWDLVQTLGEGAYGEVQLA-VNRVT--------EEAVAVKIVDMKRAVDCPENIKKEIC 55
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
+H N+VK G+ E L EY G L + + +P +
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQL 112
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
+ +LH + +RD K N+LLD N K+SDFGLA + + + ++ GT
Sbjct: 113 MAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 278 YAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336
Y APE + + DV+ G+VL ML G D S +
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--------------- 215
Query: 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ + K ++ K L P R ++ ++ +
Sbjct: 216 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-61
Identities = 66/303 (21%), Positives = 121/303 (39%), Gaps = 40/303 (13%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
+G+G FG V++G G+ VAVK + + +AE+ H N
Sbjct: 11 IGKGRFGEVWRGKWR-----------GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHEN 58
Query: 167 LVKLIGYCWEDR----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLT 222
++ I +D Q LV +Y + GSL ++L R + +K+A+ A L
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLA 114
Query: 223 FLHS------SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL--GPIDGNSHVTTRIMG 274
LH + ++ +RD K+ NIL+ + ++D GLA D +G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 275 TYGYAAPEYVAT------GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328
T Y APE + + ++D+Y G+V E+ ++ + D
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR-CSIGGIHEDYQLPYYDLVP 233
Query: 329 PSLT----DKRRLKKIMDPRLEEQYPIKGAL-LAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
+ K ++ + P + ++ AL + +I+ +C A R + + +TL
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
Query: 384 NIS 386
+S
Sbjct: 294 QLS 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 9e-61
Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 31/297 (10%)
Query: 92 QDLRAATKNFRP-DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-L 149
+ L N D LG G FG V +G + VA+K + +
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADT 53
Query: 150 REWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNT 209
E E + + + +P +V+LIG C + +LV E G L L K E +P +
Sbjct: 54 EEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSN 110
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK-LGPIDGNSHV 268
++ + + +L EK+ ++RD A N+LL + AK+SDFGL+K LG D
Sbjct: 111 VAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168
Query: 269 TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328
+ + APE + +SDV+ +GV + E L+ + E +
Sbjct: 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------ 222
Query: 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+++ + P + ++ C + ++RP V + ++
Sbjct: 223 ------AFIEQGKRMECPPECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (501), Expect = 1e-60
Identities = 67/287 (23%), Positives = 125/287 (43%), Gaps = 30/287 (10%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF 158
+ LG G +G V++G V K VAVK D+++ + E+ E
Sbjct: 17 TDITMKHKLGGGQYGEVYEG-VWKKY--------SLTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
+ + HPNLV+L+G C + F ++ E+M G+L ++L + + L +A +
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 125
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY 278
+ +L K+ I+RD A N L+ ++ K++DFGL++L +
Sbjct: 126 SAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKW 182
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338
APE +A +KSDV+ FGV+L E+ T + D ++
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQVY 226
Query: 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
++++ + P +++ C + P +RPS E+ + + +
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-60
Identities = 73/288 (25%), Positives = 121/288 (42%), Gaps = 32/288 (11%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF 158
+G G FG V G+ VA+K + ++ E +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGY--WLN--------KDKVAIKTIREGA-MSEEDFIEEAEV 53
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
+ K SHP LV+L G C E LV+E+M+ G L ++L + T L + +D
Sbjct: 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVC 111
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY 278
+ + +L E VI+RD A N L+ + K+SDFG+ + D +T +
Sbjct: 112 EGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKW 168
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338
A+PE + KSDV+ FGV++ E+ + + NR + E + D
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---------VEDISTGF 219
Query: 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386
++ PRL + QI+ C + P++RP+ +L L I+
Sbjct: 220 RLYKPRLASTH-------VYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-60
Identities = 63/288 (21%), Positives = 124/288 (43%), Gaps = 27/288 (9%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLR-EWQAEVKF 158
++G G FG V+KG L + VA+K + R ++ E
Sbjct: 8 CVTRQKVIGAGEFGEVYKG-----MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
+G+FSH N+++L G + + +++ EYM+ G+L+ L K + + A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIA 120
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG-NSHVTTRIMGTYG 277
+ +L + + ++RD A NIL++ + K+SDFGL+++ D ++ T+
Sbjct: 121 AGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337
+ APE ++ SDV+ FG+V+ E++T + E +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------V 222
Query: 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
K ++ P+ Q++++C + E RP +++ L +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-60
Identities = 63/289 (21%), Positives = 109/289 (37%), Gaps = 39/289 (13%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEV 156
+ + D +G G F V+KG +D +T VA + + + ++ E
Sbjct: 9 RFLKFDIEIGRGSFKTVYKG-LDTET--------TVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 157 KFLGKFSHPNLVKLIGYCWE----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLK 212
+ L HPN+V+ + +LV E M G+L+ +L R +
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRS 116
Query: 213 IAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG-SYNAKLSDFGLAKLGPIDGNSHVTTR 271
K L FLH+ +I+RD K NI + G + + K+ D GLA L +
Sbjct: 117 WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKA 172
Query: 272 IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331
++GT + APE DVY FG+ +LEM T + + +
Sbjct: 173 VIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------- 221
Query: 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+++ + +II C+ R S++++L
Sbjct: 222 -----YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 5e-60
Identities = 71/285 (24%), Positives = 115/285 (40%), Gaps = 32/285 (11%)
Query: 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG--LREWQAEVKFLGK 161
D LG G FG V KG+ K V K VAVK ++ E AE + +
Sbjct: 12 DKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 162 FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDL 221
+P +V++IG C + ++LV E + G L +L + + +++ + +
Sbjct: 65 LDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGM 120
Query: 222 TFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT-TRIMGTYGYAA 280
+L E + ++RD A N+LL + AK+SDFGL+K D N + T + A
Sbjct: 121 KYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 281 PEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340
PE + KSDV+ FGV++ E + + E L+K
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT------------AMLEKG 226
Query: 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
P + ++ C + +NRP V L+N
Sbjct: 227 ERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 5e-59
Identities = 65/280 (23%), Positives = 108/280 (38%), Gaps = 37/280 (13%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LG+G FG+V+K + +T A K + S + L ++ E+ L HPN
Sbjct: 20 LGDGAFGKVYKA-QNKET--------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
+VKL+ + + ++ E+ G+++ + PL + + L +LH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHD 128
Query: 227 SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT 286
+I+RD KA NIL + KL+DFG++ +GT + APE V
Sbjct: 129 --NKIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 287 GHLY-----VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM 341
K+DV+ G+ L+EM L R L KI
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEP----------------PHHELNPMRVLLKIA 228
Query: 342 -DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
P + + + KCLE R + ++L+
Sbjct: 229 KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 6e-59
Identities = 73/291 (25%), Positives = 117/291 (40%), Gaps = 30/291 (10%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAE 155
K+ R LG+G FG V +G D + G +VAVK PD + + + ++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
V + H NL++L G + V E GSL + L + T + A+
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAV 118
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHV-TTRIMG 274
A+ + +L S K I+RD A N+LL K+ DFGL + P + + +V
Sbjct: 119 QVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 275 TYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334
+ + APE + T SD + FGV L EM T + L
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW---------------IGLNGS 221
Query: 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ L KI P ++++C +P++RP+ + + L
Sbjct: 222 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 6e-59
Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 36/289 (12%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVK 157
++ +G G +GR K GK + K+ + S+ + +EV
Sbjct: 5 DYEVLYTIGTGSYGRCQKI-RRKSD--------GKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 158 FLGKFSHPNLVKLIGYCWE--DRQFLLVYEYMQKGSLENHLFRKGSA-EPLPWNTRLKIA 214
L + HPN+V+ + + +V EY + G L + + + + L L++
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 215 IDAAKDLTFLHS---SEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTR 271
L H +V++RD K +N+ LDG N KL DFGLA++ ++ ++
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173
Query: 272 IMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331
+GT Y +PE + KSD++ G +L E+ + +
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF----------------TAF 217
Query: 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ K KI + + P + + +II + L + +RPS+EE+LE
Sbjct: 218 SQKELAGKIREGKFRR-IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 1e-58
Identities = 75/304 (24%), Positives = 115/304 (37%), Gaps = 45/304 (14%)
Query: 83 PNYLKMFTLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSN 142
P+ ++F D K F +G G FG V+ D + + VA+KK +
Sbjct: 2 PDVAELFFKDDPE---KLFSDLREIGHGSFGAVYFA-RDVRN--------SEVVAIKKMS 49
Query: 143 PDSIQGLREWQ---AEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRK 199
Q +WQ EV+FL K HPN ++ G + LV EY + + K
Sbjct: 50 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK 109
Query: 200 GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259
PL + A + L +LHS ++I+RD KA NILL KL DFG A +
Sbjct: 110 K---PLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
Query: 260 GPIDGNSHVTTRIMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLLEMLTGLRALDTNR 316
+GT + APE + G K DV+ G+ +E+ L
Sbjct: 165 ------MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL---- 214
Query: 317 PSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSME 376
++ L I + + CL+ P++RP+ E
Sbjct: 215 ------------FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262
Query: 377 EVLE 380
+L+
Sbjct: 263 VLLK 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-58
Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 33/297 (11%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF 158
++ R + LG+G FG V+ G + VA+K P + + E +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQV 65
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
+ K H LV+L E+ +V EYM KGSL + L + + L + +A A
Sbjct: 66 MKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIA 123
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY 278
+ ++ + ++RD +A+NIL+ + K++DFGLA+L D +
Sbjct: 124 SGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 180
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338
APE G +KSDV+ FG++L E+ T R + E + +++
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------------DQVE 228
Query: 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVIEIEPKKK 395
+ + P ++ +C EP+ RP+ E + L++ EP+ +
Sbjct: 229 RGYRMPCPPECPES----LHDLMCQCWRKEPEERPTFEYLQAFLEDYFT-STEPQYQ 280
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-58
Identities = 74/285 (25%), Positives = 120/285 (42%), Gaps = 32/285 (11%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKFLGKFSH 164
++G G FG V+ G + G AVK N + G + ++ E + FSH
Sbjct: 34 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 165 PNLVKLIGYCWE-DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTF 223
PN++ L+G C + L+V YM+ G L N + + + + AK + F
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKF 145
Query: 224 LHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG--NSHVTTRIMGTYGYAAP 281
L K ++RD A N +LD + K++DFGLA+ + H T + A
Sbjct: 146 LA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 282 EYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK-KI 340
E + T KSDV+ FGV+L E++T P + D L +R L+ +
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTR-----GAPPYPDVNTFDITVYLLQGRRLLQPEY 258
Query: 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
L E +++KC + + RPS E++ + I
Sbjct: 259 CPDPLYE------------VMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-57
Identities = 67/297 (22%), Positives = 118/297 (39%), Gaps = 38/297 (12%)
Query: 90 TLQDLRAA------TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP 143
L+ LR+ K + +G+G G V+ +D T G+ VA+++ N
Sbjct: 5 ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTA-MDVAT--------GQEVAIRQMNL 55
Query: 144 DSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAE 203
E+ + + +PN+V + + +V EY+ GSL + +
Sbjct: 56 QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-- 113
Query: 204 PLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263
+ + + L FLHS VI+RD K+ NILL + KL+DFG I
Sbjct: 114 --DEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--IT 167
Query: 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323
+ ++GT + APE V K D++ G++ +EM+ G P
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----- 222
Query: 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ + E Q P K + + + +CL+ + + R S +E+L+
Sbjct: 223 ----------RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-57
Identities = 72/285 (25%), Positives = 118/285 (41%), Gaps = 39/285 (13%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVK---KSNPDSIQGLREWQAE 155
++F LG+G FG V+ + ++ +A+K K+ + + + E
Sbjct: 6 EDFEIGRPLGKGKFGNVYLA-REKQS--------KFILALKVLFKAQLEKAGVEHQLRRE 56
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
V+ HPN+++L GY + + L+ EY G++ L +
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYIT 113
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
+ A L++ HS K VI+RD K N+LL + K++DFG + P S T + GT
Sbjct: 114 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGT 167
Query: 276 YGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
Y PE + K D++ GV+ E L G + N T +
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN----------------TYQE 211
Query: 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
K+I R+E +P A +I + L+ P RP + EVLE
Sbjct: 212 TYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 6e-57
Identities = 69/302 (22%), Positives = 117/302 (38%), Gaps = 43/302 (14%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVK 157
+ + ++GEG FG+V K K G+ A+K+ S R++ E++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKA-RIKKD------GLRMDAAIKRMKEYASKDDHRDFAGELE 62
Query: 158 FLGKFS-HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRK-------------GSAE 203
L K HPN++ L+G C L EY G+L + L + +A
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 204 PLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263
L L A D A+ + +L K I+RD A NIL+ +Y AK++DFGL++
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQE-- 178
Query: 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323
T + A E + SDV+ +GV+L E+++ E
Sbjct: 179 -VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY- 236
Query: 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
+L + + ++ +C +P RPS ++L +L
Sbjct: 237 -----------EKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSLN 281
Query: 384 NI 385
+
Sbjct: 282 RM 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-56
Identities = 61/286 (21%), Positives = 116/286 (40%), Gaps = 27/286 (9%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNP-DSIQGLREWQAEVKFL 159
F+ +LG G FG V+KG P V VA+K+ S + +E E +
Sbjct: 11 FKKIKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 160 GKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
+P++ +L+G C L+ + M G L +++ + + L + AK
Sbjct: 66 ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAK 122
Query: 220 DLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYA 279
+ +L ++ +++RD A N+L+ + K++DFGLAKL + + +
Sbjct: 123 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 280 APEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339
A E + +SDV+ +GV + E++T P+ E +
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISS 224
Query: 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
I++ P + I++KC + +RP E++ +
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-56
Identities = 65/287 (22%), Positives = 110/287 (38%), Gaps = 29/287 (10%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEVKF 158
+GEG FG V +G AVA+K + +RE + E
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
+ +F HP++VKLIG E+ ++ + E G L + L + L + + A +
Sbjct: 62 MRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKY--SLDLASLILYAYQLS 118
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGY 278
L +L K ++RD A N+L+ + KL DFGL++ D + ++ +
Sbjct: 119 TALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKW 175
Query: 279 AAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338
APE + SDV+ FGV + E+L + + + R++
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI------------GRIE 223
Query: 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+ P ++ KC +P RP E+ L I
Sbjct: 224 NGERLPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 6e-55
Identities = 74/302 (24%), Positives = 119/302 (39%), Gaps = 37/302 (12%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-LREWQAEVKF 158
+ LG G FG+V + K + VAVK + R +E+K
Sbjct: 14 RLKLGKPLGRGAFGQVIEA----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 159 LGKFSH-PNLVKLIGYCWED-RQFLLVYEYMQKGSLENHLFRKGS-------------AE 203
L H N+V L+G C + +++ E+ + G+L +L K + +
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 204 PLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPID 263
L + + AK + FL S + I+RD A NILL K+ DFGLA+ D
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 264 GNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323
+ + APE + ++SDV+ FGV+L E+ + + E
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
RRLK+ R + + Q ++ C EP RP+ E++E L
Sbjct: 248 -----------RRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLG 292
Query: 384 NI 385
N+
Sbjct: 293 NL 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-54
Identities = 65/305 (21%), Positives = 132/305 (43%), Gaps = 34/305 (11%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVK 157
+ LG+G FG V++G VA+K N S++ E+ E
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEP----ETRVAIKTVNEAASMRERIEFLNEAS 75
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSA-------EPLPWNTR 210
+ +F+ ++V+L+G + + L++ E M +G L+++L A P +
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT 270
+++A + A + +L++ ++RD A N ++ + K+ DFG+ +
Sbjct: 136 IQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 271 RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330
+ + + +PE + G SDV+ FGVVL E+ T
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---------------QG 238
Query: 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVIEI 390
L++++ L+ +M+ L + P + +++ C + PK RPS E++ +++ E+
Sbjct: 239 LSNEQVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE----EM 293
Query: 391 EPKKK 395
EP +
Sbjct: 294 EPGFR 298
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-53
Identities = 74/301 (24%), Positives = 117/301 (38%), Gaps = 35/301 (11%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-GLREWQAEVKF 158
LGEG FG+V L K VAVK D+ + L + +E++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 159 LGKFS-HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGS-------------AEP 204
+ H N++ L+G C +D ++ EY KG+L +L + E
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 205 LPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDG 264
L + A A+ + +L S K I+RD A N+L+ K++DFGLA+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 265 NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV 324
TT + APE + +SDV+ FGV+L E+ T + P E
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245
Query: 325 DFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQN 384
L K++ P ++ C A P RP+ ++++E L
Sbjct: 246 ------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 385 I 385
I
Sbjct: 294 I 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 3e-53
Identities = 61/283 (21%), Positives = 107/283 (37%), Gaps = 35/283 (12%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEV 156
+F+ +LGEG F V + T + A+K I + E
Sbjct: 9 DFKFGKILGEGSFSTVVLA-RELAT--------SREYAIKILEKRHIIKENKVPYVTRER 59
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAID 216
+ + HP VKL +D + Y + G L ++ + G +
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAE 116
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
L +LH K +I+RD K NILL+ + +++DFG AK+ + +GT
Sbjct: 117 IVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336
Y +PE + SD++ G ++ +++ GL + +
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF----------------RAGNEYLI 218
Query: 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
+KI+ +LE +P K A ++ K L + R EE+
Sbjct: 219 FQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (449), Expect = 3e-52
Identities = 62/285 (21%), Positives = 107/285 (37%), Gaps = 36/285 (12%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFL 159
++ LG G FG V + + T G A K + E++ +
Sbjct: 27 HYDIHEELGTGAFGVVHRV-TERAT--------GNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 160 GKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
HP LV L +D + +++YE+M G L + + + + + ++ K
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCK 135
Query: 220 DLTFLHSSEKSVIYRDFKASNILL--DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
L +H E + ++ D K NI+ S KL DFGL +D V GT
Sbjct: 136 GLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTT-GTAE 190
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337
+AAPE + +D++ GV+ +L+GL D L
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF----------------GGENDDETL 234
Query: 338 KKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ + D +++ + I K L A+P R ++ + LE
Sbjct: 235 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 174 bits (443), Expect = 3e-51
Identities = 65/340 (19%), Positives = 118/340 (34%), Gaps = 49/340 (14%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPN 166
LG G FG V + V+ T G+ K N + E+ + + HP
Sbjct: 37 LGSGAFGVVHRC-VEKAT--------GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 87
Query: 167 LVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS 226
L+ L + + +L+ E++ G L + + + + + A + L +H
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHE 145
Query: 227 SEKSVIYRDFKASNILLDGSYNA--KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYV 284
S+++ D K NI+ + + K+ DFGLA + T +AAPE V
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIV 200
Query: 285 ATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKKIM--D 342
+ +D++ GV+ +L+GL D L+ + D
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPF----------------AGEDDLETLQNVKRCD 244
Query: 343 PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE-------------TLQNISVIE 389
+E + A I L+ EP+ R ++ + LE + + +
Sbjct: 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNK 304
Query: 390 IEPKKKAKARGNYNNNSNDNQRGHPHNRRSQSPLHSKHGD 429
I K K K + + + R P + D
Sbjct: 305 IRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYD 344
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (419), Expect = 1e-48
Identities = 68/297 (22%), Positives = 115/297 (38%), Gaps = 37/297 (12%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG---LREWQA 154
+ + +LG GG V D + + VAVK D + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLA-RDLRL--------HRDVAVKVLRADLARDPSFYLRFRR 56
Query: 155 EVKFLGKFSHPNLVKLIGYCWED----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTR 210
E + +HP +V + + +V EY+ +L + + +G P+
Sbjct: 57 EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRA 113
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNS-HVT 269
+++ DA + L F H +I+RD K +NI++ + K+ DFG+A+ GNS T
Sbjct: 114 IEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171
Query: 270 TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329
++GT Y +PE + +SDVY G VL E+LTG F
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--------------FTGD 217
Query: 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-SMEEVLETLQNI 385
S DP + +++K L P+NR + E+ L +
Sbjct: 218 SPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 164 bits (417), Expect = 2e-48
Identities = 73/299 (24%), Positives = 113/299 (37%), Gaps = 51/299 (17%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKK--------SNPDSIQGLRE 151
N+ P +LG G V + + T K AVK + + +Q LRE
Sbjct: 4 NYEPKEILGRGVSSVVRRC-IHKPT--------CKEYAVKIIDVTGGGSFSAEEVQELRE 54
Query: 152 -WQAEVKFLGKFS-HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNT 209
EV L K S HPN+++L + F LV++ M+KG L ++L K L
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKE 111
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269
KI + + LH ++++RD K NILLD N KL+DFG +
Sbjct: 112 TRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKL 166
Query: 270 TRIMGTYGYAAPEYVATGHLY------VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323
+ GT Y APE + + D++ GV++ +L G
Sbjct: 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF----------- 215
Query: 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGAL--LAGQIIIKCLEAEPKNRPSMEEVLE 380
L+ IM + P ++ + L +P+ R + EE L
Sbjct: 216 -----WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-47
Identities = 57/338 (16%), Positives = 118/338 (34%), Gaps = 42/338 (12%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFL 159
+ LG G FG V + V+ + K K + E+ L
Sbjct: 6 KYMIAEDLGRGEFGIVHRC-VETSS--------KKTYMAKFVKVKGTD-QVLVKKEISIL 55
Query: 160 GKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAK 219
H N++ L + ++++E++ + + L + +
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF--ELNEREIVSYVHQVCE 113
Query: 220 DLTFLHSSEKSVIYRDFKASNILLD--GSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
L FLHS ++ + D + NI+ S K+ +FG A+ N +
Sbjct: 114 ALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPE 168
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337
Y APE + +D++ G ++ +L+G+ + T+++ +
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF----------------LAETNQQII 212
Query: 338 KKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET---LQNISVIEIEP 392
+ IM + +E+ + ++ A + + L E K+R + E L+ Q I + +
Sbjct: 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272
Query: 393 KKKAKARGNYNNNSNDNQRGHPHNRRSQSP--LHSKHG 428
+ K R Y+ + R + S+ G
Sbjct: 273 IRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKG 310
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 2e-47
Identities = 65/295 (22%), Positives = 113/295 (38%), Gaps = 42/295 (14%)
Query: 92 QDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE 151
+D+R + +LG G F V D +T K VA+K +++G
Sbjct: 5 EDIR---DIYDFRDVLGTGAFSEVILA-EDKRT--------QKLVAIKCIAKKALEGKEG 52
Query: 152 -WQAEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTR 210
+ E+ L K HPN+V L L+ + + G L + + KG
Sbjct: 53 SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDA 109
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL---DGSYNAKLSDFGLAKLGPIDGNSH 267
++ + +LH + +++RD K N+L D +SDFGL+K+ +
Sbjct: 110 SRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGS 164
Query: 268 VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327
V + GT GY APE +A D + GV+ +L G
Sbjct: 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF--------------- 209
Query: 328 RPSLTDKRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
D + ++I+ + + Y + A I +E +P+ R + E+ L+
Sbjct: 210 -YDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-46
Identities = 72/332 (21%), Positives = 128/332 (38%), Gaps = 29/332 (8%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE-WQAEV 156
+ + +GEG +G V + D+ VA+KK +P Q + E+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAY-DNVN--------KVRVAIKKISPFEHQTYCQRTLREI 57
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAID 216
K L +F H N++ + + Y+ + L++ + L +
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ 117
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT-TRIMGT 275
+ L ++HS +V++RD K SN+LL+ + + K+ DFGLA++ D + T + T
Sbjct: 118 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175
Query: 276 YGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRPSG--EHVLVDFARPSLT 332
Y APE + Y KS D++ G +L EML+ H+L PS
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235
Query: 333 DKRRLKKIMDPRLEEQYPIKGAL-----------LAGQIIIKCLEAEPKNRPSMEEVLE- 380
D + + P K + A ++ K L P R +E+ L
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295
Query: 381 -TLQNISVIEIEPKKKAKARGNYNNNSNDNQR 411
L+ EP +A + + + ++
Sbjct: 296 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEK 327
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-45
Identities = 66/291 (22%), Positives = 106/291 (36%), Gaps = 32/291 (10%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG-----LREWQAEVKFLG 160
LGEG F V+K D T + VA+KK R E+K L
Sbjct: 5 FLGEGQFATVYKA-RDKNT--------NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
+ SHPN++ L+ LV+++M+ L + + +
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQG 112
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAA 280
L +LH +++RD K +N+LLD + KL+DFGLAK + T + T Y A
Sbjct: 113 LEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRA 168
Query: 281 PEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSG-----EHVLVDFARPSLTDK 334
PE + +Y V D++ G +L E+L + L + L D
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228
Query: 335 RRLKKIMDPRLEEQYPIKGAL-----LAGQIIIKCLEAEPKNRPSMEEVLE 380
L + + P+ +I P R + + L+
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-45
Identities = 63/286 (22%), Positives = 104/286 (36%), Gaps = 45/286 (15%)
Query: 107 LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG------LREWQAEVKFLG 160
LG G F V K + T G A K + + + EV L
Sbjct: 18 LGSGQFAVVKKC-REKST--------GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 161 KFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
+ HPN++ L +L+ E + G L + L K L +
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNG 125
Query: 221 LTFLHSSEKSVIYRDFKASNILLD----GSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
+ +LHS + + D K NI+L K+ DFGLA + I GT
Sbjct: 126 VYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTP 180
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336
+ APE V L +++D++ GV+ +L+G T +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG----------------ASPFLGDTKQET 224
Query: 337 LKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
L + + E++Y + LA I + L +PK R ++++ L+
Sbjct: 225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (402), Expect = 3e-45
Identities = 63/293 (21%), Positives = 110/293 (37%), Gaps = 45/293 (15%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQG------LREWQ 153
+F ++G GGFG V+ T GK A+K + I+ +
Sbjct: 5 DFSVHRIIGRGGFGEVYGC-RKADT--------GKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 154 AEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKI 213
+ + P +V + + + + M G L HL + G
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFY 112
Query: 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM 273
A + L +H+ + V+YRD K +NILLD + ++SD GLA D + +
Sbjct: 113 AAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASV 166
Query: 274 GTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332
GT+GY APE + G Y +D + G +L ++L G ++ +H +
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-------- 218
Query: 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM-----EEVLE 380
R+ M L + + + ++ L+ + R +EV E
Sbjct: 219 ---RMTLTMAVELPDSFSPE----LRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 3e-45
Identities = 65/284 (22%), Positives = 101/284 (35%), Gaps = 38/284 (13%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEV 156
+F MLG+G FG+VF KT + A+K D + + E
Sbjct: 3 DFILHKMLGKGSFGKVFLA-EFKKT--------NQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 157 KFLGK-FSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
+ L + HP L + V EY+ G L H+ + A
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAA 110
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
+ L FLH K ++YRD K NILLD + K++DFG+ K + GT
Sbjct: 111 EIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGT 166
Query: 276 YGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
Y APE + D + FGV+L EML G + D
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMDNP 220
Query: 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
+ ++ ++ +++K EP+ R + +
Sbjct: 221 FYPRWLEKEAKD------------LLVKLFVREPEKRLGVRGDI 252
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-44
Identities = 69/301 (22%), Positives = 112/301 (37%), Gaps = 30/301 (9%)
Query: 97 ATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ--- 153
A + + +GEG +G+VFK D K G+ VA+K+ + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKA-RDLKNG-------GRFVALKRVRVQTGEEGMPLSTIR 56
Query: 154 --AEVKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLEN---HLFRKGSAEPLPWN 208
A ++ L F HPN+V+L C R + ++ K +P
Sbjct: 57 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116
Query: 209 TRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHV 268
T + + L FLHS V++RD K NIL+ S KL+DFGLA+ I
Sbjct: 117 TIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMA 171
Query: 269 TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328
T ++ T Y APE + D++ G + EM + + +
Sbjct: 172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231
Query: 329 PSLTDKRRLKKIMDPRLE---------EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVL 379
++ + + PR E++ L +++KCL P R S L
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
Query: 380 E 380
Sbjct: 292 S 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 152 bits (384), Expect = 2e-43
Identities = 56/294 (19%), Positives = 112/294 (38%), Gaps = 29/294 (9%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVK 157
+ +GEG +G V+K + G+ A+KK + E+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQ--NNY--------GETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
L + H N+VKL ++ +LV+E++ + + +G L T +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQL 109
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
+ + H + V++RD K N+L++ K++DFGLA+ I + T I+ +
Sbjct: 110 LNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWY 166
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGE-----HVLVDFARPSLT 332
A + + D++ G + EM+ G + + +L +
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 333 DKRRLKK------IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ L K + +P E + ++ K L+ +P R + ++ LE
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-43
Identities = 58/294 (19%), Positives = 109/294 (37%), Gaps = 27/294 (9%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVK 157
NF+ +GEG +G V+K + T G+ VA+KK D+ E+
Sbjct: 3 NFQKVEKIGEGTYGVVYKA-RNKLT--------GEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 158 FLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDA 217
L + +HPN+VKL+ + + LV+E++ + + +P
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQL 111
Query: 218 AKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
+ L F HS V++RD K N+L++ KL+DFGLA+ + T ++ +
Sbjct: 112 LQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWY 168
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337
A + + D++ G + EM+T + + + + +
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 338 KKIMDPRLEEQYPIKGAL-----------LAGQIIIKCLEAEPKNRPSMEEVLE 380
P + +P ++ + L +P R S + L
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-42
Identities = 62/290 (21%), Positives = 103/290 (35%), Gaps = 51/290 (17%)
Query: 101 FRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLRE------WQA 154
++ +LG GGFG V+ G + VA+K D I E
Sbjct: 6 YQVGPLLGSGGFGSVYSG-IRVSD--------NLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 155 EVKFLGKFS--HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLK 212
EV L K S +++L+ + F+L+ E + + L
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 114
Query: 213 IAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS-YNAKLSDFGLAKLGPIDGNSHVTTR 271
+ + H V++RD K NIL+D + KL DFG L V T
Sbjct: 115 FFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTD 168
Query: 272 IMGTYGYAAPEYVATGHLYVKS-DVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPS 330
GT Y+ PE++ + +S V+ G++L +M+ G + +
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------------- 213
Query: 331 LTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ R + R+ + +I CL P +RP+ EE+
Sbjct: 214 -EEIIRGQVFFRQRVSSE--------CQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-42
Identities = 60/304 (19%), Positives = 105/304 (34%), Gaps = 35/304 (11%)
Query: 95 RAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA 154
R ++ ++G G FG V++ + G+ VA+KK D RE
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQA-KLCDS--------GELVAIKKVLQDKRFKNRE--- 63
Query: 155 EVKFLGKFSHPNLVKLIGYCWEDRQ------FLLVYEYMQKGSLENHLFRKGSAEPLPWN 208
++ + K H N+V+L + + + LV +Y+ + + + LP
Sbjct: 64 -LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 209 TRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD-GSYNAKLSDFGLAKLGPIDGNSH 267
+ L ++HS + +RD K N+LLD + KL DFG AK +
Sbjct: 123 YVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEP 178
Query: 268 VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV--- 324
+ I Y A DV+ G VL E+L G + + V +
Sbjct: 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 325 --------DFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSME 376
+ + +I + + + A + + LE P R +
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
Query: 377 EVLE 380
E
Sbjct: 299 EACA 302
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (375), Expect = 7e-42
Identities = 68/290 (23%), Positives = 116/290 (40%), Gaps = 45/290 (15%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAE 155
++F+ LG G FGRV G+ A+K + + + + E
Sbjct: 4 QDFQILRTLGTGSFGRVHLI-RSRHN--------GRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
L +HP ++++ G + +Q ++ +Y++ G L + L + + P A
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAA 111
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
+ L +LH K +IYRD K NILLD + + K++DFG AK P VT + GT
Sbjct: 112 EVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGT 164
Query: 276 YGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
Y APE V+T D + FG+++ EML G +
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF----------------YDSNTMK 208
Query: 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR-----PSMEEVLE 380
+KI++ L +P ++ + + + R E+V
Sbjct: 209 TYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (372), Expect = 1e-41
Identities = 53/302 (17%), Positives = 96/302 (31%), Gaps = 36/302 (11%)
Query: 93 DLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREW 152
+LR + +R +G G FG ++ G D G+ VA+K + +
Sbjct: 2 ELRVGNR-YRLGRKIGSGSFGDIYLG-TDIAA--------GEEVAIKLECVKTKH--PQL 49
Query: 153 QAEVKFLGKFSHPNLVKLIGYCWEDRQ-FLLVYEYMQKGSLENHLFRKGSAEPLPWNTRL 211
E K + I +C + ++V E + + F T L
Sbjct: 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVL 106
Query: 212 KIAIDAAKDLTFLHSSEKSVIYRDFKASNIL---LDGSYNAKLSDFGLAKLGPIDGNS-- 266
+A + ++HS K+ I+RD K N L + DFGLAK
Sbjct: 107 LLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164
Query: 267 ---HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL 323
+ GT YA+ + D+ G VL+ G + + +
Sbjct: 165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224
Query: 324 VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383
+ + L + YP + + C ++P + + +
Sbjct: 225 YE------RISEKKMSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 384 NI 385
N+
Sbjct: 275 NL 276
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-41
Identities = 68/308 (22%), Positives = 116/308 (37%), Gaps = 41/308 (13%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQA--EVK 157
+ +G+G FG VFK KT G+ VA+KK ++ + A E+K
Sbjct: 11 KYEKLAKIGQGTFGEVFKA-RHRKT--------GQKVALKKVLMENEKEGFPITALREIK 61
Query: 158 FLGKFSHPNLVKLIGYCWE--------DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNT 209
L H N+V LI C LV+++ + +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSE 118
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269
++ L ++H ++ +++RD KA+N+L+ KL+DFGLA+ + NS
Sbjct: 119 IKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176
Query: 270 --TRIMGTYGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTGLRALDTNRPSG------- 319
T + T Y PE + Y D++G G ++ EM T + N
Sbjct: 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236
Query: 320 ------EHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGA-LLAGQIIIKCLEAEPKNR 372
V + L +K L K +++++ A +I K L +P R
Sbjct: 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 296
Query: 373 PSMEEVLE 380
++ L
Sbjct: 297 IDSDDALN 304
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-40
Identities = 55/283 (19%), Positives = 105/283 (37%), Gaps = 38/283 (13%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-H 164
+LG G G+V + + +T + A+K +Q + + EV+ + S
Sbjct: 19 VLGLGINGKVLQI-FNKRT--------QEKFALKM-----LQDCPKARREVELHWRASQC 64
Query: 165 PNLVKLIGYC----WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKD 220
P++V+++ + L+V E + G L + + +G + +I +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEA 123
Query: 221 LTFLHSSEKSVIYRDFKASNILLDGSYN---AKLSDFGLAKLGPIDGNSHVTTRIMGTYG 277
+ +LHS ++ +RD K N+L KL+DFG AK + T
Sbjct: 124 IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPY 178
Query: 278 YAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337
Y APE + D++ GV++ +L G +N G + +
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN--HGLAISPGMKTRIRMGQYEF 236
Query: 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ E+ +I L+ EP R ++ E +
Sbjct: 237 PNPEWSEVSEE--------VKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-40
Identities = 59/296 (19%), Positives = 110/296 (37%), Gaps = 29/296 (9%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEV 156
+ + +GEG +G VFK + +T + VA+K+ D E+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDDDEGVPSSALREI 52
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAID 216
L + H N+V+L D++ LV+E+ + + G L
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQ 109
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
K L F H ++V++RD K N+L++ + KL++FGLA+ I + + ++ +
Sbjct: 110 LLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLW 166
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEH---VLVDFARPSLTD 333
D++ G + E+ R L + + P+
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226
Query: 334 KRRLKKIMDPRLEEQYPIKGALL---------AGQIIIKCLEAEPKNRPSMEEVLE 380
+ K+ D + YP +L+ ++ L+ P R S EE L+
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-39
Identities = 64/318 (20%), Positives = 119/318 (37%), Gaps = 43/318 (13%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEV 156
+R +G G +G V VD +T G VA+KK + E+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSA-VDGRT--------GAKVAIKKLYRPFQSELFAKRAYREL 68
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQ------FLLVYEYMQKGSLENHLFRKGSAEPLPWNTR 210
+ L H N++ L+ D F LV +M G+ L + L +
Sbjct: 69 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KLGEDRI 123
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT 270
+ K L ++H+ +I+RD K N+ ++ K+ DFGLA+ +S +T
Sbjct: 124 QFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTG 177
Query: 271 RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV------ 324
++ + A + D++ G ++ EM+TG + + +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 325 ---DFARPSLTDKRRLKKIMDPRLE----EQYPIKGALLAGQIIIKCLEAEPKNRPSMEE 377
+F + +D+ + P LE + LA ++ K L + + R + E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 378 VLET--LQNISVIEIEPK 393
L +++ E EP+
Sbjct: 298 ALAHPYFESLHDTEDEPQ 315
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (352), Expect = 7e-39
Identities = 46/297 (15%), Positives = 89/297 (29%), Gaps = 35/297 (11%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKF 158
+++ +GEG FG +F+G + + VA+K S + + E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEG-TNLLN--------NQQVAIKFEPRRSDA--PQLRDEYRT 53
Query: 159 LGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAA 218
+ + + Y ++ ++ + SLE+ L G T A
Sbjct: 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG--RKFSVKTVAMAAKQML 111
Query: 219 KDLTFLHSSEKSVIYRDFKASNILLD-----GSYNAKLSDFGLAKLGPIDGNS-----HV 268
+ +H KS++YRD K N L+ + + DFG+ K
Sbjct: 112 ARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 269 TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328
+ GT Y + + D+ G V + L G + +
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---- 225
Query: 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385
+R +K L E + + P + + +
Sbjct: 226 -----ERIGEKKQSTPLRELCAGFPEEFY-KYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-38
Identities = 71/290 (24%), Positives = 110/290 (37%), Gaps = 42/290 (14%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAE 155
+F +LG+G FG+V + T G+ A+K + I + E
Sbjct: 5 NDFDYLKLLGKGTFGKVILV-REKAT--------GRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
+ L HP L L + V EY G L HL R+
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGA 112
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
+ L +LH + V+YRD K N++LD + K++DFGL K G DG + GT
Sbjct: 113 EIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGT 168
Query: 276 YGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335
Y APE + D +G GVV+ EM+ G + +R
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----------------YNQDHER 212
Query: 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSM-----EEVLE 380
+ I+ + +P + A ++ L+ +PK R +EV+E
Sbjct: 213 LFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 2e-35
Identities = 60/289 (20%), Positives = 97/289 (33%), Gaps = 45/289 (15%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQ---AEV 156
F LG G FGRV ++ G A+K + + L++ + E
Sbjct: 42 QFDRIKTLGTGSFGRVMLV-KHKES--------GNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 157 KFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAID 216
+ L + P LVKL ++ +V EY+ G + +HL R G A
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQ 149
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTY 276
+LHS +IYRD K N+L+D +++DFG AK T + GT
Sbjct: 150 IVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTP 202
Query: 277 GYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336
APE + + D + GV++ EM G F
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP--------------FFADQPIQIYE 248
Query: 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNR-----PSMEEVLE 380
R + ++ L+ + R + ++
Sbjct: 249 KIVSGKVRFPSHFSSD----LKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (321), Expect = 4e-34
Identities = 54/306 (17%), Positives = 103/306 (33%), Gaps = 48/306 (15%)
Query: 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFL 159
+++ LG G + VF+ ++ + V VK P + + + E+K L
Sbjct: 36 DYQLVRKLGRGKYSEVFEA-INITN--------NEKVVVKILKPVKKK---KIKREIKIL 83
Query: 160 GKFS-HPNLVKLIGYCWE--DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAID 216
PN++ L + R LV+E++ + + L +
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYE 137
Query: 217 AAKDLTFLHSSEKSVIYRDFKASNILLDGS-YNAKLSDFGLAKLGPIDGNSHVTTRIMGT 275
K L + HS +++RD K N+++D +L D+GLA+ + +
Sbjct: 138 ILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVAS 192
Query: 276 YGYAAPEYVATGHLY-VKSDVYGFGVVLLEMLTG---LRALDTNRPSGEHVLVDFARPSL 331
+ PE + +Y D++ G +L M+ N + L
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252
Query: 332 TDKRRLKKI-MDPRLEEQYPIKGAL----------------LAGQIIIKCLEAEPKNRPS 374
D I +DPR + A + K L + ++R +
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312
Query: 375 MEEVLE 380
E +E
Sbjct: 313 AREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-33
Identities = 77/312 (24%), Positives = 122/312 (39%), Gaps = 44/312 (14%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI----QGLREWQA 154
+NF +LG G +G+VF + T GK A+K +I + +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVR--KISGHDT----GKLYAMKVLKKATIVQKAKTTEHTRT 77
Query: 155 EVKFLGKFSH-PNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKI 213
E + L P LV L + + L+ +Y+ G L HL ++ E +
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIY 134
Query: 214 AIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIM 273
+ L LH + +IYRD K NILLD + + L+DFGL+K + +
Sbjct: 135 VGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFC 191
Query: 274 GTYGYAAPEYVATGHLYV--KSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331
GT Y AP+ V G D + GV++ E+LTG
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF----------------TVD 235
Query: 332 TDKRRLKKIMDPRLEEQYPIKGAL--LAGQIIIKCLEAEPKNRPSM-----EEVLET--L 382
+K +I L+ + P + LA +I + L +PK R +E+ E
Sbjct: 236 GEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
Query: 383 QNISVIEIEPKK 394
Q I+ ++ KK
Sbjct: 296 QKINWDDLAAKK 307
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-32
Identities = 62/314 (19%), Positives = 111/314 (35%), Gaps = 52/314 (16%)
Query: 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEV 156
K ++ +G G G V + D + VA+KK + + E+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY-DAVL--------DRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 157 KFLGKFSHPNLVKLIGYCW------EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTR 210
+ +H N++ L+ E + LV E M +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERM 121
Query: 211 LKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTT 270
+ + LHS+ I+RD K SNI++ K+ DFGLA+ G S + T
Sbjct: 122 SYLLYQMLCGIKHLHSAGI--IHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMT 176
Query: 271 RIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG----------------LRALDT 314
+ T Y APE + D++ G ++ EM+ + L T
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
Query: 315 NRPSGEHVLVDFARPSLTDKRRLKKIMDPRL--------EEQYPIKGALLAGQIIIKCLE 366
P L R + ++ + + P+L + ++ A A ++ K L
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 367 AEPKNRPSMEEVLE 380
+P R S+++ L+
Sbjct: 297 IDPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 7e-32
Identities = 63/304 (20%), Positives = 111/304 (36%), Gaps = 41/304 (13%)
Query: 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAE 155
+ ++ + +G G +G V + D KT G VAVKK + SI + E
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAF-DTKT--------GLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 156 VKFLGKFSHPNLVKLIGYC------WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNT 209
++ L H N++ L+ E LV M G+ N++ + L +
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQ---KLTDDH 122
Query: 210 RLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVT 269
+ + L ++HS +I+RD K SN+ ++ K+ DFGLA + +T
Sbjct: 123 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMT 176
Query: 270 TRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTG-------------LRALDTNR 316
+ + A + H D++ G ++ E+LTG L
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 317 PSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSME 376
G +L + S + + M I LA ++ K L + R +
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 377 EVLE 380
+ L
Sbjct: 297 QALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (266), Expect = 2e-26
Identities = 50/335 (14%), Positives = 99/335 (29%), Gaps = 60/335 (17%)
Query: 90 TLQDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGL 149
+D R + LG G F V+ D VA+K D +
Sbjct: 9 PYKDAR-----YILVRKLGWGHFSTVWLAK-DMVN--------NTHVAMKIVRGDKVY-T 53
Query: 150 REWQAEVKFLGKFSHPNLVKLIGYC-------------WEDRQFLLVYEYMQKGSLENHL 196
+ E+K L + + + K +V + G L
Sbjct: 54 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 197 FRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD-GSYNAKLSDFG 255
+K +P +I+ L ++H +I+ D K N+L++ L
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIK 172
Query: 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTN 315
+A LG T + T Y +PE + +D++ ++ E++TG + +
Sbjct: 173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232
Query: 316 RPSGEHVLVD---------------------FARPSLTDKRRLKKIMDPRL--------- 345
D + R + L+ I +
Sbjct: 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE 292
Query: 346 EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLE 380
+ ++ A + L+ +P+ R ++
Sbjct: 293 KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.0 bits (160), Expect = 2e-13
Identities = 20/163 (12%), Positives = 42/163 (25%), Gaps = 29/163 (17%)
Query: 106 MLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS----------IQGLREWQAE 155
++GEG VF K VK G +
Sbjct: 7 LMGEGKESAVFNC-YSEK---------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVL 56
Query: 156 VKFLGKFSHPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAI 215
+ L KL G Y + ++ L + ++
Sbjct: 57 AIRSARNEFRALQKLQGLAVPKV-----YAWE-GNAVLMELIDAKELYRVRVENPDEVLD 110
Query: 216 DAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258
+++ + + +++ D N+L+ + DF +
Sbjct: 111 MILEEVAKFYH--RGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 441 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.73 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.93 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.0 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.83 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.79 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-58 Score=429.07 Aligned_cols=255 Identities=24% Similarity=0.301 Sum_probs=206.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||+||+|.. ..+++.||||++..... ...+.+.+|+.+|++++|||||++++++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~ 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVN---------RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 35799999999999999999944 44588999999865532 334568899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++.+|||||||++|+|.+++.+. ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred CceeEEEEeccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccchh
Confidence 99999999999999999998543 368999999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
|+..............+||+.|+|||++.+..+ +.++|||||||++|||+||+.||.........
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-------------- 215 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------------- 215 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--------------
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--------------
Confidence 986543333333456789999999999998887 47899999999999999999999754322110
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.................+..+.+||.+||+.||++|||++|+|++
T Consensus 216 -~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 216 -YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -HHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111111111223456678899999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=427.52 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=210.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++|++.+.||+|+||+||+|. +..+|+.||||++........+.+.+|+.+|++++|||||++++++.+++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~---------~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEE---------BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEEE---------ECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 479999999999999999994 44558999999987655445677899999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.+|||||||+||+|.+++.+. .+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 999999999999999987653 48999999999999999999997 999999999999999999999999999998
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
..... .......+||+.|+|||++.+..|+.++|||||||++|+|+||+.||...... ..+.
T Consensus 165 ~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----------------~~~~ 226 (293)
T d1yhwa1 165 QITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----------------RALY 226 (293)
T ss_dssp ECCST--TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHH
T ss_pred eeccc--cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH----------------HHHH
Confidence 64322 22345578999999999999999999999999999999999999999653211 1111
Q ss_pred hhc-CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 339 KIM-DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 339 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+. ........+..++..+++||.+||+.||++|||+.|+|+|
T Consensus 227 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 1111123345667789999999999999999999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-57 Score=420.50 Aligned_cols=247 Identities=27% Similarity=0.416 Sum_probs=209.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||+||+|.. ..+++.||+|++..... ...+.+.+|+.+|+.++|||||++++++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLARE---------KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEE---------CCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 5799999999999999999954 44588999998864322 23467889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+++.+|||||||++|+|.+++.+.+ .+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred ECCEEEEEEeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecccc
Confidence 9999999999999999999997654 48999999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+|+.... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... ..
T Consensus 152 ~a~~~~~----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----------------~~ 211 (263)
T d2j4za1 152 WSVHAPS----SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----------------QE 211 (263)
T ss_dssp SCSCCCC----CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------------HH
T ss_pred eeeecCC----CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH----------------HH
Confidence 9986432 223457899999999999999999999999999999999999999965321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+..+.... ..+|...+.++.+||.+||+.||++|||++|+|+|
T Consensus 212 ~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 212 TYKRISRVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHHHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 122222221 13455677789999999999999999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=419.21 Aligned_cols=261 Identities=27% Similarity=0.400 Sum_probs=206.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||+||+|.++ ..||||+++.. .....+.|.+|+.+|++++|||||++++++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 74 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS------------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC------------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe
Confidence 468999999999999999999543 25999998654 3445678999999999999999999999874
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
.+.++||||||++|+|.+++.... ..+++..++.++.|++.||.|||+ ++||||||||+||||+.++.+||+|||
T Consensus 75 -~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFG 149 (276)
T d1uwha_ 75 -APQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFG 149 (276)
T ss_dssp -SSSCEEEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred -ccEEEEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEcccc
Confidence 456899999999999999997644 458999999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG---HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
+|+...............||+.|+|||++.+. .|+.++|||||||+||||+||+.||........
T Consensus 150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------------ 217 (276)
T d1uwha_ 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------------ 217 (276)
T ss_dssp CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------------
T ss_pred ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------------
Confidence 99875443344445667899999999999653 578999999999999999999999975422100
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
....+............+..++..+.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus 218 ~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp HHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0001111111111223455667789999999999999999999999999987653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-57 Score=421.52 Aligned_cols=256 Identities=26% Similarity=0.386 Sum_probs=198.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||+||+|+. ..+|+.||||.+.... ....+.+.+|+++|++++|||||++++++.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 73 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRR---------KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 73 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEE---------CCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 36799999999999999999944 4458899999987653 344667899999999999999999999987
Q ss_pred e--CCeEEEEEeecCCCCHHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHhhhccC---CCCeeecCCCCCcEEEcCCCce
Q 013519 176 E--DRQFLLVYEYMQKGSLENHLFRKG-SAEPLPWNTRLKIAIDAAKDLTFLHSS---EKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 176 ~--~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~---~~~ivHrDlkp~Nill~~~~~~ 249 (441)
+ ++.+|||||||++|+|.+++.+.. ....+++..++.++.|++.||.|||+. ..+||||||||+||||+.++.+
T Consensus 74 ~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~v 153 (269)
T d2java1 74 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 153 (269)
T ss_dssp C----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCE
T ss_pred eCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence 5 456899999999999999986532 235699999999999999999999961 1249999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
||+|||+|+.... ........+||+.|+|||++.+..|+.++|||||||++|||+||+.||.....
T Consensus 154 kl~DFG~a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------------ 219 (269)
T d2java1 154 KLGDFGLARILNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------------ 219 (269)
T ss_dssp EECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------------
T ss_pred EEeeccceeeccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH------------
Confidence 9999999986432 22334567899999999999999999999999999999999999999964321
Q ss_pred ccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+..... ...+..++.++.+||.+||+.||++|||+.|+++|
T Consensus 220 ----~~~~~~i~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 220 ----KELAGKIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ----HHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HHHHHHHHcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111112222211 23455677789999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-56 Score=422.21 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=209.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
+.|++++.||+|+||+||+|+. ..+++.||||++........+.+.+|+++|++++|||||++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQN---------KETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEE---------CCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 4689999999999999999954 4458899999987766666778899999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.++||||||++|+|.+++.+.. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCEEEEechhhh
Confidence 9999999999999999987643 468999999999999999999997 999999999999999999999999999997
Q ss_pred CCCCCCCcceEeeeccccccCcchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVA-----TGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
.... ........+||+.|+|||++. ...|+.++|||||||++|||+||+.||......
T Consensus 159 ~~~~--~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--------------- 221 (288)
T d2jfla1 159 KNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--------------- 221 (288)
T ss_dssp ECHH--HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---------------
T ss_pred ccCC--CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---------------
Confidence 4211 112233568999999999984 456889999999999999999999999654221
Q ss_pred hhhhhhhcCcc-ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 334 KRRLKKIMDPR-LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 334 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+..+.... .....+..++.++.+||.+||+.||++|||+.|+|+|
T Consensus 222 -~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 222 -RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -HHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111111 1112345567789999999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-57 Score=430.34 Aligned_cols=267 Identities=25% Similarity=0.356 Sum_probs=207.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|++++.||+|+||+||+|+. ..+++.||+|+++... ......+.+|+.+|++++|||||+++++|.+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSH---------KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEE---------TTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred ccCCEEEEEEecCCCeEEEEEEE---------CCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 46899999999999999999944 4458999999986543 3345678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++.+|||||||+||+|.+++.+.+ .+++..+..++.|++.||.|||+ .+||+||||||+||||+.++.+||+|||+
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~-~~~IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH-hCCEEccccCHHHeeECCCCCEEEeeCCC
Confidence 999999999999999999998764 48999999999999999999996 24899999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecc----------
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF---------- 326 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~---------- 326 (441)
|+... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..............
T Consensus 152 a~~~~----~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
T d1s9ja_ 152 SGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227 (322)
T ss_dssp CHHHH----HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------
T ss_pred ccccC----CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCC
Confidence 98532 1223457899999999999999999999999999999999999999975432211000000
Q ss_pred ----------------cccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 327 ----------------ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 327 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..+..........+.............+.++.+||.+||+.||++|||++|+|+|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000011111111111111112345678999999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-57 Score=422.54 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=207.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++++.||+|+||+||+|.. ..+++.||||++..... ...+.+.+|+.+|++++|||||++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARE---------LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 5799999999999999999944 44588999999864321 23467889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+++.+|||||||+||+|.+++...+ .+++..++.++.|++.||.|||+ .+||||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred ECCEEEEEEEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEecccc
Confidence 9999999999999999999987765 48999999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+|+..............+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ..
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----------------~~ 217 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----------------YL 217 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HH
T ss_pred cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH----------------HH
Confidence 99875444334445567899999999999999999999999999999999999999965321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
....+.... ..+|...+..+.+||.+||+.||++|||++|++++
T Consensus 218 ~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 218 IFQKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHHHHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 122222222 13455667789999999999999999999997654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-56 Score=419.82 Aligned_cols=261 Identities=22% Similarity=0.405 Sum_probs=203.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
++|++.++||+|+||+||+|++.... .....||||.+... .....+.|.+|+.+|++++|||||++++++.++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCC------CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 46778899999999999999765321 12347899988765 444567899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++|||||++|+|.+++.... ..+++.+++.++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+|
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred CEEEEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhh--CCCccCccccceEEECCCCcEEECCcccc
Confidence 99999999999999999887543 468999999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCCcce---EeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccch
Q 013519 258 KLGPIDGNSHV---TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 258 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
+.......... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---------------- 239 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---------------- 239 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH----------------
Confidence 86543222111 122468999999999999999999999999999999998 8999965321
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
...+..+ ........+..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 240 ~~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 240 QDVINAI-EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp HHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHH-HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1111111 122223345667788999999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-56 Score=419.08 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=216.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||+||+|.+. .+++.||||+++.+.. ..+.+.+|+.+|++++|||||++++++.++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEG---------GGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEC---------CCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 467888999999999999999554 3478999999876543 356789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.++||||||++|+|.+++.+.. ...+++..++.++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+|
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred CeeEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEccccce
Confidence 99999999999999999997653 3578999999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
+..... .........||+.|+|||++.+..|+.++|||||||++|||++|..||..... ...+
T Consensus 163 ~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----------------~~~~ 225 (287)
T d1opja_ 163 RLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----------------LSQV 225 (287)
T ss_dssp TTCCSS-SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----------------HHHH
T ss_pred eecCCC-CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----------------HHHH
Confidence 864332 22223345689999999999999999999999999999999998777643211 1122
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
.+.+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 226 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2233333444556677888999999999999999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=427.15 Aligned_cols=264 Identities=28% Similarity=0.404 Sum_probs=215.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|++.++||+|+||+||+|++.... .......||+|.+.... ......+.+|+.+|.++ +|||||++++++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCS----SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCC----cccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 367899999999999999999876431 22234579999886543 33456788999999998 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC--------------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecC
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS--------------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRD 235 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrD 235 (441)
+.+.++||||||++|+|.++|..... ...+++..++.++.|++.||.|||+ ++|||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~IiHRD 189 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRD 189 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETT
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecc
Confidence 99999999999999999999976431 2358999999999999999999997 8999999
Q ss_pred CCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 013519 236 FKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDT 314 (441)
Q Consensus 236 lkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~ 314 (441)
|||+|||++.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||+| |..||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987544444444455778999999999999999999999999999999998 8999975
Q ss_pred CCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 013519 315 NRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQ 383 (441)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~ 383 (441)
.... ..+.+++........|..++..+.+||.+||+.||++|||++||+++|.
T Consensus 270 ~~~~----------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVD----------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCS----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHH----------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 4321 1122222233333456677888999999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=411.01 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=199.1
Q ss_pred CCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEe---
Q 013519 102 RPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE--- 176 (441)
Q Consensus 102 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--- 176 (441)
++.+.||+|+||+||+|... .+++.||+|++... .....+.+.+|+++|++++|||||++++++.+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~---------~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82 (270)
T ss_dssp EEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred EeeeEEecCcCcEEEEEEEC---------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc
Confidence 56678999999999999543 45789999987654 33456678999999999999999999999875
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCC--eeecCCCCCcEEEc-CCCceEEe
Q 013519 177 -DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKS--VIYRDFKASNILLD-GSYNAKLS 252 (441)
Q Consensus 177 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--ivHrDlkp~Nill~-~~~~~kl~ 252 (441)
+..+|||||||++|+|.+++.+.. .+++..++.++.|++.||.|||+ ++ |+||||||+||||+ .++.+||+
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~--~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred cCCEEEEEEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHH--CCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 356899999999999999997754 58899999999999999999997 66 99999999999996 57899999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
|||+|+... .......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||......
T Consensus 158 DFGla~~~~----~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-------------- 218 (270)
T d1t4ha_ 158 DLGLATLKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------------- 218 (270)
T ss_dssp CTTGGGGCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--------------
T ss_pred ecCcceecc----CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--------------
Confidence 999998532 223456789999999998865 6999999999999999999999999643211
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+........++...+.++.+||.+||+.||++|||+.|+|+|
T Consensus 219 -~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 219 -AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 111111222111122333455678899999999999999999999985
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-56 Score=412.85 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=201.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++|++.+.||+|+||+||+|.+.. ++.||||+++.... ..+.+.+|+.++++++|||||++++++.+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT----------TEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC----------CCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 578889999999999999996642 56799999876543 3467899999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.+++|||||++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 149 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTR 149 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred ceEEEEEecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchhe
Confidence 9999999999999999987543 468899999999999999999997 999999999999999999999999999998
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLK 338 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (441)
...... ........||+.|+|||++.+..|+.++|||||||++|||+|+..|+..... ....+
T Consensus 150 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---------------~~~~~- 212 (263)
T d1sm2a_ 150 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---------------NSEVV- 212 (263)
T ss_dssp ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---------------HHHHH-
T ss_pred eccCCC-ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---------------HHHHH-
Confidence 643322 1223346799999999999999999999999999999999996444432111 01111
Q ss_pred hhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 339 KIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
..+........|..++..+.+|+.+||+.||++|||+++|+++|+++.
T Consensus 213 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 213 EDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 111112223445666778999999999999999999999999998774
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-55 Score=418.64 Aligned_cols=247 Identities=28% Similarity=0.368 Sum_probs=204.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc---hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS---IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
..|++++.||+|+||+||+|+. ..+++.||||++.... ....+.+.+|+.+|++++|||||++++++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARD---------VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEE---------CCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 3589999999999999999944 4458899999886543 344567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+++.+|||||||.+|+|..++... ..+++..++.++.|++.||.|||+ +|||||||||+||||+.++.+||+|||
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred ECCEEEEEEEecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeecc
Confidence 999999999999999997766544 358999999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccc
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT---GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLT 332 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 332 (441)
+|+.... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.....
T Consensus 161 ~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------------- 219 (309)
T d1u5ra_ 161 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------------- 219 (309)
T ss_dssp TCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---------------
T ss_pred cccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---------------
Confidence 9985322 234689999999999864 4588999999999999999999999964321
Q ss_pred hhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+..+.........+..++..+.+||.+||+.||++|||+.|+|+|
T Consensus 220 -~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 220 -MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -HHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111222222222222344566789999999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.6e-55 Score=421.69 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=212.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||+||+|+. ..+|+.||||++........+.+.+|+.+|++++|||||++++++.++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~---------~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTE---------RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred ccCeEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 36899999999999999999944 445899999999887777778899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc--CCCceEEeccc
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD--GSYNAKLSDFG 255 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~--~~~~~kl~DFG 255 (441)
+.+|||||||+||+|.+++.+.. ..+++..++.++.||+.||.|||+ +|||||||||+|||++ .++.+||+|||
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred CEEEEEEEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeecc
Confidence 99999999999999999986433 359999999999999999999997 9999999999999995 46789999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+|+.... ........||+.|+|||++.+..|+.++|||||||++|+|++|+.||..... ..
T Consensus 172 ~a~~~~~---~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----------------~~ 232 (350)
T d1koaa2 172 LTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----------------DE 232 (350)
T ss_dssp TCEECCT---TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HH
T ss_pred hheeccc---ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH----------------HH
Confidence 9986432 2334567899999999999999999999999999999999999999965321 11
Q ss_pred hhhhhcCc--cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDP--RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+..+... ..........+..+.+||.+||+.||++|||++|+|+|
T Consensus 233 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 233 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122111 11112223456778999999999999999999999997
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-55 Score=417.65 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=193.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.+.|++.++||+|+||+||+|+. ..+++.||||++..... .....+.+|+.+|++++|||||++++++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAED---------KRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEE---------TTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEE---------CCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 46799999999999999999944 44588999999865532 233567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc---CCCceEEec
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD---GSYNAKLSD 253 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl~D 253 (441)
++.+|||||||+||+|.+++.+.+ .+++..+..++.|++.||.|||+ ++|+||||||+|||+. .++.+||+|
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred CCEEEEEEeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEec
Confidence 999999999999999999997643 59999999999999999999997 9999999999999994 578999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccch
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
||+|+.... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.....
T Consensus 154 FG~a~~~~~---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------------- 214 (307)
T d1a06a_ 154 FGLSKMEDP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---------------- 214 (307)
T ss_dssp C---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----------------
T ss_pred cceeEEccC---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH----------------
Confidence 999985422 2334557899999999999999999999999999999999999999964321
Q ss_pred hhhhhhhcCcc--ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 334 KRRLKKIMDPR--LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 334 ~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+.... .....+...+..+.+||.+||+.||++|||+.|+++|
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 215 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11111222211 1222334567789999999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.3e-55 Score=421.64 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=212.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++|++++.||+|+||+||+|+ +..+++.||||++..........+.+|+.+|++++|||||+++++|.+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~---------~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCV---------EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEE---------ETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEE---------ECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 579999999999999999994 44558999999988776666678889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEc--CCCceEEecccC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLD--GSYNAKLSDFGL 256 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~--~~~~~kl~DFGl 256 (441)
.+|||||||+||+|.+++...+ ..+++.+++.++.||+.||.|||+ +|||||||||+||||+ .++.+||+|||+
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEEcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEeeccc
Confidence 9999999999999998876543 469999999999999999999997 9999999999999997 678999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
|+.... ........||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+... ...
T Consensus 176 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----------------~~~ 236 (352)
T d1koba_ 176 ATKLNP---DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----------------LET 236 (352)
T ss_dssp CEECCT---TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----------------HHH
T ss_pred ceecCC---CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----------------HHH
Confidence 986532 2335567899999999999999999999999999999999999999965321 111
Q ss_pred hhhhc--CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 337 LKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 337 ~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+..+. ...+....+...+.++.+||.+||+.||++|||+.|+|+|
T Consensus 237 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11221 1122223344567789999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-55 Score=402.75 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=213.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
++|++.++||+|+||+||+|+++. ++.||||+++.... ..+.+.+|+.++++++|||||++++++.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETT----------TEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred HHCEEeEEEecCCCeEEEEEEECC----------CCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 689999999999999999997642 67899999876543 2467899999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.+++||||+++|+|..++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred ceEEEEEccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhhe
Confidence 9999999999999999976543 458899999999999999999997 899999999999999999999999999998
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
...... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ....
T Consensus 149 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----------------~~~~ 211 (258)
T d1k2pa_ 149 YVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----------------SETA 211 (258)
T ss_dssp BCSSSS-CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----------------HHHH
T ss_pred eccCCC-ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH----------------HHHH
Confidence 644322 222334679999999999999999999999999999999998 8999965421 1111
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
..+.. ......|..++..+.+||.+||+.||++|||+.+++++|.+|
T Consensus 212 ~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 212 EHIAQ-GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHh-CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12222 223345667778899999999999999999999999999754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-55 Score=408.75 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=209.2
Q ss_pred cCCCCCce-ecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTM-LGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~-lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|.+.+. ||+|+||+||+|.+... ..+..||||+++.. .....+.|.+|+.+|++++|||||++++++.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecC-------CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 45666664 99999999999976432 23568999998765 34456789999999999999999999999865
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
+.+|||||||++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred -CeEEEEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchh
Confidence 46899999999999999885433 468999999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCc-ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchh
Q 013519 257 AKLGPIDGNS-HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 257 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---------------- 219 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---------------- 219 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----------------
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH----------------
Confidence 9865432221 11234568999999999999999999999999999999998 89999754211
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
.....+ ........|..++.++.+||.+||+.||++|||+.+|++.|+.+-
T Consensus 220 ~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 220 EVMAFI-EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp HHHHHH-HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111111 112223456677788999999999999999999999999987643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=407.47 Aligned_cols=264 Identities=23% Similarity=0.382 Sum_probs=207.5
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
+.|.+.++||+|+||+||+|.+.... ......||||++.... ......|.+|+.+|++++|||||++++++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~-----~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSS-----GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCC-----CEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 46788899999999999999876432 1123579999987653 34456789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++|||||.++++.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CceEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEcccchh
Confidence 99999999999999999886653 468999999999999999999997 99999999999999999999999999999
Q ss_pred CCCCCCCC-cceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGN-SHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+....... ........||+.|+|||++.+..++.++|||||||++|||++|..|+..... . ..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~---------------~-~~ 221 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------------N-HE 221 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---------------H-HH
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC---------------H-HH
Confidence 86533222 1223345789999999999999999999999999999999997666543211 1 11
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
+...+........+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 222 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 122222233344566677889999999999999999999999999987653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=405.69 Aligned_cols=251 Identities=27% Similarity=0.379 Sum_probs=203.0
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDRQFLL 182 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 182 (441)
++||+|+||+||+|.+... .+++.||||+++... ....+.+.+|+.+|++++|||||++++++.+ +..+|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEccC-------CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 4799999999999976432 246789999986542 2345679999999999999999999999865 45789
Q ss_pred EEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCCC
Q 013519 183 VYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGPI 262 (441)
Q Consensus 183 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~~ 262 (441)
|||||++|+|.+++.+.. .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 85 vmE~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 999999999999997653 58999999999999999999997 8999999999999999999999999999986543
Q ss_pred CCCcc-eEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhhhhhh
Q 013519 263 DGNSH-VTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRRLKKI 340 (441)
Q Consensus 263 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (441)
..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... . .+...
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----------------~-~~~~~ 222 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------------S-EVTAM 222 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------H-HHHHH
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----------------H-HHHHH
Confidence 32222 2234579999999999999999999999999999999998 8999965321 1 11111
Q ss_pred cCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 341 MDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
+........|..++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 223 i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 223 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 212223345667788899999999999999999999999888754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=408.76 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=207.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||+||+|.++. ++.||||+++.... ..+.+.+|+.+|++++|||||++++++. +
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~ 79 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHHeEEeEEEecCCCcEEEEEEECC----------CCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeec-c
Confidence 4678899999999999999997542 56899999876543 3467899999999999999999999875 4
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.++||||||++|+|.+++.... ...+++..++.++.|++.||.|||+ ++|+||||||+||||++++.+||+|||+|
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccce
Confidence 56799999999999999875432 2358999999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
+..... .........||+.|+|||++.+..++.++|||||||++|||+||..|+..... ....+
T Consensus 157 ~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~---------------~~~~~ 220 (272)
T d1qpca_ 157 RLIEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---------------NPEVI 220 (272)
T ss_dssp EECSSS-CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---------------HHHHH
T ss_pred EEccCC-ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC---------------HHHHH
Confidence 864322 22223346789999999999999999999999999999999997665533211 11111
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
..+ ........|..++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 221 ~~i-~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 221 QNL-ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp HHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH-HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 111 12223344566777899999999999999999999999998864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=415.53 Aligned_cols=249 Identities=28% Similarity=0.401 Sum_probs=210.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++++.||+|+||+||+|+ ...+++.||||++..... ...+.+.+|+.+|++++|||||+++++|.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~---------~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 75 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVR---------EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEE---------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEE---------ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence 579999999999999999994 444689999999865422 23567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+++.+|+|||||+||+|.+++.+.+ .+++..++.++.|++.||.|||+ +|||||||||+|||++.+|.+||+|||
T Consensus 76 ~~~~~~iv~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 76 THDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred cccccccceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEeecc
Confidence 9999999999999999999998765 48899999999999999999998 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+|+..... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ..
T Consensus 151 ~a~~~~~~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~----------------~~ 212 (337)
T d1o6la_ 151 LCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------------ER 212 (337)
T ss_dssp TCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----------------HH
T ss_pred cccccccC--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH----------------HH
Confidence 99864322 2334567899999999999999999999999999999999999999975421 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-----MEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~eil~~ 381 (441)
....+.... ..+|...+.++.+||.+||+.||.+|++ +.++++|
T Consensus 213 ~~~~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 213 LFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHhcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 111222111 2346667788999999999999999994 8999886
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=407.73 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=207.4
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch------HHHHHHHHHHHHHhcCCCCCccceE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI------QGLREWQAEVKFLGKFSHPNLVKLI 171 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~ 171 (441)
.++|++++.||+|+||+||+|+. ..+|+.||||++..... ...+.+.+|+.+|++++|||||+++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~---------~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCRE---------KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEE---------CCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 36799999999999999999954 44589999998754321 2356789999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC----
Q 013519 172 GYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY---- 247 (441)
Q Consensus 172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---- 247 (441)
++|.+++.+|||||||++|+|.+++...+ .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSC
T ss_pred EEEEECCEEEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCccc
Confidence 99999999999999999999999997754 58999999999999999999997 9999999999999998776
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
.+||+|||+|+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 155 ~vkl~DfG~a~~~~~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------- 221 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---------- 221 (293)
T ss_dssp CEEECCCTTCEECTT---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------
T ss_pred ceEecchhhhhhcCC---CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH----------
Confidence 499999999986432 2233456899999999999999999999999999999999999999975321
Q ss_pred ccccchhhhhhhhcCc--cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTDKRRLKKIMDP--RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+..+... .+....+...+..+.+||.+||+.||++|||++|+++|
T Consensus 222 ------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 222 ------QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------HHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111122111 11112223456678899999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-54 Score=408.89 Aligned_cols=270 Identities=25% Similarity=0.360 Sum_probs=219.0
Q ss_pred HHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcCCCCCccceEE
Q 013519 94 LRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKFSHPNLVKLIG 172 (441)
Q Consensus 94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~ 172 (441)
++...++|++.+.||+|+||+||+|++... ....+++.||||+++.... ...+.+.+|+.+|++++||||+++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCC----ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 334567899999999999999999987542 2334578999999876543 34567999999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhcCC---------------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCe
Q 013519 173 YCWEDRQFLLVYEYMQKGSLENHLFRKGS---------------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSV 231 (441)
Q Consensus 173 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~i 231 (441)
++.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ ++|
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~i 161 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKF 161 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTC
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CCe
Confidence 99999999999999999999999965321 2358899999999999999999997 999
Q ss_pred eecCCCCCcEEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCC-C
Q 013519 232 IYRDFKASNILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGL-R 310 (441)
Q Consensus 232 vHrDlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~-~ 310 (441)
|||||||+||||+.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999997543333334445678999999999999999999999999999999999996 4
Q ss_pred CCCCCCCCCCceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 311 ALDTNRPSGEHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 311 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
||.... ....+..+.+.. ....|..++.++.+||.+||+.||++|||+.||++.|+++.
T Consensus 242 p~~~~~----------------~~e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMA----------------HEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSC----------------HHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCC----------------HHHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 665431 111222222222 23346667778999999999999999999999999999764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.6e-54 Score=408.80 Aligned_cols=246 Identities=28% Similarity=0.432 Sum_probs=208.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++++.||+|+||+||+|+. ..+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~---------~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRS---------RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEE---------CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 5799999999999999999944 44589999999865322 23567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+++.+|+|||||.||+|..++.... .+++..++.++.|++.||.|||+ +||+||||||+||||+.+|.+||+|||
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred eCCeeeeEeeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhcc--CcEEccccCchheeEcCCCCEEEecCc
Confidence 9999999999999999999887654 47889999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+|+.... .....+||+.|+|||++.+..|+.++|||||||+||||+||+.||..... ..
T Consensus 150 ~a~~~~~-----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~----------------~~ 208 (316)
T d1fota_ 150 FAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----------------MK 208 (316)
T ss_dssp SCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------------HH
T ss_pred cceEecc-----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH----------------HH
Confidence 9986432 23457899999999999999999999999999999999999999965321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
....+.... ..+|...+..+.+++.+||+.||.+|+ |++++++|
T Consensus 209 ~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 209 TYEKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 122222221 134556677899999999999999996 89999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=407.81 Aligned_cols=267 Identities=26% Similarity=0.352 Sum_probs=206.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||+||+|.+... ....+++.||||+++... ....+.+.+|+.++.++ +||||+.+++++.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEEST----TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCC----CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 46899999999999999999987643 234457899999987643 34456677888888776 5899999999887
Q ss_pred eC-CeEEEEEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcE
Q 013519 176 ED-RQFLLVYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNI 241 (441)
Q Consensus 176 ~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 241 (441)
.. ..+++|||||++|+|.++|..... ...+++..++.++.|++.||.|||+ ++||||||||+||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDlKp~NI 165 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNI 165 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcCCccce
Confidence 64 468999999999999999975421 2458899999999999999999997 9999999999999
Q ss_pred EEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCC-CCCCCCCCCCC
Q 013519 242 LLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGL-RALDTNRPSGE 320 (441)
Q Consensus 242 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~-~p~~~~~~~~~ 320 (441)
||+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. .||......
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-- 243 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-- 243 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--
Confidence 99999999999999998654433333344568999999999999999999999999999999999975 566543211
Q ss_pred ceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 321 HVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
..+...+........|..++..+.+||.+||+.||++|||+.||+++|+.+-
T Consensus 244 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 244 --------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp --------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111122222223445667778999999999999999999999999998763
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=398.97 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=202.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|++.+.||+|+||+||+|++... ...+..||||.+.... ....+.+.+|+.+|++++|||||++++++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSP------ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecC------CceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 36799999999999999999976532 1235679999986543 344567999999999999999999999985
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++.+++|||||++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred cCeEEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEccchh
Confidence 567899999999999999876543 468999999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhh
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
|+..... .........||+.|+|||++.+..++.++|||||||++|||+| |..||...... .
T Consensus 155 a~~~~~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~----------------~ 217 (273)
T d1mp8a_ 155 SRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----------------D 217 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----------------G
T ss_pred heeccCC-cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH----------------H
Confidence 9864322 2223345678999999999999999999999999999999998 88888654321 1
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
....+.. ......+..++..+.+||.+||+.||++|||+.+|+++|+.+.
T Consensus 218 ~~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 218 VIGRIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp HHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111111 1122346667788999999999999999999999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=408.15 Aligned_cols=261 Identities=23% Similarity=0.375 Sum_probs=207.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.+|+++++||+|+||+||+|.+.... ......||+|++... .....+.+.+|+.+|++++|||||++++++.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCC-----CEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 46999999999999999999765421 122347999988654 334567899999999999999999999999865
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
..+++|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ ++||||||||+||||+.++.+||+|||+|
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred -CeeEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeeccccc
Confidence 5678899999999999887654 468999999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+...............||+.|+|||++.+..|+.++|||||||++|||+| |..||...... .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-----------------~ 221 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------E 221 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-----------------G
T ss_pred eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-----------------H
Confidence 87554444444455679999999999999999999999999999999998 78888653211 1
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
+...+........|..++..+.+|+.+||+.||++|||+.+|+++|+.+.
T Consensus 222 ~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 222 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 11122222223446667788999999999999999999999999987654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-54 Score=396.73 Aligned_cols=252 Identities=28% Similarity=0.413 Sum_probs=202.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEe-C
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE-D 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 177 (441)
++|++.+.||+|+||.||+|.++ +..||||+++.+.. .+.+.+|+.+|++++|||||++++++.+ +
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHHH--HHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 56888999999999999999664 56899999976543 4678899999999999999999999865 4
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++||||+++|+|.++|..... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s 150 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLT 150 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred CcEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeecccccc
Confidence 568999999999999999976432 358899999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccchhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTDKRR 336 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (441)
+... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... .
T Consensus 151 ~~~~-----~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-----------------~ 208 (262)
T d1byga_ 151 KEAS-----STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------D 208 (262)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----------------G
T ss_pred eecC-----CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-----------------H
Confidence 8532 22334578999999999999999999999999999999998 67777543211 1
Q ss_pred hhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccccc
Q 013519 337 LKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISVI 388 (441)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~~ 388 (441)
+...+........+..++..+.+||.+||+.||++|||+.+++++|+.+...
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 209 VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 1111222233445666778899999999999999999999999999987643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.7e-53 Score=395.05 Aligned_cols=259 Identities=25% Similarity=0.388 Sum_probs=203.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYC 174 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 174 (441)
.++|++.+.||+|+||+||+|. +..+++.||||++... .......+.+|+.+|+.++|||||++++++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~ 76 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLAR---------DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEE---------ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence 4679999999999999999994 4445899999998754 334466789999999999999999999998
Q ss_pred EeCC----eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 175 WEDR----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 175 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
...+ .+|||||||+|++|.+++...+ .+++.+++.++.|++.||.|||+ +||+||||||+|||++.++.++
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~ 151 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVK 151 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEE
T ss_pred eeccCCCceEEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCcccccCccccce
Confidence 8653 4899999999999999987764 58999999999999999999997 9999999999999999999999
Q ss_pred EecccCCCCCCCCC-CcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 251 LSDFGLAKLGPIDG-NSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 251 l~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
|+|||+++...... ........+||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----------- 220 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----------- 220 (277)
T ss_dssp ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------
T ss_pred eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----------
Confidence 99999987543222 222344578999999999999999999999999999999999999999653211
Q ss_pred ccchhhhhhhhc--CccccccCChhhHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhccc
Q 013519 330 SLTDKRRLKKIM--DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-SMEEVLETLQNIS 386 (441)
Q Consensus 330 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~eil~~L~~i~ 386 (441)
..+..++ .+..........+..+.+||.+||+.||++|| |++++++.|.++.
T Consensus 221 -----~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 221 -----SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -----HHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----HHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111111 11111223345567789999999999999999 8999998887653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=397.87 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=203.9
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++.+.||+|+||+||+|++.. ++.||||++..... ..+.|.+|+.+|++++|||||++++++. +
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~ 83 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 83 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence 3679999999999999999997643 35799999876543 3467899999999999999999999985 4
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCC
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLA 257 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla 257 (441)
+.+++|||||++|+|..++.... ...+++..++.++.|++.||+|||+ ++|+||||||+||||+.++++||+|||++
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CCeEEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchh
Confidence 56899999999999999886542 2358999999999999999999997 89999999999999999999999999999
Q ss_pred CCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhh
Q 013519 258 KLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRL 337 (441)
Q Consensus 258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (441)
+...... ........||+.|+|||++....++.++|||||||++|||+||..||..... ....+
T Consensus 161 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~---------------~~~~~ 224 (285)
T d1fmka3 161 RLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---------------NREVL 224 (285)
T ss_dssp C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---------------HHHHH
T ss_pred hhccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC---------------HHHHH
Confidence 8643222 2223446799999999999999999999999999999999997666643211 11111
Q ss_pred hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 338 KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
..+ ........+..++..+.+||.+||+.||++||++.+|++.|+.+-
T Consensus 225 ~~i-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 225 DQV-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp HHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HHH-HhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 111 112233456677788999999999999999999999999988644
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-53 Score=402.97 Aligned_cols=251 Identities=18% Similarity=0.242 Sum_probs=208.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED 177 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 177 (441)
.++|++++.||+|+||+||+|.. ..+++.||||+++..... ...+.+|+.+|+.++|||||+++++|.++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~---------~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVE---------TSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEEE---------CCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 46899999999999999999944 445889999999876543 35678999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCC--CceEEeccc
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGS--YNAKLSDFG 255 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~--~~~kl~DFG 255 (441)
+.+|||||||+||+|.+++...+ ..+++.+++.++.|++.||.|||+ +||+||||||+|||++.+ ..+||+|||
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DFG 149 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred CEEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcccc
Confidence 99999999999999999996543 358999999999999999999997 999999999999999754 579999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+++... .........||+.|+|||.+.+..|+.++|||||||++|+|++|..||..... ..
T Consensus 150 ~~~~~~---~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~----------------~~ 210 (321)
T d1tkia_ 150 QARQLK---PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----------------QQ 210 (321)
T ss_dssp TCEECC---TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----------------HH
T ss_pred hhhccc---cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH----------------HH
Confidence 998642 23345567899999999999999999999999999999999999999965421 11
Q ss_pred hhhhhcCccc--cccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 336 RLKKIMDPRL--EEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+..+..... ........+.++.+||.+||..||++|||+.|+++|
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1222222111 111112346678999999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=396.41 Aligned_cols=260 Identities=28% Similarity=0.396 Sum_probs=204.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC---chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD---SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++.+.||+|+||+||+|.+...+ .....||||+++.. .....+.|.+|+.+|++++|||||++++++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~------~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCC------CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 57999999999999999999775432 12457899988754 2344678999999999999999999999996
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+ ..+++|||||++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred e-cchheeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeeccch
Confidence 5 46789999999999999887654 358999999999999999999997 899999999999999999999999999
Q ss_pred CCCCCCCCCCcce-EeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCceeecccccccch
Q 013519 256 LAKLGPIDGNSHV-TTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEHVLVDFARPSLTD 333 (441)
Q Consensus 256 la~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 333 (441)
+++.......... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||.... .
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~----------------~ 220 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN----------------G 220 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC----------------H
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC----------------H
Confidence 9987544332222 233568889999999999999999999999999999998 899996432 1
Q ss_pred hhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 334 KRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
...+..+.........+..++..+.+||.+||+.||++|||+.+|++.|++.
T Consensus 221 ~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 221 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2223333333344445566777899999999999999999999999998753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-53 Score=408.58 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=208.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
++|++++.||+|+||+||+|+. ..+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~---------~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKH---------KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEE---------CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 5799999999999999999944 44589999999864322 23567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFG 255 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 255 (441)
+...+++||||+.+|+|..++.+.+ .+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cccccccccccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeece
Confidence 9999999999999999999998765 48999999999999999999997 999999999999999999999999999
Q ss_pred CCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhh
Q 013519 256 LAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKR 335 (441)
Q Consensus 256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 335 (441)
+|+.... ......||+.|+|||++.+..|+.++|||||||++|||+||+.||..... ..
T Consensus 187 ~a~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----------------~~ 245 (350)
T d1rdqe_ 187 FAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----------------IQ 245 (350)
T ss_dssp TCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HH
T ss_pred eeeeccc-----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH----------------HH
Confidence 9986432 23456899999999999999999999999999999999999999965321 11
Q ss_pred hhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 336 RLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
.+..+.... ...+..++.++.+||.+||+.||.+|+ |++++++|
T Consensus 246 ~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 246 IYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHhcCC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 112222111 123556677899999999999999994 89999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-52 Score=407.12 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=203.2
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch------HHHHHHHHHHHHHhcCCCCCccceEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI------QGLREWQAEVKFLGKFSHPNLVKLIG 172 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~ 172 (441)
++|++.++||+|+||+||+|+ ...+|+.||||++..... .......+|+.+++.++|||||++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~---------~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCR---------KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEE---------ETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEEE---------ECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 579999999999999999994 444589999998754321 11222334578888999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEe
Q 013519 173 YCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252 (441)
Q Consensus 173 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 252 (441)
++.+++.+|||||||+||+|.++|.+.. .+++..++.++.||+.||.|||+ +|||||||||+||||+.++.+||+
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEEC
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEe
Confidence 9999999999999999999999997764 47899999999999999999997 999999999999999999999999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
|||+|+..... .....+||+.|+|||++.. ..|+.++|||||||+||||+||+.||.........
T Consensus 150 DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---------- 215 (364)
T d1omwa3 150 DLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---------- 215 (364)
T ss_dssp CCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH----------
T ss_pred eeceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH----------
Confidence 99999864322 2345689999999999975 56899999999999999999999999764322110
Q ss_pred chhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 013519 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPS-----MEEVLET 381 (441)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~eil~~ 381 (441)
....... .....++..++..+.+||.+||+.||++||| ++|+++|
T Consensus 216 ---~~~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 216 ---EIDRMTL--TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---HHHHHSS--SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---HHHHhcc--cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0011111 1122345566778999999999999999999 7999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-53 Score=400.80 Aligned_cols=266 Identities=27% Similarity=0.379 Sum_probs=219.3
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|++.++||+|+||.||+|.+... .+..+++.||||+++... ......+.+|+.+++++ +|||||++++++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 46889999999999999999987543 233467899999997653 34556788999999999 6999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC---------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCc
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS---------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASN 240 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~N 240 (441)
+.+.+++|||||++|+|.+++.+... ...+++..++.++.||+.||.|||+ ++||||||||+|
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrDLKp~N 175 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARN 175 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccccccc
Confidence 99999999999999999999976431 2358899999999999999999997 999999999999
Q ss_pred EEEcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCC-CCCCCCCC
Q 013519 241 ILLDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRA-LDTNRPSG 319 (441)
Q Consensus 241 ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p-~~~~~~~~ 319 (441)
||++.++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||+|+..| |.....
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~-- 253 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-- 253 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999999876544444444557899999999999999999999999999999999995444 433221
Q ss_pred CceeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 320 EHVLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
...+.+++........+...+..+.+||.+||+.||++|||+.+|+++|+++
T Consensus 254 --------------~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 254 --------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp --------------SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------------HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1112223333334445566677899999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-52 Score=391.90 Aligned_cols=250 Identities=27% Similarity=0.324 Sum_probs=206.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---------HHHHHHHHHHHHHhcCC-CCCcc
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---------QGLREWQAEVKFLGKFS-HPNLV 168 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpniv 168 (441)
++|++.+.||+|+||+||+|+. ..+++.||||++..... ...+.+.+|+.+|++++ |||||
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~---------~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv 73 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIH---------KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred ccCEEceEEecCcCeEEEEEEE---------CCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeE
Confidence 6899999999999999999944 44589999998755321 12345788999999997 99999
Q ss_pred ceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCc
Q 013519 169 KLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 169 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 248 (441)
++++++.+++.+|||||||++|+|.++|...+ .+++..++.++.||+.||.|||+ +||+||||||+|||++.++.
T Consensus 74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMN 148 (277)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCC
T ss_pred EEEeecccCcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCC
Confidence 99999999999999999999999999997665 58999999999999999999997 99999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhc------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT------GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV 322 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~ 322 (441)
+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 149 ~kl~DFG~a~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----- 220 (277)
T d1phka_ 149 IKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----- 220 (277)
T ss_dssp EEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred eEEccchheeEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-----
Confidence 999999999865332 22345689999999999864 3467899999999999999999999975321
Q ss_pred eecccccccchhhhhhhhcCc--cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 323 LVDFARPSLTDKRRLKKIMDP--RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
......+... ..........+.++.+|+.+||+.||++|||++|||+|
T Consensus 221 -----------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 221 -----------MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -----------HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -----------HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111122211 11222234567789999999999999999999999886
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=397.20 Aligned_cols=268 Identities=27% Similarity=0.358 Sum_probs=213.5
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch-HHHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI-QGLREWQAEVKFLGKF-SHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 175 (441)
.++|++.+.||+|+||.||+|+...... .....+..||||++..... .....+.+|+..+.++ +|||||++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~--~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCc--ccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 3689999999999999999997654321 1223356899999977643 4457788899999888 7999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEE
Q 013519 176 EDRQFLLVYEYMQKGSLENHLFRKGS-------------AEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNIL 242 (441)
Q Consensus 176 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 242 (441)
+++.+++|||||++|+|.++|..... ...+++..++.++.|++.||.|||+ .+||||||||+|||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVL 167 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEeeeeccccee
Confidence 99999999999999999999975432 2468999999999999999999997 99999999999999
Q ss_pred EcCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCCc
Q 013519 243 LDGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLT-GLRALDTNRPSGEH 321 (441)
Q Consensus 243 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~ 321 (441)
++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |..||.....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---- 243 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 243 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH----
Confidence 99999999999999986544433334455679999999999999999999999999999999998 6788754321
Q ss_pred eeecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 322 VLVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
..+...+........|..++..+.+||.+||+.||++|||+.||++.|+++-
T Consensus 244 -------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 244 -------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1111222222333455667778999999999999999999999999998774
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-53 Score=401.98 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=205.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch---HHHHHHHHHHHHHh-cCCCCCccceEEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI---QGLREWQAEVKFLG-KFSHPNLVKLIGYC 174 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~-~l~hpniv~~~~~~ 174 (441)
++|++++.||+|+||+||+|+ +..+++.||||++..... ...+.+..|..++. .++|||||++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~---------~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAE---------FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEE---------ETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEE---------ECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 579999999999999999994 445689999999864321 22445666777665 68999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecc
Q 013519 175 WEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDF 254 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 254 (441)
.+++.+|||||||++|+|.+++...+ .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ccCCceeEEEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceeecCCCceecccc
Confidence 99999999999999999999997764 48899999999999999999997 89999999999999999999999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchh
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDK 334 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 334 (441)
|+++..... .......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+....
T Consensus 148 G~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---------------- 209 (320)
T d1xjda_ 148 GMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---------------- 209 (320)
T ss_dssp TTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------
T ss_pred chhhhcccc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH----------------
Confidence 999864322 23344568999999999999999999999999999999999999999753211
Q ss_pred hhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 013519 335 RRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSME-EVLET 381 (441)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-eil~~ 381 (441)
.....+... ...+|..++..+.+||.+||+.||++||++. ++++|
T Consensus 210 ~~~~~i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 210 ELFHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHHcC--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 111111111 1234556677899999999999999999995 78764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=396.21 Aligned_cols=259 Identities=26% Similarity=0.411 Sum_probs=206.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcC-CCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKF-SHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 176 (441)
++|++.++||+|+||+||+|.+..+. ....||||++... .....+.+.+|+++|.++ +|||||++++++.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETT-------EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCC-------eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 57889999999999999999765321 1235788887543 334556789999999999 69999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhc-------------CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRK-------------GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
++.+++|||||++|+|.++|.+. .....+++..++.++.|++.||.|||+ ++|+||||||+|||+
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NIL~ 160 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILV 160 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceEEE
Confidence 99999999999999999999754 234579999999999999999999997 899999999999999
Q ss_pred cCCCceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCC-CCCCCCCCCCce
Q 013519 244 DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLR-ALDTNRPSGEHV 322 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~-p~~~~~~~~~~~ 322 (441)
+.++.+||+|||+++..... .......||..|+|||.+.+..|+.++|||||||++|||++|.. ||.....
T Consensus 161 ~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~----- 232 (309)
T d1fvra_ 161 GENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----- 232 (309)
T ss_dssp CGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----
T ss_pred cCCCceEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-----
Confidence 99999999999999753221 12234578999999999999999999999999999999999765 5643211
Q ss_pred eecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 323 LVDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
...... +........+..++.++.+||.+||+.||++|||+.||+++|+.+.
T Consensus 233 -----------~~~~~~-i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 233 -----------AELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp -----------HHHHHH-GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----------HHHHHH-HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111111 1122233456677788999999999999999999999999998764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=403.02 Aligned_cols=252 Identities=21% Similarity=0.279 Sum_probs=199.1
Q ss_pred hcCCCCC-ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhc-CCCCCccceEEEEE
Q 013519 98 TKNFRPD-TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGK-FSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~ 175 (441)
.++|.+. ++||+|+||+||+|+. ..+++.||||+++.. ..+.+|+.++.+ ++|||||+++++|.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~---------~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFN---------KRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEE---------CCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 3678876 4699999999999944 445889999998643 356789988655 57999999999987
Q ss_pred e----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC---CCc
Q 013519 176 E----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG---SYN 248 (441)
Q Consensus 176 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~ 248 (441)
+ +..+|||||||+||+|.++|.+.+. ..+++..++.++.|++.||.|||+ .||+||||||+|||++. .+.
T Consensus 76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCC
T ss_pred ecccCCCEEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHH--cCCcccccccccccccccccccc
Confidence 6 4678999999999999999976542 569999999999999999999997 99999999999999975 567
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 328 (441)
+||+|||+|+..... ......+||+.|+|||++.+..|+.++|||||||+||+|+||+.||........... .
T Consensus 153 ~Kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~--~-- 225 (335)
T d2ozaa1 153 LKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--M-- 225 (335)
T ss_dssp EEECCCTTCEECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred ccccccceeeeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH--H--
Confidence 999999999864322 223456899999999999999999999999999999999999999976533211000 0
Q ss_pred cccchhhhhhhhcCcc--ccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 PSLTDKRRLKKIMDPR--LEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...+.... +........+.++.+||.+||+.||++|||+.|+++|
T Consensus 226 --------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 --------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --------HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000001 0001112456678999999999999999999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=395.63 Aligned_cols=262 Identities=23% Similarity=0.248 Sum_probs=193.5
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchH-----HHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQ-----GLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
+++||+|+||+||+|+ +..+++.||||+++..... ..+.+.+|+.+|++++|||||++++++.+++
T Consensus 3 l~~lG~G~fg~Vy~~~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~ 73 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKAR---------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 73 (299)
T ss_dssp EEEEEEETTEEEEEEE---------CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred ceEeccCcCeEEEEEE---------ECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence 5789999999999994 4445899999998654322 1245789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 179 QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 179 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.+|||||||.++++..++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+
T Consensus 74 ~~~ivmE~~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 74 NISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAK 148 (299)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ceeehhhhhcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCcccc
Confidence 99999999998877665532 2458889999999999999999997 999999999999999999999999999998
Q ss_pred CCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-c-c---cccccc
Q 013519 259 LGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-D-F---ARPSLT 332 (441)
Q Consensus 259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-~-~---~~~~~~ 332 (441)
..... .......+||+.|+|||++... .|+.++|||||||++|||+||..||......+....+ . . ....+.
T Consensus 149 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 149 SFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 226 (299)
T ss_dssp TTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred ccCCC--cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 64332 2223446899999999998754 5789999999999999999999999654321100000 0 0 000000
Q ss_pred hhhhhhhhcC-----ccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 333 DKRRLKKIMD-----PRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 333 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.......... ...........+..+.+||.+||+.||++|||+.|+|+|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000000 000000112345678899999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=388.15 Aligned_cols=258 Identities=27% Similarity=0.388 Sum_probs=205.7
Q ss_pred CceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe-CCeEE
Q 013519 104 DTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE-DRQFL 181 (441)
Q Consensus 104 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~ 181 (441)
.++||+|+||+||+|++.... .....||||+++.. .....+.|.+|+++|++++|||||++++++.+ ++.++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEECCC------CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 468999999999999775431 12347899998753 55567889999999999999999999999876 56899
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccCCCCCC
Q 013519 182 LVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKLGP 261 (441)
Q Consensus 182 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~~~ 261 (441)
+|||||++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||||++++.+||+|||+++...
T Consensus 106 lv~E~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp EEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred EEEEEeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence 9999999999999887543 457788999999999999999997 899999999999999999999999999998653
Q ss_pred CCCCc--ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecccccccchhhhhhh
Q 013519 262 IDGNS--HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSLTDKRRLKK 339 (441)
Q Consensus 262 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (441)
..... .......||+.|+|||++....++.++||||||+++|||+||..||........ ....
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---------------~~~~ 246 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---------------ITVY 246 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------------------CHHH
T ss_pred ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---------------HHHH
Confidence 32211 122335789999999999999999999999999999999998888754321110 0011
Q ss_pred hcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 340 IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
+.. ......|..++..+.+||.+||+.||++||++.||+++|+.+..
T Consensus 247 i~~-g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 247 LLQ-GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHc-CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111 11223455667789999999999999999999999999988754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=391.05 Aligned_cols=266 Identities=23% Similarity=0.357 Sum_probs=215.8
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC-chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD-SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
.++|.+.+.||+|+||+||+|.+... .....+..||||+++.. .......+.+|+.++++++|||||++++++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCc----ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 36788999999999999999977532 12223578999999764 33445678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhc-------CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRK-------GSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
+...++|||||++|+|.+++... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCCE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecCCceE
Confidence 99999999999999999988642 223457899999999999999999997 899999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCC-CCCCCCCCCCCceeecccc
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGL-RALDTNRPSGEHVLVDFAR 328 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~-~p~~~~~~~~~~~~~~~~~ 328 (441)
||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. .||...
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------------- 239 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------------- 239 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-------------
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-------------
Confidence 999999998643333323334457899999999999999999999999999999999985 566432
Q ss_pred cccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhccc
Q 013519 329 PSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNIS 386 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~ 386 (441)
.....+..+.+.. ....+..++..+.+||.+||+.||++|||+.+|+++|+...
T Consensus 240 ---~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 240 ---SNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp ---CHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred ---CHHHHHHHHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1122222233322 23345667778999999999999999999999999998653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-51 Score=386.68 Aligned_cols=272 Identities=23% Similarity=0.321 Sum_probs=202.4
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWEDR 178 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 178 (441)
.+|.+.+.||+|+||+||+|+++ |+.||||++...... ....+.|+..+..++|||||++++++.+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-----------g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~ 70 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence 46778899999999999999653 679999998765432 122334666667889999999999998654
Q ss_pred ----eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccC------CCCeeecCCCCCcEEEcCCCc
Q 013519 179 ----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSS------EKSVIYRDFKASNILLDGSYN 248 (441)
Q Consensus 179 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivHrDlkp~Nill~~~~~ 248 (441)
.+++|||||++|+|.++|.+. .+++..++.++.|++.||.|||+. .++||||||||+||||+.++.
T Consensus 71 ~~~~~~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~ 146 (303)
T d1vjya_ 71 GTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred CcceEEEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence 689999999999999999764 489999999999999999999962 469999999999999999999
Q ss_pred eEEecccCCCCCCCCCCcc--eEeeeccccccCcchhhhcCC------CCccccchhHHHHHHHHHhCCCCCCCCCCCCC
Q 013519 249 AKLSDFGLAKLGPIDGNSH--VTTRIMGTYGYAAPEYVATGH------LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGE 320 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~elltg~~p~~~~~~~~~ 320 (441)
+||+|||+++......... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||........
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 9999999998653322211 234568999999999987643 67789999999999999999888754332221
Q ss_pred ceeecccccccchhhhhhhhcCccccccC-----ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcccc
Q 013519 321 HVLVDFARPSLTDKRRLKKIMDPRLEEQY-----PIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNISV 387 (441)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i~~ 387 (441)
... ....................++... +......+.+|+.+||+.||++|||+.||+++|+.+..
T Consensus 227 ~~~-~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 227 PYY-DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TTT-TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chh-hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111 1111111111111112222222222 22345668899999999999999999999999987763
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-52 Score=392.39 Aligned_cols=272 Identities=23% Similarity=0.345 Sum_probs=200.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++++.||+|+||+||+|.. ..+++.||||++..... .....+.+|+++|++++|||||++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARN---------KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEE---------CCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 5799999999999999999944 44588999999865432 235678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++.+|+|||||.++ +.+++.... ...+++..++.++.|++.||.|||+ +|||||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~iv~e~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp TTEEEEEEECCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred ccceeEEEeecCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCc
Confidence 99999999999765 444443322 3569999999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCCcee--ecccccccch
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL--VDFARPSLTD 333 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~ 333 (441)
|+..... ........||+.|+|||++....+ +.++|||||||++|+|++|+.||........... .....+....
T Consensus 149 a~~~~~~--~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 226 (298)
T d1gz8a_ 149 ARAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226 (298)
T ss_dssp HHHHCCC--SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ceeccCC--cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence 9764322 223344689999999999877665 6899999999999999999999975431110000 0000000000
Q ss_pred hhhhhhh--cCccccc-------cCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhcc
Q 013519 334 KRRLKKI--MDPRLEE-------QYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET--LQNI 385 (441)
Q Consensus 334 ~~~~~~~--~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~--L~~i 385 (441)
....... ....... ......+..+.+|+.+||+.||++|||+.|+|+| |+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000000 0000000 0112345678899999999999999999999987 4443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=388.85 Aligned_cols=241 Identities=25% Similarity=0.398 Sum_probs=197.9
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch------HHHHHHHHHHHHHhcCC--CCCccce
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI------QGLREWQAEVKFLGKFS--HPNLVKL 170 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~--hpniv~~ 170 (441)
++|++.++||+|+||+||+|+. ..+++.||||++..... .....+.+|+.+|++++ |||||++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~ 74 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIR---------VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 74 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred CeEEEeEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEE
Confidence 5799999999999999999944 44589999998754321 11233567999999986 9999999
Q ss_pred EEEEEeCCeEEEEEeecCC-CCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC-CCc
Q 013519 171 IGYCWEDRQFLLVYEYMQK-GSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG-SYN 248 (441)
Q Consensus 171 ~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~ 248 (441)
++++.+++.+++||||+.+ +++.+++.... .+++.+++.++.|++.||.|||+ ++|+||||||+|||++. ++.
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 75 LDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTE
T ss_pred EEEEeeCCeEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCCCe
Confidence 9999999999999999976 67888886654 58999999999999999999997 99999999999999985 479
Q ss_pred eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccc
Q 013519 249 AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHL-YVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFA 327 (441)
Q Consensus 249 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 327 (441)
+||+|||+|+.... .......||+.|+|||++.+..+ +.++|||||||++|||+||+.||....
T Consensus 150 vkl~DFG~a~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------- 214 (273)
T d1xwsa_ 150 LKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------- 214 (273)
T ss_dssp EEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred EEECccccceeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----------
Confidence 99999999986322 23445789999999999988776 577999999999999999999996421
Q ss_pred ccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 328 RPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+ ... ...++...+.++.+||.+||+.||++|||++|+++|
T Consensus 215 --------~i---~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 --------EI---IRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --------HH---HHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------HH---hhc--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 000 012334456778999999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-51 Score=386.42 Aligned_cols=272 Identities=25% Similarity=0.350 Sum_probs=200.1
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcC---CCCCccceEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKF---SHPNLVKLIG 172 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~~~~ 172 (441)
.++|++++.||+|+||+||+|+.... .++.||||++..... .....+.+|+.+|+.| +||||+++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC--------CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 46899999999999999999954322 267899998754321 1122345677776655 7999999999
Q ss_pred EEEe-----CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 173 YCWE-----DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 173 ~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
+|.. ...++++||||.++.+....... ...+++..++.++.|++.||.|||+ ++||||||||+|||++.++
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTC
T ss_pred eecccccccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCCC
Confidence 9863 34689999999987776544332 3568999999999999999999997 9999999999999999999
Q ss_pred ceEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee----
Q 013519 248 NAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL---- 323 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~---- 323 (441)
.+||+|||+++... .........||+.|+|||++.+..|+.++|||||||++|||++|+.||...........
T Consensus 154 ~~kl~dfg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 230 (305)
T d1blxa_ 154 QIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230 (305)
T ss_dssp CEEECSCCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred Ceeecchhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 99999999998532 22334567899999999999999999999999999999999999999975432110000
Q ss_pred ------ecccccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhcc
Q 013519 324 ------VDFARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET--LQNI 385 (441)
Q Consensus 324 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~--L~~i 385 (441)
..+........... ..........++...+..+.+||.+||+.||++|||+.|+|+| |+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGS-CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hCCCchhcccccccchhhhh-ccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 00000000000000 0001111122344556778899999999999999999999987 4444
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-50 Score=379.24 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=199.6
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch--HHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI--QGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|+++++||+|+||+||+|... +++.||||+++.... ...+.+.+|+.+|++++|||||++++++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 57999999999999999999553 378999999876533 235678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
++..+++|||+.++.+..+.... ..+++..+..++.|++.||.|||+ .+||||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred CCceeEEEEeehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeEcCCCCEEeccccc
Confidence 99999999999887766665433 469999999999999999999997 8999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce--ee---cccccc
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--LV---DFARPS 330 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~~---~~~~~~ 330 (441)
+...... ........|++.|+|||.+.+. .++.++|||||||++|||++|+.||.......... .. ......
T Consensus 147 a~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 147 ARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224 (286)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ceecccC--ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhh
Confidence 9754321 2223445789999999999765 56899999999999999999999996543211000 00 000000
Q ss_pred cchhhhhhh------hcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 331 LTDKRRLKK------IMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 331 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+........ ...+..........+..+.+||.+||+.||++|||+.|+|+|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 001111122234456678899999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=383.95 Aligned_cols=268 Identities=22% Similarity=0.295 Sum_probs=197.7
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++++.||+|+||+||+|. +..+++.||||++... .....+.+.+|+.+|+.++|||||+++++|.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAV---------DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEEE---------ETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEEE---------ECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 4689999999999999999994 4445899999998754 3344667889999999999999999999998
Q ss_pred eCC------eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCce
Q 013519 176 EDR------QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNA 249 (441)
Q Consensus 176 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 249 (441)
..+ .+|+||||| +.+|..++... .+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~~ 160 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCEL 160 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCE
T ss_pred cCccccccceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhccccccc
Confidence 654 579999999 66777766442 48999999999999999999997 999999999999999999999
Q ss_pred EEecccCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee----
Q 013519 250 KLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV---- 324 (441)
Q Consensus 250 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~---- 324 (441)
||+|||+|+.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||............
T Consensus 161 kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~ 235 (346)
T d1cm8a_ 161 KILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235 (346)
T ss_dssp EECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred ccccccceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhcc
Confidence 9999999986422 23456899999999999875 5679999999999999999999999654321100000
Q ss_pred -----c-ccccccchhhhhhhhcCc---cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhccc
Q 013519 325 -----D-FARPSLTDKRRLKKIMDP---RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET--LQNIS 386 (441)
Q Consensus 325 -----~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~--L~~i~ 386 (441)
. +................. ..........+..+.+||.+||..||++|||+.|+|+| |+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 000000000000000100 00111223456678899999999999999999999997 55443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=383.65 Aligned_cols=268 Identities=23% Similarity=0.306 Sum_probs=196.8
Q ss_pred CCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCccceEEEEEeC--
Q 013519 100 NFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLVKLIGYCWED-- 177 (441)
Q Consensus 100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 177 (441)
+|...++||+|+||+||+|+. ..+++.||||++..... .+.+|+.+|++++||||++++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~---------~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKL---------CDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEE---------CCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 588889999999999999944 44589999999866542 234699999999999999999998643
Q ss_pred ----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC-ceEEe
Q 013519 178 ----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY-NAKLS 252 (441)
Q Consensus 178 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~ 252 (441)
..++||||||+++.+..+.........+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl~ 165 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLC 165 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEEC
T ss_pred cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeEe
Confidence 3578999999876544443333334579999999999999999999997 9999999999999999775 89999
Q ss_pred cccCCCCCCCCCCcceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee-c-cccc
Q 013519 253 DFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV-D-FARP 329 (441)
Q Consensus 253 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-~-~~~~ 329 (441)
|||+++..... .......||+.|+|||++.+ ..|+.++|||||||++|||++|+.||............ . ...+
T Consensus 166 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~ 242 (350)
T d1q5ka_ 166 DFGSAKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242 (350)
T ss_dssp CCTTCEECCTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cccchhhccCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999764322 22345689999999999875 46899999999999999999999999654321100000 0 0000
Q ss_pred ccchhhhh---------hhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhcc
Q 013519 330 SLTDKRRL---------KKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET--LQNI 385 (441)
Q Consensus 330 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~--L~~i 385 (441)
........ .......+........+..+.+||.+||+.||++|||+.|+|+| |+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00000000 00000011112233456678999999999999999999999986 4444
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=379.20 Aligned_cols=269 Identities=22% Similarity=0.294 Sum_probs=196.2
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc-hHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS-IQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
..+|++++.||+|+||+||+|+ +..+++.||||++.... ....+.+.+|+.+|++++||||+++++++..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEE---------ETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred CCCeEEEEEEeeccCeEEEEEE---------ECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence 3579999999999999999994 44458999999987653 3456678899999999999999999999876
Q ss_pred CC----eEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEe
Q 013519 177 DR----QFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLS 252 (441)
Q Consensus 177 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 252 (441)
.. ..+++++|+.+|+|.+++... .+++..++.++.|++.||.|||+ +|||||||||+||||+.++.+||+
T Consensus 78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~~~~kl~ 151 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKIC 151 (345)
T ss_dssp SSTTTCCCEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEEC
T ss_pred ccccccceEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCCCCEEEc
Confidence 43 234555667799999999654 48999999999999999999997 999999999999999999999999
Q ss_pred cccCCCCCCCCCCc-ceEeeeccccccCcchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeec--ccc
Q 013519 253 DFGLAKLGPIDGNS-HVTTRIMGTYGYAAPEYVAT-GHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVD--FAR 328 (441)
Q Consensus 253 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~--~~~ 328 (441)
|||+++........ ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||............. ...
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~ 231 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccC
Confidence 99999764322111 12344679999999999854 467899999999999999999999996543211000000 000
Q ss_pred cccchh------hhhhhhc-Ccccc----ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 PSLTDK------RRLKKIM-DPRLE----EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 ~~~~~~------~~~~~~~-~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
+..... ....... .+... .......+..+.+|+.+||+.||++|||+.|+|+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 0000000 00000 00112334568899999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=370.20 Aligned_cols=270 Identities=23% Similarity=0.292 Sum_probs=193.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc--hHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS--IQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++++.||+|+||+||+|+.. .+++.||||++.... ......+.+|+.+|++++||||+++++++.
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~ 79 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHR---------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 79 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence 368999999999999999999543 458999999875542 223456789999999999999999999886
Q ss_pred e--------CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC
Q 013519 176 E--------DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY 247 (441)
Q Consensus 176 ~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 247 (441)
. +..+++|||||.++.+..+.. ....++...++.++.|++.||.|||+ .||+||||||+|||++.++
T Consensus 80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~ 154 (318)
T d3blha1 80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDG 154 (318)
T ss_dssp C----------CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTS
T ss_pred cccccccccCceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCCC
Confidence 5 346899999998876654432 23468899999999999999999997 9999999999999999999
Q ss_pred ceEEecccCCCCCCCCCCc--ceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee
Q 013519 248 NAKLSDFGLAKLGPIDGNS--HVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV 324 (441)
Q Consensus 248 ~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~ 324 (441)
.+||+|||+++........ ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||............
T Consensus 155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i 234 (318)
T d3blha1 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234 (318)
T ss_dssp CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHH
Confidence 9999999999754322211 122335799999999999765 6889999999999999999999999753311100000
Q ss_pred -----ccccc---ccchhhhhhhhcCccc-cccC-----ChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 325 -----DFARP---SLTDKRRLKKIMDPRL-EEQY-----PIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 325 -----~~~~~---~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
..... ..........+..... .... ....+..+.+||.+||+.||++|||++|+|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000 0000000000000000 0000 01124467799999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.8e-48 Score=364.57 Aligned_cols=262 Identities=17% Similarity=0.178 Sum_probs=205.0
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCC-CCccceEEEEEe
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSH-PNLVKLIGYCWE 176 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~ 176 (441)
.++|++++.||+|+||+||+|+. ..+++.||||++..... ...+.+|+++++.+.| +||+.+++++..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~---------~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTN---------LLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEE---------TTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 36899999999999999999944 44588999998754432 2346678999999975 899999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC-----CCceEE
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG-----SYNAKL 251 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-----~~~~kl 251 (441)
....++||||+ +++|.+++...+ ..++..++..++.|++.||.|||+ +||+||||||+|||++. ++.+||
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~vkl 147 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYV 147 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred CCccEEEEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCceEE
Confidence 99999999999 789999887654 468999999999999999999997 99999999999999964 578999
Q ss_pred ecccCCCCCCCCCCc-----ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeecc
Q 013519 252 SDFGLAKLGPIDGNS-----HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDF 326 (441)
Q Consensus 252 ~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 326 (441)
+|||+|+........ ......+||+.|+|||++.+..++.++|||||||++|||+||+.||...........
T Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~--- 224 (293)
T d1csna_ 148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK--- 224 (293)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH---
T ss_pred cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH---
Confidence 999999865332211 223456899999999999999999999999999999999999999975433211100
Q ss_pred cccccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 327 ARPSLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
...+...............++.++.+++..|+..+|++||++..+.+.|+.+
T Consensus 225 -------~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 225 -------YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp -------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred -------HHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0000000000011112233456788999999999999999999998887764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-48 Score=374.27 Aligned_cols=260 Identities=18% Similarity=0.260 Sum_probs=197.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 177 (441)
++|+++++||+|+||+||+|+ +..+++.||||+++.... +.+.+|+.+|+.+. ||||++++++|...
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~---------~~~~~~~vAiK~i~~~~~---~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAI---------NITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECSSCH---HHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred cCeEEEEEEecCcCeEEEEEE---------ECCCCCEEEEEEECHHHH---HHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 579999999999999999994 445689999999876553 56788999999996 99999999999853
Q ss_pred --CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCC-ceEEecc
Q 013519 178 --RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSY-NAKLSDF 254 (441)
Q Consensus 178 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DF 254 (441)
..+++|||||.+++|..+. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+||
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~~~~~vkl~DF 174 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDW 174 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCG
T ss_pred CCCceeEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcCCCCeeeeccc
Confidence 5699999999999987653 358999999999999999999997 9999999999999998655 6999999
Q ss_pred cCCCCCCCCCCcceEeeeccccccCcchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee--cccc---
Q 013519 255 GLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG-HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV--DFAR--- 328 (441)
Q Consensus 255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~--~~~~--- 328 (441)
|+|+..... ......+||+.|+|||.+.+. .++.++|||||||++|+|++|+.||............ ....
T Consensus 175 G~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~ 251 (328)
T d3bqca1 175 GLAEFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251 (328)
T ss_dssp GGCEECCTT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred ccceeccCC---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCch
Confidence 999864322 223456799999999998875 4789999999999999999999999654321110000 0000
Q ss_pred -------cccchhhhhhhhcCc--------cccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 329 -------PSLTDKRRLKKIMDP--------RLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 329 -------~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
............... ..........+.++.+||.+||..||++|||++|+|+|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000000 01111123355678999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-48 Score=365.62 Aligned_cols=261 Identities=20% Similarity=0.204 Sum_probs=197.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCcc-ceEEEEEeC
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNLV-KLIGYCWED 177 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~ 177 (441)
++|++.+.||+|+||+||+|+. ..+++.||||++...... ..+..|+++++.++|+|++ .+.+++.+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~---------~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTD---------IAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CEEEEeEEEeeCCCcEEEEEEE---------CCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence 5799999999999999999954 345889999987654322 3567899999999876655 555666778
Q ss_pred CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC---CCceEEecc
Q 013519 178 RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG---SYNAKLSDF 254 (441)
Q Consensus 178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~kl~DF 254 (441)
+..++||||+ +++|.+.+.... ..+++..++.++.|++.||.|||+ +||+||||||+|||++. +..+||+||
T Consensus 76 ~~~~ivme~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl~DF 150 (299)
T d1ckia_ 76 DYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDF 150 (299)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CEEEEEEEEc-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeeeecc
Confidence 8999999999 556766665433 468999999999999999999997 99999999999999854 457999999
Q ss_pred cCCCCCCCCCCc-----ceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccc
Q 013519 255 GLAKLGPIDGNS-----HVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARP 329 (441)
Q Consensus 255 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 329 (441)
|+|+........ .......||+.|+|||++.+..++.++|||||||++|||+||..||.............
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~---- 226 (299)
T d1ckia_ 151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE---- 226 (299)
T ss_dssp SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH----
T ss_pred CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH----
Confidence 999865332211 22345689999999999999999999999999999999999999997643322111100
Q ss_pred ccchhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcc
Q 013519 330 SLTDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLETLQNI 385 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~L~~i 385 (441)
........ . ........++.++.+|+.+||+.+|++||++.++.+.|+.+
T Consensus 227 ----~~~~~~~~-~-~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 227 ----RISEKKMS-T-PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ----HHHHHHHH-S-CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ----HhhcccCC-C-ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00000000 0 01112234556788999999999999999999998887754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=365.32 Aligned_cols=267 Identities=21% Similarity=0.268 Sum_probs=204.3
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|++++.||+|+||+||+|+. ..+++.||||+++.. .......+.+|+.+|+.++||||+++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKN---------RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEEE---------CCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 5799999999999999999944 445889999997544 23456788999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 013519 177 DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSDFGL 256 (441)
Q Consensus 177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFGl 256 (441)
....++|++++.+++|..++... ..+++..++.++.|++.||+|||. ++|+||||||+|||++.++.+||+|||.
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccceeEEeeeccccccccccccc---cccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecch
Confidence 99999999999999988877654 458899999999999999999997 9999999999999999999999999999
Q ss_pred CCCCCCCCCcceEeeeccccccCcchhhhcCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCCcee--ec-cc---cc
Q 013519 257 AKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH-LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVL--VD-FA---RP 329 (441)
Q Consensus 257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~--~~-~~---~~ 329 (441)
++...... .......+++.|+|||++.... ++.++|||||||++|||++|+.||.......+... .. .. ..
T Consensus 148 a~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (292)
T d1unla_ 148 ARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp CEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred hhcccCCC--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChh
Confidence 98643322 2233456789999999987765 58999999999999999999999743221111000 00 00 00
Q ss_pred ccchhhhhhhhc------CccccccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 330 SLTDKRRLKKIM------DPRLEEQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 330 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.+.......... ............+..+.+||.+||+.||.+|||++|+|+|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000 0001112233456678899999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=372.91 Aligned_cols=257 Identities=28% Similarity=0.394 Sum_probs=204.8
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCc----hHHHHHHHHHHHHHhcCCC-CCccceEEE
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDS----IQGLREWQAEVKFLGKFSH-PNLVKLIGY 173 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h-pniv~~~~~ 173 (441)
++|++++.||+|+||+||+|+... ...+|+.||||+++... ....+.+.+|+.+|++++| |||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~------~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKIS------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECS------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECc------cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 579999999999999999996532 23458899999886532 1234567789999999976 899999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceEEec
Q 013519 174 CWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAKLSD 253 (441)
Q Consensus 174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 253 (441)
+.+...+++||||+.+|+|.+++...+ .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~D 172 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTD 172 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESC
T ss_pred eccCCceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEee
Confidence 999999999999999999999997765 36788999999999999999997 9999999999999999999999999
Q ss_pred ccCCCCCCCCCCcceEeeeccccccCcchhhhcC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCCceeeccccccc
Q 013519 254 FGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATG--HLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLVDFARPSL 331 (441)
Q Consensus 254 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 331 (441)
||+++...... ........|++.|+|||.+.+. .++.++|||||||+||+|++|+.||..........
T Consensus 173 FG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--------- 242 (322)
T d1vzoa_ 173 FGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--------- 242 (322)
T ss_dssp SSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH---------
T ss_pred ccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---------
Confidence 99997543222 2223456899999999999765 46789999999999999999999997654321100
Q ss_pred chhhhhhhhcCccccccCChhhHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 013519 332 TDKRRLKKIMDPRLEEQYPIKGALLAGQIIIKCLEAEPKNRP-----SMEEVLET 381 (441)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~eil~~ 381 (441)
....... .....++..++..+.+||.+||+.||++|| +++|+++|
T Consensus 243 ---~i~~~~~--~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 243 ---EISRRIL--KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ---HHHHHHH--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ---HHHHhcc--cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0001111 111234556778899999999999999999 48999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=374.21 Aligned_cols=263 Identities=22% Similarity=0.266 Sum_probs=190.7
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCWE 176 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 176 (441)
++|+++++||+|+||+||+|+. ..+|+.||||++... +......+.+|+.+|++++|||||+++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d---------~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYD---------AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEE---------TTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCeEEEEEeecCcCeEEEEEEE---------CCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 6899999999999999999944 445899999998654 34455678899999999999999999999964
Q ss_pred ------CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 177 ------DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 177 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
...+|+|||||.++.+ +.+. ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~~k 159 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_dssp CCSTTTCCEEEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEE
T ss_pred ccccccCceeEEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhh--cccccccCCcccccccccccee
Confidence 3688999999976544 4442 348899999999999999999997 9999999999999999999999
Q ss_pred EecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCCce--e-----
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHV--L----- 323 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~--~----- 323 (441)
++|||+++.... .......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.......... +
T Consensus 160 l~df~~~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~ 236 (355)
T d2b1pa1 160 ILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_dssp ECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eechhhhhcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence 999999885432 233455689999999999999999999999999999999999999996543110000 0
Q ss_pred --ecccccccchhhh------------hhhhcCcccc---ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 324 --VDFARPSLTDKRR------------LKKIMDPRLE---EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 324 --~~~~~~~~~~~~~------------~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
.++.......... ....+..... ...+...+..+.+||.+||..||++|||++|||+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000000 0000000000 01123456788999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=371.26 Aligned_cols=264 Identities=21% Similarity=0.283 Sum_probs=195.6
Q ss_pred hcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC--chHHHHHHHHHHHHHhcCCCCCccceEEEEE
Q 013519 98 TKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD--SIQGLREWQAEVKFLGKFSHPNLVKLIGYCW 175 (441)
Q Consensus 98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 175 (441)
.++|++++.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+|++++|||||++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEE---------ETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEE---------ECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4689999999999999999994 4445899999998754 3345567889999999999999999999986
Q ss_pred eC-----CeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcCCCceE
Q 013519 176 ED-----RQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDGSYNAK 250 (441)
Q Consensus 176 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 250 (441)
.. ...++||+|+.+|+|.+++.. ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~k 161 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELK 161 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEE
T ss_pred eccccccCceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCcccccccccccc
Confidence 43 345677788889999998853 359999999999999999999997 9999999999999999999999
Q ss_pred EecccCCCCCCCCCCcceEeeeccccccCcchhhhcCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCCceee--c--
Q 013519 251 LSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGH-LYVKSDVYGFGVVLLEMLTGLRALDTNRPSGEHVLV--D-- 325 (441)
Q Consensus 251 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~--~-- 325 (441)
++|||++.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.......... .
T Consensus 162 l~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~ 236 (348)
T d2gfsa1 162 ILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236 (348)
T ss_dssp ECCC----CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccchhcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999997532 2234467999999999887765 578999999999999999999999754311000000 0
Q ss_pred -----cccccc-chhhhhhhhcCcccc---ccCChhhHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 013519 326 -----FARPSL-TDKRRLKKIMDPRLE---EQYPIKGALLAGQIIIKCLEAEPKNRPSMEEVLET 381 (441)
Q Consensus 326 -----~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~eil~~ 381 (441)
...... ............... .......+..+.+||.+||+.||++|||+.|+|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000 000000000000000 00012345678899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.8e-43 Score=339.46 Aligned_cols=267 Identities=17% Similarity=0.213 Sum_probs=195.0
Q ss_pred cCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-----------CCCc
Q 013519 99 KNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-----------HPNL 167 (441)
Q Consensus 99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpni 167 (441)
.+|+++++||+|+||+||+|+ ...+|+.||||+++.... ..+.+.+|+.+|+.+. |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~---------~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAK---------DMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEE---------ETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEEE---------ECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 359999999999999999994 445689999999987643 2456778999888775 5789
Q ss_pred cceEEEEEe--CCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEEcC
Q 013519 168 VKLIGYCWE--DRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILLDG 245 (441)
Q Consensus 168 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 245 (441)
+++++++.. ....+++|+++..+..............+++..+..++.|++.||.|||+ ..||+||||||+||||+.
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeeec
Confidence 999988764 45677888887666554444444445678999999999999999999995 589999999999999976
Q ss_pred CCc------eEEecccCCCCCCCCCCcceEeeeccccccCcchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 013519 246 SYN------AKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAPEYVATGHLYVKSDVYGFGVVLLEMLTGLRALDTNRPSG 319 (441)
Q Consensus 246 ~~~------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~ 319 (441)
++. ++++|||.++.... .....+||+.|+|||++.+..++.++|||||||++++|++|+.||.......
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 653 99999999975322 2345679999999999999999999999999999999999999997543211
Q ss_pred Ccee----e-------cccccccchhhhhhhhcCc-------------------cccccCChhhHHHHHHHHHHhcccCC
Q 013519 320 EHVL----V-------DFARPSLTDKRRLKKIMDP-------------------RLEEQYPIKGALLAGQIIIKCLEAEP 369 (441)
Q Consensus 320 ~~~~----~-------~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~li~~~l~~dp 369 (441)
.... . ................++. ......+...+..+.+||.+||..||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 1000 0 0000000000000000000 00112345667889999999999999
Q ss_pred CCCCCHHHHHHH
Q 013519 370 KNRPSMEEVLET 381 (441)
Q Consensus 370 ~~Rps~~eil~~ 381 (441)
.+|||++|+|+|
T Consensus 317 ~~Rpta~e~L~H 328 (362)
T d1q8ya_ 317 RKRADAGGLVNH 328 (362)
T ss_dssp TTCBCHHHHHTC
T ss_pred hHCcCHHHHhcC
Confidence 999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.9e-25 Score=195.76 Aligned_cols=163 Identities=13% Similarity=0.100 Sum_probs=117.3
Q ss_pred CCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCch------------------HHHHHHHHHHHHHhcCC
Q 013519 102 RPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSI------------------QGLREWQAEVKFLGKFS 163 (441)
Q Consensus 102 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 163 (441)
.+.++||+|+||+||+|... +|+.||||+++.... ........|+..+.++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 72 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred hhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence 35679999999999999543 378999998653211 11234557899999999
Q ss_pred CCCccceEEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCeeecCCCCCcEEE
Q 013519 164 HPNLVKLIGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHSSEKSVIYRDFKASNILL 243 (441)
Q Consensus 164 hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 243 (441)
|++++..+++. . .++||||+++..+.. ++......++.|++.+|.|||+ .||+||||||+|||+
T Consensus 73 ~~~v~~~~~~~--~--~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv 136 (191)
T d1zara2 73 GLAVPKVYAWE--G--NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLV 136 (191)
T ss_dssp TSSSCCEEEEE--T--TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEE
T ss_pred CCCcceEEEec--C--CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheee
Confidence 99999987653 2 379999998865432 3345567899999999999997 899999999999999
Q ss_pred cCCCceEEecccCCCCCCCCCCcceEeeeccccccCcc--h---hhhcCCCCccccchhHHHH
Q 013519 244 DGSYNAKLSDFGLAKLGPIDGNSHVTTRIMGTYGYAAP--E---YVATGHLYVKSDVYGFGVV 301 (441)
Q Consensus 244 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~~DvwSlG~i 301 (441)
+++ .++|+|||+|+....... ..|... + .+....|+.++|+||+.--
T Consensus 137 ~~~-~~~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVGEEGW----------REILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp ETT-EEEECCCTTCEETTSTTH----------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred eCC-CEEEEECCCcccCCCCCc----------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 965 489999999975321110 111111 0 0124578899999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.73 E-value=2.3e-08 Score=89.84 Aligned_cols=148 Identities=14% Similarity=0.069 Sum_probs=97.4
Q ss_pred HHHHHHhcCCCCCceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC-CCCccce
Q 013519 92 QDLRAATKNFRPDTMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS-HPNLVKL 170 (441)
Q Consensus 92 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~ 170 (441)
.++....+.|++.+..+-++.+.||+... .++.+++|+...........+.+|..++..+. +--+.++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~v 75 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKV 75 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcE
Confidence 46677778888776655555678998632 25567888876543333345677888877764 4335677
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHhcCCCCCCCHHHHHHHHHHHHHHHhhhcc------------------------
Q 013519 171 IGYCWEDRQFLLVYEYMQKGSLENHLFRKGSAEPLPWNTRLKIAIDAAKDLTFLHS------------------------ 226 (441)
Q Consensus 171 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~------------------------ 226 (441)
+.+..+++..++||++++|..+.+..... . ....++.+++..|..||+
T Consensus 76 l~~~~~~~~~~lv~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (263)
T d1j7la_ 76 LHFERHDGWSNLLMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN 147 (263)
T ss_dssp EEEEEETTEEEEEEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred EEEEecCCceEEEEEeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHH
Confidence 88888889999999999998875543111 0 111123333333333332
Q ss_pred ---------------------------------CCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 227 ---------------------------------SEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 227 ---------------------------------~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
....++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237999999999999987666799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.93 E-value=2.3e-05 Score=69.15 Aligned_cols=74 Identities=16% Similarity=0.065 Sum_probs=49.7
Q ss_pred eecccCc-eEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC--CCCccceEEEEEeCCeEEE
Q 013519 106 MLGEGGF-GRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS--HPNLVKLIGYCWEDRQFLL 182 (441)
Q Consensus 106 ~lG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~l 182 (441)
.+..|.. +.||+.... .+..+++|........ .+..|+..|+.+. .-.+.+++.+..+.+..++
T Consensus 17 ~~~~G~s~~~v~r~~~~----------~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECT----------TSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred EcCCcccCCeEEEEEeC----------CCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence 3444543 678986432 2556888987655432 3556777777664 2335667888888888999
Q ss_pred EEeecCCCCH
Q 013519 183 VYEYMQKGSL 192 (441)
Q Consensus 183 v~e~~~~g~L 192 (441)
||++++|.++
T Consensus 84 v~~~i~G~~~ 93 (255)
T d1nd4a_ 84 LLGEVPGQDL 93 (255)
T ss_dssp EEECCSSEET
T ss_pred EEEeeecccc
Confidence 9999988654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.88 E-value=2.3e-05 Score=74.05 Aligned_cols=76 Identities=18% Similarity=0.225 Sum_probs=46.4
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCC------c-hHHHHHHHHHHHHHhcCC-C-C-CccceEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPD------S-IQGLREWQAEVKFLGKFS-H-P-NLVKLIGYC 174 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~------~-~~~~~~~~~E~~~l~~l~-h-p-niv~~~~~~ 174 (441)
+.||.|....||+.... ..++.+++|.-.+. . .........|+..|+.+. + | .+.+++.
T Consensus 32 ~eig~G~~N~vfrV~~~---------~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~-- 100 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQ---------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-- 100 (392)
T ss_dssp EECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--
T ss_pred EEeCCCceEeEEEEEeC---------CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--
Confidence 47899999999998433 23678999964331 1 112233456887777663 2 2 3444543
Q ss_pred EeCCeEEEEEeecCCCC
Q 013519 175 WEDRQFLLVYEYMQKGS 191 (441)
Q Consensus 175 ~~~~~~~lv~e~~~~g~ 191 (441)
.+....++|||++.+..
T Consensus 101 ~d~~~~~lvmE~L~~~~ 117 (392)
T d2pula1 101 SDTEMAVTVMEDLSHLK 117 (392)
T ss_dssp EETTTTEEEECCCTTSE
T ss_pred EcCCCCEEEEeccCCcc
Confidence 45666789999997754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.00 E-value=0.0028 Score=57.55 Aligned_cols=134 Identities=16% Similarity=0.108 Sum_probs=74.4
Q ss_pred eEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCC-----CCccce--EEEEEeCCeEEEEEe
Q 013519 113 GRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSH-----PNLVKL--IGYCWEDRQFLLVYE 185 (441)
Q Consensus 113 g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-----pniv~~--~~~~~~~~~~~lv~e 185 (441)
-.||++... .|..|++|+..+... ...++..|...|..|.. +..+.. -..+......+.|++
T Consensus 36 N~vy~v~~~----------dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~ 104 (325)
T d1zyla1 36 NRVYQFQDE----------DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 104 (325)
T ss_dssp SEEEEECCT----------TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred ceeEEEEcC----------CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence 479987433 477899999876422 23556778888877642 211211 122345677899999
Q ss_pred ecCCCCHH-----H------HH---Hhc----C--CCCCCCH----------------------HHHHHHHHHHHHHHhh
Q 013519 186 YMQKGSLE-----N------HL---FRK----G--SAEPLPW----------------------NTRLKIAIDAAKDLTF 223 (441)
Q Consensus 186 ~~~~g~L~-----~------~l---~~~----~--~~~~l~~----------------------~~~~~i~~~i~~~l~~ 223 (441)
++.|..+. . .+ ... . ....+.. ......+..+...+.-
T Consensus 105 ~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 184 (325)
T d1zyla1 105 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 184 (325)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99764321 1 01 110 0 0011111 1112223333333322
Q ss_pred h--ccCCCCeeecCCCCCcEEEcCCCceEEecccCCCC
Q 013519 224 L--HSSEKSVIYRDFKASNILLDGSYNAKLSDFGLAKL 259 (441)
Q Consensus 224 l--H~~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~~ 259 (441)
+ .....++||+|+.|.|||++++ ..++||+-++.
T Consensus 185 ~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 185 HWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred hccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 2 1124678999999999999743 45899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.83 E-value=0.0013 Score=61.67 Aligned_cols=80 Identities=16% Similarity=0.058 Sum_probs=50.7
Q ss_pred ceecccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCCCCCc-cceEEEEEeCCeEEEE
Q 013519 105 TMLGEGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFSHPNL-VKLIGYCWEDRQFLLV 183 (441)
Q Consensus 105 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv 183 (441)
+.|+.|--=.+|++....... ......+.|++++...... .....+|..+++.+.-.++ .++++++. + .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred EEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCcch--hhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceE
Confidence 568778888999987654321 1122356677877653322 2345679999998863344 46666553 2 789
Q ss_pred EeecCCCCH
Q 013519 184 YEYMQKGSL 192 (441)
Q Consensus 184 ~e~~~~g~L 192 (441)
+||++|..|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.79 E-value=0.0037 Score=56.29 Aligned_cols=157 Identities=11% Similarity=0.018 Sum_probs=83.0
Q ss_pred cCHHHHHHHhcCCCCCceec-----ccCceEEEEEEecCCccccccccCCcEEEEEEcCCCchHHHHHHHHHHHHHhcCC
Q 013519 89 FTLQDLRAATKNFRPDTMLG-----EGGFGRVFKGWVDHKTLAPTKVGVGKAVAVKKSNPDSIQGLREWQAEVKFLGKFS 163 (441)
Q Consensus 89 ~~~~~~~~~~~~y~~~~~lG-----~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~ 163 (441)
.+.+++.....+|.+.++.. .|---+.|+.... +..+++|+..... ....+..|+.+|..|.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-----------~g~yVLri~~~~~--~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-----------KDPLILTLYEKRV--EKNDLPFFLGLMQHLA 69 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-----------SCCEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-----------CCcEEEEEcCCCC--CHHHHHHHHHHHHhhh
Confidence 45677888888898865543 4444677886433 2358999876532 1234455777777664
Q ss_pred -----CCCccceE---EEEEeCCeEEEEEeecCCCCHHH--------------HHHhcCC----C--CC-----------
Q 013519 164 -----HPNLVKLI---GYCWEDRQFLLVYEYMQKGSLEN--------------HLFRKGS----A--EP----------- 204 (441)
Q Consensus 164 -----hpniv~~~---~~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~----~--~~----------- 204 (441)
.|..+... .+..-......++.++.+..... .+..... . ..
T Consensus 70 ~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (316)
T d2ppqa1 70 AKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWD 149 (316)
T ss_dssp HTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHH
T ss_pred hccccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhh
Confidence 23222221 11223455667777766543210 0000000 0 00
Q ss_pred -------CCHHHHHHHHHHHHHHHhhhcc--CCCCeeecCCCCCcEEEcCCCceEEecccCCC
Q 013519 205 -------LPWNTRLKIAIDAAKDLTFLHS--SEKSVIYRDFKASNILLDGSYNAKLSDFGLAK 258 (441)
Q Consensus 205 -------l~~~~~~~i~~~i~~~l~~lH~--~~~~ivHrDlkp~Nill~~~~~~kl~DFGla~ 258 (441)
.........+..+...+.-.+. ...|+||+|+.+.||+++.+...-|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 150 KSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0001111222222222222221 24789999999999999988777899999885
|